Citrus Sinensis ID: 046121
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 315 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.907 | 0.397 | 0.452 | 5e-69 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.907 | 0.402 | 0.448 | 5e-68 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.914 | 0.401 | 0.438 | 1e-67 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.898 | 0.394 | 0.415 | 1e-66 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.895 | 0.414 | 0.434 | 4e-66 | |
| O65530 | 731 | Proline-rich receptor-lik | no | no | 0.901 | 0.388 | 0.450 | 8e-66 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.888 | 0.550 | 0.419 | 4e-64 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.898 | 0.551 | 0.429 | 1e-63 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.898 | 0.434 | 0.418 | 1e-63 | |
| Q9LS95 | 700 | Putative proline-rich rec | no | no | 0.895 | 0.402 | 0.439 | 2e-62 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 261 bits (667), Expect = 5e-69, Method: Compositional matrix adjust.
Identities = 132/292 (45%), Positives = 196/292 (67%), Gaps = 6/292 (2%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
FS+ E+ + T F+++N+LGEGGFG VYKG L+DG+++A K K S QG EF++EV +
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
++ H+++V L+G+C + +L+YEY+ N++L HL VLEW +R AIG+AK
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAK 478
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK-TTDDPVQTKILGTLGY 191
GL +LHE+C IIHRD++ +NILL ++ + DFGLAR TT V T+++GT GY
Sbjct: 479 GLAYLHEDCHPK-IIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGY 537
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL----IEKL 247
LAPEYA +G ++ R+DV++FG++LL+L++GRK VD ++SL +WA PL IE
Sbjct: 538 LAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETG 597
Query: 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299
L ELID R+E Y +E++ M +TA CV+ + RP M +VVR L+ + D
Sbjct: 598 DLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGD 649
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (658), Expect = 5e-68, Method: Compositional matrix adjust.
Identities = 131/292 (44%), Positives = 194/292 (66%), Gaps = 6/292 (2%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
F++ E+ T FSK N+LGEGGFG VYKG+L DG+++A K K S QG EF++EV +
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
++ H+++V L+G+C ++ +L+YEY+ N++L HL VLEW +R AIG+AK
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAK 460
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK-TTDDPVQTKILGTLGY 191
GL +LHE+C IIHRD++ +NILL +F + DFGLA+ +T V T+++GT GY
Sbjct: 461 GLAYLHEDCH-PKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGY 519
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL----IEKL 247
LAPEYA++G ++ R+DV++FG++LL+L++GRK VD ++SL +WA PL IE
Sbjct: 520 LAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETG 579
Query: 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299
EL+D R+E Y E++ M +TA CV+ + RP M +VVR L+ E D
Sbjct: 580 DFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGD 631
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 256 bits (655), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 129/294 (43%), Positives = 192/294 (65%), Gaps = 6/294 (2%)
Query: 11 MKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEV 70
+ F++ E+ Q T F K ++GEGGFG VYKG L +G+ +A K K S +G+ EF++EV
Sbjct: 356 IHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEV 415
Query: 71 YVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGT 130
+++ H+++V L+G+C E L+YE++ N +L +HL VLEW +R AIG
Sbjct: 416 EIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRRVRIAIGA 475
Query: 131 AKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK-TTDDPVQTKILGTL 189
AKGL +LHE+C IIHRD++ SNILL +F + DFGLAR T + T+++GT
Sbjct: 476 AKGLAYLHEDCH-PKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRVMGTF 534
Query: 190 GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP----LIE 245
GYLAPEYA +G ++ R+DV++FG++LL+L++GRK VD + ++SL +WA P IE
Sbjct: 535 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIE 594
Query: 246 KLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299
K + E++DPR+EN Y E+Y M +TA CV+ + RP M +VVR L+ +D
Sbjct: 595 KGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDTRDD 648
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 253 bits (647), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 120/289 (41%), Positives = 189/289 (65%), Gaps = 6/289 (2%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
F++ E+ +AT FS+ NLLG+GGFG+V+KG L++G+ +A K KE S+QG EFQ+EV +
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
++ H+++V L+G+C + +LVYE++ N +L +HL +EW R A+G+AK
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVGSAK 461
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT-TDDPVQTKILGTLGY 191
GL +LHE C IIHRD++ SNIL+ F + DFGLA+ + T+ V T+++GT GY
Sbjct: 462 GLSYLHENCN-PKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGY 520
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA--- 248
LAPEYA +G ++ ++DV++FG++LL+L++GR+ +D+N SL WA PL+ +++
Sbjct: 521 LAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSELG 580
Query: 249 -LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296
++D ++ N YD E+ M A CV+ RP M +V R+LEG
Sbjct: 581 NFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEG 629
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (642), Expect = 4e-66, Method: Compositional matrix adjust.
Identities = 126/290 (43%), Positives = 186/290 (64%), Gaps = 8/290 (2%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
FS+ E+ Q T FS++NLLGEGGFG VYKG L DG+ +A K K +QG EF++EV +
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
++ H+++V L+G+C E +LVY+Y+ N +LH+HL V+ W R A G A+
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAAR 446
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD---PVQTKILGTL 189
G+ +LHE+C IIHRD++ SNILL + F ++ DFGLA+ D V T+++GT
Sbjct: 447 GIAYLHEDCHPR-IIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTF 505
Query: 190 GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL----IE 245
GY+APEYA +G +S + DVY++G+ILL+L++GRK VD + +SL +WA PL IE
Sbjct: 506 GYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIE 565
Query: 246 KLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
EL+DPR+ ++ E++ M + A CV+ + RP M +VVR L+
Sbjct: 566 NEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALD 615
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65530|PEK14_ARATH Proline-rich receptor-like protein kinase PERK14 OS=Arabidopsis thaliana GN=PERK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 250 bits (639), Expect = 8e-66, Method: Compositional matrix adjust.
Identities = 132/293 (45%), Positives = 192/293 (65%), Gaps = 9/293 (3%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
FS+ E+ +ATG FS+ENLLGEGGFG+V+KG LK+G +A K K S QG EFQ+EV
Sbjct: 377 FSYEELSKATGGFSEENLLGEGGFGYVHKGVLKNGTEVAVKQLKIGSYQGEREFQAEVDT 436
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
++ HK++V L+G+C + +LVYE++ +L +HL +N SVLEW R A+G AK
Sbjct: 437 ISRVHHKHLVSLVGYCVNGDKRLLVYEFVPKDTLEFHLHENRGSVLEWEMRLRIAVGAAK 496
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP----VQTKILGT 188
GL +LHE+C IIHRD++ +NILL F + DFGLA++ + + + T+++GT
Sbjct: 497 GLAYLHEDCSPT-IIHRDIKAANILLDSKFEAKVSDFGLAKFFSDTNSSFTHISTRVVGT 555
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248
GY+APEYA +G V+ ++DVY+FG++LL+L++GR + QSL WA PL+ K
Sbjct: 556 FGYMAPEYASSGKVTDKSDVYSFGVVLLELITGRPSIFAKDSSTNQSLVDWARPLLTKAI 615
Query: 249 LHE----LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297
E L+D R+E +YDT ++ MA A C++++ RP M +VVR LEGE
Sbjct: 616 SGESFDFLVDSRLEKNYDTTQMANMAACAAACIRQSAWLRPRMSQVVRALEGE 668
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 244 bits (624), Expect = 4e-64, Method: Compositional matrix adjust.
Identities = 123/293 (41%), Positives = 191/293 (65%), Gaps = 13/293 (4%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
F++ ++ +AT +FS NLLG+GGFG+V++G L DG ++A K K S QG EFQ+E+
Sbjct: 131 FTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAEIQT 190
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
++ H+++V LLG+C +LVYE++ NK+L +HL + V+EW +R A+G AK
Sbjct: 191 ISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALGAAK 250
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK-TTDDPVQTKILGTLGY 191
GL +LHE+C IHRD++ +NIL+ + L DFGLAR TD V T+I+GT GY
Sbjct: 251 GLAYLHEDCN-PKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTFGY 309
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEP---QQSLRQWAEPLIEKLA 248
LAPEYA +G ++ ++DV++ G++LL+L++GR+ VD + +P S+ WA+PL+ + A
Sbjct: 310 LAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKS--QPFADDDSIVDWAKPLMIQ-A 366
Query: 249 LHE-----LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296
L++ L+DPR+EN +D E+ M A V+ + + RP M ++VR EG
Sbjct: 367 LNDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEG 419
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 243 bits (621), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 124/289 (42%), Positives = 179/289 (61%), Gaps = 6/289 (2%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
F++ E+ +AT FS+ NLLGEGGFG VYKG L +G +A K K S QG EFQ+EV +
Sbjct: 171 FTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNI 230
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
++ H+N+V L+G+C +LVYE++ N +L +HL +EW R A+ ++K
Sbjct: 231 ISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSLRLKIAVSSSK 290
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK-TTDDPVQTKILGTLGY 191
GL +LHE C IIHRD++ +NIL+ F + DFGLA+ T+ V T+++GT GY
Sbjct: 291 GLSYLHENCNPK-IIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGTFGY 349
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL----IEKL 247
LAPEYA +G ++ ++DVY+FG++LL+L++GR+ VD N SL WA PL +E+
Sbjct: 350 LAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALEES 409
Query: 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296
L D ++ N YD E+ M A CV+ RP M +VVR+LEG
Sbjct: 410 NFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEG 458
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (621), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 121/289 (41%), Positives = 183/289 (63%), Gaps = 6/289 (2%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
F++ E+ +AT FS+ NLLG+GGFG+V+KG L G+ +A K K S QG EFQ+EV +
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
++ H+++V L+G+C +LVYE++ N +L +HL +EW R A+G+AK
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAK 387
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT-TDDPVQTKILGTLGY 191
GL +LHE+C IIHRD++ SNIL+ F + DFGLA+ + T+ V T+++GT GY
Sbjct: 388 GLSYLHEDCN-PKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGY 446
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA--- 248
LAPEYA +G ++ ++DV++FG++LL+L++GR+ VD N SL WA PL+ + +
Sbjct: 447 LAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEEG 506
Query: 249 -LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296
L D ++ N YD E+ M A CV+ + RP M ++VR LEG
Sbjct: 507 DFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEG 555
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 239 bits (609), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 128/291 (43%), Positives = 188/291 (64%), Gaps = 9/291 (3%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
F++ E+ AT FS+ LLG+GGFG+V+KG L +G+ IA K K S QG EFQ+EV +
Sbjct: 325 FTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVDI 384
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
++ H+ +V L+G+C +LVYE++ N +L +HL + VL+W R A+G+AK
Sbjct: 385 ISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLKIALGSAK 444
Query: 133 GLRFLHEECRGGP-IIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD-DPVQTKILGTLG 190
GL +LHE+C P IIHRD++ SNILL F + DFGLA+ + V T+I+GT G
Sbjct: 445 GLAYLHEDCH--PRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMGTFG 502
Query: 191 YLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA-- 248
YLAPEYA +G ++ R+DV++FG++LL+L++GR+ VD+ GE + SL WA P+ A
Sbjct: 503 YLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEM-EDSLVDWARPICLNAAQD 561
Query: 249 --LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297
EL+DPR+EN Y+ +E+ M A V+ + RP M ++VR LEG+
Sbjct: 562 GDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGD 612
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 315 | ||||||
| 359492770 | 698 | PREDICTED: LRR receptor-like serine/thre | 0.996 | 0.449 | 0.819 | 1e-156 | |
| 302142725 | 595 | unnamed protein product [Vitis vinifera] | 0.996 | 0.527 | 0.819 | 1e-156 | |
| 255558472 | 552 | Serine/threonine-protein kinase PBS1, pu | 0.961 | 0.548 | 0.835 | 1e-149 | |
| 449453103 | 541 | PREDICTED: LOW QUALITY PROTEIN: proline- | 0.993 | 0.578 | 0.753 | 1e-144 | |
| 449517074 | 424 | PREDICTED: proline-rich receptor-like pr | 0.993 | 0.738 | 0.753 | 1e-143 | |
| 356518591 | 593 | PREDICTED: proline-rich receptor-like pr | 0.974 | 0.517 | 0.776 | 1e-142 | |
| 222619631 | 637 | hypothetical protein OsJ_04305 [Oryza sa | 0.993 | 0.491 | 0.711 | 1e-132 | |
| 242059443 | 694 | hypothetical protein SORBIDRAFT_03g04178 | 0.977 | 0.443 | 0.718 | 1e-132 | |
| 226507534 | 682 | uncharacterized protein LOC100280200 [Ze | 0.977 | 0.451 | 0.715 | 1e-131 | |
| 219887951 | 692 | unknown [Zea mays] gi|414879392|tpg|DAA5 | 0.977 | 0.445 | 0.715 | 1e-131 |
| >gi|359492770|ref|XP_002279129.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase HSL2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 556 bits (1432), Expect = e-156, Method: Compositional matrix adjust.
Identities = 258/315 (81%), Positives = 286/315 (90%), Gaps = 1/315 (0%)
Query: 1 MKTELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST 60
MKT LY+K+ MKFSFSE+Q AT DFSKENLLGEGG+GHVYKGELKDGQ+IAAKVRKEAS
Sbjct: 384 MKTILYIKESMKFSFSELQLATDDFSKENLLGEGGYGHVYKGELKDGQIIAAKVRKEASM 443
Query: 61 QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEW 120
QGFAEF SEV+VL+FARHKNIVMLLG+CCKEN NILVYEYICNKSL WHLFD T +VLEW
Sbjct: 444 QGFAEFHSEVFVLSFARHKNIVMLLGYCCKENFNILVYEYICNKSLEWHLFDKTATVLEW 503
Query: 121 HQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180
HQR A AIGTAKGLRFLH+ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA+W+T DDP
Sbjct: 504 HQRRAIAIGTAKGLRFLHKECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAKWRTNDDP 563
Query: 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240
V T++LGT GYLAPEYAENG+VS+RTDVYAFG++LLQL+SGRKV+D E QQSLRQWA
Sbjct: 564 VHTRVLGTFGYLAPEYAENGMVSVRTDVYAFGMVLLQLISGRKVIDPTREGHQQSLRQWA 623
Query: 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300
EPLI +LALHELIDPRIE+SYDTYELYLMA+ AYLCVQ +PE RPSMGEV RLLEGEN+
Sbjct: 624 EPLIVRLALHELIDPRIEDSYDTYELYLMARAAYLCVQSSPEMRPSMGEVTRLLEGENEH 683
Query: 301 FHHLGEKFVQRHHTK 315
HHLGE+F+ H+TK
Sbjct: 684 LHHLGEQFIP-HYTK 697
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142725|emb|CBI19928.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 556 bits (1432), Expect = e-156, Method: Compositional matrix adjust.
Identities = 258/315 (81%), Positives = 286/315 (90%), Gaps = 1/315 (0%)
Query: 1 MKTELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST 60
MKT LY+K+ MKFSFSE+Q AT DFSKENLLGEGG+GHVYKGELKDGQ+IAAKVRKEAS
Sbjct: 281 MKTILYIKESMKFSFSELQLATDDFSKENLLGEGGYGHVYKGELKDGQIIAAKVRKEASM 340
Query: 61 QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEW 120
QGFAEF SEV+VL+FARHKNIVMLLG+CCKEN NILVYEYICNKSL WHLFD T +VLEW
Sbjct: 341 QGFAEFHSEVFVLSFARHKNIVMLLGYCCKENFNILVYEYICNKSLEWHLFDKTATVLEW 400
Query: 121 HQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180
HQR A AIGTAKGLRFLH+ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA+W+T DDP
Sbjct: 401 HQRRAIAIGTAKGLRFLHKECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAKWRTNDDP 460
Query: 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240
V T++LGT GYLAPEYAENG+VS+RTDVYAFG++LLQL+SGRKV+D E QQSLRQWA
Sbjct: 461 VHTRVLGTFGYLAPEYAENGMVSVRTDVYAFGMVLLQLISGRKVIDPTREGHQQSLRQWA 520
Query: 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300
EPLI +LALHELIDPRIE+SYDTYELYLMA+ AYLCVQ +PE RPSMGEV RLLEGEN+
Sbjct: 521 EPLIVRLALHELIDPRIEDSYDTYELYLMARAAYLCVQSSPEMRPSMGEVTRLLEGENEH 580
Query: 301 FHHLGEKFVQRHHTK 315
HHLGE+F+ H+TK
Sbjct: 581 LHHLGEQFIP-HYTK 594
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558472|ref|XP_002520261.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223540480|gb|EEF42047.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1372), Expect = e-149, Method: Compositional matrix adjust.
Identities = 254/304 (83%), Positives = 277/304 (91%), Gaps = 1/304 (0%)
Query: 3 TELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQG 62
TELY+KD M+F++SEIQ AT FSKENLLGEGG+GHVYKG LKDGQ+IAAKVRKEASTQG
Sbjct: 241 TELYIKDSMQFTYSEIQLATQQFSKENLLGEGGYGHVYKGVLKDGQLIAAKVRKEASTQG 300
Query: 63 FAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQ 122
F EF SEV VLNFARHKNIVMLLGFCCKE+ NILVYEYICNKSL WHLFDN + L+WHQ
Sbjct: 301 FTEFHSEVSVLNFARHKNIVMLLGFCCKEDRNILVYEYICNKSLDWHLFDNQANTLDWHQ 360
Query: 123 RYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182
RY+ AIGTAKGLRFLHEECRGGPIIHRD+RPSNILLTHDFVPMLGDFGLARWKTTD+ VQ
Sbjct: 361 RYSIAIGTAKGLRFLHEECRGGPIIHRDVRPSNILLTHDFVPMLGDFGLARWKTTDE-VQ 419
Query: 183 TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP 242
T+ILGTLGYLAPEYAENG VS+RTDVYAFGIILLQL+SG+KVVD EE +QSLRQWAEP
Sbjct: 420 TRILGTLGYLAPEYAENGFVSVRTDVYAFGIILLQLISGQKVVDSKREEGRQSLRQWAEP 479
Query: 243 LIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302
+IE+LALHELID RI +SYDTYELYLMAK AYLCVQR+PE RPSMGEV+RLLEGEN+ H
Sbjct: 480 VIERLALHELIDQRIADSYDTYELYLMAKAAYLCVQRSPEMRPSMGEVLRLLEGENNHVH 539
Query: 303 HLGE 306
HL E
Sbjct: 540 HLRE 543
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449453103|ref|XP_004144298.1| PREDICTED: LOW QUALITY PROTEIN: proline-rich receptor-like protein kinase PERK12-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1329), Expect = e-144, Method: Compositional matrix adjust.
Identities = 236/313 (75%), Positives = 275/313 (87%)
Query: 1 MKTELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST 60
M+++L+MK+ M+FSFSEIQQAT DFS NLLGEGG+GHV+KGELKDGQ+IAAKVRKE S+
Sbjct: 228 MRSDLHMKNTMRFSFSEIQQATSDFSAANLLGEGGYGHVFKGELKDGQLIAAKVRKEESS 287
Query: 61 QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEW 120
QGF EF SE+ VL+FARHKNIVMLLG+ CKENLN+LVYEYICN+SL +HLF T +VLE
Sbjct: 288 QGFIEFHSEIQVLSFARHKNIVMLLGYSCKENLNVLVYEYICNRSLDFHLFGKTTTVLEL 347
Query: 121 HQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180
HQRY A+G AKGLRFLHEECRGGP+IHRD+RPSNILLTHDFVPMLGDFGLA+W+T D+
Sbjct: 348 HQRYGIAVGIAKGLRFLHEECRGGPVIHRDVRPSNILLTHDFVPMLGDFGLAKWRTKDET 407
Query: 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240
T+ILGT GY+APEYAENGI+S+RTDVYAFGI+LLQL+SGRKV D + QSLR+WA
Sbjct: 408 SHTRILGTFGYVAPEYAENGILSVRTDVYAFGIVLLQLISGRKVFDAKDDIQGQSLREWA 467
Query: 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300
EPLIE LALHELID R+ +YDTYELYLMA+TAYLCVQ NPE RPSMGEVVRLLEGEND
Sbjct: 468 EPLIENLALHELIDARVAKTYDTYELYLMARTAYLCVQINPENRPSMGEVVRLLEGENDH 527
Query: 301 FHHLGEKFVQRHH 313
+H+LGEK + R++
Sbjct: 528 YHYLGEKLIPRYN 540
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449517074|ref|XP_004165571.1| PREDICTED: proline-rich receptor-like protein kinase PERK12-like, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 514 bits (1324), Expect = e-143, Method: Compositional matrix adjust.
Identities = 236/313 (75%), Positives = 274/313 (87%)
Query: 1 MKTELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST 60
M+++L+MK+ M+FSFSEIQQAT DFS NLLGEGG+GHV+KGELKDGQ+IAAKVRKE S+
Sbjct: 111 MRSDLHMKNTMRFSFSEIQQATSDFSAANLLGEGGYGHVFKGELKDGQLIAAKVRKEESS 170
Query: 61 QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEW 120
QGF EF SE+ VL+FARHKNIVMLLG+ CKENLN+LVYEYICN+SL +HLF T +VLE
Sbjct: 171 QGFIEFHSEIQVLSFARHKNIVMLLGYSCKENLNVLVYEYICNRSLDFHLFGKTTTVLEL 230
Query: 121 HQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180
HQRY A+G AKGLRFLHEECRGGP+IHRD+RPSNILLTHDFVPMLGDFGLA+W+T D+
Sbjct: 231 HQRYGIAVGIAKGLRFLHEECRGGPVIHRDVRPSNILLTHDFVPMLGDFGLAKWRTKDET 290
Query: 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240
T+ILGT GY+APEYAENGI+S+RTDVYAFGI+LLQL+SGRKV D + QSLR+WA
Sbjct: 291 SHTRILGTFGYVAPEYAENGILSVRTDVYAFGIVLLQLISGRKVFDAKDDIQGQSLREWA 350
Query: 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300
EPLIE LALHELID R+ YDTYELYLMA+TAYLCVQ NPE RPSMGEVVRLLEGEND
Sbjct: 351 EPLIENLALHELIDARVAKIYDTYELYLMARTAYLCVQINPENRPSMGEVVRLLEGENDH 410
Query: 301 FHHLGEKFVQRHH 313
+H+LGEK + R++
Sbjct: 411 YHYLGEKLIPRYN 423
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356518591|ref|XP_003527962.1| PREDICTED: proline-rich receptor-like protein kinase PERK14-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 510 bits (1313), Expect = e-142, Method: Compositional matrix adjust.
Identities = 240/309 (77%), Positives = 275/309 (88%), Gaps = 2/309 (0%)
Query: 2 KTELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQ 61
+TEL +K+ MKFS+S+IQ AT DFSK+NLLGEGG+GHVYKG LKDGQ IAAKVRK+ S+Q
Sbjct: 244 RTELSIKESMKFSYSDIQNATNDFSKDNLLGEGGYGHVYKGVLKDGQQIAAKVRKQESSQ 303
Query: 62 GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWH 121
GF+EF SEVYVL+FARHKNIVMLLG+CCKEN NIL+YE+ICNKSLHWHLF+N E+VLEWH
Sbjct: 304 GFSEFHSEVYVLSFARHKNIVMLLGYCCKENKNILIYEFICNKSLHWHLFENNEAVLEWH 363
Query: 122 QRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181
QRYA A+GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA+WKT DD +
Sbjct: 364 QRYAIAVGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAKWKTGDDTL 423
Query: 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEE--PQQSLRQW 239
QT+I+GTLGYLAPEYAE+GIVS+ TDVY++GIILLQL+SGR+V + N E QQSLRQW
Sbjct: 424 QTRIMGTLGYLAPEYAEDGIVSVGTDVYSYGIILLQLISGRQVGNSNNPEQQQQQSLRQW 483
Query: 240 AEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299
AEP+I+ LALHELID + SYDT+ELYLMAK AY CVQR PE RPSMGEVVRLLEGE+
Sbjct: 484 AEPMIKNLALHELIDTHLGESYDTHELYLMAKAAYFCVQRKPEMRPSMGEVVRLLEGESS 543
Query: 300 RFHHLGEKF 308
FH L ++F
Sbjct: 544 HFHSLEDQF 552
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|222619631|gb|EEE55763.1| hypothetical protein OsJ_04305 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 477 bits (1227), Expect = e-132, Method: Compositional matrix adjust.
Identities = 224/315 (71%), Positives = 263/315 (83%), Gaps = 2/315 (0%)
Query: 1 MKTELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST 60
+K+ LY+K+ MKF FSEIQ AT +FS ENLLGEGGFGHVYKG+LKDGQ+IAAKVRKEAS+
Sbjct: 325 LKSVLYIKESMKFPFSEIQAATSEFSNENLLGEGGFGHVYKGQLKDGQVIAAKVRKEASS 384
Query: 61 QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEW 120
QG+ EF SEV VL+FARH+NIVMLLG+CCKE+ NILVYEYICNKSL WHLFD ++LEW
Sbjct: 385 QGYTEFFSEVQVLSFARHRNIVMLLGYCCKESYNILVYEYICNKSLEWHLFDKDANLLEW 444
Query: 121 HQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180
H+R+A A+G AKGLRFLHEECR GPIIHRD+RPSN+LLTHDFVPMLGDFGLA+WK ++
Sbjct: 445 HKRHAIALGIAKGLRFLHEECRAGPIIHRDLRPSNVLLTHDFVPMLGDFGLAKWKASNAS 504
Query: 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240
+ T+ILG GYLAPEYAE GIVS+RTDVYAFGI+L QL+SGRKV+D G + L QWA
Sbjct: 505 IHTRILGQSGYLAPEYAEYGIVSVRTDVYAFGIVLFQLISGRKVLDECGGQCTHIL-QWA 563
Query: 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300
EPL+E LALHELID RI +YDTY LY +A+ AYLCV+ NPE RPSMGEVVRL+E EN+
Sbjct: 564 EPLVESLALHELIDERIAETYDTYGLYHLARAAYLCVRINPEQRPSMGEVVRLIESENEH 623
Query: 301 FHHLGEKFVQRHHTK 315
L +F+ H TK
Sbjct: 624 IRDLSRQFIP-HFTK 637
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|242059443|ref|XP_002458867.1| hypothetical protein SORBIDRAFT_03g041780 [Sorghum bicolor] gi|241930842|gb|EES03987.1| hypothetical protein SORBIDRAFT_03g041780 [Sorghum bicolor] | Back alignment and taxonomy information |
|---|
Score = 476 bits (1226), Expect = e-132, Method: Compositional matrix adjust.
Identities = 222/309 (71%), Positives = 262/309 (84%), Gaps = 1/309 (0%)
Query: 1 MKTELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST 60
+K+ LY+K+ MKF FSEIQ AT DFS ENLLGEGGFGHVYKG+LKDGQ+IAAK+ KEAS+
Sbjct: 382 LKSVLYIKESMKFPFSEIQTATSDFSSENLLGEGGFGHVYKGQLKDGQVIAAKLHKEASS 441
Query: 61 QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEW 120
QG+ EF SEV VL+FARH+NIVMLLG+CCKE+ NILVYEYICN SL WHLFD + +LEW
Sbjct: 442 QGYTEFFSEVQVLSFARHRNIVMLLGYCCKESYNILVYEYICNNSLEWHLFDKSACLLEW 501
Query: 121 HQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180
H+R+A AIG AKGLRFLHEECR GPIIHRD+RPSN+LLTHDFVPMLGDFGLA+WK DD
Sbjct: 502 HKRHAIAIGIAKGLRFLHEECRAGPIIHRDLRPSNVLLTHDFVPMLGDFGLAKWKAGDDN 561
Query: 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240
+QT+ILG GYLAPEYA+ G+VS+RTDVYAFGI+L QL+SGRKV+D +G + L QWA
Sbjct: 562 IQTRILGQTGYLAPEYAQYGMVSVRTDVYAFGIVLFQLISGRKVLDEHGGQCTHIL-QWA 620
Query: 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300
PL+E LALHELID RI+++YDTY LY +AKTAYLCV+ NPE RPSMGEVVRL+E EN+
Sbjct: 621 GPLVESLALHELIDDRIKDTYDTYGLYHLAKTAYLCVRPNPEQRPSMGEVVRLIEIENEH 680
Query: 301 FHHLGEKFV 309
L +F+
Sbjct: 681 IRDLSRQFI 689
|
Source: Sorghum bicolor Species: Sorghum bicolor Genus: Sorghum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|226507534|ref|NP_001146603.1| uncharacterized protein LOC100280200 [Zea mays] gi|219887995|gb|ACL54372.1| unknown [Zea mays] gi|414879391|tpg|DAA56522.1| TPA: putative protein kinase superfamily protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1217), Expect = e-131, Method: Compositional matrix adjust.
Identities = 221/309 (71%), Positives = 259/309 (83%), Gaps = 1/309 (0%)
Query: 1 MKTELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST 60
+K+ LY+K+ MKF FSEIQ AT DFS ENLLGEGGFGHVYKG+LKDGQ+IAAKV KEAS+
Sbjct: 370 LKSVLYIKESMKFPFSEIQTATSDFSSENLLGEGGFGHVYKGQLKDGQVIAAKVHKEASS 429
Query: 61 QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEW 120
QG+ EF SEV VL+FARH+NIVMLLG+CCKE+ NILVYEYICN SL WHLFD + S+LEW
Sbjct: 430 QGYTEFFSEVQVLSFARHRNIVMLLGYCCKESYNILVYEYICNNSLEWHLFDKSASLLEW 489
Query: 121 HQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180
H+RYA AIG AKGLRFLHEECR GPIIHRD+RPSN+LLTHDFVPMLGDFGLA+WK D
Sbjct: 490 HKRYAIAIGIAKGLRFLHEECRAGPIIHRDLRPSNVLLTHDFVPMLGDFGLAKWKAGGDN 549
Query: 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240
+QT+ILG GYLAPEYA+ G+VS+RTDVYAFGI+L QL+SGRKV+D +G + L QWA
Sbjct: 550 IQTRILGQTGYLAPEYAQYGMVSVRTDVYAFGIVLFQLISGRKVLDDHGGQCTHIL-QWA 608
Query: 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300
EPL+E LALHELID RI+++ DTY LY +AK AYLC + NPE RPSMGEVVRL+E E +
Sbjct: 609 EPLVESLALHELIDDRIKDTNDTYGLYHLAKIAYLCARPNPEQRPSMGEVVRLIEIETEH 668
Query: 301 FHHLGEKFV 309
L +F+
Sbjct: 669 IRDLSRQFI 677
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|219887951|gb|ACL54350.1| unknown [Zea mays] gi|414879392|tpg|DAA56523.1| TPA: putative protein kinase superfamily protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1217), Expect = e-131, Method: Compositional matrix adjust.
Identities = 221/309 (71%), Positives = 259/309 (83%), Gaps = 1/309 (0%)
Query: 1 MKTELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST 60
+K+ LY+K+ MKF FSEIQ AT DFS ENLLGEGGFGHVYKG+LKDGQ+IAAKV KEAS+
Sbjct: 380 LKSVLYIKESMKFPFSEIQTATSDFSSENLLGEGGFGHVYKGQLKDGQVIAAKVHKEASS 439
Query: 61 QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEW 120
QG+ EF SEV VL+FARH+NIVMLLG+CCKE+ NILVYEYICN SL WHLFD + S+LEW
Sbjct: 440 QGYTEFFSEVQVLSFARHRNIVMLLGYCCKESYNILVYEYICNNSLEWHLFDKSASLLEW 499
Query: 121 HQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180
H+RYA AIG AKGLRFLHEECR GPIIHRD+RPSN+LLTHDFVPMLGDFGLA+WK D
Sbjct: 500 HKRYAIAIGIAKGLRFLHEECRAGPIIHRDLRPSNVLLTHDFVPMLGDFGLAKWKAGGDN 559
Query: 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240
+QT+ILG GYLAPEYA+ G+VS+RTDVYAFGI+L QL+SGRKV+D +G + L QWA
Sbjct: 560 IQTRILGQTGYLAPEYAQYGMVSVRTDVYAFGIVLFQLISGRKVLDDHGGQCTHIL-QWA 618
Query: 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300
EPL+E LALHELID RI+++ DTY LY +AK AYLC + NPE RPSMGEVVRL+E E +
Sbjct: 619 EPLVESLALHELIDDRIKDTNDTYGLYHLAKIAYLCARPNPEQRPSMGEVVRLIEIETEH 678
Query: 301 FHHLGEKFV 309
L +F+
Sbjct: 679 IRDLSRQFI 687
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 315 | ||||||
| TAIR|locus:2165041 | 669 | AT5G56790 [Arabidopsis thalian | 0.939 | 0.442 | 0.531 | 1.4e-85 | |
| TAIR|locus:2035686 | 676 | AT1G55200 [Arabidopsis thalian | 0.939 | 0.437 | 0.508 | 6.4e-83 | |
| TAIR|locus:2091511 | 753 | AT3G13690 [Arabidopsis thalian | 0.939 | 0.393 | 0.505 | 8.2e-83 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.907 | 0.397 | 0.448 | 2e-65 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.907 | 0.402 | 0.445 | 5.2e-65 | |
| TAIR|locus:2125692 | 731 | PERK14 "proline-rich extensin- | 0.901 | 0.388 | 0.453 | 1.1e-64 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.907 | 0.398 | 0.441 | 4.7e-64 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.895 | 0.414 | 0.434 | 4.8e-62 | |
| TAIR|locus:2010282 | 699 | PERK7 "proline-rich extensin-l | 0.898 | 0.404 | 0.429 | 1.3e-61 | |
| TAIR|locus:2093999 | 700 | PERK6 "proline-rich extensin-l | 0.898 | 0.404 | 0.437 | 4.3e-61 |
| TAIR|locus:2165041 AT5G56790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.4e-85, P = 1.4e-85
Identities = 158/297 (53%), Positives = 217/297 (73%)
Query: 2 KTELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQ 61
K + P F++SE++ AT FSK + L EGGFG V+ G L DGQ+IA K K ASTQ
Sbjct: 367 KAPKFGNPPRWFTYSELETATKGFSKGSFLAEGGFGSVHLGTLPDGQIIAVKQYKIASTQ 426
Query: 62 GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWH 121
G EF SEV VL+ A+H+N+VML+G C ++ +LVYEYICN SLH HL+ L W
Sbjct: 427 GDREFCSEVEVLSCAQHRNVVMLIGLCVEDGKRLLVYEYICNGSLHSHLYGMGREPLGWS 486
Query: 122 QRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP- 180
R A+G A+GLR+LHEECR G I+HRDMRP+NILLTHDF P++GDFGLARW+ D
Sbjct: 487 ARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPEGDKG 546
Query: 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240
V+T+++GT GYLAPEYA++G ++ + DVY+FG++L++L++GRK +D+ + QQ L +WA
Sbjct: 547 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELITGRKAMDIKRPKGQQCLTEWA 606
Query: 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297
PL++K A++EL+DPR+ N Y E+Y MA AYLC++R+P RP M +V+R+LEG+
Sbjct: 607 RPLLQKQAINELLDPRLMNCYCEQEVYCMALCAYLCIRRDPNSRPRMSQVLRMLEGD 663
|
|
| TAIR|locus:2035686 AT1G55200 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 831 (297.6 bits), Expect = 6.4e-83, P = 6.4e-83
Identities = 151/297 (50%), Positives = 215/297 (72%)
Query: 2 KTELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQ 61
K ++ K P FS+ E++ AT FS+ N L EGGFG V++G L +GQ++A K K ASTQ
Sbjct: 356 KAPVFGKPPRFFSYKELELATNGFSRANFLAEGGFGSVHRGVLPEGQIVAVKQHKVASTQ 415
Query: 62 GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWH 121
G EF SEV VL+ A+H+N+VML+GFC ++ +LVYEYICN SL HL+ + L W
Sbjct: 416 GDVEFCSEVEVLSCAQHRNVVMLIGFCIEDTRRLLVYEYICNGSLDSHLYGRHKDTLGWP 475
Query: 122 QRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD-P 180
R A+G A+GLR+LHEECR G I+HRDMRP+NIL+THD+ P++GDFGLARW+ +
Sbjct: 476 ARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDYEPLVGDFGLARWQPDGELG 535
Query: 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240
V T+++GT GYLAPEYA++G ++ + DVY+FG++L++L++GRK +D+ + QQ L +WA
Sbjct: 536 VDTRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLIELITGRKAMDIYRPKGQQCLTEWA 595
Query: 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297
L+E+ A+ EL+DPR+E Y ++ M TA LC++R+P RP M +V+RLLEG+
Sbjct: 596 RSLLEEYAVEELVDPRLEKRYSETQVICMIHTASLCIRRDPHLRPRMSQVLRLLEGD 652
|
|
| TAIR|locus:2091511 AT3G13690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 8.2e-83, P = 8.2e-83
Identities = 150/297 (50%), Positives = 218/297 (73%)
Query: 2 KTELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQ 61
K ++ K P F+++E++ ATG FS+ N L EGG+G V++G L +GQ++A K K AS+Q
Sbjct: 388 KAPVFGKPPRLFTYAELELATGGFSQANFLAEGGYGSVHRGVLPEGQVVAVKQHKLASSQ 447
Query: 62 GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWH 121
G EF SEV VL+ A+H+N+VML+GFC +++ +LVYEYICN SL HL+ + LEW
Sbjct: 448 GDVEFCSEVEVLSCAQHRNVVMLIGFCIEDSRRLLVYEYICNGSLDSHLYGRQKETLEWP 507
Query: 122 QRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP- 180
R A+G A+GLR+LHEECR G I+HRDMRP+NIL+THD P++GDFGLARW+ +
Sbjct: 508 ARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDNEPLVGDFGLARWQPDGEMG 567
Query: 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240
V T+++GT GYLAPEYA++G ++ + DVY+FG++L++L++GRK +D+ + QQ L +WA
Sbjct: 568 VDTRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAIDITRPKGQQCLTEWA 627
Query: 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297
PL+E+ A+ ELIDPR+ N + E+ M A LC++R+P RP M +V+R+LEG+
Sbjct: 628 RPLLEEYAIDELIDPRLGNRFVESEVICMLHAASLCIRRDPHLRPRMSQVLRILEGD 684
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 666 (239.5 bits), Expect = 2.0e-65, P = 2.0e-65
Identities = 131/292 (44%), Positives = 196/292 (67%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
FS+ E+ + T F+++N+LGEGGFG VYKG L+DG+++A K K S QG EF++EV +
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
++ H+++V L+G+C + +L+YEY+ N++L HL VLEW +R AIG+AK
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAK 478
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK-TTDDPVQTKILGTLGY 191
GL +LHE+C IIHRD++ +NILL ++ + DFGLAR TT V T+++GT GY
Sbjct: 479 GLAYLHEDCHP-KIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGY 537
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA--- 248
LAPEYA +G ++ R+DV++FG++LL+L++GRK VD ++SL +WA PL+ K
Sbjct: 538 LAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETG 597
Query: 249 -LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299
L ELID R+E Y +E++ M +TA CV+ + RP M +VVR L+ + D
Sbjct: 598 DLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGD 649
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 662 (238.1 bits), Expect = 5.2e-65, P = 5.2e-65
Identities = 130/292 (44%), Positives = 194/292 (66%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
F++ E+ T FSK N+LGEGGFG VYKG+L DG+++A K K S QG EF++EV +
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
++ H+++V L+G+C ++ +L+YEY+ N++L HL VLEW +R AIG+AK
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAK 460
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK-TTDDPVQTKILGTLGY 191
GL +LHE+C IIHRD++ +NILL +F + DFGLA+ +T V T+++GT GY
Sbjct: 461 GLAYLHEDCHP-KIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGY 519
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA--- 248
LAPEYA++G ++ R+DV++FG++LL+L++GRK VD ++SL +WA PL+ K
Sbjct: 520 LAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETG 579
Query: 249 -LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299
EL+D R+E Y E++ M +TA CV+ + RP M +VVR L+ E D
Sbjct: 580 DFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGD 631
|
|
| TAIR|locus:2125692 PERK14 "proline-rich extensin-like receptor kinase 14" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 659 (237.0 bits), Expect = 1.1e-64, P = 1.1e-64
Identities = 133/293 (45%), Positives = 192/293 (65%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
FS+ E+ +ATG FS+ENLLGEGGFG+V+KG LK+G +A K K S QG EFQ+EV
Sbjct: 377 FSYEELSKATGGFSEENLLGEGGFGYVHKGVLKNGTEVAVKQLKIGSYQGEREFQAEVDT 436
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
++ HK++V L+G+C + +LVYE++ +L +HL +N SVLEW R A+G AK
Sbjct: 437 ISRVHHKHLVSLVGYCVNGDKRLLVYEFVPKDTLEFHLHENRGSVLEWEMRLRIAVGAAK 496
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW-KTTDDP---VQTKILGT 188
GL +LHE+C IIHRD++ +NILL F + DFGLA++ T+ + T+++GT
Sbjct: 497 GLAYLHEDC-SPTIIHRDIKAANILLDSKFEAKVSDFGLAKFFSDTNSSFTHISTRVVGT 555
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248
GY+APEYA +G V+ ++DVY+FG++LL+L++GR + QSL WA PL+ K
Sbjct: 556 FGYMAPEYASSGKVTDKSDVYSFGVVLLELITGRPSIFAKDSSTNQSLVDWARPLLTKAI 615
Query: 249 LHE----LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297
E L+D R+E +YDT ++ MA A C++++ RP M +VVR LEGE
Sbjct: 616 SGESFDFLVDSRLEKNYDTTQMANMAACAAACIRQSAWLRPRMSQVVRALEGE 668
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 4.7e-64, P = 4.7e-64
Identities = 129/292 (44%), Positives = 191/292 (65%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
F++ E+ Q T F K ++GEGGFG VYKG L +G+ +A K K S +G+ EF++EV +
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
++ H+++V L+G+C E L+YE++ N +L +HL VLEW +R AIG AK
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRRVRIAIGAAK 477
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK-TTDDPVQTKILGTLGY 191
GL +LHE+C IIHRD++ SNILL +F + DFGLAR T + T+++GT GY
Sbjct: 478 GLAYLHEDCHP-KIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRVMGTFGY 536
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP----LIEKL 247
LAPEYA +G ++ R+DV++FG++LL+L++GRK VD + ++SL +WA P IEK
Sbjct: 537 LAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIEKG 596
Query: 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299
+ E++DPR+EN Y E+Y M +TA CV+ + RP M +VVR L+ +D
Sbjct: 597 DISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDTRDD 648
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 634 (228.2 bits), Expect = 4.8e-62, P = 4.8e-62
Identities = 126/290 (43%), Positives = 186/290 (64%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
FS+ E+ Q T FS++NLLGEGGFG VYKG L DG+ +A K K +QG EF++EV +
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
++ H+++V L+G+C E +LVY+Y+ N +LH+HL V+ W R A G A+
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAAR 446
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD---PVQTKILGTL 189
G+ +LHE+C IIHRD++ SNILL + F ++ DFGLA+ D V T+++GT
Sbjct: 447 GIAYLHEDCHPR-IIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTF 505
Query: 190 GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL----IE 245
GY+APEYA +G +S + DVY++G+ILL+L++GRK VD + +SL +WA PL IE
Sbjct: 506 GYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIE 565
Query: 246 KLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
EL+DPR+ ++ E++ M + A CV+ + RP M +VVR L+
Sbjct: 566 NEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALD 615
|
|
| TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 630 (226.8 bits), Expect = 1.3e-61, P = 1.3e-61
Identities = 125/291 (42%), Positives = 194/291 (66%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
F++ E+ AT FSK+ LLG+GGFG+V+KG L +G+ IA K K S QG EFQ+EV +
Sbjct: 324 FTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVEI 383
Query: 73 LNFARHKNIVMLLGFCCKEN-LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTA 131
++ H+++V L+G+C +LVYE++ N +L +HL + +V++W R A+G+A
Sbjct: 384 ISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGKSGTVMDWPTRLKIALGSA 443
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP-VQTKILGTLG 190
KGL +LHE+C IIHRD++ SNILL H+F + DFGLA+ ++ V T+++GT G
Sbjct: 444 KGLAYLHEDCHP-KIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTHVSTRVMGTFG 502
Query: 191 YLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250
YLAPEYA +G ++ ++DV++FG++LL+L++GR VD++G+ + SL WA PL ++A
Sbjct: 503 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDM-EDSLVDWARPLCMRVAQD 561
Query: 251 ----ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297
EL+DP +E+ Y+ YE+ M A V+ + RP M ++VR LEG+
Sbjct: 562 GEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQIVRTLEGD 612
|
|
| TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 625 (225.1 bits), Expect = 4.3e-61, P = 4.3e-61
Identities = 127/290 (43%), Positives = 187/290 (64%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
F++ E+ AT FS+ LLG+GGFG+V+KG L +G+ IA K K S QG EFQ+EV +
Sbjct: 325 FTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVDI 384
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
++ H+ +V L+G+C +LVYE++ N +L +HL + VL+W R A+G+AK
Sbjct: 385 ISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLKIALGSAK 444
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD-DPVQTKILGTLGY 191
GL +LHE+C IIHRD++ SNILL F + DFGLA+ + V T+I+GT GY
Sbjct: 445 GLAYLHEDCHPR-IIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMGTFGY 503
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA--- 248
LAPEYA +G ++ R+DV++FG++LL+L++GR+ VD+ GE + SL WA P+ A
Sbjct: 504 LAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEM-EDSLVDWARPICLNAAQDG 562
Query: 249 -LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297
EL+DPR+EN Y+ +E+ M A V+ + RP M ++VR LEG+
Sbjct: 563 DYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGD 612
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00014346001 | SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (315 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | GSVIVG00019217001 | SubName- Full=Chromosome chr7 scaffold_20, whole genome shotgun sequence; (355 aa) | • | 0.439 | |||||||
 | GSVIVG00035471001 | SubName- Full=Chromosome chr12 scaffold_78, whole genome shotgun sequence; (356 aa) | • | 0.425 | |||||||
 | GSVIVG00013590001 | SubName- Full=Chromosome chr2 scaffold_508, whole genome shotgun sequence; (340 aa) | • | 0.402 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 315 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-41 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-40 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-15 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-10 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.002 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 5e-41
Identities = 71/269 (26%), Positives = 119/269 (44%), Gaps = 28/269 (10%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAAKV--RKEASTQGFAEFQSEVYVLNFARHKNIVMLLGF 87
LG G FG VYK G+++A K+ ++ ++ + E+ +L H NIV L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 88 CCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPII 147
++ LV EY L +L L + A+ +GL +LH II
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHSN----GII 120
Query: 148 HRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE-YAENGIVSIRT 206
HRD++P NILL + V + DFGLA+ T +GT Y+APE +
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180
Query: 207 DVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYEL 266
DV++ G+IL +L++G+ E ++++L L I +D +
Sbjct: 181 DVWSLGVILYELLTGK-------------PPFSGENILDQLQLIRRI-LGPPLEFDEPKW 226
Query: 267 YLMAKTAYL----CVQRNPEGRPSMGEVV 291
++ A C+ ++P RP+ E++
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 9e-41
Identities = 73/201 (36%), Positives = 103/201 (51%), Gaps = 9/201 (4%)
Query: 31 LGEGGFGHVYKGE-LKDGQMIAAKV-RKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFC 88
LGEGGFG VY K G+ +A K+ +KE S+ E E+ +L H NIV L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 89 CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIH 148
EN LV EY SL L +N E L + + +GL +LH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN-EGKLSEDEILRILLQILEGLEYLHSN----GIIH 115
Query: 149 RDMRPSNILLTHD-FVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRT 206
RD++P NILL D L DFGL++ T+D + I+GT Y+APE G S ++
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 207 DVYAFGIILLQLMSGRKVVDM 227
D+++ G+IL +L + ++
Sbjct: 176 DIWSLGVILYELPELKDLIRK 196
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-40
Identities = 86/283 (30%), Positives = 130/283 (45%), Gaps = 40/283 (14%)
Query: 26 SKENLLGEGGFGHVYKGELKDG-----QMIAAKV-RKEASTQGFAEFQSEVYVLNFARHK 79
+ LGEG FG VYKG LK +A K +++AS Q EF E ++ H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
NIV LLG C +E ++V EY+ L +L N L + A+ A+G+ +L
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY--LAPEYA 197
+ IHRD+ N L+ + V + DFGL+R DD G L +APE
Sbjct: 122 K----NFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 198 ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID--- 254
+ G + ++DV++FG++L ++ + GEEP + E + E +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT-------LGEEPYPGM-----SNAE---VLEYLKKGY 221
Query: 255 --PRIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLL 294
P+ N ELY LM + C +PE RP+ E+V +L
Sbjct: 222 RLPKPPNCPP--ELYKLMLQ----CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 7e-40
Identities = 89/290 (30%), Positives = 133/290 (45%), Gaps = 51/290 (17%)
Query: 29 NLLGEGGFGHVYKGELKDGQMIAAKV-----RKEASTQGFAEFQSEVYVLNFARHKNIVM 83
LGEG FG VYKG+LK +V +++AS + +F E V+ H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHL-------FDNTESVLEWHQRYAAAIGTAKGLRF 136
LLG C +E LV EY+ L +L +S L + AI AKG+ +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL--GYLAP 194
L + +HRD+ N L+ D V + DFGL+R DD + K G L ++AP
Sbjct: 121 LASK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 195 EYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254
E ++GI + ++DV++FG++L ++ + G P L E+++
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT-------LGATPYPGLS-----------NEEVLE 218
Query: 255 --------PRIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
P+ E D ELY LM C Q +PE RP+ E+V LE
Sbjct: 219 YLRKGYRLPKPEYCPD--ELYELMLS----CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-39
Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 25 FSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKNIV 82
+ LGEG FG VY + K G+++A K ++K+ + E+ +L +H NIV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDN---TESVLEWHQRYAAAIGTAKGLRFLHE 139
L E+ LV EY L L +E + Y I L +LH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA---RFYLRQI--LSALEYLHS 115
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN 199
+ I+HRD++P NILL D L DFGLAR + T +GT Y+APE
Sbjct: 116 KG----IVHRDLKPENILLDEDGHVKLADFGLAR-QLDPGEKLTTFVGTPEYMAPEVLLG 170
Query: 200 GIVSIRTDVYAFGIILLQLMSGR 222
D+++ G+IL +L++G+
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 1e-38
Identities = 87/280 (31%), Positives = 131/280 (46%), Gaps = 35/280 (12%)
Query: 26 SKENLLGEGGFGHVYKGELKD-----GQMIAAKV-RKEASTQGFAEFQSEVYVLNFARHK 79
+ LGEG FG VYKG+LK +A K +++AS Q EF E ++ H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
N+V LLG C +E +V EY+ L +L N L + A+ A+G+ +L
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFALQIARGMEYLES 120
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY--LAPEYA 197
+ IHRD+ N L+ + V + DFGL+R DD K G L +APE
Sbjct: 121 K----NFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 198 ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEP--QQSLRQWAEPLIEKLALHELIDP 255
+ G + ++DV++FG++L ++ + GE+P S + E L L P
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFT-------LGEQPYPGMSNEEVLEYLKNGYRL-----P 223
Query: 256 RIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLL 294
+ N ELY LM + C +PE RP+ E+V +L
Sbjct: 224 QPPNCPP--ELYDLMLQ----CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 5e-38
Identities = 84/281 (29%), Positives = 129/281 (45%), Gaps = 46/281 (16%)
Query: 31 LGEGGFGHVYKGELKD-----GQMIAAKVRKE-ASTQGFAEFQSEVYVLNFARHKNIVML 84
LGEG FG VYKG LK +A K KE AS + EF E ++ H NIV L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 85 LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGG 144
LG C + +V EY+ L L + E L A+ AKG+ +L +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLESK---- 121
Query: 145 PIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLG---YLAPEYAENGI 201
+HRD+ N L+T + V + DFGL+R +D K G ++APE ++G
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSR-DIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 202 VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261
+ ++DV++FG++L ++ + GE+P ++ E+++ +E+ Y
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL-------GEQPYPG-----------MSNEEVLE-LLEDGY 221
Query: 262 -------DTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLL 294
ELY LM + C +PE RP+ E+V L
Sbjct: 222 RLPRPENCPDELYELMLQ----CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-31
Identities = 74/289 (25%), Positives = 126/289 (43%), Gaps = 50/289 (17%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAK-VR-KEASTQGFAEFQSEVYVLNFARHKN 80
++++ LLG G FG VY KD G+++A K V S + + E+ +L+ +H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 81 IVMLLGFCCKE---NLNILVYEYICNKSLHWHLFDN----TESVLEWHQRYAAAIGTAKG 133
IV G E LNI + EY+ SL L E V+ ++Y I +G
Sbjct: 61 IVRYYGSERDEEKNTLNIFL-EYVSGGSL-SSLLKKFGKLPEPVI---RKYTRQI--LEG 113
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD--PVQTKILGTLGY 191
L +LH I+HRD++ +NIL+ D V L DFG A+ + + GT +
Sbjct: 114 LAYLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE-----PLIEK 246
+APE D+++ G ++++ +G+ W+E + K
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP--------------WSELGNPMAALYK 215
Query: 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ E+ + + +L C++R+P+ RP+ E LL+
Sbjct: 216 IGSSGEPPEIPEHLSEEAKDFLR-----KCLRRDPKKRPTADE---LLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-30
Identities = 74/282 (26%), Positives = 113/282 (40%), Gaps = 57/282 (20%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
F +G+GGFG VYK + G+ +A KV K S + + +E+ +L +H NIV
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 83 MLLG-FCCKENLNILVYEYICNKSL------HWHLFDNTESVLEWHQRYAAAI--GTAKG 133
G + K+ L I V E+ SL ++ A + KG
Sbjct: 61 KYYGSYLKKDELWI-VMEFCSGGSLKDLLKSTNQTLTESQ---------IAYVCKELLKG 110
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLA 193
L +LH IIHRD++ +NILLT D L DFGL+ + T ++GT ++A
Sbjct: 111 LEYLHSN----GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT-MVGTPYWMA 165
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMSGR---------KVVDMNGEEPQQSLRQWAEPLI 244
PE + D+++ GI ++L G+ K + LR
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR------- 218
Query: 245 EKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS 286
+ E K C+Q+NPE RP+
Sbjct: 219 -------------NPEKWSDEFKDFLK---KCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 3e-27
Identities = 77/287 (26%), Positives = 120/287 (41%), Gaps = 33/287 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKV--RKEASTQGFAE-FQSEVYVL-NFARHK 79
+ LGEG FG VY +D +++A KV +K S E F E+ +L +
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDN-TESVLEWHQRYAAAIGTAKGLRFLH 138
NIV L F E LV EY+ SL L + L + L +LH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 139 EECRGGPIIHRDMRPSNILLTHD-FVPMLGDFGLARW------KTTDDPVQTKILGTLGY 191
+ IIHRD++P NILL D V L DFGLA+ ++ + + +GT GY
Sbjct: 119 SKG----IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 192 LAPEYAE---NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248
+APE S +D+++ GI L +L++G P + + +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP--------PFEGEKNSSATSQTLKI 226
Query: 249 LHELIDPRIENSYDTYELYLMAKTAY----LCVQRNPEGRPSMGEVV 291
+ EL P + + L++K A + ++P+ R S +
Sbjct: 227 ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 83/274 (30%), Positives = 126/274 (45%), Gaps = 23/274 (8%)
Query: 27 KENLLGEGGFGHVYKGELKDGQM--IAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVML 84
+EN++ G G YKG+ M + ++ S SE+ + +H NIV L
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKL 748
Query: 85 LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGG 144
+G C E L++EYI K+L L L W +R AIG AK LRFLH CR
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAKALRFLH--CRCS 801
Query: 145 P-IIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVS 203
P ++ ++ P I++ P L L TD TK + Y+APE E ++
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTD----TKCFISSAYVAPETRETKDIT 856
Query: 204 IRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN--SY 261
++D+Y FG+IL++L++G+ D S+ +WA L IDP I S
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAE-FGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915
Query: 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ E+ + A C +P RP +V++ LE
Sbjct: 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIAAK--VRKEASTQGFAEFQSEVYVLNFARHKN 80
++ +L+G G FG VYKG L+ G +A K ++ + E+ +L +H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 81 IVMLLGFC-CKENLNILVYEYICNKSL-----HWHLFDNTESVLEWHQRYAAAIGTAKGL 134
IV +G ++L I + EY N SL + F + + +Q +GL
Sbjct: 61 IVKYIGSIETSDSLYI-ILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------VLQGL 112
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAP 194
+LHE+ +IHRD++ +NIL T D V L DFG+A ++GT ++AP
Sbjct: 113 AYLHEQ----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAP 168
Query: 195 EYAENGIVSIRTDVYAFGIILLQLMSGR 222
E E S +D+++ G +++L++G
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 71/290 (24%), Positives = 126/290 (43%), Gaps = 55/290 (18%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIAAKV----------RKEASTQGFAEFQSEVYV 72
+ +G+G FG VY DG++ K R++A +EV +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA--------LNEVKI 52
Query: 73 LNFARHKNIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTES--------VLEWHQR 123
L H NI+ F K L I V EY L + + +L+W
Sbjct: 53 LKKLNHPNIIKYYESFEEKGKLCI-VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF-- 109
Query: 124 YAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183
+ L++LH I+HRD++P NI LT + + LGDFG+++ ++ +
Sbjct: 110 ----VQLCLALKYLHSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK 161
Query: 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL 243
++GT YL+PE +N + ++D+++ G +L +L + + + GE + L
Sbjct: 162 TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE--GENLLE--------L 211
Query: 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293
K+ L P I + Y + EL +Q++PE RPS+ ++++
Sbjct: 212 ALKI-LKGQYPP-IPSQYSS-EL---RNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
+F+ E LG G FG V++G K+ +A K+ K +FQ EV L RHK+++
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L C ++ E + SL L VL A A+G+ +L E+
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV----QTKILGTLGYLAPEYAEN 199
IHRD+ NIL+ D V + DFGLAR + V KI + APE A +
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLAR--LIKEDVYLSSDKKI--PYKWTAPEAASH 178
Query: 200 GIVSIRTDVYAFGIILLQLMS 220
G S ++DV++FGI+L ++ +
Sbjct: 179 GTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 7e-24
Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
+ +G+G FG V G+ + GQ +A K K+ ST A F +E V+ RH N+V
Sbjct: 7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQ 64
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
LLG + N +V EY+ SL +L +V+ Q+ A+ +G+ +L E+
Sbjct: 65 LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK--- 121
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL--GYLAPEYAENGI 201
+HRD+ N+L++ D V + DFGLA+ + Q + G L + APE
Sbjct: 122 -NFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKK 175
Query: 202 VSIRTDVYAFGIILLQLMS-GR 222
S ++DV++FGI+L ++ S GR
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 3e-23
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 32/213 (15%)
Query: 25 FSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAEFQS----EVYVLNFARH 78
+ K LGEG +G VYK + K G+++A K +R + +G S E+ +L +H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGI---PSTALREISLLKELKH 57
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQ--RYAAAIGTAKGLRF 136
NIV LL E LV+EY C+ L D L + + +GL +
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEY-CDMDLK-KYLDKRPGPLSPNLIKSIMYQL--LRGLAY 113
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE- 195
H I+HRD++P NIL+ D V L DFGLAR T + TL Y APE
Sbjct: 114 CHSHR----ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169
Query: 196 ------YAENGIVSIRTDVYAFGIILLQLMSGR 222
Y S D+++ G I ++++G+
Sbjct: 170 LLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 68/227 (29%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 17 EIQQATGDFSKENLLGEGGFGHVYKGEL------KDGQMIAAK-VRKEASTQGFAEFQSE 69
EI + F +E LGEG FG VYKGEL +A K +++ A + EF+ E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 70 VYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDN--------------TE 115
+++ +H NIV LLG C KE +++EY+ + LH L N +
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 116 SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175
S L+ AI A G+ +L +HRD+ N L+ + DFGL+R
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
Query: 176 TTDD--PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS 220
+ D VQ+K L + ++ PE G + +D+++FG++L ++ S
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 1e-22
Identities = 67/199 (33%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 31 LGEGGFGHVYKGELKD-GQMIAAKV---RKEASTQGFAEFQSEVYVLNFARHKNIVMLL- 85
LG+G FG V KD G++ A KV +K + +E +L+ H IV L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 86 GFCCKENLNILVYEYICNKSLHWHLFDNTESVL--EWHQRYAAAIGTAKGLRFLHEECRG 143
F +E L LV EY L HL + E E + YAA I A L +LH G
Sbjct: 61 AFQTEEKLY-LVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLA--LEYLHS--LG 113
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVS 203
II+RD++P NILL D L DFGLA+ +++ GT YLAPE
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171
Query: 204 IRTDVYAFGIILLQLMSGR 222
D ++ G++L ++++G+
Sbjct: 172 KAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 8e-22
Identities = 72/210 (34%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAA--KVRKEASTQGFAEFQS--EVYVLNFARHK 79
+F K N +GEG +G VY+ I A KVR + G S E+ +L RH
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIP-ISSLREITLLLNLRHP 66
Query: 80 NIVMLLGFCCKENLN--ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFL 137
NIV L ++L+ LV EY C + L L DN + Q + +GL++L
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEY-CEQDLA-SLLDNMPTPFSESQVKCLMLQLLRGLQYL 124
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ--TKILGTLGYLAPE 195
HE IIHRD++ SN+LLT + DFGLAR T P + T + TL Y APE
Sbjct: 125 HENF----IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWYRAPE 178
Query: 196 Y---AENGIVSIRTDVYAFGIILLQLMSGR 222
+I D++A G IL +L++ +
Sbjct: 179 LLLGCTTYTTAI--DMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 9e-21
Identities = 82/309 (26%), Positives = 134/309 (43%), Gaps = 51/309 (16%)
Query: 9 DPMKFSFSEIQQATGDFSKENL-----LGEGGFGHVYK----GELKDGQMIAAKVRKEAS 59
DP + + +F + NL LG G FG V + G K ++ V+
Sbjct: 20 DPTQLPYDL----KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP 75
Query: 60 TQGFAEFQ---SEVYVLN-FARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTE 115
T +E + SE+ +++ H+NIV LLG C +++ EY C L L E
Sbjct: 76 TAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE 135
Query: 116 SVLEWHQRYAAAIGTAKGLRFL-HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174
S L + + AKG+ FL + C IHRD+ N+LLTH + + DFGLAR
Sbjct: 136 SFLTLEDLLSFSYQVAKGMAFLASKNC-----IHRDLAARNVLLTHGKIVKICDFGLARD 190
Query: 175 KTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRK-----VVD 226
D V+ + ++APE N + + +DV+++GI+L ++ S G VD
Sbjct: 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD 250
Query: 227 MNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS 286
+ + + A+P + E+Y + KT C +P RP+
Sbjct: 251 SKFYKLIKEGYRMAQP-----------------EHAPAEIYDIMKT---CWDADPLKRPT 290
Query: 287 MGEVVRLLE 295
++V+L+
Sbjct: 291 FKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-20
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 11/212 (5%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAK---VRKEASTQGFAEFQSEVYVLNFARHK 79
DF N +G+G FG V+K K D ++ A K + K + + E E VL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAIDEARVLAKLDSS 59
Query: 80 NIVMLL-GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
I+ F K LNI++ EY N LH L L Q + I GL LH
Sbjct: 60 YIIRYYESFLDKGKLNIVM-EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE 198
+ I+HRD++ N+ L +GD G+A+ + + I+GT YL+PE E
Sbjct: 119 SK----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE 174
Query: 199 NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGE 230
+ + ++DV+A G++L + +G+ D N +
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 78/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 25 FSKENL-----LGEGGFGHVYKGEL-----KDGQMIAAKV-RKEASTQGFAEFQSEVYVL 73
F K +L LGEG FG V G+ +A K Q ++F+ E+ +L
Sbjct: 1 FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL 60
Query: 74 NFARHKNIVMLLGFCCKENLNI--LVYEYICNKSLHWHLFDNTESVLEWHQ-RYAAAIGT 130
H+NIV G C K L+ EY+ + SL +L + + + +++ I
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI-- 118
Query: 131 AKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD----------- 179
KG+ +L + IHRD+ NIL+ + + + DFGLA+ D
Sbjct: 119 CKGMDYLGSQ----RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQ 238
P+ + APE S +DV++FG+ L +L + G + P + LR
Sbjct: 175 PIF--------WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP----SQSPPAEFLRM 222
Query: 239 WA--------EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEV 290
L+E L E + PR + D E+Y + K LC + P+ RPS ++
Sbjct: 223 IGIAQGQMIVTRLLELLKEGERL-PRPPSCPD--EVYDLMK---LCWEAEPQDRPSFADL 276
Query: 291 VRLLE 295
+ +++
Sbjct: 277 ILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 63/235 (26%), Positives = 90/235 (38%), Gaps = 53/235 (22%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV------RKEASTQGFAEFQSEVYVLN-- 74
DF ++GEG F V E + + A K+ KE + YV
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVK---------YVKIEK 52
Query: 75 -----FARHKNIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESV-LEWHQRYAAA 127
H I+ L F +ENL V EY N L S+ + + YAA
Sbjct: 53 EVLTRLNGHPGIIKLYYTFQDEENL-YFVLEYAPNGEL-LQYIRKYGSLDEKCTRFYAAE 110
Query: 128 IGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR-WKTTDDPVQTKIL 186
I L +LH +G IIHRD++P NILL D + DFG A+ P K
Sbjct: 111 I--LLALEYLHS--KG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 187 -------------------GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
GT Y++PE +D++A G I+ Q+++G+
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-19
Identities = 79/302 (26%), Positives = 128/302 (42%), Gaps = 67/302 (22%)
Query: 30 LLGEGGFGHVYKGELKD------GQMIAAKVRKE-ASTQGFAEFQSEVYVLN-FARHKNI 81
LGEG FG V K E +A K+ K+ A+ + ++ SE+ ++ +HKNI
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDN--------------TESVLEWHQRYAAA 127
+ LLG C +E +V EY + +L L E L + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 128 IGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR--------WKTTDD 179
A+G+ FL + IHRD+ N+L+T D V + DFGLAR KTT+
Sbjct: 139 YQVARGMEFLASK----KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQW 239
+ K ++APE + + + ++DV++FG++L ++ + G P
Sbjct: 195 RLPVK------WMAPEALFDRVYTHQSDVWSFGVLLWEIFT-------LGGSPYPG---- 237
Query: 240 AEPLIEKLALHELID-----PRIEN-SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293
+ + EL R+E T ELY + + C P RP+ ++V
Sbjct: 238 -------IPVEELFKLLKEGYRMEKPQNCTQELYHLMRD---CWHEVPSQRPTFKQLVED 287
Query: 294 LE 295
L+
Sbjct: 288 LD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-19
Identities = 77/282 (27%), Positives = 124/282 (43%), Gaps = 38/282 (13%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
D + ++ LG G +G VY+G K +A K KE T EF E V+ +H N+V
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
LLG C +E ++ E++ +L +L + + A + + +L ++
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 123
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAPEYAEN 199
IHRD+ N L+ + + + DFGL+R T D T G + + APE
Sbjct: 124 --NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAY 179
Query: 200 GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP--RI 257
SI++DV+AFG++L ++ + G P P I+ ++EL++ R+
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT-------YGMSPY--------PGIDLSQVYELLEKGYRM 224
Query: 258 ENSY----DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E YEL C Q NP RPS E+ + E
Sbjct: 225 ERPEGCPPKVYELMRA------CWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-19
Identities = 79/274 (28%), Positives = 128/274 (46%), Gaps = 40/274 (14%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKVRK-EASTQGFAEFQSEVYVLNFARHKNIVMLLGFCC 89
+GEG FG V +GE GQ +A K K + + Q F E E V+ HKN+V LLG
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVRLLGVIL 69
Query: 90 KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHR 149
L I V E + +L L +++ Q ++ A+G+ +L + ++HR
Sbjct: 70 HNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK----KLVHR 124
Query: 150 DMRPSNILLTHDFVPMLGDFGLARWK-----TTDDPVQTKILGTLGYLAPEYAENGIVSI 204
D+ NIL++ D V + DFGLAR + PV+ + APE ++ S
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK--------WTAPEALKHKKFSS 176
Query: 205 RTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263
++DV+++G++L ++ S GR P+ SL++ E + + + +P D
Sbjct: 177 KSDVWSYGVLLWEVFSYGRA------PYPKMSLKEVKECVEKGYRM----EPPEGCPADV 226
Query: 264 YELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297
Y LM C + P+ RPS ++ LE E
Sbjct: 227 Y--VLMTS----CWETEPKKRPSFHKLREKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 9e-19
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 25 FSKENLLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAE---FQS--EVYVLNFARH 78
+ K LGEG + VYK + G+++A K K + + F + E+ +L +H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 79 KNIVMLLG-FCCKENLNILVYEYICNKSLHW---HLFDNTESVLEWHQRYAAAIGTAKGL 134
NI+ LL F K N+N LV+E+ + + + VL + + T +GL
Sbjct: 62 PNIIGLLDVFGHKSNIN-LVFEF-----METDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAP 194
+LH I+HRD++P+N+L+ D V L DFGLAR + + T + T Y AP
Sbjct: 116 EYLHSNW----ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAP 171
Query: 195 EY---AENGIVSIRTDVYAFGIILLQLMSGR 222
E A + V + D+++ G I +L+
Sbjct: 172 ELLFGARHYGVGV--DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 9e-19
Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 51/287 (17%)
Query: 28 ENLLGEGGFGHVYKGEL----KDGQMIAAKVRKEASTQG-FAEFQSEVYVLNFARHKNIV 82
E ++G G FG V +G L K +A K K S+ +F +E ++ H NI+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
L G K +++ EY+ N SL L + Q G A G+++L E
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT----KILGTLGYLAPEYAE 198
+HRD+ NIL+ + V + DFGL+R + T KI + + APE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIA 181
Query: 199 NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258
+ +DV++FGI++ ++MS GE P + ++I +E
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMS-------YGERPYWDMSN-----------QDVIK-AVE 222
Query: 259 NSYD----------TYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ Y Y+L L C Q++ RP+ ++V L+
Sbjct: 223 DGYRLPPPMDCPSALYQLMLD------CWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 31 LGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLL-GFC 88
LG+G FG VYK + K+ G AAK+ + S + +F E+ +L+ +H NIV L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 89 CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIH 148
+ L IL+ E+ +L + E L Q + L FLH +IH
Sbjct: 73 YENKLWILI-EFCDGGALD-SIMLELERGLTEPQIRYVCRQMLEALNFLHSH----KVIH 126
Query: 149 RDMRPSNILLTHDFVPMLGDFGL-ARWKTTDDPVQTKILGTLGYLAPE------YAENGI 201
RD++ NILLT D L DFG+ A+ K+T T I GT ++APE + +N
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPY 185
Query: 202 VSIRTDVYAFGIILLQLMSGR 222
+ D+++ GI L++L
Sbjct: 186 DY-KADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-18
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 29/213 (13%)
Query: 31 LGEGGFGHVYKGEL------KDGQMIAAKVRKEASTQGFAE-FQSEVYVLNFARHKNIVM 83
LGEG FG V+ GE D +++A K KE ++ + F+ E +L +H+NIV
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 84 LLGFCCKENLNILVYEYI----CNKSLHWH--------LFDNTESVLEWHQRYAAAIGTA 131
G C + + I+V+EY+ NK L H D+ L Q A+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT--- 188
G+ +L +HRD+ N L+ +D V +GDFG++R T D ++ G
Sbjct: 133 SGMVYL----ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD--YYRVGGHTML 186
Query: 189 -LGYLAPEYAENGIVSIRTDVYAFGIILLQLMS 220
+ ++ PE + +DV++FG++L ++ +
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-18
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 31 LGEGGFGHVYKGEL-----KDGQMIAAKVRKE-ASTQGFAEFQSEVYVLNFARHKNIVML 84
LGE FG +YKG L Q++A K K+ + Q + EFQ E ++ H NIV L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 85 LGFCCKENLNILVYEYICNKSLHWHLF--------------DNT-ESVLEWHQRYAAAIG 129
LG +E +++EY+ LH L D T +S L+ AI
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 130 TAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD--PVQTKILG 187
A G+ +L +H+D+ NIL+ + D GL+R + D VQ K L
Sbjct: 133 IAAGMEYLSSHF----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 188 TLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS 220
+ ++ PE G S +D+++FG++L ++ S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-18
Identities = 69/280 (24%), Positives = 125/280 (44%), Gaps = 32/280 (11%)
Query: 25 FSKENLLGEGGFGHVYKGELKDGQMIAAK------VRKEASTQGFAEFQSEVYVLNFARH 78
++K +LG+G +G VY G GQ+IA K A+ + + + Q EV +L +H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
NIV LG C +N + E++ S+ L +Y I G+ +LH
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLH 119
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR---W---KTTDDPVQTKILGTLGYL 192
C ++HRD++ +N++L + + L DFG AR W T + + GT ++
Sbjct: 120 NNC----VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 193 APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252
APE ++D+++ G + ++ +G+ P S+ + A + + H
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKP--------PLASMDRLAA--MFYIGAHRG 225
Query: 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
+ PR+ +S+ C+ R+ RPS +++R
Sbjct: 226 LMPRLPDSFSAAA----IDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-18
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 30 LLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGF-AEFQSEVYVLNFARHKNIVMLLGFC 88
+G+G FG VYKG LK +A K + +F E +L H NIV L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 89 CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIH 148
++ +V E + SL L ++ L + ++ A G+ +L + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKN----CIH 116
Query: 149 RDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT----LGYLAPEYAENGIVSI 204
RD+ N L+ + V + DFG++R + + T G + + APE G +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 205 RTDVYAFGIILLQLMSG 221
+DV+++GI+L + S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-18
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK 90
LG G FG V+ G +A K K T F E ++ RH +V L C +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRD 150
E +V EY+ SL L L Q A A+G+ +L IHRD
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR----NYIHRD 128
Query: 151 MRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAPEYAENGIVSIRTD 207
+ NIL+ + V + DFGLAR DD + G + + APE A G +I++D
Sbjct: 129 LAARNILVGENLVCKIADFGLAR-LIEDDEYTAR-EGAKFPIKWTAPEAANYGRFTIKSD 186
Query: 208 VYAFGIILLQL----------MSGRKVVDM 227
V++FGI+L ++ M+ R+V++
Sbjct: 187 VWSFGILLTEIVTYGRVPYPGMTNREVLEQ 216
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 65/269 (24%), Positives = 113/269 (42%), Gaps = 24/269 (8%)
Query: 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAK--VRKEASTQGFAEFQSEVYVLNFARHKN 80
D LG G G V K + I A +R E + + E+ +L+
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEE 140
IV G + EY+ SL + + + A+ KGL +LHE+
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLD-KILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 141 CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENG 200
+ IIHRD++PSNIL+ L DFG++ + + +T + GT Y+APE +
Sbjct: 120 HK---IIHRDVKPSNILVNSRGQIKLCDFGVSG-QLVNSLAKTFV-GTSSYMAPERIQGN 174
Query: 201 IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID---PRI 257
S+++D+++ G+ L++L +GR + P L +++ PR+
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFEL----------LQYIVNEPPPRL 224
Query: 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPS 286
+ + + LC+ ++P RPS
Sbjct: 225 PSGKFSPDFQDFVN---LCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 79/303 (26%), Positives = 131/303 (43%), Gaps = 59/303 (19%)
Query: 24 DFSKENLLGEGGFGHVYKGEL-KDGQMIAAKVRKE---ASTQGFAEFQSEVYVL-NFARH 78
D ++++GEG FG V K + KDG + A +++ AS +F E+ VL H
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFD------------------NTESVLEW 120
NI+ LLG C L EY + H +L D +T S L
Sbjct: 68 PNIINLLGACEHRGYLYLAIEY----APHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 121 HQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180
Q A A+G+ +L ++ IHRD+ NIL+ ++V + DFGL+R + +
Sbjct: 124 QQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFGLSRGQ---EV 176
Query: 181 VQTKILGTLG--YLAPEYAENGIVSIRTDVYAFGIILLQLMS--GRKVVDMNGEEPQQSL 236
K +G L ++A E + + +DV+++G++L +++S G M E
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 231
Query: 237 RQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVV----R 292
L EKL ++ + + Y+L C + P RPS +++ R
Sbjct: 232 ------LYEKLPQGYRLEKPLNCDDEVYDLMRQ------CWREKPYERPSFAQILVSLNR 279
Query: 293 LLE 295
+LE
Sbjct: 280 MLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-17
Identities = 64/241 (26%), Positives = 111/241 (46%), Gaps = 34/241 (14%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKNIV 82
+ +G+G FG V G+ + G +A K ++ +A+ Q F +E V+ RH N+V
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFL---AEASVMTQLRHSNLV 62
Query: 83 MLLGFCCKENLNI-LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
LLG +E + +V EY+ SL +L SVL ++ + + +L
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---- 118
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR-WKTTDDPVQTKILGTLGYLAPEYAENG 200
+HRD+ N+L++ D V + DFGL + +T D + + T APE
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREK 174
Query: 201 IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260
S ++DV++FGI+L ++ S +V P ++ L +++ PR+E
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRV-----------------PY-PRIPLKDVV-PRVEKG 215
Query: 261 Y 261
Y
Sbjct: 216 Y 216
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 29 NLLGEGGFGHVYKG-ELKDGQMIAAKVRK--EASTQGFAEFQSEVYVLNFARHKNIVMLL 85
N +G G FG VY L G+++A K + + + E E+ VL +H N+V
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 86 GF-CCKENLNILVYEYICNKSL-----HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
G +E + I + EY +L H + D E V+ + Y + +GL +LH
Sbjct: 66 GVEVHREKVYIFM-EYCSGGTLEELLEHGRILD--EHVI---RVYTLQL--LEGLAYLHS 117
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFG----LARWKTTDDPVQTKILGTLGYLAPE 195
I+HRD++P+NI L H+ V LGDFG L TT + GT Y+APE
Sbjct: 118 H----GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 196 YAENGIVSIR---TDVYAFGIILLQLMSGRK 223
G D+++ G ++L++ +G++
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 73/281 (25%), Positives = 123/281 (43%), Gaps = 40/281 (14%)
Query: 31 LGEGGFGHVYKGEL------KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVML 84
LGEG FG V+ E +D ++A K KEAS +FQ E +L +H++IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 85 LGFCCKENLNILVYEYI----CNKSLHWH-----LFDNTESV----LEWHQRYAAAIGTA 131
G C + ++V+EY+ N+ L H + E V L Q A A A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR--WKTTDDPVQTKILGTL 189
G+ +L +HRD+ N L+ V +GDFG++R + T V + + +
Sbjct: 133 SGMVYL----ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 190 GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249
++ PE + +D+++FG++L ++ + G++P L E +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT-------YGKQPWYQLSN-TEAIECITQG 240
Query: 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEV 290
EL PR E+Y + + C QR P+ R + ++
Sbjct: 241 RELERPRTCPP----EVYAIMQG---CWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 34 GGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQS---EVYVLNFARHKNIV-MLLGFC 88
G +G V+ + K G + A KV K+A + E +L+ A+ +V + F
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 89 CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-YAAAIGTAKGLRFLHEECRGGPII 147
K+NL LV EY+ L L +N S+ E R Y A I L +LH II
Sbjct: 64 GKKNL-YLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAEI--VLALEYLHSN----GII 115
Query: 148 HRDMRPSNILLTHDFVPMLGDFGLAR-------WKTTDDPVQT-KILGTLGYLAPEYAEN 199
HRD++P NIL+ + L DFGL++ DD + +I+GT Y+APE
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 200 GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ 234
S D ++ G IL + + G + +GE P++
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVG--IPPFHGETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-17
Identities = 76/283 (26%), Positives = 126/283 (44%), Gaps = 40/283 (14%)
Query: 28 ENLLGEGGFGHVYKGELK----DGQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIV 82
E ++G G FG V +G LK +A K K T + +F SE ++ H NI+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
L G K +++ E++ N +L L N + Q G A G+++L E
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM-- 125
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARW--KTTDDPVQTKILG---TLGYLAPEYA 197
+HRD+ NIL+ + V + DFGL+R+ T DP T LG + + APE
Sbjct: 126 --NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 198 ENGIVSIRTDVYAFGIILLQLMS--GRKVVDMNGEEPQQSLRQ---WAEPLIEKLALHEL 252
+ +DV+++GI++ ++MS R DM+ ++ ++ Q P+ ALH+L
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQL 243
Query: 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ C Q++ RP G++V L+
Sbjct: 244 M--------------------LDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-17
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK 90
LG G FG V++G + +A K K T +F +E ++ RH ++ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRD 150
E +V E + SL +L L+ Q A A G+ +L + IHRD
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ----NYIHRD 128
Query: 151 MRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAPEYAENGIVSIRTD 207
+ N+L+ + + + DFGLAR + + G + + APE A SI++D
Sbjct: 129 LAARNVLVGENNICKVADFGLAR--VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 208 VYAFGIILLQL----------MSGRKVVDM 227
V++FGI+L ++ M+ +V+
Sbjct: 187 VWSFGILLTEIVTYGRMPYPGMTNAEVLQQ 216
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-17
Identities = 72/283 (25%), Positives = 117/283 (41%), Gaps = 48/283 (16%)
Query: 25 FSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVML 84
F KE LG G FG V+ G+ + +A K+ +E + +F E V+ H N+V L
Sbjct: 8 FLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQL 64
Query: 85 LGFCCKENLNILVYEYICNKSL------HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
G C K+ +V EY+ N L TE +L+ + + +L
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKL-GTEWLLD------MCSDVCEAMEYLE 117
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAPE 195
IHRD+ N L+ D V + DFGLAR+ D T GT + + PE
Sbjct: 118 SNG----FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--YTSSQGTKFPVKWAPPE 171
Query: 196 YAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255
+ S ++DV++FG+++ ++ S G+ P E+ + E+++
Sbjct: 172 VFDYSRFSSKSDVWSFGVLMWEVFSE-------GKMP-----------YERFSNSEVVE- 212
Query: 256 RIENSYDTYELYLMAKTAY----LCVQRNPEGRPSMGEVVRLL 294
+ Y Y L Y C PE RP+ +++ L
Sbjct: 213 SVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-17
Identities = 81/272 (29%), Positives = 125/272 (45%), Gaps = 32/272 (11%)
Query: 30 LLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFA-EFQSEVYVLNFARHKNIVMLLGFC 88
LLG+G FG V+KG LKD +A K KE Q +F SE +L H NIV L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 89 CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH-EECRGGPII 147
+ +V E + L + L+ Q A+ A G+ +L + C I
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLESKNC-----I 115
Query: 148 HRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT-----KILGTLGYLAPEYAENGIV 202
HRD+ N L+ + V + DFG++R + DD + + +I + + APE G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQE--DDGIYSSSGLKQI--PIKWTAPEALNYGRY 171
Query: 203 SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYD 262
S +DV+++GI+L + S V G QQ+ Q +EK + + P+ + D
Sbjct: 172 SSESDVWSYGILLWETFS-LGVCPYPGMTNQQAREQ-----VEK--GYRMSCPQ-KCPDD 222
Query: 263 TYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294
Y+ +M + C PE RP E+ + L
Sbjct: 223 VYK--VMQR----CWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 6e-17
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAEFQ-SEVYVLNFARHKNIVMLLGF 87
+GEG +G VYK + G+++A K ++ ++G + E+ +L H NI+ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 88 CCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPII 147
+ LV+E+ + L + L + + L + +GL F H I+
Sbjct: 67 FRHKGDLYLVFEF-MDTDL-YKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH----GIL 120
Query: 148 HRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE-------YAENG 200
HRD++P N+L+ + V L DFGLAR + T + T Y APE Y+
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP- 179
Query: 201 IVSIRTDVYAFGIILLQLMSGR 222
D+++ G I +L+S R
Sbjct: 180 -----VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 6e-17
Identities = 85/312 (27%), Positives = 142/312 (45%), Gaps = 68/312 (21%)
Query: 24 DFSKENL-----LGEGGFGHVYKGEL----KDGQ----MIAAKVRKE-ASTQGFAEFQSE 69
+F ++ L LGEG FG V + E K +A K+ K+ A+ + A+ SE
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISE 67
Query: 70 VYVLN-FARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHL-----------FDNT--- 114
+ ++ +HKNI+ LLG C +E ++ EY +L L FD T
Sbjct: 68 MELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 115 ESVLEWHQRYAAAIGTAKGLRFLH-EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173
E L + + A A+G+ +L C IHRD+ N+L+T D V + DFGLAR
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRRC-----IHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 174 W--------KTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQL--MSGRK 223
KT++ + K ++APE + + + ++DV++FGI++ ++ + G
Sbjct: 183 GVHDIDYYKKTSNGRLPVK------WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
Query: 224 VVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEG 283
+ EE + LR+ H + P S T+ELY++ + C P
Sbjct: 237 YPGIPVEELFKLLREG----------HRMDKP----SNCTHELYMLMRE---CWHAVPTQ 279
Query: 284 RPSMGEVVRLLE 295
RP+ ++V L+
Sbjct: 280 RPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-17
Identities = 57/194 (29%), Positives = 95/194 (48%), Gaps = 8/194 (4%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK 90
LG G FG V+ G +A K K+ S A F +E ++ +H +V L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRD 150
E + I + EY+ N SL L L ++ A A+G+ F+ + IHRD
Sbjct: 73 EPIYI-ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK----NYIHRD 127
Query: 151 MRPSNILLTHDFVPMLGDFGLARW-KTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVY 209
+R +NIL++ + DFGLAR + + + + + APE G +I++DV+
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 210 AFGIILLQLMS-GR 222
+FGI+L ++++ GR
Sbjct: 188 SFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 73/290 (25%), Positives = 114/290 (39%), Gaps = 74/290 (25%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKNI 81
F LGEG +G VYK + GQ++A K V E Q E E+ +L I
Sbjct: 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPYI 60
Query: 82 VMLLGFCCKENLNILVYEY-----------ICNKSLHWHLFDNTESVLEWHQRYAAAI-- 128
V G K +V EY I NK+L TE + AAI
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL-------TEEEI-------AAILY 106
Query: 129 GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT 188
T KGL +LH IHRD++ NILL + L DFG++ T + ++GT
Sbjct: 107 QTLKGLEYLHSN----KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGT 162
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR---------KVVDMNGEEPQQSLR-- 237
++APE + + + D+++ GI +++ G+ + + M +P +L
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDP 222
Query: 238 -QWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS 286
+W+ + + C+ ++PE RPS
Sbjct: 223 EKWSPEFNDFVK--------------------------KCLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-16
Identities = 79/273 (28%), Positives = 119/273 (43%), Gaps = 36/273 (13%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK 90
LG G FG V+ G +A K K T F E ++ RH +V L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRD 150
E + I V EY+ SL L D L+ A A G+ ++ IHRD
Sbjct: 73 EPIYI-VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM----NYIHRD 127
Query: 151 MRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAPEYAENGIVSIRTD 207
+R +NIL+ V + DFGLAR +D T G + + APE A G +I++D
Sbjct: 128 LRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 208 VYAFGIILLQLMSGRKV--VDMNGEEP-QQSLRQWAEPLIE--KLALHELIDPRIENSYD 262
V++FGI+L +L++ +V MN E +Q R + P + ++LHEL+
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM--------- 236
Query: 263 TYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
C +++PE RP+ + LE
Sbjct: 237 -----------LQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 61/181 (33%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 25 FSKENLLGEGGFGHVYKGE-LKDGQMIAAK-VRKEASTQGFAEFQS--EVYVLNFARHKN 80
+ K +GEG +G VYK K G+++A K +R E +GF + E+ +L RH N
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFP-ITAIREIKLLQKLRHPN 59
Query: 81 IVMLLGFCCKENLN--ILVYEYI---CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLR 135
IV L + +V+EY+ L TES + + Y + +GL+
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQI---KCYMKQL--LEGLQ 114
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD-DPVQTKILGTLGYLAP 194
+LH G I+HRD++ SNIL+ +D V L DFGLAR T T + TL Y P
Sbjct: 115 YLHS--NG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170
Query: 195 E 195
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-16
Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 37/277 (13%)
Query: 27 KENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFA-----EFQSEVYVLNFARHKN 80
K LLG G FG VY+G L DG A K A + + E+ +L+ +H N
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 81 IVMLLGFCCKE-NLNILVYEYICNKSLHWHL--FDN-TESVLEWHQRYAAAIGTAKGLRF 136
IV LG +E NL I + E + SL L + + E V+ + Y I GL +
Sbjct: 64 IVQYLGTEREEDNLYIFL-ELVPGGSLAKLLKKYGSFPEPVI---RLYTRQI--LLGLEY 117
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY 196
LH+ R +HRD++ +NIL+ + V L DFG+A+ ++ G+ ++APE
Sbjct: 118 LHD--RN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAPE- 171
Query: 197 AENGIVSIRTDVYAFGIILLQLMSGRKVVDM-NGEEPQQSLRQWAEPLIEKLALHELIDP 255
V + Y + L G V++M G+ P L A + K+ + + P
Sbjct: 172 -----VIAQQGGYGLAADIWSL--GCTVLEMATGKPPWSQLEGVA--AVFKIGRSKELPP 222
Query: 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
++ D + +++ C+QR+P RP+ E++
Sbjct: 223 IPDHLSDEAKDFIL-----KCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
D+ +G G +G VYK L G++ A K+ K F+ Q E++++ +H NIV
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 83 MLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
G + +E L I + EY SL ++ T + E Y T +GL +LH +
Sbjct: 70 AYFGSYLSREKLWICM-EYCGGGSLQ-DIYHVTGPLSELQIAYVCR-ETLQGLAYLHSKG 126
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYA---E 198
+ +HRD++ +NILLT + L DFG+A T + +GT ++APE A +
Sbjct: 127 K----MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 199 NGIVSIRTDVYAFGIILLQL 218
NG + D++A GI ++L
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-16
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 29 NLLGEGGFGHVYKGELKD-------GQMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKN 80
N LG G FG VY+G D +A K +RK A+ Q EF E ++++ H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTES-----VLEWHQRYAAAIGTAKGLR 135
IV LLG C ++ E + L +L D +L + + AKG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 136 FLHEECRGGPIIHRDMRPSNILLTH-----DFVPMLGDFGLARWKTTDDPVQTKILGTLG 190
+L E+ IHRD+ N L++ D V +GDFGLAR D + + G L
Sbjct: 121 YL-EQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 191 --YLAPEYAENGIVSIRTDVYAFGIILLQLMS 220
++APE +G + ++DV++FG+++ ++++
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 63/192 (32%), Positives = 93/192 (48%), Gaps = 9/192 (4%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCC 89
+G G +G VYK ++ G+++A KV K F Q E+ +L RH NIV G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 90 KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHR 149
+ + +V EY SL ++ T L Q T KGL +LHE + IHR
Sbjct: 71 RRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK----IHR 125
Query: 150 DMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE---NGIVSIRT 206
D++ +NILLT D L DFG++ T + +GT ++APE A G +
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKC 185
Query: 207 DVYAFGIILLQL 218
D++A GI ++L
Sbjct: 186 DIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 25 FSKENLLGEGGFGHVYKGELKD-GQMIAAKV---RKEASTQGFAEFQSEVYVLNFARHKN 80
F ++G+G FG V + +D +M A K +K +E +L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 81 IV-MLLGFCCKENLNILVYEYICNKSLHWHLFDN---TESVLEWHQRYAAAIGTAKGLRF 136
+V + F +EN+ LV + + L +HL +E + + + I A L +
Sbjct: 62 LVNLWYSFQDEENM-YLVVDLLLGGDLRYHLSQKVKFSEEQV---KFWICEIVLA--LEY 115
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY 196
LH + IIHRD++P NILL + DF +A K T D + T GT GY+APE
Sbjct: 116 LHSK----GIIHRDIKPDNILLDEQGHVHITDFNIAT-KVTPDTLTTSTSGTPGYMAPEV 170
Query: 197 AENGIVSIRTDVYAFGIILLQLMSGRK 223
S+ D ++ G+ + + G++
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-16
Identities = 77/273 (28%), Positives = 123/273 (45%), Gaps = 36/273 (13%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK 90
LG+G FG V+ G +A K K + A F E ++ RH +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRD 150
E + I V E++ SL L + L+ Q A A G+ ++ IHRD
Sbjct: 73 EPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM----NYIHRD 127
Query: 151 MRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAPEYAENGIVSIRTD 207
+R +NIL+ + V + DFGLAR +D T G + + APE A G +I++D
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 208 VYAFGIILLQLMSGRKVV---DMNGEEPQQSLRQWAEPLIEKL--ALHELIDPRIENSYD 262
V++FGI+L +L++ +V +N E +Q R + P + +LHEL+
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMK-------- 237
Query: 263 TYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
LC +++P+ RP+ + LE
Sbjct: 238 ------------LCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-16
Identities = 64/206 (31%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVY-VLNFAR---HKNIVMLLG 86
LGEG G V K LK+ MI A K +T + Q ++ L + IV G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFAL--KTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 87 FCCKE---NLNILVYEYICNKSLHWHLFDNT-ESVLEWHQRYAA------AIGTAKGLRF 136
E ++ I + EY SL D+ + V + R A KGL +
Sbjct: 67 AFLDESSSSIGIAM-EYCEGGSL-----DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY 196
LH IIHRD++PSNILLT L DFG++ + GT Y+APE
Sbjct: 121 LHSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--LAGTFTGTSFYMAPER 174
Query: 197 AENGIVSIRTDVYAFGIILLQLMSGR 222
+ SI +DV++ G+ LL++ R
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-16
Identities = 77/279 (27%), Positives = 112/279 (40%), Gaps = 44/279 (15%)
Query: 31 LGEGGFGHVYKG--ELKDGQMIAAKVR---KEASTQGFAEFQSEVYVLNFARHKNIVMLL 85
LG G FG V KG +K G+ + V+ +E G EF E V+ H IV L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 86 GFCCKENLNILVYEYICNKSLHWHLFDNTE----SVLEW-HQRYAAAIGTAKGLRFLHEE 140
G C E L +LV E L +L E + E HQ A G+ +L E
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ-------VAMGMAYL-ES 113
Query: 141 CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR-WKTTDDPVQTKILGT--LGYLAPEYA 197
+HRD+ N+LL + + DFG++R D + G L + APE
Sbjct: 114 KH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 198 ENGIVSIRTDVYAFGIILLQLMS--GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255
G S ++DV+++G+ L + S + +M G E L E+L E
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-----ERLPRPEECPQ 225
Query: 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294
I Y +M C + PE RP+ E+
Sbjct: 226 EI---YS-----IMLS----CWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 62/197 (31%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK 90
LG+G FG V+ G +A K K + A F E V+ RH+ +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRD 150
E + I V EY+ SL L L Q A A G+ ++ +HRD
Sbjct: 73 EPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRD 127
Query: 151 MRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAPEYAENGIVSIRTD 207
+R +NIL+ + V + DFGLAR +D T G + + APE A G +I++D
Sbjct: 128 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 208 VYAFGIILLQLMSGRKV 224
V++FGI+L +L + +V
Sbjct: 186 VWSFGILLTELTTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 75/286 (26%), Positives = 127/286 (44%), Gaps = 38/286 (13%)
Query: 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAE-----FQSEVYVLNFAR 77
+K+ ++G G FG V++G LK V + G+ E F SE ++
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 78 HKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFL 137
H NI+ L G K +++ EY+ N +L +L D+ + +Q G A G+++L
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYL 123
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT------KILGTLGY 191
+ +HRD+ NIL+ + + DFGL+R DDP T KI + +
Sbjct: 124 SDM----NYVHRDLAARNILVNSNLECKVSDFGLSR-VLEDDPEGTYTTSGGKI--PIRW 176
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMS--GRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249
APE + +DV++FGI++ ++MS R DM+ E +++
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG---------- 226
Query: 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
L P ++ Y+L L C Q++ RP ++V LL+
Sbjct: 227 FRLPAP-MDCPSAVYQLMLQ------CWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 30 LLGEGGFGHVYKGELKD-GQMIAAKVRKEA-STQGFAEF-QSEVYVLNFARHKNIVMLLG 86
++GEG +G V K K G+++A K KE+ + + EV VL RH+NIV L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 87 FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPI 146
++ LV+EY ++L L + + L + + + + H I
Sbjct: 68 AFRRKGRLYLVFEY-VERTLL-ELLEASPGGLPPDAVRSYIWQLLQAIAYCH----SHNI 121
Query: 147 IHRDMRPSNILLTHDFVPMLGDFGLARWKTTD-DPVQTKILGTLGYLAPE----YAENGI 201
IHRD++P NIL++ V L DFG AR T + T Y APE G
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG- 180
Query: 202 VSIRTDVYAFGIILLQLMSGR 222
DV+A G I+ +L+ G
Sbjct: 181 --KPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-16
Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 24 DFSKEN---LLGEGGFGHVYKGELKDGQM-IAAKVRKEASTQGFAEFQSEVYVLNFARHK 79
++ + +LG+G +G VY Q+ IA K E ++ E+ + ++ +H+
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 80 NIVMLLGFCCKENLNILVY-EYICNKSL------HWHLFDNTESVLEWHQRYAAAIGTAK 132
NIV LG EN ++ E + SL W + E + ++ + +
Sbjct: 66 NIVQYLG-SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-----ILE 119
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILL-THDFVPMLGDFGLARWKTTDDPVQTKILGTLGY 191
GL++LH+ I+HRD++ N+L+ T+ V + DFG ++ +P GTL Y
Sbjct: 120 GLKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQY 175
Query: 192 LAPEYAENGI--VSIRTDVYAFGIILLQLMSGR 222
+APE + G D+++ G ++++ +G+
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-16
Identities = 76/292 (26%), Positives = 133/292 (45%), Gaps = 47/292 (16%)
Query: 30 LLGEGGFGHVYK---GELKD--GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVML 84
LG+G FG V L+D G+++A K + ++ + +F+ E+ +L +H NIV
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 85 LGFCC---KENLNILVYEYICNKSLHWHLFDNTESVLEWHQR---YAAAIGTAKGLRFLH 138
G C + NL LV EY+ SL +L + E + H++ YA+ I KG+ +L
Sbjct: 71 KGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLD--HRKLLLYASQI--CKGMEYLG 125
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR-------WKTTDDPVQTKILGTLGY 191
+ +HRD+ NIL+ + +GDFGL + + +P ++ I +
Sbjct: 126 SK----RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----W 177
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251
APE S+ +DV++FG++L +L + D + P + +R ++ ++
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPAEFMRMMGNDKQGQMIVYH 234
Query: 252 LID--------PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
LI+ P E+Y + K C +P RPS E+ +E
Sbjct: 235 LIELLKNNGRLPAPPGCPA--EIYAIMK---ECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-16
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 23 GDFSKENLLGEGGFGHVYKG----ELKDGQM-IAAKV-RKEASTQGFAEFQSEVYVLNFA 76
+ K +LG G FG VYKG E + ++ +A KV R+E S + E E YV+
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66
Query: 77 RHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNT-----ESVLEWHQRYAAAIGTA 131
H ++V LLG C + L+ + + L ++ ++ + +L W + A
Sbjct: 67 DHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIA 119
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT--L 189
KG+ +L EE R ++HRD+ N+L+ + DFGLA+ D+ G +
Sbjct: 120 KGMSYL-EEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 190 GYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRK 223
++A E + I + ++DV+++G+ + +LM+ G K
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 72/272 (26%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFC 88
LG G FG V+ G + +A K K S Q F E E ++ +H +V L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTLQHDKLVRLYAVV 70
Query: 89 CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIH 148
KE ++ EY+ SL L + + + + A+G+ ++ + IH
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK----NYIH 126
Query: 149 RDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAPEYAENGIVSIR 205
RD+R +N+L++ + + DFGLAR +D T G + + APE G +I+
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 206 TDVYAFGIILLQLMSGRKV--VDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263
+DV++FGI+L ++++ K+ M+ + +L++ PR+EN D
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM------------PRMENCPD- 231
Query: 264 YELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
ELY + KT C + E RP+ + +L+
Sbjct: 232 -ELYDIMKT---CWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 8e-16
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 36/223 (16%)
Query: 9 DPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV------RKEASTQ 61
DP + + +++ +GEG G VYK + G+ +A K KE
Sbjct: 16 DPREL-YKNLEK----------IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN 64
Query: 62 GFAEFQSEVYVLNFARHKNIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEW 120
E+ ++ +H NIV + + L +V EY+ SL + +
Sbjct: 65 -------EILIMKDCKHPNIVDYYDSYLVGDEL-WVVMEYMDGGSL-TDIITQNFVRMNE 115
Query: 121 HQRYAAAI--GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178
Q A + +GL +LH +IHRD++ NILL+ D L DFG A T +
Sbjct: 116 PQ--IAYVCREVLQGLEYLH----SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169
Query: 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
+ ++GT ++APE + + D+++ GI+ +++ G
Sbjct: 170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 77/289 (26%), Positives = 120/289 (41%), Gaps = 70/289 (24%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQ---SEVYVLNFARHKNIVMLLG 86
+G G FG VY +++ +++A K + Q ++Q EV L RH N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 87 FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-----YAAAI--GTAKGLRFLHE 139
+E+ LV EY C S +LE H++ AAI G +GL +LH
Sbjct: 83 CYLREHTAWLVMEY-CLGS--------ASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY--- 196
R IHRD++ NILLT L DFG A P + +GT ++APE
Sbjct: 134 HER----IHRDIKAGNILLTEPGTVKLADFGSASLV---SPANS-FVGTPYWMAPEVILA 185
Query: 197 AENGIVSIRTDVYAFGIILLQLMSGRK--VVDMNG----------EEPQQSLRQWAEPLI 244
+ G + DV++ GI ++L + RK + +MN + P S W++
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL-AERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSD--- 241
Query: 245 EKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293
+D C+Q+ P+ RPS E+++
Sbjct: 242 ---YFRNFVD--------------------SCLQKIPQDRPSSEELLKH 267
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 30 LLGEGGFGHVYKGELKD-GQMIAAKV-RKEASTQ--GFAEFQSEVYVLNFA-RHKNIVML 84
+LG+G FG V ELK ++ A KV +K+ Q +E VL A +H + L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 85 LGFCC---KENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKGLRF 136
C K+ L V EY+ L +H+ FD + YAA I GL+F
Sbjct: 62 --HSCFQTKDRL-FFVMEYVNGGDLMFHIQRSGRFDEPRARF-----YAAEI--VLGLQF 111
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY 196
LHE RG II+RD++ N+LL + + DFG+ + + GT Y+APE
Sbjct: 112 LHE--RG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEI 167
Query: 197 AENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEE 231
D +A G++L ++++G+ + + E+
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 59/180 (32%), Positives = 85/180 (47%), Gaps = 21/180 (11%)
Query: 29 NLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAEFQS---EVYVL---NFARHKN 80
+GEG +G VYK +L G+ +A K VR S +G S E+ +L H N
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLKQLESFEHPN 62
Query: 81 IVMLLGFC-----CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLR 135
IV LL C +E LV+E+ ++ L +L + L +G+
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE 195
FLH I+HRD++P NIL+T D + DFGLAR + + T ++ TL Y APE
Sbjct: 122 FLHSHR----IVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMALTSVVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 13/195 (6%)
Query: 31 LGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLL-GFC 88
LG+G FG VYK + K+ G + AAKV S + ++ E+ +L H NIV LL F
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 89 CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIH 148
+ NL IL+ E+ ++ + + E L Q T + L +LHE IIH
Sbjct: 73 YENNLWILI-EFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHEN----KIIH 126
Query: 149 RDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY-----AENGIVS 203
RD++ NIL T D L DFG++ T + +GT ++APE +++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186
Query: 204 IRTDVYAFGIILLQL 218
+ DV++ GI L+++
Sbjct: 187 YKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 53/285 (18%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQS---EVYVLNFARHK 79
DF LG+G +G VYK + L D Q A K + E + E+ +L H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD-LGSMSQKEREDAVNEIRILASVNHP 59
Query: 80 NIVMLLGFCCKENL---NILV-----------YEYICNKSLHWHLFDNTESVLEWHQRYA 125
NI+ KE N L + I + L E + W R
Sbjct: 60 NII-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLI--PEQEI-W--RIF 109
Query: 126 AAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKI 185
I +GL+ LHE+ I+HRD++ +NILL + + +GD G+++ + +T+I
Sbjct: 110 --IQLLRGLQALHEQ----KILHRDLKSANILLVANDLVKIGDLGISK-VLKKNMAKTQI 162
Query: 186 LGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE 245
GT Y+APE + S ++D+++ G +L ++ + Q LR
Sbjct: 163 -GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA--PPFEARS-MQDLRY------- 211
Query: 246 KLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEV 290
K+ + P I Y + +L ++ +Q P+ RP+ ++
Sbjct: 212 KVQRGKY--PPIPPIY-SQDLQNFIRS---MLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 63/300 (21%)
Query: 31 LGEGGFGHVYKGEL----KDGQMIAAKV-----RKEASTQGFAEFQSEVYVLNF-ARHKN 80
LGEG FG V E K+ KV + +A+ + ++ SE+ ++ +HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHL--------------FDNTESVLEWHQRYAA 126
I+ LLG C ++ ++ EY +L +L E L + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 127 AIGTAKGLRFL-HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR--------WKTT 177
A A+G+ +L ++C IHRD+ N+L+T D V + DFGLAR KTT
Sbjct: 146 AYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQL--MSGRKVVDMNGEEPQQS 235
+ + K ++APE + I + ++DV++FG++L ++ + G + EE +
Sbjct: 201 NGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254
Query: 236 LRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
L++ H + P S T ELY+M + C P RP+ ++V L+
Sbjct: 255 LKEG----------HRMDKP----SNCTNELYMMMRD---CWHAVPSQRPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-15
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 31 LGEGGFGHVYKGELKD-GQMIAAKV---RKEASTQGFAEFQSEVYVLNFARHKNIV-MLL 85
LG+GGFG V ++K G+M A K ++ +G +E +L + IV +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 86 GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR--YAAAIGTAKGLRFLHEECRG 143
F K++L LV + L +H+++ E + YAA I GL LH+
Sbjct: 61 AFETKDDLC-LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQI--ICGLEHLHQR--- 114
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKI---LGTLGYLAPEYAENG 200
I++RD++P N+LL + D GLA + KI GT GY+APE +
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLA----VELKGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 201 IVSIRTDVYAFGIILLQLMSGR 222
+ D +A G L ++++GR
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 71/288 (24%), Positives = 122/288 (42%), Gaps = 48/288 (16%)
Query: 31 LGEGGFGHVYKGELKD------GQMIAAKVRKEASTQG-FAEFQSEVYVL-NFARHKNIV 82
LG+G FG VY+G K +A K E ++ EF +E V+ F H ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH-HVV 72
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHL--------FDNTESVLEWHQRYAAAIGTAKGL 134
LLG ++V E + L +L + + A A G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT-------KILG 187
+L + +HRD+ N ++ D +GDFG+ R D +T K L
Sbjct: 133 AYLAAK----KFVHRDLAARNCMVAEDLTVKIGDFGMTR-----DIYETDYYRKGGKGLL 183
Query: 188 TLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL 247
+ ++APE ++G+ + ++DV++FG++L ++ + E+P Q L E +++ +
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT-------LAEQPYQGLSN--EEVLKFV 234
Query: 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+D EL M C Q NP+ RP+ E+V L+
Sbjct: 235 IDGGHLDLPENCPDKLLELMRM------CWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-15
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 30 LLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQ---SEVYVLNFARHKNIVMLL 85
+LG+G FG V LK G++ A KV K+ + + +E +L+ AR+ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 86 GFCCKENLNIL--VYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKGLRFLH 138
+CC + + L V E++ L +H+ FD + + YAA I +A L FLH
Sbjct: 62 -YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-----RFYAAEITSA--LMFLH 113
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE 198
+ +G II+RD++ N+LL H+ L DFG+ + + + GT Y+APE +
Sbjct: 114 D--KG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 199 NGIVSIRTDVYAFGIILLQLMSG 221
+ D +A G++L +++ G
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 9/146 (6%)
Query: 31 LGEGGFGHVYKGELKDGQMIAA--KVRKEASTQGFAEFQ-SEVYVLNFARHKNIVMLLGF 87
+GEG +G V+K + ++ I A +VR + +G E+ +L +HKNIV L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 88 CCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPII 147
+ LV+EY C++ L FD+ ++ + KGL F H ++
Sbjct: 68 LHSDKKLTLVFEY-CDQDLK-KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH----NVL 121
Query: 148 HRDMRPSNILLTHDFVPMLGDFGLAR 173
HRD++P N+L+ + L DFGLAR
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-15
Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 35/219 (15%)
Query: 27 KENLLGEGGFGHVYKG-ELKDGQMIAAKV---------RKEASTQGFAE-FQSEVYVLNF 75
K L+G+G +G VY + G+M+A K R ++ + + +SE+ L
Sbjct: 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 76 ARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAI------G 129
H NIV LGF E + EY+ S+ S L + R+ +
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSI--------GSCLRTYGRFEEQLVRFFTEQ 116
Query: 130 TAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD--DPVQTKIL- 186
+GL +LH + I+HRD++ N+L+ D + + DFG+++ K+ D D Q +
Sbjct: 117 VLEGLAYLHSK----GILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDNDQNMSMQ 171
Query: 187 GTLGYLAPEYAENGI--VSIRTDVYAFGIILLQLMSGRK 223
G++ ++APE + S + D+++ G ++L++ +GR+
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 5e-15
Identities = 80/290 (27%), Positives = 137/290 (47%), Gaps = 52/290 (17%)
Query: 31 LGEGGFGHVYKGELKD---GQM---IAAK-VRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
LG+G FG VY+G +D G+ +A K V + AS + EF +E V+ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 84 LLGFCCKENLNILVYEYICN---KSLHWHLFDNTES-------VLEWHQRYAAAIGTAKG 133
LLG K ++V E + + KS L E+ L+ + AA I A G
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI--ADG 131
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR--WKTTDDPVQTKILGTLGY 191
+ +L+ + +HRD+ N ++ HDF +GDFG+ R ++T K L + +
Sbjct: 132 MAYLNAK----KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE------ 245
+APE ++G+ + +D+++FG++L ++ S E+P Q L E +++
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSN--EQVLKFVMDGG 238
Query: 246 KLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
L + R+ + LM +C Q NP+ RP+ E+V LL+
Sbjct: 239 YLDQPDNCPERVTD--------LMR----MCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 36/222 (16%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVR--KE-ASTQGFAEFQSEVYVL-NFARH 78
D E+++GEG FG V + +K DG + A ++ KE AS +F E+ VL H
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFD------------------NTESVLEW 120
NI+ LLG C + EY + + +L D T S L
Sbjct: 63 PNIINLLGACENRGYLYIAIEY----APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 121 HQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180
Q A A G+++L E+ IHRD+ N+L+ + + DFGL+R ++
Sbjct: 119 QQLLQFASDVATGMQYLSEK----QFIHRDLAARNVLVGENLASKIADFGLSR---GEEV 171
Query: 181 VQTKILGTLG--YLAPEYAENGIVSIRTDVYAFGIILLQLMS 220
K +G L ++A E + + ++DV++FG++L +++S
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-15
Identities = 76/306 (24%), Positives = 141/306 (46%), Gaps = 56/306 (18%)
Query: 24 DFSKENL-----LGEGGFGHVYKGEL--------KDGQMIAAKVRKEASTQ-GFAEFQSE 69
+FS++ L LGEG FG V E K+ +A K+ K+ +T+ ++ SE
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 70 VYVLNF-ARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHL-----------FDNT--- 114
+ ++ +HKNI+ LLG C ++ ++ EY +L +L +D
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 115 ESVLEWHQRYAAAIGTAKGLRFL-HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173
+ + + + A+G+ +L ++C IHRD+ N+L+T + V + DFGLAR
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 174 WKTTDDPVQTKILGTL--GYLAPEYAENGIVSIRTDVYAFGIILLQL--MSGRKVVDMNG 229
D + G L ++APE + + + ++DV++FG+++ ++ + G +
Sbjct: 186 DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245
Query: 230 EEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGE 289
EE + L++ H + P + T ELY+M + C P RP+ +
Sbjct: 246 EELFKLLKEG----------HRMDKP----ANCTNELYMMMRD---CWHAIPSHRPTFKQ 288
Query: 290 VVRLLE 295
+V L+
Sbjct: 289 LVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 7e-15
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 42/284 (14%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQS----EVYVLNFARH 78
D + +LG+G G VYK K G++ A K + EF+ E+ L
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE---EFRKQLLRELKTLRSCES 58
Query: 79 KNIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIG--TAKGLR 135
+V G F + ++I V EY+ SL D + V + + A I KGL
Sbjct: 59 PYVVKCYGAFYKEGEISI-VLEYMDGGSLA----DLLKKVGKIPEPVLAYIARQILKGLD 113
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR-WKTTDDPVQTKILGTLGYLAP 194
+LH + IIHRD++PSN+L+ + DFG+++ + T D T + GT+ Y++P
Sbjct: 114 YLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSP 169
Query: 195 EYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQ--WAEPLIEKLALHEL 252
E + S D+++ G+ LL+ G+ P Q + E L++ +
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGK--------FPFLPPGQPSFFE-LMQAICDGPP 220
Query: 253 ID-PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
P E S + + C+Q++P+ RPS E LL+
Sbjct: 221 PSLPAEEFSPEFRDFISA------CLQKDPKKRPSAAE---LLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-15
Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 22 TGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV-----RKEASTQGFAEFQSEVYVLNF 75
+ K LLG G FG V+KG + +G I V + + Q F E + +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 76 ARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESV-----LEWHQRYAAAIGT 130
H IV LLG C +L LV + SL H+ + +S+ L W +
Sbjct: 66 LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQI 118
Query: 131 AKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP--VQTKILGT 188
AKG+ +L E ++HR++ NILL D + + DFG+A DD ++
Sbjct: 119 AKGMYYLEEHR----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP 174
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP-LIEK 246
+ ++A E G + ++DV+++G+ + ++MS G EP +R P L+EK
Sbjct: 175 IKWMALESILFGRYTHQSDVWSYGVTVWEMMS-------YGAEPYAGMRPHEVPDLLEK 226
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-15
Identities = 74/287 (25%), Positives = 130/287 (45%), Gaps = 43/287 (14%)
Query: 31 LGEGGFGHVYKGE------LKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVML 84
LGEG FG V+ E KD ++A K K+ + +FQ E +L +H++IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 85 LGFCCKENLNILVYEYI----CNKSLHWH------LFD----NTESVLEWHQRYAAAIGT 130
G C + I+V+EY+ NK L H L D + L Q A
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 131 AKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD--PVQTKILGT 188
A G+ +L + +HRD+ N L+ + + +GDFG++R + D V +
Sbjct: 133 ASGMVYLASQ----HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248
+ ++ PE + +DV++FG+IL ++ + G++P L +IE +
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT-------YGKQPWFQLSN--TEVIECIT 239
Query: 249 LHELID-PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294
+++ PR+ + Y++ L C QR P+ R ++ E+ ++L
Sbjct: 240 QGRVLERPRV-CPKEVYDIMLG------CWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 9e-15
Identities = 72/284 (25%), Positives = 125/284 (44%), Gaps = 38/284 (13%)
Query: 31 LGEGGFGHVYKGEL------KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVML 84
LGEG FG V+ E +D ++A K K+AS +F E +L +H++IV
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 85 LGFCCKENLNILVYEYI----CNKSLHWHLFD-------NTESVLEWHQRYAAAIGTAKG 133
G C + + I+V+EY+ NK L H D N + L Q A A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR--WKTTDDPVQTKILGTLGY 191
+ +L + +HRD+ N L+ + + +GDFG++R + T V + + +
Sbjct: 133 MVYLASQ----HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251
+ PE + +DV++ G++L ++ + G++P L +IE +
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT-------YGKQPWYQLSN--NEVIECITQGR 239
Query: 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
++ + Y+L L C QR P R ++ E+ LL+
Sbjct: 240 VLQRPRTCPKEVYDLMLG------CWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-15
Identities = 69/210 (32%), Positives = 99/210 (47%), Gaps = 31/210 (14%)
Query: 30 LLGEGGFGHVYKGELKD-GQMIAA------------KVRKEASTQGFAEFQSEVYVLNFA 76
LG G FG VYK K+ GQ + A K ++E + + SEV ++
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRE-RDKSIGDIVSEVTIIKEQ 65
Query: 77 -RHKNIVMLL-GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRY------AAAI 128
RH NIV F + L I V + I L H S+ E QR+ +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYI-VMDLIEGAPLGEHF----NSLKEKKQRFTEERIWNIFV 120
Query: 129 GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT 188
LR+LH+E R I+HRD+ P+NI+L D + DFGLA+ K + + T ++GT
Sbjct: 121 QMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL-TSVVGT 176
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQL 218
+ Y PE +N + DV+AFG IL Q+
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 42/211 (19%)
Query: 31 LGEGGFGHVYKGELKD-GQMIAAK----------VRKEASTQGFAEFQSEVYVLNFARHK 79
+GEG +G V+K ++ GQ++A K ++K A E+ +L +H
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--------LREIRMLKQLKHP 60
Query: 80 NIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
N+V L+ F K L+ LV+EY C+ ++ L N V E H T + + F H
Sbjct: 61 NLVNLIEVFRRKRKLH-LVFEY-CDHTVLNELEKNPRGVPE-HLIKKIIWQTLQAVNFCH 117
Query: 139 EE-CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE-- 195
+ C IHRD++P NIL+T L DFG AR T T + T Y APE
Sbjct: 118 KHNC-----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL 172
Query: 196 -----YAENGIVSIRTDVYAFGIILLQLMSG 221
Y DV+A G + +L++G
Sbjct: 173 VGDTQYGPP------VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 80/296 (27%), Positives = 137/296 (46%), Gaps = 55/296 (18%)
Query: 31 LGEGGFGHVYKGEL----KD----GQMIAAKVRKEAST-QGFAEFQSEVYVLNF-ARHKN 80
LGEG FG V E KD +A K+ K+ +T + ++ SE+ ++ +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHL-----------FDNT---ESVLEWHQRYAA 126
I+ LLG C ++ ++ EY +L +L FD E L + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 127 AIGTAKGLRFL-HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKI 185
A A+G+ +L ++C IHRD+ N+L+T D V + DFGLAR D +
Sbjct: 140 AYQVARGMEYLASQKC-----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 186 LGTL--GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL 243
G L ++APE + + + ++DV++FG++L ++ + G P + P+
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT-------LGGSPYPGI-----PV 242
Query: 244 IEKLAL----HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E L H + P + T+ELY++ + + V P RP+ ++V L+
Sbjct: 243 EELFKLLKEGHRMDKP----ANCTHELYMIMRECWHAV---PSQRPTFKQLVEDLD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 70/279 (25%), Positives = 129/279 (46%), Gaps = 38/279 (13%)
Query: 31 LGEGGFGHVY----KGELKD---GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
LG+G FG VY KG +KD ++ V + AS + EF +E V+ ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLF--------DNTESVLEWHQRYAAAIGTAKGLR 135
LLG + +++ E + L +L + ++ + A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR--WKTTDDPVQTKILGTLGYLA 193
+L+ +HRD+ N ++ DF +GDFG+ R ++T K L + +++
Sbjct: 134 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253
PE ++G+ + +DV++FG++L ++ + E+P Q + E ++ + L+
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGMSN--EQVLRFVMEGGLL 240
Query: 254 DPRIENSYDT-YELYLMAKTAYLCVQRNPEGRPSMGEVV 291
D + +N D +EL M C Q NP+ RPS E++
Sbjct: 241 D-KPDNCPDMLFELMRM------CWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 42/227 (18%)
Query: 21 ATGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV------RKEASTQGFAEFQSEVYVL 73
TG F ++GEG +G VYK K GQ++A K+ +E E + E +L
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-------EIKEEYNIL 56
Query: 74 -NFARHKNIVMLLGFCCKENLNI------LVYEYICNKSLHWHLFDNTESVLEWHQR--- 123
++ H NI G K+N LV E S+ D + + + +R
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV----TDLVKGLRKKGKRLKE 112
Query: 124 -YAAAI--GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR-WKTTDD 179
+ A I T +GL +LHE +IHRD++ NILLT + L DFG++ +T
Sbjct: 113 EWIAYILRETLRGLAYLHEN----KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG 168
Query: 180 PVQTKILGTLGYLAPEY---AENGIVSI--RTDVYAFGIILLQLMSG 221
T I GT ++APE E S R+DV++ GI ++L G
Sbjct: 169 RRNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 29 NLLGEGGFGHVYKGEL--KDG----QMIAAKVRKE-ASTQGFAEFQSEVYVLNFARHKNI 81
LG G FG VY+G +DG +A K E S Q ++F E +++ H+NI
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDN-----TESVLEWHQRYAAAIGTAKGLRF 136
V L+G + ++ E + L L +N S L A AKG ++
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 137 LHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLAR--WKTTDDPVQTKILGTLGY 191
L EE IHRD+ N LLT V + DFG+AR ++ + + + + +
Sbjct: 132 L-EENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMS 220
+ PE +GI + +TDV++FG++L ++ S
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-14
Identities = 67/267 (25%), Positives = 116/267 (43%), Gaps = 26/267 (9%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK 90
+G G FG V+ G + + +A K +E + +F E V+ H +V L G C +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRD 150
+ LV+E++ + L +L + +G+ +L +IHRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLESSN----VIHRD 125
Query: 151 MRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAPEYAENGIVSIRTD 207
+ N L+ + V + DFG+ R+ D T GT + + +PE S ++D
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 208 VYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELY 267
V++FG+++ ++ S G+ P ++ R +E + A L PR+ S YE
Sbjct: 184 VWSFGVLMWEVFS-------EGKTPYEN-RSNSEVVETINAGFRLYKPRLA-SQSVYE-- 232
Query: 268 LMAKTAYLCVQRNPEGRPSMGEVVRLL 294
LM C + PE RPS ++ L
Sbjct: 233 LMQH----CWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-14
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
DF +G G +G VYK + G++ A KV K + FA Q E+ ++ +H NIV
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
G + + + E+ SL ++ T + E Y + T +GL +LH + +
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQ-DIYHVTGPLSESQIAYVSR-ETLQGLYYLHSKGK 127
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYA---EN 199
+HRD++ +NILLT + L DFG++ T + +GT ++APE A
Sbjct: 128 ----MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 200 GIVSIRTDVYAFGIILLQL 218
G + D++A GI ++L
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-14
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 25 FSKENLLGEGGFGHVYKGE-LKDGQMIA-AKVRKEASTQGFAEFQ-SEVYVLNFARHKNI 81
F K +GEG +G VYK G+++A K+R + T+G E+ +L H NI
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
V LL EN LV+E++ ++ L + + S + + +GL F C
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF----C 116
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKI--LGTLGYLAPE-YAE 198
++HRD++P N+L+ + L DFGLAR PV+T + TL Y APE
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEILLG 174
Query: 199 NGIVSIRTDVYAFGIILLQLMSGR 222
S D+++ G I ++++ R
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 22/199 (11%)
Query: 31 LGEGGFGHVY--KGELKDGQMIAAKV--------RKEASTQGFAEFQSEVYVLNFARHKN 80
+GEG FG +Y K + + ++ KEAS + EV +L +H N
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-------KKEVILLAKMKHPN 60
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEE 140
IV + +V EY L + + Q + + + GL+ +H+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 141 CRGGPIIHRDMRPSNILLTHD-FVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN 199
I+HRD++ NI L+ + V LGDFG+AR + +GT YL+PE +N
Sbjct: 121 ----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 200 GIVSIRTDVYAFGIILLQL 218
+ +TD+++ G +L +L
Sbjct: 177 RPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-14
Identities = 55/268 (20%), Positives = 116/268 (43%), Gaps = 31/268 (11%)
Query: 31 LGEGGFGH--VYKGELKDGQMIAAKVR-KEASTQGFAEFQSEVYVLNFARHKNIVMLLGF 87
LG+G FG +Y+ D ++ +V S + + +E+ +L+ +H NI+
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 88 CCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPII 147
+N ++ EY +L+ + + E + ++H+ I+
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA----GIL 123
Query: 148 HRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTD 207
HRD++ NI LT + LGDFG+++ ++ + ++GT Y++PE + + ++D
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSD 183
Query: 208 VYAFGIILLQLMSGRKVVDM-NGEEPQQSLRQ--WA-EPLIEKLALHELIDPRIENSYDT 263
++A G +L +L++ ++ D N + Q + + L L+
Sbjct: 184 IWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLV---------- 233
Query: 264 YELYLMAKTAYLCVQRNPEGRPSMGEVV 291
+ +Q++PE RP+ EV+
Sbjct: 234 ----------HSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-14
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 9/201 (4%)
Query: 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKNIV 82
+ K + LGEG + V+KG K ++A K +R E EV +L +H NIV
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
L E LV+EY+ + + DN +++ H +GL + H+
Sbjct: 67 TLHDIIHTERCLTLVFEYLDSDLKQY--LDNCGNLMSMHNVKIFMFQLLRGLSYCHKR-- 122
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI- 201
I+HRD++P N+L+ L DFGLAR K+ + + TL Y P+
Sbjct: 123 --KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 202 VSIRTDVYAFGIILLQLMSGR 222
S D++ G IL ++ +GR
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 31/273 (11%)
Query: 25 FSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRK-EASTQGFAEFQSEVYVLNFARHKNIV 82
F+K +G+G FG VYKG + + +++A K+ E + + Q E+ VL+ I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAI--GTAKGLRFLHEE 140
G K ++ EY+ S L LE + Y A I KGL +LH E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLE--ETYIATILREILKGLDYLHSE 120
Query: 141 CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENG 200
+ IHRD++ +N+LL+ L DFG+A T + +GT ++APE +
Sbjct: 121 RK----IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 201 IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260
+ D+++ GI ++L GE P L P+ + + P +E
Sbjct: 177 AYDFKADIWSLGITAIEL--------AKGEPPNSDL----HPMRVLFLIPKNSPPTLEGQ 224
Query: 261 YDT-YELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
Y ++ ++ A C+ ++P RP+ E+++
Sbjct: 225 YSKPFKEFVEA-----CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 73/296 (24%), Positives = 118/296 (39%), Gaps = 48/296 (16%)
Query: 25 FSKENL-----LGEGGFGHVYKGELK------DGQMIAAKV---RKEASTQGFAEFQSEV 70
F + NL LG G FG V+ + K ++ K K+ + Q +EF+ E+
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQ--SEFRREL 59
Query: 71 YVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESV-------LEWHQR 123
+ HKN+V LLG C + + ++ EY L L L Q+
Sbjct: 60 DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 124 YAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD---P 180
A A G+ L +HRD+ N L++ + L++ +
Sbjct: 120 VALCTQIALGMDHLSN----ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKL 175
Query: 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240
I L +LAPE + S ++DV++FG+++ ++ + GE P L
Sbjct: 176 RNALI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-------QGELPFYGLSD-- 224
Query: 241 EPLIEKLALHELIDPRIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E ++ +L +L P E LY LM + C NP+ RPS E+V L
Sbjct: 225 EEVLNRLQAGKLELPVPEGCPSR--LYKLMTR----CWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 79/312 (25%), Positives = 122/312 (39%), Gaps = 84/312 (26%)
Query: 31 LGEGGFGHVYKGEL------KDGQMIAAKVRKE-ASTQGFAEFQSEVYVLNFARHKNIVM 83
+G+G FG V++ + M+A K+ KE AS A+FQ E ++ H NIV
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDN----TESVLEWHQRYAA------------- 126
LLG C L++EY+ L+ L S+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 127 ---AIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183
A A G+ +L E +HRD+ N L+ + V + DFGL+R
Sbjct: 133 LCIAKQVAAGMAYLSER----KFVHRDLATRNCLVGENMVVKIADFGLSR---------- 178
Query: 184 KILGTLGYLAPEY--AENGIVSIR---------------TDVYAFGIILLQLMSGRKVVD 226
I Y A Y +EN + IR +DV+A+G++L ++ S
Sbjct: 179 NI-----YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS------ 227
Query: 227 MNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT--YELY-LMAKTAYLCVQRNPEG 283
G +P + E +I + + D + + D ELY LM LC + P
Sbjct: 228 -YGMQPYYGMAH--EEVI-----YYVRDGNVLSCPDNCPLELYNLMR----LCWSKLPSD 275
Query: 284 RPSMGEVVRLLE 295
RPS + R+L+
Sbjct: 276 RPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 9/201 (4%)
Query: 25 FSKENLLGEGGFGHVYKG--ELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
+ K + LGEG + VYKG +L D + ++R E EV +L +H NIV
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
L E LV+EY+ +K L +L D+ + + H +GL + H
Sbjct: 68 TLHDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYCHRR-- 123
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI- 201
++HRD++P N+L+ L DFGLAR K+ + + TL Y P+
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTD 181
Query: 202 VSIRTDVYAFGIILLQLMSGR 222
S + D++ G I ++ +GR
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIA-AKVRKEASTQGFAEFQ-SEVYVLNFARHKN 80
D++K +GEG +G VYKG K GQ++A K+R E+ +G E+ +L +H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESV----LEWHQRYAAAIGTAKGLRF 136
IV L +E+ L++E++ + L +L D+ E + Y I +G+ F
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQI--LQGILF 116
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY 196
H ++HRD++P N+L+ + V L DFGLAR V T + TL Y APE
Sbjct: 117 CHSR----RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172
Query: 197 AENGI-VSIRTDVYAFGIILLQLMSGR 222
S D+++ G I ++ + +
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 38/210 (18%)
Query: 30 LLGEGGFGHVYKGELKD-GQMIAAK----------VRKEASTQGFAEFQSEVYVLNFARH 78
L+GEG +G V K + K+ GQ++A K V+K A E+ +L RH
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA--------MREIRMLKQLRH 59
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
+N+V L+ ++ LV+E++ D+T VL+ ++Y + ++ ++L
Sbjct: 60 ENLVNLIEVFRRKKRLYLVFEFV----------DHT--VLDDLEKYPNGLDESRVRKYLF 107
Query: 139 EECRG------GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL 192
+ RG IIHRD++P NIL++ V L DFG AR V T + T Y
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYR 167
Query: 193 APEYAENGIVSIR-TDVYAFGIILLQLMSG 221
APE R D++A G ++ ++++G
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 9/201 (4%)
Query: 25 FSKENLLGEGGFGHVYKG--ELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
+ K LGEG + V+KG +L + + ++R E EV +L +H NIV
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
L + LV+EY+ +K L ++ D+ +++ H +GL + H
Sbjct: 68 TLHDIVHTDKSLTLVFEYL-DKDLKQYM-DDCGNIMSMHNVKIFLYQILRGLAYCHRR-- 123
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE-YAENGI 201
++HRD++P N+L+ L DFGLAR K+ + + TL Y P+ +
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181
Query: 202 VSIRTDVYAFGIILLQLMSGR 222
S + D++ G I ++ SGR
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 31 LGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQ-SEVYVLNFARHKNIVMLLGFC 88
LGEG + VYKG + G+++A K + +G E+ ++ +H+NIV L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 89 CKENLNILVYEYICNKSLHWHLFDNTES-VLEWHQRYAAAIGTAKGLRFLHEECRGGPII 147
EN +LV+EY +K L ++ + L+ + + KG+ F HE ++
Sbjct: 68 HTENKLMLVFEY-MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN----RVL 122
Query: 148 HRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT--KILGTLGYLAPEYAENGIVSIR 205
HRD++P N+L+ L DFGLAR PV T + TL Y AP+ ++ R
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLAR--AFGIPVNTFSNEVVTLWYRAPDV----LLGSR 176
Query: 206 T-----DVYAFGIILLQLMSGR 222
T D+++ G I+ ++++GR
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-13
Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 29 NLLGEGGFGHVYKGELK-DG-QMIAA-KVRKE-ASTQGFAEFQSEVYVL-NFARHKNIVM 83
+++GEG FG V K +K DG +M AA K KE AS +F E+ VL H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGL------R 135
LLG C L EY + H +L D VLE +A A TA L
Sbjct: 61 LLGACEHRGYLYLAIEY----APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 136 FLHEECRG------GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL 189
F + RG IHRD+ NIL+ ++V + DFGL+R + K +G L
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 173
Query: 190 G--YLAPEYAENGIVSIRTDVYAFGIILLQLMS 220
++A E + + +DV+++G++L +++S
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 13/216 (6%)
Query: 30 LLGEGGFGHVYKGELKDGQMIAAK--VRKEA--STQGFAEFQSEVYVLNFARHKNIVMLL 85
++G G + V LK I A V+KE + Q+E +V A ++ L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 86 GFCCK-ENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-YAAAIGTAKGLRFLHEECRG 143
C + + LV EY+ L +H+ + E H R YAA I A L FLHE RG
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIA--LNFLHE--RG 116
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVS 203
II+RD++ N+LL D L D+G+ + + GT Y+APE
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 204 IRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQW 239
D +A G+++ ++M+GR D+ + P + +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 7e-13
Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 30 LLGEGGFGHV-YKGELKDGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVML- 84
LLG+G FG V E G+ A K+ K+ + A +E VL RH + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 85 LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGG 144
F K+ L V EY+ L +HL + + Y A I +A L +LH G
Sbjct: 62 YSFQTKDRL-CFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA--LDYLHS----G 114
Query: 145 PIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSI 204
I++RD++ N++L D + DFGL + TD GT YLAPE E+
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 205 RTDVYAFGIILLQLMSGR 222
D + G+++ ++M GR
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-13
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 33/229 (14%)
Query: 17 EIQQATGDFSKENLLGEGGFGHVYKGEL------KDGQMIAAKVRKEASTQGF-AEFQSE 69
EI +T F +E LGE FG VYKG L + Q +A K K+ + EF+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 70 VYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLF-------------DNT-E 115
+ + +H NIV LLG KE +++ Y + LH L D T +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 116 SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175
S LE A G+ FL ++H+D+ N+L+ + D GL R
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 176 TTDDPVQTKILGT----LGYLAPEYAENGIVSIRTDVYAFGIILLQLMS 220
D K++G + +++PE G SI +D++++G++L ++ S
Sbjct: 175 YAAD--YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 66/271 (24%), Positives = 118/271 (43%), Gaps = 27/271 (9%)
Query: 25 FSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRK-EASTQGFAEFQSEVYVLNFARHKNIV 82
F+K +G+G FG V+KG + + +++A K+ E + + Q E+ VL+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTE-SVLEWHQRYAAAIGTAKGLRFLHEEC 141
G K+ ++ EY+ S D E L+ Q KGL +LH E
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI 201
+ IHRD++ +N+LL+ L DFG+A T + +GT ++APE +
Sbjct: 122 K----IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 202 VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261
+ D+++ GI ++L GE P L P+ + + P +E +Y
Sbjct: 178 YDSKADIWSLGITAIEL--------AKGEPPHSEL----HPMKVLFLIPKNNPPTLEGNY 225
Query: 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
+ + C+ + P RP+ E+++
Sbjct: 226 SK----PLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 71/272 (26%), Positives = 120/272 (44%), Gaps = 30/272 (11%)
Query: 31 LGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCC 89
LG+G FG VYK + K+ G + AAKV + S + ++ E+ +L H IV LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 90 KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHR 149
+ ++ E+ ++ + + + E Q + L++LH IIHR
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQVICRQMLEALQYLHSM----KIIHR 134
Query: 150 DMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYA-----ENGIVSI 204
D++ N+LLT D L DFG++ + +GT ++APE ++
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194
Query: 205 RTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN-SYDT 263
+ D+++ GI L+++ E P L P+ L + + P + S +
Sbjct: 195 KADIWSLGITLIEM--------AQIEPPHHEL----NPMRVLLKIAKSEPPTLSQPSKWS 242
Query: 264 YELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E KTA + ++PE RPS +LLE
Sbjct: 243 MEFRDFLKTA---LDKHPETRPS---AAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 14/215 (6%)
Query: 30 LLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQS---EVYVLNFARHKNIV--M 83
+LG+G FG V+ ELK Q A K K+ + + E VL+ A + +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
F KENL V EY+ L +H+ + L YAA I GL+FLH +
Sbjct: 62 YCTFQTKENL-FFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEI--ICGLQFLHSK--- 115
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVS 203
I++RD++ NILL D + DFG+ + D GT Y+APE +
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174
Query: 204 IRTDVYAFGIILLQLMSGRKVVD-MNGEEPQQSLR 237
D ++FG++L +++ G+ + EE QS+R
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 24/202 (11%)
Query: 9 DPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFA-E 65
D +F F + + K +G+G FG V+K K Q++A K V E +GF
Sbjct: 1 DQYEFPFCDE---VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPIT 57
Query: 66 FQSEVYVLNFARHKNIVMLLGFCCKENLN--------ILVYEYICNKSLHWHLFDNTESV 117
E+ +L +H+N+V L+ C + LV+E+ C L L N
Sbjct: 58 ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF-CEHDLA-GLLSNKNVK 115
Query: 118 LEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW--- 174
+ GL ++H I+HRDM+ +NIL+T D + L DFGLAR
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRN----KILHRDMKAANILITKDGILKLADFGLARAFSL 171
Query: 175 -KTTDDPVQTKILGTLGYLAPE 195
K + T + TL Y PE
Sbjct: 172 SKNSKPNRYTNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 63/281 (22%), Positives = 126/281 (44%), Gaps = 40/281 (14%)
Query: 25 FSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRK-EASTQGFAEFQSEVYVLNFARH---K 79
+ + L+G G +G VY+G + G+++A K+ + ++ Q EV +L+ R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLE---WHQRYAAAI--GTAKGL 134
NI G K ++ EY S+ ++++ ++Y + I L
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSV--------RTLMKAGPIAEKYISVIIREVLVAL 114
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAP 194
+++H+ +IHRD++ +NIL+T+ L DFG+A + ++ +GT ++AP
Sbjct: 115 KYIHKV----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170
Query: 195 EYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253
E G + D+++ GI + ++ +G + + +++ LI K
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNP--PYSDVDAFRAMM-----LIPKSK----- 218
Query: 254 DPRIE-NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293
PR+E N Y L+ + C+ P+ R S E+++
Sbjct: 219 PPRLEDNGYSK----LLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 31 LGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGF-AEFQSEVYVLNFARHKNIVMLLGFC 88
+G G FG V+ G L+ D +A K +E A+F E +L H NIV L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 89 CKENLNILVYEYICNKSLHWHLFDNTESV-LEWHQRYAAAIGTAKGLRFLHEECRGGPII 147
++ +V E + + + F TE L+ + A G+ +L + I
Sbjct: 63 TQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH----CI 116
Query: 148 HRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT----LGYLAPEYAENGIVS 203
HRD+ N L+T V + DFG++R +D V G + + APE G S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 204 IRTDVYAFGIILLQLMS 220
+DV++FGI+L + S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-12
Identities = 72/288 (25%), Positives = 115/288 (39%), Gaps = 47/288 (16%)
Query: 31 LGEGGFGHVYKGELKDG----QMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLG 86
+G G FG V GE G +++ ++R A+ F EV H N++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 87 FCCKENLNILVYEYICNKSLHWHLFDNTESVL-----EWHQRYAAAIGTAKGLRFLHEEC 141
C + +LV E+ L +L N V + QR A + A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV--ASGLLWLHQ-- 118
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK--ILGTLGYLAPEYAEN 199
IH D+ N LT D +GD+GLA + +D TK L +LAPE E
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 200 GIVSIRT-------DVYAFGIILLQLMSGRKVVDMNGEEP------QQSLRQWAEPLIEK 246
+ ++++ G+ + +L + ++P +Q L+Q K
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFT-------AADQPYPDLSDEQVLKQVVREQDIK 229
Query: 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294
L +L + Y+ + + +PE RP+ EV LL
Sbjct: 230 LPKPQLDLKYSDRWYEVMQFCWL----------DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFA-EFQSEVYVLNFAR---HKNIVML 84
+G G +G VYK + G +A K VR + + G EV +L H NIV L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 85 LGFCC-----KENLNILVYEYICNKSLHWHLFD------NTESVLEWHQRYAAAIGTAKG 133
+ C +E LV+E++ ++ L +L E++ + +++ +G
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFL------RG 120
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLA 193
L FLH C I+HRD++P NIL+T L DFGLAR + + T ++ TL Y A
Sbjct: 121 LDFLHANC----IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL-TPVVVTLWYRA 175
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ 233
PE + D+++ G I ++ + + N E Q
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 25 FSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAE-----FQSEVYVLNFARHK 79
+ K ++G G FG V+ K Q + + K+ + + Q+E VL H
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLV--IIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
NI+ ++ ++V EY +L ++ S+L+ + L +H
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 140 ECRGGPIIHRDMRPSNILLT-HDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE 198
+ I+HRD++ NILL H V +GDFG+++ ++ T ++GT Y++PE E
Sbjct: 120 KL----ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCE 174
Query: 199 NGIVSIRTDVYAFGIILLQLMSGRKVVD 226
+ ++D++A G +L +L S ++ +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-12
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 11/201 (5%)
Query: 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQG--FAEFQSEVYVLNFARHKNI 81
+ K LGEG + VYKG+ K +G+++A KV + +G F + E +L +H NI
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANI 65
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
V+L + LV+EY+ + D L +GL ++H+
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHTDLCQY--MDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI 201
I+HRD++P N+L++ L DFGLAR K+ + + TL Y P+
Sbjct: 124 ----ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST 179
Query: 202 -VSIRTDVYAFGIILLQLMSG 221
S D++ G I ++++ G
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 76/298 (25%), Positives = 129/298 (43%), Gaps = 58/298 (19%)
Query: 4 ELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQG 62
EL+ KD + FS++++ +G G FG VY ++++ +++A K + Q
Sbjct: 6 ELFFKDDPEKLFSDLRE----------IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 55
Query: 63 FAEFQ---SEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLE 119
++Q EV L RH N + G +E+ LV EY + +LE
Sbjct: 56 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC---------LGSASDLLE 106
Query: 120 WHQR-----YAAAI--GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172
H++ AA+ G +GL +LH +IHRD++ NILL+ + LGDFG A
Sbjct: 107 VHKKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSA 162
Query: 173 RWKTTDDPVQTKILGTLGYLAPEY---AENGIVSIRTDVYAFGIILLQLMSGR-KVVDMN 228
+ P +GT ++APE + G + DV++ GI ++L + + +MN
Sbjct: 163 ---SIMAPANX-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
Query: 229 GEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS 286
+ Q P ++ E N D+ C+Q+ P+ RP+
Sbjct: 219 AMSALYHIAQNESPALQSGHWSE----YFRNFVDS------------CLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 70/296 (23%), Positives = 128/296 (43%), Gaps = 50/296 (16%)
Query: 31 LGEGGFGHVYKG---ELKDG---QMIAAKVRKEASTQG-FAEFQSEVYVLNFARHKNIVM 83
LGEG FG V K LK +A K+ KE ++ + SE +L H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 84 LLGFCCKENLNILVYEYICNKSLH----------------------WHLFDNTESVLEWH 121
L G C ++ +L+ EY SL +L + E L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 122 QRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181
+ A ++G+++L E ++HRD+ N+L+ + DFGL+R +D
Sbjct: 128 DLISFAWQISRGMQYLAEM----KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 182 QTKILGTL--GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQW 239
+ G + ++A E + I + ++DV++FG++L ++++ G P +
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-------LGGNPYPGIA-- 234
Query: 240 AEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E L L ++ R EN + E+Y + T C ++ P+ RP+ ++ + LE
Sbjct: 235 PERLFNLLKTGYRME-RPENCSE--EMYNLMLT---CWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAA--KVRKEASTQGFA-EFQSEVYVLNFAR---HKNIVM 83
+GEG +G V+K +LK+G A +VR + +G EV VL H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 84 LLGFCC-----KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
L C +E LV+E++ ++ L +L E + +GL FLH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE 198
++HRD++P NIL+T L DFGLAR + T ++ TL Y APE
Sbjct: 128 SH----RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-QMALTSVVVTLWYRAPEVLL 182
Query: 199 NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ 233
+ D+++ G I ++ + + + + Q
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 13/209 (6%)
Query: 30 LLGEGGFGHVYKGELKDGQMI-AAKVRKEASTQGFAEF---QSEVYVLNFARHKNIVMLL 85
++G G + V ELK + I A KV K+ + Q+E +V A + ++ L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 86 GFCCK-ENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-YAAAIGTAKGLRFLHEECRG 143
C + E+ V E++ L +H+ + E H R Y+A I A L FLHE RG
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHM-QRQRKLPEEHARFYSAEISLA--LNFLHE--RG 116
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVS 203
II+RD++ N+LL + L D+G+ + + GT Y+APE
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 204 IRTDVYAFGIILLQLMSGRKVVDMNGEEP 232
D +A G+++ ++M+GR D+ G
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 31 LGEGGFGHV----YKGELKD-GQMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKNIVML 84
LGEG FG V Y E + G+ +A K ++ E+ A+ + E+ +L H+NIV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 85 LGFCCKENLN--ILVYEYICNKSLHWHLFDNTESV-LEWHQRYAAAIGTAKGLRFLHEEC 141
G C ++ N L+ E++ + SL +L N + L+ +YA I KG+ +L
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI--CKGMDYLGSR- 128
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD---PVQTKILGTLGYLAPEYAE 198
+HRD+ N+L+ + +GDFGL + TD V+ + + + APE
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 199 NGIVSIRTDVYAFGIILLQLMS 220
I +DV++FG+ L +L++
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 31 LGEGGFGHVYKGELK-DGQMIAAKVRKEASTQG--FAEFQSEVYVLNFARHKNIVMLLGF 87
LGEG + VYKG + +GQ++A KV + +G F + E +L +H NIV+L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDI 71
Query: 88 C-CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPI 146
KE L V+EY+ + L ++ + L + +GL ++H G I
Sbjct: 72 IHTKETLT-FVFEYM-HTDLAQYMIQHPGG-LHPYNVRLFMFQLLRGLAYIH----GQHI 124
Query: 147 IHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI-VSIR 205
+HRD++P N+L+++ L DFGLAR K+ + + TL Y P+ S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 206 TDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQW 239
D++ G I ++++ G+ + +Q + W
Sbjct: 185 LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 62/203 (30%), Positives = 87/203 (42%), Gaps = 25/203 (12%)
Query: 31 LGEGGFGHVYKGELK-DGQMIAAKV--------RKEASTQGFAEFQSEVYVL-NFARHKN 80
+G+G FG V + K DG+ A KV +KE +E VL +H
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQK-----HIMAERNVLLKNVKHPF 57
Query: 81 IVML-LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-YAAAIGTAKGLRFLH 138
+V L F + L V +Y+ L +HL S E R YAA I +A G +LH
Sbjct: 58 LVGLHYSFQTADKL-YFVLDYVNGGELFFHL-QRERSFPEPRARFYAAEIASALG--YLH 113
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE 198
II+RD++P NILL +L DFGL + + GT YLAPE
Sbjct: 114 SL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR 169
Query: 199 NGIVSIRTDVYAFGIILLQLMSG 221
D + G +L +++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-12
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 27 KENLLGEGGFGHVYKG-ELKDGQMIAAK----VRKEASTQG--FAEFQSEVYVLNFARHK 79
K LG G F Y+ ++K G ++A K VR +S Q + E+ ++ H
Sbjct: 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 80 NIVMLLGFCC-KENLNILVYEYICNKSLHWHLFDN----TESVLEWHQRYAAAIGTAKGL 134
+I+ +LG C + N+ V E++ S+ HL E+V+ Y + +GL
Sbjct: 64 HIIRMLGATCEDSHFNLFV-EWMAGGSVS-HLLSKYGAFKEAVI---INYTEQL--LRGL 116
Query: 135 RFLHEECRGGPIIHRDMRPSNILLT---HDFVPMLGDFGLARWKTTD----DPVQTKILG 187
+LHE IIHRD++ +N+L+ + DFG A Q ++LG
Sbjct: 117 SYLHEN----QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLG 170
Query: 188 TLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
T+ ++APE DV++ G +++++ + +
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 65/204 (31%), Positives = 93/204 (45%), Gaps = 27/204 (13%)
Query: 31 LGEGGFGHVYKGELK-DGQMIAAK-VRKEASTQGFAE--FQSEVYVLNFARHKNIVMLL- 85
LG GGFG V ++K + A K V+K + + SE +L H IV L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 86 GFCCKENLNILVYEYICNKSLHWH------LFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
F K+ + +L+ EY L W LFD + + Y A + A +LH
Sbjct: 61 TFKDKKYIYMLM-EYCLGGEL-WTILRDRGLFDEYTA-----RFYIACVVLA--FEYLHN 111
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK-ILGTLGYLAPEYAE 198
RG II+RD++P N+LL + L DFG A K +T GT Y+APE
Sbjct: 112 --RG--IIYRDLKPENLLLDSNGYVKLVDFGFA--KKLKSGQKTWTFCGTPEYVAPEIIL 165
Query: 199 NGIVSIRTDVYAFGIILLQLMSGR 222
N D ++ GI+L +L++GR
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-12
Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 29 NLLGEGGFGHVYKGEL--KDGQMIAAKVR---KEASTQGFAEFQSEVYVLNFARHKNIVM 83
++G+G FG VY G L DGQ I V+ + + +F E ++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 84 LLGFCC-KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
LLG C E ++V Y+ + L + + + AKG+ +L +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLR-NFIRSETHNPTVKDLIGFGLQVAKGMEYLASK-- 117
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLAR--WKTTDDPVQTKILGTL--GYLAPEYAE 198
+HRD+ N +L F + DFGLAR + V L ++A E +
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 199 NGIVSIRTDVYAFGIILLQLMS 220
+ ++DV++FG++L +LM+
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-12
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 25 FSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVML 84
F KE LG G FG V G+ + +A K+ KE S EF E V+ H+ +V L
Sbjct: 8 FLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQL 64
Query: 85 LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGG 144
G C K+ +V EY+ N L +L + Q +G+ +L +
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLESK---- 119
Query: 145 PIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAPEYAENGI 201
IHRD+ N L+ + DFGL+R+ D+ T +G+ + + PE
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSK 177
Query: 202 VSIRTDVYAFGIILLQLMS 220
S ++DV+AFG+++ ++ S
Sbjct: 178 FSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-12
Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAKV---RKEASTQGFAEFQSEVYVLNFARHKN 80
F + +LG+GGFG V +++ G+M A K ++ +G + +E +L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 81 IVML-LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR--YAAAIGTAKGLRFL 137
+V L + K+ L LV + L +H++ E+ E + YAA I GL L
Sbjct: 62 VVSLAYAYETKDAL-CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICC--GLEDL 118
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYA 197
H+E I++RD++P NILL + D GLA ++ ++ GT+GY+APE
Sbjct: 119 HQE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVV 173
Query: 198 ENGIVSIRTDVYAFGIILLQLMSGR 222
+N + D +A G +L ++++G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 74/277 (26%), Positives = 119/277 (42%), Gaps = 48/277 (17%)
Query: 31 LGEGGFGHVY-KGELKDGQMIAAKVRKEASTQGFAEFQ---SEVYVLNFARHKNIVMLLG 86
+G G FG VY +++A K + Q ++Q EV L +H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 87 FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-----YAAAI--GTAKGLRFLHE 139
KE+ LV EY + +LE H++ AAI G +GL +LH
Sbjct: 89 CYLKEHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY--- 196
+IHRD++ NILLT L DFG A + P + +GT ++APE
Sbjct: 140 HN----MIHRDIKAGNILLTEPGQVKLADFGSA---SKSSPANS-FVGTPYWMAPEVILA 191
Query: 197 AENGIVSIRTDVYAFGIILLQLMSGR-KVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255
+ G + DV++ GI ++L + + +MN + Q P ++ +E D
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQS---NEWTD- 247
Query: 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
S+ + Y C+Q+ P+ RP+ E++R
Sbjct: 248 ----SFRGFVDY--------CLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 84/315 (26%), Positives = 131/315 (41%), Gaps = 67/315 (21%)
Query: 27 KENLLGEGGFGHV----YKGELKD-GQMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKN 80
K +LGEG FG V Y G+M+A K +++E Q + ++ E+ +L H+N
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 81 IVMLLGFCCKENLN---ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFL 137
IV G CC E L+ EY+ SL +L + L Q A +G+ +L
Sbjct: 68 IVKYKG-CCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYL 123
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT-----------DDPVQTKIL 186
H + IHRD+ N+LL +D + +GDFGLA+ D PV
Sbjct: 124 HSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV----- 174
Query: 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG--------RKVVDMNGEEPQQSLRQ 238
+ A E + S +DV++FG+ L +L++ +K +M G P+Q
Sbjct: 175 ---FWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG--PKQGQMT 229
Query: 239 WAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298
LIE L + P +N E+Y++ K C + + RP+
Sbjct: 230 -VVRLIELLERGMRL-PCPKNC--PQEVYILMKN---CWETEAKFRPT------------ 270
Query: 299 DRFHHLGEKFVQRHH 313
F L + HH
Sbjct: 271 --FRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 73/289 (25%), Positives = 123/289 (42%), Gaps = 54/289 (18%)
Query: 28 ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAE-----FQSEVYVLNFARHKNIV 82
E ++G G FG V G LK V + G+ E F SE ++ H NI+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAI-------GTAKGLR 135
L G K ++V EY+ N SL ++ L H I G A G++
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSL--------DAFLRKHDGQFTVIQLVGMLRGIASGMK 120
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLG--Y 191
+L + +HRD+ NIL+ + V + DFGL+R DDP T G + +
Sbjct: 121 YLSDM----GYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRW 175
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMS--GRKVVDMNGEEPQQSLRQ---WAEPLIEK 246
APE + +DV+++GI++ ++MS R +M+ ++ +++ + P+
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCP 235
Query: 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
ALH+L+ C Q++ RP ++V +L+
Sbjct: 236 AALHQLM--------------------LDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 25 FSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKNIV 82
F+K +G+G FG V+KG + + Q++A K + E + + Q E+ VL+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 83 MLLGFCCKENLNILVYEYICNKS----LHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
G K ++ EY+ S L FD + + KGL +LH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKE-------ILKGLDYLH 118
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE 198
E + IHRD++ +N+LL+ L DFG+A T + +GT ++APE +
Sbjct: 119 SEKK----IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ 174
Query: 199 NGIVSIRTDVYAFGIILLQLMSG 221
+ D+++ GI ++L G
Sbjct: 175 QSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 74/310 (23%), Positives = 125/310 (40%), Gaps = 66/310 (21%)
Query: 31 LGEGGFGHVYKGELKDGQ-----------------MIAAKV-RKEASTQGFAEFQSEVYV 72
LGEG FG V+ E+ + Q ++A K+ R +A+ +F EV +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSL-----HWHLFDNTES----------- 116
L+ + NI+ LLG C E+ ++ EY+ N L HL D E+
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 117 -VLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175
+ + A+ A G+++L +HRD+ N L+ + + DFG++R
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL----NFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 176 TTDD--PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ 233
D +Q + + + ++A E G + +DV+AFG+ L +++ + E+P
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM------LCKEQPY 242
Query: 234 QSLRQWAEPLIEKLALHELIDPRIENSY---------DTYELYLMAKTAYLCVQRNPEGR 284
L E +IE E + Y YEL L C R+ R
Sbjct: 243 GELTD--EQVIENAG--EFFRDQGRQVYLFRPPPCPQGLYELMLQ------CWSRDCRER 292
Query: 285 PSMGEVVRLL 294
PS ++ L
Sbjct: 293 PSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 57/217 (26%), Positives = 105/217 (48%), Gaps = 25/217 (11%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMI----AAKVRKEA-STQGFAEFQSEVYVLNFAR 77
+F K +LG G FG VYKG + +G+ + A K +EA S + E E YV+
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 78 HKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESV-----LEWHQRYAAAIGTAK 132
+ ++ LLG C + L+ + + L ++ ++ +++ L W + AK
Sbjct: 68 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 120
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT--LG 190
G+ +L E ++HRD+ N+L+ + DFGLA+ D+ G +
Sbjct: 121 GMNYLEER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 191 YLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVD 226
++A E + I + ++DV+++G+ + +LM+ G K D
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 47 GQMIAAKVRKEASTQG---FAEFQSEVYVLNFARHKNIVMLLGF-CCKENLNILVYEYIC 102
G +A K+ + + + A F+ E + H NIV LL L V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT-HD 161
++L L + L + + L H +G I+HRD++P NI+++
Sbjct: 63 GRTLREVL--AADGALPAGETGRLMLQVLDALACAHN--QG--IVHRDLKPQNIMVSQTG 116
Query: 162 FVP--MLGDFGLARW--KTTDDPVQT-----KILGTLGYLAPEYAENGIVSIRTDVYAFG 212
P + DFG+ D V T ++LGT Y APE V+ +D+YA+G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 213 IILLQLMSGRKVVDMNGEEPQQSLRQWAEP 242
+I L+ ++G++V + G + L Q P
Sbjct: 177 LIFLECLTGQRV--VQGASVAEILYQQLSP 204
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 15/218 (6%)
Query: 30 LLGEGGFGHVYKGELKDGQMIAAK--VRKEA--STQGFAEFQSEVYVLNFARHKNIVMLL 85
++G G + V LK + I A V+KE + Q+E +V A + ++ L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 86 GFCCK-ENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-YAAAIGTAKGLRFLHEECRG 143
C + E+ V EY+ L +H+ + E H R Y+A I A L +LHE RG
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLA--LNYLHE--RG 116
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVS 203
II+RD++ N+LL + L D+G+ + + GT Y+APE
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 204 IRTDVYAFGIILLQLMSGRKVVDMNG--EEPQQSLRQW 239
D +A G+++ ++M+GR D+ G + P Q+ +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 212
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 41/169 (24%), Positives = 81/169 (47%), Gaps = 15/169 (8%)
Query: 127 AIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186
A+ +GL +L+ R I+HRD++PSNIL+ L DFG++ + + +
Sbjct: 109 AVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVS--GELINSIADTFV 163
Query: 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK 246
GT Y++PE + G ++++DV++ GI +++L G+ + + I
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG---ILD 220
Query: 247 LALHELID---PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
L L +++ PR+ +S +L C+ ++P RP+ ++
Sbjct: 221 L-LQQIVQEPPPRLPSSDFPEDLRDFVD---ACLLKDPTERPTPQQLCA 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 28 ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGF 87
E LG G FG V+ +A K K + F +E V+ +H +V L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 88 CCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPII 147
KE + I+ E++ SL L + S + + A+G+ F+ + I
Sbjct: 70 VTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR----NYI 124
Query: 148 HRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAPEYAENGIVSI 204
HRD+R +NIL++ V + DFGLAR +D T G + + APE G +I
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 182
Query: 205 RTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTY 264
++DV++FGI+L+++++ G P + + P + + PR EN +
Sbjct: 183 KSDVWSFGILLMEIVT-------YGRIPYPGM---SNPEVIRALERGYRMPRPENCPE-- 230
Query: 265 ELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
ELY +M + C + PE RP+ + +L+
Sbjct: 231 ELYNIMMR----CWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 81/310 (26%), Positives = 133/310 (42%), Gaps = 90/310 (29%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQS---------EVYVLN-FARHK 79
LG+G +G V+K + + +++A K + F F++ E+ L H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK-------KIFDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 80 NIVMLLGFCCKEN-LNI-LVYEYICNKSLHWHLFDNTESVL------EWHQRYAAAIGTA 131
NIV LL EN +I LV+EY+ LH +V+ + H+RY
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYM-ETDLH--------AVIRANILEDVHKRYIM-YQLL 117
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT-----DDPVQTKIL 186
K L+++H G +IHRD++PSNILL D L DFGLAR + ++PV T +
Sbjct: 118 KALKYIHS----GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 187 GTLGYLAPE-------YAENGIVSIRTDVYAFGIILLQLMSGR-------------KVVD 226
T Y APE Y + G+ D+++ G IL +++ G+ K+++
Sbjct: 174 ATRWYRAPEILLGSTRYTK-GV-----DMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227
Query: 227 MNGEEPQQSLRQ----WAEPLIEKLA------LHELIDPRIENSYDTYELYLMAKTAYLC 276
+ G + + +A +++ L L EL+ L L+ K
Sbjct: 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL-----PKASDDALDLLKK----L 278
Query: 277 VQRNPEGRPS 286
+ NP R +
Sbjct: 279 LVFNPNKRLT 288
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 34/265 (12%)
Query: 30 LLGEGGFGH--VYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGF 87
++GEG FG + + D + ++R S+ + + E +L +H NIV
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 88 CCKENLNILVYEYICNKSLHWHLFDN------TESVLEWHQRYAAAIGTAKGLRFLHEEC 141
+ +V EY L + +++L+W + G++ +HE+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF------VQMCLGVQHIHEK- 119
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI 201
++HRD++ NI LT + LGDFG AR T+ +GT Y+ PE EN
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP 176
Query: 202 VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261
+ ++D+++ G IL +L + + P Q+ W LI K+ P S+
Sbjct: 177 YNNKSDIWSLGCILYELCTLK--------HPFQA-NSWKN-LILKVC-QGSYKPL--PSH 223
Query: 262 DTYELYLMAKTAYLCVQRNPEGRPS 286
+YEL + K + +RNP RPS
Sbjct: 224 YSYELRSLIKQMF---KRNPRSRPS 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 30 LLGEGGFGHVYKGELKDGQ----MIAAKVRKEASTQGFAE-FQSEVYVLNFARHKNIVML 84
+GEG FG VY+G + +A K K ++ E F E Y++ H +IV L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 85 LGFCCKENLNILVYEYICNKSLHWHLFDNTESV-LEWHQRYAAAIGTAKGLRFLHEECRG 143
+G EN +V E L +L N S+ L Y+ + TA L +L
Sbjct: 73 IGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA--LAYLE----S 125
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL--GYLAPEYAENGI 201
+HRD+ N+L++ LGDFGL+R+ D+ G L ++APE
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY-LEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 202 VSIRTDVYAFGIILLQ-LMSGRK 223
+ +DV+ FG+ + + LM G K
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 73/282 (25%), Positives = 112/282 (39%), Gaps = 45/282 (15%)
Query: 30 LLGEGGFGHVYKGELKD--GQMI--AAK-VRKEASTQGFAEFQSEVYVLNFARHKNIVML 84
LG+G FG V +GE G++I A K ++ + + +F E +++ H+N++ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 85 LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGG 144
G L ++V E SL L + A+ A G+R+L +
Sbjct: 62 YGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---- 116
Query: 145 PIIHRDMRPSNILLTHDFVPMLGDFGLAR-WKTTDD----PVQTKILGTLGYLAPEYAEN 199
IHRD+ NILL D +GDFGL R +D K+ + APE
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRT 174
Query: 200 GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259
S +DV+ FG+ L ++ + GEEP L +++K ID E
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT-------YGEEPWAGLS--GSQILKK------IDKEGER 219
Query: 260 -------SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294
D Y + L C NP RP+ + L
Sbjct: 220 LERPEACPQDIYNVMLQ------CWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAK--------VRKEASTQGFAEFQSEVYVLNFARHKNIV 82
+G+G FG VY+ KD + I A V K+ E + V +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGE--RNILVRTLLDESPFI 58
Query: 83 MLLGFCCKENLNI-LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
+ L F + + ++ LV +Y+ L WHL + + Y A + A L LH+
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA--LEHLHKY- 115
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE-YAENG 200
I++RD++P NILL L DFGL++ TD+ GT YLAPE +
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 201 IVSIRTDVYAFGIILLQLMSG 221
+ D ++ G+++ ++ G
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 30 LLGEGGFGHV-YKGELKDGQMIAAKV-RKEA--STQGFAEFQSEVYVLNFARHKNIVML- 84
LLG+G FG V E G+ A K+ RKE + A +E VL RH + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 85 LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGG 144
F + L V EY L +HL E + Y A I +A L +LH
Sbjct: 62 YAFQTHDRL-CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLHSR---- 114
Query: 145 PIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSI 204
+++RD++ N++L D + DFGL + +D GT YLAPE E+
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 205 RTDVYAFGIILLQLMSGR 222
D + G+++ ++M GR
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 52/194 (26%), Positives = 87/194 (44%), Gaps = 47/194 (24%)
Query: 32 GEGGFGHVYKGELK---DGQMIAAKVRKEASTQGFAEFQS---EVYVLNFARHKNIVMLL 85
G G +G VYK + K DG+ A K K Q QS E+ +L +H+N+V L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 86 GFCCKENLNILVYEYICNKSLHWHLFDNTE----SVLEWHQRYAAAI---GTAK------ 132
+ +KS+ + LFD E ++++H++ K
Sbjct: 69 EVFLEHA----------DKSV-YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 133 --GLRFLHEECRGGPIIHRDMRPSNILLTHDF----VPMLGDFGLARWKTTDDPVQT--- 183
G+ +LH ++HRD++P+NIL+ + V +GD GLAR + P++
Sbjct: 118 LNGVHYLHSNW----VLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLAD 171
Query: 184 --KILGTLGYLAPE 195
++ T+ Y APE
Sbjct: 172 LDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 39/211 (18%)
Query: 31 LGEGGFGHVYK-GELKDGQMIAAKVRKEASTQGFAEFQS----EVYVLNFARHKNIVMLL 85
+GEG G V+K + + G+ +A K K A + + E+ L +H +V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALK--KVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 86 -----GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWH-QRYAAAIGTAKGLRFLHE 139
G +LV EY L L D + E + Y + KG+ ++H
Sbjct: 66 DVFPHGSGF-----VLVMEY-MPSDLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHA 117
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ-TKILGTLGYLAPE--- 195
I+HRD++P+N+L++ D V + DFGLAR + ++P + + T Y APE
Sbjct: 118 N----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 196 ----YAENGIVSIRTDVYAFGIILLQLMSGR 222
Y G+ D++A G I +L++G
Sbjct: 174 GARKYDP-GV-----DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 74/304 (24%), Positives = 131/304 (43%), Gaps = 58/304 (19%)
Query: 4 ELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVY-KGELKDGQMIAAKVRKEASTQG 62
EL+ K+ + F+++++ +G G FG VY +++ +++A K + Q
Sbjct: 16 ELFFKEDPEKLFTDLRE----------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS 65
Query: 63 FAEFQ---SEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLE 119
++Q EV L +H N + G +E+ LV EY + +LE
Sbjct: 66 NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC---------LGSASDLLE 116
Query: 120 WHQR-----YAAAI--GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172
H++ AAI G +GL +LH +IHRD++ NILLT L DFG A
Sbjct: 117 VHKKPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSA 172
Query: 173 RWKTTDDPVQTKILGTLGYLAPEY---AENGIVSIRTDVYAFGIILLQLMSGR-KVVDMN 228
+ P + +GT ++APE + G + DV++ GI ++L + + +MN
Sbjct: 173 ---SIASPANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228
Query: 229 GEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMG 288
+ Q P ++ + N D+ C+Q+ P+ RP+
Sbjct: 229 AMSALYHIAQNESPTLQSNEWSDY----FRNFVDS------------CLQKIPQDRPTSE 272
Query: 289 EVVR 292
E+++
Sbjct: 273 ELLK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 22/181 (12%)
Query: 25 FSKENLLGEGGFGHVYKG-ELKDGQMIA-AKVRKEASTQGFAEFQ-SEVYVLNFARHKNI 81
+ K +GEG +G VYK + G+++A K+R E +G E+ +L H NI
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKGLRF 136
V LL EN LV+E++ + L ++ ++ + Y + +G+ +
Sbjct: 61 VRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLI---KSYLYQL--LQGIAY 114
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ--TKILGTLGYLAP 194
C ++HRD++P N+L+ + L DFGLAR PV+ T + TL Y AP
Sbjct: 115 ----CHSHRVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHEVVTLWYRAP 168
Query: 195 E 195
E
Sbjct: 169 E 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-11
Identities = 71/285 (24%), Positives = 122/285 (42%), Gaps = 56/285 (19%)
Query: 30 LLGEGGFGHVYKG-ELKDGQMIAAK----------VRKEASTQGFAEFQSEVYVLNFARH 78
LLG+G FG VY ++ G+ +A K +KE + + E+ +L +H
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVN-----ALECEIQLLKNLQH 63
Query: 79 KNIVMLLGFCCKENLNILVY-EYICNKSLHWHLFDN---TESVLEWHQRYAAAIGTAKGL 134
+ IV G C +++ + ++ EY+ S+ L TE+V ++Y I +G+
Sbjct: 64 ERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVT---RKYTRQI--LEGV 117
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT---KILGTLGY 191
+LH I+HRD++ +NIL LGDFG ++ T T + GT +
Sbjct: 118 EYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA--EPL--IEKL 247
++PE + DV++ G VV+M E+P WA E + I K+
Sbjct: 174 MSPEVISGEGYGRKADVWSVGC---------TVVEMLTEKP-----PWAEFEAMAAIFKI 219
Query: 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
A +P++ + + N + RPS E++R
Sbjct: 220 ATQP-TNPQLPSHVSPDARNFLR----RTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 4e-11
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 36/209 (17%)
Query: 31 LGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQS-----EVYVL-NFARHKNIVM 83
LG+G FG VY K+ G+++A K K + F ++ EV L H NIV
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 84 LLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAI--GTAKGLRFLHEE 140
L F + L V+EY +L+ + D +I +GL +H
Sbjct: 63 LKEVFRENDELY-FVFEY-MEGNLYQLMKDRKGKPFSESV--IRSIIYQILQGLAHIH-- 116
Query: 141 CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENG 200
+ G HRD++P N+L++ V + DFGLAR + P T + T Y APE
Sbjct: 117 -KHG-FFHRDLKPENLLVSGPEVVKIADFGLAR-EIRSRPPYTDYVSTRWYRAPE----- 168
Query: 201 IVSIRT-------DVYAFGIILLQLMSGR 222
+ +R+ D++A G I+ +L + R
Sbjct: 169 -ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 5e-11
Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 47/219 (21%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV---------RKEASTQGFAEFQSEVYVL 73
DF LG G FG V K G+ A K+ ++ +E +L
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVL------NEKRIL 55
Query: 74 NFARHKNIVMLLGFCCKENLNI-LVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAA 127
RH +V L G +++ N+ LV EY+ L HL F + YAA
Sbjct: 56 QSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPE-----PVARFYAAQ 109
Query: 128 IGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILG 187
+ A L +LH I++RD++P N+LL D + DFG A K T + G
Sbjct: 110 VVLA--LEYLHSL----DIVYRDLKPENLLLDSDGYIKITDFGFA--KRVKGRTYT-LCG 160
Query: 188 TLGYLAPEYAENGIVSIR-----TDVYAFGIILLQLMSG 221
T YLAPE I+ + D +A GI++ ++++G
Sbjct: 161 TPEYLAPE-----IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 5e-11
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 24/220 (10%)
Query: 18 IQQATGDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVLN-F 75
++ G F L+G G +G VYKG +K GQ+ A KV + + E + E+ +L +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV-MDVTGDEEEEIKQEINMLKKY 59
Query: 76 ARHKNIVMLLGFCCKENLN------ILVYEYICNKSLHWHLFDNTESVL---EWHQRYAA 126
+ H+NI G K+N LV E+ C L NT+ EW
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEF-CGAGSVTDLIKNTKGNTLKEEWIAYICR 118
Query: 127 AIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186
I +GL LH+ +IHRD++ N+LLT + L DFG++ + +
Sbjct: 119 EI--LRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 172
Query: 187 GTLGYLAPEYAE-----NGIVSIRTDVYAFGIILLQLMSG 221
GT ++APE + ++D+++ GI +++ G
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 23/202 (11%)
Query: 31 LGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQS--EVYVLNFARHKNIVMLLGF 87
LGEG + VYKG K GQ++A K + +G A F + E +L +H NIV L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDI 71
Query: 88 CCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPII 147
+ LV+EY + L ++ D+ L H +GL + H+ ++
Sbjct: 72 IHTKKTLTLVFEY-LDTDLKQYM-DDCGGGLSMHNVRLFLFQLLRGLAYCHQR----RVL 125
Query: 148 HRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAP-------EYAENG 200
HRD++P N+L++ L DFGLAR K+ + + TL Y P EY
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEY---- 181
Query: 201 IVSIRTDVYAFGIILLQLMSGR 222
S D++ G I ++ +GR
Sbjct: 182 --STSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-11
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 30 LLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQS---EVYVLNFARHKNIVMLL 85
+LG+G FG V ELK G+ A K K+ + + E VL A + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 86 --GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
F KE+L V E++ L +H+ D L YAA I GL+FLH +
Sbjct: 62 YCTFQTKEHL-FFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEI--VCGLQFLHSK--- 115
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVS 203
II+RD++ N++L D + DFG+ + D + GT Y+APE + +
Sbjct: 116 -GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 204 IRTDVYAFGIILLQLMSGR 222
D ++FG++L +++ G+
Sbjct: 175 FSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-11
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 25 FSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQ-SEVYVLNFARHKNIV 82
+++ +G+G G VY ++ GQ +A K + Q E +E+ V+ +H NIV
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIK-QMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 83 MLL-GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
L + + L + V EY+ SL + TE+ ++ Q A + L FLH
Sbjct: 80 NYLDSYLVGDELWV-VMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN- 134
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI 201
+IHRD++ NILL D L DFG T + ++ ++GT ++APE
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 202 VSIRTDVYAFGIILLQLMSG 221
+ D+++ GI+ ++++ G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-11
Identities = 72/285 (25%), Positives = 117/285 (41%), Gaps = 51/285 (17%)
Query: 25 FSKENLLGEGGFGH-VYKGELKDGQMIAAKVRKE-----ASTQGFAEFQSEVYVLNFARH 78
+ K +GEG FG + +DG+ V KE S + E + EV VL+ +H
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQY---VIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 79 KNIVMLL-GFCCKENLNILVYEYICNKSLHWHLFDNT-------ESVLEWHQRYAAAIGT 130
NIV F +EN N+ + C + + + +L+W + A
Sbjct: 59 PNIVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA--- 113
Query: 131 AKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLG 190
L+ +H+ I+HRD++ NI LT D LGDFG+AR + + +GT
Sbjct: 114 ---LKHVHDR----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPY 166
Query: 191 YLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250
YL+PE EN + ++D++A G +L ++ + + E +
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA-------------------FEAGNMK 207
Query: 251 ELIDPRIENSYDTYELYLMAKTAYLCVQ---RNPEGRPSMGEVVR 292
L+ I SY + L Q RNP RPS+ ++
Sbjct: 208 NLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 29 NLLGEGGFGHVYKGELKD-GQMIA-AKVRKEASTQGFA-EFQSEVYVLNFARHKNIVML- 84
+GEG +G VYK KD G+++A KVR + +GF E+ +L H+NIV L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 85 ---------LGFCCKENLNILVYEYICNKSLHWHLFDNTESVL-EWHQRYAAAIGTA--K 132
L F + LV+EY+ + L ES L + + + + +
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIKSFMKQLLE 127
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD--PVQTKILGTLG 190
GL + H++ +HRD++ SNILL + L DFGLAR +++ P K++ TL
Sbjct: 128 GLNYCHKK----NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLW 182
Query: 191 YLAPEY---AENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ 233
Y PE E +I DV++ G IL +L + + + N E Q
Sbjct: 183 YRPPELLLGEERYGPAI--DVWSCGCILGELFTKKPIFQANQELAQ 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 6e-11
Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 127 AIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186
+ K L +L E+ +IHRD++PSNILL L DFG++ + D +T+
Sbjct: 120 TVAIVKALHYLKEK---HGVIHRDVKPSNILLDASGNVKLCDFGISG-RLVDSKAKTRSA 175
Query: 187 GTLGYLAPEYAE----NGIVSIRTDVYAFGIILLQLMSGR 222
G Y+APE + N IR DV++ GI L++L +G+
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-11
Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 31 LGEGGFGHVYKGELKD-GQMIAAKVR-----KEASTQGFAEFQSEVYVLNFARHKNIVML 84
LG+GGFG V ++K+ G+M A K K+ S + A + E+ L IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 85 -LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQ--RYAAAIGTAKGLRFLHEEC 141
F K +L LV + L +H+++ E LE + Y+A I G+ LH
Sbjct: 59 AYAFESKTHL-CLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI--TCGILHLHSM- 114
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI 201
I++RDM+P N+LL L D GLA + D T+ GT GY+APE +
Sbjct: 115 ---DIVYRDMKPENVLLDDQGNCRLSDLGLAV-ELKDGKTITQRAGTNGYMAPEILKEEP 170
Query: 202 VSIRTDVYAFGIILLQLMSGR 222
S D +A G + ++++GR
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 7e-11
Identities = 51/198 (25%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 25 FSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
+++ +G+G G VY ++ GQ +A K +E+ V+ ++ NIV
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L + +V EY+ SL + TE+ ++ Q A + L FLH
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSN--- 134
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVS 203
+IHRD++ NILL D L DFG T + ++ ++GT ++APE
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 204 IRTDVYAFGIILLQLMSG 221
+ D+++ GI+ ++++ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 8e-11
Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 25 FSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
+++ +G+G G VY ++ GQ +A + +E+ V+ ++ NIV
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L + +V EY+ SL + TE+ ++ Q A + L FLH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVS 203
+IHRD++ NILL D L DFG T + ++ ++GT ++APE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 204 IRTDVYAFGIILLQLMSG 221
+ D+++ GI+ ++++ G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-11
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 30 LLGEGGFGHVYKGELK-DGQMIAAKV-RKEASTQG--FAEFQSEVYVLNFARHKNIVMLL 85
+LG+G FG V ELK ++ A KV +K+ Q +E +L A + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 86 GFCC---KENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKGLRFL 137
CC K+ L V EY+ L + + FD S YAA + A L FL
Sbjct: 62 -HCCFQTKDRL-FFVMEYVNGGDLMFQIQRSRKFDEPRSRF-----YAAEVTLA--LMFL 112
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYA 197
H R G +I+RD++ NILL + L DFG+ + + T GT Y+APE
Sbjct: 113 H---RHG-VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL 168
Query: 198 ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEE 231
+ D +A G+++ ++M+G+ + + E+
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFEADNED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-11
Identities = 62/264 (23%), Positives = 118/264 (44%), Gaps = 24/264 (9%)
Query: 31 LGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV-MLLGFC 88
+GEG G V +K G+++A K Q +EV ++ +H+N+V M +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 89 CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIH 148
+ L + V E++ +L + T + + Q A + K L LH + +IH
Sbjct: 88 VGDELWV-VMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLHAQ----GVIH 139
Query: 149 RDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDV 208
RD++ +ILLTHD L DFG + + P + ++GT ++APE D+
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 209 YAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYL 268
++ GI++++++ G E P ++++ + L KL + P ++ D
Sbjct: 200 WSLGIMVIEMVDGEP--PYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRL---- 253
Query: 269 MAKTAYLCVQRNPEGRPSMGEVVR 292
+ R+P R + E+++
Sbjct: 254 --------LVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 30 LLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQS---EVYVLNFA-RHKNIVML 84
+LG+G FG V ELK + A K K+ + + E VL A H + L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 85 L-GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
F KE+L V EY+ L +H+ + + YAA I GL+FLH+ +G
Sbjct: 62 FCTFQTKEHL-FFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEI--ICGLQFLHK--KG 116
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVS 203
II+RD++ N+LL D + DFG+ + + + GT Y+APE + +
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN 174
Query: 204 IRTDVYAFGIILLQLMSGRKVVDMNGEE 231
D ++FG++L +++ G+ E+
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 68/282 (24%), Positives = 122/282 (43%), Gaps = 56/282 (19%)
Query: 31 LGEGGFGHV--YKGELKDGQMIAAKVR-KEASTQGFAEFQSEVYVLNFARHKNIVM---- 83
+G+G +G V + Q + K+ + AS + + E +L+ +H NIV
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 84 ----------LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKG 133
++GFC +L Y K L + V+EW + A A
Sbjct: 68 WEGEDGLLYIVMGFCEGGDL------YHKLKEQKGKLLPENQ-VVEWFVQIAMA------ 114
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLA 193
L++LHE+ I+HRD++ N+ LT + +GD G+AR + + ++GT Y++
Sbjct: 115 LQYLHEK----HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMS 170
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMSGRKVV---DMNGEEPQQSLRQWAEPLIEKLALH 250
PE N + ++DV+A G + ++ + + DMN L+ ++
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-------------LVYRIIEG 217
Query: 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
+L P + Y EL + T + + PE RPS+ ++R
Sbjct: 218 KL--PPMPKDYSP-ELGELIATM---LSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 40/286 (13%)
Query: 24 DFSKENLLGEGGFGHVYK-GELKDGQMIAAKVRKEASTQGFAEFQ-----SEVYVLNFAR 77
D+ +G+G FG V K DG+++ V KE E + SEV +L +
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKIL---VWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 78 HKNIVMLLG-FCCKENLNI-LVYEYICNK----SLHWHLFDNTESVLE---WHQRYAAAI 128
H NIV + N + +V EY C L + + E W R +
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEY-CEGGDLAQLIQKCKKERKYIEEEFIW--RILTQL 114
Query: 129 GTAKGLRFLHEECRGGP-IIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILG 187
A L H G ++HRD++P+NI L + LGDFGLA+ D +G
Sbjct: 115 LLA--LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG 172
Query: 188 TLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL 247
T Y++PE + ++D+++ G ++ +L + P + R + L K+
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS---------PPFTARNQLQ-LASKI 222
Query: 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293
+ RI Y + EL + K + +P+ RPS E+++L
Sbjct: 223 KEGKF--RRIPYRYSS-ELNEVIK---SMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 43/283 (15%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMI----AAKV-RKEASTQGFAEFQSEVYVLNFAR 77
+ K +LG G FG VYKG + DG+ + A KV R+ S + E E YV+
Sbjct: 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 78 HKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDN-----TESVLEWHQRYAAAIGTAK 132
+ LLG C + LV + + L ++ +N ++ +L W + AK
Sbjct: 68 SPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAK 120
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT--LG 190
G+ +L EE R ++HRD+ N+L+ + DFGLAR D+ G +
Sbjct: 121 GMSYL-EEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176
Query: 191 YLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP-LIEKLAL 249
++A E + + ++DV+++G+ + +LM+ G +P + P L+EK
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMT-------FGAKPYDGIPAREIPDLLEK--G 227
Query: 250 HELIDPRIENSYDTYELYL-MAKTAYLCVQRNPEGRPSMGEVV 291
L P I T ++Y+ M K C + E RP E+V
Sbjct: 228 ERLPQPPI----CTIDVYMIMVK----CWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 61/200 (30%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 30 LLGEGGFGHV-YKGELKDGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVML- 84
LLG+G FG V E G+ A K+ K+ + A +E VL RH + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 85 LGFCCKENLNILVYEYICNKSLHWHLFDNTESVL-EWHQR-YAAAIGTAKGLRFLHEECR 142
F + L V EY L +HL + E V E R Y A I +A L +LH
Sbjct: 62 YSFQTHDRL-CFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSA--LGYLHS--- 113
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIV 202
+++RD++ N++L D + DFGL + +D GT YLAPE E+
Sbjct: 114 -CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 203 SIRTDVYAFGIILLQLMSGR 222
D + G+++ ++M GR
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 56/192 (29%), Positives = 93/192 (48%), Gaps = 41/192 (21%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAEFQS--EVYVLNFARHK 79
++ K N + EG +G VY+ + K G+++A K ++ E +GF S E+ +L +H
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFP-ITSLREINILLKLQHP 64
Query: 80 NIV----MLLGFCCKENLN--ILVYEYICN--KSLHWHLFDNTESVLEWHQRYAAAIGTA 131
NIV +++G NL+ +V EY+ + KSL +E +
Sbjct: 65 NIVTVKEVVVG----SNLDKIYMVMEYVEHDLKSL-----------ME-TMKQPFLQSEV 108
Query: 132 K--------GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183
K G+ LH+ I+HRD++ SN+LL + + + DFGLAR + T
Sbjct: 109 KCLMLQLLSGVAHLHDNW----ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT 164
Query: 184 KILGTLGYLAPE 195
+++ TL Y APE
Sbjct: 165 QLVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 78/290 (26%), Positives = 130/290 (44%), Gaps = 52/290 (17%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKVRKE----ASTQGFAEF--QSEVYVLNFARHKNIVML 84
+G G FG V E+ +A V KE AS++ EF Q + Y + +H NI+
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRI--LQHPNILQC 60
Query: 85 LGFCCKENLNILVYE---------YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLR 135
LG C + +LV+E Y+ + WH N++ +L QR A I A G+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQE--QWH-RRNSQLLL--LQRMACEI--AAGVT 113
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT--KILGTLGYLA 193
+H+ +H D+ N LT D +GD+G+ + +D ++T L +LA
Sbjct: 114 HMHKH----NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLA 169
Query: 194 PEYA---ENGIVSIR----TDVYAFGIILLQLMSGRKVVDMNGEEPQQSL--RQWAEPLI 244
PE G+++ ++V+A G+ L +L N +P L R+ +I
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFE-------NAAQPYSHLSDREVLNHVI 222
Query: 245 EKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294
+ + +L P++E Y + Y + + +L +PE R + EV RLL
Sbjct: 223 KDQQV-KLFKPQLELPY-SERWYEVLQFCWL----SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKV---RKEASTQGFAEFQSEVYVLNFARHK 79
D + +G G FG V+ + A KV + + +E VL H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKGL 134
I+ L + ++ EY+ L +L F N+ + YA+ I A L
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-----YASEIVCA--L 114
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAP 194
+LH I++RD++P NILL + L DFG A K D T + GT YLAP
Sbjct: 115 EYLH----SKEIVYRDLKPENILLDKEGHIKLTDFGFA--KKLRDRTWT-LCGTPEYLAP 167
Query: 195 EYAENGIVSIRTDVYAFGIILLQLMSG 221
E ++ + D +A GI++ +++ G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 14/201 (6%)
Query: 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
G F K L+ E G Y ++ ++I AK A +E VL +RH +
Sbjct: 6 GTFGKVILVKEKATGRYYAMKILKKEVIVAK-------DEVAHTLTENRVLQNSRHPFLT 58
Query: 83 ML-LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
L F + L V EY L +HL + + Y A I +A L +LH E
Sbjct: 59 ALKYSFQTHDRL-CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLHSE- 114
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI 201
+++RD++ N++L D + DFGL + D GT YLAPE E+
Sbjct: 115 --KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 202 VSIRTDVYAFGIILLQLMSGR 222
D + G+++ ++M GR
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 62/248 (25%), Positives = 113/248 (45%), Gaps = 45/248 (18%)
Query: 31 LGEGGFGHVYKGELK-------------DGQ--MIAAK-VRKEASTQGFAEFQSEVYVLN 74
LGEG FG V+ E + DGQ ++A K +R + + +F E+ +++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 75 FARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHL-----------FDNTESVLEWHQR 123
++ NI+ LLG C ++ ++ EY+ N L+ L +N SV +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 124 YAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD--PV 181
Y A A G+++L +HRD+ N L+ + + + DFG++R + D +
Sbjct: 133 YMAV-QIASGMKYLASL----NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQ-----------LMSGRKVVDMNGE 230
Q + + + ++A E G + +DV+AFG+ L + L+S +V++ GE
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGE 247
Query: 231 EPQQSLRQ 238
+ RQ
Sbjct: 248 FFRNQGRQ 255
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 64/235 (27%), Positives = 100/235 (42%), Gaps = 27/235 (11%)
Query: 5 LYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYK-GELKDGQMIAAKVRKEASTQGF 63
L+ + + T + +G+G +G VYK KDG + A K+ S
Sbjct: 4 LFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD- 62
Query: 64 AEFQSEVYVLNF-ARHKNIVMLLGFCCKENLNI-----LVYEYICNKSLHWHLFDNTESV 117
E ++E +L H N+V G K + + LV E +CN L + +
Sbjct: 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE-LCNGGSVTEL---VKGL 118
Query: 118 LEWHQRYAAAI------GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGL 171
L QR A+ G GL+ LH IIHRD++ +NILLT + L DFG+
Sbjct: 119 LICGQRLDEAMISYILYGALLGLQHLHNN----RIIHRDVKGNNILLTTEGGVKLVDFGV 174
Query: 172 ARWKTTDDPVQTKILGTLGYLAPEYAE-----NGIVSIRTDVYAFGIILLQLMSG 221
+ T+ + +GT ++APE + R DV++ GI ++L G
Sbjct: 175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 48/193 (24%), Positives = 85/193 (44%), Gaps = 35/193 (18%)
Query: 127 AIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186
A+ K L +LH + +IHRD++PSN+L+ + L DFG++ + D +T
Sbjct: 109 AVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGY-LVDSVAKTIDA 164
Query: 187 GTLGYLAPEY----AENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP 242
G Y+APE +++DV++ GI +++L +GR D + + P Q L+Q E
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-SWKTPFQQLKQVVEE 223
Query: 243 LIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302
+L + + K C+++N + RP+ E+
Sbjct: 224 PSPQLP---------AEKFSPEFQDFVNK----CLKKNYKERPNYPEL------------ 258
Query: 303 HLGEKFVQRHHTK 315
L F + H +K
Sbjct: 259 -LQHPFFELHLSK 270
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 50/195 (25%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 31 LGEGGFGHV-YKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV-MLLGFC 88
+GEG G V E G+ +A K+ Q +EV ++ +H+N+V M +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 89 CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTA--KGLRFLHEECRGGPI 146
E L +L+ E++ +L + S ++ A + + + L +LH + +
Sbjct: 89 VGEELWVLM-EFLQGGAL-----TDIVSQTRLNEEQIATVCESVLQALCYLHSQ----GV 138
Query: 147 IHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRT 206
IHRD++ +ILLT D L DFG + D P + ++GT ++APE
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 207 DVYAFGIILLQLMSG 221
D+++ GI++++++ G
Sbjct: 199 DIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 11/203 (5%)
Query: 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAK---VRKEASTQGFAEFQSEVYVLNFARHKN 80
F + +LG+GGFG V +++ G+M A K ++ +G + +E +L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 81 IVML-LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
+V L + K+ L LV + L +H+++ E + A GL LH
Sbjct: 62 VVNLAYAYETKDAL-CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN 199
E ++RD++P NILL + D GLA + ++ ++ GT+GY+APE N
Sbjct: 121 E----NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-GTVGYMAPEVLNN 175
Query: 200 GIVSIRTDVYAFGIILLQLMSGR 222
++ D + G ++ +++ G+
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 74/274 (27%), Positives = 115/274 (41%), Gaps = 44/274 (16%)
Query: 25 FSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRK-EASTQGFAEFQSEVYVLNFARHKNIV 82
F+ +G+G FG VYK + + Q++A KV E + + Q E+ L+ R I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 83 MLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAI--GTAKGLRFLHE 139
G F L I + EY S D + + Y A I GL +LHE
Sbjct: 63 KYYGSFLKGSKLWI-IMEYCGGGSC----LDLLKPGK-LDETYIAFILREVLLGLEYLHE 116
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA-RWKTTDDPVQTKILGTLGYLAPEYAE 198
E + IHRD++ +NILL+ + L DFG++ + +T T +GT ++APE +
Sbjct: 117 EGK----IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVIK 171
Query: 199 NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP-----LIEKLALHELI 253
+ D+++ GI ++L GE P L P LI K L
Sbjct: 172 QSGYDEKADIWSLGITAIEL--------AKGEPPLSDL----HPMRVLFLIPKNNPPSLE 219
Query: 254 DPRIENSY-DTYELYLMAKTAYLCVQRNPEGRPS 286
+ + D LC+ ++P+ RPS
Sbjct: 220 GNKFSKPFKDFVS---------LCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 62/281 (22%), Positives = 116/281 (41%), Gaps = 43/281 (15%)
Query: 22 TGDFSKENLLGEGGFGHVYKGE-LKDGQ-----------MIAAKVRKEASTQGFAEFQSE 69
G+F E +G+G F VYK L DG+ M+ AK R++ E
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCL--------KE 52
Query: 70 VYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHL--FDNTESVLEWHQRYAAA 127
+ +L H N++ L + N +V E L + F + ++ +
Sbjct: 53 IDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF 112
Query: 128 IGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILG 187
+ L +H + I+HRD++P+N+ +T V LGD GL R+ ++ ++G
Sbjct: 113 VQLCSALEHMHSK----RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 188 TLGYLAPEYA-ENGIVSIRTDVYAFGIILLQL--------MSGRKVVDM-----NGEEPQ 233
T Y++PE ENG + ++D+++ G +L ++ + + + P
Sbjct: 169 TPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP 227
Query: 234 QSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAY 274
++E L + ++ DP E D + +AK +
Sbjct: 228 LPADHYSEELRDLVSRCINPDP--EKRPDISYVLQVAKEMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 38/100 (38%), Positives = 59/100 (59%), Gaps = 9/100 (9%)
Query: 127 AIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186
A+ T K L +L EE + IIHRD++PSNILL + L DFG++ + D +T+
Sbjct: 113 AVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISG-QLVDSIAKTRDA 168
Query: 187 GTLGYLAPE----YAENGIVSIRTDVYAFGIILLQLMSGR 222
G Y+APE A +G +R+DV++ GI L ++ +G+
Sbjct: 169 GCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-10
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRK-EASTQGFAEFQSEVYVLNFARHKNI 81
D + +LG G G VYK L +++A KV + + + + SE+ +L I
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61
Query: 82 VMLLGFCCKENLNILVYEYICNKSL--HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
+ G EN + E++ SL + + E VL R A A+ KGL +L
Sbjct: 62 IGFYGAFFVENRISICTEFMDGGSLDVYRKI---PEHVL---GRIAVAV--VKGLTYLW- 112
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN 199
I+HRD++PSN+L+ L DFG++ + + +GT Y+APE
Sbjct: 113 ---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISG 167
Query: 200 GIVSIRTDVYAFGIILLQLMSGR 222
I +DV++ GI ++L GR
Sbjct: 168 EQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 50/204 (24%), Positives = 81/204 (39%), Gaps = 20/204 (9%)
Query: 31 LGEGGFGHVYKGELKDGQMIAA--KVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLG-F 87
+G G VY A ++ E E + EV ++ H N+V F
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 88 CCKENLNILVYEYICNKSLHWHL--FDNTESVLEWHQRYAAAI--GTAKGLRFLHEECRG 143
+ L + V Y+ SL + L+ + A + KGL +LH +
Sbjct: 69 VVGDELWL-VMPYLSGGSLL-DIMKSSYPRGGLD--EAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK----ILGTLGYLAPEYAEN 199
IHRD++ NILL D + DFG++ K +GT ++APE E
Sbjct: 124 ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 200 GI-VSIRTDVYAFGIILLQLMSGR 222
+ D+++FGI ++L +G
Sbjct: 181 VHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 27 KENLLGEGGFGHVYKG-ELKDGQMIAAK--------VRKEASTQGFAE-FQSEVYVLNFA 76
K L+G G FG VY G G+++A K + + + E+ +L
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 77 RHKNIVMLLGFCCKEN-LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLR 135
+H+NIV LG + LNI + EY+ S+ L +N + E R KGL
Sbjct: 64 QHENIVQYLGSSLDADHLNIFL-EYVPGGSVA-ALLNNYGAFEETLVRNFVR-QILKGLN 120
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR------WKTTDDPVQTKILGTL 189
+LH RG IIHRD++ +NIL+ + + DFG+++ T + + + G++
Sbjct: 121 YLHN--RG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 190 GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
++APE + + + D+++ G +++++++G+
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 30 LLGEGGFGHVYKGELK--DG--QMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVM 83
+LGEG FG V +G+L DG +A K K + EF SE + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 84 LLGFCCK-ENLN-----ILVYEYICNKSLHWHLF-----DNTESV-LEWHQRYAAAIGTA 131
L+G C + +L +++ ++ + LH L E + L+ ++ I A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI--A 123
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV-QTKILGT-L 189
G+ +L IHRD+ N +L D + DFGL++ + D Q +I +
Sbjct: 124 LGMEYLSNR----NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 190 GYLAPEYAENGIVSIRTDVYAFGIILLQLMS 220
++A E + + + ++DV+AFG+ + ++ +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 77/310 (24%), Positives = 124/310 (40%), Gaps = 74/310 (23%)
Query: 31 LGEGGFGHVYKGE--------LKDGQ---------MIAAKV-RKEASTQGFAEFQSEVYV 72
LGEG FG V+ E K ++A KV R +AS +F EV +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGT-- 130
L+ NI LLG C + ++ EY+ N L+ L Q++ A
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL-----------QKHVAETSGLA 121
Query: 131 ------------------AKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172
A G+R+L +HRD+ N L+ ++ + DFG++
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLESL----NFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 173 RWKTTDD--PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGE 230
R + D VQ + + ++A E G + ++DV+AFG+ L ++++ + E
Sbjct: 178 RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR------E 231
Query: 231 EPQQSL--RQWAEPLIEKLA---LHELIDPRIENSY-DTYELYLMAKTAYLCVQRNPEGR 284
+P + L +Q E + PR N D YEL L C +R+ E R
Sbjct: 232 QPYEHLTDQQVIENAGHFFRDDGRQIYL-PRPPNCPKDIYELMLE------CWRRDEEDR 284
Query: 285 PSMGEVVRLL 294
P+ E+ L
Sbjct: 285 PTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-10
Identities = 45/187 (24%), Positives = 72/187 (38%), Gaps = 32/187 (17%)
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY 191
+GLR+LH IIHRD++ NI + +GD G A++ P + GT+
Sbjct: 168 EGLRYLH----AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-APAFLGLAGTVET 222
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVV----DMNGEEPQQSLRQWAEPLIEKL 247
APE + + D+++ GI+L ++++ + EE +S +I L
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282
Query: 248 ALHELIDPRIENSYDTYELYLMAK------TAYLCVQR-----------------NPEGR 284
+H PR S A T Y C QR + R
Sbjct: 283 KVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMR 342
Query: 285 PSMGEVV 291
PS E++
Sbjct: 343 PSAEEIL 349
|
Length = 357 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-10
Identities = 64/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 25 FSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVML 84
F KE LG G FG V+ G+ + +A K E + +F E V+ H +V L
Sbjct: 8 FMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQL 64
Query: 85 LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGG 144
G C ++ +V E++ N L + + L + +G+ +L
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCL-LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---- 119
Query: 145 PIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAPEYAENGI 201
IHRD+ N L++ V + DFG+ R+ D+ + G + + PE
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS--GAKFPVKWSPPEVFNFSK 177
Query: 202 VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261
S ++DV++FG+++ ++ + G+ P + + E + L P++ +
Sbjct: 178 YSSKSDVWSFGVLMWEVFT-------EGKMPFEKKSNY-EVVEMISRGFRLYRPKLASMT 229
Query: 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294
YE+ Y C PEGRP+ E++R +
Sbjct: 230 -VYEV------MYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 8e-10
Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 25 FSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
+++ +G+G G V+ ++ GQ +A K +E+ V+ ++ NIV
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L + +V EY+ SL + TE+ ++ Q A + L FLH
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLH----A 133
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVS 203
+IHRD++ N+LL D L DFG T + ++ ++GT ++APE
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 204 IRTDVYAFGIILLQLMSG 221
+ D+++ GI+ ++++ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMI----AAKVRKEAS-TQGFAEFQSEVYVLNFAR 77
+ + +LG G FG VYKG + +G+ + A K+ E + + EF E ++
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 78 HKNIVMLLGFCCKENLNIL--------VYEYICNKSLHWHLFDNTES--VLEWHQRYAAA 127
H ++V LLG C + ++ + +Y+ H H DN S +L W
Sbjct: 68 HPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYV-----HEHK-DNIGSQLLLNW------C 115
Query: 128 IGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILG 187
+ AKG+ +L E ++HRD+ N+L+ + DFGLAR D+ G
Sbjct: 116 VQIAKGMMYLEER----RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171
Query: 188 TL--GYLAPEYAENGIVSIRTDVYAFGIILLQLMS 220
+ ++A E + ++DV+++G+ + +LM+
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 31 LGEGGFGHVYKGELKDGQMIAA--KVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFC 88
LG+G +G VYK + + A ++R E F + E+ +L+ A IV G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 89 CKENLNILVYEYICNKSLHWHLFDNT-------ESVLEWHQRYAAAIGTAKGLRFLHEEC 141
E + EY+ SL L+ E VL +R A+ KGL+FL EE
Sbjct: 69 FIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVL---RRITYAV--VKGLKFLKEEH 122
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY----- 196
IIHRD++P+N+L+ + L DFG++ +T I G Y+APE
Sbjct: 123 N---IIHRDVKPTNVLVNGNGQVKLCDFGVSG-NLVASLAKTNI-GCQSYMAPERIKSGG 177
Query: 197 -AENGIVSIRTDVYAFGIILLQLMSGR 222
+N ++++DV++ G+ +L++ GR
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 18/200 (9%)
Query: 31 LGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQS---EVYVL---NFARHKNIVM 83
LG G FG V E K G++ A K K+ E +S E + N RH +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 84 LLGFCC--KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
L F C E+ V EY L H+ + S YAA + GL++LHE
Sbjct: 67 L--FACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-EPRAVFYAACV--VLGLQYLHEN- 120
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI 201
I++RD++ N+LL + + DFGL + + GT +LAPE
Sbjct: 121 ---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS 177
Query: 202 VSIRTDVYAFGIILLQLMSG 221
+ D + G+++ +++ G
Sbjct: 178 YTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 68/274 (24%), Positives = 113/274 (41%), Gaps = 55/274 (20%)
Query: 30 LLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAE--FQSEVYVLNFARHKNIVMLL 85
L+G+GG G VY + + +A K +R++ S + F E + H IV +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 86 GFCCKENLNILVYEYICNKSLHWHLFDNT---ESVLEWHQRYAAAIGTAKG--LRFLHEE 140
C + YI +L L + ES+ + A T+ G L H+
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLK-SLLKSVWQKESLSKEL-----AEKTSVGAFLSIFHKI 122
Query: 141 C--------RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT--------- 183
C +G ++HRD++P NILL ++ D+G A +K ++
Sbjct: 123 CATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 184 ---------KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS---------GRKVV 225
KI+GT Y+APE S TD+YA G+IL Q+++ GRK+
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240
Query: 226 DMNGEEPQQSLRQWAE--PLIEKLALHEL-IDPR 256
+ + + E P + ++A+ L +DP
Sbjct: 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPA 274
|
Length = 932 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 28/171 (16%)
Query: 131 AKGLRFL-HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL 189
AKG+ FL + C IHRD+ NILLTH + + DFGLAR D K L
Sbjct: 224 AKGMSFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 190 --GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL 247
++APE N + + +DV+++GI+L ++ S G P + P+ K
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS-------LGSSPYPGM-----PVDSK- 325
Query: 248 ALHELIDP--RIEN-SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+++I R+ + E+Y + K+ C +P RP+ ++V+L+E
Sbjct: 326 -FYKMIKEGYRMLSPECAPSEMYDIMKS---CWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQS---EVYVLNFARHK 79
DF+ +LG+G FG V E K ++ A K+ K+ + + E VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 80 NIVMLLGFCCKENLNI-LVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKG 133
+ L C + + V EY+ L +H+ F ++V YAA I + G
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF-----YAAEI--SVG 113
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLA 193
L FLH RG II+RD++ N++L + + DFG+ + D GT Y+A
Sbjct: 114 LFFLHR--RG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIA 169
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEE 231
PE D +A+G++L ++++G+ D E+
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 55/181 (30%), Positives = 84/181 (46%), Gaps = 28/181 (15%)
Query: 30 LLGEGGFGHVYKGELKDG----QMIAAKVRKEA----STQGFAEFQSEVYVLNFARHKNI 81
+LG+GG+G V++ G ++ A KV K+A + + A ++E +L +H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 82 VMLL-GFCCKENLNILVYEYICNKSLHWHL------FDNTESVLEWHQRYAAAIGTAKGL 134
V L+ F L L+ EY+ L HL ++T Y + I A L
Sbjct: 63 VDLIYAFQTGGKL-YLILEYLSGGELFMHLEREGIFMEDTACF------YLSEISLA--L 113
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAP 194
LH++ II+RD++P NILL L DFGL + + V GT+ Y+AP
Sbjct: 114 EHLHQQ----GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169
Query: 195 E 195
E
Sbjct: 170 E 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 60/263 (22%), Positives = 117/263 (44%), Gaps = 24/263 (9%)
Query: 31 LGEGGFGHV-YKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV-MLLGFC 88
+GEG G V E G+ +A K Q +EV ++ H+N+V M +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 89 CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIH 148
+ L + V E++ +L + T + + Q + + L +LH + +IH
Sbjct: 90 VGDELWV-VMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQ----GVIH 141
Query: 149 RDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDV 208
RD++ +ILLT D L DFG + + P + ++GT ++APE D+
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 209 YAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYL 268
++ GI++++++ G E P Q++R+ + + + PR+++S+ +
Sbjct: 202 WSLGIMVIEMIDGEP--PYFNEPPLQAMRR----------IRDNLPPRVKDSHKVSS--V 247
Query: 269 MAKTAYLCVQRNPEGRPSMGEVV 291
+ L + R P R + E++
Sbjct: 248 LRGFLDLMLVREPSQRATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 15 FSEIQQATGDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVL 73
S ++ G F ++G G +G VYKG +K GQ+ A KV + + E + E+ +L
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKV-MDVTEDEEEEIKLEINML 66
Query: 74 N-FARHKNIVMLLGFCCK------ENLNILVYEYICNKSLHWHLFDNTESVL---EWHQR 123
++ H+NI G K ++ LV E+ C L NT+ +W
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF-CGAGSVTDLVKNTKGNALKEDWIAY 125
Query: 124 YAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183
I +GL LH +IHRD++ N+LLT + L DFG++ +
Sbjct: 126 ICREI--LRGLAHLHAH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 179
Query: 184 KILGTLGYLAPEYA---EN--GIVSIRTDVYAFGIILLQLMSG 221
+GT ++APE EN R+D+++ GI +++ G
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 28 ENLLGEGGFGHVYKGEL----KDGQMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKNIV 82
E +LG G FG + +G L K +A +R S + F +E L H NIV
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
L G + N ++V EY+ N +L L + E L Q G A G+++L E
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM-- 126
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLG------YLAPEY 196
+H+ + +L+ D V + F + +D + I T+ + APE
Sbjct: 127 --GYVHKGLAAHKVLVNSDLVCKISGFR----RLQEDKSEA-IYTTMSGKSPVLWAAPEA 179
Query: 197 AENGIVSIRTDVYAFGIILLQLMS--GRKVVDMNGEE 231
+ S +DV++FGI++ ++MS R DM+G++
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 45/204 (22%), Positives = 90/204 (44%), Gaps = 10/204 (4%)
Query: 23 GDFSKENLLGEGGFGHVYKGE-LKDGQMIAAK---VRKEASTQGFAEFQSEVYVLNFARH 78
+F E +G G F VY+ L DG +A K + + A+ E+ +L H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHL--FDNTESVLEWHQRYAAAIGTAKGLRF 136
N++ ++N +V E L + F + ++ + + L
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY 196
+H ++HRD++P+N+ +T V LGD GL R+ ++ ++GT Y++PE
Sbjct: 122 MHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 197 AENGIVSIRTDVYAFGIILLQLMS 220
+ ++D+++ G +L ++ +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 49/232 (21%)
Query: 27 KENLLGEGGFGHVYKGE-LKDGQMIAAKVRK--EASTQGFAEFQ------------SEVY 71
K LGEG +G V K G+++A K K E S + Q E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 72 VLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHL---FDNTESVLEWHQRYAAAI 128
++N +H+NI+ L+ + + LV + + L D + E + +
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDI-----MASDLKKVVDRKIRLTESQVK-CILL 126
Query: 129 GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ------ 182
GL LH+ +HRD+ P+NI + + + DFGLAR + P
Sbjct: 127 QILNGLNVLHKWY----FMHRDLSPANIFINSKGICKIADFGLAR-RYGYPPYSDTLSKD 181
Query: 183 ---------TKILGTLGYLAPEY---AENGIVSIRTDVYAFGIILLQLMSGR 222
T + TL Y APE AE ++ D+++ G I +L++G+
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-09
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 31 LGEGGFGHVYKGELK-DGQMIAAKV---RKEASTQGFAEFQSEVYVLNFARHKNIVML-L 85
LG+GGFG V +++ G++ A K ++ +G+ E +L + IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 86 GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR----YAAAIGTAKGLRFLHEEC 141
F K +L LV + L +H+++ E + + Y A I GL LH+
Sbjct: 61 AFQTKTDL-CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQI--ISGLEHLHQR- 116
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK-ILGTLGYLAPEYAENG 200
II+RD++P N+LL +D + D GLA + D +TK GT G++APE +
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAV-ELKDGQSKTKGYAGTPGFMAPELLQGE 172
Query: 201 IVSIRTDVYAFGIILLQLMSGRKVVDMNGEE 231
D +A G+ L ++++ R GE+
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 5/96 (5%)
Query: 127 AIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186
+I KGL +L E+ + I+HRD++PSNIL+ L DFG++ D + +
Sbjct: 109 SIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV 163
Query: 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
GT Y++PE + S+++D+++ G+ L+++ GR
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 5/96 (5%)
Query: 127 AIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186
+I +GL +L E+ + I+HRD++PSNIL+ L DFG++ D + +
Sbjct: 109 SIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV 163
Query: 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
GT Y++PE + S+++D+++ G+ L++L GR
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 57/212 (26%), Positives = 85/212 (40%), Gaps = 46/212 (21%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR---------HKN 80
+GEG F V K K G+ A K K+ F+S V N H N
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKH-------FKSLEQVNNLREIQALRRLSPHPN 59
Query: 81 IVML-----------LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIG 129
I+ L L E +++ +YE I + L + + Y +
Sbjct: 60 ILRLIEVLFDRKTGRLALVF-ELMDMNLYELIKGR--KRPLPEKRV------KSYMYQL- 109
Query: 130 TAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL 189
K L +H R G I HRD++P NIL+ D + L DFG R P T+ + T
Sbjct: 110 -LKSLDHMH---RNG-IFHRDIKPENILI-KDDILKLADFGSCR-GIYSKPPYTEYISTR 162
Query: 190 GYLAPE-YAENGIVSIRTDVYAFGIILLQLMS 220
Y APE +G + D++A G + +++S
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 30 LLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVY-----VLNFARHKNIVM 83
++G+G FG V + K DG A KV ++ + E Q+ + +L +H +V
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG 60
Query: 84 L-LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-YAAAIGTAKGLRFLHEEC 141
L F E L V +Y+ L +HL LE R YAA + +A G +LH
Sbjct: 61 LHYSFQTAEKL-YFVLDYVNGGELFFHL-QRERCFLEPRARFYAAEVASAIG--YLHSL- 115
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI 201
II+RD++P NILL +L DFGL + + + GT YLAPE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 202 VSIRTDVYAFGIILLQLMSG 221
D + G +L +++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 22/230 (9%)
Query: 23 GDFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQ---SEVYVLNFARH 78
DF +G+GG+G V+ + KD G+++A K K++ E + +E +L +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 79 KNIVMLL-GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-YAAAIGTAKGLRF 136
+ +V LL F E L L EY+ L +N + E H R Y A + A +
Sbjct: 61 EWLVKLLYAFQDDEYL-YLAMEYVPGGDFR-TLLNNLGVLSEDHARFYMAEMFEA--VDA 116
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY 196
LHE IHRD++P N L+ L DFGL++ T ++G+ Y+APE
Sbjct: 117 LHEL----GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEV 169
Query: 197 AENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ---SLRQWAEPL 243
D ++ G +L + + G +G P + +L+ W E L
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG--FPPFSGSTPNETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 68/271 (25%), Positives = 117/271 (43%), Gaps = 36/271 (13%)
Query: 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAKV---RKEASTQGFAEFQSEVYVLNFARHKN 80
F +LG+GGFG V +++ G+M A K ++ +G A +E +L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 81 IVML-LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR---YAAAIGTAKGLRF 136
+V L + K+ L LV + L +H+++ + QR YAA + GL
Sbjct: 62 VVSLAYAYETKDAL-CLVLTIMNGGDLKFHIYNMGNPGFD-EQRAIFYAAELCC--GLED 117
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY 196
L E I++RD++P NILL + D GLA + V+ ++ GT+GY+APE
Sbjct: 118 LQRE----RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-GTVGYMAPEV 172
Query: 197 AENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256
N + D + G ++ +++ G Q R+ E + E +D R
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQG-----------QSPFRKRKERV-----KREEVDRR 216
Query: 257 IENSYDTYELYLMAKTAYLCVQ---RNPEGR 284
++ + Y +C +NP+ R
Sbjct: 217 VKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 45/163 (27%), Positives = 83/163 (50%), Gaps = 18/163 (11%)
Query: 69 EVYVLNFARHKNIVML---LGFCCKENLN--ILVYEYICNKSLHWHLFDNTESVLEWHQR 123
E+ +L H+N++ + + +E N +VYE + + LH + +++++ + H +
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE-LMDTDLH-QIIRSSQTLSDDHCQ 111
Query: 124 YAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183
Y +GL+++H ++HRD++PSN+LL + + DFGLAR + T
Sbjct: 112 YFL-YQLLRGLKYIHS----ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMT 166
Query: 184 KILGTLGYLAPEY---AENGIVSIRTDVYAFGIILLQLMSGRK 223
+ + T Y APE +I DV++ G I +L+ GRK
Sbjct: 167 EYVVTRWYRAPELLLNCSEYTTAI--DVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-09
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 31 LGEGGFGHVYKG--ELKDGQM-IAAKVRKEASTQGFA-EFQSEVYVLNFARHKNIVMLLG 86
LG G FG V KG +++ Q+ +A KV K + + E E +++ + IV ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 87 FCCKENLNILVYEYICNKSLHWHLFDN-----TESVLE-WHQRYAAAIGTAKGLRFLHEE 140
C E L +LV E L+ L +V+E HQ + G+++L +
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQ-------VSMGMKYLEGK 114
Query: 141 CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILG---TLGYLAPEYA 197
+HRD+ N+LL + + DFGL++ DD L + APE
Sbjct: 115 ----NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170
Query: 198 ENGIVSIRTDVYAFGIILLQLMS--GRKVVDMNGEE 231
S R+DV+++GI + + S + M G E
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-09
Identities = 46/202 (22%), Positives = 90/202 (44%), Gaps = 12/202 (5%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIAAK---VRKEASTQGFAEFQSEVYVLNFARHK 79
+F E +G G F VY+ L D + +A K + + + + E+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 80 NIVMLL-GFCCKENLNILVYEYICNKSLHWHL--FDNTESVLEWHQRYAAAIGTAKGLRF 136
N++ L F LNI V E L + F + ++ + + +
Sbjct: 63 NVIKYLDSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY 196
+H ++HRD++P+N+ +T V LGD GL R+ ++ ++GT Y++PE
Sbjct: 122 MHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 197 AENGIVSIRTDVYAFGIILLQL 218
+ ++D+++ G +L ++
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 60/224 (26%), Positives = 106/224 (47%), Gaps = 18/224 (8%)
Query: 24 DFSKENLLGEGGFGHVY---KGELKD-GQMIAAKVRKEASTQGFAEF----QSEVYVLNF 75
+F +LG G +G V+ K D G++ A KV K+A+ A+ ++E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 76 ARHKNIVMLLGFCCKENLNI-LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGL 134
R ++ L + + + + L+ +YI L HL + Q Y+ I A L
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLA--L 118
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT-KILGTLGYLA 193
LH+ II+RD++ NILL + +L DFGL++ D+ + GT+ Y+A
Sbjct: 119 EHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 194 PEYAENGIV--SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQS 235
P+ G D ++ G+++ +L++G ++GE+ Q+
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 58/234 (24%), Positives = 108/234 (46%), Gaps = 30/234 (12%)
Query: 35 GFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94
G +G+ K ++IA +V+ A ++ + ++E+ L H+NI+ + +E L
Sbjct: 181 GVNSTNQGKPKCERLIAKRVK--AGSRAAIQLENEILALGRLNHENILKI-----EEILR 233
Query: 95 ILVYEYICNKSLHWHL--------FDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPI 146
Y+ + + L FD + L R A + ++H++ +
Sbjct: 234 SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK----KL 288
Query: 147 IHRDMRPSNILLTHDFVPMLGDFGLAR-WKTTDDPVQTKILGTLGYLAPE-YAENGIVSI 204
IHRD++ NI L D +LGDFG A ++ + +GT+ +PE A +G I
Sbjct: 289 IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI 348
Query: 205 RTDVYAFGIILLQLMSGRKV-VDMNGEEPQQSLRQWAEPLIEKLAL--HELIDP 255
TD+++ G+ILL ++S + G +P + L + +I+ L++ E DP
Sbjct: 349 -TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK----IIDSLSVCDEEFPDP 397
|
Length = 501 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 8e-09
Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY 191
K L FLH + +IHRD++ +ILLT D L DFG + + P + ++GT +
Sbjct: 126 KALSFLHAQ----GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 181
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
+APE D+++ GI++++++ G
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 9e-09
Identities = 67/271 (24%), Positives = 119/271 (43%), Gaps = 36/271 (13%)
Query: 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAK---VRKEASTQGFAEFQSEVYVLNFARHKN 80
F +LG+GGFG V +++ G+M A K ++ +G A +E +L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 81 IVML-LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR---YAAAIGTAKGLRF 136
+V L + K+ L LV + L +H+++ + +R YAA I GL
Sbjct: 62 VVSLAYAYETKDAL-CLVLTLMNGGDLKFHIYNMGNPGFD-EERAVFYAAEI--TCGLED 117
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY 196
LH E I++RD++P NILL + D GLA + ++ ++ GT+GY+APE
Sbjct: 118 LHRE----RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-GTVGYMAPEV 172
Query: 197 AENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256
+N + D + G ++ +++ G + RQ E + E ++ R
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEG-----------KSPFRQRKEKV-----KREEVERR 216
Query: 257 IENSYDTYELYLMAKTAYLCVQ---RNPEGR 284
++ + Y +C Q ++P R
Sbjct: 217 VKEDQEEYSEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 9e-09
Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQ-----SEVYVLNFARH 78
DF+ LG G FG V K+ +++ ++ + Q SE +LN+ H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGT--AKGLRF 136
V L G E+ LV E++ + L ++R+ +G A +
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFF--------TFLRRNKRFPNDVGCFYAAQIVL 142
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY 196
+ E + I++RD++P N+LL D + DFG A K D T + GT Y+APE
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA--KVVDTRTYT-LCGTPEYIAPEI 199
Query: 197 AENGIVSIRTDVYAFGIILLQLMSG 221
N D + GI + +++ G
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 9e-09
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 40/227 (17%)
Query: 31 LGEGGFGHVYKGELK---DGQ--------MIAAKVRKEASTQGFAEFQSEVYVLNFARHK 79
LG+G F ++YKG L+ D + KV + F +++ HK
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-RDSLAFFETASLMSQLSHK 61
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESV-LEWHQRYAAAIGTAKGLRFLH 138
++V L G C ++ NI+V EY+ L L +V L W + A A L +L
Sbjct: 62 HLVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 139 EECRGGPIIHRDMRPSNILLTHD-----FVPM--LGDFGLARWKTTDDPVQTKILGTLGY 191
++ ++H ++ NIL+ +VP L D G+ + + +I +
Sbjct: 119 DK----KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI----PW 170
Query: 192 LAPEYAENGIVSIRT--DVYAFGIILLQLMSGRKVVDMNGEEPQQSL 236
+APE NG S+ D ++FG LL++ S NGEEP +L
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICS-------NGEEPLSTL 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 29/96 (30%), Positives = 56/96 (58%), Gaps = 5/96 (5%)
Query: 127 AIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186
+I +GL +L E+ + I+HRD++PSNIL+ L DFG++ D + +
Sbjct: 105 SIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV 159
Query: 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
GT Y++PE + ++++D+++ G+ L+++ GR
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQ---SEVYVLNFARHK 79
DF LG G FG V + K G+ A K K+ + Q E +L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 80 NIV-MLLGFCCKENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKG 133
IV M+ F + + L+ E++ L HL F N + + Y A + A
Sbjct: 79 FIVNMMCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPNDVA-----KFYHAELVLA-- 130
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL-GTLGYL 192
+LH + II+RD++P N+LL + + DFG A+ K D +T L GT YL
Sbjct: 131 FEYLHSK----DIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPD---RTFTLCGTPEYL 182
Query: 193 APEYAENGIVSIRTDVYAFGIILLQLMSG 221
APE ++ D + G++L + ++G
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 28/170 (16%)
Query: 131 AKGLRFL-HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR--WKTTDDPVQTKILG 187
AKG+ FL +C IHRD+ NILL+ + V + DFGLAR +K D +
Sbjct: 189 AKGMEFLASRKC-----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 188 TLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLR---QWAEPLI 244
L ++APE + + +I++DV++FG++L ++ S G P ++ ++ L
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLK 296
Query: 245 EKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294
E + Y T E+Y +T C P RP+ E+V L
Sbjct: 297 EGTRMR-------APDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 65/238 (27%), Positives = 91/238 (38%), Gaps = 49/238 (20%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV--RKEASTQG-FAEFQSEVYVLNFARHK 79
F K LLG+G G V+ LK G++ A KV +KE + +E +L H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVL-EWHQR-YAAAIGTAKGLRFL 137
+ L E LV +Y L L L E R YAA + A L +L
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA--LEYL 119
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL----------- 186
H G I++RD++P NILL ML DF L++ + P +K L
Sbjct: 120 H--LLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 187 ------------------GTLGYLAPE----YAENGIVSIRTDVYAFGIILLQLMSGR 222
GT Y+APE V D + GI+L +++ G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 39/126 (30%), Positives = 67/126 (53%), Gaps = 13/126 (10%)
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY 191
+GL+++H IIHRD++PSN+ + D + DFGLAR TDD + T + T Y
Sbjct: 131 RGLKYIHS----ADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWY 183
Query: 192 LAPEYAENGI-VSIRTDVYAFGIILLQLMSGRKVVDMNG--EEPQQSLRQWAEP---LIE 245
APE N + + D+++ G I+ +L++GR + ++ + LR P L++
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243
Query: 246 KLALHE 251
K++
Sbjct: 244 KISSES 249
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDG-QMIAAKVRKEASTQGFAEFQS---EVYVLNFARHK 79
DF+ +LG+G FG V E K ++ A K+ K+ + + E VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 80 NIVMLLGFCCKENLNIL--VYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAK 132
+ L C + ++ L V EY+ L +H+ F +V YAA I A
Sbjct: 61 PFLTQL-HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVF-----YAAEI--AI 112
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL 192
GL FLH +G II+RD++ N++L + + DFG+ + GT Y+
Sbjct: 113 GLFFLHS--KG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYI 168
Query: 193 APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEE 231
APE D +AFG++L ++++G+ D E+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 20/225 (8%)
Query: 24 DFSKENLLGEGGFGHVY----KGELKDGQMIAAKVRKEAST---QGFAEF-QSEVYVLNF 75
+F +LG G +G V+ G G++ A KV K+A+ AE ++E VL
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 76 ARHKNIVMLL--GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKG 133
R ++ L F L+ L+ +Y+ L HL+ + Y A I A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLH-LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA-- 117
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT-KILGTLGYL 192
L LH+ G II+RD++ NILL + +L DFGL++ ++ + GT+ Y+
Sbjct: 118 LDHLHQ--LG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 193 APEYAENGIV--SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQS 235
APE G D ++ G++ +L++G ++GE+ QS
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 77/286 (26%), Positives = 120/286 (41%), Gaps = 43/286 (15%)
Query: 31 LGEGGFGHVYKGELKDG----QMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLG 86
+G G FG V GE+ G Q++ ++R AS Q +F E +H N++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 87 FCCKENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
C + +LV E+ L +L + QR A I A GL LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI--ALGLLHLHKN- 119
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT--KILGTLGYLAPEYAE- 198
IH D+ N LLT D +GD+GL+ K +D T ++ L ++APE +
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 199 ---NGIVSIRT---DVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE- 251
N +V +T +V++ G+ + +L E Q R ++ + + E
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF----------ELGSQPYRHLSDEQVLTYTVREQ 226
Query: 252 ---LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294
L PR++ Y + + +L PE RPS EV LL
Sbjct: 227 QLKLPKPRLKLPLSDR-WYEVMQFCWL----QPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 24/168 (14%)
Query: 131 AKGLRFL-HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR--WKTTDDPVQTKILG 187
A+G+ FL +C IHRD+ NILL+ + V + DFGLAR +K D +
Sbjct: 183 ARGMEFLASRKC-----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 188 TLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL 247
L ++APE + + + ++DV++FG++L ++ S G P + Q E +L
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS-------LGASPYPGV-QIDEEFCRRL 289
Query: 248 AL-HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294
+ P Y T E+Y C NPE RP+ E+V +L
Sbjct: 290 KEGTRMRAPE----YATPEIY---SIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 73/279 (26%), Positives = 112/279 (40%), Gaps = 52/279 (18%)
Query: 31 LGEGGFGHVYKG---ELKDGQMIAAKVRKEASTQGFA--EFQSEVYVLNFARHKNIVMLL 85
LG G FG V KG K + +A K+ K + E E V+ + IV ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 86 GFCCKENLNILVYEYICNKSLHWHLFDN--------TESVLEWHQRYAAAIGTAKGLRFL 137
G C E+ +LV E L+ L N TE V HQ + G+++L
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNITELV---HQ-------VSMGMKYL 111
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD---PVQTKILGTLGYLAP 194
E +HRD+ N+LL + DFGL++ D+ +T + + AP
Sbjct: 112 EET----NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167
Query: 195 EYAENGIVSIRTDVYAFGIILLQLMS-GRK-VVDMNGEEPQQSLRQWAEPLIEKLALHEL 252
E S ++DV++FG+++ + S G+K M G E Q +IE
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ--------MIES------ 213
Query: 253 IDPRIENSYD-TYELYLMAKTAYLCVQRNPEGRPSMGEV 290
R+E E+Y + K LC + RP V
Sbjct: 214 -GERMECPQRCPPEMYDLMK---LCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 61/201 (30%), Positives = 89/201 (44%), Gaps = 22/201 (10%)
Query: 31 LGEGGFGHVYKGELKDGQMI-AAKVRKEASTQGFAEFQ---SEVYVLNFARHKNIVML-L 85
+G+G FG V + +D Q I A K ++A +E +E VL IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 86 GFCCKENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKGLRFLHEE 140
F E L LV +I L HL FD + + + Y A + A L LH+
Sbjct: 61 SFQSPEKL-YLVLAFINGGELFHHLQREGRFDLSRA-----RFYTAELLCA--LENLHKF 112
Query: 141 CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENG 200
+I+RD++P NILL + L DFGL + DD GT YLAPE
Sbjct: 113 ----NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 201 IVSIRTDVYAFGIILLQLMSG 221
+ D + G++L ++++G
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 47/175 (26%), Positives = 75/175 (42%), Gaps = 25/175 (14%)
Query: 21 ATGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFA-EFQSEVYVLNFAR 77
D+ LGEG FG VYK ++K G+++A K + GF E+ +L +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 78 HKNIVMLLGFCCKENLNI--------LVYEYICNKSLHWH----LFDNTESVLEWHQRYA 125
H N+V L+ + +V Y+ H L +N L Q
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD------HDLSGLLENPSVKLTESQIKC 119
Query: 126 AAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180
+ +G+ +LHE I+HRD++ +NIL+ + + + DFGLAR P
Sbjct: 120 YMLQLLEGINYLHEN----HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 64/286 (22%), Positives = 119/286 (41%), Gaps = 44/286 (15%)
Query: 31 LGEGGFGHVYKGELKDGQMI---AAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLL 85
LGEG FG V +G+L I A K K A + +F SE + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 86 GFCCKENLN------ILVYEYICNKSLHWHLF----DNTESVLEWHQRYAAAIGTAKGLR 135
G C + + +++ ++ + LH L + L A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL--GYLA 193
+L + IHRD+ N +L + + DFGL++ D + + + ++A
Sbjct: 127 YLSSK----SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253
E + + + ++DV++FG+ + ++ + G+ P P +E +++ +
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIAT-------RGQTPY--------PGVENSEIYDYL 227
Query: 254 DP--RIENSYDTYE-LY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
R++ D + LY LM+ C NP+ RPS + LE
Sbjct: 228 RQGNRLKQPPDCLDGLYSLMSS----CWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 28/181 (15%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQS------EVYVLNFARHKNIVM 83
+G G +G V + + G+ +A K A F E+ +L +H NI+
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHA----FDVPTLAKRTLRELKILRHFKHDNIIA 68
Query: 84 LLG-FCCKENLNILVYEYI----CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
+ VY + + LH H+ + + + E H RY +GL+++H
Sbjct: 69 IRDILRPPGADFKDVYVVMDLMESD--LH-HIIHSDQPLTEEHIRYFLY-QLLRGLKYIH 124
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ----TKILGTLGYLAP 194
+IHRD++PSN+L+ D +GDFG+AR ++ T+ + T Y AP
Sbjct: 125 SAN----VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 195 E 195
E
Sbjct: 181 E 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 62/199 (31%), Positives = 90/199 (45%), Gaps = 15/199 (7%)
Query: 30 LLGEGGFGHVYKGELK-DGQMIAAKV-RKEASTQGFAE--FQSEVYVL-NFARHKNIVML 84
++G+G FG V K + + A KV +K+A + E SE VL +H +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 85 -LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-YAAAIGTAKGLRFLHEECR 142
F + L V +YI L +HL LE R YAA I +A G +LH
Sbjct: 62 HFSFQTADKL-YFVLDYINGGELFYHL-QRERCFLEPRARFYAAEIASALG--YLHSL-- 115
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIV 202
I++RD++P NILL +L DFGL + + + GT YLAPE
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 203 SIRTDVYAFGIILLQLMSG 221
D + G +L +++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 25 FSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQS----EVYVLNFARHKN 80
F ++GEG +G V K K+ + I A ++K ++ E + E+ +L + +N
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVA-IKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE- 139
IV L + LV+EY+ +++LE + + K ++++
Sbjct: 62 IVELKEAFRRRGKLYLVFEYV------------EKNMLELLEEMPNGVPPEKVRSYIYQL 109
Query: 140 -----ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR-WKTTDDPVQTKILGTLGYLA 193
C I+HRD++P N+L++H+ V L DFG AR + T+ + T Y +
Sbjct: 110 IKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRS 169
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMSGR 222
PE D+++ G IL +L G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 29/200 (14%)
Query: 34 GGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLG------ 86
G FG VY + + G A KV K++ ++ V N + I+M+ G
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSD------MIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 87 -----FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
F K+ L LV EY+ + +W ++Y A + G+ LH+
Sbjct: 61 KLYYSFQSKDYL-YLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEV--VLGVEDLHQ-- 115
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI 201
RG IIHRD++P N+L+ L DFGL+R + K +GT YLAPE
Sbjct: 116 RG--IIHRDIKPENLLIDQTGHLKLTDFGLSR----NGLENKKFVGTPDYLAPETILGVG 169
Query: 202 VSIRTDVYAFGIILLQLMSG 221
+D ++ G ++ + + G
Sbjct: 170 DDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 19/224 (8%)
Query: 24 DFSKENLLGEGGFGHVY----KGELKDGQMIAAKVRKEASTQGFAEFQ----SEVYVLNF 75
+F +LG G +G V+ G++ A KV ++A+ A+ +E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 76 ARHKNIVMLLGFCCKENLNI-LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGL 134
R ++ L + + + L+ +Y+ + HL+ + + Y+ I A L
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA--L 118
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT-KILGTLGYLA 193
LH+ I++RD++ NILL + +L DFGL++ +++ +T GT+ Y+A
Sbjct: 119 EHLHKL----GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 194 PEY--AENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQS 235
PE + G D ++ GI++ +L++G + GE QS
Sbjct: 175 PEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLEGERNTQS 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 30 LLGEGGFGHVYKGELKD-GQMIAAKV---RKEASTQGFAEFQSEVYVLNFARHKN----I 81
++G GGFG VY D G+M A K ++ QG +E +L+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
M F + L + + + LH+HL + + + YA I GL +H
Sbjct: 61 CMTYAFHTPDKL-CFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEI--ILGLEHMHNRF 117
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI 201
+++RD++P+NILL + D GLA + P + +GT GY+APE + G
Sbjct: 118 ----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGT 171
Query: 202 V-SIRTDVYAFGIILLQLMSG 221
D ++ G +L +L+ G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 8/92 (8%)
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY 191
+GL+++H IIHRD++PSNI + D + DFGLAR TDD + T + T Y
Sbjct: 129 RGLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWY 181
Query: 192 LAPEYAENGIVSIRT-DVYAFGIILLQLMSGR 222
APE N + +T D+++ G I+ +L++G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 74/244 (30%), Positives = 103/244 (42%), Gaps = 39/244 (15%)
Query: 30 LLGEGGFGHVYKGELK-DGQMIAAKV--------RKEASTQGFAEFQSEVYVLNFARHKN 80
++G+G FG V + K DG+ A KV RKE Q + V + N +H
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE---QKHIMAERNVLLKN-VKHPF 57
Query: 81 IVML-LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-YAAAIGTAKGLRFLH 138
+V L F E L V +++ L +HL S E R YAA I +A G +LH
Sbjct: 58 LVGLHYSFQTTEKL-YFVLDFVNGGELFFHL-QRERSFPEPRARFYAAEIASALG--YLH 113
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE 198
I++RD++P NILL +L DFGL + T GT YLAPE
Sbjct: 114 SI----NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 199 NGIVSIRTDVYAFGIILLQLMSG------RKVVDMNGE--------EPQQSLRQWA--EP 242
D + G +L +++ G R V +M P SL W+ E
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEE 229
Query: 243 LIEK 246
L+EK
Sbjct: 230 LLEK 233
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-08
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 30 LLGEGGFGHVYKGELKD-GQMIAAKV---RKEASTQGFAEFQSEVYVLNFARHKN----I 81
++G GGFG VY D G+M A K ++ QG +E +L+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDN---TESVLEWHQRYAAAIGTAKGLRFLH 138
M F + L+ ++ + + LH+HL + +E+ + + YAA I GL +H
Sbjct: 61 CMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEAEMRF---YAAEI--ILGLEHMH 114
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE 198
R +++RD++P+NILL + D GLA + P + +GT GY+APE +
Sbjct: 115 N--RF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQ 168
Query: 199 NGIV-SIRTDVYAFGIILLQLMSG 221
G+ D ++ G +L +L+ G
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 8e-08
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 22/102 (21%)
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILG---- 187
+GL++LH +IHRD++PSNIL+ + + DFGLAR D + L
Sbjct: 114 RGLKYLHS----ANVIHRDLKPSNILVNSNCDLKICDFGLAR-GVDPDEDEKGFLTEYVV 168
Query: 188 TLGYLAPE-------YAENGIVSIRTDVYAFGIILLQLMSGR 222
T Y APE Y + +I D+++ G I +L++ +
Sbjct: 169 TRWYRAPELLLSSSRYTK----AI--DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 9e-08
Identities = 66/304 (21%), Positives = 122/304 (40%), Gaps = 62/304 (20%)
Query: 31 LGEGGFGHVYKGEL-----------------KDGQMIAAK-VRKEASTQGFAEFQSEVYV 72
LGEG FG V+ E ++A K +R++A+ +F E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHL---------FDNTESVLEWHQR 123
++ + NI+ LL C + ++ EY+ N L+ L + +
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 124 YAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD--PV 181
A A G+++L +HRD+ N L+ ++ + DFG++R + D +
Sbjct: 133 IFMATQIASGMKYLSSL----NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQL-----------MSGRKVVDMNGE 230
Q + + + +++ E G + +DV+AFG+ L ++ +S +V++ GE
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248
Query: 231 EPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEV 290
+ RQ P +S Y+L L C +RN + RPS E+
Sbjct: 249 FFRDQGRQVYLPK----------PALCPDSL--YKLMLS------CWRRNAKERPSFQEI 290
Query: 291 VRLL 294
L
Sbjct: 291 HATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDG-QMIAAKVRKEASTQGFAEFQS---EVYVLNFARHK 79
DF+ +LG+G FG V E K ++ A K+ K+ + + E VL +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 80 NIVMLLGFCCKENLNI-LVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKG 133
+ L C + + V EY+ L + + F +V YAA I A G
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF-----YAAEI--AIG 113
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLA 193
L FLH + II+RD++ N++L + + DFG+ + D GT Y+A
Sbjct: 114 LFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIA 169
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEE 231
PE D +AFG++L ++++G+ + E+
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-08
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 25 FSKENLLGEGGFGHVYKGELKDGQMIAA--KVRKEASTQGFAEFQ-SEVYVLNFARHKNI 81
+ K +GEG +G VYK + A K+R E +G E+ +L +H NI
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWH---QRYAAAIGTAKGLRFLH 138
V L E LV+EY+ + L H+ D++ + + Y I +G+ + H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL-DLDLKKHM-DSSPDFAKNPRLIKTYLYQI--LRGIAYCH 119
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPM-LGDFGLARWKTTDDPVQ--TKILGTLGYLAPE 195
++HRD++P N+L+ + L DFGLAR PV+ T + TL Y APE
Sbjct: 120 SH----RVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRAPE 173
Query: 196 YAENG-IVSIRTDVYAFGIILLQLMSGR 222
S D+++ G I ++++ +
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 28/83 (33%), Positives = 48/83 (57%), Gaps = 2/83 (2%)
Query: 146 IIHRDMRPSNILLTHDFVPMLGDFGLARW--KTTDDPVQTKILGTLGYLAPEYAENGIVS 203
+IHRD++ +NILL + + LGDFG ++ T D V GT Y+APE S
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 204 IRTDVYAFGIILLQLMSGRKVVD 226
+ D+++ G++L +L++ ++ D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 8/93 (8%)
Query: 131 AKGLRFL-HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL 189
A+G+ FL + C IHRD+ N+LLT V + DFGLAR D K L
Sbjct: 222 AQGMDFLASKNC-----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 190 --GYLAPEYAENGIVSIRTDVYAFGIILLQLMS 220
++APE + + ++++DV+++GI+L ++ S
Sbjct: 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 32/93 (34%), Positives = 54/93 (58%), Gaps = 8/93 (8%)
Query: 131 AKGLRFL-HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR--WKTTDDPVQTKILG 187
A+G+ FL +C IHRD+ NILL+ + V + DFGLAR +K D +
Sbjct: 184 ARGMEFLASRKC-----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 188 TLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS 220
L ++APE + + + ++DV++FG++L ++ S
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 17/96 (17%)
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL 192
G++ LH IIHRD++PSNI++ D + DFGLAR + T + T Y
Sbjct: 130 GIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYR 184
Query: 193 APE------YAENGIVSIRTDVYAFGIILLQLMSGR 222
APE Y EN D+++ G I+ +++ G
Sbjct: 185 APEVILGMGYKEN------VDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY 191
+GL+++H IIHRD++PSN+ + D + DFGLAR DD + T + T Y
Sbjct: 129 RGLKYIHS----AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEM-TGYVATRWY 181
Query: 192 LAPEYAENGIVSIRT-DVYAFGIILLQLMSGR 222
APE N + +T D+++ G I+ +L+ G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 67/291 (23%), Positives = 122/291 (41%), Gaps = 41/291 (14%)
Query: 25 FSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARH 78
F+ +LG+G FG V + +LK Q +A K+ K S+ EF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 79 KNIVMLLGFCCKEN------LNILVYEYICNKSLHWHLF-----DNTESV-LEWHQRYAA 126
N++ L+G + + +++ ++ + LH L + ++ L+ R+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 127 AIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186
I A G+ +L + IHRD+ N +L + + DFGL++ + D +
Sbjct: 121 DI--ASGMEYLSSK----NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 187 GTL--GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI 244
L +LA E + + + +DV+AFG+ + ++M+ G+ P + +E
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT-------RGQTPYAGVEN-SEIYN 226
Query: 245 EKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ + L P + D YEL C P+ RPS + LE
Sbjct: 227 YLIKGNRLKQP-PDCLEDVYEL------MCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 30/220 (13%)
Query: 15 FSEIQQATGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAEFQ-SEVY 71
F + + T + +G G FG V + GQ +A K + K ST A+ E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 72 VLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLE--WHQRYAAAIG 129
+L RH+NI+ L +I + LH L T LE + Q + I
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL---TSRPLEKQFIQYFLYQI- 117
Query: 130 TAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL 189
+GL+++H ++HRD++PSNIL+ + + DFGLAR DP T + T
Sbjct: 118 -LRGLKYVHS----AGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMTGYVSTR 169
Query: 190 GYLAPE-------YAENGIVSIRTDVYAFGIILLQLMSGR 222
Y APE Y + D+++ G I +++ G+
Sbjct: 170 YYRAPEIMLTWQKY------DVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 30 LLGEGGFGHVY---KGELKD-GQMIAAKVRKEASTQGFAEFQS--EVYVLNFARHKNIVM 83
+LG+G FG V+ K D GQ+ A KV K+A+ + ++ E +L H IV
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L E L+ +++ L L E + Y A + A L LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL--ALALDHLH----S 116
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVS 203
II+RD++P NILL + L DFGL++ + GT+ Y+APE +
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176
Query: 204 IRTDVYAFGIILLQLMSG 221
D ++FG+++ ++++G
Sbjct: 177 QSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 69 EVYVLNFARHKNIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAA 127
E+ +L HKNI+ LL F +++L Y+ + + +L L+ H+R +
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELD-HERMSYL 128
Query: 128 I-GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186
+ G++ LH IIHRD++PSNI++ D + DFGLAR T+ + T +
Sbjct: 129 LYQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-MMTPYV 183
Query: 187 GTLGYLAPE------YAENGIVSIRTDVYAFGIILLQLMSG 221
T Y APE Y EN D+++ G I+ +L+ G
Sbjct: 184 VTRYYRAPEVILGMGYKEN------VDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 14 SFSEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKV---RKEASTQGFAEFQSE 69
S SE+++ N +G G G VYK + G++ A KV E + + + E
Sbjct: 72 SLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR--RQICRE 122
Query: 70 VYVLNFARHKNIVMLLGFCCKE------NLNILVYEYICNKSLHWHLFDNTESVLEWHQR 123
+ +L H N+V C + + +L+ E++ SL E ++
Sbjct: 123 IEILRDVNHPNVVK-----CHDMFDHNGEIQVLL-EFMDGGSL--------EGTHIADEQ 168
Query: 124 YAA--AIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR-WKTTDDP 180
+ A A G+ +LH I+HRD++PSN+L+ + DFG++R T DP
Sbjct: 169 FLADVARQILSGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224
Query: 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYA-----FGIILLQLMSGR 222
+ + GT+ Y++PE + D YA G+ +L+ GR
Sbjct: 225 CNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 24 DFSKENLLGEGGFGHVY-KGELKDGQMIAAKVRKEAST---QGFAEFQSEVYVLNFARHK 79
DF ++L+G G FG V E G + A KV K++ + + F+ E +L+ +
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 80 NIVMLL-GFCCKENLNILVYEYICNKSL------HWHLFDNTESVLEWHQRYAAAIGTAK 132
I L F K+NL LV EY L + FD E + Q Y A + A
Sbjct: 62 WIPQLQYAFQDKDNL-YLVMEYQPGGDLLSLLNRYEDQFD--EDMA---QFYLAELVLA- 114
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKI-LGTLGY 191
+ +H+ +HRD++P N+L+ L DFG A T + V +K+ +GT Y
Sbjct: 115 -IHSVHQM----GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 192 LAPEY------AENGIVSIRTDVYAFGIILLQLMSGR 222
+APE G + D ++ G+I +++ GR
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 63/238 (26%), Positives = 100/238 (42%), Gaps = 26/238 (10%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLL-GFCC 89
L G G V+ K G KV +A T G E+ +L H+ I+ L+ +
Sbjct: 100 LTPGSEGEVFVC-TKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYRW 157
Query: 90 KENLNILVYEYICNKSLHWHLFDNTESV--LEWHQRYAAAIGTAKGLRFLHEECRGGPII 147
K + +++ +Y C+ LF + L Q + L +LH RG II
Sbjct: 158 KSTVCMVMPKYKCD------LFTYVDRSGPLPLEQAITIQRRLLEALAYLHG--RG--II 207
Query: 148 HRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL---APEYAENGIVSI 204
HRD++ NI L +LGDFG A K P + G G L +PE
Sbjct: 208 HRDVKTENIFLDEPENAVLGDFG-AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA 266
Query: 205 RTDVYAFGIILLQLMSGRKVVDMNGEEPQQS--LRQWAEPLIEKLALHELIDPRIENS 260
+TD+++ G++L + MS + V + S LR +I + +H L P+ ++
Sbjct: 267 KTDIWSAGLVLFE-MSVKNVTLFGKQVKSSSSQLRS----IIRCMQVHPLEFPQNGST 319
|
Length = 392 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 69 EVYVLNFARHKNIV----MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRY 124
E+ +L RH +IV ++L +E +I V + LH + N + E HQ +
Sbjct: 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFF 108
Query: 125 AAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ-- 182
+ + L+++H + HRD++P NIL D + DFGLAR D P
Sbjct: 109 LYQL--LRALKYIHT----ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 162
Query: 183 -TKILGTLGYLAPEYAEN--GIVSIRTDVYAFGIILLQLMSGR 222
T + T Y APE + + D+++ G I ++++G+
Sbjct: 163 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 9e-07
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 31 LGEGGFGHVYKGELKDGQMIAA---KVRKEASTQGFAEFQS-----EVYVLNFARHKNIV 82
LG+G FG VY +KD + +A KV KE ++ E +L+ H IV
Sbjct: 8 LGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 83 MLLG-FCCKENLNILVYEYICNKSLHWHL--FDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
F ++ I+ EY + L L +T L +Q I G+ ++H+
Sbjct: 66 KFHASFLERDAFCIIT-EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN 199
I+HRD++ NI L ++ + +GDFG++R + T GT Y++PE ++
Sbjct: 125 R----RILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 200 GIVSIRTDVYAFGIILLQL 218
++D+++ G IL ++
Sbjct: 180 QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 69 EVYVLNFARHKNIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAA 127
E+ ++ HKNI+ LL F +++L YI + + +L + L+ H+R +
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL 131
Query: 128 I-GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186
+ G++ LH IIHRD++PSNI++ D + DFGLAR T + ++
Sbjct: 132 LYQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 187
Query: 187 GTLGYLAPE------YAENGIVSIRTDVYAFGIILLQLMSGR 222
T Y APE Y EN D+++ G I+ +++ G
Sbjct: 188 -TRYYRAPEVILGMGYKEN------VDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 4/85 (4%)
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD---PVQTKILGTLGYLAPE 195
+E ++HRD++ +NI L + LGDFG ++ + +D V + GT YLAPE
Sbjct: 183 DEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPE 241
Query: 196 YAENGIVSIRTDVYAFGIILLQLMS 220
E S + D+++ G+IL +L++
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 18/99 (18%)
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ-TKILGTLG 190
+GL++LH I+HRD++P N+L+ + V + DFGLAR + D+ T+ + T
Sbjct: 114 RGLKYLH----SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169
Query: 191 YLAPE-------YAENGIVSIRTDVYAFGIILLQLMSGR 222
Y APE Y D+++ G I +L+ R
Sbjct: 170 YRAPEILMGSRHYTS------AVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY 191
KGL+++H IIHRD++P N+ + D + DFGLAR D T + T Y
Sbjct: 129 KGLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWY 181
Query: 192 LAPEYAENGIVSIRT-DVYAFGIILLQLMSGR 222
APE N + +T D+++ G I+ ++++G+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 30 LLGEGGFGHVYKG-ELKDGQMIAAKV-----RKEASTQGFAEFQSEVYVLNFARHKNIVM 83
LLG+G FG VY ++ G+ +AAK +++ + + E+ +L +H+ IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 84 LLGFCCK---ENLNILVYEYICNKSLHWHLFDN---TESVLEWHQRYAAAIGTAKGLRFL 137
G C + E + EY+ S+ L TESV ++Y I +G+ +L
Sbjct: 69 YYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVT---RKYTRQI--LEGMSYL 122
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT---KILGTLGYLAP 194
H I+HRD++ +NIL LGDFG ++ T T + GT +++P
Sbjct: 123 H----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 195 EYAENGIVSIRTDVYAFGIILLQLMSGR 222
E + DV++ G ++++++ +
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 67/286 (23%), Positives = 124/286 (43%), Gaps = 53/286 (18%)
Query: 31 LGEGGFGHVYKG---ELKDGQM-----IAAKVRKEASTQGFAE-FQSEVYVLNFARHKNI 81
LG+G F ++KG E+ D + KV + S + ++E F +++ HK++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVL-DKSHRNYSESFFEAASMMSQLSHKHL 61
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESV-LEWHQRYAAAIGTAKGLRFLHEE 140
V+ G C + +I+V EY+ SL +L N + + W A + A L FL ++
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWA--LHFLEDK 119
Query: 141 CRGGPIIHRDMRPSNILLTHD---------FVPMLGDFGLARWKTTDDPVQTKILGTLGY 191
+ H ++ N+LL + F+ L D G++ + + +I +
Sbjct: 120 ----GLTHGNVCAKNVLLIREEDRKTGNPPFIK-LSDPGISITVLPKEILLERI----PW 170
Query: 192 LAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDM--NGEEPQQSLRQWAEPLIEKLA 248
+ PE EN +S+ D ++FG L ++ SG D + + Q+ L+ + +
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG---GDKPLSALDSQKKLQFYEDR------ 221
Query: 249 LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294
H+L P+ EL + C+ P+ RPS ++R L
Sbjct: 222 -HQLPAPKWT------ELANLINQ---CMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQ-SEVYVLNFARHKNI 81
+ + +GEG +G V G +A K Q F + E+ +L +H+NI
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLHE 139
+ +L + YI + + L+ T+ + H +Y +GL+++H
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL-YQILRGLKYIH- 123
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT-TDDPVQ--TKILGTLGYLAPE- 195
++HRD++PSN+LL + + DFGLAR D T+ + T Y APE
Sbjct: 124 ---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 196 ------YAENGIVSIRTDVYAFGIILLQLMSGR 222
Y + +I D+++ G IL +++S R
Sbjct: 181 MLNSKGYTK----AI--DIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 51/160 (31%), Positives = 78/160 (48%), Gaps = 22/160 (13%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHK 79
+F + G FG VY G K + ++ A KV K+A + + Q+E L ++
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64
Query: 80 NIVMLLGFCCKENLNILVYEYICN---KSLHWHL---FDNTESVLEWHQRYAAAIGTAKG 133
IV L N LV EY+ KSL H+ FD +V +Y + + A
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSL-LHIYGYFDEEMAV-----KYISEVALA-- 116
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173
L +LH R G IIHRD++P N+L++++ L DFGL++
Sbjct: 117 LDYLH---RHG-IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 130 TAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL 189
GL+++H IIHRD++P N+ + D + DFGLAR D T + T
Sbjct: 126 MLCGLKYIHS----AGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTR 178
Query: 190 GYLAPEYAENGIVSIRT-DVYAFGIILLQLMSGR 222
Y APE N + +T D+++ G I+ ++++G+
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 28/93 (30%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 131 AKGLRFL-HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK--ILG 187
A+G+ FL + C +HRD+ N+LL + + DFGLAR D +K
Sbjct: 247 ARGMEFLASKNC-----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 188 TLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS 220
+ ++APE + + + +DV+++GI+L ++ S
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 5e-06
Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 26/172 (15%)
Query: 69 EVYVLNFARHKNIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAA 127
E+ ++ HKNI+ LL F +++L Y+ + + +L + L+ H+R +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL 124
Query: 128 I-GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186
+ G++ LH IIHRD++PSNI++ D + DFGLAR T + T +
Sbjct: 125 LYQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 179
Query: 187 GTLGYLAPE------YAENGIVSIRTDVYAFGIILLQ------LMSGRKVVD 226
T Y APE Y EN D+++ G I+ + L GR +D
Sbjct: 180 VTRYYRAPEVILGMGYKEN------VDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 31 LGEGGFGHVYK-GELKDGQMIAAKVRKEASTQGFAEFQSEVYVLN-FARHKNIVMLLGFC 88
+G+G +G V+K K+G A K+ E ++E +L + H N+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 89 CKENLNI-----LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAI------GTAKGLRFL 137
K+++ LV E +CN + D + L+ +R I GL+ L
Sbjct: 85 YKKDVKNGDQLWLVLE-LCNGG---SVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYA 197
H IHRD++ +NILLT + L DFG++ T+ + +GT ++APE
Sbjct: 141 HVN----KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196
Query: 198 E-----NGIVSIRTDVYAFGIILLQLMSG 221
+ R DV++ GI ++L G
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW----KTTDDPVQTKILGT 188
GL+++H ++HRD++P N+L+ D + DFGLAR + T+ + T
Sbjct: 117 GLKYIHS----ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 189 LGYLAPEYA-ENGIVSIRTDVYAFGIILLQLMSGRKV 224
Y APE + DV++ G IL +L+ + V
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 27/207 (13%)
Query: 30 LLGEGGFGHVYKGELKD-GQMIAAKV-----RKEASTQGFAEFQSEVYVLNFARHKNIVM 83
LLG G FG VY D G+ +A K + +++ + E+ +L RH IV
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 84 LLGFCCKE----NLNILVYEYICNKSLHWHLFDN---TESVLEWHQRYAAAIGTAKGLRF 136
G C ++ L+I V EY+ S+ L TE+V +RY I +G+ +
Sbjct: 69 YYG-CLRDPEEKKLSIFV-EYMPGGSIKDQLKAYGALTENVT---RRYTRQI--LQGVSY 121
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKI---LGTLGYLA 193
LH I+HRD++ +NIL LGDFG ++ T T I GT +++
Sbjct: 122 LH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMS 220
PE + DV++ ++++++
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 23/179 (12%)
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
N+V L + E+ LV ++ L H+ E +R+AA + A L LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA--LDALHR 103
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN 199
E I+ RD+ P+NILL L F RW +D + + + Y APE
Sbjct: 104 E----GIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM-YCAPEV--- 153
Query: 200 GIVSIRT---DVYAFGIILLQLMSGRKVVDMN----GEEPQQSLRQW----AEPLIEKL 247
G +S T D ++ G IL +L++G+ +V+ + ++ +W A L+++L
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQL 212
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 29/99 (29%), Positives = 48/99 (48%), Gaps = 24/99 (24%)
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILL-THDFVPMLGDFGLARWKTTDDPVQTKILGTLG 190
+GL+++H ++HRD++P+N+ + T D V +GDFGLAR
Sbjct: 125 RGLKYIHS----ANVLHRDLKPANVFINTEDLVLKIGDFGLAR----------------- 163
Query: 191 YLAPEYAENGIVS--IRTDVYAFGIILLQLMSGRKVVDM 227
+ P Y+ G +S + T Y +LL + K +DM
Sbjct: 164 IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDM 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-05
Identities = 32/147 (21%), Positives = 58/147 (39%), Gaps = 15/147 (10%)
Query: 30 LLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV--MLLGF 87
LL G VY KD + ++ S + A+ + EV +L K + +L
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV---LKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 88 CCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPII 147
+ + L+ E+I ++L + +E E A + L LH+ +
Sbjct: 62 GESDGWSYLLMEWIEGETL----DEVSEEEKEDIAEQLAEL-----LAKLHQ-LPLLVLC 111
Query: 148 HRDMRPSNILLTHDFVPMLGDFGLARW 174
H D+ P NIL+ + + D+ A +
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 66/269 (24%), Positives = 103/269 (38%), Gaps = 62/269 (23%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHK 79
DF ++G G FG V + KD G + A K+ ++A + ++E +L A
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 80 NIV-MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAA----AIGTAKGL 134
+V M F K NL L+ E++ + L E Q Y A AI + L
Sbjct: 62 WVVKMFYSFQDKLNL-YLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA---------------------- 172
F IHRD++P N+LL L DFGL
Sbjct: 121 GF----------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170
Query: 173 -------------RWKTTDDPVQTKILGTLGYLAPE-YAENGIVSIRTDVYAFGIILLQL 218
WK + +GT Y+APE + + G + D ++ G+I+ ++
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEM 229
Query: 219 MSGRKVVDMNGEEPQQSLRQ---WAEPLI 244
+ G E PQ++ ++ W E LI
Sbjct: 230 LIGYP--PFCSETPQETYKKVMNWKETLI 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 65/265 (24%), Positives = 104/265 (39%), Gaps = 54/265 (20%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHK 79
DF ++G G FG V + KD G + A K+ ++A + A ++E +L A
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 80 NIV-MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
+V M F K NL L+ E++ + L E Q Y A T + +H
Sbjct: 62 WVVKMFYSFQDKRNL-YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAE--TVLAIDAIH 118
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA-------------------------- 172
+ IHRD++P N+LL L DFGL
Sbjct: 119 QL----GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 173 ---------RWKTTDDPVQTKILGTLGYLAPE-YAENGIVSIRTDVYAFGIILLQLMSGR 222
WK + +GT Y+APE + + G + D ++ G+I+ +++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGY 233
Query: 223 KVVDMNGEEPQQSLRQ---WAEPLI 244
E PQ++ R+ W E L+
Sbjct: 234 P--PFCSETPQETYRKVMNWKETLV 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 29/212 (13%)
Query: 29 NLLGEGGFGHVYKGEL------KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
+LL EG FG ++ G L K+ ++ V+ AS E +L H+NI+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 83 MLLGFCCKENLNILV-YEYICNKSLHWHLFD------NTESVLEWHQRYAAAIGTAKGLR 135
+L C ++ V Y Y+ +L L N L Q AI A G+
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD--PVQTKILGT----- 188
+LH+ RG +IH+D+ N ++ + + D L+R D P+ LG
Sbjct: 132 YLHK--RG--VIHKDIAARNCVIDEELQVKITDNALSR-----DLFPMDYHCLGDNENRP 182
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMS 220
+ ++A E N S +DV++FG++L +LM+
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 28/219 (12%)
Query: 18 IQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAK--------VRKEASTQGFAEFQSE 69
+Q D+ ++G G FG V K Q + A +++ S A F E
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS----AFFWEE 93
Query: 70 VYVLNFARHKNIVMLLGFCCKENLNIL--VYEYICNKSLHWHLFDNTESVLEWHQRYAAA 127
++ FA +V L FC ++ L V EY+ L +L N + +W + Y A
Sbjct: 94 RDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAE 150
Query: 128 IGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKI-L 186
+ A L +H +IHRD++P N+LL L DFG V+ +
Sbjct: 151 VVLA--LDAIHSM----GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204
Query: 187 GTLGYLAPEYAE----NGIVSIRTDVYAFGIILLQLMSG 221
GT Y++PE + +G D ++ G+ L +++ G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 9/94 (9%)
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY 191
+ +++LHE IIHRD++ NI + H LGDFG A + D K G G
Sbjct: 193 RAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGAACFPV--DINANKYYGWAGT 246
Query: 192 LA---PEYAENGIVSIRTDVYAFGIILLQLMSGR 222
+A PE D+++ GI+L ++ +
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 131 AKGLRFL-HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK--ILG 187
A G+ FL + C +HRD+ N+L+ + + DFGLAR D +K
Sbjct: 249 ANGMEFLASKNC-----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 188 TLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS 220
L ++APE N + + +DV++FGI+L ++ +
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 7e-05
Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 37/220 (16%)
Query: 25 FSKENLLGEGGFGHVYKG-ELKDGQMIA-AKVRKEASTQGFAEFQ-SEVYVLNFARHKN- 80
+ K +GEG +G VYK + G+++A K R E +G E+ +L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 81 IVMLLGFCCKENLN-----ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGL- 134
IV LL E N LV+EY L + + ++ + R G + L
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEY---------LDSDLKKFMDSNGR-----GPGRPLP 108
Query: 135 -----RFLHEECRGGP------IIHRDMRPSNILLTHD-FVPMLGDFGLARWKTTDDPVQ 182
F+++ +G ++HRD++P N+L+ + + D GL R +
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY 168
Query: 183 TKILGTLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMSG 221
T + TL Y APE S D+++ G I ++
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 59/241 (24%), Positives = 96/241 (39%), Gaps = 59/241 (24%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQ-SEVYVLNFARHKNIVMLLG-FC 88
+G G +GHVYK + KDG+ K+ G + E+ +L +H N++ L F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 89 CKENLNILVYEYICNKSLHWHLFDNTESVLEWH--QRYAAAIGTAK-------------- 132
+ + W LFD E L WH + + A+ K
Sbjct: 69 SHSDRKV------------WLLFDYAEHDL-WHIIKFHRASKANKKPMQLPRSMVKSLLY 115
Query: 133 ----GLRFLHEECRGGPIIHRDMRPSNILLTHDFVP----MLGDFGLARWKTTD------ 178
G+ +LH ++HRD++P+NIL+ + + D G AR +
Sbjct: 116 QILDGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171
Query: 179 -DPVQTKILGTLGYLAPEY---AENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ 234
DPV T Y APE A + +I D++A G I +L++ + E+ +
Sbjct: 172 LDPVVV----TFWYRAPELLLGARHYTKAI--DIWAIGCIFAELLTSEPIFHCRQEDIKT 225
Query: 235 S 235
S
Sbjct: 226 S 226
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 8e-05
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 57/240 (23%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQ-SEVYVLNFARHKNIVMLLGFCC 89
+G G +GHVYK + KDG+ K+ G + E+ +L +H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQK--- 65
Query: 90 KENLNILVYEYICNKSLHWHLFDNTESVLEWH--QRYAAAIGTAK--------------- 132
V+ ++ + W LFD E L WH + + A+ K
Sbjct: 66 -------VFLSHADRKV-WLLFDYAEHDL-WHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 133 ---GLRFLHEECRGGPIIHRDMRPSNILLTHDFVP----MLGDFGLARWKTTD------- 178
G+ +LH ++HRD++P+NIL+ + + D G AR +
Sbjct: 117 ILDGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 179 DPVQTKILGTLGYLAPEY---AENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQS 235
DPV T Y APE A + +I D++A G I +L++ + E+ + S
Sbjct: 173 DPVVV----TFWYRAPELLLGARHYTKAI--DIWAIGCIFAELLTSEPIFHCRQEDIKTS 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 67/248 (27%), Positives = 102/248 (41%), Gaps = 61/248 (24%)
Query: 23 GDFSKENLLGEGGFGHVYKGELKDG-QMIAAK-------VRKEASTQGFAEFQSEVYVLN 74
DF L+ G +G VY K+ Q A K + + Q F E +L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERD----ILT 56
Query: 75 FARHKNIVMLLGFCCKENLNIL--VYEYI----CNKSLHWHLFDNTESV-LEWHQRYAAA 127
FA + +V + FC E L V EY+ C L N ++ ++ + Y A
Sbjct: 57 FAENPFVVSM--FCSFETKRHLCMVMEYVEGGDCAT-----LLKNIGALPVDMARMYFAE 109
Query: 128 IGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW------------- 174
T L +LH I+HRD++P N+L+T L DFGL++
Sbjct: 110 --TVLALEYLHNY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH 163
Query: 175 --KTTDDPVQTKILGTLGYLAPEYAENGIVSIR------TDVYAFGIILLQLMSGRKVVD 226
K T + + ++ GT Y+APE V +R D +A GIIL + + G V
Sbjct: 164 IEKDTREFLDKQVCGTPEYIAPE------VILRQGYGKPVDWWAMGIILYEFLVG--CVP 215
Query: 227 MNGEEPQQ 234
G+ P++
Sbjct: 216 FFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 64/248 (25%), Positives = 94/248 (37%), Gaps = 71/248 (28%)
Query: 23 GDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV-RKEASTQG--FAEFQSEVYVLNFARH 78
DF ++G G FG V+ + GQ+ A KV RK + A ++E +L A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 79 KNIVMLL-GFCCKENLNILVYEYICNKSL-----HWHLFDNTESVLEWHQRYAA----AI 128
IV L F +E+L LV EY+ L +F E + Y A A+
Sbjct: 61 PWIVKLYYSFQDEEHL-YLVMEYMPGGDLMNLLIRKDVFPE-----ETARFYIAELVLAL 114
Query: 129 GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA---RWK---------T 176
+ L F IHRD++P NIL+ D L DFGL +
Sbjct: 115 DSVHKLGF----------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 177 TDDPVQTKIL-----------------GTLGYLAPEYAENGIVSIRT------DVYAFGI 213
+ + +L GT Y+APE V T D ++ G+
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE------VLRGTPYGLECDWWSLGV 218
Query: 214 ILLQLMSG 221
IL +++ G
Sbjct: 219 ILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 25/213 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAA-------KVRKEASTQGFAEFQSEVYVLNFA 76
DF ++G G FG V +LK+ + A ++ K A T A F+ E VL
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET---ACFREERDVLVNG 58
Query: 77 RHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRY--AAAIGTAKGL 134
++ I L EN LV +Y L L + + E R+ A + +
Sbjct: 59 DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKI-LGTLGYLA 193
LH +HRD++P NIL+ + L DFG D VQ+ + +GT Y++
Sbjct: 119 HQLH-------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 194 PEYAE-----NGIVSIRTDVYAFGIILLQLMSG 221
PE + G D ++ G+ + +++ G
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 46/205 (22%), Positives = 89/205 (43%), Gaps = 19/205 (9%)
Query: 30 LLGEGGFGHVYKG-ELKDGQMIAAKV-----RKEASTQGFAEFQSEVYVLNFARHKNIVM 83
LLG+G FG VY + G+ +A K +++ + E+ +L H+ IV
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 84 LLGFC---CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEE 140
G + L+I + E++ S+ L ++Y I +G+ +LH
Sbjct: 69 YYGCLRDPMERTLSIFM-EHMPGGSIKDQLKSYGALTENVTRKYTRQI--LEGVSYLHSN 125
Query: 141 CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT---DDPVQTKILGTLGYLAPEYA 197
I+HRD++ +NIL LGDFG ++ T + GT +++PE
Sbjct: 126 M----IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 198 ENGIVSIRTDVYAFGIILLQLMSGR 222
+ D+++ G ++++++ +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 16/214 (7%)
Query: 17 EIQQATGDFSKENLLGEGGFGHV----YKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
+++ D+ ++G G FG V +K K M + A F E +
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
+ FA +V L + +V EY+ L +L N + +W + Y A + A
Sbjct: 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLA- 154
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKI-LGTLGY 191
L +H IHRD++P N+LL L DFG + V+ +GT Y
Sbjct: 155 -LDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209
Query: 192 LAPEYAE----NGIVSIRTDVYAFGIILLQLMSG 221
++PE + +G D ++ G+ L +++ G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 54/226 (23%), Positives = 95/226 (42%), Gaps = 40/226 (17%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQS-----EVYVLNFARHKNIVMLL 85
+G G FG V+ + K Q K S +G E + EV V+ +HKNIV +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFC--WKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYI 78
Query: 86 G-FCCKENLNILVYEYIC-------NKSLHWHLFDNTE--SVLEWHQRYAAAIGTAKGLR 135
F K N + + C N + +F E ++++ ++ A+ L+
Sbjct: 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLK 138
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDF-----------------VPMLGDFGLARWKTTD 178
+ G ++HRD++P NI L+ + +GDFGL++
Sbjct: 139 ---DGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK-NIGI 194
Query: 179 DPVQTKILGTLGYLAPEYA--ENGIVSIRTDVYAFGIILLQLMSGR 222
+ + +GT Y +PE E ++D++A G I+ +L SG+
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAA-------KVRKEASTQGFAEFQSEVYVLNFA 76
DF ++G G FG V ++K + I A ++ K A T A F+ E VL
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAET---ACFREERNVLVNG 58
Query: 77 RHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRY-----AAAIGTA 131
+ I L EN LV +Y L L + + E R+ AI +
Sbjct: 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKI-LGTLG 190
L + +HRD++P N+LL + L DFG D VQ+ + +GT
Sbjct: 119 HQLHY----------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD 168
Query: 191 YLAPEY---AENGI--VSIRTDVYAFGIILLQLMSG 221
Y++PE E+G+ D ++ G+ + +++ G
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 56/186 (30%), Positives = 81/186 (43%), Gaps = 28/186 (15%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKVR------KEASTQGFAEFQSEVYVLNFA 76
DF ++G G FG V ++K+ GQ+ A K+ K A T A F+ E VL
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET---ACFREERDVLVNG 58
Query: 77 RHKNIVML-LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-YAA----AIGT 130
+ I L F + NL LV +Y L L + + E R Y A AI +
Sbjct: 59 DRRWITNLHYAFQDENNL-YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDS 117
Query: 131 AKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKI-LGTL 189
L + +HRD++P N+LL + L DFG D VQ+ + +GT
Sbjct: 118 VHQLGY----------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167
Query: 190 GYLAPE 195
Y++PE
Sbjct: 168 DYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 40/226 (17%)
Query: 78 HKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFL 137
HK+IV+L G C ++ NI+V E++ L + ++ VL ++ A A L +L
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYL 121
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILG------TLGY 191
++ ++H ++ NILL + + G+ G K +D + +L + +
Sbjct: 122 EDK----DLVHGNVCTKNILLAREGID--GECG-PFIKLSDPGIPITVLSRQECVERIPW 174
Query: 192 LAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250
+APE E+ +SI D ++FG L ++ NGE P + + L EK +
Sbjct: 175 IAPECVEDSKNLSIAADKWSFGTTLWEIC-------YNGEIPLKD-----KTLAEKERFY 222
Query: 251 E----LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
E L+ P + +A C+ +P RP ++R
Sbjct: 223 EGQCMLVTPSCKE---------LADLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.002
Identities = 26/84 (30%), Positives = 35/84 (41%), Gaps = 11/84 (13%)
Query: 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPS 154
I+V EYI + L D S + IG G LH IIH D+ S
Sbjct: 75 IIVMEYIEGEPLK----DLINSNGMEELELSREIGRLVGK--LHS----AGIIHGDLTTS 124
Query: 155 NILLTHDFVPMLGDFGLARWKTTD 178
N++L+ + L DFGLA +
Sbjct: 125 NMILSGGKI-YLIDFGLAEFSKDL 147
|
Length = 211 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 28/223 (12%)
Query: 14 SFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAK--------VRKEASTQGFAE 65
++++ DF ++G G FG V K + + A +++ S A
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS----AF 89
Query: 66 FQSEVYVLNFARHKNIVMLLGFCCKENLNIL--VYEYICNKSLHWHLFDNTESVLEWHQR 123
F E ++ A + IV L ++ L V EY+ L +L N + +W +
Sbjct: 90 FWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEKWARF 146
Query: 124 YAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183
Y A + A L +H IHRD++P N+LL L DFG + V+
Sbjct: 147 YTAEVVLA--LDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200
Query: 184 KI-LGTLGYLAPEY----AENGIVSIRTDVYAFGIILLQLMSG 221
+GT Y++PE +G D ++ G+ L +++ G
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 315 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.19 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.1 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.08 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.01 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.0 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.96 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.85 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.7 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.69 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.63 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.59 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.58 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.58 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.51 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.48 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.4 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.22 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.19 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.18 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.16 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.15 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.08 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.03 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.01 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.97 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.94 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.92 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.9 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.81 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.81 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.69 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.64 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.52 | |
| PLN02236 | 344 | choline kinase | 97.49 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.46 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.38 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.33 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.24 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.01 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.96 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.92 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.91 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.88 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.75 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.73 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.69 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.65 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.43 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.41 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.29 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.05 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.72 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.49 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.83 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.74 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=352.49 Aligned_cols=249 Identities=26% Similarity=0.374 Sum_probs=217.1
Q ss_pred cCCcccceecCCCceEEEEEEe-CCCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGEL-KDGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
.+|...+.||+|+|+.+|.+++ .+|+.||+|++.+. .....+.+.+|+++-+.++||||++++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6899999999999999999988 68999999998763 3455667899999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
|+|+.++|..++. ..+++++.++..+++||+.|+.|||+. +|+|||||..|++++++.++||+|||+++.....
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~----~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL----GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc----CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999998885 667799999999999999999999999 9999999999999999999999999999988877
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
.....+.+|||.|.|||++.....+..+||||+||++|.|++|++||+...-. .........+-
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk----------ety~~Ik~~~Y------ 235 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK----------ETYNKIKLNEY------ 235 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH----------HHHHHHHhcCc------
Confidence 77778899999999999999999999999999999999999999999754321 11111111111
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
..|...+....+||.++|+.||.+|||+++++.+-
T Consensus 236 -~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 236 -SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred -ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 12234555688999999999999999999998753
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-51 Score=339.53 Aligned_cols=258 Identities=24% Similarity=0.316 Sum_probs=210.5
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc-------cHHHHHHHHHHHhhcCCCCccceeeeEEecC
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ-------GFAEFQSEVYVLNFARHKNIVMLLGFCCKEN 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (315)
.++.|.+.+.||+|+||.|-+|..+ +++.||+|++++.... ......+|+++|++++||||++++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 7789999999999999999999654 7999999998754221 1223579999999999999999999999999
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC---CceeECCC
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD---FVPMLGDF 169 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~---~~i~l~df 169 (315)
..|+||||++||.|.+.+.. +..+.+.....++.|++.|+.|||++ ||+||||||+|||+..+ ..+|++||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~----GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQ----GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHc----CcccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999954 45588888899999999999999999 99999999999999776 78999999
Q ss_pred CcccccCCCCCccccccccccccCccccccCCC---cccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhh
Q 046121 170 GLARWKTTDDPVQTKILGTLGYLAPEYAENGIV---SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK 246 (315)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (315)
|+++... ......+.+|||.|.|||++.++.. ..+.|+||+||++|-+++|.+||......+- +.. ++ ..
T Consensus 324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~e---QI-~~ 396 (475)
T KOG0615|consen 324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LKE---QI-LK 396 (475)
T ss_pred chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HHH---HH-hc
Confidence 9998444 5666678999999999999986553 3478999999999999999999975544321 110 00 00
Q ss_pred hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
... .+........++...+||.+||..||++|||+.|++++-|-.
T Consensus 397 G~y------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 397 GRY------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred Ccc------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 000 011122334566789999999999999999999999988765
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-51 Score=324.28 Aligned_cols=261 Identities=23% Similarity=0.349 Sum_probs=213.8
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceee-eE-EecCee
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLG-FC-CKENLN 94 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~-~~~~~~ 94 (315)
....+|+++++||+|+||+||++.+. ++..+|.|.++-. .....+.+..|+.+|++++||||+++++ .+ ++...+
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 34568999999999999999999654 7999999876632 3444556889999999999999999998 44 444558
Q ss_pred EEEEEeccCCcccccccc--CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 95 ILVYEYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
++|||++.+|+|...+.. ...+.+++..+|+++.|++.|+.++|+++..+-|.||||||.||+++.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999998854 455679999999999999999999999777666999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
..+..........+|||.||+||.+.+..|+.+|||||+||++|||+..++||..++ ...++.. +..
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~L~~K----I~q------ 242 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLSLCKK----IEQ------ 242 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHHHHHH----HHc------
Confidence 877777666677899999999999999999999999999999999999999997652 1122211 111
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
...++....+.+..+..++..|+.+||+.||+.-.++..+.
T Consensus 243 --gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 243 --GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 12222333567888999999999999999999555444443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-49 Score=323.62 Aligned_cols=261 Identities=23% Similarity=0.301 Sum_probs=214.1
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecC-eeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN-LNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~~ 99 (315)
++.+.+..||+|..|+|+++.++ +++.+|+|++... .+...+++.+|+++++..+||+|+.+++.|.... .++++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 47888899999999999999887 6899999998543 4555678999999999999999999999999988 5999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||++|+|.+.+... +.+++.....++.+++++|.|||. . +|+||||||+|+|++..|.|||+|||.+......
T Consensus 159 YMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~----~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEER----KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhcc----CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999988544 559999999999999999999996 7 9999999999999999999999999999755443
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
...++.||..|||||.+.+..|+.++||||||++++|+.+|+.|+....+........ ...+.. -..|.++
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L-l~~Iv~------~ppP~lP 303 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL-LCAIVD------EPPPRLP 303 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH-HHHHhc------CCCCCCC
Confidence 4456789999999999999999999999999999999999999997652222211111 111110 1112222
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
.. ..+..+++++..||++||.+|||+.+++++-.-.+..-
T Consensus 304 ~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 304 EG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred cc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 22 35667889999999999999999999998766554433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=320.62 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=210.7
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|+++++||+|+||+|+.++.+ +++.+|+|++++.. ....+....|..+|..++||.|++++..|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 4579999999999999999999755 69999999988653 3346678899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
|++|+.||.|..++ +.+..+++..+..++..|+.||.|||++ ||+|||+||+|||+|.+|+++|+|||+|....
T Consensus 103 Vld~~~GGeLf~hL--~~eg~F~E~~arfYlaEi~lAL~~LH~~----gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL--QREGRFSEDRARFYLAEIVLALGYLHSK----GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHH--HhcCCcchhHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999888 4556699999999999999999999999 99999999999999999999999999998766
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
..+....+.+||+.|+|||++.+..++.++|.||||+++|+|++|.+||...+.... ...+... .
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~------~~~I~~~----k----- 241 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM------YDKILKG----K----- 241 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH------HHHHhcC----c-----
Confidence 666677788999999999999999999999999999999999999999965442211 1111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCC----CHHHHHH
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRP----SMGEVVR 292 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp----s~~~il~ 292 (315)
....+...+...++++.++|+.||++|. ++.+|-+
T Consensus 242 -~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 242 -LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred -CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 1223333555688899999999999996 4555433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-48 Score=320.32 Aligned_cols=203 Identities=31% Similarity=0.450 Sum_probs=182.9
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
..++|...+.||.|+||+||+|+.+ ++..||||.+... .....+.+..|+.+|+.++||||+.+++++..++.+|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4579999999999999999999876 5899999987765 566677889999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC------CceeECCCCc
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD------FVPMLGDFGL 171 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~------~~i~l~dfg~ 171 (315)
||||.||+|.+++.+. ..+++..+..++.|++.|+++||++ +|+||||||+||+++.. ..+||.|||+
T Consensus 88 MEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~----~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHEN----NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999999544 3699999999999999999999999 99999999999999875 5689999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCC
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGE 230 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~ 230 (315)
+.... ......+.+|+|-|||||++..+.|+.|+|+||+|+++|+|++|..||...+.
T Consensus 162 AR~L~-~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 162 ARFLQ-PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhhCC-chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 98544 44455678999999999999999999999999999999999999999975443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-47 Score=325.33 Aligned_cols=262 Identities=30% Similarity=0.463 Sum_probs=214.6
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCc--ccHHHHHHHHHHHhhcCCCCccceeeeEEecC-eeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST--QGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN-LNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~~ 99 (315)
....+.+.||+|+||+||.|.+.+...+|+|++..... ...+.+.+|+.++++++||||+++++++.+.. .+++|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 45556667999999999999998777699998875432 22568999999999999999999999999887 7999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCC-eEeecCccCcEEEcCCC-ceeECCCCcccccCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGP-IIHRDMRPSNILLTHDF-VPMLGDFGLARWKTT 177 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~-i~h~di~p~nil~~~~~-~i~l~dfg~~~~~~~ 177 (315)
|+.+|+|.++++......++...++.++.+|+.|+.|||+. + |+|+||||+|+|++.++ ++||+|||++.....
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~----~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE----GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC----CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999776677899999999999999999999999 8 99999999999999998 999999999975444
Q ss_pred CCCccccccccccccCccccc--cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 178 DDPVQTKILGTLGYLAPEYAE--NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
.........||+.|+|||++. ...++.++||||||+++|||+||..||..... .+. .... ......+
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~----~~~v-----~~~~~Rp 265 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQV----ASAV-----VVGGLRP 265 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHH----HHHH-----HhcCCCC
Confidence 322333367899999999999 66899999999999999999999999975543 111 1111 1122223
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccccc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~ 303 (315)
.+... ....+..++..||..||+.||++.+++..|+.+......
T Consensus 266 ~~p~~----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 266 PIPKE----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCcc----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 33332 444577788889999999999999999999988776654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=322.14 Aligned_cols=289 Identities=46% Similarity=0.808 Sum_probs=246.5
Q ss_pred CCcccHHHHHHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEE
Q 046121 10 PMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCC 89 (315)
Q Consensus 10 ~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (315)
...+.+.++....+.|.-...||+|+||+||+|...++..||+|...........++.+|+.++.+++|||+++++|+|.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 34478899999999999999999999999999999988999999766544331455999999999999999999999999
Q ss_pred ecC-eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECC
Q 046121 90 KEN-LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGD 168 (315)
Q Consensus 90 ~~~-~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~d 168 (315)
+.+ +.++|+||+.+|+|.++++.....+++|....+|+.+++.||.|||..+. ..|+|||||++||++|.+...|++|
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~-~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCP-PPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCC-CCEecCCCCHHHeeECCCCCEEccC
Confidence 988 59999999999999999976554378999999999999999999999741 1499999999999999999999999
Q ss_pred CCcccccCCCCCccccc-cccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh
Q 046121 169 FGLARWKTTDDPVQTKI-LGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL 247 (315)
Q Consensus 169 fg~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (315)
||++............. .|+.+|+|||+...+..+.++||||||+++.|+++|+.+.+.........+..|........
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99995332212211222 78999999999998899999999999999999999999887665555556788888888888
Q ss_pred ccccccCCccc-CCCCH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 248 ALHELIDPRIE-NSYDT-YELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 248 ~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
.+.+++|+.+. ..++. .....+..+...|++.+|++||++.++++.|+.+..
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 89999999987 55554 567778999999999999999999999999966543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=305.90 Aligned_cols=265 Identities=24% Similarity=0.285 Sum_probs=207.6
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
+.|+.+.++|+|++|+|++++++ +|+.||+|.+..+.+ ...+-..+|+++|+++.|+|++.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46899999999999999999987 699999999876543 223346899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|++..-| +.+.+..+ ..+...+..++.|++.|+.++|++ +++||||||+||+++.+|.+||||||++......+
T Consensus 82 ~~dhTvL-~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~----n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVL-HELERYPN-GVPSELVKKYLYQLLKAIHFCHKN----NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHH-HHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhc----CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 9866544 44544444 488999999999999999999999 99999999999999999999999999998777666
Q ss_pred CccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH-H-------HHHh-hhcc
Q 046121 180 PVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA-E-------PLIE-KLAL 249 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~-------~~~~-~~~~ 249 (315)
.....+.-|-.|.|||.+.| .+|+.+.||||+||++.||++|.+.|.+.++-.+.-..... . .... ..-.
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 65566778899999999887 67999999999999999999999999876654332222110 0 0000 1111
Q ss_pred ccccCCcc-----cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 250 HELIDPRI-----ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 250 ~~~~~~~~-----~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
..+.-|.. ...--+..+..+.+++..||..||++|++-++++.+
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111111 111112234578899999999999999999998753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=324.02 Aligned_cols=250 Identities=24% Similarity=0.296 Sum_probs=216.0
Q ss_pred cCCcccceecCCCceEEEEEEe-CCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 23 GDFSKENLLGEGGFGHVYKGEL-KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
..|...++||+|+.|.||.|.. .+++.||+|.+........+.+.+|+.+++..+|+||+.+++.|...+.++.||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 5788999999999999999965 468889999988877776778899999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
+||+|.+.+ ....+++.+++.+++.++.||+|||.+ ||+|+|||.+||+++.+|.+||+|||+|.........
T Consensus 353 ~ggsLTDvV---t~~~~~E~qIA~Icre~l~aL~fLH~~----gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 353 EGGSLTDVV---TKTRMTEGQIAAICREILQGLKFLHAR----GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCCchhhhh---hcccccHHHHHHHHHHHHHHHHHHHhc----ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 999999988 445599999999999999999999999 9999999999999999999999999999877776666
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
..+-.|||.|+|||+.....|+.+.||||||++++||+.|.+||-. +.+.+.+..... ........
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln--E~PlrAlyLIa~------------ng~P~lk~ 491 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN--ENPLRALYLIAT------------NGTPKLKN 491 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC--CChHHHHHHHhh------------cCCCCcCC
Confidence 6777999999999999999999999999999999999999999953 222222221111 11222233
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
+...+..+++++.+||..|+++|++++|+|++
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 44566779999999999999999999999975
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=321.45 Aligned_cols=257 Identities=27% Similarity=0.369 Sum_probs=212.8
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
+.++.++.||+|.||.||+|.+++...|++|.+... ....+.+.+|++++++++|++|+++++++..++.++|||||+.
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 456677899999999999999999989999988764 3445677899999999999999999999999899999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc-
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV- 181 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~- 181 (315)
.|+|.+++.......+...+.+.++.|||++++||+++ ++|||||-++||||+.++.+|++|||+++........
T Consensus 285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~----~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK----NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC----CccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 99999999876777899999999999999999999999 9999999999999999999999999999843333322
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
....--+..|.|||.+..+.++.+|||||||++||||+| |+.|++.... ..+....... ..-.
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------~ev~~~le~G----------yRlp 424 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------EEVLELLERG----------YRLP 424 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH------HHHHHHHhcc----------CcCC
Confidence 222334678999999999999999999999999999998 8888764432 1111211111 1111
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
.|..++..+.++|..||..+|++||||+.+...|+.+...
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 2333556688899999999999999999999999887553
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=318.00 Aligned_cols=256 Identities=23% Similarity=0.301 Sum_probs=212.5
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc----Cc-ccHHHHHHHHHHHhhcC-CCCccceeeeEEecC
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA----ST-QGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKEN 92 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~----~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 92 (315)
...++|++.+.||+|+||+|++|.+. ++..+|+|++... .. ...+.+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45679999999999999999999765 6899999976653 12 33456778999999999 999999999999999
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC-CceeECCCCc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD-FVPMLGDFGL 171 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~-~~i~l~dfg~ 171 (315)
.+++||||+.||.|.+++.+ ...+.+..+..+++|++.|+.|||+. ||+||||||+|++++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~----gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR----GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999966 56689999999999999999999999 99999999999999999 9999999999
Q ss_pred ccccCCCCCccccccccccccCccccccCC-Cc-ccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcc
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAENGI-VS-IRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (315)
+...........+.+|++.|+|||++.+.. |+ .++||||+|++||.|++|..||+..+... +. ..+.
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l~---~ki~----- 236 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---LY---RKIR----- 236 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---HH---HHHh-----
Confidence 985543445566789999999999999877 75 78999999999999999999998632211 11 0000
Q ss_pred ccccCCcccCCCCHHH-HHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 250 HELIDPRIENSYDTYE-LYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~-~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
...-.++... +..+++|+.+||..||.+|+|+.+++.+-|-..
T Consensus 237 ------~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 237 ------KGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ------cCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 0111122222 556889999999999999999999997777665
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=310.30 Aligned_cols=261 Identities=24% Similarity=0.322 Sum_probs=210.1
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecC--eeEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN--LNILVY 98 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~ 98 (315)
..+|...+.||+|+||+||++.+. ++...|+|..........+.+.+|+.+|+.++||||+++++...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 457899999999999999999876 48999999877654444777999999999999999999999854444 689999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC-CCceeECCCCcccccCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH-DFVPMLGDFGLARWKTT 177 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~-~~~i~l~dfg~~~~~~~ 177 (315)
||+.+|+|.+++.+... .+++..+..+.+|+++++.|||++ |++|+||||+||+++. ++.++|+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~----g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK----GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999987777 799999999999999999999999 9999999999999999 79999999999875553
Q ss_pred CC---CccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 178 DD---PVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 178 ~~---~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
.. .......|++.|+|||++..+ ....++|||||||++.||+||.+||... ... ..+.....
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~----~~~~~~ig--------- 236 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEE----AEALLLIG--------- 236 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cch----HHHHHHHh---------
Confidence 11 112346799999999999853 3345999999999999999999999643 000 00001111
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
.....+..+...+...++++..|+..||++|||+.++|++....++..
T Consensus 237 ~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 237 REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 111112444456667889999999999999999999999887765543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=319.21 Aligned_cols=260 Identities=23% Similarity=0.273 Sum_probs=212.3
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCee
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 94 (315)
....+|.+++.||+|+|++|++|+.+ +++.+|+|++.+. .+...+.+..|-.+|..+ .||+|++++..|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34579999999999999999999765 7999999997754 344455677888889888 799999999999999999
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
|+|++|.++|+|.+++.+. ..+++.....++.+|+.||.|||+. |||||||||+|||+|++++++|+|||.+..
T Consensus 150 YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~----GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSN----GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999999655 5599999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCc-----------c--ccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH
Q 046121 175 KTTDDPV-----------Q--TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE 241 (315)
Q Consensus 175 ~~~~~~~-----------~--~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 241 (315)
+...... + ..++||..|.+||++..+..+..+|+|+|||++|+|+.|.+||...++... .+.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli--Fqk--- 298 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI--FQK--- 298 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH--HHH---
Confidence 4322111 1 347899999999999999999999999999999999999999976554321 111
Q ss_pred HHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 242 PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
+. .+.-.+++..+..+.+|+.++|..||++|+|+.+|-++.=--.-.|.
T Consensus 299 -I~-----------~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 299 -IQ-----------ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred -HH-----------HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 11 11222333344668889999999999999999998766433333343
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=305.92 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=214.4
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCccc-HHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQG-FAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
+...++|++.+.||.|..++||+|+.. .+..|+||++....... .+.+++|+..++.++||||++++..|..+..+|+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 345689999999999999999999765 68999999988665444 5889999999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||+||.+|++.+.+...-...+++..+..+.++++.||.|||.+ |.+|||||+.||+++.+|.|+|+|||.+....
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~----G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN----GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc----CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999999887778899999999999999999999999 99999999999999999999999999886554
Q ss_pred CCCCcc----ccccccccccCccccc--cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccc
Q 046121 177 TDDPVQ----TKILGTLGYLAPEYAE--NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250 (315)
Q Consensus 177 ~~~~~~----~~~~~~~~~~aPE~~~--~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (315)
..+... .+..|+++|+|||++. ...|+.|+||||||++..|+.+|..||....+-. .+. .........
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl---~tLqn~pp~- 251 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLL---LTLQNDPPT- 251 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHH---HHhcCCCCC-
Confidence 443222 4568999999999854 3458999999999999999999999996543211 111 111000000
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
.....+..+-.......++.++..||++||++|||++++++.-
T Consensus 252 -~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 252 -LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred -cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 0011122222233455788999999999999999999998753
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=322.81 Aligned_cols=251 Identities=21% Similarity=0.266 Sum_probs=213.3
Q ss_pred hcCCcccceecCCCceEEEEEEe-CCCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGEL-KDGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
.+-|+.++.||.|+.|.|-+|++ .+|+..|||++.+.. ......+.+|+.+++.+.|||++.+++++++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 46799999999999999999975 489999999988652 33345588999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
.||+.||-|.+++. ..+++++.++++++.||+.++.|||.. +++|+|+||+|+++|..++|||+|||++. ...
T Consensus 91 lEyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~----~icHRDLKpENlLLd~~~nIKIADFGMAs-Le~ 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAF----NICHRDLKPENLLLDVKNNIKIADFGMAS-LEV 163 (786)
T ss_pred EEecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhh----cceeccCCchhhhhhcccCEeeeccceee-ccc
Confidence 99999999999995 445699999999999999999999999 99999999999999999999999999998 555
Q ss_pred CCCccccccccccccCccccccCCC-cccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH-hhhccccccCC
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI-EKLALHELIDP 255 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 255 (315)
.+....+.||.|.|++||++.|.+| +.++||||+|++||.|++|++||++++.. .....+. ....
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir------~LLlKV~~G~f~------- 230 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR------VLLLKVQRGVFE------- 230 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH------HHHHHHHcCccc-------
Confidence 6667778899999999999999887 57999999999999999999999855432 2111111 1111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.+...+....+|+++||..||.+|+|.++|+++.+-.
T Consensus 231 -----MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 231 -----MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred -----CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 2223344577899999999999999999999986644
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=310.73 Aligned_cols=265 Identities=24% Similarity=0.303 Sum_probs=208.2
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHH-HHHHHHHHhhcC-CCCccceeeeEEecC-eeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAE-FQSEVYVLNFAR-HKNIVMLLGFCCKEN-LNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~-~~~e~~~l~~l~-~~~i~~~~~~~~~~~-~~~l 96 (315)
+-++|+++++||.|+||.||+|..+ ++..||+|.++..-..+.+. -.+|+..|++++ ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4579999999999999999999765 68999999877654443232 368999999999 999999999998887 9999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||| ..+|++++... +..+++..+..|+.||+++|.|+|.+ |++|||+||+|||+..+..|||+|||++....
T Consensus 88 VfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~----GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH----GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc----CcccccCChhheEecccceeEecccccccccc
Confidence 99998 67888888766 88899999999999999999999999 99999999999999999999999999998444
Q ss_pred CCCCccccccccccccCccccc-cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhH-HH---------hHHHHHh
Q 046121 177 TDDPVQTKILGTLGYLAPEYAE-NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSL-RQ---------WAEPLIE 245 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~-~~---------~~~~~~~ 245 (315)
... ....++.|-.|+|||++. .+.|+.+.|+||+||+++|+.+-++.|.+.++..+... .. |......
T Consensus 162 Skp-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 162 SKP-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred cCC-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 433 345578899999999765 56789999999999999999999999976654322111 11 1110000
Q ss_pred ----hhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 246 ----KLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 246 ----~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...+.......+..-.+ ..+....+||..|+..||++|||+.+++++
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00111111111112222 366678899999999999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=292.12 Aligned_cols=261 Identities=22% Similarity=0.257 Sum_probs=214.1
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++++.||.|+||.|.+++.+ ++..+|+|++.+.. -...+...+|..+|+.+.||.++.+.+.+.+.+.+|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 3468999999999999999999876 68899999987653 3335567899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.||.|..++. ....+++..+..++.+|+.|++|||+. ++++||+||+|||+|.+|.++++|||++....
T Consensus 122 vmeyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~----~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSL----DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEeccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhc----CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999984 445699999999999999999999999 99999999999999999999999999997443
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
.. ..+.+|||.|+|||.+.++.+..++|.||||+++|||+.|.+||..+++ ...... +..
T Consensus 196 ~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~iY~K----I~~----------- 255 (355)
T KOG0616|consen 196 GR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQIYEK----ILE----------- 255 (355)
T ss_pred Cc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHHHHH----HHh-----------
Confidence 32 4567999999999999999999999999999999999999999976655 111111 110
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCC-----CCHHHHHHHHhccccccccccch
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGR-----PSMGEVVRLLEGENDRFHHLGEK 307 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~R-----ps~~~il~~L~~~~~~~~~~~~~ 307 (315)
..-.+|...+..+++|+..+|+.|-.+| ...++|..+-|--.-.|..+..+
T Consensus 256 ~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r 311 (355)
T KOG0616|consen 256 GKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQR 311 (355)
T ss_pred CcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhc
Confidence 1123455556678899999999999999 34555555555555555544433
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=282.67 Aligned_cols=267 Identities=24% Similarity=0.278 Sum_probs=210.0
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.+|...++||+|.||.||+|++. +|+.||+|.+.... +.......+|++.|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 58999999999999999999765 79999999877543 3334567899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+ ..+|...+. .....++...+..++.+++.+++|||++ .|.||||||.|++++.+|.+|+.|||+++.+...+
T Consensus 82 fm-~tdLe~vIk-d~~i~l~pa~iK~y~~m~LkGl~y~H~~----~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FM-PTDLEVVIK-DKNIILSPADIKSYMLMTLKGLAYCHSK----WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ec-cccHHHHhc-ccccccCHHHHHHHHHHHHHHHHHHHhh----hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 98 557766664 4556799999999999999999999999 99999999999999999999999999999777776
Q ss_pred CccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHH----------HhHHH-HHhhh
Q 046121 180 PVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLR----------QWAEP-LIEKL 247 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~----------~~~~~-~~~~~ 247 (315)
.......-|-.|.|||.+.| +.|+...|+||.||++.||+-|.+.|.+.++-.+.... +|.+- .....
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 66666677889999997765 55999999999999999999999998766543221111 01000 00000
Q ss_pred ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.......+......-+..+..+.+|+..||.+||.+|+|+.+++++=.
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 001111111112234445556789999999999999999999987643
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=306.70 Aligned_cols=249 Identities=26% Similarity=0.335 Sum_probs=214.7
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
..|+..+.||+|+||.||+|.+. +++.||+|++.... ...+..+++|+.++.+++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 47888899999999999999765 79999999988653 45577899999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.||++.+.+ .....+.+..+..+++.++.++.|||.. +.+|+|||+.||++..+|.++++|||.+........
T Consensus 93 ~~gGsv~~lL--~~~~~~~E~~i~~ilre~l~~l~ylH~~----~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL--KSGNILDEFEIAVILREVLKGLDYLHSE----KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh--ccCCCCccceeeeehHHHHHHhhhhhhc----ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999998 3445568889999999999999999999 999999999999999999999999999987766666
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
...+..|||.|||||++.+..|+.++||||||++.+||.+|.+|+....+- ...-++....++.
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~PP~ 230 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAPPR 230 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCCCc
Confidence 667889999999999999889999999999999999999999999644321 1111222333344
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
+....+..+++++..||++||+.|||+.+++++
T Consensus 231 L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 231 LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 444667778999999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=305.23 Aligned_cols=269 Identities=23% Similarity=0.276 Sum_probs=205.9
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEec--Ce
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE--NL 93 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 93 (315)
+...+.|+.+++||+|+||.||+|++. +|+.||+|.+.... +.......+|+.+|+++.||||+++.++..+. +.
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 335568999999999999999999765 79999999866544 56667789999999999999999999998776 78
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+|+|+|||+. +|.-++ .+..-.+++.++..++.||+.++.|||++ |++|||||..|||+|.+|.+||+|||++.
T Consensus 193 iYlVFeYMdh-DL~GLl-~~p~vkft~~qIKc~mkQLl~Gl~~cH~~----gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLL-SSPGVKFTEPQIKCYMKQLLEGLEYCHSR----GVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEEEecccc-hhhhhh-cCCCcccChHHHHHHHHHHHHHHHHHhhc----CeeeccccccceEEcCCCCEEecccccee
Confidence 9999999965 454444 34455699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc-cccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHH-HhHHHHHhhhc--
Q 046121 174 WKTTDDPV-QTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLR-QWAEPLIEKLA-- 248 (315)
Q Consensus 174 ~~~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~-- 248 (315)
.+...... ....+-|..|.|||++.| ..|+.+.|+||+||++.||+.|++.|...++-.+.... .......+...
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 55554433 344667899999998876 45999999999999999999999999877653322211 11100001110
Q ss_pred --cc--cccCCccc-----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 249 --LH--ELIDPRIE-----NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 249 --~~--~~~~~~~~-----~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
+. ..+.+.-. .......+....+|+..||..||.+|.|+.+++..
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00 11111100 00011234456788899999999999999998764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=308.92 Aligned_cols=247 Identities=29% Similarity=0.389 Sum_probs=209.5
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
++|.+.+.||+|+||.||+|+-+ +.+.||+|.+.+. .+.+...+.+|+++++.++||||+.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 47999999999999999999765 7899999998765 45557789999999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.| +|...+.. ...++++.+..++.+++.|+.|||+. +|.|+|+||.||+++++|.+|++|||++.......
T Consensus 82 ~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~----rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSN----RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhc----CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9866 99888854 45599999999999999999999999 99999999999999999999999999998777766
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
......-|+|.|+|||+..+++|+..+|+|||||++||+++|++||-.. ...+.+..+..+ +..
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d-------~v~--- 218 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKD-------PVK--- 218 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcC-------CCC---
Confidence 6666778999999999999999999999999999999999999999421 112222211111 111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.+...+..+..++..+|.+||.+|.|..+++.+
T Consensus 219 -~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 -PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 122455567889999999999999999998754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=310.21 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=207.0
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcC-CCCccceeeeEEecCee
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLN 94 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 94 (315)
...++|.++++||+|+||+|+++..+ +++.+|||++++. ...+++..+.|.+++.... ||.+..++..|...+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34579999999999999999999876 6889999998865 4566778889999998886 99999999999999999
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
|+||||+.||++.... ....+++..+..++..|+.||.|||++ ||++||||.+||++|..|.+||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~----~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHEN----GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhc----CceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999954443 445699999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 175 KTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
..-.+....+.+|||.|+|||++.++.|+.+.|.|+|||++|+|+.|..||..++++...... ..
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI------~~--------- 582 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI------VN--------- 582 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------hc---------
Confidence 655666777899999999999999999999999999999999999999999866654321111 11
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSM 287 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~ 287 (315)
....++...+.....++.++|.+||++|...
T Consensus 583 --d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 --DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1122333445557778888999999999865
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=296.00 Aligned_cols=253 Identities=19% Similarity=0.281 Sum_probs=212.2
Q ss_pred HhcCCcccceecCCCceEEEEEEe-CCCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGEL-KDGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
...+|++.+.||.|+||.|-+|.. ..|+.||+|.+.+.. +++.-.+.+|+++++.++||||+.++++|++.+.+.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 567999999999999999999965 689999999877653 4445568899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||..+|.|++++. ....+++.++..+++||+.|+.|||.+ +++|+|||.+||++|.+++++|.|||++.++
T Consensus 131 vMEYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHkn----rVvHRDLKLENILLD~N~NiKIADFGLSNly- 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKN----RVVHRDLKLENILLDQNNNIKIADFGLSNLY- 203 (668)
T ss_pred EEEecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhc----cceecccchhheeecCCCCeeeeccchhhhh-
Confidence 999999999999994 445699999999999999999999999 9999999999999999999999999999744
Q ss_pred CCCCccccccccccccCccccccCCC-cccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
.......+++|.|.|.+||..+|.+| ++..|-||||++||.++.|.-||++..-. ..+.+ +..+.. ..|
T Consensus 204 ~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------~lvrQ-Is~GaY---rEP 273 (668)
T KOG0611|consen 204 ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------RLVRQ-ISRGAY---REP 273 (668)
T ss_pred ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------HHHHH-hhcccc---cCC
Confidence 44555677899999999999999887 57899999999999999999999754321 11111 111111 122
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
.- +...+-||++||..||++|.|+++|..+-|-.+
T Consensus 274 ~~--------PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 274 ET--------PSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred CC--------CchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 11 223677999999999999999999999887543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=297.53 Aligned_cols=263 Identities=22% Similarity=0.314 Sum_probs=206.4
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.|+..+.||+|+||+||+|.+. +++.+|+|.+.... ......+.+|+.+++.++|++++++.+.+.+.+..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4788999999999999999764 78999999876432 2223456789999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|...+.......+++..+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE----RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence 99999998877655555789999999999999999999999 9999999999999999999999999998743222
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||......... ...... .. ....
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~~~-~~----------~~~~ 222 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVDRR-VK----------EDQE 222 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHHHH-hh----------cccc
Confidence 2223346889999999999989999999999999999999999999754432111 110000 00 0011
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHhccccccccc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPS-----MGEVVRLLEGENDRFHHL 304 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps-----~~~il~~L~~~~~~~~~~ 304 (315)
.++...+..+.+++.+||+.||++||+ +.+++++-+-....+..+
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 272 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL 272 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHH
Confidence 122233456788999999999999997 888888655433334433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=302.24 Aligned_cols=266 Identities=21% Similarity=0.258 Sum_probs=211.8
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
...++|++++.||+|+||.||+|+-+ +|..+|+|++.+.. ...+..+..|-.+|....+|+|++++..|.+.+++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35679999999999999999999754 79999999988753 344666788999999999999999999999999999
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
|||||++||++..++. ....+++..+..++.+.+.||..+|+. |++||||||+|+|||..|++||+|||+|.-.
T Consensus 218 LiMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~----gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQL----GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHc----CcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999884 556799999999999999999999999 9999999999999999999999999998421
Q ss_pred CC--------------------C---CC-----cc-------------------ccccccccccCccccccCCCcccccc
Q 046121 176 TT--------------------D---DP-----VQ-------------------TKILGTLGYLAPEYAENGIVSIRTDV 208 (315)
Q Consensus 176 ~~--------------------~---~~-----~~-------------------~~~~~~~~~~aPE~~~~~~~~~~~Dv 208 (315)
.. . .. .. ....|||-|+|||++.++.|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 10 0 00 00 11368999999999999999999999
Q ss_pred hhhhHHHHHHHhCCCccCCCCCc-cchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC--
Q 046121 209 YAFGIILLQLMSGRKVVDMNGEE-PQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRP-- 285 (315)
Q Consensus 209 wslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-- 285 (315)
|||||++|||+.|-+||...++. ....+..|..... .| .....+...++||.+|+. ||++|.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---------fP-----~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK---------FP-----EEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---------CC-----CcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 99999999999999999755432 1222222221110 00 001112557889999998 999997
Q ss_pred -CHHHHHHHHhccccccccccc
Q 046121 286 -SMGEVVRLLEGENDRFHHLGE 306 (315)
Q Consensus 286 -s~~~il~~L~~~~~~~~~~~~ 306 (315)
+++||-++-.--...|.++.+
T Consensus 437 ~G~~EIK~HPfF~~v~W~~l~~ 458 (550)
T KOG0605|consen 437 KGAEEIKKHPFFKGVDWDHLRE 458 (550)
T ss_pred ccHHHHhcCCccccCCcchhhc
Confidence 588887777666666766654
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=304.89 Aligned_cols=251 Identities=21% Similarity=0.279 Sum_probs=216.0
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCe-eEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL-NILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~ 98 (315)
++|..++.+|+|+||.+++++.+ +++.+++|.+.... +.......+|+.+++++.||||+.+.+.|.+++. +++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 58999999999999999999876 57788888766443 3333467899999999999999999999998888 99999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
+|++||++.+.+.+.....+++..+..++.|++.|+.|||+. .|+|||||+.||++++++.|+|+|||+++.....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~----~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN----RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh----hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999999888888899999999999999999999999 9999999999999999999999999999977776
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
.....+..|||.|+.||.+.+.+|..++|||||||++|||++-+++|...+... ...... +...
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki~----------~~~~ 223 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKIN----------RGLY 223 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHHHHh----------hccC
Confidence 656667899999999999999999999999999999999999999996543221 111111 1122
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...+...+..+..++..||..+|..||++.+++..
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 33455567778999999999999999999999876
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=293.51 Aligned_cols=256 Identities=28% Similarity=0.387 Sum_probs=211.0
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
..+|++.++||.|++|+||+|.+.++..+++|++..........+.+|+.+++.++|||++++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45799999999999999999998889999999988766656677899999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.+++|.+++.+.....++...+..++.|++.|+.+||+. +++|+||+|+||+++.++.++++|||.+.........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ----NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999876667789999999999999999999999 9999999999999999999999999998654332222
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
.....++..|+|||...+..++.++|+||||+++|+|++ |..||...... .... ..... ....
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~----~~~~~----------~~~~ 224 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYD----QITAG----------YRMP 224 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHH----HHHhC----------CcCC
Confidence 223345668999999988889999999999999999998 88998643311 1111 11100 0011
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1223345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=304.30 Aligned_cols=259 Identities=25% Similarity=0.363 Sum_probs=200.5
Q ss_pred hcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccceeeeEEec-C
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKE-N 92 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~ 92 (315)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 468999999999999999999641 35679999876432 23345688999999999 899999999988654 4
Q ss_pred eeEEEEEeccCCccccccccCC----------------------------------------------------------
Q 046121 93 LNILVYEYICNKSLHWHLFDNT---------------------------------------------------------- 114 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~---------------------------------------------------------- 114 (315)
.++++|||+.+|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6799999999999988875432
Q ss_pred --CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC--cccccccccc
Q 046121 115 --ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLG 190 (315)
Q Consensus 115 --~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~ 190 (315)
...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++........ ......+++.
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 13477888999999999999999999 999999999999999999999999999864322211 1122345678
Q ss_pred ccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHH
Q 046121 191 YLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLM 269 (315)
Q Consensus 191 ~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (315)
|+|||++.+..++.++||||||+++|+|++ |..||....... .... . ..... ... .+...+..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~---~-~~~~~-----~~~----~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQ---R-LKDGT-----RMR----APENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHH---H-HhcCC-----CCC----CCCCCCHHH
Confidence 999999988889999999999999999997 999996543211 1111 1 11100 011 122234568
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 270 AKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 270 ~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
.+++.+||+.||++|||+.++++.|+.+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=301.97 Aligned_cols=244 Identities=24% Similarity=0.302 Sum_probs=197.5
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNK 104 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (315)
+.||+|+||.||++.+. +++.+|+|++.... ......+.+|+.+++.++||||+++++.+...+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999765 68999999887532 233456778999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcccc
Q 046121 105 SLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK 184 (315)
Q Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~ 184 (315)
+|.+.+.. ...+++..+..++.|++.++.|||+. |++|+||||+||+++.++.++|+|||++............
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSC----DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 99888854 34689999999999999999999999 9999999999999999999999999998643333333344
Q ss_pred ccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHH
Q 046121 185 ILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTY 264 (315)
Q Consensus 185 ~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (315)
..|++.|+|||++.+..++.++|||||||++|+|++|..||....... .. ...... .. .++..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~---~~~~~~-------~~----~~p~~ 217 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF---ELILME-------EI----RFPRT 217 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HH---HHHHcC-------CC----CCCCC
Confidence 578999999999999889999999999999999999999996432211 00 110000 01 12223
Q ss_pred HHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHh
Q 046121 265 ELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLE 295 (315)
Q Consensus 265 ~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~ 295 (315)
.+..+.+++.+||..||++|| ++.+++++-+
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence 445678899999999999999 8999987644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=294.95 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=206.1
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--------------cccHHHHHHHHHHHhhcCCCCccc
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--------------TQGFAEFQSEVYVLNFARHKNIVM 83 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--------------~~~~~~~~~e~~~l~~l~~~~i~~ 83 (315)
.+..++|++.+.||.|.||.|-+|++. +++.||+|++.+.. ....+...+|+.+++++.||||++
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345679999999999999999999876 69999999977531 122457889999999999999999
Q ss_pred eeeeEEe--cCeeEEEEEeccCCccccccccCCCCc-cCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC
Q 046121 84 LLGFCCK--ENLNILVYEYICNKSLHWHLFDNTESV-LEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH 160 (315)
Q Consensus 84 ~~~~~~~--~~~~~lv~~~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~ 160 (315)
++++..+ .+.+|+|+||+..|.+.+.- ..++ +++.+++.+++.++.+|.|||.+ ||+||||||+|+|++.
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q----giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ----GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEEcC
Confidence 9999865 56789999999999886543 3444 89999999999999999999999 9999999999999999
Q ss_pred CCceeECCCCcccccCCCCC-----ccccccccccccCccccccCC----CcccccchhhhHHHHHHHhCCCccCCCCCc
Q 046121 161 DFVPMLGDFGLARWKTTDDP-----VQTKILGTLGYLAPEYAENGI----VSIRTDVYAFGIILLQLMSGRKVVDMNGEE 231 (315)
Q Consensus 161 ~~~i~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~----~~~~~DvwslG~~l~~l~~g~~p~~~~~~~ 231 (315)
+|.+||+|||.+........ ......|||.|+|||...++. .+.+.||||+|++||.|+.|+.||..+...
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 99999999999974422211 112357999999999877633 356789999999999999999999644321
Q ss_pred cchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 232 PQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
.. . .++....+.....+...+.+++||.+||.+||++|.+..+|..+.|-..+
T Consensus 326 ~l----------~-----~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 326 EL----------F-----DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HH----------H-----HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 10 0 11222222222223456678999999999999999999999999887765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=298.88 Aligned_cols=250 Identities=20% Similarity=0.202 Sum_probs=203.1
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++.+.||+|+||+||+|.+. +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999876 68899999876432 223456788999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+++... ..+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSK----EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999888543 4588999999999999999999999 9999999999999999999999999998643321
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ... ..... ..
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~~----~i~~~-------~~--- 215 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--IYE----KILAG-------KL--- 215 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHhC-------Cc---
Confidence 123468899999999998889999999999999999999999996543211 111 11100 00
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHhccc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPS-----MGEVVRLLEGEN 298 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps-----~~~il~~L~~~~ 298 (315)
.++......+.+++.+||+.||++||+ +++++++-+-..
T Consensus 216 -~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 216 -EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred -CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 112223445789999999999999995 999998866543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=295.66 Aligned_cols=264 Identities=23% Similarity=0.273 Sum_probs=198.9
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.++|++.+.||.|+||+||+|.+. ++..+++|++.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 357999999999999999999765 68899999876443 2234467789999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+ +|.+++... ...++...+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 84 YLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKR----KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 9865 787776433 33578899999999999999999999 99999999999999999999999999986443333
Q ss_pred CccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH-------HHh----hh
Q 046121 180 PVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP-------LIE----KL 247 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~----~~ 247 (315)
.......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||........ ....... ... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE--LHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhccccch
Confidence 33334567889999998865 5578899999999999999999999965432211 1100000 000 00
Q ss_pred ccccccCCccc----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 248 ALHELIDPRIE----NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 248 ~~~~~~~~~~~----~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.......+... ....+..+..+.+++.+||+.||.+|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000111100 00011234457899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=301.97 Aligned_cols=255 Identities=21% Similarity=0.247 Sum_probs=204.9
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
.++|++.+.||+|+||.||+|.+. +++.+++|++.... ......+.+|+.+++.++||||+++++.+..++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 468999999999999999999876 68899999876532 23345678999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|||+.+++|.+.+.+. ..+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 97 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSK----DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999888543 4588899999999999999999999 999999999999999999999999999864432
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
. .....|++.|+|||++.+..++.++|||||||++|+|++|..||...... ... ...... . ..
T Consensus 171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~----~~i~~~----~---~~- 233 (329)
T PTZ00263 171 R---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RIY----EKILAG----R---LK- 233 (329)
T ss_pred C---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HHH----HHHhcC----C---cC-
Confidence 2 22356899999999999888999999999999999999999999643221 111 111100 0 01
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHhccccccc
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPS-----MGEVVRLLEGENDRFH 302 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps-----~~~il~~L~~~~~~~~ 302 (315)
.+...+..+.+++.+||+.||++||+ +++++.+-+-....|.
T Consensus 234 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 234 ---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 11123345789999999999999997 7888877554433333
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=273.43 Aligned_cols=268 Identities=24% Similarity=0.282 Sum_probs=211.2
Q ss_pred cHHHHHHHhcCCcccceecCCCceEEEEEE-eCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEec-
Q 046121 14 SFSEIQQATGDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE- 91 (315)
Q Consensus 14 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 91 (315)
.-..+-..+.||++.+.||+|+|+-|+++. ..++..+|+|.+.-.+.+..+..++|++..++++|||+++.++....+
T Consensus 12 ~~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 12 RRGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred CCCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 334555678899999999999999999997 457889999987766677788899999999999999999999876433
Q ss_pred ----CeeEEEEEeccCCccccccccC--CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCcee
Q 046121 92 ----NLNILVYEYICNKSLHWHLFDN--TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM 165 (315)
Q Consensus 92 ----~~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~ 165 (315)
...|++++|+..|+|.+.+.+. .+..+++.++++++.+++.++.+||+..+ .++|+||||.||++...+.++
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~--~yAH~DiKP~NILls~~~~~v 169 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP--PYAHRDIKPANILLSDSGLPV 169 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC--cccccCCCcceeEecCCCceE
Confidence 3479999999999999988653 34569999999999999999999999922 399999999999999999999
Q ss_pred ECCCCcccccCCCCCcc---------ccccccccccCccccc---cCCCcccccchhhhHHHHHHHhCCCccCCCCCccc
Q 046121 166 LGDFGLARWKTTDDPVQ---------TKILGTLGYLAPEYAE---NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ 233 (315)
Q Consensus 166 l~dfg~~~~~~~~~~~~---------~~~~~~~~~~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~ 233 (315)
++|||.++...-....+ .....+..|.|||.+. +...+.++|||||||++|.|+.|..||+.--.
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--- 246 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--- 246 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---
Confidence 99999986332211111 1123577899999886 44567899999999999999999999952111
Q ss_pred hhHHHhHHHHHhhhccc-cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 234 QSLRQWAEPLIEKLALH-ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 234 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
...++. ....+..........++.+..++.+||+.||.+||++.+++..++..
T Consensus 247 -----------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 -----------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111111 11122222222333788899999999999999999999999998764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=299.27 Aligned_cols=256 Identities=20% Similarity=0.230 Sum_probs=204.5
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999876 58899999887542 233456788999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.|++|.+++.. ...+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHEL----GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999998853 34588999999999999999999999 999999999999999999999999999864332
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||....... .... ... ....+.....
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~----i~~---~~~~~~~~~~ 222 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--TWEN----LKY---WKETLQRPVY 222 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--HHHH----HHh---ccccccCCCC
Confidence 2234568999999999998899999999999999999999999996543211 1110 000 0001111011
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.......+..+.+++.+||..+|++||++.+++++.+-
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~ 260 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFF 260 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCccc
Confidence 11112235567889999999999999999999987543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=297.13 Aligned_cols=270 Identities=21% Similarity=0.265 Sum_probs=206.9
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.++|++.+.||+|+||.||++.+. ++..+++|++.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999876 68889999876542 3334568899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|.+++... ..+++..+..++.|++.++.|||+.. +++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH---QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 99999999988543 45889999999999999999999861 5999999999999999999999999998643322
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH-hh-hc---------
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI-EK-LA--------- 248 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~-~~--------- 248 (315)
......+++.|+|||++.+..++.++|+||||+++|+|++|..||....... +........ .. ..
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCccc
Confidence 2233468899999999998889999999999999999999999996432211 100000000 00 00
Q ss_pred -----------------------cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 249 -----------------------LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 249 -----------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
...+.............+..+.+++.+||+.||++|||+++++++.+-.....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 00000000001011123456889999999999999999999999876544333
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=297.67 Aligned_cols=250 Identities=25% Similarity=0.303 Sum_probs=199.3
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNK 104 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (315)
+.||+|+||.||++.+. +++.+|+|++... .......+.+|+.+++.++||||+++.+.+...+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999865 6899999988753 2334456788999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcccc
Q 046121 105 SLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK 184 (315)
Q Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~ 184 (315)
+|...+.. ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++............
T Consensus 81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSG----KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 99887744 34589999999999999999999999 9999999999999999999999999998643332223334
Q ss_pred ccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHH
Q 046121 185 ILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTY 264 (315)
Q Consensus 185 ~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (315)
..|++.|+|||.+.+..++.++|||||||++|+|++|..||....... . ..... . ... .++..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--~----~~~~~----~---~~~----~~p~~ 217 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--L----FELIL----M---EDI----KFPRT 217 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--H----HHHhc----c---CCc----cCCCC
Confidence 568999999999998889999999999999999999999996432211 0 00000 0 001 11222
Q ss_pred HHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhcccccc
Q 046121 265 ELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEGENDRF 301 (315)
Q Consensus 265 ~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~~~~~~ 301 (315)
.+..+.+++.+||..||++|| ++.+++++-+-....|
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 344578899999999999997 8999998755443333
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=291.10 Aligned_cols=262 Identities=23% Similarity=0.360 Sum_probs=198.7
Q ss_pred hcCCcccceecCCCceEEEEEEeCC-----------------CcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccc
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKD-----------------GQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVM 83 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~-----------------~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~ 83 (315)
.++|++.++||+|+||.||+|.+.+ +..+++|++.... ......+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4689999999999999999997532 3468999877543 233456889999999999999999
Q ss_pred eeeeEEecCeeEEEEEeccCCccccccccCC-----------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCe
Q 046121 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNT-----------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPI 146 (315)
Q Consensus 84 ~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~-----------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i 146 (315)
+++++...+..++||||+.+++|.+++.... ...++...++.++.|++.|+.+||+. ++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i 159 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL----NF 159 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC----Cc
Confidence 9999999999999999999999988774421 12467788999999999999999999 99
Q ss_pred EeecCccCcEEEcCCCceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh--CC
Q 046121 147 IHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS--GR 222 (315)
Q Consensus 147 ~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~--g~ 222 (315)
+|+||||+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++||||||+++|+|++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999864332221 1122345678999999988889999999999999999987 45
Q ss_pred CccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 223 KVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 223 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.||...... ..... .......... ......++..+..+.+++.+||+.||++|||+.++.+.|++
T Consensus 240 ~p~~~~~~~--~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTDE--QVIEN-AGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCHH--HHHHH-HHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 666533211 11111 1111110000 00111122334568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=291.63 Aligned_cols=266 Identities=23% Similarity=0.285 Sum_probs=197.7
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.++|++.+.||+|+||+||+|.+. +++.+|+|++..... .......+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 688999998765432 223456789999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+. ++|.+.+... ...+++..+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR----YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 985 5666666443 34588899999999999999999999 99999999999999999999999999986433322
Q ss_pred CccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh---------cc
Q 046121 180 PVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL---------AL 249 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~ 249 (315)
.......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||....... ..+..... ..... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ-DQLERIFL-VLGTPNEDTWPGVHSL 235 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHH-HhCCCChhhccchhhc
Confidence 22334567889999998765 457889999999999999999999997532211 11111000 00000 00
Q ss_pred ccccCCcccCCCCH---------HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 250 HELIDPRIENSYDT---------YELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 250 ~~~~~~~~~~~~~~---------~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
............+. .....+.+++.+||+.||++|||+++++++-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 00000000000000 01245779999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=285.78 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=205.4
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.++|+++++||+|++|.||+|...++..+++|..... ....+.+.+|+.+++.++|+|++++++.+...+..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 4689999999999999999999888888999986643 233567889999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC-
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP- 180 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~- 180 (315)
.+++|.+++.......++...+..++.+++.++.+||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK----NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998766666789999999999999999999999 999999999999999999999999999974432221
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
......++..|+|||...+..++.++|+||||+++|+|++ |..||....... .. ...... ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~---~~~~~~------~~~~--- 224 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VM---SALQRG------YRMP--- 224 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HH---HHHHcC------CCCC---
Confidence 1122334667999999988888999999999999999998 899986433211 11 111100 0000
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.....+..+.+++.+||..+|++|||++++++.|+.
T Consensus 225 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 -RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111233457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=270.51 Aligned_cols=255 Identities=23% Similarity=0.300 Sum_probs=216.3
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
...++|++++.||+|.||.||+|+.+ ++-.+|+|++.++. .....++.+|+++-+.++||||++.+++|.+....|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 35579999999999999999999755 68889999977643 334456889999999999999999999999999999
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+++||..+|++...+.......+++...+.+..|++.|+.|+|.. +|+||||||+|++++..+.+++.|||.+...
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k----~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK----RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC----CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999999888888899999999999999999999999 9999999999999999999999999999532
Q ss_pred CCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
......+-+||.-|.+||...+...+...|+|++|++.||++.|.+||...... .......
T Consensus 175 --p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------etYkrI~------- 235 (281)
T KOG0580|consen 175 --PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------ETYKRIR------- 235 (281)
T ss_pred --CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------HHHHHHH-------
Confidence 244556779999999999999999999999999999999999999999644311 1111111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
+....++...+....++|..|+..+|.+|.+..+++.+-+-.
T Consensus 236 k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 236 KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred HccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 112223344555688999999999999999999999887644
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=287.59 Aligned_cols=247 Identities=17% Similarity=0.227 Sum_probs=196.4
Q ss_pred cceecCCCceEEEEEEeCCCcEEEEEEecccCccc---HHHHHHHHHHHhhcCCCCccceeeeEEe----cCeeEEEEEe
Q 046121 28 ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQG---FAEFQSEVYVLNFARHKNIVMLLGFCCK----ENLNILVYEY 100 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~~~ 100 (315)
...|++|+++.||+|.. +++.||+|.+....... .+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36899999999999988 57889999887543333 4667899999999999999999999876 4567999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+|+|.+++... ..+++.....++.+++.++.+||+.. +++|+||+|+||+++.++.++++|||++.......
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999998543 45888999999999999999999732 78899999999999999999999999986433211
Q ss_pred ccccccccccccCcccccc--CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 181 VQTKILGTLGYLAPEYAEN--GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...... ... ...... ....
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~----~~i~~~-----~~~~--- 241 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIY----DLIINK-----NNSL--- 241 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHH----HHHHhc-----CCCC---
Confidence 23457889999999876 67899999999999999999999999754321 111 111110 0111
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
..+...+..+.+++.+||+.||++|||+.++++.|+.++
T Consensus 242 -~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 -KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 112234556889999999999999999999999998764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=296.70 Aligned_cols=246 Identities=24% Similarity=0.298 Sum_probs=196.7
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNK 104 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (315)
+.||+|+||.||++.+. +++.+|+|++... .......+.+|+.+++.++||||+++++.+...+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999865 6899999987753 2233455678999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcccc
Q 046121 105 SLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK 184 (315)
Q Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~ 184 (315)
+|...+.. ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++............
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 99887744 34689999999999999999999999 9999999999999999999999999998643332222334
Q ss_pred ccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHH
Q 046121 185 ILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTY 264 (315)
Q Consensus 185 ~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (315)
..|++.|+|||.+.+..++.++|+|||||++|+|++|..||....... ... ..... ... ++..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~~----~~~~~-------~~~----~p~~ 217 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFE----LILME-------EIR----FPRT 217 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--HHH----HHhcC-------CCC----CCCC
Confidence 568999999999998889999999999999999999999996433211 000 00000 001 1222
Q ss_pred HHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhcc
Q 046121 265 ELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEGE 297 (315)
Q Consensus 265 ~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~~ 297 (315)
.+..+.+++.+||+.||++|| ++.+++++-+-.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~ 255 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcC
Confidence 344578899999999999998 899988765433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=292.11 Aligned_cols=263 Identities=22% Similarity=0.269 Sum_probs=200.4
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
++|++.+.||+|+||+||+|.++ +++.+++|++.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999876 68889999876432 3334567889999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.++++..... ....+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKN----DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 998877754432 234589999999999999999999999 99999999999999999999999999987543222
Q ss_pred C-ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH-----------HHHhhh
Q 046121 180 P-VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE-----------PLIEKL 247 (315)
Q Consensus 180 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------~~~~~~ 247 (315)
. ......+++.|+|||++.+..++.++|+||||+++|+|++|.+||....... ....... ......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID--QLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhhCCCCHHHHHhhhccc
Confidence 1 1223467889999999988889999999999999999999999997543211 1111000 000000
Q ss_pred ccccccCCccc------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 248 ALHELIDPRIE------NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 248 ~~~~~~~~~~~------~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.......+... .......+..+.+++.+||+.||++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000001000 01111245568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=284.43 Aligned_cols=259 Identities=19% Similarity=0.315 Sum_probs=206.4
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++.+.||+|+||.||+|.+. +++.+++|.+... .......+.+|+.+++.++|||++++++.+...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999865 6889999976542 2333446788999999999999999999999999999999
Q ss_pred EeccCCccccccccC--CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 99 EYICNKSLHWHLFDN--TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
+|+.+++|.+++... ....+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999998877532 234588999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
..........+++.|+|||.+.+..++.++|+||+|+++|+|++|..||......... .. .. ... . .
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~-~~---~~-~~~-----~---~ 224 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS-LC---QK-IEQ-----C---D 224 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH-HH---HH-Hhc-----C---C
Confidence 3332223346788999999998888899999999999999999999998543322111 11 11 110 0 0
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
.........+..+.+++.+||..+|++|||++++++.++.+.
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111112234456889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=294.91 Aligned_cols=241 Identities=23% Similarity=0.244 Sum_probs=194.0
Q ss_pred ecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCcc
Q 046121 31 LGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSL 106 (315)
Q Consensus 31 lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (315)
||+|+||+||+|.+. +++.+|+|++... .......+.+|+.+++.++||||+++++.+...+..++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999876 5888999987643 233455678899999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcccccc
Q 046121 107 HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186 (315)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~ 186 (315)
.+.+.. ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++..............
T Consensus 81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQR--EGRFDLSRARFYTAELLCALENLHKF----NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 988854 34589999999999999999999999 999999999999999999999999999864333333333456
Q ss_pred ccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHH
Q 046121 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYEL 266 (315)
Q Consensus 187 ~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (315)
|++.|+|||++.+..++.++|||||||++|+|++|..||...... ......... ...++...+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~-----------~~~~~~~~~ 217 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQE-----------PLRFPDGFD 217 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcC-----------CCCCCCcCC
Confidence 899999999999988999999999999999999999999643221 111111100 011222334
Q ss_pred HHHHHHHHhhcCCCCCCCCC---HHHHHHHH
Q 046121 267 YLMAKTAYLCVQRNPEGRPS---MGEVVRLL 294 (315)
Q Consensus 267 ~~l~~l~~~~l~~~p~~Rps---~~~il~~L 294 (315)
..+.+++.+||+.||++||+ +.+++.+-
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence 56789999999999999975 56776653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=298.71 Aligned_cols=255 Identities=22% Similarity=0.223 Sum_probs=203.9
Q ss_pred HhcCCcccceecCCCceEEEEEEeCC--CcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKD--GQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
..++|++.+.||+|+||.||+|.+.. +..+++|.+... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 45689999999999999999997543 468999987643 2334556788999999999999999999999999999
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+||||+.+++|.+++.+. ..+++..+..++.|++.++.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 108 lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSL----NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999988543 4588999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
... .....|++.|+|||++.+..++.++|+|||||++|+|++|..||....... ... ..... .
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~----~i~~~-----~--- 244 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--IYQ----KILEG-----I--- 244 (340)
T ss_pred CCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--HHH----HHhcC-----C---
Confidence 321 234568999999999998889999999999999999999999996543211 001 11100 0
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhcccccc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEGENDRF 301 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~~~~~~ 301 (315)
..++...+..+.+++.+||+.||++|+ |+++++++-+-..-.|
T Consensus 245 ---~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 245 ---IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 011222334577899999999999995 8999988765443333
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=290.61 Aligned_cols=263 Identities=24% Similarity=0.300 Sum_probs=195.4
Q ss_pred cCCcccceecCCCceEEEEEEeC--CCcEEEEEEecccC--cccHHHHHHHHHHHhhc---CCCCccceeeeEE-----e
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK--DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFA---RHKNIVMLLGFCC-----K 90 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----~ 90 (315)
++|++.+.||+|+||+||+|.+. ++..+|+|.+.... ........+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999863 46789999876432 22233455677766655 6999999999875 3
Q ss_pred cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCC
Q 046121 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
...+++|+||+. ++|.+++.......+++..+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~----~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999985 5888888766666789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH--hhhc
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI--EKLA 248 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~ 248 (315)
++...... .......+++.|+|||.+.+..++.++||||||+++|+|++|.+||....... .+........ ....
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 156 LARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGEED 232 (290)
T ss_pred ceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhh
Confidence 98644332 22334567899999999988889999999999999999999999997544321 1111110000 0000
Q ss_pred c-------ccccCCcc---cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 249 L-------HELIDPRI---ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 249 ~-------~~~~~~~~---~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
. ...+.+.. .....+..+..+.+++.+||+.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 00000000 000112234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=294.92 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=195.7
Q ss_pred CcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHH---hhcCCCCccceeeeEEecCeeEEE
Q 046121 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVL---NFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
|++++.||+|++|.||+|.+. +++.+++|++.... ....+.+.+|+.++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999865 68999999987432 23345566666655 566799999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|||+.+++|...+. ...+++..+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHEN----KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999987773 34689999999999999999999999 999999999999999999999999999864333
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... . ....... ..
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--~----~~~i~~~-------~~-- 218 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--V----FDSIVND-------EV-- 218 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--H----HHHHHhC-------CC--
Confidence 3333344578999999999998889999999999999999999999996543211 1 1111110 01
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHH
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLL 294 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L 294 (315)
..+...+..+.+++.+||+.||++|| ++.+++++-
T Consensus 219 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 219 --RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 11222345577899999999999999 577777754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=296.23 Aligned_cols=255 Identities=21% Similarity=0.273 Sum_probs=198.9
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.++|+.++.||+|+||+||+|.+. +++.|++|++..... .....+.+|+.+++.++|+||+++++++...+.+++|+|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 467889999999999999999865 689999998765432 334568899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|.... ...+..+..++.|++.+|.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 153 ~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 153 FMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred cCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999986432 356778888999999999999999 99999999999999999999999999987544332
Q ss_pred CccccccccccccCcccccc-----CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 180 PVQTKILGTLGYLAPEYAEN-----GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
.......|+..|+|||.+.. ...+.++|||||||++|+|++|..||............. .. ...
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~----~~~---- 291 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AI----CMS---- 291 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HH----hcc----
Confidence 22234568899999998743 334568999999999999999999997433222111110 00 000
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
.....+......+.+++.+||..||++|||+.+++++-+-...
T Consensus 292 --~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 292 --QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred --CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 0111122344568899999999999999999999998654443
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=282.66 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=204.6
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
+|++.+.||+|++|.||++.+. +++.+++|.+... .....+.+.+|+.+++.++|+|++++++.+..+..++++++|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5899999999999999999876 6888999987543 3344567788999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.+++|.+.+.......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+.........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999998888766666789999999999999999999999 9999999999999999999999999998755444433
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
.....+++.|+|||++.+..++.++|+||||+++|+|++|..||...... ....... ... . ...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~-~~~----~-----~~~ 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILKVC-QGS----Y-----KPL 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHHHh-cCC----C-----CCC
Confidence 34456788999999998888999999999999999999999999643211 1001100 000 0 011
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
+...+..+.+++.+||+.||++|||+.+++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22334557899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=281.57 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=205.5
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.++|++.+.||+|++|.||+|.+++++.+++|.+.... .....+.+|+.+++.++|||++++++++...+..++++|++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46799999999999999999988778889999876543 33567889999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.+++|.+++.......++...+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ----NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 999999998766656789999999999999999999999 9999999999999999999999999998754422211
Q ss_pred cc-cccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 182 QT-KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 182 ~~-~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.. ....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... .... . ... .. ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~----~-~~~-----~~----~~ 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQ----Q-VDQ-----GY----RM 223 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHH----H-HHc-----CC----CC
Confidence 11 1122357999999988889999999999999999999 99998643211 1110 0 100 00 00
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1122234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=287.95 Aligned_cols=262 Identities=22% Similarity=0.297 Sum_probs=207.1
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.|++.++||+|+||+||++.+. +++.+|+|++.... ......+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4889999999999999999865 68899999876432 1223446789999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|.+.+.......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE----RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG- 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-
Confidence 99999998887665556799999999999999999999999 9999999999999999999999999998643222
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.......|++.|+|||++.+..++.++|+||+|+++|+|++|..||........ ....... .. ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~~~~~-~~----------~~~~ 222 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REEVERR-VK----------EDQE 222 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHHHHHH-hh----------hccc
Confidence 222234678999999999888899999999999999999999999975432211 1111110 00 0111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhcccccccc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~~~~~~~~ 303 (315)
..+...+..+.+++.+||..||++|| ++.+++++-+-....|..
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~ 271 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence 12233455688999999999999999 888998875554444443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=283.03 Aligned_cols=255 Identities=27% Similarity=0.358 Sum_probs=205.1
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
.++|.+.+.||+|++|.||+|.+. +++.+++|+.... ......+.+|+..++.++|||++++++++..++..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 457899999999999999999765 5888999987643 33456788999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.......++...+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999988766666789999999999999999999999 999999999999999999999999999864432221
Q ss_pred cc-ccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 181 VQ-TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 181 ~~-~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
.. .....+..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... ... ...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~-~~~---------~~~ 223 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYEL-LEK---------GYR 223 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH-HHC---------CCC
Confidence 11 11223567999999988889999999999999999998 88888643211 10011 110 011
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
...+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 112223345688899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=286.40 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=203.0
Q ss_pred hcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccCcc-cHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEASTQ-GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
.++|.+.+.||+|++|.||+|.+. ++..+++|++...... ....+.+|+++++.++|||++++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 357999999999999999999753 3578999987765443 356788999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccCC------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC
Q 046121 95 ILVYEYICNKSLHWHLFDNT------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF 162 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~ 162 (315)
++||+|+.+++|.+++.... ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ----HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeeccccccceEEEcCCC
Confidence 99999999999999886432 24578889999999999999999999 999999999999999999
Q ss_pred ceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHh
Q 046121 163 VPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQW 239 (315)
Q Consensus 163 ~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 239 (315)
.++|+|||.+........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ .
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~-- 234 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---I-- 234 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---H--
Confidence 999999999864322211 1122345678999999998889999999999999999998 9999864432110 0
Q ss_pred HHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 240 AEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.. .... .....+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus 235 -~~-~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 -EC-ITQG---------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HH-HHcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 00 0000 0111112234557899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=282.47 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=204.4
Q ss_pred HhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
..++|+++++||+|+||.||+|...+++.+++|.+.... .....+.+|+.+++.++|+|++++++++. .+..++++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 457899999999999999999998888999999877543 33567889999999999999999999874 4568999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+.+.......++......++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK----NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999988766666789999999999999999999999 999999999999999999999999999864432221
Q ss_pred -ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 181 -VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 181 -~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
......++..|+|||.+.+..++.++|+||||+++|++++ |.+||....... ... . ... .....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~-~~~-----~~~~~-- 223 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQ----N-LER-----GYRMP-- 223 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHH----H-HHc-----CCCCC--
Confidence 1222344678999999988889999999999999999998 999996433211 100 0 000 00011
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.+...+..+.+++.+||..+|++|||++++++.|+.
T Consensus 224 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 --RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 112234458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=308.01 Aligned_cols=264 Identities=21% Similarity=0.245 Sum_probs=217.5
Q ss_pred HhcCCcccceecCCCceEEEEEEeCCC-cEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceee-eEEe------c
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKDG-QMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLG-FCCK------E 91 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~-~~~~------~ 91 (315)
-..+++|.+.|.+|+|+.||+|.+..+ ..+|+|.+....+...+.+.+|+.++++|+ |+||+.|++ .... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345788999999999999999987765 999999887778888889999999999997 999999999 3321 1
Q ss_pred CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCc
Q 046121 92 NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGL 171 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~ 171 (315)
....|+||||.|+.|-++++......|++.++++|+.++++|+.+||..-+ .+||||||-+|||++.+|.+||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~p--PiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKP--PIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCC--ccchhhhhhhheEEcCCCCEEeCcccc
Confidence 345899999999999999987777779999999999999999999999933 599999999999999999999999999
Q ss_pred ccccCCCCCcc---------ccccccccccCcccc---ccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHh
Q 046121 172 ARWKTTDDPVQ---------TKILGTLGYLAPEYA---ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQW 239 (315)
Q Consensus 172 ~~~~~~~~~~~---------~~~~~~~~~~aPE~~---~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 239 (315)
++-........ .....|+.|+|||.+ .+...+.|+|||+|||+||-|+....||+..+...
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------- 265 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------- 265 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------
Confidence 97433322111 123468999999966 47778999999999999999999999998765432
Q ss_pred HHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccccccc
Q 046121 240 AEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLG 305 (315)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~~ 305 (315)
++......-..+..+..+++||..||+.||.+||++-++++.+-++..+-..+.
T Consensus 266 ------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 266 ------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred ------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 222222222335678889999999999999999999999999988877655443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=284.05 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=201.0
Q ss_pred hcCCcccceecCCCceEEEEEEeC----CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..+|++.+.||+|+||.||+|.+. .+..+++|...... ......+.+|+..++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457999999999999999999653 36688999877542 2334567899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.+++|.+++.... ..+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~----~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM----GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC----CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999998886543 4689999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCC-ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 177 TDDP-VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 177 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
.... ......++..|+|||.+.+..++.++||||||+++|++++ |..||....... .. ... ... ..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~---~~~-~~~-----~~ 226 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VI---KAV-EDG-----FR 226 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HH---HHH-HCC-----CC
Confidence 1111 1112234568999999988889999999999999999775 999996443211 00 111 110 00
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
. ..+...+..+.+++.+||+.+|++|||+++|++.|.+.
T Consensus 227 ~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 L----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred C----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1 11223455688899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=299.17 Aligned_cols=254 Identities=25% Similarity=0.272 Sum_probs=204.0
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|.+.+.||+|+||+||+|.+. +++.+|+|++.... ......+.+|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999876 68999999987532 234556788999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+++.+. ..+++..+..++.|++.||.+||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~----giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL----GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999988654 5689999999999999999999999 9999999999999999999999999998654433
Q ss_pred C-----------------------------CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCC
Q 046121 179 D-----------------------------PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNG 229 (315)
Q Consensus 179 ~-----------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~ 229 (315)
. .......|++.|+|||.+.+..++.++|||||||++|+|++|..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 11223568899999999999999999999999999999999999997544
Q ss_pred CccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHHHhc
Q 046121 230 EEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS-MGEVVRLLEG 296 (315)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps-~~~il~~L~~ 296 (315)
... .. ...... ......+. ....+..+.+++.+||. +|.+||+ +++++++.+-
T Consensus 235 ~~~--~~----~~i~~~--~~~~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~ 288 (350)
T cd05573 235 LQE--TY----NKIINW--KESLRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288 (350)
T ss_pred HHH--HH----HHHhcc--CCcccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence 211 10 111100 00000010 00134557788888997 9999999 9999987554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=281.60 Aligned_cols=251 Identities=23% Similarity=0.382 Sum_probs=200.0
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
++|++.+.||+|+||.||++.++++..+++|.+... ......+.+|+.+++.++||||+++++++......++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 578999999999999999999888888999987643 3334678889999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc-
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV- 181 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~- 181 (315)
+++|.+.+.... ..+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++++|||.+.........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN----SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999998886443 3588999999999999999999999 9999999999999999999999999988643322211
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... .. ....... ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~----~~~i~~~---~~~~------- 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EV----VEMISRG---FRLY------- 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HH----HHHHHCC---CCCC-------
Confidence 112234567999999988889999999999999999999 88998643211 01 1111100 0000
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112345789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=296.16 Aligned_cols=246 Identities=24% Similarity=0.299 Sum_probs=196.4
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNK 104 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (315)
+.||+|+||.||++.+. +++.+++|++.... ......+.+|+.+++.++||||+++.+.+...+..++||||+.++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 68999999887532 233455678999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 105 SLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
+|...+.. ...+++..+..++.|++.++.|||+ . +++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~----~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC----CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 99887743 3458999999999999999999997 7 999999999999999999999999999864333333333
Q ss_pred cccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCH
Q 046121 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (315)
...|++.|+|||++.+..++.++||||||+++|+|++|..||........ ....... ... ++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~------~~~i~~~-------~~~----~p~ 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILME-------EIR----FPR 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH------HHHHhcC-------CCC----CCC
Confidence 45689999999999988899999999999999999999999964332110 0000000 011 112
Q ss_pred HHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhcc
Q 046121 264 YELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEGE 297 (315)
Q Consensus 264 ~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~~ 297 (315)
..+..+.+++.+||+.||++|+ ++.+++++-+-.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~ 256 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA 256 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence 2334578899999999999997 899998875543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=285.93 Aligned_cols=254 Identities=29% Similarity=0.432 Sum_probs=201.9
Q ss_pred cCCcccceecCCCceEEEEEEeCC------CcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKD------GQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
++|++.+.||+|++|.||+|...+ ...+++|.+.... ......+.+|+..++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 489999999999999999997543 2578888876443 233456789999999999999999999999989999
Q ss_pred EEEEeccCCccccccccCCC--------------CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC
Q 046121 96 LVYEYICNKSLHWHLFDNTE--------------SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD 161 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~ 161 (315)
+++||+.+++|.+++..... ..++...++.++.|++.++.+||+. +++|+||+|+||+++.+
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccccceEEEcCC
Confidence 99999999999988865321 4588899999999999999999999 99999999999999999
Q ss_pred CceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHH
Q 046121 162 FVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQ 238 (315)
Q Consensus 162 ~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 238 (315)
+.++|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...... .
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------~ 234 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------E 234 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH------H
Confidence 9999999999864332221 1123345778999999988889999999999999999998 99898643321 1
Q ss_pred hHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 239 WAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.... ... ......+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus 235 ~~~~-i~~---------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEM-IRS---------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH-HHc---------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111 111 01111223345668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=294.07 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=196.5
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCC-CccceeeeEEecCeeEEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHK-NIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~ 98 (315)
+|++++.||+|+||.||+|.+. +++.+|+|++... .......+..|..++..+.|+ +|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999866 5788999987753 233455677889999988765 5788999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+.+... ..+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999998888543 4588999999999999999999999 9999999999999999999999999998643333
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
........|++.|+|||++.+..++.++|+||+|+++|+|++|..||....... .. ...... .
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~----~~i~~~-------~---- 217 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LF----QSIMEH-------N---- 217 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HH----HHHHcC-------C----
Confidence 333344578999999999999889999999999999999999999996443211 11 111100 0
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHH
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSM-----GEVVRL 293 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~-----~~il~~ 293 (315)
..++...+..+.+++.+||..||++|++. .+++++
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 218 VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11122234457889999999999999976 666655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=280.10 Aligned_cols=259 Identities=20% Similarity=0.320 Sum_probs=208.0
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++.+.||+|++|.||+|.+. +++.+++|.+... .......+.+|+.+++.++|++++++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999876 7899999977532 2233567889999999999999999999999999999999
Q ss_pred EeccCCccccccccC--CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 99 EYICNKSLHWHLFDN--TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||+.+++|.+++... ....++...+..++.+++.++.+||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK----RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999998887542 345689999999999999999999999 99999999999999999999999999986444
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
..........+++.|.|||.+.+..++.++|+||||+++|+|++|..||....... ........ . ..
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~-~--------~~ 224 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKKIE-K--------CD 224 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH----HHHHhhhh-c--------CC
Confidence 33322233467888999999988889999999999999999999999985443211 11111100 0 00
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
.........+..+.+++.+||..+|++|||+.++++.|+.+.
T Consensus 225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111111234456889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=281.83 Aligned_cols=258 Identities=19% Similarity=0.316 Sum_probs=206.5
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++.+.||+|++|.||++.+. +++.+++|.+.... ......+.+|+.+++.++|||++++++++..++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999864 78899999765432 223456788999999999999999999999999999999
Q ss_pred EeccCCcccccccc--CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 99 EYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 99 ~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
+|+.+++|.+++.. .....+++..++.++.+++.++.+||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999888753 2345689999999999999999999999 99999999999999999999999999986444
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
..........++..|+|||.+.+..++.++|+||||+++|+|++|..||............ .. . . ..
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~-~-----~---~~ 224 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KI-E-----Q---CD 224 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh----hh-h-----c---CC
Confidence 3333233456788999999998888899999999999999999999998643322111110 00 0 0 01
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.........+..+.+++.+||..+|++|||+.++++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11111223455688999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=297.11 Aligned_cols=270 Identities=27% Similarity=0.405 Sum_probs=205.5
Q ss_pred CCCcccHHHH-HHHhcCCcccceecCCCceEEEEEEe------CCCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCC
Q 046121 9 DPMKFSFSEI-QQATGDFSKENLLGEGGFGHVYKGEL------KDGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHK 79 (315)
Q Consensus 9 ~~~~~~~~~~-~~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~ 79 (315)
||..+.+..- ..-.++|++.+.||+|+||+||+|.+ .++..||+|++.... ......+.+|+.+++.+ +||
T Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~Hp 99 (375)
T cd05104 20 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHI 99 (375)
T ss_pred cCCCCCCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCc
Confidence 4555544422 22345899999999999999999963 246689999876432 23345678999999999 899
Q ss_pred CccceeeeEEecCeeEEEEEeccCCccccccccCC---------------------------------------------
Q 046121 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNT--------------------------------------------- 114 (315)
Q Consensus 80 ~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~--------------------------------------------- 114 (315)
||+++++++...+..++||||+++|+|.+++....
T Consensus 100 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 179 (375)
T cd05104 100 NIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVV 179 (375)
T ss_pred ceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccc
Confidence 99999999999999999999999999988875422
Q ss_pred ----------------------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeE
Q 046121 115 ----------------------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPML 166 (315)
Q Consensus 115 ----------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l 166 (315)
...+++..+..++.|++.++.|||+. +++|+||||+||+++.++.++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nill~~~~~~kl 255 (375)
T cd05104 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK----NCIHRDLAARNILLTHGRITKI 255 (375)
T ss_pred ccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCchhhEEEECCCcEEE
Confidence 12477888999999999999999999 9999999999999999999999
Q ss_pred CCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHH
Q 046121 167 GDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 167 ~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .... .
T Consensus 256 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~----~ 329 (375)
T cd05104 256 CDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYK----M 329 (375)
T ss_pred ecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHH----H
Confidence 999998644332211 112234567999999998899999999999999999998 888886432211 1111 1
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
..... ... .+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 330 ~~~~~-----~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 330 IKEGY-----RML----SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHhCc-----cCC----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11100 000 1111234588999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=281.68 Aligned_cols=254 Identities=24% Similarity=0.282 Sum_probs=210.1
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
-.++|++++.||+|.-|+||+++.. ++..+|+|++.+.. .....+.+.|.++|+.++||.++.++..++.+...|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 3468899999999999999999876 47999999988754 3335567889999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
+||||.||+|...++++.++.+++..+..++..++.||+|||.. |||.|||||+|||+.++|+|.|+||.++....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml----GivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML----GIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh----ceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999999999999999999999999999999999999 99999999999999999999999999874211
Q ss_pred C---------------------------------C-C----------------------CccccccccccccCccccccC
Q 046121 177 T---------------------------------D-D----------------------PVQTKILGTLGYLAPEYAENG 200 (315)
Q Consensus 177 ~---------------------------------~-~----------------------~~~~~~~~~~~~~aPE~~~~~ 200 (315)
. . . ..+...+||..|+|||++.|.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 011235688899999999999
Q ss_pred CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCC
Q 046121 201 IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRN 280 (315)
Q Consensus 201 ~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~ 280 (315)
..+.++|.|+||+++|||+.|.-||-+.+.. ..+.++.. ..+.-...+..+..+++||+++|.+|
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~--~Tl~NIv~-------------~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK--ETLRNIVG-------------QPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCch--hhHHHHhc-------------CCCcCCCCCcchhHHHHHHHHHhccC
Confidence 9999999999999999999999999655433 22222111 11111111256677999999999999
Q ss_pred CCCCCC----HHHHHHH
Q 046121 281 PEGRPS----MGEVVRL 293 (315)
Q Consensus 281 p~~Rps----~~~il~~ 293 (315)
|++|.. +.||-++
T Consensus 376 P~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhhccccchHHhhcC
Confidence 999998 7777654
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=280.52 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=202.6
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.++|++.+.||+|++|.||+|.+.++..+++|.+..... ..+.+.+|+.+++.++|++++++++++. ....+++|+|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 468999999999999999999888888899998765433 3456889999999999999999999875 45679999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC-
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP- 180 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~- 180 (315)
.+++|.+++.......+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM----NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999988766566689999999999999999999999 999999999999999999999999999864433221
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
......++..|+|||...+..++.++|+||||+++|+|++ |.+||...... ... .... . ... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~----~~~~-~-----~~~----~ 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVL----EQVE-R-----GYR----M 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHH----HHHH-c-----CCC----C
Confidence 1112234567999999988889999999999999999999 88888643211 111 1110 0 001 1
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
..+...+..+.+++.+||..+|++|||+.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=279.57 Aligned_cols=250 Identities=25% Similarity=0.324 Sum_probs=204.9
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+|.+.+.||+|++|.||+|.+. +++.+++|.+... .......+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5888999999999999999875 6888999987643 334456688999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.......++...++.++.+++.++.+||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~----~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998776567799999999999999999999999 999999999999999999999999999875444333
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
......+++.|+|||+..+..++.++|+||||+++|+|++|..||...... ... ... .. .....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~----~~~-~~---------~~~~~ 220 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALI----LKI-IR---------GVFPP 220 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHH----HHH-Hc---------CCCCC
Confidence 333456788999999999888999999999999999999999999644311 000 000 00 00111
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 122344568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=290.71 Aligned_cols=251 Identities=23% Similarity=0.309 Sum_probs=196.5
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||.||++.+. +++.+|+|++... .......+.+|..+++.+ +||||+++++++.....+++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 6889999998753 233345678899999888 699999999999999999999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|..++.+. ..+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 9998877433 4699999999999999999999999 999999999999999999999999999864333333334
Q ss_pred cccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCcc--chhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEP--QQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
...|++.|+|||++.+..++.++|+||||+++|+|++|..||...+... ................ .. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~----~ 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------IR----I 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------CC----C
Confidence 4678999999999999889999999999999999999999996433211 1111111111111100 01 1
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCC------HHHHHHHHh
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPS------MGEVVRLLE 295 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps------~~~il~~L~ 295 (315)
+...+..+.+++.+||+.||.+|+| +.+++++-+
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF 264 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence 1223445788999999999999997 678876533
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=291.24 Aligned_cols=258 Identities=23% Similarity=0.232 Sum_probs=218.3
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc---cHHHHHHHHHHHhhcC-CCCccceeeeEEecCe
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ---GFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENL 93 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 93 (315)
......|++.+.||+|.||.||.+..+ +|+.+|+|++.+.... ....+.+|+.+++.+. ||||+.+.+++++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 446678999999999999999999876 5999999998765442 3467899999999998 9999999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC----CceeECCC
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD----FVPMLGDF 169 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~----~~i~l~df 169 (315)
.++|||++.||.|.+.+... . +++..+..++.|++.++.|||+. |++|+|+||+|+++... +.++++||
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~~----gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHSL----GVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHhC----CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 99999999999999999766 3 99999999999999999999999 99999999999999543 57999999
Q ss_pred CcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcc
Q 046121 170 GLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249 (315)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (315)
|++..... .......+|++.|+|||++....++..+|+||+|+++|.|++|.+||...+...... ....
T Consensus 184 Gla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~--- 252 (382)
T KOG0032|consen 184 GLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILR--- 252 (382)
T ss_pred CCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHc---
Confidence 99986665 555667899999999999999999999999999999999999999997554322111 0111
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.+..+........+..+++++..|+..||..|+|+.+++++.|-.
T Consensus 253 ---~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~ 297 (382)
T KOG0032|consen 253 ---GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIK 297 (382)
T ss_pred ---CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence 111334444555677799999999999999999999999987643
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=292.29 Aligned_cols=244 Identities=24% Similarity=0.366 Sum_probs=194.7
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||+||+|.++ +++.+|+|++... ..........|..+++.+ +||||+++++++...+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 5889999987643 233445567788888766 699999999999999999999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|.+.+... ..+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~----~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 9998887543 4589999999999999999999999 999999999999999999999999999864333333334
Q ss_pred cccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCH
Q 046121 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (315)
...|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+... . ....... . ...+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~----~~~i~~~----~-------~~~~~ 217 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--L----FEAILND----E-------VVYPT 217 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--H----HHHHhcC----C-------CCCCC
Confidence 4578999999999998889999999999999999999999997543211 1 1111100 0 01122
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCH------HHHHHHHh
Q 046121 264 YELYLMAKTAYLCVQRNPEGRPSM------GEVVRLLE 295 (315)
Q Consensus 264 ~~~~~l~~l~~~~l~~~p~~Rps~------~~il~~L~ 295 (315)
..+..+.+++.+||+.||++||++ ++++.+-+
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~ 255 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF 255 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence 234567899999999999999998 66766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=281.85 Aligned_cols=255 Identities=25% Similarity=0.317 Sum_probs=202.3
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
.++|++.+.||+|+||.||+|.+. +++.+++|+...........+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 458999999999999999999875 6888999988765555566788999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.+. ..+++..+..++.|++.++.+||+. +++|+|++|+||+++.++.++++|||++........
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK----GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999888543 4588999999999999999999999 999999999999999999999999999875433322
Q ss_pred ccccccccccccCccccc---cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 181 VQTKILGTLGYLAPEYAE---NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
......+++.|+|||.+. ...++.++|+||+|+++|+|++|..||......... ..........+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~----------~~~~~~~~~~~~~ 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL----------FLMSKSNFQPPKL 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh----------eeeecCCCCCCCC
Confidence 223346788999999874 344678999999999999999999998533211100 0000000000111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
. .....+..+.+++.+||+.+|++|||+++++++|
T Consensus 232 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 1122345688999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=291.59 Aligned_cols=245 Identities=24% Similarity=0.339 Sum_probs=195.8
Q ss_pred cceecCCCceEEEEEEe----CCCcEEEEEEecccC----cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 28 ENLLGEGGFGHVYKGEL----KDGQMIAAKVRKEAS----TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~----~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
++.||+|+||.||++.. .+++.+|+|++.... ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 46899999999999975 257889999876432 2233456789999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|.+.+.+ ...+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 81 YLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQ----GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999888854 34578888999999999999999999 99999999999999999999999999986433333
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ......... . .
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~-------~----~ 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKG-------K----L 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcC-------C----C
Confidence 3333456899999999999888899999999999999999999999654321 101111100 0 0
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHh
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLE 295 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~ 295 (315)
..+...+..+.+++.+||..+|++|| ++.+++++-+
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 11222344578999999999999999 8999888654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=292.34 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=201.7
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.++|++.++||+|+||.||++.+. ++..+++|++... .......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 479999999999999999999876 6888888887654 23334568899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|.+++.. ...+++..+..++.+++.++.|||+.. +++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999998854 345889999999999999999999741 6999999999999999999999999998643221
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh------------
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL------------ 247 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 247 (315)
......++..|+|||++.+..++.++|+|||||++|+|++|..||............ .......
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF---GCPVEGDPAESETSPRPRP 233 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHh---cCcccCCccccccCcccCC
Confidence 122346788999999999888999999999999999999999998643221100000 0000000
Q ss_pred -------------------cccc-ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 248 -------------------ALHE-LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 248 -------------------~~~~-~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.... ..............+..+.+++.+||+.||++|||+.+++.+-.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 0000 000000000001123457899999999999999999999876554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=279.86 Aligned_cols=268 Identities=23% Similarity=0.287 Sum_probs=204.5
Q ss_pred HHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEec--ccCcccHHHHHHHHHHHhhcCCCCccceeeeEEe----
Q 046121 18 IQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRK--EASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK---- 90 (315)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 90 (315)
...+..+|..++.||.|++|.|+.+.++ +++.||+|.+. -.+....++..+|++.|+.++|+||+.+.+++..
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 3446677888899999999999999766 78999999877 3456667888999999999999999999999854
Q ss_pred -cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCC
Q 046121 91 -ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDF 169 (315)
Q Consensus 91 -~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~df 169 (315)
-..+|+|+|+| +.+|...+. .+..++...+..++.|++.|++|+|+. +++|||+||.|++++.+..+|++||
T Consensus 97 ~f~DvYiV~elM-etDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSA----nViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSA----NVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHH--cCccccHHHHHHHHHHHHHhcchhhcc----cccccccchhheeeccCCCEEeccc
Confidence 35679999998 778888873 344499999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCC--CCccccccccccccCccccc-cCCCcccccchhhhHHHHHHHhCCCccCCCCCccc-------------
Q 046121 170 GLARWKTTD--DPVQTKILGTLGYLAPEYAE-NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ------------- 233 (315)
Q Consensus 170 g~~~~~~~~--~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~------------- 233 (315)
|++...... ......+.-|..|.|||.+. ...|+.+.||||+||++.||++|++.|.+.....+
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 999855432 22224467788999999664 56799999999999999999999999976533211
Q ss_pred hhHHHhHHHHHhhh--ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 234 QSLRQWAEPLIEKL--ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 234 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
..+........... .+.......+ ...-+.......+|+.+||..||.+|+|++|+|.+
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f-~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPF-SSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCH-HHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111111111110 0111111111 11122345567889999999999999999999875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=276.41 Aligned_cols=270 Identities=22% Similarity=0.248 Sum_probs=205.9
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc--cHHHHHHHHHHHhhcCCCCccceeeeEE--ecCe
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ--GFAEFQSEVYVLNFARHKNIVMLLGFCC--KENL 93 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~ 93 (315)
....+.|+++..|++|+||.||+|+++ +++.||+|.++...+. ---...+|+.+|.+++||||+.+-++.. +-+.
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 345578999999999999999999876 7999999987754322 2224579999999999999999998874 3456
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+|+||+|++. +|...+.. ...++.+.++..++.|++.+++|||.. .|+|||||++|+++...|.+|++|||++.
T Consensus 152 iy~VMe~~Eh-DLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~~----wilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHDN----WILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred eeeeHHHHHh-hHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhhc----eeEecccchhheeeccCCcEEecccchhh
Confidence 8999999855 56555543 346799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHH-hHHH----HHhh-
Q 046121 174 WKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQ-WAEP----LIEK- 246 (315)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~----~~~~- 246 (315)
.+..........+-|..|.|||.+.| ..|+.+.|+||+||++.||+++.+.|.+.++..+....- .... ....
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 77766555556677899999998876 458999999999999999999999997665433211110 0000 0000
Q ss_pred --------hccccccCCcccCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 247 --------LALHELIDPRIENSYDTY-ELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 247 --------~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
.....-....+...+... .++.-.+|+..+|.+||.+|.|+++.|++=
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 001111111122222222 456678999999999999999999998753
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=292.06 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=199.8
Q ss_pred CCcccceecCCCceEEEEEEeC----CCcEEEEEEeccc----CcccHHHHHHHHHHHhhcC-CCCccceeeeEEecCee
Q 046121 24 DFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEA----STQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLN 94 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 94 (315)
+|++++.||+|+||+||++... +++.+++|++... .......+.+|+.+++.+. ||+|+.+++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999652 5889999987643 2233456778999999994 89999999999999999
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++||||+.+++|.+++.. ...+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKL----GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999888854 34589999999999999999999999 999999999999999999999999999864
Q ss_pred cCCCCC-ccccccccccccCccccccCC-CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 175 KTTDDP-VQTKILGTLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 175 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
...... ......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||......... .........
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~------- 225 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILK------- 225 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhc-------
Confidence 433222 222356899999999987654 788999999999999999999999654332211 111111110
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhcc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEGE 297 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~~ 297 (315)
.++. .+...+..+.+++.+||+.||++|| ++++++++-+-.
T Consensus 226 ~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 271 (332)
T cd05614 226 CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271 (332)
T ss_pred CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence 1111 1222344578899999999999999 788888775543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=289.95 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=194.3
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||+||+|.+. +++.+|+|++... .......+.+|+.++..+ +||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 6889999988753 223345577888888766 799999999999999999999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|...+.. ...+++..+..++.|++.++.|||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 999877743 34689999999999999999999999 999999999999999999999999999864333333334
Q ss_pred cccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCcc--chhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEP--QQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
...|++.|+|||++.+..++.++|+||||+++|+|++|..||....... ......+........ ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----------~~~~ 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------QIRI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC----------CCCC
Confidence 4578999999999999889999999999999999999999996322111 111111111111100 0112
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHHHH
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPSM------GEVVRLL 294 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps~------~~il~~L 294 (315)
+...+..+.+++.+||+.||++||++ .+++++-
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 263 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence 22334557889999999999999984 6776553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=304.12 Aligned_cols=251 Identities=20% Similarity=0.238 Sum_probs=201.4
Q ss_pred hcCCcccceecCCCceEEEEEEeC-C-CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-D-GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
...|.+.+.||+|++|.||+|... + +..+++|............+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 345999999999999999999654 3 67788887655555555667889999999999999999999999999999999
Q ss_pred eccCCccccccccC--CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 100 YICNKSLHWHLFDN--TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|+.|++|.+.+... ...++++..+..++.|++.+|.+||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR----KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999998877542 345688999999999999999999999 999999999999999999999999999975433
Q ss_pred CCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 178 DDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 178 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...... ......... . ..
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~~-~----~~- 289 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLYG-K----YD- 289 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC-C----CC-
Confidence 221 123456899999999999888999999999999999999999999643221 111111100 0 00
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~ 292 (315)
..+...+..+.+++.+||..||++|||+.+++.
T Consensus 290 ----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 ----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112223455889999999999999999999875
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=277.93 Aligned_cols=268 Identities=25% Similarity=0.268 Sum_probs=205.3
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--ccHHHHHHHHHHHhhcCCCC-ccceeeeEEecC-----
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--QGFAEFQSEVYVLNFARHKN-IVMLLGFCCKEN----- 92 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~----- 92 (315)
...|+.+++||+|+||+||+|+.+ +|+.||+|.+..... ..-....+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456888999999999999999866 689999998776544 23445789999999999999 999999998877
Q ss_pred -eeEEEEEeccCCccccccccCCC--CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCC
Q 046121 93 -LNILVYEYICNKSLHWHLFDNTE--SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDF 169 (315)
Q Consensus 93 -~~~lv~~~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~df 169 (315)
.+++|+||+ .-+|..++..... ..++...+..+++|++.|+.|||+. +|+||||||+|++++..|.+||+||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~----~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH----GILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCcceEEECCCCcEeeecc
Confidence 889999997 5577777755443 4577789999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh-
Q 046121 170 GLARWKTTDDPVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL- 247 (315)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 247 (315)
|++.-............+|..|.|||++.|. .|+...||||+||++.||+++++.|.+..+. ..+..... .....
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql~~If~-~lGtP~ 241 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQLFRIFR-LLGTPN 241 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHHHHHHH-HcCCCC
Confidence 9998555444444556788899999998876 6899999999999999999999999766552 11111111 11100
Q ss_pred --ccccc-----cCCcc-----cCCCCHHH---HHHHHHHHHhhcCCCCCCCCCHHHHHHH--Hhcc
Q 046121 248 --ALHEL-----IDPRI-----ENSYDTYE---LYLMAKTAYLCVQRNPEGRPSMGEVVRL--LEGE 297 (315)
Q Consensus 248 --~~~~~-----~~~~~-----~~~~~~~~---~~~l~~l~~~~l~~~p~~Rps~~~il~~--L~~~ 297 (315)
.+... .+..+ ........ .....+++.+||+.+|.+|.|++.++++ +...
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 00000 00001 11111111 1367889999999999999999999987 4444
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=291.76 Aligned_cols=245 Identities=23% Similarity=0.331 Sum_probs=195.2
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||.||+|.+. +++.+|+|++... .......+..|..++..+ +||+|+.+++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 5889999987753 233345567788888765 799999999999999999999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|...+... ..+++..+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH----GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 9998887533 4588999999999999999999999 999999999999999999999999999864333333334
Q ss_pred cccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCH
Q 046121 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (315)
...|++.|+|||++.+..++.++||||||+++|+|++|..||...+... .. ...... .. ..+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~----~~i~~~----~~-------~~p~ 217 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--LF----ESILHD----DV-------LYPV 217 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--HH----HHHHcC----CC-------CCCC
Confidence 4568999999999998889999999999999999999999997543211 11 111110 00 1111
Q ss_pred HHHHHHHHHHHhhcCCCCCCCC-------CHHHHHHHHhc
Q 046121 264 YELYLMAKTAYLCVQRNPEGRP-------SMGEVVRLLEG 296 (315)
Q Consensus 264 ~~~~~l~~l~~~~l~~~p~~Rp-------s~~~il~~L~~ 296 (315)
..+..+.+++.+||+.||++|| ++.+++++-+-
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~ 257 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF 257 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence 2344578899999999999999 88888877543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=279.70 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=205.9
Q ss_pred HhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
..++|++.+.||+|++|+||+|.+++++.+++|.+.... ...+.+.+|+..++.++|||++++++++......++++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 457899999999999999999998888889999877543 3456788999999999999999999999988999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.......++...+..++.+++.++.+||+. +++|+||+|+||+++.++.++++|||.+........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR----NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999776666799999999999999999999999 999999999999999999999999999864432111
Q ss_pred c-cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 181 V-QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 181 ~-~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
. ......+..|+|||.+.+..++.++|+||+|++++++++ |..||...... .... .... ....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~----~~~~------~~~~--- 223 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLE----QVER------GYRM--- 223 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHc------CCCC---
Confidence 1 111223567999999988889999999999999999998 99998543211 1111 1100 0000
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
..+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1111124458889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=289.21 Aligned_cols=242 Identities=25% Similarity=0.362 Sum_probs=191.4
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhh-cCCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNF-ARHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||+||+|.+. +++.+|+|++.... .........|..+++. ++||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999877542 2334456667777775 4899999999999999999999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|.+.+.. ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSK----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 999888853 34588999999999999999999999 999999999999999999999999999864333333334
Q ss_pred cccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCH
Q 046121 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (315)
...|++.|+|||++.+..++.++|+||+||++|+|++|..||...... ... ...... .+. .+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~----~~i~~~-------~~~----~~~ 217 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELF----QSIRMD-------NPC----YPR 217 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHH----HHHHhC-------CCC----CCc
Confidence 456899999999999888999999999999999999999999644321 111 111000 011 112
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCHH-HHHHH
Q 046121 264 YELYLMAKTAYLCVQRNPEGRPSMG-EVVRL 293 (315)
Q Consensus 264 ~~~~~l~~l~~~~l~~~p~~Rps~~-~il~~ 293 (315)
..+..+.+++.+||+.||++||++. ++.++
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 2344578899999999999999997 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=279.91 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=200.3
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
++|++.+.||+|++|+||+|.+.++..+++|.+... ....+.+.+|+.+++.++||||+++++++......+++|||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 579999999999999999998877777999977643 2334678899999999999999999999998889999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcc
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~ 182 (315)
+++|.+++..... .+++..++.++.|++.++.+||+. +++|+||+|.||+++.++.++++|||.+..........
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK----QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999998865433 589999999999999999999999 99999999999999999999999999886443322111
Q ss_pred -ccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 183 -TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 183 -~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+... ........ . .. .
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~-~-----~~----~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TVEKVSQG-L-----RL----Y 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHhcC-C-----CC----C
Confidence 11234567999999988889999999999999999998 999986433211 00111100 0 00 0
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.+...+..+.+++.+||+.+|++|||+.+++..|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11123456788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=274.47 Aligned_cols=257 Identities=23% Similarity=0.272 Sum_probs=209.1
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecc--cCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKE--ASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
..+.|.+.+.||+|.|+.|+++... +|+.+++|++.. .+....+.+.+|+++.+.++||||+.+.+.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4568999999999999999999654 789999987653 2344677899999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc---CCCceeECCCCcccc
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT---HDFVPMLGDFGLARW 174 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~---~~~~i~l~dfg~~~~ 174 (315)
+|++.|+.|..-+... ..+++..+-..++||++++.|+|.+ +|+|||+||.|+++. ...-+||+|||++..
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n----~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN----GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999996655332 4578888899999999999999999 999999999999994 456799999999986
Q ss_pred cCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 175 KTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
.. .+..-....|+|.|+|||++...+++.++|||+.|+++|-++.|.+||.+..... ...+ +. ...
T Consensus 163 l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--lye~----I~-~g~------ 228 (355)
T KOG0033|consen 163 VN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYEQ----IK-AGA------ 228 (355)
T ss_pred eC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--HHHH----Hh-ccc------
Confidence 66 4444456789999999999999999999999999999999999999996532211 1111 11 100
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
-...+...+..++..++|+++||..||.+|+|+.|.|.+-|-.
T Consensus 229 yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 229 YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 1122223344566789999999999999999999999887754
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=291.10 Aligned_cols=247 Identities=22% Similarity=0.305 Sum_probs=195.3
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
+|.+.+.||+|+||.||+|.+. +++.+|+|++.... .........|..++..+ .|++++.+++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999876 57899999877532 22334456677777776 4788999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+.+... ..+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999998887443 4588999999999999999999999 9999999999999999999999999998643323
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
........|++.|+|||++.+..++.++|+|||||++|+|++|..||....... . ....... .
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--~----~~~i~~~----~------- 217 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--L----FQSIMEH----N------- 217 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--H----HHHHHhC----C-------
Confidence 333334578999999999999999999999999999999999999996543211 1 1111110 0
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHH
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSM-----GEVVRL 293 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~-----~~il~~ 293 (315)
..++...+..+.+++.+||+.+|++|++. .+++++
T Consensus 218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 11122234557889999999999999985 566544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=289.14 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=216.4
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc--cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ--GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
+.+-|.+.+.||+|.|+.|-+|++- +|..||+|++.+..-. ....+.+|++.++.++||||++++++......+|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 5678999999999999999999765 7999999998875433 345689999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE-cCCCceeECCCCcccccC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL-THDFVPMLGDFGLARWKT 176 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~-~~~~~i~l~dfg~~~~~~ 176 (315)
.|.=++|+|.+++.+... .+.+..+.+++.||+.|+.|+|+. .++||||||+||.+ .+-|-+||+|||++-.+.
T Consensus 96 LELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqL----HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQL----HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhh----hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999987655 499999999999999999999999 99999999999887 567999999999997554
Q ss_pred CCCCccccccccccccCccccccCCCc-ccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVS-IRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
. +....+.+|...|.|||.+.|..|+ ++.||||||++||.+++|++||...++.....+ +++.
T Consensus 171 P-G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImDC 234 (864)
T KOG4717|consen 171 P-GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMDC 234 (864)
T ss_pred C-cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhcc
Confidence 4 4445677999999999999998886 578999999999999999999986665432111 1222
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.-..+.+++...++||.+||..||++|.|.++|...-|-
T Consensus 235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl 273 (864)
T KOG4717|consen 235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL 273 (864)
T ss_pred --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence 234567888889999999999999999999999887654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=296.70 Aligned_cols=253 Identities=21% Similarity=0.255 Sum_probs=198.8
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++.+.||+|+||+||+|.+. +++.+|+|++.... ......+.+|+.+++.++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999876 68899999986532 233456788999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+++... ..+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL----GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999988543 4589999999999999999999999 9999999999999999999999999998643211
Q ss_pred CC--------------------------------------ccccccccccccCccccccCCCcccccchhhhHHHHHHHh
Q 046121 179 DP--------------------------------------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS 220 (315)
Q Consensus 179 ~~--------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 220 (315)
.. ......|++.|+|||++.+..++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10 0012358999999999998889999999999999999999
Q ss_pred CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHHHHh
Q 046121 221 GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS---MGEVVRLLE 295 (315)
Q Consensus 221 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps---~~~il~~L~ 295 (315)
|..||...... .... ... ..... +........+..+.+++.+|+. +|.+|++ +.+++.+-+
T Consensus 235 G~~Pf~~~~~~--~~~~----~i~---~~~~~----~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 235 GYPPFCSDNPQ--ETYR----KII---NWKET----LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred CCCCCCCCCHH--HHHH----HHH---cCCCc----cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 99999654321 1111 110 00000 0000011224457788888886 9999998 999888654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=288.36 Aligned_cols=241 Identities=23% Similarity=0.365 Sum_probs=189.8
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhh-cCCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNF-ARHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||+||+|.+. +++.||+|++.... .........|..++.. .+||||+++++++...+..++||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 58889999887532 2233445556666654 4799999999999999999999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|...+... ..+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKK----GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 9998887543 4589999999999999999999999 999999999999999999999999999864433333334
Q ss_pred cccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCH
Q 046121 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (315)
...|++.|+|||.+.+..++.++|||||||++|+|++|..||...... ... ..... ..+ ..+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~----~~i~~-------~~~----~~~~ 217 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELF----DSILN-------DRP----HFPR 217 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHH----HHHHc-------CCC----CCCC
Confidence 457899999999999888999999999999999999999999654321 111 11110 011 1222
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 046121 264 YELYLMAKTAYLCVQRNPEGRPSMG-EVVR 292 (315)
Q Consensus 264 ~~~~~l~~l~~~~l~~~p~~Rps~~-~il~ 292 (315)
..+..+.+++.+||+.||++||++. ++++
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 3344577899999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=278.66 Aligned_cols=254 Identities=26% Similarity=0.361 Sum_probs=202.2
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.++|++.++||+|++|+||+|.+.+...+++|...... .....+.+|+.+++.++||||+++++.+. ....++||+|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 36799999999999999999988776779999877532 23456889999999999999999999875 45679999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.+++|.+++.......+++..+..++.+++.++.++|+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998765556688999999999999999999999 9999999999999999999999999998644332211
Q ss_pred -cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 182 -QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 182 -~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.....++..|+|||...+..++.++|+||||+++|+|++ |..||....... .. ...... . ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~----~~~~~~------~----~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VL----DQVERG------Y----RM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HH----HHHhcC------C----CC
Confidence 112335667999999988889999999999999999999 888886443211 00 010000 0 00
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
..+...+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11223455688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=295.87 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=200.4
Q ss_pred HhcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccceeeeEEecC
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKEN 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 92 (315)
-.++|++.+.||+|+||.||+|.+. ++..|++|++.... ......+.+|+.+++.+ +|+||+++++.+....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3458999999999999999998742 24579999886542 33345678999999999 8999999999999999
Q ss_pred eeEEEEEeccCCccccccccCC----------------------------------------------------------
Q 046121 93 LNILVYEYICNKSLHWHLFDNT---------------------------------------------------------- 114 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~---------------------------------------------------------- 114 (315)
..++||||+.+++|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999988774321
Q ss_pred ----------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC--cc
Q 046121 115 ----------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP--VQ 182 (315)
Q Consensus 115 ----------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~--~~ 182 (315)
..++++..++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++........ ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK----NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 13478889999999999999999999 999999999999999999999999999864332211 11
Q ss_pred ccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 183 TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 183 ~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
....++..|+|||++.+..++.++||||||+++|+|++ |..||....... .... .... ......
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~~~-----~~~~~~---- 336 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MVKR-----GYQMSR---- 336 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HHHc-----ccCccC----
Confidence 12234567999999988889999999999999999997 999986432211 1111 0000 001111
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=283.44 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=205.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
...+|++.+.||+|++|.||+|.+. +++.+++|.+..........+.+|+.+++.++|||++++++.+......++|+|
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 3468999999999999999999865 688999998876655556778899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|.+++.. ..++..++..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 98 ~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~----gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999988843 3478899999999999999999999 99999999999999999999999999886433322
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ... . .. . ......
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~---~-~~-~-------~~~~~~ 236 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALY---L-IA-T-------NGTPEL 236 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHH---H-Hh-c-------CCCCCC
Confidence 22233467889999999988888999999999999999999999996443211 000 0 00 0 000011
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
..+......+.+++.+||..+|++|||+.+++++-
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence 11233445688999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=284.98 Aligned_cols=248 Identities=33% Similarity=0.470 Sum_probs=192.4
Q ss_pred ccceecCCCceEEEEEEeC-----CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 27 KENLLGEGGFGHVYKGELK-----DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~-----~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+.+.||.|.||.||+|.+. .+..|++|++.... ....+.+.+|++.++.++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 5678999999999999766 36788999886543 33467889999999999999999999999988889999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.......+++..++.++.|++.|+.|||+. +++|++|+++||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~----~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN----NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT----TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccc
Confidence 9999999999887667799999999999999999999999 999999999999999999999999999975522211
Q ss_pred --ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 181 --VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 181 --~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
.......+..|+|||.+.+..++.++||||||+++||+++ |..|+..... ....... .....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~-~~~~~-------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKL-KQGQR-------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHH-HTTEE--------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc-ccccc--------
Confidence 1223446678999999988889999999999999999999 6788754321 1111111 11111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
...+...+..+.+++..||..+|++|||+.++++.|
T Consensus 224 -~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112223345577899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=289.47 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=195.9
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||+||+|.+. +++.+|+|++... .......+..|..+++.+ +||||+++++++...+.+++||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 5889999988753 233445667888888877 699999999999999999999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|...+.+. ..+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHER----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 9998877543 3589999999999999999999999 999999999999999999999999999864333333333
Q ss_pred cccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCH
Q 046121 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (315)
...|++.|+|||++.+..++.++|+|||||++|+|++|..||....... . ....... . ...+.
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--~----~~~i~~~-------~----~~~~~ 217 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--L----FQSILED-------E----VRYPR 217 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--H----HHHHHcC-------C----CCCCC
Confidence 4568899999999999899999999999999999999999996443211 0 1111100 0 11122
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHHHhc
Q 046121 264 YELYLMAKTAYLCVQRNPEGRPSM-----GEVVRLLEG 296 (315)
Q Consensus 264 ~~~~~l~~l~~~~l~~~p~~Rps~-----~~il~~L~~ 296 (315)
..+..+.+++.+||..||++|||+ .+++++-+-
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~ 255 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCc
Confidence 334567899999999999999999 888876443
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=278.75 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=201.8
Q ss_pred hcCCcccceecCCCceEEEEEEeC----CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
.++|++.+.||+|+||+||+|.+. +...+++|+..... ......+.+|+..++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357999999999999999999764 24578888876543 3334567889999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
+|||+.+++|.+++..... .+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 83 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998865443 689999999999999999999999 99999999999999999999999999997553
Q ss_pred CCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 177 TDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 177 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ...... .... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~-~~~~----~ 226 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------DVIKAV-EDGY----R 226 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------HHHHHH-HcCC----C
Confidence 11111 112234568999999998889999999999999999997 99988543211 101111 1100 0
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.+ .+...+..+.+++.+||+.+|++||+++++++.|+++
T Consensus 227 ~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 LP-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 1112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=293.04 Aligned_cols=261 Identities=18% Similarity=0.199 Sum_probs=195.0
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
..+|.+++.||+|+||.||++.+. +++.||+|.... ..+.+|+.+++.++||||+++++++......++|+++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 368999999999999999999865 688999996432 3467899999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC-
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD- 179 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~- 179 (315)
+ +++|..++... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 165 ~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~----~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 Y-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred C-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 7 46777776433 4588999999999999999999999 99999999999999999999999999986322211
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCcc-----chhHHHhHHHH-----------
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEP-----QQSLRQWAEPL----------- 243 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~----------- 243 (315)
.......|++.|+|||++.+..++.++|||||||++|+|++|..|+....... ...+.......
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 12223568999999999998889999999999999999999997764321100 00111000000
Q ss_pred -------HhhhccccccCCcccCC--CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 244 -------IEKLALHELIDPRIENS--YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 244 -------~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
...........+..... .....+..+.+++.+||+.||++|||+++++++-+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 00000000000000000 00123456889999999999999999999997544
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=283.52 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=204.9
Q ss_pred hcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
..+|.+.+.||+|+||+||++.+. ++..+++|.+..........+.+|+.+++.++|||++++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 457999999999999999999642 34568888877665555667899999999999999999999999999999
Q ss_pred EEEEeccCCccccccccCC-----------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCce
Q 046121 96 LVYEYICNKSLHWHLFDNT-----------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVP 164 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i 164 (315)
+++||+.+++|.+++.... ...+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~----~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcE
Confidence 9999999999988875432 23489999999999999999999999 99999999999999999999
Q ss_pred eECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHH
Q 046121 165 MLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAE 241 (315)
Q Consensus 165 ~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 241 (315)
+|+|||++......... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||....... ...
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~~~ 233 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIE 233 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence 99999998643322111 112234678999999998889999999999999999998 889885433211 001
Q ss_pred HHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 242 PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
.. ..... .... ...+..+.+++.+||+.||.+|||+.+++..|+.+..+
T Consensus 234 ~i-~~~~~-----~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 CI-TQGRV-----LQRP----RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HH-HcCCc-----CCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11 11000 0111 12234588999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=291.12 Aligned_cols=264 Identities=20% Similarity=0.298 Sum_probs=193.8
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEec-----CeeE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE-----NLNI 95 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 95 (315)
+|++.+.||+|+||.||+|.+. +++.|++|.+... .......+.+|+.+++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6899999999999999999865 6899999987643 223345678999999999999999999987543 3479
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+||||+ +++|.+.+.+ ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELM-ESDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTA----NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecC-CCCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999998 5678777743 34589999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCC---ccccccccccccCcccccc--CCCcccccchhhhHHHHHHHhCCCccCCCCCccchh-------------HH
Q 046121 176 TTDDP---VQTKILGTLGYLAPEYAEN--GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQS-------------LR 237 (315)
Q Consensus 176 ~~~~~---~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~-------------~~ 237 (315)
..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.......... ..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 22211 1123468899999998865 568889999999999999999999996543211000 00
Q ss_pred HhHHHHHhh--hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 238 QWAEPLIEK--LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 238 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.+....... ..............+ +.....+.+++.+||+.||++|||+++++++-+
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 000000000 000000000000000 112345678999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=288.32 Aligned_cols=242 Identities=23% Similarity=0.341 Sum_probs=191.0
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhh-cCCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNF-ARHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||.||+|.+. +++.+|+|++.... .........|..++.. .+||+|+++++.+.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999876 68899999887532 2334456677777765 4899999999999999999999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|...+.. ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSK----GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 999888754 34588999999999999999999999 999999999999999999999999999863322223334
Q ss_pred cccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCH
Q 046121 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (315)
...|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ... ..... ..+.. +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~----~~~~~-------~~~~~----~~ 217 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELF----ESIRV-------DTPHY----PR 217 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHH----HHHHh-------CCCCC----CC
Confidence 457899999999999989999999999999999999999999644321 111 11000 01111 12
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCHH-HHHHH
Q 046121 264 YELYLMAKTAYLCVQRNPEGRPSMG-EVVRL 293 (315)
Q Consensus 264 ~~~~~l~~l~~~~l~~~p~~Rps~~-~il~~ 293 (315)
..+..+.+++.+||..||++||++. +++++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 2344578899999999999999985 56544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=288.01 Aligned_cols=250 Identities=23% Similarity=0.314 Sum_probs=195.4
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||+||+|.+. +++.+++|++.... ......+.+|+.++..+ +||+|+.+++++...+.+++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999865 67889999887542 23445677899988887 599999999999999999999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|...+.. ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHER----GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 999887743 34589999999999999999999999 999999999999999999999999999864333333334
Q ss_pred cccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCH
Q 046121 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (315)
...|++.|+|||++.+..++.++|+||||+++|+|++|..||...................... ....+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~p~ 224 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK----------PIRIPR 224 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC----------CCCCCC
Confidence 4678999999999999899999999999999999999999996433322222111111111110 011122
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCH------HHHHHHH
Q 046121 264 YELYLMAKTAYLCVQRNPEGRPSM------GEVVRLL 294 (315)
Q Consensus 264 ~~~~~l~~l~~~~l~~~p~~Rps~------~~il~~L 294 (315)
..+..+.+++.+||+.||++|+++ ++++++-
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 233457789999999999999984 5776553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=276.55 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=201.9
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.++|++.+.||+|++|.||+|.+.++..+++|...... ...+.+.+|+.+++.++|||++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 36799999999999999999988777778998765432 33456788999999999999999998875 45679999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC-
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP- 180 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~- 180 (315)
.+++|.+++.......++...+..++.+++.|+.+||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM----NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999998766556689999999999999999999999 999999999999999999999999999864432221
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
......++..|+|||...+..++.++|+||||+++|+|++ |..||....... ... ... . ....
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~----~~~-~-----~~~~---- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLE----QVE-R-----GYRM---- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHH-c-----CCCC----
Confidence 1122345667999999988889999999999999999999 889986433211 100 000 0 0011
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
..+...+..+.+++.+||..||++||+++++++.|+.+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11223456688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=295.64 Aligned_cols=252 Identities=21% Similarity=0.212 Sum_probs=193.8
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|+++++||+|+||+||+|.+. +++.+|+|++.... ......+.+|+.+++.++||||+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999865 68899999876532 233456788999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+.+.+. ..+++..+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~----~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 81 DYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999888543 4588999999999999999999999 9999999999999999999999999987422100
Q ss_pred C-----------------------------------------------CccccccccccccCccccccCCCcccccchhh
Q 046121 179 D-----------------------------------------------PVQTKILGTLGYLAPEYAENGIVSIRTDVYAF 211 (315)
Q Consensus 179 ~-----------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvwsl 211 (315)
. .......|++.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 00112368899999999998889999999999
Q ss_pred hHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC---HH
Q 046121 212 GIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS---MG 288 (315)
Q Consensus 212 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps---~~ 288 (315)
||++|+|++|.+||....... .... .. .... ..........+..+.+++.+|+ .+|++|++ +.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~--~~~~----i~---~~~~----~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLE--TQMK----VI---NWQT----SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHH--HHHH----HH---ccCC----CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 999999999999996543211 1000 00 0000 0000001112334556666665 59999997 88
Q ss_pred HHHHHH
Q 046121 289 EVVRLL 294 (315)
Q Consensus 289 ~il~~L 294 (315)
+++++-
T Consensus 301 ei~~hp 306 (382)
T cd05625 301 EIKAHP 306 (382)
T ss_pred HHhcCC
Confidence 887653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=282.60 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=205.7
Q ss_pred hcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
.++|.+.+.||+|++|.||+|.+. ++..+++|............+.+|+..++.++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 457899999999999999999642 35567888876655555567889999999999999999999999999999
Q ss_pred EEEEeccCCccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC
Q 046121 96 LVYEYICNKSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD 161 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~ 161 (315)
+||||+.+++|.+++.... ...+++..++.++.|++.++.+||+. +++|+||+|+||+++.+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ----HFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccC
Confidence 9999999999999886432 23488999999999999999999999 99999999999999999
Q ss_pred CceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHH
Q 046121 162 FVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQ 238 (315)
Q Consensus 162 ~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 238 (315)
+.++++|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~ 236 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIE 236 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence 9999999999864332221 1122345678999999988889999999999999999998 999986543211 000
Q ss_pred hHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 239 WAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
....... ...+...+..+.+++.+||+.+|++|||+.++++.|+.+...
T Consensus 237 ----~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 ----CITQGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ----HHhCCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 0111100 011122345688999999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=293.09 Aligned_cols=201 Identities=22% Similarity=0.297 Sum_probs=173.5
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++++.||+|+||+||++.+. +++.+|+|++.... ......+.+|+.+++.++||+|+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999765 68899999986532 233456788999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.|++|.+++.+ ...+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~----givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQL----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999998854 34689999999999999999999999 9999999999999999999999999998643211
Q ss_pred CC-----------------------------------ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCC
Q 046121 179 DP-----------------------------------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRK 223 (315)
Q Consensus 179 ~~-----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 223 (315)
.. ......|++.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 00 0113468999999999998889999999999999999999999
Q ss_pred ccCCCC
Q 046121 224 VVDMNG 229 (315)
Q Consensus 224 p~~~~~ 229 (315)
||....
T Consensus 235 Pf~~~~ 240 (363)
T cd05628 235 PFCSET 240 (363)
T ss_pred CCCCCC
Confidence 996543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=279.20 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=200.7
Q ss_pred CcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHH--HHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFA--EFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~--~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
|++++.||+|+||+||++.+. +++.+|+|++......... ...+|+.+++.++||||+++++++......+++|+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 788999999999999999876 5678999998876544333 2356999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.+++|.+++. ....++...+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~----~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK----GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT----TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccc--ccccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccc
Confidence 9999998886 445689999999999999999999999 9999999999999999999999999998743333344
Q ss_pred cccccccccccCccccc-cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 182 QTKILGTLGYLAPEYAE-NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
.....+++.|+|||++. +..++.++|+||||+++|+|++|..||........... ...............
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~------ 225 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI---IEKILKRPLPSSSQQ------ 225 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH---HHHHHHTHHHHHTTS------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh---hhhcccccccccccc------
Confidence 44567788999999998 78899999999999999999999999975411111111 111110000000000
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
.......+.+++.+||+.||++|||+++++++-
T Consensus 226 -~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~ 258 (260)
T PF00069_consen 226 -SREKSEELRDLIKKMLSKDPEQRPSAEELLKHP 258 (260)
T ss_dssp -HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred -cchhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence 000015688999999999999999999998753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=293.58 Aligned_cols=258 Identities=19% Similarity=0.191 Sum_probs=202.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++.+.||+|+||+||++.+. +++.+|+|++... .......+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3468999999999999999999876 6889999988643 22333457789999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.|++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999988743 3478889999999999999999999 99999999999999999999999999986543
Q ss_pred CCCC-ccccccccccccCccccccC----CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 177 TDDP-VQTKILGTLGYLAPEYAENG----IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 177 ~~~~-~~~~~~~~~~~~aPE~~~~~----~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
.... ......|++.|+|||.+.+. .++.++|+|||||++|+|++|..||...... .... ......
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~----~i~~~~---- 263 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYS----KIMDHK---- 263 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--HHHH----HHHcCC----
Confidence 3221 22345689999999988653 3788999999999999999999999754321 1111 111000
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHHhccc
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEG--RPSMGEVVRLLEGEN 298 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~--Rps~~~il~~L~~~~ 298 (315)
..+........+..+.+++.+||+.+|++ |+|+.+++.+-+-..
T Consensus 264 ---~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 264 ---NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred ---CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 00000011123556788999999999988 999999988765433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=293.96 Aligned_cols=254 Identities=20% Similarity=0.202 Sum_probs=195.0
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
..|++++.||+|+||+||+|.+. +++.+|+|++.... ......+.+|+.+++.++||||+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999765 68899999886532 333456789999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.|++|.+++.+. ..+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~----givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 81 DYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM----GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999888543 4588999999999999999999999 9999999999999999999999999987422100
Q ss_pred C-----------------------------------------------CccccccccccccCccccccCCCcccccchhh
Q 046121 179 D-----------------------------------------------PVQTKILGTLGYLAPEYAENGIVSIRTDVYAF 211 (315)
Q Consensus 179 ~-----------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvwsl 211 (315)
. .......|++.|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0 00012468999999999988889999999999
Q ss_pred hHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHh--hcCCCCCCCCCHHH
Q 046121 212 GIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYL--CVQRNPEGRPSMGE 289 (315)
Q Consensus 212 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--~l~~~p~~Rps~~~ 289 (315)
||++|+|++|..||......... . .... ....+.-...... +..+.+++.+ |+..+|..||++.+
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~--~----~i~~---~~~~~~~~~~~~~----s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQ--L----KVIN---WENTLHIPPQVKL----SPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHH--H----HHHc---cccccCCCCCCCC----CHHHHHHHHHHccCcccccCCCCHHH
Confidence 99999999999999654321110 0 0000 0000000001112 2335566655 45566667999999
Q ss_pred HHHHHh
Q 046121 290 VVRLLE 295 (315)
Q Consensus 290 il~~L~ 295 (315)
++.+-+
T Consensus 302 ~l~hp~ 307 (381)
T cd05626 302 IKAHPF 307 (381)
T ss_pred HhcCcc
Confidence 998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=283.13 Aligned_cols=262 Identities=26% Similarity=0.270 Sum_probs=193.3
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhc---CCCCccceeeeEEe-----cC
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFA---RHKNIVMLLGFCCK-----EN 92 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~~ 92 (315)
+|++.+.||+|++|+||+|.+. +++.+++|.+.... ........+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999876 68899999876432 12223455666666655 69999999998754 34
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
..++++|++.+ +|.+++.......+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 57999999864 787777665556689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh--hhccc
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE--KLALH 250 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 250 (315)
....... ......+++.|+|||++.+..++.++||||+||++|+|++|.+||....... .+......... ...+.
T Consensus 156 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 156 RIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred ccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHHhCCCChhhCc
Confidence 6443222 2223457889999999988889999999999999999999999986443211 11111100000 00000
Q ss_pred -------cccCCc---ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 251 -------ELIDPR---IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 251 -------~~~~~~---~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
....+. ......+..+..+.+++.+||+.||++|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 0011112345567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=296.60 Aligned_cols=253 Identities=20% Similarity=0.193 Sum_probs=196.0
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++++.||+|+||+||+|++. +++.+|+|++.... ......+.+|+.+++.++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999865 68999999876432 233456788999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+++... ..+++..+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999988543 4588899999999999999999999 9999999999999999999999999987422100
Q ss_pred C-------------------------------------------CccccccccccccCccccccCCCcccccchhhhHHH
Q 046121 179 D-------------------------------------------PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIIL 215 (315)
Q Consensus 179 ~-------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l 215 (315)
. .......|++.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 000123689999999999998899999999999999
Q ss_pred HHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC---CHHHHHH
Q 046121 216 LQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRP---SMGEVVR 292 (315)
Q Consensus 216 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp---s~~~il~ 292 (315)
|+|++|..||........ .. ... ............. .+..+.+++.+|+ .+|.+|+ |+.+++.
T Consensus 235 yell~G~~Pf~~~~~~~~--~~----~i~---~~~~~~~~~~~~~----~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAET--QL----KVI---NWETTLHIPSQAK----LSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHH--HH----HHh---ccCccccCCCCCC----CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999999975432111 00 000 0000000000111 2334556666665 4999999 8999988
Q ss_pred HHh
Q 046121 293 LLE 295 (315)
Q Consensus 293 ~L~ 295 (315)
+-+
T Consensus 301 h~~ 303 (376)
T cd05598 301 HPF 303 (376)
T ss_pred CCC
Confidence 754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=279.90 Aligned_cols=245 Identities=25% Similarity=0.291 Sum_probs=192.2
Q ss_pred ecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCcc
Q 046121 31 LGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSL 106 (315)
Q Consensus 31 lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (315)
||+|+||+||++... +++.+++|.+.... .........|+++++.++||||+++.+.+..+...++||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 68999999876422 12233456799999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcccccc
Q 046121 107 HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186 (315)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~ 186 (315)
.+.+.......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM----DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC----CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccC
Confidence 8888766666789999999999999999999999 9999999999999999999999999998644322 2222346
Q ss_pred ccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHH
Q 046121 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYEL 266 (315)
Q Consensus 187 ~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (315)
+++.|+|||++.+..++.++|+||+||++|+|++|..||........ ......... ..... ......+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~---------~~~~~-~~~~~~~ 223 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTL---------EDEVK-FEHQNFT 223 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhh---------ccccc-cccccCC
Confidence 78899999999888899999999999999999999999964332111 011101000 00000 0111234
Q ss_pred HHHHHHHHhhcCCCCCCCCCHHHHHH
Q 046121 267 YLMAKTAYLCVQRNPEGRPSMGEVVR 292 (315)
Q Consensus 267 ~~l~~l~~~~l~~~p~~Rps~~~il~ 292 (315)
..+.+++.+||+.||++||+++++++
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchh
Confidence 45789999999999999999976553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=280.72 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=201.8
Q ss_pred hcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
..+|.+.++||+|+||.||++... ++..+++|............+.+|+++++.++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 468899999999999999999632 35678888877666666677899999999999999999999999999999
Q ss_pred EEEEeccCCccccccccCCC-------------CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC
Q 046121 96 LVYEYICNKSLHWHLFDNTE-------------SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF 162 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~ 162 (315)
+++||+.+++|.+++..... ..+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL----HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC----CeecccccHhhEEEcCCC
Confidence 99999999999988864331 3588999999999999999999999 999999999999999999
Q ss_pred ceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHh
Q 046121 163 VPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQW 239 (315)
Q Consensus 163 ~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 239 (315)
.++|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||........
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------ 233 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------ 233 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------
Confidence 999999999864332211 1112234678999999998889999999999999999998 8898854322110
Q ss_pred HHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 240 AEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
... ..... .. ..+...+..+.+++.+||+.||++||++.++++.|++
T Consensus 234 ~~~-~~~~~-----~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 IEC-ITQGR-----EL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHH-HHcCc-----cC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 000 00000 00 1111233457899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=284.56 Aligned_cols=267 Identities=24% Similarity=0.284 Sum_probs=197.9
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
++|++.+.||+|+||+||+|.+. +++.+++|.+..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67999999999999999999876 688899998764432 2234567899999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+ +|.+.+... ...++...+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 86 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 865 676666433 34578899999999999999999999 999999999999999999999999999864433332
Q ss_pred ccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHH-HhHH-------HHH-hhhccc
Q 046121 181 VQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLR-QWAE-------PLI-EKLALH 250 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~-------~~~-~~~~~~ 250 (315)
......+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||...+........ .... +.. ......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2333467889999998765 45788999999999999999999999754432111100 0000 000 000000
Q ss_pred cccCCcc----cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 251 ELIDPRI----ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 251 ~~~~~~~----~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
..-.+.. .....+..+..+.+++.+||+.||++|||+.+++++-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 0000000 00011123455789999999999999999999998443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=280.71 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=195.7
Q ss_pred ecCCCceEEEEEEeC-CCcEEEEEEecccCc---ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCcc
Q 046121 31 LGEGGFGHVYKGELK-DGQMIAAKVRKEAST---QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSL 106 (315)
Q Consensus 31 lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (315)
||+|+||+||++.+. +++.+++|.+..... .....+..|+.+++.++|++|+++.+++..+...++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999765 688999998764322 2234567899999999999999999999999999999999999999
Q ss_pred cccccc--CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcccc
Q 046121 107 HWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK 184 (315)
Q Consensus 107 ~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~ 184 (315)
...+.. .....+++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||.+............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR----RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence 877643 2345689999999999999999999999 9999999999999999999999999998654433333334
Q ss_pred ccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHH
Q 046121 185 ILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTY 264 (315)
Q Consensus 185 ~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (315)
..|++.|+|||.+.+..++.++|+||||+++|+|++|..||......... ...... .... ....+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~---------~~~~--~~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQR---------ILND--SVTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHh---------hccc--CCCCccc
Confidence 56889999999999989999999999999999999999999754332110 000000 0000 0112223
Q ss_pred HHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHh
Q 046121 265 ELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLE 295 (315)
Q Consensus 265 ~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~ 295 (315)
.+..+.+++.+||+.||++|| ++++++++-+
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~ 259 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL 259 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence 445678899999999999999 7788887644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=280.54 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=201.6
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.|++.+.||+|+||+||++.+. +++.+++|.+.... ......+.+|+.+++.++|++++.+.+.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4788899999999999999766 68899999876432 1223456789999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|.+.+.......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~- 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG- 155 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-
Confidence 99999999888665556799999999999999999999999 9999999999999999999999999998643222
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccc-hhHHHhHHHHHhhhccccccCCccc
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ-QSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
.......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||........ ..... .... ..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~----~~~~----------~~ 221 (285)
T cd05630 156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----LVKE----------VQ 221 (285)
T ss_pred ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh----hhhh----------hh
Confidence 222234688999999999988899999999999999999999999975432111 01111 0000 00
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHh
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPS-----MGEVVRLLE 295 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps-----~~~il~~L~ 295 (315)
...+......+.+++.+||+.||++||| +++++++-+
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 1112223445789999999999999999 889988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=276.92 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=199.5
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
.+|++.+.||+|++|.||++.+.++..+++|++... ......+.+|+.+++.++|||++++++++...+..++|+||+.
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 468999999999999999998887778999987643 2234567889999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcc
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~ 182 (315)
+++|.+++..... .+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+..........
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN----GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999998865443 589999999999999999999999 99999999999999999999999999886433221111
Q ss_pred -ccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 183 -TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 183 -~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... .. .... ..... .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~----~~~~------~~~~~----~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VV----ESVS------AGYRL----Y 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HH----HHHH------cCCcC----C
Confidence 11123457999999988889999999999999999998 789886433211 00 0000 00111 1
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.+...+..+.+++.+||..+|++|||+.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 11223456889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=275.70 Aligned_cols=251 Identities=27% Similarity=0.382 Sum_probs=204.2
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.++|++.+.||.|++|.||+|... ++.+++|.+..... ..+.+.+|+.+++.++|+|++++++++......++|+||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 468999999999999999999875 77889998876543 4567889999999999999999999999899999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.+++|.+++.......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK----NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 999999998766656799999999999999999999999 99999999999999999999999999987442211
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... .... ..... ... .
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---~~~~~------~~~----~ 219 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP---HVEKG------YRM----E 219 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH---HHhcC------CCC----C
Confidence 12234567999999988888999999999999999997 99998643211 1111 11100 011 1
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.+...+..+.+++.+||..+|++|||+.+++..|+.+
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1122345678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=280.39 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=199.1
Q ss_pred cCCcccceecCCCceEEEEEEeC-----CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-----DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
++|++.+.||+|+||+||+|.+. .+..+++|...... ......+.+|+.+++.++|||++++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 57899999999999999999742 46788888876432 3334568899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCC---------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC
Q 046121 97 VYEYICNKSLHWHLFDNT---------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD 161 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~ 161 (315)
+|||+.+++|.+++.... ...+++..+..++.+++.++.|||+. +++|+||+|+||+++.+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~nili~~~ 160 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH----FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc----CeehhccccceEEEcCC
Confidence 999999999988874321 23578889999999999999999999 99999999999999999
Q ss_pred CceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHH
Q 046121 162 FVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQ 238 (315)
Q Consensus 162 ~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 238 (315)
+.++++|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~- 236 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVI- 236 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH-
Confidence 9999999999864432221 1222345667999999988889999999999999999998 88888543211 101
Q ss_pred hHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 239 WAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
. ....... . ..+...+..+.+++.+||+.||++||++.++++.|..
T Consensus 237 --~-~~~~~~~-----~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 --E-MVRKRQL-----L----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --H-HHHcCCc-----C----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 1111000 0 1111233457889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=302.93 Aligned_cols=257 Identities=23% Similarity=0.311 Sum_probs=202.9
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecC-
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN- 92 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 92 (315)
......++|++.+.||+|+||+||+|.+. +++.||+|++... .......+.+|+..+..++|+|++++++.+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 33445679999999999999999999765 6899999987654 2334556788999999999999999988764332
Q ss_pred -------eeEEEEEeccCCccccccccC--CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc
Q 046121 93 -------LNILVYEYICNKSLHWHLFDN--TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV 163 (315)
Q Consensus 93 -------~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~ 163 (315)
.+++||||+.+++|.+.+... ....+++..+..++.|++.++.|||+. +++|+||||+||+++.++.
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~----~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK----HMIHRDIKSANILLCSNGL 181 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEeCCCC
Confidence 368999999999999888543 245689999999999999999999999 9999999999999999999
Q ss_pred eeECCCCcccccCCC--CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH
Q 046121 164 PMLGDFGLARWKTTD--DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE 241 (315)
Q Consensus 164 i~l~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 241 (315)
++|+|||++...... ........|++.|+|||++.+..++.++||||||+++|+|++|..||...... ....
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~ 255 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMH 255 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHH
Confidence 999999998644322 11223457899999999999988999999999999999999999999643211 1111
Q ss_pred HHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 242 PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.... .... ..+...+..+.+++.+||+.||++||++.+++.+
T Consensus 256 ~~~~-----~~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KTLA-----GRYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHhc-----CCCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1110 0011 1222344568899999999999999999999865
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=294.27 Aligned_cols=254 Identities=21% Similarity=0.230 Sum_probs=197.2
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++++.||+|+||+||++.+. +++.+|+|++... .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999765 6889999987643 2233456788999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.|++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~----givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKL----GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999988854 34588999999999999999999999 9999999999999999999999999998522110
Q ss_pred CC------------c-----------------------------------cccccccccccCccccccCCCcccccchhh
Q 046121 179 DP------------V-----------------------------------QTKILGTLGYLAPEYAENGIVSIRTDVYAF 211 (315)
Q Consensus 179 ~~------------~-----------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Dvwsl 211 (315)
.. . .....|++.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 001358899999999998889999999999
Q ss_pred hHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCC---CCHH
Q 046121 212 GIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGR---PSMG 288 (315)
Q Consensus 212 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~R---ps~~ 288 (315)
||++|+|++|.+||....... .... ... ....+ .+.. ....+..+.+++.+||. +|.+| +|+.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~--~~~~----i~~---~~~~~--~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE--TYRK----IIN---WRETL--YFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH--HHHH----HHc---cCCcc--CCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999996443211 1111 100 00000 0000 11233457788888997 67765 5999
Q ss_pred HHHHHHhc
Q 046121 289 EVVRLLEG 296 (315)
Q Consensus 289 ~il~~L~~ 296 (315)
+++.+-+-
T Consensus 301 ~~l~hp~~ 308 (377)
T cd05629 301 EIKSHPFF 308 (377)
T ss_pred HHhcCCCc
Confidence 99887654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=290.70 Aligned_cols=239 Identities=24% Similarity=0.315 Sum_probs=190.7
Q ss_pred cceecCCCceEEEEEEe----CCCcEEEEEEecccCc--ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 28 ENLLGEGGFGHVYKGEL----KDGQMIAAKVRKEAST--QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~----~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
++.||+|+||.||++.. .+++.+++|++..... .......+|+.+++.++||||+++++++...+..|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999965 2588999998875432 22345678999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.+++|.+.+.+ ...+++..+..++.|++.++.|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 81 RGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 99999888844 34589999999999999999999999 9999999999999999999999999998644333233
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ... ...... ....
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~----~~i~~~-----------~~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETM----TMILKA-----------KLGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHH----HHHHcC-----------CCCC
Confidence 33456889999999999888899999999999999999999999643211 111 111000 0011
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPSMGE 289 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps~~~ 289 (315)
+...+..+.+++.+||+.||++|||+.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2223455788999999999999999443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=287.68 Aligned_cols=242 Identities=24% Similarity=0.301 Sum_probs=189.7
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHH-HHhhcCCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVY-VLNFARHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||+||+|.+. +++.+++|++.... ......+..|.. +++.++||||+++++.+...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999876 68999999886532 222334445544 56788999999999999999999999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|...+.+ ...+++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++...........
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 999888754 34688999999999999999999999 999999999999999999999999999864333333333
Q ss_pred cccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCH
Q 046121 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (315)
...|++.|+|||++.+..++.++||||||+++|+|++|..||...... ......... ... .++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~-------~~~----~~~ 217 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILNK-------PLR----LKP 217 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHcC-------CCC----CCC
Confidence 456899999999999988999999999999999999999999643211 111111110 001 112
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCHH----HHHHH
Q 046121 264 YELYLMAKTAYLCVQRNPEGRPSMG----EVVRL 293 (315)
Q Consensus 264 ~~~~~l~~l~~~~l~~~p~~Rps~~----~il~~ 293 (315)
..+..+.+++.+||+.||++||++. +++++
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 2345578899999999999999884 66554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=282.27 Aligned_cols=260 Identities=25% Similarity=0.333 Sum_probs=202.1
Q ss_pred cCCcccceecCCCceEEEEEEeCC-C--cEEEEEEeccc-CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKD-G--QMIAAKVRKEA-STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~-~--~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 97 (315)
++|++.+.||+|+||.||+|..+. + ..+++|.+... .....+.+.+|+.+++++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 689999999999999999997653 3 34677776642 233445688899999989 699999999999999999999
Q ss_pred EEeccCCccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc
Q 046121 98 YEYICNKSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV 163 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~ 163 (315)
+||+.+++|.+++.... ...++...+..++.|++.|+.+||+. +++|+||||+||+++.++.
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK----QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCcCCcceEEECCCCe
Confidence 99999999998885432 13588899999999999999999999 9999999999999999999
Q ss_pred eeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHH
Q 046121 164 PMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEP 242 (315)
Q Consensus 164 i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 242 (315)
++|+|||++...... ........+..|+|||...+..++.++||||||+++|+|++ |..||...... .....
T Consensus 158 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~~~~~ 230 (297)
T cd05089 158 SKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------ELYEK 230 (297)
T ss_pred EEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH
Confidence 999999998522211 11111223457999999988889999999999999999997 99998543221 11111
Q ss_pred HHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccccc
Q 046121 243 LIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~ 303 (315)
... ......+...+..+.+++.+||+.+|.+|||+.++++.|+.+..++..
T Consensus 231 ~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 231 LPQ----------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred Hhc----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 110 011111222345678999999999999999999999999988876654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=292.04 Aligned_cols=259 Identities=19% Similarity=0.200 Sum_probs=200.6
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++.+.||+|+||.||++.+. +++.+|+|++... .......+.+|+.+++.++||||+++++.+..+...++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4578999999999999999999876 6889999987642 22234457789999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.+++|.+++.. ..+++..+..++.|++.|+.+||+. +++||||||+||+++.++.++|+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~----~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM----GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999998843 3478899999999999999999999 99999999999999999999999999987543
Q ss_pred CCCC-ccccccccccccCccccccCC----CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 177 TDDP-VQTKILGTLGYLAPEYAENGI----VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 177 ~~~~-~~~~~~~~~~~~aPE~~~~~~----~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
.... ......|++.|+|||++.+.. ++.++|+||+||++|+|++|..||...... ... .........
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--~~~----~~i~~~~~~-- 265 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--GTY----SKIMDHKNS-- 265 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--HHH----HHHHhCCcc--
Confidence 3222 123456899999999887543 678999999999999999999999644321 111 111110000
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHHhcccc
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEG--RPSMGEVVRLLEGEND 299 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~--Rps~~~il~~L~~~~~ 299 (315)
...+ .....+..+.+++..||..++++ |+|+.+++++-+-...
T Consensus 266 ---~~~p--~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 266 ---LNFP--EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred ---cCCC--CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 0011 11123455778888899755544 8999999998664433
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=281.63 Aligned_cols=270 Identities=23% Similarity=0.310 Sum_probs=199.4
Q ss_pred cCCcccceecCCCceEEEEEEe-----CCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEe--cCeeE
Q 046121 23 GDFSKENLLGEGGFGHVYKGEL-----KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK--ENLNI 95 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 95 (315)
.+|++.+.||+|+||+||.+.. .++..+++|.+..........+.+|+.+++.++|||++++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5899999999999999999963 2578899999876666666778999999999999999999997643 34679
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+|+||+.+++|.+++.+.. ..+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK----RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999885443 3588999999999999999999999 9999999999999999999999999998744
Q ss_pred CCCCCc---cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 176 TTDDPV---QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 176 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..++.......................+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 322211 11122344599999998888999999999999999999987665322111000000000000000000000
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.........+...+..+.+++.+||..+|++|||+.+++..|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000001111222345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=287.17 Aligned_cols=241 Identities=24% Similarity=0.323 Sum_probs=191.8
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcC-CCCccceeeeEEecCeeEEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 98 (315)
+|++.+.||+|+||+||+|.+. +++.||+|++... ..........|..+++.+. |++++++.+++...+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999865 6889999987753 2333455677888888886 567888999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.|++|.+++... ..+++..+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~----~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRR----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999998887433 4589999999999999999999999 9999999999999999999999999998643333
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
........|++.|+|||++.+..++.++|+||+|+++|+|++|..||...... .. ....... .
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~----~~~i~~~----~------- 217 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--EL----FQSIMEH----N------- 217 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HH----HHHHHhC----C-------
Confidence 33333456899999999999888999999999999999999999999654321 11 1111110 0
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSM 287 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~ 287 (315)
...+...+..+.+++.+||+.+|.+|++.
T Consensus 218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01122234457889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=281.00 Aligned_cols=268 Identities=24% Similarity=0.327 Sum_probs=199.8
Q ss_pred cCC-cccceecCCCceEEEEEEe-----CCCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEec--Ce
Q 046121 23 GDF-SKENLLGEGGFGHVYKGEL-----KDGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE--NL 93 (315)
Q Consensus 23 ~~y-~~~~~lg~g~~~~v~~~~~-----~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 93 (315)
++| ++.+.||+|+||+||++.. .++..+++|+..... ......+.+|+.+++.++|||++++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 355 9999999999999988642 257789999876543 23345678899999999999999999987653 45
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.+++|||+.+++|.+++.. ..+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccChheEEEcCCCcEEEeeccccc
Confidence 7899999999999988853 3489999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCCCc---cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccc
Q 046121 174 WKTTDDPV---QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250 (315)
Q Consensus 174 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (315)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..|+............. ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP-KQGQMTVVRLI 234 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcc-cccccchhhhh
Confidence 44322211 112234567999999988888999999999999999999999985433211100000 00000000000
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
...........+...+..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 011111111122334556889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=277.85 Aligned_cols=254 Identities=26% Similarity=0.323 Sum_probs=205.6
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
++|++.+.||.|++|.||+|.+. +++.+++|...... ......+.+|+.+++.++|||++++.+.+..+..+++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47999999999999999999866 68899999876543 34456678999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++... .+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE----GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999888543 689999999999999999999999 999999999999999999999999999875544433
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... .... .... ...+.+...
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~~~-----~~~~-----~~~~~~~~~ 221 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RVLF-----LIPK-----NNPPSLEGN 221 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HHHH-----Hhhh-----cCCCCCccc
Confidence 334456788899999999888999999999999999999999999643311 0000 0000 011111111
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
..+..+.+++.+||..+|++|||+++++++-+-..
T Consensus 222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred ---ccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 13445788999999999999999999988655443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=290.53 Aligned_cols=254 Identities=21% Similarity=0.242 Sum_probs=200.4
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++.+.||+|+||+||++.+. +++.+|+|++.... ......+.+|+.+++.++||+|+++++.+.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999866 68899999887542 234456788999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+++.+.. ..+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~----~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM----GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC----CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999886542 4589999999999999999999999 9999999999999999999999999999754433
Q ss_pred CCc-cccccccccccCccccc------cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 179 DPV-QTKILGTLGYLAPEYAE------NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 179 ~~~-~~~~~~~~~~~aPE~~~------~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
... .....|++.|+|||++. +..++.++||||||+++|+|++|..||....... .. ...... ..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~----~~i~~~---~~ 226 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--TY----NNIMNF---QR 226 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--HH----HHHHcC---CC
Confidence 222 22346889999999886 4557789999999999999999999996443211 11 111110 00
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
... .. .....+..+.+++..||+ +|++|||+++++.+-+
T Consensus 227 ~~~--~~--~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 227 FLK--FP--EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred ccC--CC--CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 000 00 011234457788888998 9999999999987644
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=275.05 Aligned_cols=250 Identities=21% Similarity=0.314 Sum_probs=201.6
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEe-cCeeEEEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCK-ENLNILVYE 99 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~~ 99 (315)
+|++.+.||.|++|.||++.+. +++.+++|.+.... ....+.+.+|+.+++.++|+|++++.+.+.. +..+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999865 57889999876432 2344567889999999999999999988764 446799999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|.+++.......+++.++..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~----~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK----HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999988766666789999999999999999999999 99999999999999999999999999987554333
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.......+++.|+|||.+.+..++.++|+||||+++++|++|..||...... ....... ... . .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~-~~~----~-----~ 220 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRII-EGK----L-----P 220 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHH-hcC----C-----C
Confidence 3333456788999999999888999999999999999999999998643211 1111111 100 0 1
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
..+...+..+.+++.+||+.+|++|||+.+++.+
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1223345568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=287.67 Aligned_cols=238 Identities=23% Similarity=0.280 Sum_probs=186.7
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHH-HHHhhcCCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEV-YVLNFARHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||+||+|.+. +++.+++|++.... ......+..|. .+++.++||||+++++.+...+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57889999876532 12223334443 456788999999999999999999999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|.+.+.. ...+++..+..++.|++.+|.+||+. |++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~----giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 999888854 34578889999999999999999999 999999999999999999999999999864333333334
Q ss_pred cccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCH
Q 046121 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (315)
...|++.|+|||++.+..++.++|||||||++|+|++|.+||....... ... ..... .....+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~----~i~~~-----------~~~~~~ 217 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYD----NILNK-----------PLQLKP 217 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--HHH----HHHhC-----------CcCCCC
Confidence 4578999999999999889999999999999999999999996433211 111 11100 001112
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCHHH
Q 046121 264 YELYLMAKTAYLCVQRNPEGRPSMGE 289 (315)
Q Consensus 264 ~~~~~l~~l~~~~l~~~p~~Rps~~~ 289 (315)
..+..+.+++.+||+.||.+||++.+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 23445788999999999999998874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=287.15 Aligned_cols=264 Identities=23% Similarity=0.251 Sum_probs=197.0
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecC----
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN---- 92 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 92 (315)
...++|++.+.||+|+||.||++.+. ++..+|+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 35689999999999999999999875 6889999987643 2334556789999999999999999999986443
Q ss_pred --eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCC
Q 046121 93 --LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 93 --~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
..|+||||+.+ ++...+. ..++...+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46999999865 4544442 2478889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH----------
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA---------- 240 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------- 240 (315)
++..... ........+++.|+|||++.+..++.++||||||+++|+|++|..||....... ......
T Consensus 169 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACT-NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID--QWNKVIEQLGTPSAEF 245 (359)
T ss_pred Ccccccc-CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCcHHH
Confidence 9864322 222233567889999999999899999999999999999999999997443210 000000
Q ss_pred ----HHHHhhhc-----cc-----cccCCc---ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 241 ----EPLIEKLA-----LH-----ELIDPR---IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 241 ----~~~~~~~~-----~~-----~~~~~~---~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
........ .. +..... ............+.+++.+||..||++|||+.+++.+-+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00000000 00 000000 000111123456789999999999999999999998765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=276.75 Aligned_cols=254 Identities=23% Similarity=0.278 Sum_probs=198.4
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
++|++++.||+|++|.||+|.+. +++.+++|+.... .......+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 37899999999999999999764 6888999987654 233345688999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|... ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSL----KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 999988543 2478888999999999999999999 9999999999999999999999999998643322
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccch-hHHHhHHHHHhhhccccccCCcccC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ-SLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... .......... . ...+..
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~-- 220 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-D-----EDPPVL-- 220 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-c-----cCCCCC--
Confidence 223356788999999999888999999999999999999999999643221111 0001000000 0 000111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.....+..+.+++.+||+.+|++||++++++++.+-.
T Consensus 221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~ 257 (279)
T cd06619 221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV 257 (279)
T ss_pred -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence 1111234578899999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=280.16 Aligned_cols=256 Identities=25% Similarity=0.386 Sum_probs=198.6
Q ss_pred HhcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (315)
..++|++.+.||+|++|.||.|.+. ++..+++|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999998653 25678998875432 2234457889999999999999999999999999
Q ss_pred eEEEEEeccCCccccccccCC--------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCcee
Q 046121 94 NILVYEYICNKSLHWHLFDNT--------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM 165 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~ 165 (315)
.++||||+.+++|.+++.+.. ...++...+..++.|++.++.+||+. +++|+||||+||+++.++.++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCcchheEEEcCCCCEE
Confidence 999999999999998875422 12457788899999999999999999 999999999999999999999
Q ss_pred ECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHH
Q 046121 166 LGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEP 242 (315)
Q Consensus 166 l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 242 (315)
++|||++......... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...... ....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~----- 232 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLR----- 232 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH-----
Confidence 9999998643222111 112244678999999988889999999999999999998 67888543221 1110
Q ss_pred HHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 243 LIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
........ ..+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 233 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 01111110 1112234468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=279.19 Aligned_cols=255 Identities=24% Similarity=0.314 Sum_probs=202.3
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
.+.|+++++||.|++|.||+|.+. +++.+++|+...........+.+|+.+++.++|||++++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367999999999999999999876 5889999998776666677788999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|...+.+. ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 91 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 91 CPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSM----KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcC----CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999997766433 34589999999999999999999999 999999999999999999999999998864333222
Q ss_pred ccccccccccccCccccc-----cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 181 VQTKILGTLGYLAPEYAE-----NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
......+++.|+|||.+. ...++.++|+||||+++|+|++|.+||...... ..... .. . ...+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~----~~-~-----~~~~ 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLK----IA-K-----SEPP 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHH----Hh-c-----CCCc
Confidence 223445778999999874 344677899999999999999999998643311 11110 00 0 0001
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
....+...+..+.+++.+||+.+|++||++++++++-.
T Consensus 234 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 234 --TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred --cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 01112233445788999999999999999999987543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=281.47 Aligned_cols=255 Identities=21% Similarity=0.268 Sum_probs=206.5
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
....+|++++.||+|++|.||++.+. +++.+++|.+........+.+.+|+.+++.++|+|++++++.+......++|+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 35589999999999999999999864 78999999887655555567889999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+++.+ ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+......
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~----~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999988743 3578889999999999999999999 9999999999999999999999999998644333
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
........+++.|+|||.+.+..++.++|+||||+++|+|++|..||.......... ... ......
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------------~~~--~~~~~~ 234 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------------LIA--TNGTPE 234 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------------eec--cCCCCC
Confidence 322334467889999999988889999999999999999999999996433211000 000 000001
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
...+...+..+.+++.+||..+|++||++++++++-+
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF 271 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 1122334556788999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=279.03 Aligned_cols=263 Identities=24% Similarity=0.251 Sum_probs=196.5
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+|++.+.||+|++|.||+|.+. ++..+++|.+.... ......+.+|+.+++.++|||++++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5889999999999999999875 68899999876432 22345678899999999999999999999999999999999
Q ss_pred ccCCccccccccCC-CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 101 ICNKSLHWHLFDNT-ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 101 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
+. ++|.+++.... ...+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR----RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 86 57777665433 35689999999999999999999999 99999999999999999999999999986443332
Q ss_pred CccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH----------h-hh
Q 046121 180 PVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI----------E-KL 247 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------~-~~ 247 (315)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||....... .......... . ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhH
Confidence 222334567889999987654 46889999999999999999999996443211 0000000000 0 00
Q ss_pred ccccccC---CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 248 ALHELID---PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 248 ~~~~~~~---~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
....... ...........+..+.+++.+||..||++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000 000000111134457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=273.89 Aligned_cols=247 Identities=26% Similarity=0.360 Sum_probs=193.7
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCcc
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSL 106 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (315)
+.||+|+||.||+|.+. +++.+++|...... .+....+.+|+++++.++||||+++++++......++|+||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999875 68889999765432 33456688999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcc--cc
Q 046121 107 HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ--TK 184 (315)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~--~~ 184 (315)
.+++... ...+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.......... ..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESK----HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9888543 23588999999999999999999999 99999999999999999999999999986432211111 11
Q ss_pred ccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCH
Q 046121 185 ILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263 (315)
Q Consensus 185 ~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (315)
...+..|+|||.+.+..++.++|+||||+++|+|++ |..||....... .. ..... . .....+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~----~~~~~-----~----~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TR----EAIEQ-----G----VRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HH----HHHHc-----C----CCCCCcc
Confidence 122456999999988889999999999999999997 888885432211 00 00110 0 0111122
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 264 YELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 264 ~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
..+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 334568889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=272.89 Aligned_cols=254 Identities=28% Similarity=0.331 Sum_probs=204.8
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
++|++.+.||.|++|.||+|.+. +++.+++|++..........+.+|+.+++.++|||++++++.+.....++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 58999999999999999999875 57889999988766666778999999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.+++|.+++... ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+.........
T Consensus 83 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 83 GGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET----GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred CCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC----CceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 999998887543 24588999999999999999999999 9999999999999999999999999998754433323
Q ss_pred cccccccccccCccccccC---CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 182 QTKILGTLGYLAPEYAENG---IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~---~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|.+||....... .... ..... ...+.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~-----~~~~~---~~~~~-- 225 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFL-----ISKSN---FPPPK-- 225 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HHhcc---CCCcc--
Confidence 3344677889999998776 78889999999999999999999986433111 0000 00000 00011
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.......+..+.+++.+||..+|.+|||+.+++.+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11223345668899999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=274.27 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=199.3
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeE-EecCeeEEEEEec
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFC-CKENLNILVYEYI 101 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~~~~ 101 (315)
.+|++.+.||+|++|.||++... +..+++|..... ...+.+.+|+.+++.++|++++++++++ ...+..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 58999999999999999999765 667888887643 3356788999999999999999999975 4556789999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.+++|.+++.......+++..++.++.+++.++.+||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999998766666689999999999999999999999 99999999999999999999999999986332221
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... ....... .. .....
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~-~~---------~~~~~ 219 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRV-EK---------GYKMD 219 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-hc---------CCCCC
Confidence 22234567999999988889999999999999999997 8998853321 1111111 10 00111
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1223345678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=290.54 Aligned_cols=260 Identities=24% Similarity=0.321 Sum_probs=202.4
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhcC-CCCccceeeeEEec
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKE 91 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 91 (315)
...++|++++.||+|+||+||+|.+. .+..||+|++.... ....+.+.+|+.+++.+. ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 34678999999999999999999753 23468999886543 233456889999999996 99999999999999
Q ss_pred CeeEEEEEeccCCccccccccCC---------------------------------------------------------
Q 046121 92 NLNILVYEYICNKSLHWHLFDNT--------------------------------------------------------- 114 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~--------------------------------------------------------- 114 (315)
...++||||+.+++|.+++..+.
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999988775421
Q ss_pred -------------------------------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEE
Q 046121 115 -------------------------------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNIL 157 (315)
Q Consensus 115 -------------------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil 157 (315)
...+++..+..++.|++.++.|||+. +++|+||||+||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dikp~Nil 269 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK----NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHhEE
Confidence 12477888899999999999999999 9999999999999
Q ss_pred EcCCCceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccch
Q 046121 158 LTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQ 234 (315)
Q Consensus 158 ~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~ 234 (315)
++.++.++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-- 347 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-- 347 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--
Confidence 99999999999999864432221 1122345678999999988889999999999999999997 888886432111
Q ss_pred hHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 235 SLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
... ...... .. ...+...+..+.+++.+||+.+|++|||+.++.+.|+...
T Consensus 348 ~~~----~~~~~~-----~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 TFY----NKIKSG-----YR----MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHH----HHHhcC-----CC----CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 000 001100 00 1112234456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=283.64 Aligned_cols=266 Identities=25% Similarity=0.279 Sum_probs=200.1
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.++|++.+.||.|++|.||+|.+. +++.+++|.+.... ......+.+|+.+++.++||||+++++++......++|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 468999999999999999999875 68889999876443 2233457789999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+. ++|...+... ...+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 85 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 986 5777776543 33588999999999999999999999 99999999999999999999999999986443333
Q ss_pred CccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh---hhccccc---
Q 046121 180 PVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE---KLALHEL--- 252 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--- 252 (315)
.......+++.|+|||.+.+. .++.++||||||+++|+|++|.+||........ ... ...... ...+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ--LHF-IFRILGTPTEETWPGILSN 235 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHcCCCChhhchhhhcc
Confidence 223334568899999987653 478899999999999999999999965432111 000 000000 0000000
Q ss_pred ------cCCccc----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 253 ------IDPRIE----NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 253 ------~~~~~~----~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
-.+... .......+..+.+++.+||+.||.+|||+.+++++-+-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f 289 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 000000 01112234567899999999999999999999986554
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=273.70 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=203.1
Q ss_pred HhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
..++|++.+.||+|+||.||++.+.++..+++|..... ......+.+|+.+++.++|+|++++++.+.. ...++++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 35789999999999999999998877788999977643 3345678889999999999999999999887 778999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.......++...+..++.+++.++.+||+. +++|+||+|+||+++.++.++++|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999998766666788899999999999999999999 999999999999999999999999998864432211
Q ss_pred -ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 181 -VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 181 -~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
......++..|+|||.+.++.++.++|+||||+++|++++ |..||....... ... . .... ..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~---~-~~~~---------~~ 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIR---A-LERG---------YR 221 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHH---H-HhCC---------CC
Confidence 1112234567999999988888999999999999999998 899986432211 111 0 0000 00
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.......+..+.+++.+||..+|++||++.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112234558889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=273.68 Aligned_cols=247 Identities=33% Similarity=0.481 Sum_probs=199.8
Q ss_pred ceecCCCceEEEEEEeCC----CcEEEEEEecccCccc-HHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELKD----GQMIAAKVRKEASTQG-FAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~----~~~~~~k~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||.||+|.+.. +..+++|++....... ...+.+|+..++.++|+|++++++++......++++||+.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999997653 7889999887654433 67788999999999999999999999999999999999999
Q ss_pred CccccccccCC-------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 104 KSLHWHLFDNT-------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 104 ~~L~~~l~~~~-------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
++|.+++.... ...+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC----CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999986542 36699999999999999999999999 99999999999999999999999999997544
Q ss_pred CCC--CccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 177 TDD--PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 177 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
... .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...... ........
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~-------- 222 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------EVLEYLRK-------- 222 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHc--------
Confidence 332 11223456788999999988889999999999999999998 68998654211 11111110
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
......+...+..+.+++.+||+.+|++|||+.+++++|+
T Consensus 223 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 --GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0011122233556889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=274.84 Aligned_cols=251 Identities=20% Similarity=0.263 Sum_probs=199.6
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc-----ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-----QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
+.|++.+.||+|++|.||.+.+. +++.+++|.+..... .....+.+|+.+++.++||||+++++++.....+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999765 688999998764321 123467889999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
++||+.+++|.+.+... ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999998888543 4588899999999999999999999 99999999999999999999999999986433
Q ss_pred CCCCcc---ccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 177 TDDPVQ---TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 177 ~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
...... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~----~~--------- 220 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--AAIFK----IA--------- 220 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--HHHHH----Hh---------
Confidence 221111 2245678899999999888999999999999999999999998532211 00000 00
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
........+......+.+++.+||..+|++|||+.+++.+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 221 TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 00011122233445578899999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=272.60 Aligned_cols=251 Identities=20% Similarity=0.338 Sum_probs=204.1
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+|++.+.||.|++|.||.+... ++..+++|.+... .......+.+|+.+++.++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5899999999999999999765 5888899976643 344456788999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+.+.+.....+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA----GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999998766556789999999999999999999999 999999999999999999999999999875443332
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
......+++.|.|||...+..++.++|+||||+++|+|++|..||...... ....... . ....+
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-~----~~~~~----- 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIV-Q----GNYTP----- 220 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-c----CCCCC-----
Confidence 333456788999999998888889999999999999999999998643211 1111111 0 01111
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
.+...+..+.+++.+||..+|++|||++++++.+
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1123345578899999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=280.16 Aligned_cols=252 Identities=22% Similarity=0.289 Sum_probs=203.8
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.+|++.+.||.|++|+||+|.+. +++.+++|.+..........+.+|+..++.++|||++++++.+......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46999999999999999999764 68899999887665555677889999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.+++|..++.. ..+++.++..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~----~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN----QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999888743 3589999999999999999999999 9999999999999999999999999998644433332
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ .. . ..... .+. ...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~----~-~~~~~-----~~~--~~~ 237 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY----L-IATNG-----TPE--LQN 237 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----H-HHhcC-----Ccc--cCC
Confidence 3334678889999999888899999999999999999999999965432110 00 0 00000 000 011
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
+...+..+.+++.+||..+|++|||+.+++.+=+
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~ 271 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 2223445788999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=280.14 Aligned_cols=258 Identities=26% Similarity=0.372 Sum_probs=202.3
Q ss_pred HhcCCcccceecCCCceEEEEEEeC------CCcEEEEEEeccc-CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecC
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKEN 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 92 (315)
..++|++.+.||+|++|.||++.+. ....+++|..... .......+.+|+.+++.+ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4568999999999999999999754 2367888887643 233345678899999999 7999999999999999
Q ss_pred eeEEEEEeccCCcccccccc--------------CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE
Q 046121 93 LNILVYEYICNKSLHWHLFD--------------NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL 158 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~ 158 (315)
.++++|||+.+++|..++.. .....+++..++.++.|++.++.|||+. +++|+||+|+||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~Nil~ 165 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK----KCIHRDLAARNVLV 165 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CccccccceeeEEE
Confidence 99999999999999988854 2245688999999999999999999999 99999999999999
Q ss_pred cCCCceeECCCCcccccCCCCCcc--ccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchh
Q 046121 159 THDFVPMLGDFGLARWKTTDDPVQ--TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQS 235 (315)
Q Consensus 159 ~~~~~i~l~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~ 235 (315)
+.++.++|+|||.+.......... ....++..|+|||...+..++.++||||||+++|++++ |..||........
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 243 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-- 243 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH--
Confidence 999999999999986443322111 11234567999999988889999999999999999997 8888864322110
Q ss_pred HHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 236 LRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
. .. .... .....+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 244 -~---~~-~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 -F---KL-LKEG---------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -H---HH-HHcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0 00 0000 001112223445788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=285.34 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=199.1
Q ss_pred hcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccceeeeEEe-cC
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCK-EN 92 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~ 92 (315)
.++|++.+.||+|+||.||+|... +++.|++|++.... ......+.+|+.+++.+ +|+||+++++.+.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 358999999999999999999532 35789999876432 22345677899999999 79999999998754 45
Q ss_pred eeEEEEEeccCCccccccccCC----------------------------------------------------------
Q 046121 93 LNILVYEYICNKSLHWHLFDNT---------------------------------------------------------- 114 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~---------------------------------------------------------- 114 (315)
.++++++|+.+++|.+.+....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 7889999999999988875422
Q ss_pred -CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC--ccccccccccc
Q 046121 115 -ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGY 191 (315)
Q Consensus 115 -~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~ 191 (315)
...+++..+..++.|++.++.|||+. +++|+||||.||+++.++.++|+|||++........ ......++..|
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~----~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 12678999999999999999999999 999999999999999999999999999874432211 11223446689
Q ss_pred cCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHH
Q 046121 192 LAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMA 270 (315)
Q Consensus 192 ~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (315)
+|||++.+..++.++|||||||++|+|++ |..||....... .... ...... .. ..+......+.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~~-----~~----~~~~~~~~~~~ 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCR----RLKEGT-----RM----RAPEYATPEIY 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHH----HHhccC-----CC----CCCccCCHHHH
Confidence 99999999999999999999999999998 999986432211 1111 111100 00 11122345578
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 271 KTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 271 ~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
+++.+||+.+|++||++.+++++|+.+.
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=283.54 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=200.5
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCc----EEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQ----MIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~----~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
..+|++.+.||+|+||+||+|.+. ++. .+++|++.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 358999999999999999999764 333 48888876443 33456788899999999999999999998764 568
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
++++|+.+++|.+.+.... ..++...++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 85 ~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~----~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEecCCCcEEEccccccccc
Confidence 9999999999999886543 3478889999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCcc--ccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 176 TTDDPVQ--TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 176 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... ...... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~--~~ 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGE--RL 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHhCCC--CC
Confidence 4322211 11233567999999998889999999999999999997 999986432211 111 111100 00
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
+ .+......+.+++..||..+|++|||+.+++..+..+..+.
T Consensus 231 --~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 --P-----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred --C-----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0 01122345778999999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=281.63 Aligned_cols=260 Identities=27% Similarity=0.343 Sum_probs=199.6
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCc--EEEEEEeccc-CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQ--MIAAKVRKEA-STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~--~~~~k~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 96 (315)
.++|++.+.||+|+||.||+|.+. ++. .+++|..... .......+.+|+.++..+ +||||+++++++...+.+++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 358999999999999999999865 343 4566655432 233445678899999999 89999999999999999999
Q ss_pred EEEeccCCccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC
Q 046121 97 VYEYICNKSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF 162 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~ 162 (315)
|+||+.+++|.+++.+.. ...+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEecCCC
Confidence 999999999998886432 23578999999999999999999999 999999999999999999
Q ss_pred ceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHH
Q 046121 163 VPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAE 241 (315)
Q Consensus 163 ~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 241 (315)
.++|+|||++...... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 162 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~ 234 (303)
T cd05088 162 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYE 234 (303)
T ss_pred cEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHHH
Confidence 9999999998522111 11111223567999999988888999999999999999998 99998543221 1111
Q ss_pred HHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 242 PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
... . .. ....+...+..+.+++.+||+.+|++||++.+++..|+.+...-.
T Consensus 235 ~~~-~-----~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 235 KLP-Q-----GY----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHh-c-----CC----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 110 0 00 001111233457899999999999999999999999887655433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=303.52 Aligned_cols=256 Identities=28% Similarity=0.405 Sum_probs=209.2
Q ss_pred hcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccCcc-cHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEASTQ-GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
.++-...+.||+|.||.||+|+.. ....||||.++...+. ...++++|+..+..++||||++++|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 346677789999999999999643 3567999998877666 677899999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccCC--------CC----ccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC
Q 046121 95 ILVYEYICNKSLHWHLFDNT--------ES----VLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF 162 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~--------~~----~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~ 162 (315)
|+|+|||..|+|.+++.... .. +++..+.+.++.||+.++.||.++ .+|||||-.+|.+|.++.
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~----~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH----HFVHRDLATRNCLVGENL 640 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----cccccchhhhhceeccce
Confidence 99999999999999885422 22 388999999999999999999999 999999999999999999
Q ss_pred ceeECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHh
Q 046121 163 VPMLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQW 239 (315)
Q Consensus 163 ~i~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 239 (315)
.|||+|||+++......+- .....-+.+|||||.+..+.++.+|||||+||++||+++ |..|+.......-
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV------ 714 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV------ 714 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH------
Confidence 9999999999765544332 112345789999999999999999999999999999997 8888854332211
Q ss_pred HHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 240 AEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
+. .+....+ -..+.+++..+..||..||+.+|++||+|+||-..|+..
T Consensus 715 Ie-~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 715 IE-CIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred HH-HHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 11 1111111 223445566788999999999999999999998888754
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=276.63 Aligned_cols=254 Identities=25% Similarity=0.329 Sum_probs=201.5
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
.++|++.+.||+|+||.||+|.+. +++.+++|++..........+.+|+.+++.++|||++++++.+...+..++++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 358999999999999999999765 6889999988765555556678899999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++... ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 88 CGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSK----GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 9999999887543 4589999999999999999999999 999999999999999999999999999865443333
Q ss_pred ccccccccccccCccccc---cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 181 VQTKILGTLGYLAPEYAE---NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
......|++.|+|||.+. ...++.++|+||||+++|+|++|..||......... .. . .. .....+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~~----~-~~---~~~~~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FL----M-TK---SNFQPPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--Hh----h-hc---cCCCCCcc
Confidence 334456889999999874 455788999999999999999999998543321110 00 0 00 00001111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.. ....+..+.+++.+||..+|++|||+.+++++
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 10 01123457889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=274.39 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=203.0
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+|++.+.||+|++|.+|.+... +++.+++|.+... .......+.+|+.+++.++|||++++.+++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 6899999999999999999765 6888999987643 233445788999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+.+.......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999888765555688999999999999999999999 999999999999999999999999999875443332
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
......+++.|+|||.+.+..++.++|+||||+++++|++|..||...... ........ .. .+ .
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~-----~~-~~----~ 220 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIR-----GS-YP----P 220 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhc-----CC-CC----C
Confidence 233345788899999998888999999999999999999999998643211 11111110 00 01 1
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.+......+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 122334568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=290.43 Aligned_cols=274 Identities=23% Similarity=0.261 Sum_probs=212.2
Q ss_pred HHHHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcC-C-----CCccceeee
Q 046121 15 FSEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-H-----KNIVMLLGF 87 (315)
Q Consensus 15 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~ 87 (315)
+..-+.+..+|++++.||+|+||.|.+|.+. +++.||+|+++.. .....+...|+.+|..++ | -|++.++++
T Consensus 178 ~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 178 LVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred EEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 3333445559999999999999999999654 7999999998864 444566788999999987 3 589999999
Q ss_pred EEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC--Ccee
Q 046121 88 CCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD--FVPM 165 (315)
Q Consensus 88 ~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~--~~i~ 165 (315)
|...+++|+|+|.+ ..+|.+++..+...+++...+..++.||+.+|..||+. +|||+||||+|||+... ..||
T Consensus 257 F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l----~IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 257 FYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL----GIIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred cccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCChhheeeccCCcCcee
Confidence 99999999999987 78999999999999999999999999999999999999 99999999999999653 4799
Q ss_pred ECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH-----
Q 046121 166 LGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA----- 240 (315)
Q Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----- 240 (315)
++|||.++.....- ..++.+-.|+|||++.|.+|+.+.|||||||+++||++|.+.|.+.++..+.....-.
T Consensus 332 VIDFGSSc~~~q~v---ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 332 VIDFGSSCFESQRV---YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred EEecccccccCCcc---eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 99999998433322 2567788899999999999999999999999999999998888766543221111000
Q ss_pred ----------HHHHhh-h---------c-----------------cccccCC----cccCCCCHHHHHHHHHHHHhhcCC
Q 046121 241 ----------EPLIEK-L---------A-----------------LHELIDP----RIENSYDTYELYLMAKTAYLCVQR 279 (315)
Q Consensus 241 ----------~~~~~~-~---------~-----------------~~~~~~~----~~~~~~~~~~~~~l~~l~~~~l~~ 279 (315)
..+... . . ..+...| .+...........+.+++.+||..
T Consensus 409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~ 488 (586)
T KOG0667|consen 409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW 488 (586)
T ss_pred HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence 000000 0 0 0000001 011112223455678999999999
Q ss_pred CCCCCCCHHHHHHHHhcc
Q 046121 280 NPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 280 ~p~~Rps~~~il~~L~~~ 297 (315)
||.+|+|+.+++++-+-.
T Consensus 489 dP~~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 489 DPAERITPAQALNHPFLT 506 (586)
T ss_pred CchhcCCHHHHhcCcccc
Confidence 999999999999876544
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=290.04 Aligned_cols=262 Identities=19% Similarity=0.205 Sum_probs=201.6
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecC
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN 92 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (315)
......++|++.+.||+|+||.||++.+. +++.+|+|++.... ......+.+|+.+++.++||||+++++.+..+.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445689999999999999999999876 68899999876422 223345678999999999999999999999999
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
..++||||+.|++|.+++.. ..+++..+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999988843 3478889999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCC-ccccccccccccCccccccCC----CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh
Q 046121 173 RWKTTDDP-VQTKILGTLGYLAPEYAENGI----VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL 247 (315)
Q Consensus 173 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~----~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (315)
........ ......|++.|+|||++.+.. ++.++|||||||++|+|++|..||...+.. .. ........
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~----~~~i~~~~ 263 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GT----YSKIMNHK 263 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--HH----HHHHHcCC
Confidence 75433222 223457899999999986533 778999999999999999999999654321 01 11111100
Q ss_pred ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHHhccc
Q 046121 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEG--RPSMGEVVRLLEGEN 298 (315)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~--Rps~~~il~~L~~~~ 298 (315)
. ..........+..+.+++..||..++.+ |+++.+++++.+-..
T Consensus 264 ~-------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 264 N-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred C-------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 0 0000111234556788888899844433 789999999875443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=282.26 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=202.6
Q ss_pred hcCCcccceecCCCceEEEEEEeC--------CCcEEEEEEeccc-CcccHHHHHHHHHHHhhc-CCCCccceeeeEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK--------DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKE 91 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 91 (315)
.++|.+.+.||+|+||.||++.+. +...+++|.+... .......+.+|+.+++.+ +|||++++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 468999999999999999999753 2346899987753 233455678899999999 799999999999999
Q ss_pred CeeEEEEEeccCCccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEE
Q 046121 92 NLNILVYEYICNKSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNIL 157 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil 157 (315)
...++|+||+.+++|.+++.... ...++...+..++.|++.++.+||+. +++|+||+|+||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~Nil 172 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVL 172 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHHheE
Confidence 99999999999999999886532 23588899999999999999999999 9999999999999
Q ss_pred EcCCCceeECCCCcccccCCCCCcc--ccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccch
Q 046121 158 LTHDFVPMLGDFGLARWKTTDDPVQ--TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQ 234 (315)
Q Consensus 158 ~~~~~~i~l~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~ 234 (315)
++.++.++|+|||.+.......... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--- 249 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 249 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---
Confidence 9999999999999986443221111 11223467999999988889999999999999999998 88888543211
Q ss_pred hHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 235 SLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
..... .... .....+...+..+.+++.+||..+|++|||+.++++.|+.+...
T Consensus 250 ---~~~~~-~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 ---ELFKL-LKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred ---HHHHH-HHcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11111 1110 01112223345678899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=279.59 Aligned_cols=260 Identities=27% Similarity=0.395 Sum_probs=204.9
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccceeeeEEe
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCK 90 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 90 (315)
+-..++|.+.+.||+|+||.||++.+. .+..+++|.+.... ....+.+.+|+.+++.+ +||||+++++.+..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 345578999999999999999999642 35578888876543 33345688999999999 79999999999999
Q ss_pred cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCC
Q 046121 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
.+..++++||+.+++|.+++.......+++.+...++.+++.++.+||+. +++|+||+|+||+++.++.++++|||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999998765555689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhh
Q 046121 171 LARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKL 247 (315)
Q Consensus 171 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (315)
++........ ......++..|+|||.+.+..++.++||||+|+++|+|++ |..||....... .... ....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~----~~~~- 259 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYK----LIKE- 259 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHH----HHHc-
Confidence 9864432221 1112234678999999988889999999999999999998 899986433211 1111 0110
Q ss_pred ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
......+...+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 260 --------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 --------GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 001111122344688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=286.95 Aligned_cols=237 Identities=23% Similarity=0.292 Sum_probs=186.7
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHH-HHhhcCCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVY-VLNFARHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||+||+|.+. +++.+++|++.... ......+..|.. +++.++||||+++++.+...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 68899999876532 223334455544 56778999999999999999999999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|...+.. ...+++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~----givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSI----NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 999887743 34689999999999999999999999 999999999999999999999999999864333333334
Q ss_pred cccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCH
Q 046121 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (315)
...|++.|+|||++.+..++.++|||||||++|+|++|..||...... ... ...... .. ...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~----~~~~~~----~~-------~~~~ 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--EMY----DNILHK----PL-------VLRP 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--HHH----HHHHcC----Cc-------cCCC
Confidence 457899999999999988999999999999999999999999644321 111 111110 00 0111
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCHH
Q 046121 264 YELYLMAKTAYLCVQRNPEGRPSMG 288 (315)
Q Consensus 264 ~~~~~l~~l~~~~l~~~p~~Rps~~ 288 (315)
..+..+.+++.+||..+|++||++.
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCC
Confidence 2334577888999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=277.35 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=199.1
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.|+..+.||.|+||+||+|.+. +++.+++|.+.... ......+.+|+.+++.++|++++.+.+.+..++..+++++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4788899999999999999765 68899999876432 2223446789999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|.+.+.......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~----~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE----NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998888665556799999999999999999999999 99999999999999999999999999886432221
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ ....... .... ..
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~-~~~~----------~~ 222 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRR-VLET----------EE 222 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHh-hhcc----------cc
Confidence 12234688999999999888899999999999999999999999964432111 1110000 0000 01
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPS-----MGEVVRL 293 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps-----~~~il~~ 293 (315)
.++...+..+.+++..||+.||++||+ +.+++.+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 112223345778999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=284.84 Aligned_cols=237 Identities=23% Similarity=0.293 Sum_probs=186.0
Q ss_pred ceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHH-HHHhhcCCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEV-YVLNFARHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||.||+|.+. +++.+++|++.... ......+..|. .+++.++||||+++++.+...+..++||||+.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999876 68899999876432 12233444454 467889999999999999999999999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|...+.. ...+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 999877743 34588999999999999999999999 999999999999999999999999999864322222233
Q ss_pred cccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCH
Q 046121 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (315)
...|++.|+|||.+.+..++.++|||||||++|+|++|..||...... ......... ....+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~-----------~~~~~~ 217 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDNILHK-----------PLQLPG 217 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHHHhcC-----------CCCCCC
Confidence 456889999999998888999999999999999999999999654311 111111100 011122
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCHH
Q 046121 264 YELYLMAKTAYLCVQRNPEGRPSMG 288 (315)
Q Consensus 264 ~~~~~l~~l~~~~l~~~p~~Rps~~ 288 (315)
.....+.+++.+||+.||.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2345578999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=279.07 Aligned_cols=265 Identities=21% Similarity=0.252 Sum_probs=202.1
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
++|++.+.||+|+||.||++.+. ++..+++|..... .......+.+|+++++.++||||+++++.+..++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999865 5788888877643 233345678999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
+.+++|.+++... ..+++..+..++.|++.++.|||+ . +++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC----CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999988544 558899999999999999999997 5 8999999999999999999999999988533221
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcc----------
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL---------- 249 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------- 249 (315)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........ .............
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccccccccCCcccccCC
Confidence 22345678899999999888889999999999999999999999853321110 0000000000000
Q ss_pred --------------ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 250 --------------HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 250 --------------~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
................+..+.+++.+||..+|++|||+.+++.+.+-..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 0000000000001113445889999999999999999999999876543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=275.93 Aligned_cols=255 Identities=25% Similarity=0.320 Sum_probs=201.8
Q ss_pred CcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccC
Q 046121 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
|++.+.||+|++|.||+|.+. ++..+++|.+..........+.+|+.+++.++|||++++++.+..++..++|+||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 788899999999999999876 5778888887765555667788999999999999999999999999999999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|...+.+. ..++++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++...........
T Consensus 87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 9998776432 34689999999999999999999999 999999999999999999999999999864433322233
Q ss_pred cccccccccCccccc-----cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 184 KILGTLGYLAPEYAE-----NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~-----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
...+++.|+|||++. +..++.++|+||+|+++|+|++|.+||...... ..... .... ..+.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~----~~~~------~~~~-- 227 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLK----IAKS------EPPT-- 227 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHH----Hhhc------CCCC--
Confidence 456788999999873 445778999999999999999999998543211 11111 0000 0000
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
...+...+..+.+++.+||+.+|++|||+.+++.+-+-..
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 228 LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 0112223456889999999999999999999987765443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=294.51 Aligned_cols=262 Identities=18% Similarity=0.244 Sum_probs=191.7
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEec--------C
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE--------N 92 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~ 92 (315)
.++|++++.||+|+||+||+|.+. +++.||+|.+.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 468999999999999999999875 68899999775432 2345799999999999999998876432 2
Q ss_pred eeEEEEEeccCCcccccccc--CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC-ceeECCC
Q 046121 93 LNILVYEYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF-VPMLGDF 169 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~-~i~l~df 169 (315)
.+++||||+.+ ++.+.+.. .....+++..+..++.|++.||.|||+. +++||||||+||+++.++ .++|+||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~----~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK----FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCcCHHHEEEcCCCCceeeecc
Confidence 46799999865 56555532 2345689999999999999999999999 999999999999998665 7999999
Q ss_pred CcccccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH-----
Q 046121 170 GLARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL----- 243 (315)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----- 243 (315)
|++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||....... .+.......
T Consensus 216 Gla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCH
Confidence 9997443322 2233567899999998765 468999999999999999999999996543211 111111000
Q ss_pred ---------HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 244 ---------IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 244 ---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.............+...++...+..+.+|+.+||+.||.+|||+.+++.+-+
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0000000000011111122233456889999999999999999999986644
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=289.01 Aligned_cols=245 Identities=22% Similarity=0.355 Sum_probs=199.9
Q ss_pred cceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCccc
Q 046121 28 ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLH 107 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L~ 107 (315)
++=||.|+.|.||+|+.. ++.||+|......+ .+++-|++++||||+.|.++|....-+|+|||||..|.|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 456999999999999986 56678876654433 4677799999999999999999999999999999999999
Q ss_pred cccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccccccc
Q 046121 108 WHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILG 187 (315)
Q Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~~ 187 (315)
+.+ ..+.++.......|..+|+.++.|||.. .|||||||.-||||..+..|||+|||-++..... .....+.|
T Consensus 201 ~VL--ka~~~itp~llv~Wsk~IA~GM~YLH~h----KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaG 273 (904)
T KOG4721|consen 201 EVL--KAGRPITPSLLVDWSKGIAGGMNYLHLH----KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAG 273 (904)
T ss_pred HHH--hccCccCHHHHHHHHHHhhhhhHHHHHh----hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhh
Confidence 999 4566789999999999999999999999 9999999999999999999999999998744333 33345789
Q ss_pred cccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHH
Q 046121 188 TLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELY 267 (315)
Q Consensus 188 ~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (315)
|..|||||++...+.+.++|||||||+||||+||..||.+-.... . +. ..-...+.--.+..+++
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----I--Iw---------GVGsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----I--IW---------GVGSNSLHLPVPSTCPD 338 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----e--EE---------eccCCcccccCcccCch
Confidence 999999999999999999999999999999999999984211100 0 00 00011122223444566
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 268 LMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 268 ~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
-++-|+++||+-.|.+||+|.+|+.+|+-....+-
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 68889999999999999999999999987766443
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=277.56 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=199.5
Q ss_pred CCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
+|++.+.||+|+||.||+|.+. +...+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5889999999999999999753 23567888766443 2334568899999999999999999999999999999
Q ss_pred EEEeccCCccccccccC----------------------CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccC
Q 046121 97 VYEYICNKSLHWHLFDN----------------------TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPS 154 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~----------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~ 154 (315)
+++|+.+++|.+++... ....+++..++.++.|++.++.+||+. +++|+||+|+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~ivH~dikp~ 156 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM----KLVHRDLAAR 156 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC----Ceehhhhhhh
Confidence 99999999998876432 123578899999999999999999999 9999999999
Q ss_pred cEEEcCCCceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCc
Q 046121 155 NILLTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEE 231 (315)
Q Consensus 155 nil~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~ 231 (315)
||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999864332221 1122234668999999988889999999999999999998 99998643221
Q ss_pred cchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 232 PQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
. ... .... ......+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 237 ~---~~~----~~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 R---LFN----LLKT---------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred H---HHH----HHhC---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 1 111 1111 0011112223456888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=273.86 Aligned_cols=254 Identities=23% Similarity=0.285 Sum_probs=206.0
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
...|+..+.||.|++|.||.|.+. ++..+++|++.... ......+.+|+.+++.+.|||++++++.+.+....++|||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 357889999999999999999875 58899999876442 3445678899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|.+++.. ..+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 83 ~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~----~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 83 YLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE----KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC----CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999988743 4588899999999999999999999 99999999999999999999999999986444333
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... . ........
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~----------~~~~~~~~ 219 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------F----------LIPKNNPP 219 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------h----------hhhcCCCC
Confidence 2223345677899999998888899999999999999999999998643321100 0 00011112
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
......+..+.+++.+||+.+|++||++.+++..-.-..
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence 233445667889999999999999999999988755443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=282.63 Aligned_cols=192 Identities=21% Similarity=0.320 Sum_probs=162.2
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
...+|++++.||+|+||.||+|.+. +++.+++|+.... ....|+.+++.++||||+++++++......++|++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3468999999999999999999876 5788899874432 23568999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
++. ++|.+++... ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++..... .
T Consensus 138 ~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ----RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-A 210 (357)
T ss_pred ccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEecCcccccccc-C
Confidence 985 5776666443 34689999999999999999999999 999999999999999999999999999863222 2
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCcc
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVV 225 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~ 225 (315)
.......|++.|+|||++.+..++.++|||||||++|+|+++..++
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 2223356889999999999888999999999999999999865444
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=274.90 Aligned_cols=253 Identities=24% Similarity=0.341 Sum_probs=198.9
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeeeEEec------C
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKE------N 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~------~ 92 (315)
..+.|++.+.||+|+||.||+|.+. +++.+++|...... .....+.+|+.+++.+ +|||++++++.+... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4568999999999999999999765 68889999876543 3446778899999988 699999999998653 4
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
..++++||+.+++|.+++.......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~----~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 679999999999999988766666789999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCccccc-----cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAE-----NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL 247 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (315)
..............|++.|+|||++. +..++.++|+||+|+++|+|++|..||...... .... .....
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~--~~~~~ 231 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALF--LIPRN 231 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHH--HHhcC
Confidence 64433323333456788999999875 335778999999999999999999998533211 0000 00000
Q ss_pred ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
. .. .......+..+.+++.+||..+|.+|||+.+++++
T Consensus 232 ~-----~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 P-----AP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred C-----CC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 00 00111233457899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=271.76 Aligned_cols=245 Identities=24% Similarity=0.307 Sum_probs=192.0
Q ss_pred eecCCCceEEEEEEeC---CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCC
Q 046121 30 LLGEGGFGHVYKGELK---DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNK 104 (315)
Q Consensus 30 ~lg~g~~~~v~~~~~~---~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (315)
.||+|+||+||+|.+. ++..+++|++.... ....+.+.+|+.+++.++||||+++++++. ....++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999643 57889999876443 233456888999999999999999999875 45678999999999
Q ss_pred ccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc---
Q 046121 105 SLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV--- 181 (315)
Q Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~--- 181 (315)
+|.+++.. ...+++..+..++.|++.++.+||+. +++|+||+|.||+++.++.++++|||++.........
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEET----NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99988843 34589999999999999999999999 9999999999999999999999999998644332221
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... .. .. ..... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~---~~-i~~~~---------~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VT---QM-IESGE---------RME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HH-HHCCC---------CCC
Confidence 112233568999999988888999999999999999998 999996443211 11 11 11100 011
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.+...+..+.+++.+||+.||++||++.+|.+.|+..
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1223345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=290.62 Aligned_cols=264 Identities=28% Similarity=0.407 Sum_probs=210.9
Q ss_pred HhcCCcccceecCCCceEEEEEEeCC--C--cE-EEEEEecc---cCcccHHHHHHHHHHHhhcCCCCccceeeeEEecC
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKD--G--QM-IAAKVRKE---ASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~--~--~~-~~~k~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (315)
..++-++.++||+|+||.||+|.... + .. ||+|.... ........+.+|.++++.++||||++++|+...+.
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34566777999999999999996542 2 23 78887774 34566778999999999999999999999999999
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
.+++|||++.||+|.+++..+.. .++..+...++.+.+.+++|||++ +++||||-++|+|++.++.+|++|||++
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k----~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK----NCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC----CCcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999977766 599999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
.............--+..|+|||.+....++.++||||+|+++||+++ |..||...... +....+..
T Consensus 310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~------ 377 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVK------ 377 (474)
T ss_pred cCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHh------
Confidence 643311111111134678999999999999999999999999999998 88888654322 11111111
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccc
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHL 304 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~ 304 (315)
.......+...+..+..++.+||..+|+.|||+.++.+.|+.+.......
T Consensus 378 ---~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 378 ---NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred ---cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 11112222245566778888999999999999999999999887766643
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=277.24 Aligned_cols=255 Identities=25% Similarity=0.342 Sum_probs=204.4
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
++|++.+.||.|++|.||++.+. ++..+++|+.........+.+.+|+.+++.++|||++++++.+..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 57999999999999999999865 68899999987666666677889999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.+++|.+++.+. ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+.........
T Consensus 85 ~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 85 DGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSH----KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred CCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999998887543 34589999999999999999999999 9999999999999999999999999988644433333
Q ss_pred cccccccccccCccccc-----cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 182 QTKILGTLGYLAPEYAE-----NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
.....+++.|+|||.+. +..++.++|+||||+++|+|++|..||...... ..... . ... ..+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~----~-~~~-----~~~~ 227 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLK----I-LKS-----EPPT 227 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHH----H-hcC-----CCCC
Confidence 33456788999999874 344677999999999999999999999643211 11111 0 000 0010
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
+ ..+...+..+.+++..||+.+|.+||++++++++-+-
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (280)
T cd06611 228 L--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265 (280)
T ss_pred c--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence 0 1122234457889999999999999999999887553
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=271.70 Aligned_cols=250 Identities=26% Similarity=0.319 Sum_probs=203.2
Q ss_pred cCCcccceecCCCceEEEEEEeCC-CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
++|++.+.||.|.+|.||+|.+.. +..+++|.+..... .+.+.+|+.+++.++|||++++++.+......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 689999999999999999998764 78899998765433 678899999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.+++|.+.+... ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 81 GAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN----KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred CCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 999999887543 34689999999999999999999999 9999999999999999999999999998754433323
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .... ......+ ....
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~--~~~~----------~~~~~~~--~~~~ 221 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--AIFM----------IPNKPPP--TLSD 221 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh--hhhh----------hccCCCC--CCCc
Confidence 334457889999999988889999999999999999999999986432211 0000 0000001 1112
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
+......+.+++.+||+.||++|||++++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 22344568899999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=277.83 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=198.1
Q ss_pred cCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccCcc-cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEASTQ-GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
.+|.+.+.||+|+||+||+|.+. .++.+++|++...... ....+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 46888999999999999999753 2578999988754332 2345788999999999999999999999999999
Q ss_pred EEEEeccCCccccccccC--------------CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC
Q 046121 96 LVYEYICNKSLHWHLFDN--------------TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD 161 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~--------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~ 161 (315)
++++|+.+++|.+++... ....+++..+..++.|++.|+.++|+. +++|+||||.||+++.+
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~----gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc----CccccccchhheEecCC
Confidence 999999999998887421 123578889999999999999999999 99999999999999999
Q ss_pred CceeECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHH
Q 046121 162 FVPMLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQ 238 (315)
Q Consensus 162 ~~i~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 238 (315)
+.++|+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~ 234 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------D 234 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------H
Confidence 99999999988643322211 122345678999999988889999999999999999998 77887543221 1
Q ss_pred hHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 239 WAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
........ . ....+...+..+.+++.+||+.+|++||++++++..|+.
T Consensus 235 ~~~~i~~~-~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNR-Q---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcC-C---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111110 0 001122334557889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=287.92 Aligned_cols=266 Identities=26% Similarity=0.426 Sum_probs=210.4
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
+.-.++.++.+.||+|+||+||+|+|-+ .||||++... .++..+.+.+|+.++++-+|.||+-++|++.+... .+
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 3345677889999999999999998853 4789987754 34556779999999999999999999999998887 99
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
|..+++|.+|+.+++... ..+.+.+.+.|+.|+++++.|||.+ +|+|+|||..||++.+++.|+|+|||++....
T Consensus 465 iTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK----~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK----NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh----hhhhhhccccceEEccCCcEEEecccceeeee
Confidence 999999999999997665 4599999999999999999999999 99999999999999999999999999996433
Q ss_pred CCCCc--cccccccccccCcccccc---CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 177 TDDPV--QTKILGTLGYLAPEYAEN---GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 177 ~~~~~--~~~~~~~~~~~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
.-... .....|...|+|||++.- .+++..+||||||+++|||++|..||...+.+.. +-. ....+..
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--ifm----VGrG~l~-- 611 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--IFM----VGRGYLM-- 611 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--EEE----ecccccC--
Confidence 22111 122356778999998863 4478899999999999999999999974333221 111 0011001
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccc
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHL 304 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~ 304 (315)
+. ........+..+++|+..||.+++++||.+.+|+..|+.+..+.+.+
T Consensus 612 ---pd-~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki 660 (678)
T KOG0193|consen 612 ---PD-LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKI 660 (678)
T ss_pred ---cc-chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccc
Confidence 11 11122345667899999999999999999999999888887765443
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=279.84 Aligned_cols=258 Identities=26% Similarity=0.367 Sum_probs=201.2
Q ss_pred hcCCcccceecCCCceEEEEEEeC--------CCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccceeeeEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK--------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKE 91 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 91 (315)
.++|.+.+.||+|++|.||++.+. ....+++|...... ......+.+|+.+++.+ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 468999999999999999999642 24568888876432 33455678899999999 599999999999998
Q ss_pred CeeEEEEEeccCCccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEE
Q 046121 92 NLNILVYEYICNKSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNIL 157 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil 157 (315)
...++++||+.+++|.+++.... ...++...+..++.|++.|+.+||+. |++|+||+|+||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~Nil 166 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR----RCIHRDLAARNVL 166 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC----CeeeccccceeEE
Confidence 99999999999999998885532 24588899999999999999999999 9999999999999
Q ss_pred EcCCCceeECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccch
Q 046121 158 LTHDFVPMLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQ 234 (315)
Q Consensus 158 ~~~~~~i~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~ 234 (315)
++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-- 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-- 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 999999999999998644322211 111233457999999988889999999999999999998 888885432211
Q ss_pred hHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 235 SLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
...... ... ....+...+..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 245 ----~~~~~~-~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 ----LFKLLR-EGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred ----HHHHHH-cCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111111 100 001122234457789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=275.52 Aligned_cols=262 Identities=24% Similarity=0.339 Sum_probs=201.0
Q ss_pred hcCCcccceecCCCceEEEEEEeCC-----------------CcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccc
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKD-----------------GQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVM 83 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~-----------------~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~ 83 (315)
.++|++++.||+|+||.||+|.+.. +..+++|.+.... ....+.+.+|+++++.++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4689999999999999999986542 2457888876543 334567889999999999999999
Q ss_pred eeeeEEecCeeEEEEEeccCCccccccccCC---------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccC
Q 046121 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNT---------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPS 154 (315)
Q Consensus 84 ~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~ 154 (315)
+++++..+...++++|++.+++|.+++.+.. ...+++..++.++.|++.++.+||+. +++|+||||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~----~i~H~dlkp~ 159 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL----NFVHRDLATR 159 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc----Cccccccchh
Confidence 9999999999999999999999998886543 23689999999999999999999999 9999999999
Q ss_pred cEEEcCCCceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh--CCCccCCCCC
Q 046121 155 NILLTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS--GRKVVDMNGE 230 (315)
Q Consensus 155 nil~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~--g~~p~~~~~~ 230 (315)
||+++.++.++++|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ +..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999864332211 1223345678999999988889999999999999999998 5677753321
Q ss_pred ccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 231 EPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
....... .. .............+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 240 --~~~~~~~-~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENA-GH------FFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHH-Hh------ccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111110 00 000001111111222334568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=274.92 Aligned_cols=254 Identities=26% Similarity=0.361 Sum_probs=198.0
Q ss_pred hcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
.++|.+.+.||+|++|.||+|.+. .+..+++|...... ......+.+|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467999999999999999999765 35678888766433 22345678899999999999999999999988899
Q ss_pred EEEEEeccCCccccccccCCC-----CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC---ceeE
Q 046121 95 ILVYEYICNKSLHWHLFDNTE-----SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF---VPML 166 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~---~i~l 166 (315)
++||||+.+++|.+++..... ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++ .++|
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN----HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchheEEEeccCCCcceEe
Confidence 999999999999998865432 3588999999999999999999999 999999999999998765 5899
Q ss_pred CCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHH
Q 046121 167 GDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 167 ~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
+|||++......... ......+..|+|||++.+..++.++|||||||++|+|++ |..||....... .. ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~---~~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VM---EFV 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---HHH
Confidence 999998744222111 112233567999999988889999999999999999997 999986433211 11 111
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
... .. ...+...+..+.+++.+||+.+|++|||+.+++++|+
T Consensus 235 ~~~------~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGG------GR----LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcC------Cc----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 100 00 1112223456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=275.32 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=200.2
Q ss_pred hcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
.++|++.+.||+|+||.||+|.+. ++..+++|...... ......+.+|+.+++.++|||++++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 468999999999999999999764 24678999876442 23344678899999999999999999999999999
Q ss_pred EEEEEeccCCccccccccCC--------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeE
Q 046121 95 ILVYEYICNKSLHWHLFDNT--------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPML 166 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l 166 (315)
++|+||+.+++|.+++.... ...+++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++|
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK----KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccChheEEEcCCCCEEE
Confidence 99999999999998885432 23477889999999999999999999 9999999999999999999999
Q ss_pred CCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHH
Q 046121 167 GDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 167 ~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
+|||++........ ......++..|+|||.+.+..++.++|+||||+++|++++ |..||....... ... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~---~- 233 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLK---F- 233 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHH---H-
Confidence 99999864332221 1223345678999999988889999999999999999998 889986433211 111 1
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
..... ... .+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 234 ~~~~~-----~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 VIDGG-----HLD----LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HhcCC-----CCC----CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11100 011 111224568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=289.12 Aligned_cols=259 Identities=20% Similarity=0.240 Sum_probs=198.5
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++.+.||+|+||+||++.+. +++.+|+|++... .......+.+|+.++..++||+|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999865 6889999988643 2333556788999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.|++|.+++.+. ..+++..+..++.|++.++.+||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~----givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL----GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999988543 4589999999999999999999999 9999999999999999999999999997533211
Q ss_pred CC-----------------------------------ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCC
Q 046121 179 DP-----------------------------------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRK 223 (315)
Q Consensus 179 ~~-----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 223 (315)
.. ......|++.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 0112468999999999999899999999999999999999999
Q ss_pred ccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHHHHhccccc
Q 046121 224 VVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS---MGEVVRLLEGENDR 300 (315)
Q Consensus 224 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps---~~~il~~L~~~~~~ 300 (315)
||....... ... .... ....+ ..... ...+..+.+++.+|+ .||++|++ +.+++++-+-....
T Consensus 235 Pf~~~~~~~--~~~----~i~~---~~~~~--~~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 300 (360)
T cd05627 235 PFCSETPQE--TYR----KVMN---WKETL--VFPPE--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVD 300 (360)
T ss_pred CCCCCCHHH--HHH----HHHc---CCCce--ecCCC--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCC
Confidence 996543211 111 0110 00000 00110 012345677777766 49999985 67887775533333
Q ss_pred c
Q 046121 301 F 301 (315)
Q Consensus 301 ~ 301 (315)
|
T Consensus 301 ~ 301 (360)
T cd05627 301 W 301 (360)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=275.75 Aligned_cols=261 Identities=23% Similarity=0.288 Sum_probs=203.8
Q ss_pred HHhcCCcccceecCCCceEEEEEEeCC-----CcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEe-cC
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELKD-----GQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCK-EN 92 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 92 (315)
...++|++.+.||+|+||.||+|.+.. +..+++|.+... .......+.+|+.+++.++|||++++++++.. ..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 346789999999999999999998764 678888877643 33445667899999999999999999998765 56
Q ss_pred eeEEEEEeccCCccccccccCCC------CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeE
Q 046121 93 LNILVYEYICNKSLHWHLFDNTE------SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPML 166 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l 166 (315)
..+++++|+.+++|.+++..... ..+++..++.++.+++.|+.|||+. +++|+||+|+||+++.++.+++
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR----GVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCHhhEEEcCCCcEEE
Confidence 77999999999999988855322 4589999999999999999999999 9999999999999999999999
Q ss_pred CCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHH
Q 046121 167 GDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 167 ~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
+|||++......... .....++..|+|||++.+..++.++||||||+++|++++ |..||...... .... ..
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~---~~ 232 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAA---YL 232 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHH---HH
Confidence 999998643322211 112234567999999988889999999999999999998 99998643221 1111 10
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
... ... ..+...+..+.+++.+||..+|++|||+.++++.|+.+..+
T Consensus 233 ~~~------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 233 KDG------YRL----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HcC------CCC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 100 000 01112334578999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=269.30 Aligned_cols=247 Identities=26% Similarity=0.363 Sum_probs=196.2
Q ss_pred ceecCCCceEEEEEEeCCCcEEEEEEecccCcc-cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCccc
Q 046121 29 NLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQ-GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLH 107 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L~ 107 (315)
++||+|++|.||++.+.+++.+++|........ ....+.+|+.+++.++||||+++++++......++|++|+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999998777999999987754333 4567889999999999999999999999999999999999999999
Q ss_pred cccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcc--ccc
Q 046121 108 WHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ--TKI 185 (315)
Q Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~--~~~ 185 (315)
+++.... ..++...+..++.+++.++.+||++ +++|+||+|+||+++.++.++|+|||.+.......... ...
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC----CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 8885443 3578999999999999999999999 99999999999999999999999999986443211111 112
Q ss_pred cccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHH
Q 046121 186 LGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTY 264 (315)
Q Consensus 186 ~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (315)
..+..|+|||.+.++.++.++|+||||+++|+|++ |..||....... ... . ... ......+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~---~-~~~---------~~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRE---R-IES---------GYRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHH---H-Hhc---------CCCCCCCcc
Confidence 23567999999988889999999999999999998 788885443211 111 0 000 001111223
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 265 ELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 265 ~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.+..+.+++.+||..+|++|||+.++++.|+.
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 34568889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=268.28 Aligned_cols=246 Identities=30% Similarity=0.376 Sum_probs=194.6
Q ss_pred ceecCCCceEEEEEEeCCCcEEEEEEecccCcc-cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCccc
Q 046121 29 NLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQ-GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLH 107 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L~ 107 (315)
++||+|++|.||+|...++..+++|........ ....+.+|+.+++.++|||++++++++......++||||+.+++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 468999999999998778889999987654332 2345788999999999999999999999999999999999999998
Q ss_pred cccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc-ccccc
Q 046121 108 WHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV-QTKIL 186 (315)
Q Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~-~~~~~ 186 (315)
+++.... ..+++..+..++.+++.++.++|+. +++|+||+|+||+++.++.++++|||++......... .....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 8875443 3578999999999999999999999 9999999999999999999999999998633222111 11123
Q ss_pred ccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHH
Q 046121 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYE 265 (315)
Q Consensus 187 ~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (315)
++..|+|||++.+..++.++|+||||+++|++++ |..||....... .. ... .. .... ..+...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~---~~~-~~-----~~~~----~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AR---EQV-EK-----GYRM----SCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HH---HHH-Hc-----CCCC----CCCCCC
Confidence 3567999999988889999999999999999998 899986442211 00 111 11 0011 111223
Q ss_pred HHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 266 LYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 266 ~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=275.80 Aligned_cols=262 Identities=22% Similarity=0.348 Sum_probs=197.6
Q ss_pred hcCCcccceecCCCceEEEEEEeCC---------------CcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCcccee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKD---------------GQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLL 85 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~---------------~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (315)
.++|++.+.||+|+||.||++.+.+ ...+++|..... .......+.+|+++++.++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4689999999999999999986532 235788887654 233345688999999999999999999
Q ss_pred eeEEecCeeEEEEEeccCCccccccccCC----------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCc
Q 046121 86 GFCCKENLNILVYEYICNKSLHWHLFDNT----------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSN 155 (315)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~n 155 (315)
+++...+..++||||+.+++|.+++.... ...++...++.++.+++.++.+||+. +++|+||+|+|
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~N 159 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL----NFVHRDLATRN 159 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc----CeeccccChhh
Confidence 99999999999999999999988875422 12367888999999999999999999 99999999999
Q ss_pred EEEcCCCceeECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh--CCCccCCCCCc
Q 046121 156 ILLTHDFVPMLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS--GRKVVDMNGEE 231 (315)
Q Consensus 156 il~~~~~~i~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~--g~~p~~~~~~~ 231 (315)
|+++.++.++|+|||++......... .....++..|+|||.+.++.++.++|+||||+++|+|++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999998643322211 112234668999999988889999999999999999998 55666543221
Q ss_pred cchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 232 PQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
............... ......+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 240 --~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 --QVIENTGEFFRNQGR-------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHHhhhhccc-------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111110000000 00001111233468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=285.20 Aligned_cols=263 Identities=22% Similarity=0.292 Sum_probs=195.9
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecC-----eeE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN-----LNI 95 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 95 (315)
+|++.+.||+|+||+||++.+. +++.+|+|.+... .......+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5889999999999999999865 6899999987643 2233456889999999999999999999998766 789
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+|++|+. ++|...+. ....+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSA----GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999985 56766663 334689999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCC-ccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH------------
Q 046121 176 TTDDP-VQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE------------ 241 (315)
Q Consensus 176 ~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 241 (315)
..... ......+++.|+|||.+.+. .++.++||||+||++|+|++|..||........ ......
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMRS 231 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHHH
Confidence 32221 12234568889999988764 478899999999999999999999965432211 110000
Q ss_pred H--HHhhhccccccCC-ccc--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 242 P--LIEKLALHELIDP-RIE--NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 242 ~--~~~~~~~~~~~~~-~~~--~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
. ............+ ... .......+..+.+++.+||+.||++|||+.+++.+-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 0 0000000000000 000 0111223456789999999999999999999998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=273.16 Aligned_cols=261 Identities=22% Similarity=0.350 Sum_probs=198.0
Q ss_pred cCCcccceecCCCceEEEEEEeC-----------------CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccce
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-----------------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVML 84 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-----------------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (315)
++|++.+.||+|+||+||++.+. +...+++|+..... ......+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998543 23468888876542 3334578899999999999999999
Q ss_pred eeeEEecCeeEEEEEeccCCccccccccCCC---------CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCc
Q 046121 85 LGFCCKENLNILVYEYICNKSLHWHLFDNTE---------SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSN 155 (315)
Q Consensus 85 ~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~n 155 (315)
++++...+..+++|||+.+++|.+++..... ..++...+..++.|++.|+.+||+. +++|+||||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dlkp~N 160 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL----NFVHRDLATRN 160 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CeecccCChhe
Confidence 9999999999999999999999888855321 2467788999999999999999999 99999999999
Q ss_pred EEEcCCCceeECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh--CCCccCCCCCc
Q 046121 156 ILLTHDFVPMLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS--GRKVVDMNGEE 231 (315)
Q Consensus 156 il~~~~~~i~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~--g~~p~~~~~~~ 231 (315)
|+++.++.++|+|||++......... .....+++.|++||...++.++.++|+||||+++|+|++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999998644322211 112234578999998888889999999999999999998 66777533221
Q ss_pred cchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 232 PQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
...... ......... ....+ .+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 241 --~~~~~~-~~~~~~~~~-~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 --QVIENT-GEFFRDQGR-QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HHHHHH-HHHHhhccc-cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111 111100000 00001 112233568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=275.58 Aligned_cols=260 Identities=24% Similarity=0.327 Sum_probs=198.7
Q ss_pred cCCcccceecCCCceEEEEEEe-----CCCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEec--Cee
Q 046121 23 GDFSKENLLGEGGFGHVYKGEL-----KDGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE--NLN 94 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 94 (315)
.-|++++.||+|+||.||++.. .++..+++|.+.... ......+.+|+.+++.++|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3579999999999999999963 257889999876443 33445688999999999999999999998765 567
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++||||+.|++|.+++.+.. ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccchheEEEcCCCCEEECCCccccc
Confidence 99999999999998885443 3589999999999999999999999 999999999999999999999999999874
Q ss_pred cCCCCC---ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCc---------cchhHHHhHHH
Q 046121 175 KTTDDP---VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEE---------PQQSLRQWAEP 242 (315)
Q Consensus 175 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~~ 242 (315)
...... ......++..|+|||.+.+..++.++|+||||+++|+|+++..|....... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 433221 112334566799999988888999999999999999999987654221100 00000110000
Q ss_pred HHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 243 LIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
... ... ...+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 239 -~~~-----~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 -LEE-----GKR----LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHc-----Ccc----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000 000 011122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=273.58 Aligned_cols=256 Identities=25% Similarity=0.335 Sum_probs=196.6
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCc----EEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQ----MIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~----~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
++|++.+.||+|+||+||+|.+. ++. .+++|...... ......+..|+..++.++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 58999999999999999999864 343 46677665332 223456777888899999999999999875 455788
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
+++|+.+++|.+++.... ..+++..+..++.|++.++.|||+. +++|+||||+||+++.++.++|+|||.+....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH----RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999886433 3589999999999999999999999 99999999999999999999999999986443
Q ss_pred CCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 177 TDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 177 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
.... ......++..|+|||.+.+..++.++||||||+++|++++ |..||....... ..+ ....... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~----~~~~~~~--~~ 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPD----LLEKGER--LA 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHCCCc--CC
Confidence 2221 1122345678999999988889999999999999999998 999986443211 111 1111110 00
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
. +......+.+++.+||..||++|||+.++++.|..+.+.
T Consensus 232 ~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 232 Q-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 1 111234467888899999999999999999999886654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=265.19 Aligned_cols=258 Identities=21% Similarity=0.237 Sum_probs=203.2
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC----cccHH----HHHHHHHHHhhc-CCCCccceeeeE
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS----TQGFA----EFQSEVYVLNFA-RHKNIVMLLGFC 88 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~----~~~~~----~~~~e~~~l~~l-~~~~i~~~~~~~ 88 (315)
+..-..|.-.+.||+|..++|-++..+ +++.+++|++.... .+... .-.+|+.+|+++ .||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 445567888899999999999888655 68888888766432 11122 345799999988 599999999999
Q ss_pred EecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECC
Q 046121 89 CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGD 168 (315)
Q Consensus 89 ~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~d 168 (315)
+.+...++|++.+..|.|.|++ ++.-.+++.....+++|+..+++|||.+ +|+|+|+||+||+++.+.+|+|+|
T Consensus 93 es~sF~FlVFdl~prGELFDyL--ts~VtlSEK~tR~iMrqlfegVeylHa~----~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYL--TSKVTLSEKETRRIMRQLFEGVEYLHAR----NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHh--hhheeecHHHHHHHHHHHHHHHHHHHHh----hhhhcccChhheeeccccceEEec
Confidence 9999999999999999999999 5566799999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCCCccccccccccccCcccccc------CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH
Q 046121 169 FGLARWKTTDDPVQTKILGTLGYLAPEYAEN------GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP 242 (315)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 242 (315)
||+++.... +......+|||+|+|||.+.. ..|+...|+|++|+++|.++.|.+||--.. +-...+
T Consensus 167 FGFa~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR 238 (411)
T KOG0599|consen 167 FGFACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLR 238 (411)
T ss_pred cceeeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHH
Confidence 999985554 444566799999999998753 346778999999999999999999994221 111111
Q ss_pred HHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 243 LIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.+..+ -.++..| -..+.+...++|+.+||+.||++|.|++|+|.+-.-
T Consensus 239 ~ImeG-kyqF~sp-----eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 239 MIMEG-KYQFRSP-----EWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred HHHhc-ccccCCc-----chhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 11111 1111111 122345558899999999999999999999876544
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=274.70 Aligned_cols=250 Identities=25% Similarity=0.323 Sum_probs=200.7
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
..|+..+.||+|++|.||+|.+. ++..+++|...... ....+.+.+|+.+++.++|||++++++.+..+...++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 46788899999999999999765 57889999876443 33455688999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+.+. ...+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~----~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLK---PGPLEETYIATILREILKGLDYLHSE----RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC----CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999988874 34588999999999999999999999 999999999999999999999999999864443322
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
......++..|+|||.+.+..++.++|+||||+++|+|++|..|+........ .. . ......+ .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~-----~-----~~~~~~~----~ 220 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LF-----L-----IPKNSPP----T 220 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hh-----h-----hhcCCCC----C
Confidence 22334577889999999988899999999999999999999999864322110 00 0 0001111 1
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.....+..+.+++.+||+.+|++|||+.+++.+-+
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 12223455788999999999999999999998543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=269.42 Aligned_cols=247 Identities=25% Similarity=0.309 Sum_probs=193.4
Q ss_pred ceecCCCceEEEEEEeC-C---CcEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK-D---GQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-~---~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
++||+|+||.||+|.+. . +..+++|.+..... ...+.+.+|+.+++.+.|||++++++++. .+..++|++|+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999653 2 36889998775433 24456889999999999999999999876 4567999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|.+++.... .+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK----HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc----CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999986544 689999999999999999999999 999999999999999999999999999875433322111
Q ss_pred ---cccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 184 ---KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 184 ---~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
...++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...... .... ..... . ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~---~~~~~---~-------~~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIA---MLESG---E-------RL 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHH---HHHcC---C-------cC
Confidence 1122357999999988889999999999999999998 99998643221 1111 11000 0 00
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
..+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 112223456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=273.04 Aligned_cols=259 Identities=25% Similarity=0.322 Sum_probs=200.7
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCc----EEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQ----MIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~----~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
..+|++.+.||+|+||+||+|.+. ++. .|++|+..... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 468999999999999999999754 333 47888876432 33345678899999999999999999998754 468
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
++++|+.+++|.+.+.... ..+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~----~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV----RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 9999999999998885433 3589999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 176 TTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 176 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
...... .....+++.|+|||...+..++.++||||||+++|+|++ |..||....... ... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~----- 227 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPD----LLEKG----- 227 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHCC-----
Confidence 322211 111234568999999988889999999999999999998 889986432211 111 01110
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
... ..+...+..+.+++.+||..||++||++.++++.|.....+..
T Consensus 228 ~~~----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 228 ERL----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred CcC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 000 1112234457889999999999999999999999988876653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=271.48 Aligned_cols=255 Identities=25% Similarity=0.341 Sum_probs=200.0
Q ss_pred hcCCcccceecCCCceEEEEEEeC----CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
.++|++.+.||+|+||.||+|.+. .+..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 358999999999999999999764 23368888776432 3335578899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
+|||+.+++|.+++.... ..++..++..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC----CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999886543 3588999999999999999999999 99999999999999999999999999986443
Q ss_pred CCCCccc---cccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 177 TDDPVQT---KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 177 ~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
....... ...++..|+|||.+.+..++.++|+||||+++|++++ |..||....... . .......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~----~~~~~~~------ 225 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--V----IKAIEEG------ 225 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--H----HHHHhCC------
Confidence 3221111 1122457999999998889999999999999999886 999986433211 0 1111110
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.... .+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 226 ~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 YRLP----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CcCC----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0000 1112344578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=268.68 Aligned_cols=249 Identities=21% Similarity=0.325 Sum_probs=200.4
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+|+..+.||+|++|.||++.+. +++.+++|.+... .......+.+|+.+++.++|||++++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5899999999999999999765 6888999987653 233456788999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC-CceeECCCCcccccCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD-FVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~-~~i~l~dfg~~~~~~~~~ 179 (315)
+.+++|.+++.......+++..+..++.+++.++.+||+. +++|+||+|+||+++.+ +.++++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK----LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999766666789999999999999999999999 99999999999999865 467999999987443322
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ... .... .. ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~----~~~~-----~~-----~~ 219 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVL----KIMS-----GT-----FA 219 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHH----HHHh-----cC-----CC
Confidence 2223457889999999988888999999999999999999999986433211 110 0000 00 00
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
..+...+..+.+++.+||..+|++|||+.+++.+
T Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1112234457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=284.43 Aligned_cols=264 Identities=21% Similarity=0.215 Sum_probs=196.8
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEec-----
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE----- 91 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 91 (315)
...++|++.+.||+|+||.||++.+. +++.+++|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35689999999999999999999765 6888999987643 233345677899999999999999999988543
Q ss_pred -CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCC
Q 046121 92 -NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 92 -~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
...++||||+.+ ++...+. ..++...+..++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEECCCCCEEEeeCc
Confidence 356999999865 5555542 2478889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH---------
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE--------- 241 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 241 (315)
++...... .......+++.|+|||++.+..++.++|+||||+++|+|++|..||...... ........
T Consensus 165 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHH
Confidence 99643322 2223456789999999999888999999999999999999999999644311 11100000
Q ss_pred ---------HHHhhh-ccccccCCc-----c---cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 242 ---------PLIEKL-ALHELIDPR-----I---ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 242 ---------~~~~~~-~~~~~~~~~-----~---~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
...... .......+. . ....+......+.+++.+||+.||++|||+.+++++-+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence 000000 000000000 0 01111223456789999999999999999999998743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=270.90 Aligned_cols=248 Identities=22% Similarity=0.343 Sum_probs=197.7
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc---------cHHHHHHHHHHHhhcCCCCccceeeeEEecCe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ---------GFAEFQSEVYVLNFARHKNIVMLLGFCCKENL 93 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (315)
+|++.+.||.|++|.||+|.+. +++.+++|.+...... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999765 5888999987654322 12457889999999999999999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.++++||+.+++|.+++... ..++...+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~----~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR----GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc----CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999888543 4588889999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCCC------ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh
Q 046121 174 WKTTDDP------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL 247 (315)
Q Consensus 174 ~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (315)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~----~~---- 224 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIF----KI---- 224 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHHH----HH----
Confidence 4432111 111234678899999998888899999999999999999999999643211 0000 00
Q ss_pred ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.....+. .+...+..+.+++.+||+.||++||++.++++.
T Consensus 225 --~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 --GENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred --hccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0011111 222344567889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=270.54 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=196.3
Q ss_pred CcccceecCCCceEEEEEEeC----CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCe-----
Q 046121 25 FSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL----- 93 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----- 93 (315)
|.+++.||+|+||.||.|... .+..+++|.+.... ......+.+|+..++.++|||++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678899999999999999754 24679999876432 3335578899999999999999999998865544
Q ss_pred -eEEEEEeccCCccccccccC----CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECC
Q 046121 94 -NILVYEYICNKSLHWHLFDN----TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGD 168 (315)
Q Consensus 94 -~~lv~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~d 168 (315)
.+++++|+.+++|...+... ....+++..+..++.|++.|+.+||+. +++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR----NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchheEEECCCCeEEECC
Confidence 79999999999998877432 234689999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHh
Q 046121 169 FGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIE 245 (315)
Q Consensus 169 fg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (315)
||++......... ......+..|+|||.+.+..++.++||||||+++|+|++ |.+||...... . ......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~----~~~~~~- 229 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--E----IYDYLR- 229 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--H----HHHHHH-
Confidence 9998644322211 111234567999999988889999999999999999999 88888543211 1 111111
Q ss_pred hhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 246 KLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
... . ...+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 230 ~~~-----~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGN-----R----LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCC-----C----CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 100 0 111223345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=276.82 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=203.2
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC--------CCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccceeeeEE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK--------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCC 89 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 89 (315)
...++|.+.+.||+|+||.||+|.+. ++..+++|...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 45678999999999999999999641 24578888876432 34456788999999999 7999999999999
Q ss_pred ecCeeEEEEEeccCCccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCc
Q 046121 90 KENLNILVYEYICNKSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSN 155 (315)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~n 155 (315)
.....+++|||+.+++|.+++.+.. ...++...+..++.|++.|+.|||+. |++|+||||+|
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----givH~dlkp~N 167 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ----KCIHRDLAARN 167 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC----Ceeecccccce
Confidence 9999999999999999998886532 23578888999999999999999999 99999999999
Q ss_pred EEEcCCCceeECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCcc
Q 046121 156 ILLTHDFVPMLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEP 232 (315)
Q Consensus 156 il~~~~~~i~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~ 232 (315)
|+++.++.++|+|||.+......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~- 246 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 246 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence 99999999999999998644332221 112234567999999988889999999999999999998 77887533211
Q ss_pred chhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 233 QQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
......... . ....+...+..+.+++.+||..+|++|||+.++++.|.++..
T Consensus 247 -----~~~~~~~~~-~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 247 -----ELFKLLKEG-H---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred -----HHHHHHHcC-C---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 111111100 0 001122334568889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=271.63 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=198.6
Q ss_pred cCCcccceecCCCceEEEEEEeCC-C---cEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKD-G---QMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~-~---~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
++|.+.+.||+|+||.||+|.+.. + ..+++|+.... .......+..|+.+++.++||||+++.+++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 578999999999999999997652 2 36899987654 334456788999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
+||+.+++|.+++.... ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~----g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999988885443 4588999999999999999999999 999999999999999999999999998864332
Q ss_pred CCCc--ccccc---ccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 178 DDPV--QTKIL---GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 178 ~~~~--~~~~~---~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
.... ..... .+..|+|||.+.+..++.++||||||+++|++++ |..||...... ... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~---~~i~~~----- 227 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVI---NAIEQD----- 227 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHH---HHHHcC-----
Confidence 2111 01111 1347999999988889999999999999999886 99998643221 111 111100
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.... .+...+..+.+++.+||..+|++||++++++..|+..
T Consensus 228 -~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 -YRLP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -CcCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 1112344578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=268.50 Aligned_cols=246 Identities=24% Similarity=0.297 Sum_probs=191.6
Q ss_pred eecCCCceEEEEEEeC---CCcEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCc
Q 046121 30 LLGEGGFGHVYKGELK---DGQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKS 105 (315)
Q Consensus 30 ~lg~g~~~~v~~~~~~---~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~ 105 (315)
.||+|+||.||+|.+. ++..+++|+...... ...+.+.+|+.+++.++||||+++++++. ....++||||+.+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 355689998765433 23456889999999999999999999875 456799999999999
Q ss_pred cccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc---c
Q 046121 106 LHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV---Q 182 (315)
Q Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~---~ 182 (315)
|.+++... ...+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++......... .
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK----NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc----CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99887533 34689999999999999999999999 9999999999999999999999999998643322211 1
Q ss_pred ccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 183 TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 183 ~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
....+++.|+|||.+.+..++.++|+||||+++|++++ |..||....... .. ...... .....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~-~~~~~~---------~~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VM-SFIEQG---------KRLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HH-HHHHCC---------CCCCC
Confidence 11223567999999988888999999999999999996 999986443211 00 011110 11112
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
+...+..+.+++.+||..+|++||++.++.+.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 233455688899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=274.27 Aligned_cols=261 Identities=21% Similarity=0.320 Sum_probs=205.0
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.++|++++.||+|++|+||++.+. +++.+++|+..... ......+.+|+++++.++||||+++++.+......++|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 468999999999999999999865 58889999876543 3345678899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
|+.+++|.+.+... ..+++..+..++.+++.++.+||+ . +++|+||+|+||+++.++.++++|||++......
T Consensus 84 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~----~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVH----RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhc----CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999998887543 458999999999999999999996 5 8999999999999999999999999988533221
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccc-----hhHHHhHHHHHhhhcccccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ-----QSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 253 (315)
......++..|+|||++.+..++.++|+|||||++|++++|..||........ ............. .
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 229 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------P 229 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------c
Confidence 12234678899999999888899999999999999999999999975443211 0001111111100 0
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
.+.+. ....+..+.+++.+||+.||++|||+.+++.+..-+..
T Consensus 230 ~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 230 PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 01111 11234568899999999999999999999987665544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=281.76 Aligned_cols=264 Identities=20% Similarity=0.208 Sum_probs=196.7
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEec-----
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE----- 91 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 91 (315)
...++|++.+.||+|+||.||++.+. .++.+++|++... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 35679999999999999999999865 6888999987643 233345678899999999999999999987543
Q ss_pred -CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCC
Q 046121 92 -NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 92 -~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
...|+||||+.+ +|...+. ..++...+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999865 5655552 2478889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH---------
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE--------- 241 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 241 (315)
++...... .......+++.|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 172 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHH
Confidence 99643322 2223456789999999999988999999999999999999999999644321 11111000
Q ss_pred ---------HHHhhhc-cc-----cccCCcc---cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 242 ---------PLIEKLA-LH-----ELIDPRI---ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 242 ---------~~~~~~~-~~-----~~~~~~~---~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
....... .. ....... ...........+.+++.+||+.||++|||+.+++++-+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 0000000 00 0000000 00111112346789999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=301.61 Aligned_cols=257 Identities=23% Similarity=0.274 Sum_probs=198.5
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++.++||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999876 58899999876432 222456889999999999999999999999999999999
Q ss_pred EeccCCccccccccCC---------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCC
Q 046121 99 EYICNKSLHWHLFDNT---------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDF 169 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~df 169 (315)
||+.|++|.+.+.... ....+...++.++.|++.|+.+||+. |++||||||+||+++.++.++++||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~----GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK----GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC----CccccCCchheEEEcCCCCEEEEec
Confidence 9999999988875321 23356677889999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCC------------------CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCc
Q 046121 170 GLARWKTTDD------------------PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEE 231 (315)
Q Consensus 170 g~~~~~~~~~------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~ 231 (315)
|++....... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9986441110 0011246899999999999989999999999999999999999999642211
Q ss_pred cchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhcc
Q 046121 232 PQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRP-SMGEVVRLLEGE 297 (315)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-s~~~il~~L~~~ 297 (315)
.... . . ....+. ........+..+.+++.+||..||++|| +++++++.|+..
T Consensus 238 ki~~-~---~---------~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 238 KISY-R---D---------VILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhh-h---h---------hccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1000 0 0 000000 0000112334577889999999999996 566677766654
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=270.37 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=193.4
Q ss_pred CcccceecCCCceEEEEEEeCC-Cc--EEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEec------Ce
Q 046121 25 FSKENLLGEGGFGHVYKGELKD-GQ--MIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE------NL 93 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~~-~~--~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 93 (315)
|.+.+.||+|+||.||+|.+.. +. .+++|..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4577899999999999998764 32 5888876643 234456788899999999999999999976422 24
Q ss_pred eEEEEEeccCCccccccccC----CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCC
Q 046121 94 NILVYEYICNKSLHWHLFDN----TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDF 169 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~df 169 (315)
.+++++|+.+++|.+++... ....+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++++||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK----SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhheEEcCCCCEEECCC
Confidence 68999999999998776321 234588999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhh
Q 046121 170 GLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEK 246 (315)
Q Consensus 170 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (315)
|++......... .....+++.|++||...+..++.++|+||||+++|+|++ |..||...... ... .. ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~----~~-~~~ 229 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIY----DY-LRQ 229 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HH-HHc
Confidence 998754332211 122345678999999998889999999999999999999 78888543211 111 11 111
Q ss_pred hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
... .. .+...+..+.+++.+||..||++|||+.++++.|+.+
T Consensus 230 ~~~-----~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GNR-----LK----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC-----CC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 00 1122344578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=269.31 Aligned_cols=247 Identities=27% Similarity=0.362 Sum_probs=197.2
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
++|++.+.||+|+||.||.+.. +++.+++|..... .....+.+|+.+++.++|||++++++++... ..+++|||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5799999999999999999875 5677899887543 2345788999999999999999999998655 4699999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcc
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~ 182 (315)
+++|.+++.......++...++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++...... .
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~ 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK----KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---V 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCcEEECCCccceecccc---C
Confidence 99999998766666789999999999999999999999 9999999999999999999999999998643221 1
Q ss_pred ccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 183 TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 183 ~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ..... ... ......
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~-~~~---------~~~~~~ 218 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKEC-VEK---------GYRMEP 218 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHH-HhC---------CCCCCC
Confidence 12233567999999988889999999999999999997 89998643321 11111 111 001111
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 22334567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=273.04 Aligned_cols=254 Identities=22% Similarity=0.312 Sum_probs=199.8
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
++|++++.||+|++|.||++.+. ++..+++|.+... .......+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47999999999999999999876 6889999977643 334456788999999999999999999999999999999999
Q ss_pred ccCCccccccccCC-CCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 101 ICNKSLHWHLFDNT-ESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 101 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
+.+++|..++.... ...+++..+..++.+++.++.+||+ . +++|+||+|+||+++.++.++++|||.+......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH----NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC----CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999988775432 2368999999999999999999996 5 8999999999999999999999999998643222
Q ss_pred CCccccccccccccCccccccCC------CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGI------VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~------~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||....... .... ... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~-~~~---------~ 222 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQ-LSA---------I 222 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHH-HHH---------H
Confidence 222345778899999886543 4778999999999999999999996432111 0000 000 0
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
. .......+...+..+.+++.+||+.+|++||++.+++..-+
T Consensus 223 ~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 223 V-DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred h-hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 0 00111222335566788999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=267.83 Aligned_cols=250 Identities=30% Similarity=0.452 Sum_probs=198.9
Q ss_pred CcccceecCCCceEEEEEEeCC-----CcEEEEEEecccCcc-cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 25 FSKENLLGEGGFGHVYKGELKD-----GQMIAAKVRKEASTQ-GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
+++.+.||.|+||.||++.+.. +..+++|+....... ....+.+|+..++.++|+|++++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4678899999999999997653 488999988655433 5667889999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
+++.+++|.+++.......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~----~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC----CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999988655444489999999999999999999999 9999999999999999999999999998644433
Q ss_pred CCccc-cccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 179 DPVQT-KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 179 ~~~~~-~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
..... ...+++.|+|||.+.+..++.++|+||||+++++|++ |.+||...... ..... .....
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~------~~~~~-~~~~~-------- 221 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE------EVLEY-LKKGY-------- 221 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HhcCC--------
Confidence 11111 1235688999999988889999999999999999998 77887542211 10011 11100
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
....+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111122455688899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=268.62 Aligned_cols=251 Identities=22% Similarity=0.372 Sum_probs=198.8
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
.+|++.+.||+|++|.||++.+.++..+++|...... .....+.+|+++++.++||+++++++++......+++++|+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4789999999999999999988777889999876432 234568889999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc-
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV- 181 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~- 181 (315)
+++|.+++.... ..+++..++.++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS----NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC----CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 999988875433 3578899999999999999999999 9999999999999999999999999988643222111
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
.....++..|+|||.+.++.++.++|+||||+++|+|++ |..||....... ...... . ......+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~-~--~~~~~~~----- 223 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETIN-A--GFRLYKP----- 223 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHh-C--CCCCCCC-----
Confidence 112234568999999988889999999999999999998 889986433211 011100 0 0011111
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 224 --~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 --RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112456889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=273.42 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=203.9
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
.++|++.+.||+|+||+||++.+. +++.+++|.+........+.+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 479999999999999999999764 6788999987655555556788999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.+ ..++...+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~----gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC----CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999988843 3478889999999999999999999 999999999999999999999999998865444333
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
......+++.|++||.+.+..++.++|+||||+++|++++|..||.......... . ... .+.....
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--~----------~~~--~~~~~~~ 236 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L----------IAT--NGTPELQ 236 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--e----------hhc--CCCCCCC
Confidence 3334467888999999988888999999999999999999999996433211000 0 000 0000111
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
.+......+.+++.+||..+|++||++.+++.+-
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 1222345688999999999999999999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=273.82 Aligned_cols=263 Identities=25% Similarity=0.266 Sum_probs=199.1
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
++|++.+.||+|++|.||+|.+. +++.+++|.+.... ......+.+|+.+++.++|||++++++++......++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999876 58899999876432 2233457889999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.++++...... ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKH----NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999888766532 33589999999999999999999999 99999999999999999999999999997554433
Q ss_pred CccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH----------hhhc
Q 046121 180 PVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI----------EKLA 248 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------~~~~ 248 (315)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||........ ......... ....
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChHHhhhccccc
Confidence 22334456788999998865 4578899999999999999999999965432111 111000000 0000
Q ss_pred c-ccccCCcccCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 249 L-HELIDPRIENSY-----DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 249 ~-~~~~~~~~~~~~-----~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
. .....+...... .+..+..+.+++.+||+.+|++|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 000001000000 01234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=281.28 Aligned_cols=262 Identities=22% Similarity=0.241 Sum_probs=194.1
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEec-----
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE----- 91 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 91 (315)
.+.++|++++.||.|+||+||+|.+. +++.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 35689999999999999999999765 68899999876432 22334577899999999999999999887533
Q ss_pred -CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCC
Q 046121 92 -NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 92 -~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
...+++++++ +++|.+.+. ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSA----GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecccCChhhEEECCCCCEEEcCCc
Confidence 3468899986 788877663 34589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH------
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL------ 243 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------ 243 (315)
++..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..........
T Consensus 164 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 164 LARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVGTPSPE 238 (343)
T ss_pred cceecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence 9874332 2234567899999998876 56788999999999999999999999643321 1111100000
Q ss_pred -H--------hhh--ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 244 -I--------EKL--ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 244 -~--------~~~--~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
. ... .........+... .......+.+++.+||+.||++|||+.+++.+-+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKI-FRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 0 000 0000000000000 0012234679999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=277.03 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=203.2
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc---cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ---GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++.+.||+|++|+||+|... +++.+++|.+...... ....+.+|+.+++.++||||+++++.+......++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999876 5899999987754322 3456788999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+++.......+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL----GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988766667799999999999999999999999 9999999999999999999999999987533221
Q ss_pred CC-----------------------------ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCC
Q 046121 179 DP-----------------------------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNG 229 (315)
Q Consensus 179 ~~-----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~ 229 (315)
.. ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 10 1112356788999999988888999999999999999999999996443
Q ss_pred CccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC----HHHHHHHHh
Q 046121 230 EEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS----MGEVVRLLE 295 (315)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps----~~~il~~L~ 295 (315)
.. ..... .. ............+..+.+++.+||..+|++||| +++++.+-+
T Consensus 237 ~~--~~~~~----~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 237 RD--ETFSN----IL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred hH--HHHHH----Hh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence 21 11110 00 000000011114566889999999999999999 888887643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=268.30 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=196.0
Q ss_pred ceecCCCceEEEEEEeCC--C--cEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELKD--G--QMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~--~--~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|++|.||+|.+.+ + ..+++|.+..... ...+.+.+|+..++.++||||+++++.+.. ...++++||+.+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999997643 2 3589998876655 556678899999999999999999999887 888999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc--
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV-- 181 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~-- 181 (315)
++|.+.+.++....+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK----RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC----CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 9999988765545689999999999999999999999 9999999999999999999999999998754332211
Q ss_pred -cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 182 -QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 182 -~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... .... ..... .. .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~-----~~----~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKK----IDKEG-----ER----L 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HHhcC-----Cc----C
Confidence 112345678999999988889999999999999999998 999985432211 1111 11000 00 0
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123456888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=270.03 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=199.4
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CC---cEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DG---QMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~---~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
.++|+..+.||+|++|.||+|... ++ ..+++|..... .......+.+|+.+++.++|||++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357889999999999999999765 23 36888877644 23345568899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.+++|.+++.... ..+++.....++.+++.|+.+||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM----NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999988885433 4588999999999999999999999 99999999999999999999999999986443
Q ss_pred CCCCccc---cccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 177 TDDPVQT---KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 177 ~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
....... ....+..|+|||++.+..++.++|+||||+++|+|++ |..||...... ... .... .. .
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~----~~i~-~~----~ 227 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVM----KAIN-DG----F 227 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHH----HHHh-cC----C
Confidence 3222111 1122457999999988888999999999999999997 99998543221 111 1111 00 0
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
..+. +...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 ~~~~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 RLPA-----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111 112234578999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=269.93 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=198.7
Q ss_pred CCcccceecCCCceEEEEEEeCCCcEEEEEEecccC------cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAS------TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
+|++.+.||.|+||+||+|...+++.+++|.+.... ......+.+|+.+++.++|+|++++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 589999999999999999988888999999866432 12234578899999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
+||+.+++|.+++.+. ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999988543 3578999999999999999999999 999999999999999999999999998864321
Q ss_pred C------CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 178 D------DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 178 ~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
. ........++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .... ... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~----~~~----~~ 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFY----IGA----HR 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHH----hhh----cc
Confidence 1 111123457888999999998888999999999999999999999996432111 0000 000 00
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...+.. +...+..+.+++.+||+.+|++||++.+++++
T Consensus 225 ~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 225 GLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 011111 22344557889999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=273.27 Aligned_cols=257 Identities=24% Similarity=0.313 Sum_probs=199.7
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeeeEEe----
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCK---- 90 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~---- 90 (315)
......+.|++.+.||+|+||.||+|.+. +++.+++|+..... .....+..|+.+++.+ +|+|++++++++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 33345689999999999999999999875 68889999876543 3345678899999888 69999999998842
Q ss_pred --cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECC
Q 046121 91 --ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGD 168 (315)
Q Consensus 91 --~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~d 168 (315)
....+++|||+.+++|.+++.......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dl~~~nili~~~~~~~l~d 164 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH----KVIHRDIKGQNVLLTENAEVKLVD 164 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEee
Confidence 46789999999999999988766666788999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCCCccccccccccccCccccc-----cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH
Q 046121 169 FGLARWKTTDDPVQTKILGTLGYLAPEYAE-----NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
||++..............+++.|+|||.+. +..++.++|+||||+++|+|++|..||........ .. .
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~~----~- 237 (282)
T cd06636 165 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--LF----L- 237 (282)
T ss_pred CcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--hh----h-
Confidence 999864432222223346788999999875 34577899999999999999999999954321100 00 0
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.. ....+ .......+..+.+++.+||+.||.+|||+.++++.
T Consensus 238 ~~-----~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 238 IP-----RNPPP---KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred Hh-----hCCCC---CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00 00011 11112234568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=284.21 Aligned_cols=272 Identities=18% Similarity=0.170 Sum_probs=202.4
Q ss_pred HhcCCcccceecCCCceEEEEEEeC---CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK---DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
...+|++++.||+|+||.||++... .+..+++|..... ....+|+.+++.++||||+++++.+......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 4568999999999999999999643 3677888876543 2346899999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|+++. ++|.+++ .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 165 ~e~~~-~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH~~----givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLHGR----GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99974 5777777 3345689999999999999999999999 999999999999999999999999999864433
Q ss_pred CCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCcc-chhHHHhHHHHHhhh-c-----
Q 046121 178 DDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEP-QQSLRQWAEPLIEKL-A----- 248 (315)
Q Consensus 178 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~-~----- 248 (315)
... ......|++.|+|||++.+..++.++|||||||++|+|++|..||....... ...+........... .
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 221 1223568999999999998889999999999999999999999986543221 111111111000000 0
Q ss_pred ----------cccccCCc--ccCCC-CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccc
Q 046121 249 ----------LHELIDPR--IENSY-DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHL 304 (315)
Q Consensus 249 ----------~~~~~~~~--~~~~~-~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~ 304 (315)
......+. ..... .......+.+++.+||..||++|||+.+++.+-+-....++.+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~ 386 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLL 386 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhh
Confidence 00000000 00000 0112345778999999999999999999999876655444443
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=273.88 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=197.7
Q ss_pred HhcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (315)
..++|++.+.||+|+||.||+|.++ .+..+++|...... ......+.+|+.+++.++|||++++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999643 24578998765432 2223356789999999999999999999999999
Q ss_pred eEEEEEeccCCccccccccCC--------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCcee
Q 046121 94 NILVYEYICNKSLHWHLFDNT--------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM 165 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~ 165 (315)
.++||||+.+++|.+++.... ....+...+..++.|++.++.+||+. +++|+||+|+||+++.++.++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK----KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCCChheEEEcCCCcEE
Confidence 999999999999999885422 13346678888999999999999999 999999999999999999999
Q ss_pred ECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHH
Q 046121 166 LGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEP 242 (315)
Q Consensus 166 l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 242 (315)
|+|||++......... .....++..|+|||.+.++.++.++|+||||+++|+|++ |..||...... .....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~ 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKF 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence 9999998633222111 112234677999999988889999999999999999998 77888542211 11111
Q ss_pred HHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 243 LIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.. .... . ..+...+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 234 ~~-~~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 VM-DGGY-----L----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HH-cCCC-----C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11 0000 0 01112235688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=283.55 Aligned_cols=243 Identities=24% Similarity=0.291 Sum_probs=186.6
Q ss_pred ecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhc---CCCCccceeeeEEecCeeEEEEEeccC
Q 046121 31 LGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFA---RHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 31 lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
||+|+||+||+|.+. +++.+|+|++.... .........|..++... +||+|+.+++.+......++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 68999999876432 12223344566666554 699999999999999999999999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
++|.+.+.+ ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKY----DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 999888754 34589999999999999999999999 999999999999999999999999999864333333334
Q ss_pred cccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCC
Q 046121 184 KILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYD 262 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (315)
...|++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ... .... .... .+. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--~~~----~~i~----~~~~---~~~---~ 218 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--QMY----RNIA----FGKV---RFP---K 218 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--HHH----HHHH----cCCC---CCC---C
Confidence 45789999999988754 4789999999999999999999999643221 110 1100 0000 011 1
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC----CHHHHHHHHh
Q 046121 263 TYELYLMAKTAYLCVQRNPEGRP----SMGEVVRLLE 295 (315)
Q Consensus 263 ~~~~~~l~~l~~~~l~~~p~~Rp----s~~~il~~L~ 295 (315)
...+..+.+++.+||..||++|| ++.+++++-+
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~ 255 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF 255 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence 11344577899999999999998 6777776544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=275.19 Aligned_cols=259 Identities=20% Similarity=0.261 Sum_probs=204.8
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
..|.....||+|+||.||++.+. +++.+++|.+..........+.+|+.+++.++|||++++++++..++..++++||+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 45666778999999999999865 68899999887655555667889999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.+++|...+. ...+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 101 ~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 101 QGGALTDIVS---QTRLNEEQIATVCESVLQALCYLHSQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred CCCCHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence 9999988763 24588999999999999999999999 9999999999999999999999999998644333322
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ..+.. ..... .+ ....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~-----~~~~~-----~~--~~~~ 239 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKR-----LRDSP-----PP--KLKN 239 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-----HhccC-----CC--Cccc
Confidence 33456788999999998888999999999999999999999998643221 11111 00000 00 0001
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
.......+.+++.+||+.+|++||++++++++-.-.+..+.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 11233457889999999999999999999997554444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=271.32 Aligned_cols=254 Identities=27% Similarity=0.333 Sum_probs=199.6
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeeeEEecC------
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKEN------ 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~------ 92 (315)
..++|++.+.||+|++|.||+|.+. +++.+++|++..... ....+.+|+.+++.+ +|+|++++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4589999999999999999999875 578899998775433 346788999999998 6999999999986644
Q ss_pred eeEEEEEeccCCccccccccCC--CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCC
Q 046121 93 LNILVYEYICNKSLHWHLFDNT--ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
..++|+||+.+++|.+.+.... ...+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN----KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999988876543 46789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCcccccc-----CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAEN-----GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE 245 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (315)
++..............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...... ..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~- 231 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK----IP- 231 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH----hh-
Confidence 98644333333334567889999998753 34677899999999999999999999633211 11111 00
Q ss_pred hhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 246 KLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
. ...+.. ..+...+..+.+++.+||..||++|||+.+++++
T Consensus 232 ~-----~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 R-----NPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred c-----cCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 001111 1112245568899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=276.60 Aligned_cols=257 Identities=21% Similarity=0.204 Sum_probs=195.9
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++.+.||+|+||+||++... +++.+|+|++... .......+.+|+.+++.++|++|+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999865 6889999998642 2233455788999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.|++|.+++.+. ...+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL----GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999888543 34588999999999999999999999 9999999999999999999999999998644332
Q ss_pred CC-ccccccccccccCcccccc-----CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 179 DP-VQTKILGTLGYLAPEYAEN-----GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 179 ~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
.. ......|++.|+|||++.+ ..++.++||||+||++|+|++|..||...... ...............
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~ 229 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQF 229 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCcccC
Confidence 22 2223468999999998863 45678999999999999999999999643211 111111111000000
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCC--CCCCCHHHHHHHHhc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNP--EGRPSMGEVVRLLEG 296 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p--~~Rps~~~il~~L~~ 296 (315)
+... ...+..+.+++.+||..++ ..|+++++++++-+-
T Consensus 230 --~~~~----~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~ 269 (331)
T cd05597 230 --PPDV----TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269 (331)
T ss_pred --CCcc----CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence 1011 1134456677777765433 348899999988654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=273.11 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=199.6
Q ss_pred hcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
.++|++.+.||+|+||.||+|.+. ++..+++|++.... ......+.+|+.+++.++|||++++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 468999999999999999999753 46788999876543 23345688899999999999999999999999999
Q ss_pred EEEEEeccCCccccccccCC--------------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccC
Q 046121 95 ILVYEYICNKSLHWHLFDNT--------------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPS 154 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~ 154 (315)
++++||+.+++|.+++.... ...++...++.++.|++.++.+||+. +++|+||+|+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~----~i~H~dl~p~ 159 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER----KFVHRDLATR 159 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CeecccccHh
Confidence 99999999999988885321 13478888999999999999999999 9999999999
Q ss_pred cEEEcCCCceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCc
Q 046121 155 NILLTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEE 231 (315)
Q Consensus 155 nil~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~ 231 (315)
||+++.++.++++|||++........ .......+..|+|||...+..++.++|+||||+++|+|++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999864332211 1122234567999999988889999999999999999997 77787533221
Q ss_pred cchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 232 PQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
..... ...... . ..+...+..+.+++.+||+.+|++|||+.+++..|+.
T Consensus 240 ------~~~~~-~~~~~~---~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ------EVIYY-VRDGNV---L------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHH-HhcCCC---C------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 111100 0 0112234568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=270.11 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=200.2
Q ss_pred cCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccCcc-cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEASTQ-GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
++|++.+.||+|+||+||+|..+ +.+.+++|........ ....+.+|+++++.++|||++++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 68999999999999999999754 3567888877654333 4567889999999999999999999999989999
Q ss_pred EEEEeccCCccccccccCCC-------CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECC
Q 046121 96 LVYEYICNKSLHWHLFDNTE-------SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGD 168 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~d 168 (315)
+||||+.+++|.+++..... ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA----RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc----CcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999998865442 2589999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCCC-ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhh
Q 046121 169 FGLARWKTTDDP-VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEK 246 (315)
Q Consensus 169 fg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (315)
||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ... .. ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~----~~-~~~ 233 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVL----NR-LQA 233 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHH----HH-HHc
Confidence 998853322111 1122345677999999888888899999999999999998 77888532211 110 11 000
Q ss_pred hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.. .....+...+..+.+++.+||+.+|++|||+.+++..|++
T Consensus 234 ~~--------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 234 GK--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CC--------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 00 0000111234468889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=264.89 Aligned_cols=250 Identities=25% Similarity=0.312 Sum_probs=208.3
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
.-++|..+++||+|+||.|-+++.+ +++.+|+|++++.- ...+..-..|-++|+..+||.+..+...|...+++|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4578999999999999999999866 79999999988653 3344556789999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||+|..||.|.-++ +....+++.....+...|+.||.|||++ +|+.||+|.+|.++|++|+||+.|||+|+-..
T Consensus 246 VMeyanGGeLf~HL--srer~FsE~RtRFYGaEIvsAL~YLHs~----~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHL--SRERVFSEDRTRFYGAEIVSALGYLHSR----NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeeh--hhhhcccchhhhhhhHHHHHHhhhhhhC----CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999998887 4567799999999999999999999999 99999999999999999999999999998777
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
..+....+.+|+|.|+|||++....|+.+.|.|.+|+++|+|++|++||-....+....+.. ..
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-----~e----------- 383 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-----ME----------- 383 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-----hh-----------
Confidence 77777888999999999999999999999999999999999999999995433221111111 01
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRL 293 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~ 293 (315)
...++...+...+.|+..+|.+||++|. .++||.++
T Consensus 384 -d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 384 -DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred -hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 1112233334467788889999999996 45666543
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=266.79 Aligned_cols=252 Identities=25% Similarity=0.320 Sum_probs=206.0
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
++|++.+.||.|++|.||+|.+. +++.+++|.+..... .....+.+|+..++.++|+|++++++++......++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36899999999999999999876 589999998776543 4456788999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
+.+++|.+++... ..+++..++.++.|++.++.+||+ . +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~----~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR----HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC----CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998544 568999999999999999999999 9 99999999999999999999999999987554433
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||........... ...... ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~~~~~----------~~~~ 221 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL---MQAICD----------GPPP 221 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH---HHHHhc----------CCCC
Confidence 333345677889999999888899999999999999999999999965543111111 111110 0111
Q ss_pred CCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 260 SYDTY-ELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 260 ~~~~~-~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
..+.. .+..+.+++.+||..+|++|||+.++++.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11222 45668899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=268.86 Aligned_cols=257 Identities=23% Similarity=0.302 Sum_probs=200.2
Q ss_pred HhcCCcccceecCCCceEEEEEEeCC----CcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKD----GQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
...+|.+.+.||+|++|.||+|.+.+ ...+++|...... ....+.+.+|+.+++.++|||++++++++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34679999999999999999997542 3467888776544 3445678899999999999999999998875 4568
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+||||+.+++|.+++.... ..++...+..++.+++.++.+||+. +++|+||+|+||+++.++.++++|||++...
T Consensus 83 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK----RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999886543 3589999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCCCcc-ccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 176 TTDDPVQ-TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 176 ~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
....... ....++..|+|||.+.+..++.++|+||||+++|++++ |..||........ .. . .... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~----~-~~~~-----~ 225 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IG----R-IENG-----E 225 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HH----H-HHcC-----C
Confidence 3322111 12233467999999988889999999999999999986 9999864432110 00 0 0000 0
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
... .+...+..+.+++.+||..+|++|||+.++++.|+.+.+
T Consensus 226 ~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 RLP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 001 112234468889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=276.16 Aligned_cols=194 Identities=23% Similarity=0.312 Sum_probs=156.7
Q ss_pred cceecCCCceEEEEEEeC---CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEe--cCeeEEEEEecc
Q 046121 28 ENLLGEGGFGHVYKGELK---DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK--ENLNILVYEYIC 102 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~~~~~ 102 (315)
.++||+|+||+||+|.+. +++.+++|.+.... ......+|+.+++.++||||+++++++.. ....+++++|+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999754 46789999876432 23457789999999999999999998854 456789999974
Q ss_pred CCccccccccC-------CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE----cCCCceeECCCCc
Q 046121 103 NKSLHWHLFDN-------TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL----THDFVPMLGDFGL 171 (315)
Q Consensus 103 ~~~L~~~l~~~-------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~----~~~~~i~l~dfg~ 171 (315)
++|.+.+... ....+++..+..++.|++.|+.|||+. +++|+||||+||++ +..+.++|+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5666655321 123589999999999999999999999 99999999999999 4567899999999
Q ss_pred ccccCCCCC---ccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCC
Q 046121 172 ARWKTTDDP---VQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMN 228 (315)
Q Consensus 172 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~ 228 (315)
+........ ......+++.|+|||++.+ ..++.++|+||+||++|+|++|.+||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 975433221 1223567889999998876 45788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=274.23 Aligned_cols=263 Identities=22% Similarity=0.237 Sum_probs=195.2
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+|++.+.||+|++|.||+|.+. +++.+++|.+.... ......+.+|+.+++.++|||++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5899999999999999999876 68889999876432 22234567899999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+. ++|.+.+... ...+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH----NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 86 4676666433 34589999999999999999999999 999999999999999999999999999874433322
Q ss_pred ccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH----------HHhhhcc
Q 046121 181 VQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP----------LIEKLAL 249 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------~~~~~~~ 249 (315)
......+++.|+|||.+.+. .++.++|+||||+++|+|++|..|+....... ..+...... .......
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHHHHHHHhCCCChHHhHHhhhccc
Confidence 22334567889999988664 46889999999999999999988864322211 111110000 0000000
Q ss_pred ccccCCcccC-----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 250 HELIDPRIEN-----SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 250 ~~~~~~~~~~-----~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
... .+.... ...+..+..+.+++.+||+.||.+|||+++++++.
T Consensus 234 ~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~ 282 (284)
T cd07839 234 YKP-YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282 (284)
T ss_pred ccc-cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence 000 000000 11122456678999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=272.85 Aligned_cols=262 Identities=22% Similarity=0.261 Sum_probs=200.7
Q ss_pred HHHHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeeeEE---
Q 046121 15 FSEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGFCC--- 89 (315)
Q Consensus 15 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~--- 89 (315)
+.......++|++.+.||+|++|+||++.+. +++.+++|+..... .....+.+|+.+++.+ +|||++++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3344456789999999999999999999765 57889999876432 2235677899999998 6999999999873
Q ss_pred --ecCeeEEEEEeccCCcccccccc--CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCcee
Q 046121 90 --KENLNILVYEYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM 165 (315)
Q Consensus 90 --~~~~~~lv~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~ 165 (315)
.++.+++||||+.+++|.+.+.. .....+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN----KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC----CccccCCCHHhEEECCCCCEE
Confidence 34678999999999999887653 2335688999999999999999999999 999999999999999999999
Q ss_pred ECCCCcccccCCCCCccccccccccccCcccccc-----CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH
Q 046121 166 LGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN-----GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240 (315)
Q Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 240 (315)
++|||++..............+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||....... ....
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~-- 240 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK-- 240 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh--
Confidence 9999998654433323334467889999998753 447889999999999999999999986432211 0000
Q ss_pred HHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
......+. ...+......+.+++.+||+.||++|||+.++++++.
T Consensus 241 --------~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 241 --------IPRNPPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred --------ccccCCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 00000000 0011122345889999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=273.64 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=202.4
Q ss_pred hcCCcccceecCCCceEEEEEEeC-----CCcEEEEEEecccCcc-cHHHHHHHHHHHhhcCCCCccceeeeEEe--cCe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-----DGQMIAAKVRKEASTQ-GFAEFQSEVYVLNFARHKNIVMLLGFCCK--ENL 93 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 93 (315)
.++|++.+.||+|+||.||+|... +++.+++|++...... ....+.+|+..++.++|||++++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 357899999999999999999743 3788999988765443 45678999999999999999999999877 567
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.++++||+.+++|.+++..... .++...+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+.
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQ----RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 8999999999999998865443 489999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCc---cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccch---------hHHHhHH
Q 046121 174 WKTTDDPV---QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ---------SLRQWAE 241 (315)
Q Consensus 174 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~---------~~~~~~~ 241 (315)
........ .....++..|++||.+.+..++.++|+||||+++++|++|..|+......... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 54422111 11123345699999998888999999999999999999999887543221100 0111100
Q ss_pred HHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 242 PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.... ......+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 238 -~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 -LLKE---------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -HHHc---------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000 000111122335688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=268.71 Aligned_cols=249 Identities=27% Similarity=0.353 Sum_probs=191.8
Q ss_pred ceecCCCceEEEEEEeCC-Cc--EEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELKD-GQ--MIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~-~~--~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||.||+|.+.. +. .+++|...... ......+.+|+.+++.+ +||||+++++++...+..+++|||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998753 33 46777766432 33445688899999999 799999999999999999999999999
Q ss_pred CccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCC
Q 046121 104 KSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDF 169 (315)
Q Consensus 104 ~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~df 169 (315)
++|.+++..+. ...++...+..++.|++.|+.+||+. +++|+||+|+||+++.++.++++||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccccceEEEcCCCeEEECCC
Confidence 99998886432 23478999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhc
Q 046121 170 GLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLA 248 (315)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (315)
|++...... ........+..|+|||++.+..++.++|+||||+++|+|++ |..||...... .........
T Consensus 157 gl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~~~~-- 227 (270)
T cd05047 157 GLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKLPQG-- 227 (270)
T ss_pred CCccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHHhCC--
Confidence 998522111 11111223567999999988889999999999999999997 99998543211 111111100
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 249 LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
.....+...+..+.+++.+||..+|.+|||+.+++..|..+.
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000111223345789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=273.11 Aligned_cols=265 Identities=25% Similarity=0.302 Sum_probs=194.8
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.++|++.+.||+|++|+||+|.+. +++.+++|.+..... .....+.+|+.+++.++||||+++++++......++|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 368999999999999999999876 688999998764332 222446789999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+ +|.+++.+... .+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR----RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9975 88777754433 688999999999999999999999 99999999999999999999999999986332222
Q ss_pred CccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH--------HHhhhccc
Q 046121 180 PVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP--------LIEKLALH 250 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 250 (315)
.......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||........ ........ ........
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED-QLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHHHHHhcCCCChhhhhhhhhcc
Confidence 22222345788999998865 4578899999999999999999999964432111 11000000 00000000
Q ss_pred c-------ccC-CcccCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 251 E-------LID-PRIENSYD-TYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 251 ~-------~~~-~~~~~~~~-~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
. ... ..+....+ -.....+.+++.+||+.+|++|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 000 00000000 0011456789999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=303.31 Aligned_cols=260 Identities=20% Similarity=0.271 Sum_probs=197.9
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEe--c
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCK--E 91 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 91 (315)
..+...++|++++.||+|+||+||+|.+. ++..+++|++... .......+..|+.+++.++||||+++++++.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34556789999999999999999999876 5778888887643 23345668899999999999999999998854 4
Q ss_pred CeeEEEEEeccCCccccccccC--CCCccCHHHHHHHHHHHHHHHHhhhcccC---CCCeEeecCccCcEEEcC------
Q 046121 92 NLNILVYEYICNKSLHWHLFDN--TESVLEWHQRYAAAIGTAKGLRFLHEECR---GGPIIHRDMRPSNILLTH------ 160 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---~~~i~h~di~p~nil~~~------ 160 (315)
..+|+||||+.+++|.+++... ....+++..++.++.||+.||.|||+... ..+|+|+||||+||+++.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5689999999999999888643 23569999999999999999999998520 115999999999999964
Q ss_pred -----------CCceeECCCCcccccCCCCCccccccccccccCcccccc--CCCcccccchhhhHHHHHHHhCCCccCC
Q 046121 161 -----------DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN--GIVSIRTDVYAFGIILLQLMSGRKVVDM 227 (315)
Q Consensus 161 -----------~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~ 227 (315)
.+.++|+|||++....... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3458999999986443222 2234468999999998854 4578899999999999999999999964
Q ss_pred CCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 228 NGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.... .......... +.+. ....+..+.+||..||..+|.+|||+.+++..
T Consensus 246 ~~~~-----~qli~~lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 246 ANNF-----SQLISELKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCcH-----HHHHHHHhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 3211 1111111100 1111 01123457889999999999999999999853
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=274.72 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=201.2
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
.+.|.....||+|+||.||++.+. ++..+++|.+........+.+.+|+..++.++|+|++++++.+...+..++|+||
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 345666788999999999999865 6889999988765555566788999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.. ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 101 ~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 101 LEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ----GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 999999887732 3488999999999999999999999 999999999999999999999999999864433332
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ..... .. ....+....
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~----~~------~~~~~~~~~- 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRR----IR------DNLPPRVKD- 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----HH------hcCCCcccc-
Confidence 233456788999999998888899999999999999999999998643221 11110 00 011111111
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
....+..+.+++.+||..||++|||+++++++
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234457889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=268.12 Aligned_cols=250 Identities=23% Similarity=0.304 Sum_probs=200.6
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEe--cCeeEEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCK--ENLNILVY 98 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 98 (315)
+|++.+.||.|++|.||++.+. ++..+++|.+... .....+.+.+|+.+++.++|||++++++.+.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5889999999999999999765 6788999987643 23345567889999999999999999997753 45679999
Q ss_pred EeccCCccccccccC--CCCccCHHHHHHHHHHHHHHHHhhh-----cccCCCCeEeecCccCcEEEcCCCceeECCCCc
Q 046121 99 EYICNKSLHWHLFDN--TESVLEWHQRYAAAIGTAKGLRFLH-----EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGL 171 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~lh-----~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~ 171 (315)
||+.+++|.+++.+. ....+++..++.++.+++.++.+|| +. +++|+||+|+||+++.++.++++|||+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~----~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN----TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC----cceecCCCHHHEEEecCCCEEEecccc
Confidence 999999999888543 2456899999999999999999999 77 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
+..............+++.|+|||.+.+..++.++|+||||+++++|++|..||...... ... .. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~---~~-~~~----- 224 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLA---SK-IKE----- 224 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHH---HH-Hhc-----
Confidence 975554443233456788999999998888899999999999999999999999754311 111 11 111
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
......+...+..+.+++.+||+.+|++|||+++++++
T Consensus 225 ----~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 ----GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11112233345568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=271.06 Aligned_cols=262 Identities=24% Similarity=0.275 Sum_probs=197.7
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
.|+.++.||.|++|.||+|.+. +++.+++|.+.... ......+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4889999999999999999875 68899999876432 22335678999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+. ++|..++.......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~----~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 85 5788877666666789999999999999999999999 999999999999999999999999999864433322
Q ss_pred ccccccccccccCccccccCC-CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH--------------h
Q 046121 181 VQTKILGTLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI--------------E 245 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------~ 245 (315)
......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||....... .......... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHH
Confidence 223345678899999876644 5788999999999999999999996543211 1111000000 0
Q ss_pred -hhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 246 -KLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 246 -~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...........+ ....+.....+.+++.+||+.||++|||+++++.+
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000 00011233457789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=277.41 Aligned_cols=265 Identities=18% Similarity=0.210 Sum_probs=195.1
Q ss_pred cccceecCC--CceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 26 SKENLLGEG--GFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 26 ~~~~~lg~g--~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+++++||+| ++++||++..+ +++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 357889999 67899999765 78999999876542 23345678899999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.......+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.+++.||+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999988665555689999999999999999999999 999999999999999999999999976532211111
Q ss_pred -------ccccccccccccCcccccc--CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH--------
Q 046121 181 -------VQTKILGTLGYLAPEYAEN--GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL-------- 243 (315)
Q Consensus 181 -------~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 243 (315)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKLNGTVPCLLDTTT 235 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH-HHHhcCCccccccccc
Confidence 0112345677999999875 45889999999999999999999999643221100 00000000
Q ss_pred --Hhhhcc---ccccCCc-----------------ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 244 --IEKLAL---HELIDPR-----------------IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 244 --~~~~~~---~~~~~~~-----------------~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
...... ....+.. .........+..+.+++.+||+.||++|||+.+++++-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 000000 0000000 000112223456889999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=269.46 Aligned_cols=259 Identities=23% Similarity=0.332 Sum_probs=201.9
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CC----cEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DG----QMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~----~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
.++|++.+.||+|+||+||+|.+. ++ ..+++|....... .....+.+|+..++.++|||++++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 468999999999999999999764 23 2578887665432 334567899999999999999999999887 7889
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+|++|+.+++|.+++.++.. .+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEK----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC----CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999998865433 489999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCccc--cccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 176 TTDDPVQT--KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 176 ~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
........ ...++..|+|||.+.+..++.++|+||||+++|++++ |..||...... ......... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~---~~- 229 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EIPDLLEKG---ER- 229 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhCC---CC-
Confidence 42221111 1123467999999988888999999999999999998 99998643321 111111100 00
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
...+...+..+.+++.+||..+|++|||+.++++.|.....+..
T Consensus 230 ------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 230 ------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 01111223457788999999999999999999999998866544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=265.98 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=203.1
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
++|++.+.||.|++|+||+|.+. ++..+++|++.... ......+.+|+..++.++|+|++++++.+......++++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999865 67889999876543 23566789999999999999999999999999999999999
Q ss_pred ccCCccccccccCCC-CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 101 ICNKSLHWHLFDNTE-SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
+.+++|.+.+..... ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~----~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN----GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999998865433 5689999999999999999999999 99999999999999999999999999986544332
Q ss_pred Cc----cccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 180 PV----QTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 180 ~~----~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
.. .....++..|+|||.+... .++.++|+||||+++|+|++|..||....... .... .... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~----~~~~------~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLML----TLQN------DP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHH----HhcC------CC
Confidence 22 1233578889999988766 68899999999999999999999996443211 1111 0000 01
Q ss_pred CcccCCC-CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 255 PRIENSY-DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 255 ~~~~~~~-~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
+...... ....+..+.+++.+||..||++|||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111111 12345567899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=273.76 Aligned_cols=263 Identities=25% Similarity=0.333 Sum_probs=198.2
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc--cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ--GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
++|++.++||+|++|.||+|.+. +++.+++|.+...... ..+.+.+|+++++.++|||++++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47999999999999999999876 5889999986643322 24567889999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.++++...... ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999888776533 23489999999999999999999999 99999999999999999999999999987544333
Q ss_pred CccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH-------HHhhhcccc
Q 046121 180 PVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP-------LIEKLALHE 251 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 251 (315)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...... ......... .........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI--DQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH--HHHHHHHHHhCCCchhhHHHhccch
Confidence 33333457888999998765 44678899999999999999999998643321 111110000 000000000
Q ss_pred ----ccCCccc-----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 252 ----LIDPRIE-----NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 252 ----~~~~~~~-----~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...+... ....+..+..+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000 00112235668899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=292.26 Aligned_cols=267 Identities=17% Similarity=0.206 Sum_probs=191.2
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCC------CCccceeeeEEec
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARH------KNIVMLLGFCCKE 91 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~ 91 (315)
....++|+++++||+|+||+||+|.+. +++.||+|++.... ........|+.+++.+.| ++++.+++++...
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 334678999999999999999999865 68889999886432 223345567777766654 4577888887654
Q ss_pred -CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEcCCC-------
Q 046121 92 -NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLTHDF------- 162 (315)
Q Consensus 92 -~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~~~~------- 162 (315)
.+.|+||+++ |++|.+++.+. ..+++..+..++.|++.||.|||+ . ||+|+||||+||+++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~----gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTEL----HLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHEEEecCCccccccc
Confidence 5788999986 77887777543 458999999999999999999997 6 999999999999998765
Q ss_pred ---------ceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccc
Q 046121 163 ---------VPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ 233 (315)
Q Consensus 163 ---------~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~ 233 (315)
.++|+|||.+.... .......|++.|+|||++.+..++.++|||||||++|+|++|.+||........
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred ccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 49999999875322 222345789999999999999999999999999999999999999975443211
Q ss_pred hhHH-HhH----HHHHhh---------hccccccCCccc-----------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 046121 234 QSLR-QWA----EPLIEK---------LALHELIDPRIE-----------NSYDTYELYLMAKTAYLCVQRNPEGRPSMG 288 (315)
Q Consensus 234 ~~~~-~~~----~~~~~~---------~~~~~~~~~~~~-----------~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~ 288 (315)
.... ... ...... ......+.+... ..........+.+||.+||+.||++|||++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 1100 000 000000 000000000000 000011234578999999999999999999
Q ss_pred HHHHHHhc
Q 046121 289 EVVRLLEG 296 (315)
Q Consensus 289 ~il~~L~~ 296 (315)
+++++-+-
T Consensus 434 e~L~Hp~~ 441 (467)
T PTZ00284 434 QMTTHPYV 441 (467)
T ss_pred HHhcCccc
Confidence 99986554
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=267.86 Aligned_cols=255 Identities=25% Similarity=0.337 Sum_probs=202.7
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
++|++.+.||.|++|.||++.+. +++.+++|.+.... ......+.+|+.+++.++|||++++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47889999999999999999876 68889999876553 34455688999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
+.+++|.+++.... ..+++..+..++.|++.++.++|+ . +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~----~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH----KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC----CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999998886543 568999999999999999999999 8 99999999999999999999999999885332221
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
. ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .......... ..+....
T Consensus 156 ~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~ 226 (265)
T cd06605 156 A--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-FELLQYIVNE------PPPRLPS 226 (265)
T ss_pred h--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-HHHHHHHhcC------CCCCCCh
Confidence 1 12567788999999998889999999999999999999999996543211111 1111111100 0111111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
...+..+.+++.+||..+|++|||+.+++.+-
T Consensus 227 ---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 258 (265)
T cd06605 227 ---GKFSPDFQDFVNLCLIKDPRERPSYKELLEHP 258 (265)
T ss_pred ---hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCc
Confidence 11455588999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=281.98 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=201.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhcC-CCCccceeeeEEecC
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKEN 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 92 (315)
..++|.+.+.||+|+||.||+|.+. .++.||+|++.... ......+.+|+.++..+. ||||+++++.+...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 4457899999999999999999753 35679999987542 233446889999999997 999999999999999
Q ss_pred eeEEEEEeccCCccccccccCCC---------------------------------------------------------
Q 046121 93 LNILVYEYICNKSLHWHLFDNTE--------------------------------------------------------- 115 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~--------------------------------------------------------- 115 (315)
..++|+||+.+++|.+++.++..
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999988864321
Q ss_pred ---------------------------------------CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcE
Q 046121 116 ---------------------------------------SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNI 156 (315)
Q Consensus 116 ---------------------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~ni 156 (315)
..++...+..++.|++.|+.|||+. +++|+||+|+||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrdlkp~Ni 270 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK----NCVHRDLAARNV 270 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CcCcccCCcceE
Confidence 2356777888999999999999999 999999999999
Q ss_pred EEcCCCceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccc
Q 046121 157 LLTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQ 233 (315)
Q Consensus 157 l~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~ 233 (315)
+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~- 349 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE- 349 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-
Confidence 999999999999999864322211 1122345778999999988888999999999999999998 888885432111
Q ss_pred hhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 234 QSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
... ...... ... ..+...+..+.+++.+||..+|++||++.+|+..|+..
T Consensus 350 -~~~----~~~~~~-----~~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 -QFY----NAIKRG-----YRM----AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred -HHH----HHHHcC-----CCC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 000 111110 001 11222345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=266.05 Aligned_cols=240 Identities=23% Similarity=0.349 Sum_probs=185.8
Q ss_pred ceecCCCceEEEEEEeCC-------------CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 29 NLLGEGGFGHVYKGELKD-------------GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~-------------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
+.||+|+||.||+|.... ...+++|+...........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999996432 2357888876655555567788999999999999999999999988999
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc-------eeECC
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV-------PMLGD 168 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~-------i~l~d 168 (315)
+++||+.+++|..++... ...+++..++.++.|++.|+.|||+. +++|+||+|+||+++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDK----DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC----CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999998776433 34589999999999999999999999 9999999999999987664 89999
Q ss_pred CCcccccCCCCCccccccccccccCccccc-cCCCcccccchhhhHHHHHHH-hCCCccCCCCCccchhHHHhHHHHHhh
Q 046121 169 FGLARWKTTDDPVQTKILGTLGYLAPEYAE-NGIVSIRTDVYAFGIILLQLM-SGRKVVDMNGEEPQQSLRQWAEPLIEK 246 (315)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwslG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (315)
||++...... ....++..|+|||.+. +..++.++||||||+++|+|+ .|..|+....... .. .....
T Consensus 156 ~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~----~~~~~ 224 (262)
T cd05077 156 PGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE---KE----RFYEG 224 (262)
T ss_pred CCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---HH----HHHhc
Confidence 9988533221 2235678899999886 566889999999999999998 5778875432111 00 00000
Q ss_pred hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
. .... ......+.+++.+||+.||++||++++|++.++
T Consensus 225 -~-~~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 -Q-CMLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -C-ccCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 0000 111345789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=276.61 Aligned_cols=259 Identities=25% Similarity=0.358 Sum_probs=201.3
Q ss_pred HhcCCcccceecCCCceEEEEEEeC--------CCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccceeeeEEe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK--------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCK 90 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 90 (315)
...+|++++.||+|+||.||+|.+. ....+++|+..... ......+.+|+.+++.+ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3458999999999999999999642 12368888776432 33456788999999999 79999999999999
Q ss_pred cCeeEEEEEeccCCccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcE
Q 046121 91 ENLNILVYEYICNKSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNI 156 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~ni 156 (315)
.+..++++||+.+++|.+++.+.. ...++...+..++.|++.|+.+||+. +++|+||+|+||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----givH~dlkp~Ni 165 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ----KCIHRDLAARNV 165 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceE
Confidence 999999999999999998886432 23578888999999999999999999 999999999999
Q ss_pred EEcCCCceeECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccc
Q 046121 157 LLTHDFVPMLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQ 233 (315)
Q Consensus 157 l~~~~~~i~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~ 233 (315)
+++.++.++|+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 243 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 243 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence 9999999999999998643322211 111223467999999988889999999999999999998 78888543211
Q ss_pred hhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 234 QSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
......... .....+...+..+.+++.+||+.+|++|||+.+++..|+.+..
T Consensus 244 ----~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 244 ----ELFKLLKEG----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ----HHHHHHHcC----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 111111100 0011112233457889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=269.31 Aligned_cols=261 Identities=21% Similarity=0.266 Sum_probs=194.7
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecC-----eeEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN-----LNIL 96 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l 96 (315)
=.|+-.+++|+|+||.||.|... +++.+|+|..-.... .-.+|+++++.+.||||+.+..+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 36888899999999999999755 578899986543322 2257999999999999999999885432 3468
Q ss_pred EEEeccCCcccccccc--CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC-CceeECCCCccc
Q 046121 97 VYEYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD-FVPMLGDFGLAR 173 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~-~~i~l~dfg~~~ 173 (315)
||||+ ..+|...+.. ..+..++...+.-+..|++.|+.|||+. ||+||||||.|+++|.+ |.+||+|||.++
T Consensus 100 Vleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~----~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 100 VLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH----GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc----CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 99998 5577777753 2345688888888999999999999999 99999999999999986 999999999998
Q ss_pred ccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHH-HhHH----------
Q 046121 174 WKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLR-QWAE---------- 241 (315)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~---------- 241 (315)
......+. ..+..+-.|+|||.+.| ..|+.+.||||.||++.||+-|++.|.+.+...+.... ....
T Consensus 175 ~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 175 VLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 76665554 45566888999998776 55899999999999999999999999765432221111 0000
Q ss_pred -HHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 242 -PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
..........+....+...+.......+.+++.++|+++|++|.++.+++.+
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0000001111111112222444456678899999999999999999998753
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=268.36 Aligned_cols=248 Identities=23% Similarity=0.292 Sum_probs=201.3
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
+|++.+.||.|++|.||+|.+. +++.+++|++.... ....+.+.+|+++++.++|||++++++.+......++|++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999876 68899999887543 2345678899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.|++|.+.+... .++++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999888544 5689999999999999999999999 99999999999999999999999999987544332
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||............ ..... ...
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~~-------~~~ 219 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-------AKQET-------ADV 219 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-------HHhcc-------ccc
Confidence 223345778899999998888899999999999999999999999754432111111 00000 111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCH--HHHHH
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSM--GEVVR 292 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~--~~il~ 292 (315)
..+...+..+.+++.+||+.||.+||++ ++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1222344668899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=266.21 Aligned_cols=248 Identities=24% Similarity=0.328 Sum_probs=199.3
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-----cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-----TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
+|+..+.||+|++|.||+|.+. ++..+++|.+.... ......+.+|+.+++.++|+|++++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5888999999999999999876 78899999876533 22456688999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
+||+.+++|.+++.+. ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999888544 3588999999999999999999999 999999999999999999999999999864433
Q ss_pred CCCccccccccccccCccccccCC-CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
.. ......+++.|++||.+.... ++.++|+||||+++|+|++|..||...... ... ........ .+
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~----~~~~~~~~-----~~- 221 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAV----FKIGRSKE-----LP- 221 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHH----HHHHhccc-----CC-
Confidence 22 223456788899999887666 889999999999999999999999644311 000 00000000 01
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
..+......+.+++.+||+.+|++||++.+++..
T Consensus 222 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 ---PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1222344567889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=272.17 Aligned_cols=262 Identities=25% Similarity=0.287 Sum_probs=199.1
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc-----cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ-----GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
+|.+.+.||+|++|.||+|.+. +++.+++|.+...... ....+.+|+.+++.++|+|++++++++......++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 5889999999999999999865 6889999987654322 234567899999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|||+ +++|.+++.... ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN----WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899988885543 3689999999999999999999999 999999999999999999999999999975544
Q ss_pred CCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH--------Hhhhc
Q 046121 178 DDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL--------IEKLA 248 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~ 248 (315)
.........+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||....... ......... .....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhccc
Confidence 3333333455778999998754 457889999999999999999988776433211 111110000 00000
Q ss_pred cccccCCcc-----cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 249 LHELIDPRI-----ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 249 ~~~~~~~~~-----~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
......... ........+..+.+++.+||+.+|++|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000 011112335678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=266.55 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=196.3
Q ss_pred CcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccC
Q 046121 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
......||+|+||.||+|.+. ++..+++|............+.+|+.+++.++|+||+++++++..++..++++||+.+
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence 334468999999999999865 5788999987766666667889999999999999999999999999999999999999
Q ss_pred CccccccccCCC-CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC-CCceeECCCCcccccCCCCCc
Q 046121 104 KSLHWHLFDNTE-SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH-DFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 104 ~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~-~~~i~l~dfg~~~~~~~~~~~ 181 (315)
++|.+++..... ...+...+..++.|++.++.+||+. +++|+||+|+||+++. ++.++|+|||.+.........
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 999988864322 1237888889999999999999999 9999999999999976 679999999998644333333
Q ss_pred cccccccccccCccccccCC--CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 182 QTKILGTLGYLAPEYAENGI--VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||............ . .. .....
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~---~------~~-----~~~~~ 231 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK---V------GM-----FKIHP 231 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh---h------hh-----hccCC
Confidence 33345788999999886543 778999999999999999999998543221110000 0 00 00111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
..+......+.+++.+||+.+|++|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 232 EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1233345568889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=266.63 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=201.3
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+|.+.+.||.|++|.||+|.++ ++..+++|.+.... ....+.+.+|+.+++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5889999999999999999876 57889999876432 23345678999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC-ceeECCCCcccccCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF-VPMLGDFGLARWKTTDD 179 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~-~i~l~dfg~~~~~~~~~ 179 (315)
+.+++|.+++.+.....+++..+..++.+++.++.+||+. +++|+||+|+||+++.++ .++++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988776666789999999999999999999999 999999999999999886 46999999987554333
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.......+++.|+|||...+..++.++|+||||+++++|++|..||...... ........ ....
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-----~~~~----- 220 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQ-----GYFA----- 220 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc-----ccCC-----
Confidence 3333346788899999998888899999999999999999999998543211 11111110 0010
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...+..+..+.+++.+||..+|++|||+.+++.+
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112234458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=269.11 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=200.0
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
+|...+.||+|++|.||++.+. +++.+++|..........+.+.+|+.+++.++|||++++++++...+..+++++|+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 5666789999999999999865 688899998765555555668899999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcc
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~ 182 (315)
+++|.+.+.. ..++...+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+..........
T Consensus 100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ----GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence 9999988854 4588999999999999999999999 99999999999999999999999999876443333333
Q ss_pred ccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCC
Q 046121 183 TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYD 262 (315)
Q Consensus 183 ~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (315)
....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... ..... .. .. ..+... ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~~----~~-~~-----~~~~~~--~~ 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMKR----IR-DN-----LPPKLK--NL 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHHH----HH-hc-----CCCCCc--cc
Confidence 3456788999999998888999999999999999999999998643221 11111 00 00 001110 01
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 263 TYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 263 ~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...+..+.+++.+||+.+|++|||+++++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 1134568899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=270.87 Aligned_cols=247 Identities=24% Similarity=0.279 Sum_probs=200.6
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++.+.||+|++|.||++.+. +++.+++|++.... ......+.+|+++++.++||||+++++++......+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999876 68999999876532 233456788999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+++... ..+++..+..++.|++.++.+||+. +++|+||+|.||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL----DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999888544 5689999999999999999999999 9999999999999999999999999998644332
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ...... .. .. ...
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~----~~-~~------~~~-- 216 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQIYEK----IL-EG------KVR-- 216 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH----Hh-cC------Ccc--
Confidence 2334678899999999888888999999999999999999999864331 111110 00 00 011
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHh
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLE 295 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~ 295 (315)
.+...+..+.+++.+||..||++|+ ++++++.+-+
T Consensus 217 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 217 --FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred --CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 1122345678899999999999999 8888876644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=277.34 Aligned_cols=259 Identities=27% Similarity=0.389 Sum_probs=197.0
Q ss_pred hcCCcccceecCCCceEEEEEEe------CCCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccceeeeEEe-cC
Q 046121 22 TGDFSKENLLGEGGFGHVYKGEL------KDGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCK-EN 92 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~ 92 (315)
.++|++.+.||+|+||+||+|.+ .+++.+|+|++.... ......+.+|+.++..+ +||||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999964 247789999886533 23345678999999999 68999999998765 45
Q ss_pred eeEEEEEeccCCccccccccCC----------------------------------------------------------
Q 046121 93 LNILVYEYICNKSLHWHLFDNT---------------------------------------------------------- 114 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~---------------------------------------------------------- 114 (315)
..+++|||+.+++|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999988875421
Q ss_pred -------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc--cccc
Q 046121 115 -------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV--QTKI 185 (315)
Q Consensus 115 -------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~--~~~~ 185 (315)
...++......++.|++.|+.|||+. +++|+||||.||+++.++.++++|||++......... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 12367788889999999999999999 9999999999999999999999999998643322211 1122
Q ss_pred cccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHH
Q 046121 186 LGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTY 264 (315)
Q Consensus 186 ~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (315)
.++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... .... .. ..... ...... .
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~---~~-~~~~~-----~~~~~~----~ 306 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFC---RR-LKEGT-----RMRAPD----Y 306 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHH---HH-HhccC-----CCCCCC----C
Confidence 34567999999988889999999999999999997 88888543221 1111 11 11100 011111 1
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 265 ELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 265 ~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
.+..+.+++..||+.+|++|||+.++++.|+.+..
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22347788899999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=267.53 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=199.5
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+-|++.+.||.|+||.||+|.+. ++..+++|+..... ......+.+|+..++.++|||++++++.+..+...++|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45888999999999999999765 68899999876432 23345688899999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.. ..++...+..++.+++.++.+||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC----CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999888743 3588999999999999999999999 999999999999999999999999998864433322
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... .. .. ... ...+ .
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~----~~-~~~-----~~~~----~ 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VL----FL-IPK-----NNPP----T 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HH----HH-Hhc-----CCCC----C
Confidence 2333457788999999988888899999999999999999999986432211 00 00 000 0011 1
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.....+..+.+++.+||+.+|++||++.+++.+
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 222334557789999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=265.65 Aligned_cols=252 Identities=21% Similarity=0.354 Sum_probs=199.7
Q ss_pred CCcccceecCCCceEEEEEEe-CCCcEEEEEEecccCc------ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 24 DFSKENLLGEGGFGHVYKGEL-KDGQMIAAKVRKEAST------QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
+|+..+.||+|++|.||++.+ .+++.+++|++..... .....+.+|+.+++.++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588899999999999999976 4688999998764331 134568899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC-ceeECCCCccccc
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF-VPMLGDFGLARWK 175 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~-~i~l~dfg~~~~~ 175 (315)
|++|+.+++|.+++.+. .++++..+..++.|++.|+.+||+. +++|+||+|.||+++.++ .++|+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~----~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999888543 4588999999999999999999999 999999999999998776 6999999998644
Q ss_pred CCCCC----ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 176 TTDDP----VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 176 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
..... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||.......... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~-------- 223 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKI-------- 223 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHH--------
Confidence 33211 1123456788999999988888999999999999999999999986432211111 00000
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.........+......+.+++.+||..+|++|||+.+++.+
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 224 -ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00111223334455668889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=269.85 Aligned_cols=263 Identities=24% Similarity=0.269 Sum_probs=200.5
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+|++.+.||.|++|.||+|.+. +++.+++|++.... ......+.+|+.+++.++|||++++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5899999999999999999875 68899999877543 33356788999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+ +++|.+.+.... ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999988875443 5699999999999999999999999 999999999999999999999999999875443321
Q ss_pred -ccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH-------hh-hc--
Q 046121 181 -VQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI-------EK-LA-- 248 (315)
Q Consensus 181 -~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~-~~-- 248 (315)
......++..|+|||.+.+. .++.++||||+|+++++|++|.+||...... ........... .. ..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--EQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--HHHHHHHHHcCCCChHHHhhccCcc
Confidence 12234678899999988654 4688999999999999999998888543321 11111000000 00 00
Q ss_pred -cccccCCc----ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 249 -LHELIDPR----IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 249 -~~~~~~~~----~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
......+. ......+.....+++++.+||+.+|++|||+++++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00000000 00001112346789999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=264.43 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=199.1
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc--cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ--GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+|++.+.||+|++|.||+|.+. +++.+++|.+...... ....+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 6899999999999999999765 6889999987755443 567789999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++... ..+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH----GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999988543 3478889999999999999999999 999999999999999999999999999875443322
Q ss_pred ccc----cccccccccCccccccCC---CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 181 VQT----KILGTLGYLAPEYAENGI---VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 181 ~~~----~~~~~~~~~aPE~~~~~~---~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
... ...+++.|+|||.+.+.. ++.++|+||||++++++++|..||....... ... .. ... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~----~~--~~~----~~ 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIM----FH--VGA----GH 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHH----HH--Hhc----CC
Confidence 211 245678999999988766 7889999999999999999999996432110 000 00 000 01
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.+.+... ......+.+++.+||+.+|++|||+.+++.+
T Consensus 224 ~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 224 KPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111111 1124457789999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=281.25 Aligned_cols=262 Identities=20% Similarity=0.176 Sum_probs=193.3
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
..+|.+.+.||+|+||.||++.+. .++.|++|... .....+|+.+++.++|+||+++++++...+..++|+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999876 57889998532 23456899999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+. ++|.+++... ...+++..+..++.|++.+|.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 242 ~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGE----GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 84 6777766433 23689999999999999999999999 999999999999999999999999999864432211
Q ss_pred --ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCcc-c----hhHHHhHHHHHhh-hcccc-
Q 046121 181 --VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEP-Q----QSLRQWAEPLIEK-LALHE- 251 (315)
Q Consensus 181 --~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~-~----~~~~~~~~~~~~~-~~~~~- 251 (315)
......|++.|+|||++.+..++.++|||||||++|+|++|..++....... . ..+.+........ .....
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1123468999999999999889999999999999999999876543221111 0 1111111100000 00000
Q ss_pred ---------------ccCCcccCCCCH---HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 252 ---------------LIDPRIENSYDT---YELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 252 ---------------~~~~~~~~~~~~---~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
...+........ .....+.+|+.+||+.||++|||+.|++++-+
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence 000000000000 12235788999999999999999999998743
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=300.14 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=211.3
Q ss_pred hcCCcccceecCCCceEEEEEEeC--CCc----EEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK--DGQ----MIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~--~~~----~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
....+..+.||+|.||.||.|... .+. .|++|.+... +.+....+.+|..+++.++||||++++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 456677889999999999999644 343 3777776654 566677899999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccCC-----CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCC
Q 046121 95 ILVYEYICNKSLHWHLFDNT-----ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDF 169 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~df 169 (315)
++++|||+||+|..++.+.+ ...+++...+.++.+|+.++.||+++ ++|||||..+|+|++....+|++||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~----~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK----HFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC----CCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999997642 45699999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCccc--cccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhh
Q 046121 170 GLARWKTTDDPVQT--KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEK 246 (315)
Q Consensus 170 g~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (315)
|++........... ...-+..|||||.+..+.++.++||||||+++||+++ |..||+...... +.......
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------v~~~~~~g 920 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------VLLDVLEG 920 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------HHHHHHhC
Confidence 99985443333222 2345679999999999999999999999999999998 889996543211 11111111
Q ss_pred hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
. .-..+.+++..+-++|.+||+.+|++||+|..|++.+..+...
T Consensus 921 g----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 921 G----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred C----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 1 2334566677788999999999999999999999988777553
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=271.64 Aligned_cols=263 Identities=26% Similarity=0.320 Sum_probs=199.9
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
++|++.+.||+|++|.||+|.+. +++.+++|.+... .......+.+|+++++.++|+||+++++++...+..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999876 5889999987643 23334678899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.++.+..... ....+++..++.++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSH----NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 998876655442 234489999999999999999999999 99999999999999999999999999987544433
Q ss_pred C-ccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH-------Hhhh---
Q 046121 180 P-VQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL-------IEKL--- 247 (315)
Q Consensus 180 ~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~--- 247 (315)
. ......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||....... ......... ....
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHhhhcccC
Confidence 2 22335677889999998877 78899999999999999999999986443211 111000000 0000
Q ss_pred -ccc--cccCC----cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 248 -ALH--ELIDP----RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 248 -~~~--~~~~~----~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
... ..... .....++...+..+.+++.+||..+|++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 00000 00011222336678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=268.08 Aligned_cols=261 Identities=25% Similarity=0.281 Sum_probs=201.3
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCCccceeeeEEe--cCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVMLLGFCCK--ENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 98 (315)
++|...+.||.|++|.||++.+. +++.+++|.+..... .....+.+|+++++.++||||+++++++.. .+.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 47889999999999999999875 688899998765432 345568899999999999999999998854 34789999
Q ss_pred EeccCCcccccccc--CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 99 EYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 99 ~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||+.+++|.+.+.. .....++...+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999887643 2345588999999999999999999999 99999999999999999999999999985333
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... ......... ...+.
T Consensus 157 ~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~------~~~~~ 227 (287)
T cd06621 157 NSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP-IELLSYIVN------MPNPE 227 (287)
T ss_pred ccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh-HHHHHHHhc------CCchh
Confidence 221 123356778999999988889999999999999999999999997553311111 111111010 00111
Q ss_pred ccCCCC--HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 257 IENSYD--TYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 257 ~~~~~~--~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
+..... ...+..+.+++.+||..+|.+|||+.+++++-+-
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 111111 1245668899999999999999999999995544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=276.61 Aligned_cols=257 Identities=19% Similarity=0.208 Sum_probs=196.7
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++.+.||+|+||+||++.+. +++.+|+|++... .......+.+|..++..++|++|+.+++.+...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999876 6888999987642 2223445778999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.|++|.+++.+. ...+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~----~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL----HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999988653 24588999999999999999999999 9999999999999999999999999998644332
Q ss_pred CCc-cccccccccccCcccccc-----CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 179 DPV-QTKILGTLGYLAPEYAEN-----GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 179 ~~~-~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
... .....|++.|+|||++.+ +.++.++|+||||+++|+|++|..||...... .. ......... ..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~----~~~i~~~~~--~~ 227 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--ET----YGKIMNHEE--RF 227 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--HH----HHHHHcCCC--cc
Confidence 221 223568999999998875 45788999999999999999999999643321 01 111110000 00
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHHhc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEG--RPSMGEVVRLLEG 296 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~--Rps~~~il~~L~~ 296 (315)
.+... ....+..+.+++.+||..++++ |+++++++.+-+-
T Consensus 228 ---~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f 269 (331)
T cd05624 228 ---QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF 269 (331)
T ss_pred ---cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCc
Confidence 01111 1123455778888888866554 4688888877543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=268.75 Aligned_cols=261 Identities=23% Similarity=0.250 Sum_probs=197.6
Q ss_pred CcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
|++.+.||.|++|.||+|.+. ++..+++|++.... ......+.+|+.+++.++|||++++++++.+.+..+++++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 788999999999999999865 68999999876443 223356788999999999999999999999999999999998
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
+++|.+++.......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~----~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH----RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 46888888666555789999999999999999999999 9999999999999999999999999998644332222
Q ss_pred cccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH-----------h--h-
Q 046121 182 QTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI-----------E--K- 246 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------~--~- 246 (315)
.....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||....... .......... . .
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhh
Confidence 2233457889999987654 46889999999999999999999996543211 1111000000 0 0
Q ss_pred -hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 247 -LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 247 -~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...... .........+..+..+.+++.+||+.+|++|||+++++.+
T Consensus 234 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKW-ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccc-cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 0000011122234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=264.47 Aligned_cols=249 Identities=21% Similarity=0.278 Sum_probs=193.2
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-----cccHHHHHHHHHHHhhcCCCCccceeeeEEe--cCee
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-----TQGFAEFQSEVYVLNFARHKNIVMLLGFCCK--ENLN 94 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 94 (315)
..|++.+.||+|++|.||+|.+. ++..+++|...... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36999999999999999999765 68899999765332 1234567889999999999999999998865 4677
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++++||+.+++|.+.+... ..++....+.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~----~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999888543 3478899999999999999999999 999999999999999999999999999864
Q ss_pred cCCCC---CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 175 KTTDD---PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 175 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
..... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... .. .... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~----~~~~--~~~ 224 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AA----IFKI--ATQ 224 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HH----HHHH--hcC
Confidence 32211 1112234678899999999888999999999999999999999999643211 10 0000 000
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.. ....+......+.+++ +||..+|++||++++++++
T Consensus 225 ~~----~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 225 PT----NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CC----CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 01 1222333445566777 5888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=266.56 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=198.4
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcC---CCCccceeeeEEecCeeEEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFAR---HKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~ 98 (315)
.|++.+.||+|++|.||+|.+. +++.+++|.+... .......+.+|+.+++.++ |||++++++.+..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5888999999999999999864 6889999987654 3344566788999998886 999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+++.. ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+......
T Consensus 82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988743 2688999999999999999999999 9999999999999999999999999998755444
Q ss_pred CCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 179 DPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||........ . . .......+.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~-~---------~~~~~~~~~~ 222 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA--M-M---------LIPKSKPPRL 222 (277)
T ss_pred ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh--h-h---------ccccCCCCCC
Confidence 333334567888999998765 4468899999999999999999999964322110 0 0 0000111111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
... ..+..+.+++.+||+.||++||++.+++..-
T Consensus 223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 111 1344578899999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=262.91 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=204.6
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+|.+.+.||.|++|.||++.+. ++..+++|.+..... .....+.+|+++++.++|||++++.+.+......++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999876 688999998775433 4556788999999999999999999999999999999999
Q ss_pred ccCCccccccccCC--CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 101 ICNKSLHWHLFDNT--ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 101 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
+.+++|.+.+.+.. ...+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++++|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~----~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999998886543 46799999999999999999999999 9999999999999999999999999998755444
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
........+++.|+|||...+..++.++|+||+|+++++|++|..||...... ....... . ...
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~-~----~~~----- 220 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKIL-K----GQY----- 220 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHh-c----CCC-----
Confidence 33334456788999999998888899999999999999999999998543311 1111111 0 001
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...+......+.+++.+||..+|++|||+.+++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11122334557889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=282.48 Aligned_cols=247 Identities=25% Similarity=0.318 Sum_probs=201.4
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.|.=++.||.|+||.||.|++. +.+.||||.++-.. .+....+..|+.+|+.+.|||++.|.++|..+.+.|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4666788999999999999865 78899999877543 4446678999999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|| -|+-.|.+. ...+++-+.++..++.+.+.+|.|||+. +.||+|||+.||+++..|.|||+|||.+....+
T Consensus 107 YC-lGSAsDlle-VhkKplqEvEIAAi~~gaL~gLaYLHS~----~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLE-VHKKPLQEVEIAAITHGALQGLAYLHSH----NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HH-hccHHHHHH-HHhccchHHHHHHHHHHHHHHHHHHHHh----hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 98 456666553 3356799999999999999999999999 999999999999999999999999999864433
Q ss_pred CccccccccccccCccccc---cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 180 PVQTKILGTLGYLAPEYAE---NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
.+.++|||.|+|||++. .+.|+-++||||||++..++...++|+...+. +.. +..+....
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----MSA----------LYHIAQNe 241 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSA----------LYHIAQNE 241 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----HHH----------HHHHHhcC
Confidence 24578999999999874 57799999999999999999999998754332 111 11111122
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.+.-..++.+..++.++..||++-|.+|||.++++.+-=
T Consensus 242 sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 242 SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 222235567888999999999999999999999987643
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=273.89 Aligned_cols=256 Identities=20% Similarity=0.200 Sum_probs=194.7
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++.++||+|+||+||++..+ +++.+++|++.+. .......+.+|+.++..++|++|+++++.+.+...+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999876 5788999987642 2223345778999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+++.+. ...+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~----~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999988643 23588999999999999999999999 9999999999999999999999999998643322
Q ss_pred CC-ccccccccccccCccccc-----cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 179 DP-VQTKILGTLGYLAPEYAE-----NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 179 ~~-~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
.. ......|++.|+|||++. ...++.++|+||||+++|+|++|..||...... ... ........ ..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~--~~~----~~i~~~~~--~~ 227 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETY----GKIMNHKE--RF 227 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH--HHH----HHHhCCCc--cc
Confidence 22 222356899999999885 345788999999999999999999999643211 111 11111000 00
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHHh
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEG--RPSMGEVVRLLE 295 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~--Rps~~~il~~L~ 295 (315)
..+. .....+..+.+++.+|+..++++ |+++.+++++-+
T Consensus 228 ~~p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 228 QFPA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred cCCC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 0011 11123445677788877654444 689999988854
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=264.48 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=197.3
Q ss_pred CCcccceecCCCceEEEEEEeCC--CcEEEEEEeccc----------CcccHHHHHHHHHHHhh-cCCCCccceeeeEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELKD--GQMIAAKVRKEA----------STQGFAEFQSEVYVLNF-ARHKNIVMLLGFCCK 90 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~k~~~~~----------~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~ 90 (315)
.|++.+.||+|++|.||+|.+.. ++.+++|.+... .......+.+|+.++.. ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999998764 788899876532 22234456778887764 789999999999999
Q ss_pred cCeeEEEEEeccCCcccccccc--CCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEcCCCceeEC
Q 046121 91 ENLNILVYEYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLTHDFVPMLG 167 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~~~~~i~l~ 167 (315)
.+..++++||+.+++|.+.+.. .....+++..++.++.|++.++.+||+ . +++|+||+|+||+++.++.++|+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~----~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK----RIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC----ceeecCCCHHHEEECCCCcEEEe
Confidence 9999999999999999887743 234568999999999999999999996 5 89999999999999999999999
Q ss_pred CCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh
Q 046121 168 DFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL 247 (315)
Q Consensus 168 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (315)
|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .. ..... ..
T Consensus 157 dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--~~----~~~~~-~~ 228 (269)
T cd08528 157 DFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--SL----ATKIV-EA 228 (269)
T ss_pred cccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--HH----HHHHh-hc
Confidence 999997544332 223456788899999999888999999999999999999999998533211 00 01111 10
Q ss_pred ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
. ..+.. ....+..+.+++.+||+.||++||++.++...++
T Consensus 229 ~----~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 V----YEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred c----CCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 01100 1123345888999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=268.08 Aligned_cols=261 Identities=25% Similarity=0.297 Sum_probs=200.6
Q ss_pred cHHHHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeeeEEec
Q 046121 14 SFSEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKE 91 (315)
Q Consensus 14 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 91 (315)
.+..+....++|.+.+.||+|++|.||++... +++.+++|+..... .....+.+|+.+++.+ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 33445556789999999999999999999875 68889999876432 2345677899999888 799999999998653
Q ss_pred -----CeeEEEEEeccCCcccccccc--CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCce
Q 046121 92 -----NLNILVYEYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVP 164 (315)
Q Consensus 92 -----~~~~lv~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i 164 (315)
...++|+||+.+++|.+++.. .....+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.+
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN----RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCE
Confidence 357999999999999887753 2345689999999999999999999999 99999999999999999999
Q ss_pred eECCCCcccccCCCCCccccccccccccCccccccC-----CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHh
Q 046121 165 MLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENG-----IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQW 239 (315)
Q Consensus 165 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 239 (315)
+++|||++..............++..|+|||.+... .++.++|+||||+++|+|++|.+||...... .....
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~~- 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLFK- 244 (291)
T ss_pred EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHHH-
Confidence 999999986444333223334678889999987543 2578999999999999999999998643211 11110
Q ss_pred HHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 240 AEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
. ... ..+.. ..+......+.+++.+||+.+|++||++.+++++
T Consensus 245 ---~-~~~-----~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 ---I-PRN-----PPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ---H-hcC-----CCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 000 00000 1112234468899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=264.44 Aligned_cols=238 Identities=25% Similarity=0.405 Sum_probs=185.8
Q ss_pred ceecCCCceEEEEEEeCC-C----------cEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 29 NLLGEGGFGHVYKGELKD-G----------QMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~-~----------~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
+.||+|+||.||+|.+.. + ..+++|+....... ...+.+|+.+++.++|||++++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999998763 3 24677766544333 5678899999999999999999999887 778999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC-------ceeECCCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF-------VPMLGDFG 170 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~-------~i~l~dfg 170 (315)
+||+.+++|.+++..... .++...+..++.|++.++.+||+. +++|+||||+||+++.++ .++++|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK----KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC----CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999998865443 688999999999999999999999 999999999999999887 89999999
Q ss_pred cccccCCCCCccccccccccccCccccccC--CCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhh
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAENG--IVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKL 247 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (315)
++..... .....++..|+|||++.+. .++.++|+||||+++|+|++ |..|+........ .. . ...
T Consensus 154 ~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~---~-~~~- 221 (259)
T cd05037 154 IPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ER---F-YQD- 221 (259)
T ss_pred ccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HH---H-Hhc-
Confidence 9864332 2223456779999998776 68899999999999999999 5677754321110 00 0 000
Q ss_pred ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
......+ ....+.+++.+||..+|++|||+.++++.|+
T Consensus 222 -~~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 -QHRLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -CCCCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000000 0156889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=266.28 Aligned_cols=266 Identities=23% Similarity=0.275 Sum_probs=194.2
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.++|++.+.||+|++|.||+|.+. +++.+++|.+..... .....+.+|+.+++.++|+||+++.+++..+...++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 468999999999999999999765 688999998765432 223356789999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+. +++.+.+.... ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ----HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 995 56655554332 4577888889999999999999999 99999999999999999999999999886433322
Q ss_pred CccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh-------hhcccc
Q 046121 180 PVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE-------KLALHE 251 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 251 (315)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.............+...... ......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 222334568899999988754 478899999999999999999999964432211111110000000 000000
Q ss_pred ----ccCCcccCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 252 ----LIDPRIENSYD-----TYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 252 ----~~~~~~~~~~~-----~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
........... -.....+.+++.+|+..||++|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000 0013457789999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=262.69 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=186.3
Q ss_pred ceecCCCceEEEEEEeC---CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCC
Q 046121 29 NLLGEGGFGHVYKGELK---DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNK 104 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~---~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (315)
+.||+|+||.||+|.+. ++..+++|...... ......+.+|+.+++.++||||+++++.+.+....++||||+.++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999754 34568888765433 223346788999999999999999999999888999999999999
Q ss_pred ccccccccCC---CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC-
Q 046121 105 SLHWHLFDNT---ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP- 180 (315)
Q Consensus 105 ~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~- 180 (315)
+|.+++.... ....+...+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN----NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9998886432 23456677888999999999999999 999999999999999999999999999863322211
Q ss_pred -ccccccccccccCccccccC-------CCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 181 -VQTKILGTLGYLAPEYAENG-------IVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 181 -~~~~~~~~~~~~aPE~~~~~-------~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
......++..|+|||++.+. .++.++|+||||+++|+|++ |..||........ . . .........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~-~----~~~~~~~~~ 229 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--L-T----YTVREQQLK 229 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--H-H----HHhhcccCC
Confidence 11223467789999987542 35779999999999999996 9999964332111 0 0 000111111
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
...+.... ..+..+.+++..|| .+|++|||+++++..|+
T Consensus 230 ~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 12222221 12334677888898 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=265.78 Aligned_cols=248 Identities=26% Similarity=0.406 Sum_probs=192.8
Q ss_pred ceecCCCceEEEEEEeCC-------CcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 29 NLLGEGGFGHVYKGELKD-------GQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~-------~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+.||+|++|.||+|.+.+ +..+++|.+.... ......+.+|+.+++.++||||+++++++......++++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997542 3578888765432 23456788999999999999999999999998999999999
Q ss_pred ccCCccccccccCC-----CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC-----ceeECCCC
Q 046121 101 ICNKSLHWHLFDNT-----ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF-----VPMLGDFG 170 (315)
Q Consensus 101 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~-----~i~l~dfg 170 (315)
+.+++|.+++.+.. ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++ .++++|||
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM----HFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC----CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999998886532 23478899999999999999999999 999999999999999887 89999999
Q ss_pred cccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhh
Q 046121 171 LARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKL 247 (315)
Q Consensus 171 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (315)
++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .... . ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~---~-~~~- 228 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQ---H-VTA- 228 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHH---H-Hhc-
Confidence 9864322211 1122344678999999998889999999999999999998 99998643221 1110 0 000
Q ss_pred ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
......+...+..+.+++.+||..+|++||++.++++.|+.
T Consensus 229 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 --------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00111122345568899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=263.05 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=187.8
Q ss_pred ceecCCCceEEEEEEeC----CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEE-ecCeeEEEEEecc
Q 046121 29 NLLGEGGFGHVYKGELK----DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCC-KENLNILVYEYIC 102 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~~~~~ 102 (315)
+.||+|+||.||+|.+. ....+++|..... .......+.+|+.+++.++|||++++++++. .+...+++++|+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 2457888876543 2334567788999999999999999999765 4556799999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC--
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP-- 180 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~-- 180 (315)
+++|.+++.+... ..+......++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASK----KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999998865433 356777888999999999999999 999999999999999999999999999864322111
Q ss_pred --ccccccccccccCccccccCCCcccccchhhhHHHHHHHhC-CCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 181 --VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG-RKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 181 --~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
......+++.|+|||.+.+..++.++||||||+++|+|++| .+||...... ... ..... ......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~---~~~~~------~~~~~~ 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DIT---VYLLQ------GRRLLQ 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---HHHhc------CCCCCC
Confidence 01122346689999999888899999999999999999995 5666432211 111 11100 000111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
+...+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 224 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1122345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=268.84 Aligned_cols=263 Identities=22% Similarity=0.255 Sum_probs=197.5
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEec--CeeEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE--NLNILV 97 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 97 (315)
++|++.+.||.|.+|.||+|.+. +++.+++|.+.... ......+.+|+.+++.++||||+++.+++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 58999999999999999999876 58889999876433 22233467899999999999999999998777 889999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
+||+. ++|.+.+.... ..+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN----WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99986 48877775433 3689999999999999999999999 999999999999999999999999999875444
Q ss_pred CCCccccccccccccCccccccCC-CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH----------Hhh
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL----------IEK 246 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~ 246 (315)
.........+++.|+|||.+.+.. ++.++|+||||+++|+|++|.+||...... .......... ...
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI--DQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchHHHHHhhc
Confidence 322223345678899999886544 688999999999999999999999644321 1111100000 000
Q ss_pred ------hccccccCCcccCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 247 ------LALHELIDPRIENSYDTY-ELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 247 ------~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
..........+...++.. ....+.+++.+||+.+|++|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000111111222222 35668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=266.26 Aligned_cols=240 Identities=24% Similarity=0.354 Sum_probs=185.9
Q ss_pred ceecCCCceEEEEEEeCC--------CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 29 NLLGEGGFGHVYKGELKD--------GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~--------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+.||.|+||.||+|.+.. ...+++|..........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997642 234777776554444556788899999999999999999999998999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc--------eeECCCCcc
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV--------PMLGDFGLA 172 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~--------i~l~dfg~~ 172 (315)
+.+++|..++..... .+++..+..++.|++.++.|||+. +++|+||||+||+++.++. ++++|||.+
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK----GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999988865443 588999999999999999999999 9999999999999987764 689999988
Q ss_pred cccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCC-CccCCCCCccchhHHHhHHHHHhhhccc
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGR-KVVDMNGEEPQQSLRQWAEPLIEKLALH 250 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (315)
..... .....++..|+|||++.+ ..++.++|+||||+++|+|++|. +|+....... ... ....
T Consensus 156 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~----~~~~---- 220 (258)
T cd05078 156 ITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQ----FYED---- 220 (258)
T ss_pred cccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHH----HHHc----
Confidence 53322 122356788999999876 45788999999999999999985 5554322111 000 0000
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.. ..+......+.+++.+||+.+|++|||++++++.|+
T Consensus 221 ---~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ---RH----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---cc----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 111122345789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=262.10 Aligned_cols=250 Identities=19% Similarity=0.211 Sum_probs=194.7
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-----cccHHHHHHHHHHHhhcCCCCccceeeeEEec--Cee
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-----TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE--NLN 94 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 94 (315)
..|++.+.||+|++|.||.|.+. ++..+++|.+.... ......+.+|+.+++.+.||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47999999999999999999865 58899999765321 12345678899999999999999999988653 567
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++++||+.+++|.+++.+. ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN----MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999887543 3478888999999999999999999 999999999999999999999999998864
Q ss_pred cCCCC---CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 175 KTTDD---PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 175 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
..... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~-~~~~------- 222 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AAI-FKIA------- 222 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HHH-HHHh-------
Confidence 33211 1112245778899999998888899999999999999999999998633111 100 0000
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
........+......+.+++.+|+. +|++||++++++++-
T Consensus 223 --~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 223 --TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred --cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 0011122334455667788888884 999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=268.69 Aligned_cols=264 Identities=22% Similarity=0.233 Sum_probs=196.2
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
++|++.+.||.|.+|+||+|.++ +++.+++|.+.... ......+.+|+.+++.++|||++++++++......++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999876 68899999876432 2234567889999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC-CCceeECCCCcccccCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH-DFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~-~~~i~l~dfg~~~~~~~~ 178 (315)
|+. +++.+.+.......+++..+..++.|++.|+.+||+. +++|+||+|+||+++. ++.++++|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 985 5777776555555578889999999999999999999 9999999999999985 567999999998644332
Q ss_pred CCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh--hhc-------
Q 046121 179 DPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE--KLA------- 248 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~------- 248 (315)
........+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||...... ............ ...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChhhccccccc
Confidence 222233456788999998765 45788999999999999999999999654321 111110000000 000
Q ss_pred -----cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 249 -----LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 249 -----~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
......+.......+..+..+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000112234457889999999999999999999874
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=271.35 Aligned_cols=266 Identities=23% Similarity=0.253 Sum_probs=197.9
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEec-----
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE----- 91 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 91 (315)
.+.++|++.+.||+|++|+||+|.+. +++.+++|.+... .......+.+|+.+++.++|||++++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 46789999999999999999999865 6889999987642 233445677899999999999999999987543
Q ss_pred -CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCC
Q 046121 92 -NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 92 -~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
...|+|+||+. ++|.+.+.. .++...+..++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999985 477666632 288889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccc------------hhHHH
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ------------QSLRQ 238 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~------------~~~~~ 238 (315)
++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........ .....
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 164 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred cceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 997443322 22334578889999999998899999999999999999999999964432100 00000
Q ss_pred hHHHHHhhhc----------cccccC----CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 239 WAEPLIEKLA----------LHELID----PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 239 ~~~~~~~~~~----------~~~~~~----~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.......... ...... +......+......+.+++.+||+.||++|||+.+++.+-+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 0000000000 000000 00001112234556789999999999999999999997753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=259.07 Aligned_cols=250 Identities=29% Similarity=0.395 Sum_probs=202.3
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
+|++.+.||+|++|.||++.+. +++.+++|............+.+|+..++.++|++++++.+++......+++++|+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 5889999999999999999876 688899998876655566788999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcc
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~ 182 (315)
+++|.+.+.... ..+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN----GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC----CEecCCCCHHHEEEccCCeEEEeecccccccccccc-c
Confidence 999998875443 4689999999999999999999999 999999999999999999999999999864443322 2
Q ss_pred ccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCC
Q 046121 183 TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYD 262 (315)
Q Consensus 183 ~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (315)
....++..|+|||.+.+..++.++|+||||+++++|++|..||...... .... ... ... .+.... .
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~----~~~-~~~-----~~~~~~--~ 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALF----KIA-TNG-----PPGLRN--P 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHH----HHH-hcC-----CCCcCc--c
Confidence 3446788899999998888899999999999999999999998643211 0000 000 000 001100 1
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 263 TYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 263 ~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...+..+.+++.+||+.||++|||+.+++++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1124558899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=264.99 Aligned_cols=240 Identities=21% Similarity=0.335 Sum_probs=184.1
Q ss_pred ceecCCCceEEEEEEeC-------------------------CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccc
Q 046121 29 NLLGEGGFGHVYKGELK-------------------------DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~-------------------------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (315)
.+||+|+||.||+|... ....+++|++..........+.+|+.+++.++||||++
T Consensus 1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeee
Confidence 36999999999998632 12357788776554444556788899999999999999
Q ss_pred eeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC-
Q 046121 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF- 162 (315)
Q Consensus 84 ~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~- 162 (315)
+++++......++||||+.+++|..++... ...+++..+..++.|++.++.|||+. +++|+||||+||+++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK----NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC----CccCCCCCcccEEEeccCc
Confidence 999999999999999999999998877543 34588999999999999999999999 999999999999997644
Q ss_pred ------ceeECCCCcccccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHH-hCCCccCCCCCccch
Q 046121 163 ------VPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLM-SGRKVVDMNGEEPQQ 234 (315)
Q Consensus 163 ------~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~-~g~~p~~~~~~~~~~ 234 (315)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|+++ +|..||........
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred ccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 4799999987532211 22346778999998865 55789999999999999985 68888864432211
Q ss_pred hHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 235 SLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.. ..... ...... ....+.+++.+||+.+|++|||+.++++.|.
T Consensus 231 --~~----~~~~~-------~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 --ER----FYEKK-------HRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HH----HHHhc-------cCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11 01100 001111 1224788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=280.97 Aligned_cols=246 Identities=24% Similarity=0.353 Sum_probs=208.2
Q ss_pred eecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCcccc
Q 046121 30 LLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHW 108 (315)
Q Consensus 30 ~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~ 108 (315)
+||+|++|+||.|++. +...+|+|-+........+.+..|+..-+.+.|.||++++|.+.+++.+-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999987 466788898888777788889999999999999999999999999999999999999999998
Q ss_pred ccccC-CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc-CCCceeECCCCcccccCCCCCcccccc
Q 046121 109 HLFDN-TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT-HDFVPMLGDFGLARWKTTDDPVQTKIL 186 (315)
Q Consensus 109 ~l~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~-~~~~i~l~dfg~~~~~~~~~~~~~~~~ 186 (315)
.+... +.-.-++.++..+..||++++.|||++ .|+|||||-+||+++ -.|.+||+|||-++.....++...++.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen----~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN----KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc----ceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 88432 222348889999999999999999999 999999999999995 579999999999998888899999999
Q ss_pred ccccccCccccccCC--CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHH
Q 046121 187 GTLGYLAPEYAENGI--VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTY 264 (315)
Q Consensus 187 ~~~~~~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (315)
||..|||||++..++ |+.++|||||||++.||.||++||-..+.... . .-+..+. +.-+..+..
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-A--------MFkVGmy-----KvHP~iPee 803 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-A--------MFKVGMY-----KVHPPIPEE 803 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-h--------hhhhcce-----ecCCCCcHH
Confidence 999999999997544 88899999999999999999999964443211 0 0111111 122345667
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 265 ELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 265 ~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.+...+.+|.+|+.++|..||++++++..
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 77888899999999999999999999863
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=268.85 Aligned_cols=258 Identities=23% Similarity=0.350 Sum_probs=197.5
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCc----EEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQ----MIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~----~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
.++|+..+.||+|++|.||+|.+. ++. .+++|...... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 458899999999999999999764 343 46788765432 22234678899999999999999999998654 467
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
++++|+.+++|.+++.... ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 85 ~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER----RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc----CeeccccccceeeecCCCceEEccccccccc
Confidence 8999999999998885443 3478899999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 176 TTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 176 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..... ..... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~----~~~~~---~~ 229 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPD----LLEKG---ER 229 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHCC---CC
Confidence 332221 112234568999999988889999999999999999997 8888854321 11111 11110 00
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
. ..+...+..+.+++..||..+|++||++.++++.|..+....
T Consensus 230 ~------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 230 L------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred C------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0 011122345788999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=262.23 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=196.2
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc----------ccHHHHHHHHHHHhhcCCCCccceeeeEEecC
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST----------QGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN 92 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (315)
+|.+.+.||.|++|.||+|... +++.+++|.+..... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5889999999999999999765 688899997653211 11235678999999999999999999999999
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
..++|+||+.+++|.+.+.+. ..++...+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK----GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC----CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999888544 4688999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCC--CccccccccccccCccccccCC--CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhc
Q 046121 173 RWKTTDD--PVQTKILGTLGYLAPEYAENGI--VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248 (315)
Q Consensus 173 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (315)
....... .......++..|+|||.+.+.. ++.++|+||||+++|++++|..||...... ..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~----~~~--- 226 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFK----LGN--- 226 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHH----hhc---
Confidence 6432211 1112345678899999887654 788999999999999999999998532211 00000 000
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 249 LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
....+..........+..+.+++.+||..+|++|||+++++++
T Consensus 227 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 --KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred --cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0111111122222345668889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=263.86 Aligned_cols=257 Identities=23% Similarity=0.308 Sum_probs=205.5
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
..+.|++.+.||+|.+|.||+|.+. ++..+++|++..... ....+.+|+..++.++|+|++++++.+......+++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567999999999999999999876 688899998875443 45678899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|.+++.... ..++...+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~----gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ----NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999986544 3689999999999999999999999 99999999999999999999999999886443332
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ..... .. .... +...
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~~----~~-~~~~-----~~~~- 237 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFL----IT-TKGI-----PPLK- 237 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----HH-hcCC-----CCCc-
Confidence 2223345678899999998888899999999999999999999998533221 11110 00 0000 0011
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.....+..+.+++.+||+.+|.+|||+.++++...-.
T Consensus 238 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 274 (286)
T cd06614 238 -NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274 (286)
T ss_pred -chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhh
Confidence 1112345678899999999999999999998754433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=259.65 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=204.4
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--ccHHHHHHHHHHHhhcCCCCccceeeeEEec--CeeEEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--QGFAEFQSEVYVLNFARHKNIVMLLGFCCKE--NLNILVY 98 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 98 (315)
+|...+.||+|++|.||+|.+. +++.+++|+...... ...+.+.+|+.+++.++|||++++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5888999999999999999876 688999998765442 4467788999999999999999999999888 8899999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
|++.+++|.+++.+.. .+++..++.++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~----~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN----GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999886544 789999999999999999999999 9999999999999999999999999998755443
Q ss_pred CC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 179 DP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 179 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
.. ......++..|+|||.+.+...+.++|+||||+++++|++|..||....... .. .. . .....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~-~~----~-----~~~~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM----AA-LY----K-----IGSSG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH----HH-HH----h-----ccccC
Confidence 32 1234567889999999988889999999999999999999999996544110 00 00 0 00111
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.....+...+..+.+++.+||..+|++||++.+++.+
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1122333346678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=259.48 Aligned_cols=248 Identities=25% Similarity=0.350 Sum_probs=202.3
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+|++.+.||+|++|.||++.+. +++.+++|.+..... .....+.+|+++++.++|||++++++++...+..++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5889999999999999999765 678899998776543 4566789999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+.+.+. ..+++..++.++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999888544 5689999999999999999999999 999999999999999999999999999975554443
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
......++..|+|||...+..++.++|+|++|+++++|++|..||...... ..... .. . ... ..
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~~~~----~~-~-----~~~----~~ 218 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--AALFR----IV-Q-----DDH----PP 218 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HHHHH----Hh-c-----cCC----CC
Confidence 333446788899999988877889999999999999999999998643211 00000 00 0 001 11
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.+......+.+++.+||..+|++|||+.+++..
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 222334567899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=269.05 Aligned_cols=194 Identities=23% Similarity=0.315 Sum_probs=155.6
Q ss_pred cceecCCCceEEEEEEeC---CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEE--ecCeeEEEEEecc
Q 046121 28 ENLLGEGGFGHVYKGELK---DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCC--KENLNILVYEYIC 102 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~~~~~ 102 (315)
.++||+|+||+||+|... ++..+++|.+.... ....+.+|+.+++.++||||+++++++. .+...++|++|+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 358999999999999764 45788998776432 2345788999999999999999999884 3567799999975
Q ss_pred CCcccccccc-------CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE----cCCCceeECCCCc
Q 046121 103 NKSLHWHLFD-------NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL----THDFVPMLGDFGL 171 (315)
Q Consensus 103 ~~~L~~~l~~-------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~----~~~~~i~l~dfg~ 171 (315)
++|.+.+.. .....+++..+..++.|++.|+.+||+. +++|+||||+||++ +.++.++|+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 466555432 1223588999999999999999999999 99999999999999 5667999999999
Q ss_pred ccccCCCCC---ccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCC
Q 046121 172 ARWKTTDDP---VQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMN 228 (315)
Q Consensus 172 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~ 228 (315)
+........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 975433221 1123467889999998876 45788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=273.86 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=198.7
Q ss_pred HHHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEec--ccCcccHHHHHHHHHHHhhcC-CCCccceeeeEEecCee
Q 046121 18 IQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRK--EASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLN 94 (315)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~--~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 94 (315)
+.+....|+++++||+|+.+.||++...+.+.+++|.+. ....+..+-+.+|+..|.+++ |.+|++++++-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 344668899999999999999999998887888877543 345666778999999999996 89999999999999999
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
|+|||+ -..+|...+...... ++.-.+..+..|++.++.++|.. ||||.||||.|+++-+ |.+||+|||++..
T Consensus 436 YmvmE~-Gd~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~----gIVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMEC-GDIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQH----GIVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred EEEeec-ccccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHh----ceeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 999997 466777777554443 33337788889999999999999 9999999999998865 5899999999975
Q ss_pred cCCCCC--ccccccccccccCccccccC-----------CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH
Q 046121 175 KTTDDP--VQTKILGTLGYLAPEYAENG-----------IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE 241 (315)
Q Consensus 175 ~~~~~~--~~~~~~~~~~~~aPE~~~~~-----------~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 241 (315)
...... ....++||+.||+||.+..- ..++++|||||||+||+|+.|+.||+. ..+
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~--------~~n--- 577 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ--------IIN--- 577 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH--------HHH---
Confidence 443332 24568999999999977421 146789999999999999999999952 111
Q ss_pred HHHhhhccccccCCcccCCCCHHHHHH-HHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 242 PLIEKLALHELIDPRIENSYDTYELYL-MAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.-..+..+.+|.-+..++..-... +.++|..||..||++|||+.++|++
T Consensus 578 ---~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 578 ---QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 111233344554444433332222 8899999999999999999999864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=256.05 Aligned_cols=273 Identities=21% Similarity=0.228 Sum_probs=210.5
Q ss_pred cCCCCCCcccHHHHHHHhcCCcccc-eecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhh-cCCCCc
Q 046121 5 LYMKDPMKFSFSEIQQATGDFSKEN-LLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNF-ARHKNI 81 (315)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~y~~~~-~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~-l~~~~i 81 (315)
.-|...+.+.+++.. +.++|.+.. +||-|-.|.|-.+..+ +++.+|+|++... ...++|++.--. -.||||
T Consensus 44 ~~~~~~~~m~~k~~~-itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~i 117 (400)
T KOG0604|consen 44 PPMSEESDMDFKEYS-ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHI 117 (400)
T ss_pred CCcchhhhcchhccc-chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCce
Confidence 345555666664433 456777765 8999999999988765 7999999987654 344667765433 369999
Q ss_pred cceeeeEEe----cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEE
Q 046121 82 VMLLGFCCK----ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNIL 157 (315)
Q Consensus 82 ~~~~~~~~~----~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil 157 (315)
+.++++|++ ..-+.+|||.++||.|...+.+.+...+++.++..++.||+.|+.|||+. +|.||||||+|++
T Consensus 118 V~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~----nIAHRDlKpENLL 193 (400)
T KOG0604|consen 118 VSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM----NIAHRDLKPENLL 193 (400)
T ss_pred EEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc----chhhccCChhhee
Confidence 999999865 45678999999999999999999999999999999999999999999999 9999999999999
Q ss_pred EcC---CCceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCC-CCccc
Q 046121 158 LTH---DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMN-GEEPQ 233 (315)
Q Consensus 158 ~~~---~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~-~~~~~ 233 (315)
... +..+||+|||+++.... .....+.+-||.|.|||++....|+...|+||+|+++|-|++|-+||-.+ +....
T Consensus 194 yt~t~~na~lKLtDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais 272 (400)
T KOG0604|consen 194 YTTTSPNAPLKLTDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 272 (400)
T ss_pred eecCCCCcceEecccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC
Confidence 965 55799999999974443 33344567799999999999999999999999999999999999998432 21111
Q ss_pred hhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 234 QSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
..++... ......+.. .-...+++..+++|+.+|..+|.+|.|+++++.+-|-..
T Consensus 273 pgMk~rI-----~~gqy~FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 273 PGMKRRI-----RTGQYEFPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred hhHHhHh-----hccCccCCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 1111100 011111122 222346788999999999999999999999988766543
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=260.20 Aligned_cols=245 Identities=25% Similarity=0.317 Sum_probs=196.4
Q ss_pred ecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCcc
Q 046121 31 LGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSL 106 (315)
Q Consensus 31 lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (315)
||.|++|.||++.+. +++.+++|++.... ....+.+.+|+.+++.++||||+++++.+.++...++++||+.+++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999876 58899999876542 23345688999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcccccc
Q 046121 107 HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186 (315)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~ 186 (315)
.+++.+. ..++...+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~----~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNR----GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 9988543 3488999999999999999999999 99999999999999999999999999987443322 222346
Q ss_pred ccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHH
Q 046121 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYEL 266 (315)
Q Consensus 187 ~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (315)
+++.|++||.+.+..++.++|+||+|+++|+|++|..||............. .. ........+...+
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~---------~~~~~~~~~~~~~ 220 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND----IL---------KGNGKLEFPNYID 220 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH----Hh---------ccCCCCCCCcccC
Confidence 7889999999888888999999999999999999999997554311111111 00 0011112222235
Q ss_pred HHHHHHHHhhcCCCCCCCCC-----HHHHHHHHh
Q 046121 267 YLMAKTAYLCVQRNPEGRPS-----MGEVVRLLE 295 (315)
Q Consensus 267 ~~l~~l~~~~l~~~p~~Rps-----~~~il~~L~ 295 (315)
..+.+++.+||..+|++||+ +++++++-+
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence 56889999999999999999 899888544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=262.08 Aligned_cols=253 Identities=24% Similarity=0.361 Sum_probs=193.7
Q ss_pred CcccceecCCCceEEEEEEeC----CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecC------
Q 046121 25 FSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN------ 92 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 92 (315)
|.+.+.||+|++|+||+|.+. +++.+++|++... .....+.+.+|+.+++.++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999643 4688999987653 2334566889999999999999999999875432
Q ss_pred eeEEEEEeccCCccccccccC----CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECC
Q 046121 93 LNILVYEYICNKSLHWHLFDN----TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGD 168 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~d 168 (315)
..+++++|+.+++|.+++... ....++...+..++.|++.++.|||+. +++|+||+|+||+++.++.++++|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK----NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccchhhEEEcCCCCEEECc
Confidence 247889999999997766422 123478889999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHh
Q 046121 169 FGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIE 245 (315)
Q Consensus 169 fg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (315)
||++........ ......+++.|++||.+.+..++.++||||||+++|+|++ |.+||...... .... ....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~---~~~~ 230 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYN---YLIK 230 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHH---HHHc
Confidence 999874432221 1122334567999999988888999999999999999998 88888643221 1111 0110
Q ss_pred hhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 246 KLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
. . ... .+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 231 ~-~-----~~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 G-N-----RLK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C-C-----cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 000 1112334688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=265.21 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=197.9
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
.|....+||+|++|.||++... +++.+++|.+..........+.+|+.+++.++|+|++++++.+...+..+++|||+.
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 3444578999999999999775 688999998765555556678899999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcc
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~ 182 (315)
+++|.+.+.. ..+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++++|||++..........
T Consensus 101 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~----givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 101 GGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence 9999887632 3478999999999999999999999 99999999999999999999999999876443322222
Q ss_pred ccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCC
Q 046121 183 TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYD 262 (315)
Q Consensus 183 ~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (315)
....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... ..... ... ...+.+.. .
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~-----~~~-----~~~~~~~~--~ 239 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKM-----IRD-----NLPPKLKN--L 239 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-----HHh-----hCCcccCC--c
Confidence 3346788899999998888899999999999999999999998643211 11100 000 01111111 1
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 263 TYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 263 ~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
...+..+.+++.+||+.+|.+||++.+++++=.
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~ 272 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 272 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcChH
Confidence 112334778899999999999999999998533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=283.24 Aligned_cols=253 Identities=24% Similarity=0.328 Sum_probs=210.3
Q ss_pred cCCcccceecCCCceEEEEEEeCC-CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
+.|.++..||.|+||.||+|..+. +-..|.|++...+.+....+.-|+.+|...+||+|+++++.|..++.++++++||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 568899999999999999998774 5556778888888888899999999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.||-+...+.. -+..+.+.++..++.|++.||.|||++ +|+|||||+.||+++-+|.|+|.|||.+.........
T Consensus 112 ~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~----~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQ----NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred CCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhc----chhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 99988665543 345699999999999999999999999 9999999999999999999999999999755555555
Q ss_pred cccccccccccCccccc-----cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 182 QTKILGTLGYLAPEYAE-----NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
...++|||.|+|||+.. ..+|++++||||||++|.+|..+.+|...-++ ...+.. +-.+.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--MRVllK-------------iaKSe 251 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLK-------------IAKSE 251 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--HHHHHH-------------HhhcC
Confidence 66789999999999763 57799999999999999999999999853321 111111 11111
Q ss_pred ccC-CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 257 IEN-SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 257 ~~~-~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.+. -.+...+..+.+++..||.+||..||++.+++++-+
T Consensus 252 PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 252 PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 111 134556778999999999999999999999988654
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=265.76 Aligned_cols=252 Identities=25% Similarity=0.295 Sum_probs=196.4
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
.+|.+.+.||+|++|+||+|.+. +++.+++|.+.... ......+.+|+.+++.++|||++++.+++......++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56999999999999999999865 68899999876432 233456789999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+. +++.+.+... ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~----~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH----ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9986 4565555332 34589999999999999999999999 9999999999999999999999999988633222
Q ss_pred CCccccccccccccCccccc---cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 179 DPVQTKILGTLGYLAPEYAE---NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
....+++.|+|||++. ...++.++||||||+++|+|++|..||....... . ...... .
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~----~~~~~~---------~ 229 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A----LYHIAQ---------N 229 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--H----HHHHhc---------C
Confidence 2345678899999874 4557889999999999999999999985432111 0 000000 0
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
..........+..+.+++.+||+.+|++||++.+++.+.+-...
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 230 DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 00111122245568899999999999999999999987654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=268.39 Aligned_cols=269 Identities=26% Similarity=0.272 Sum_probs=197.0
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--ccHHHHHHHHHHHhhcCCCCccceeeeEEec--CeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--QGFAEFQSEVYVLNFARHKNIVMLLGFCCKE--NLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 96 (315)
.++|++.+.||+|++|.||+|.+. +++.|++|.+..... .......+|+.+++.++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999875 689999998764322 2223456899999999999999999998654 56899
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
|+||+.+ +|.+.+... ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 86 v~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHEN----FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999854 676666443 25689999999999999999999999 99999999999999999999999999987544
Q ss_pred CCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH----------h
Q 046121 177 TDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI----------E 245 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------~ 245 (315)
..........+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.. ........... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI--EQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChhhchhhh
Confidence 33222223345678999998865 45788999999999999999999999644321 11111110000 0
Q ss_pred hhcccccc--CCcccCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 246 KLALHELI--DPRIENS---YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 246 ~~~~~~~~--~~~~~~~---~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
........ ....... .....+..+.+++.+||+.||++|||+++++.+-+-..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 00000000 0000000 00113456788999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=262.37 Aligned_cols=248 Identities=25% Similarity=0.315 Sum_probs=194.4
Q ss_pred ecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCcc
Q 046121 31 LGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSL 106 (315)
Q Consensus 31 lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (315)
||+|+||+||++.+. +++.+++|++.... ......+.+|+.+++.++|||++++++.+...+..|+|+||+.+++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999765 68899999876432 22233457899999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcccccc
Q 046121 107 HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186 (315)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~ 186 (315)
.+.+.......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+..... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR----RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCcccccc
Confidence 9988766656799999999999999999999999 999999999999999999999999998864332 22222345
Q ss_pred ccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHH
Q 046121 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYEL 266 (315)
Q Consensus 187 ~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (315)
++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... . .... .. ......+...+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~----~~~~-~~------~~~~~~~~~~~ 222 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--E----LKRR-TL------EMAVEYPDKFS 222 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--H----HHhc-cc------cccccCCccCC
Confidence 6778999999988888999999999999999999999996543311100 0 0000 00 00111222234
Q ss_pred HHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhc
Q 046121 267 YLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEG 296 (315)
Q Consensus 267 ~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~ 296 (315)
..+.+++.+||+.+|++|| ++.+++.+-+-
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence 5678999999999999999 77778765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=273.54 Aligned_cols=263 Identities=23% Similarity=0.340 Sum_probs=213.4
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccH-HHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGF-AEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
.+...+.++||+|-||.|.++...++..||+|+.+....... ..+.+|+++|.+++||||+.++++|..++.+++++||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 457889999999999999999988889999999887765554 6799999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
++.|+|..++.++............++.||+.+++||.+. +++|||+.++|+++++++++|++|||++........
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~----nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL----NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh----chhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999999776544456667788999999999999999 999999999999999999999999999975444433
Q ss_pred --ccccccccccccCccccccCCCcccccchhhhHHHHHHH--hCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 181 --VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLM--SGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 181 --~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
.......+.+|+|||.+.-++++.++|+|++|+++||++ +...||+....+. ... ....+..--...
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vve-------n~~~~~~~~~~~ 763 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVE-------NAGEFFRDQGRQ 763 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHH-------hhhhhcCCCCcc
Confidence 233456678999999998889999999999999999987 4678886443321 111 111111111112
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
....-++.++..+.++|..||..+.++|||++++-.+|...
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 22233445566777999999999999999999999888764
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=266.62 Aligned_cols=254 Identities=23% Similarity=0.259 Sum_probs=195.5
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++.+.||+|++|.||++.+. +++.|++|.+.... ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999876 57889999876543 223456778999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.|++|.+++... ..+++..+..++.+++.++.+||+. +++|+||+|.||+++.++.++++|||++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999888543 4589999999999999999999999 9999999999999999999999999987521100
Q ss_pred C---------------CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH
Q 046121 179 D---------------PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 179 ~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--~~~----~~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELF----GQV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH----HHH
Confidence 0 0001234677899999998888999999999999999999999999643221 111 111
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
... ....+. .....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~~----~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISD----DIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hhc----ccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 100 000111 111234457899999999999999985444444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=263.79 Aligned_cols=263 Identities=25% Similarity=0.312 Sum_probs=197.4
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
+|++.+.||.|++|.||+|.+. ++..+++|.+..... .....+.+|+.+++.++|||++++++.+...+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5899999999999999999876 688899998775432 33456778999999999999999999999999999999999
Q ss_pred cCCccccccccCC-CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 102 CNKSLHWHLFDNT-ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
.+ +|.+++.... ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN----RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 75 7777665433 35689999999999999999999999 999999999999999999999999999864433222
Q ss_pred ccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH-------Hhhhccccc
Q 046121 181 VQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL-------IEKLALHEL 252 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 252 (315)
......+++.|++||.+.+ ..++.++|+||||+++|+|++|..||...... .......... .........
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--DQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhHHHHhcCch
Confidence 2233456788999998765 34688999999999999999999999654321 1111100000 000000000
Q ss_pred cCCccc-------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 253 IDPRIE-------NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 253 ~~~~~~-------~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...... ....+..+..+.+++.+||+.||.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 01112234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=259.37 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=183.8
Q ss_pred ceecCCCceEEEEEEeCC---CcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCC
Q 046121 29 NLLGEGGFGHVYKGELKD---GQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNK 104 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~---~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (315)
+.||+|+||.||+|...+ ...+++|...... ......+.+|+..++.++||||+++++.+......++||||+.++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999996432 3467777655332 233446788999999999999999999999999999999999999
Q ss_pred ccccccccCCC---CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC-
Q 046121 105 SLHWHLFDNTE---SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP- 180 (315)
Q Consensus 105 ~L~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~- 180 (315)
+|.+++..... ...++.....++.|++.++.|||+. +++|+||||+||+++.++.++++|||++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA----DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc----CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99998865432 3356778889999999999999999 999999999999999999999999999853322211
Q ss_pred -ccccccccccccCccccc-------cCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 181 -VQTKILGTLGYLAPEYAE-------NGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 181 -~~~~~~~~~~~~aPE~~~-------~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
......++..|+|||+.. +..++.++||||||+++|+|++ |..||...... ..... .. ......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~----~~-~~~~~~ 229 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLKQ----VV-REQDIK 229 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHH----Hh-hccCcc
Confidence 112234466799999864 2346789999999999999998 77888543221 11111 01 111112
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
...+..... .+..+.+++..|| .||++|||++++++.|.
T Consensus 230 ~~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222222222 3344556677788 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=264.56 Aligned_cols=257 Identities=25% Similarity=0.313 Sum_probs=194.8
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcC-CCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
++|+..+.||+|+||.||++.+. +++.+++|.+.... ......+.+|+..+.++. ||||+++++++..+...+++++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 46778889999999999999865 58899999876432 234456788999998886 9999999999998889999999
Q ss_pred eccCCcccc---ccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 100 YICNKSLHW---HLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 100 ~~~~~~L~~---~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
++. .++.+ .+.......+++..+..++.+++.++.|||+.. +++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 974 34433 333334466999999999999999999999632 89999999999999999999999999986433
Q ss_pred CCCCccccccccccccCccccccC---CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENG---IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
.... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||..... ... .. ... ....
T Consensus 160 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~----~~-~~~--~~~~ 227 (288)
T cd06616 160 DSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFD----QL-TQV--VKGD 227 (288)
T ss_pred cCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHH----HH-hhh--cCCC
Confidence 2221 1223577889999998765 688899999999999999999999964321 000 00 000 0011
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.+.+........+..+.+++.+||+.+|++|||+++++.+-+
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 122222222335566889999999999999999999988644
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=264.65 Aligned_cols=257 Identities=24% Similarity=0.309 Sum_probs=199.9
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
..|...+.||+|+||.||++.+. ++..+++|.+.... ......+.+|+.+++.++|||++++++++..+...++|+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 35888999999999999999865 68899999876432 233456788999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.| ++.+.+... ...+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 105 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~----~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 105 EYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred eCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 99865 666655432 34589999999999999999999999 999999999999999999999999998753222
Q ss_pred CCccccccccccccCccccc---cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 179 DPVQTKILGTLGYLAPEYAE---NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
.....+++.|+|||.+. ++.++.++|+||||+++|+|++|..||...... .... .... .
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~----~~~~---------~ 239 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALY----HIAQ---------N 239 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHH----HHHh---------c
Confidence 22345788899999873 456788999999999999999999998543211 0000 0000 0
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHL 304 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~ 304 (315)
..........+..+.+++.+||+.+|.+||++.++++++..........
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~ 288 (317)
T cd06635 240 ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV 288 (317)
T ss_pred cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence 0111112234456889999999999999999999999887766655544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=265.62 Aligned_cols=264 Identities=22% Similarity=0.221 Sum_probs=193.7
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--ccHHHHHHHHHHHhhcC-CCCccceeeeEEecCe-----
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--QGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENL----- 93 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~----- 93 (315)
++|++.+.||+|++|.||+|.+. +++.+++|....... .....+.+|+.+++.+. |||++++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999875 688999998665432 23456788999999995 6999999999877665
Q ss_pred eEEEEEeccCCccccccccCC---CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC-CCceeECCC
Q 046121 94 NILVYEYICNKSLHWHLFDNT---ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH-DFVPMLGDF 169 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~-~~~i~l~df 169 (315)
.++++||+.+ +|.+++.... ...+++..++.++.|++.++.+||+. +++|+||+|+||+++. ++.++++||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH----GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEecCCCeEEEeec
Confidence 7999999975 6777765432 34689999999999999999999999 9999999999999998 899999999
Q ss_pred CcccccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh--h
Q 046121 170 GLARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE--K 246 (315)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 246 (315)
|++..............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+... ........... .
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFKLLGTPTE 233 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHhCCCCh
Confidence 998644332222223356788999998764 457889999999999999999999996543211 11110000000 0
Q ss_pred hc------cc-----cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 247 LA------LH-----ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 247 ~~------~~-----~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.. .. ....+.......+..+..+.+++.+||..||++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 00 0000000001112234557899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=259.12 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=201.1
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+|++.+.||+|++|.||++.+. +++.+++|.+.... ......+.+|+.+++.++|+||+++.+++......++|++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5889999999999999999765 68889999876532 33345677899999999999999999999999999999999
Q ss_pred ccCCccccccccC--CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 101 ICNKSLHWHLFDN--TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
+.+++|.+++.+. ....+++..++.++.+++.|+.+||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~----~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ----KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999998887552 235689999999999999999999999 9999999999999999999999999998644433
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ... . ... ...
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~---~-~~~---------~~~ 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRY---K-VQR---------GKY 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-Hhc---------CCC
Confidence 2233467889999999988888999999999999999999999996443211 000 0 000 111
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...+......+.+++.+||+.+|++|||+.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11223445668999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=261.08 Aligned_cols=259 Identities=21% Similarity=0.256 Sum_probs=190.7
Q ss_pred CcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcC-CCCccceeeeEEec--CeeEEEEE
Q 046121 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKE--NLNILVYE 99 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv~~ 99 (315)
|++.+.||+|++|.||+|.+. +++.+++|.+.... ........+|+..++.+. |+|++++++++.+. +.+++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 778999999999999999765 68889999876532 222233457888888885 99999999999887 88999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+ ++.+.+.... ..+++..+..++.|++.++.+||+. +++|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN----GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9865 6666664332 4689999999999999999999999 9999999999999999 999999999987443322
Q ss_pred CccccccccccccCccccc-cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH-------HHHhhhcccc
Q 046121 180 PVQTKILGTLGYLAPEYAE-NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE-------PLIEKLALHE 251 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 251 (315)
. .....+++.|+|||.+. ++.++.++|+||||+++|+|++|.+||...+... ....... ..........
T Consensus 154 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 P-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred C-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhcccc
Confidence 2 22345788999999764 4557889999999999999999999996543211 0000000 0000000000
Q ss_pred ccCCcccC-------CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 252 LIDPRIEN-------SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 252 ~~~~~~~~-------~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
........ ...+..+..+.+++.+||+++|++|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000 0112346778999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=271.86 Aligned_cols=263 Identities=21% Similarity=0.255 Sum_probs=195.9
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEec-----C
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE-----N 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 92 (315)
+.++|.+.+.||+|++|+||+|.+. +++.+++|.+... .......+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3568999999999999999999765 6889999987643 233345677899999999999999999987543 3
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
..+++++|+. ++|.+.+.. ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSA----NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 5799999984 678777743 34689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH-------H
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL-------I 244 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~ 244 (315)
..............++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||....... ......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH--QLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCChHHh
Confidence 754333222233457888999998764 458899999999999999999999996432111 000000000 0
Q ss_pred ---hhhc-------cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 245 ---EKLA-------LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 245 ---~~~~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.... ......+... ...+..+..+.+++.+||+.+|++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000 0000000000 0112234567899999999999999999999988
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=266.75 Aligned_cols=265 Identities=22% Similarity=0.260 Sum_probs=194.0
Q ss_pred CCcccceecCCCceEEEEEEeC---CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEec--CeeE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK---DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE--NLNI 95 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 95 (315)
+|.+.+.||+|++|.||+|.+. ++..+++|.+.... ......+.+|+.+++.++|||++++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 5889999999999999999765 47899999887633 34446678899999999999999999999887 8899
Q ss_pred EEEEeccCCccccccccC---CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC----CCceeECC
Q 046121 96 LVYEYICNKSLHWHLFDN---TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH----DFVPMLGD 168 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~----~~~i~l~d 168 (315)
+|+||+.+ ++.+.+... ....+++..++.++.|++.++.+||+. +++|+||+|+||+++. ++.++++|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN----WVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 99999865 555554322 223689999999999999999999999 9999999999999999 99999999
Q ss_pred CCcccccCCCCC---ccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccc-------hhHH
Q 046121 169 FGLARWKTTDDP---VQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ-------QSLR 237 (315)
Q Consensus 169 fg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-------~~~~ 237 (315)
||++........ ......+++.|+|||.+.+ ..++.++|+||||+++++|++|.+||........ ..+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999874433222 1123456788999998765 4578899999999999999999999975443220 0000
Q ss_pred HhHHHH-----------Hhhhcccc----ccCCccc-CC----CCH--HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 238 QWAEPL-----------IEKLALHE----LIDPRIE-NS----YDT--YELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 238 ~~~~~~-----------~~~~~~~~----~~~~~~~-~~----~~~--~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...... ........ ....... .. ... ..+..+.+++.+||+.||++|||+.+++.+
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 00000000 0000000 00 000 223457889999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=263.57 Aligned_cols=261 Identities=24% Similarity=0.233 Sum_probs=198.3
Q ss_pred CcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
|.+.+.||+|++|.||++.+. +++.+++|.+..... .....+.+|+.+++.++|++++++++++..+...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 678899999999999999875 688899998765432 24556788999999999999999999999999999999998
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.+ ++.+.+.... ..+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++++|||.+.........
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH----GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC----CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 65 7766664432 5689999999999999999999999 9999999999999999999999999998655443322
Q ss_pred cccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhh--hcccc-------
Q 046121 182 QTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK--LALHE------- 251 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~------- 251 (315)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+... ............ .....
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCchHhcccchhhhhh
Confidence 2334567889999988776 68899999999999999999999996544211 111110000000 00000
Q ss_pred ----ccCC--cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 252 ----LIDP--RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 252 ----~~~~--~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.... .......+..+..+.+++.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 00011222346678999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=283.61 Aligned_cols=272 Identities=21% Similarity=0.265 Sum_probs=187.6
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeCC--CcEEEEE--------------Eec---ccCcccHHHHHHHHHHHhhcCCC
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELKD--GQMIAAK--------------VRK---EASTQGFAEFQSEVYVLNFARHK 79 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~k--------------~~~---~~~~~~~~~~~~e~~~l~~l~~~ 79 (315)
....++|++++.||+|+||+||++..+. +...+.| .+. .........+.+|+.+++.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 4456799999999999999999986432 2222211 000 11122344578999999999999
Q ss_pred CccceeeeEEecCeeEEEEEeccCCccccccccCC---CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcE
Q 046121 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNT---ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNI 156 (315)
Q Consensus 80 ~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~ni 156 (315)
||+++++++...+..+++++++. +++.+++.... ........+..++.|++.||.|||+. +++|+||||+||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~----gIiHrDLKP~NI 298 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK----KLIHRDIKLENI 298 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHE
Confidence 99999999999999999999874 45555553321 12234566778999999999999999 999999999999
Q ss_pred EEcCCCceeECCCCcccccCCCCC-ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCC-ccCCCCCccch
Q 046121 157 LLTHDFVPMLGDFGLARWKTTDDP-VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRK-VVDMNGEEPQQ 234 (315)
Q Consensus 157 l~~~~~~i~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~-p~~~~~~~~~~ 234 (315)
+++.++.++|+|||++........ ......|++.|+|||++.+..++.++|||||||++|+|++|.. |+.........
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 999999999999999975443222 2223568999999999999889999999999999999999874 45433322222
Q ss_pred hHHHhHHHHH---hhh-----ccccccCCc----ccCCCCH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 235 SLRQWAEPLI---EKL-----ALHELIDPR----IENSYDT-----YELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 235 ~~~~~~~~~~---~~~-----~~~~~~~~~----~~~~~~~-----~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.+........ ... .+...+... .....+. .....+.+++.+||+.||++|||+.|++.+-+
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 2221111000 000 000000000 0000000 01234567788999999999999999998644
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=260.68 Aligned_cols=260 Identities=22% Similarity=0.282 Sum_probs=194.0
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc-ccHHHHHHHHHH-HhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-QGFAEFQSEVYV-LNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
++|++.+.||+|+||.||++.+. +++.||+|....... .....+..|+.. ++..+|||++++++++..++..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47999999999999999999876 689999998765422 223344555554 677789999999999999999999999
Q ss_pred eccCCccccccccC--CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 100 YICNKSLHWHLFDN--TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|+. ++|.+.+... ....+++..++.++.|++.++.+||+.. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL---SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 985 5676665432 2356899999999999999999999853 799999999999999999999999999864332
Q ss_pred CCCccccccccccccCcccccc----CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 178 DDPVQTKILGTLGYLAPEYAEN----GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ...... .. . ..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~----~~-~-----~~ 224 (283)
T cd06617 157 SV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQ----VV-E-----EP 224 (283)
T ss_pred cc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHH----HH-h-----cC
Confidence 11 1122456788999998865 44678999999999999999999998642221 111111 00 0 00
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
.+... ....+..+.+++.+||..+|++||++.++++.-+-.....
T Consensus 225 ~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 225 SPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 11111 1123455788999999999999999999998655554443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=270.94 Aligned_cols=261 Identities=22% Similarity=0.235 Sum_probs=198.4
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecC-----eeE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN-----LNI 95 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 95 (315)
+|++.+.||.|++|.||+|.+. +++.+++|.+.... ....+.+.+|+.+++.++|||++++.+++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6899999999999999999876 58899999876543 334567889999999999999999999987765 789
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
++++|+. ++|.+.+.+. ..+++..++.++.+++.++.+||+. |++|+||+|.||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~----gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSA----NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999986 5787777443 3799999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCC---CccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH-------
Q 046121 176 TTDD---PVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI------- 244 (315)
Q Consensus 176 ~~~~---~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 244 (315)
.... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...+.... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ--LNLIVEVLGTPSEEDL 231 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHhcCCCChhHh
Confidence 4432 122334568889999999877 788999999999999999999999965543211 110000000
Q ss_pred ---hhhcccccc---CCc---ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 245 ---EKLALHELI---DPR---IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 245 ---~~~~~~~~~---~~~---~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
......... ... ......+..+..+.+++.+||+.+|++|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 000 0000111235568899999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=268.70 Aligned_cols=264 Identities=22% Similarity=0.265 Sum_probs=192.9
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEec-----Ce
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE-----NL 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 93 (315)
+.++|++.+.||+|++|+||+|.+. +++.|++|.+.... ......+.+|+.+++.++|||++++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999765 68899999876432 23345677899999999999999999987543 35
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.+++++|+.+ ++...+ ....+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~-~l~~~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELMET-DLYKLI---KTQHLSNDHIQYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhccc-CHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEECccccee
Confidence 7999999854 666555 234689999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCCCc---cccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccc-------------hhH
Q 046121 174 WKTTDDPV---QTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ-------------QSL 236 (315)
Q Consensus 174 ~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-------------~~~ 236 (315)
........ .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||........ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 44322211 123467889999998654 5678899999999999999999999964321100 000
Q ss_pred HHhHHHHHhhhcccccc-CCccc-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 237 RQWAEPLIEKLALHELI-DPRIE-NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.......... ...... .+... ....+..+..+.+++.+||+.+|++|||+.+++++
T Consensus 235 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARN-YIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhh-HHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 000000 00000 00011234558899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=265.87 Aligned_cols=263 Identities=19% Similarity=0.268 Sum_probs=194.0
Q ss_pred cceecCC--CceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 28 ENLLGEG--GFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 28 ~~~lg~g--~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
...||+| ++|+||++.+. +++.|++|+.... .....+.+.+|+.+++.++||||+++++++..++..++|++|+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3466776 89999999875 7999999987643 23345678899999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcc
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~ 182 (315)
++++.+++.+.....+++..+..++.|++.+|.|||+. +++|+||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN----GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999988766556689999999999999999999999 99999999999999999999999997543221111100
Q ss_pred -------ccccccccccCccccccC--CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH------------
Q 046121 183 -------TKILGTLGYLAPEYAENG--IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE------------ 241 (315)
Q Consensus 183 -------~~~~~~~~~~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 241 (315)
....++..|+|||++.+. .++.++|+||+|+++|+|++|..||........ ......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCcccccc
Confidence 011235569999998764 367899999999999999999999964321110 000000
Q ss_pred --HH---------Hh----hhcc-----ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 242 --PL---------IE----KLAL-----HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 242 --~~---------~~----~~~~-----~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.. .. .... ................+..+.+|+.+||+.||++|||+.+++++-+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 00 00 0000 00000111111233456678999999999999999999999876553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=261.38 Aligned_cols=261 Identities=26% Similarity=0.287 Sum_probs=195.9
Q ss_pred CcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEec--CeeEEEEE
Q 046121 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE--NLNILVYE 99 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~~ 99 (315)
|++.+.||.|++|.||+|.+. +++.+++|.+.... ......+.+|+.+++.++|||++++++++... +..++|++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 788999999999999999876 58899999887653 33445678899999999999999999999887 88999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+ +|.+.+.... ..+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~----~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN----GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9864 7777765432 4689999999999999999999999 99999999999999999999999999987554432
Q ss_pred C-ccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh--hhccc-----
Q 046121 180 P-VQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE--KLALH----- 250 (315)
Q Consensus 180 ~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~----- 250 (315)
. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....... ........... .....
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchhhccccccc
Confidence 1 1122345778999997764 457889999999999999999999996544211 11111000000 00000
Q ss_pred ---cc------cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 251 ---EL------IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 251 ---~~------~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.. ....+........+..+.+++.+||+.+|++||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 00000011111125568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=261.07 Aligned_cols=250 Identities=25% Similarity=0.323 Sum_probs=209.7
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.-|.++++||+|++|.||+|.++ +|..+|+|.... +...+++..|+.++.+.+.|+++++++.+-....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 45788999999999999999766 699999997764 455788999999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
-.|++.+.+ +.+++++++.++..++...+.+|+|||.. .-+|||||+.||+++.+|..+|.|||.+-.....-..
T Consensus 111 GAGSiSDI~-R~R~K~L~E~EIs~iL~~TLKGL~YLH~~----~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 111 GAGSISDIM-RARRKPLSEQEISAVLRDTLKGLQYLHDL----KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CCCcHHHHH-HHhcCCccHHHHHHHHHHHHhHHHHHHHH----HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 999998876 45677899999999999999999999999 8999999999999999999999999999765554455
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC-CcccCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID-PRIENS 260 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 260 (315)
.++.+|||-|+|||++..-.|..++||||||++..+|..|++||.+- .+.. ...-+.. |..--.
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI--HPMR-------------AIFMIPT~PPPTF~ 250 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI--HPMR-------------AIFMIPTKPPPTFK 250 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc--cccc-------------eeEeccCCCCCCCC
Confidence 56789999999999999888999999999999999999999999531 1110 1111111 111112
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
.+...+..+.+++++||-++|++|-|+.+++++-
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 3445577799999999999999999999988763
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=254.60 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=183.6
Q ss_pred ceecCCCceEEEEEEeCCC---cEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCC
Q 046121 29 NLLGEGGFGHVYKGELKDG---QMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNK 104 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~~---~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (315)
+.||+|+||+||+|...++ ..+++|...... ......+.+|+..++.++|||++++++.+......++||||+.++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999965433 344556544332 334567889999999999999999999999999999999999999
Q ss_pred ccccccccCC--CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC--C
Q 046121 105 SLHWHLFDNT--ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD--P 180 (315)
Q Consensus 105 ~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~--~ 180 (315)
+|.+++.+.. ....+...+..++.|++.|+.+||+. +++|+||||+||+++.++.++++|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH----NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9998886542 23466777888999999999999999 99999999999999999999999999875322111 1
Q ss_pred ccccccccccccCcccccc-------CCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 181 VQTKILGTLGYLAPEYAEN-------GIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~-------~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
......++..|+|||++.. ..++.++||||||+++|+|++ |..||...... ..... .. .......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~----~~-~~~~~~~ 229 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR--EVLNH----VI-KDQQVKL 229 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HH-hhccccc
Confidence 1123456788999998743 234678999999999999997 56677533211 11111 11 1111222
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.++.+...+ ...+.+++..|| .+|++||++.++++.|.
T Consensus 230 ~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333333333 334566777798 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=266.69 Aligned_cols=269 Identities=19% Similarity=0.232 Sum_probs=198.1
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEe----cCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCK----ENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 94 (315)
.++|++.+.||+|++|.||+|.+. +++.+++|.+.... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999765 68999999876542 2345667889999999999999999998753 3567
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++|++|+. ++|...+.. ...+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSA----NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999985 578777743 34589999999999999999999999 999999999999999999999999999864
Q ss_pred cCCCCCc----cccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH-----HHHH
Q 046121 175 KTTDDPV----QTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA-----EPLI 244 (315)
Q Consensus 175 ~~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~ 244 (315)
....... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||............... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 4322211 123467888999998765 45788999999999999999999999654321110000000 0000
Q ss_pred hh---hcc---ccccCCccc---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 245 EK---LAL---HELIDPRIE---NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 245 ~~---~~~---~~~~~~~~~---~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.. ... ......... ....+..+..+.+++.+||+.+|++|||+.+++.+.+-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 00 000 000000000 001122356689999999999999999999999866553
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=270.05 Aligned_cols=253 Identities=20% Similarity=0.275 Sum_probs=207.7
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCccc--HHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQG--FAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
..+.|.+.+.||.|.|++|.+|.+. ++..||+|++.+..-.. ...+.+|+++++.++||||++++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4578999999999999999999765 79999999988764332 34478999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|||..++.+.+++.++.. +.+..+...+.|++.|++|||++ +++|+|||++|++++.+.+++|+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k----~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK----NIVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc----ceeccccchhhcccccccceeeeccccceeec-
Confidence 999999999999976554 66688899999999999999999 99999999999999999999999999998665
Q ss_pred CCCccccccccccccCccccccCCC-cccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
......+.+|++.|.|||++.|..+ ++.+|+||+|+++|.|+.|.+||++.+-..... +. +..+
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------rv---------l~gk 271 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------RV---------LRGK 271 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc------hh---------eeee
Confidence 4555667899999999999998776 578999999999999999999998654321100 00 0000
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
. ..+-..+....++|+++|-.+|.+|++..++.+.-|..
T Consensus 272 ~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n 310 (596)
T KOG0586|consen 272 Y--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN 310 (596)
T ss_pred e--cccceeechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence 0 01111223356788889999999999999998776654
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=254.83 Aligned_cols=249 Identities=19% Similarity=0.226 Sum_probs=195.6
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-----CcccHHHHHHHHHHHhhcCCCCccceeeeEEec--Cee
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-----STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE--NLN 94 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 94 (315)
.+|.+.+.||+|++|.||+|.+. +++.+++|..... .......+.+|+.+++.++|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999865 6889999976432 223345678899999999999999999998654 567
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++++||+.+++|.+.+.+. ..+++.....++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999998888543 3478889999999999999999999 999999999999999999999999999864
Q ss_pred cCCCC---CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 175 KTTDD---PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 175 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
..... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ....+ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~----~-------- 221 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAIFK----I-------- 221 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHHHH----H--------
Confidence 32211 1112345788899999998888899999999999999999999999643211 00000 0
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.........+......+.+++.+||+ +|..||++.+++.+
T Consensus 222 -~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 222 -ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 00111122334455668899999999 58999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=257.06 Aligned_cols=249 Identities=23% Similarity=0.311 Sum_probs=194.2
Q ss_pred CCcccceecCCCceEEEEEEeCC-CcEEEEEEeccc-----CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEA-----STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
+|.+.+.||+|++|+||++.+.. +..+++|+.... ..........|+.+++.++|||++++++.+......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 68999999999999999997763 444555554432 222334566789999999999999999999988999999
Q ss_pred EEeccCCcccccccc--CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 98 YEYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+||+.+++|.+.+.. .....+++..++.++.|++.++.+||+. +++|+||+|+||+++. +.++++|||.+...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR----RILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc----CccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999887754 3345689999999999999999999999 9999999999999975 56999999998654
Q ss_pred CCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
...........+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ........ ....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~------~~~~~ 223 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIV------EGPTP 223 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH------cCCCC
Confidence 4333333345577889999998888888999999999999999999999853221 00001100 00111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
..+...+..+.+++.+||+.+|++||++.+++++
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 ----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1233445568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=258.22 Aligned_cols=246 Identities=22% Similarity=0.281 Sum_probs=187.2
Q ss_pred eecCCCceEEEEEEeC-CCcEEEEEEecccCc---ccHHHHHHHHHHHh---hcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 30 LLGEGGFGHVYKGELK-DGQMIAAKVRKEAST---QGFAEFQSEVYVLN---FARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 30 ~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~---~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
.||+|+||.||++.+. +++.+++|....... .......+|..+++ ...||+++.+.+.+..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 688999998764321 11222334444333 3468999999999999999999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcc
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~ 182 (315)
+++|.+++... ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++....... .
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 152 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--c
Confidence 99998887533 4589999999999999999999999 99999999999999999999999999986433222 2
Q ss_pred ccccccccccCccccc-cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 183 TKILGTLGYLAPEYAE-NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 183 ~~~~~~~~~~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
....+++.|+|||.+. +..++.++|+||+|+++|+|++|..||.............. .. ......
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~~----------~~~~~~ 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----TL----------TVNVEL 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH----hh----------cCCcCC
Confidence 2346789999999886 45578899999999999999999999965433221111110 00 011112
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhcc
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEGE 297 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~~ 297 (315)
+...+..+.+++.+||..||++|| |+++++++..-.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~ 259 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK 259 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcccc
Confidence 233455678899999999999999 699998875443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=261.49 Aligned_cols=264 Identities=22% Similarity=0.282 Sum_probs=190.6
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecC-----
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN----- 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 92 (315)
..++|++.+.||+|++|.||+|.+. +++.+++|.+.... ........+|+.+++.++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4468999999999999999999875 68899999875432 222334568999999999999999999886544
Q ss_pred ---eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCC
Q 046121 93 ---LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDF 169 (315)
Q Consensus 93 ---~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~df 169 (315)
..++|+||+. +++.+.+... ...+++.+++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|+||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN----KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEECCCCcEEECcC
Confidence 4599999985 4666665432 34589999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCc----cccccccccccCccccccCC-CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH
Q 046121 170 GLARWKTTDDPV----QTKILGTLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI 244 (315)
Q Consensus 170 g~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (315)
|++......... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|.+||....... .... .....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~-~~~~~ 240 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTL-ISQLC 240 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHh
Confidence 998644322211 12234677899999876543 6789999999999999999999986543211 1110 00000
Q ss_pred hh--------h---------ccccccCCcccCCC-CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 245 EK--------L---------ALHELIDPRIENSY-DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 245 ~~--------~---------~~~~~~~~~~~~~~-~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.. . .............. .......+.+++.+||..||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 0 00000000000000 00113456789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=258.02 Aligned_cols=261 Identities=25% Similarity=0.276 Sum_probs=194.0
Q ss_pred CcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc--cHHHHHHHHHHHhhc---CCCCccceeeeEEecCe-----
Q 046121 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ--GFAEFQSEVYVLNFA---RHKNIVMLLGFCCKENL----- 93 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~----- 93 (315)
|++.+.||+|++|.||+|.++ +++.+++|.+...... ....+.+|+.+++.+ .|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999876 4889999987643222 223455677766655 59999999999987776
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.++++|++.+ +|.+++.......+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~----~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999864 787777665555689999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh--cc--
Q 046121 174 WKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL--AL-- 249 (315)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~-- 249 (315)
....... .....++..|+|||.+.+..++.++|+||+|+++|+|++|.+||...... .............. ..
T Consensus 156 ~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 156 IYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCCCChHhcCC
Confidence 5433222 12334678899999999888999999999999999999999998654321 11111111100000 00
Q ss_pred -----ccccCCccc---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 250 -----HELIDPRIE---NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 250 -----~~~~~~~~~---~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
......... ....+.....+.+++.+||+.||++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 11112334567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=260.28 Aligned_cols=248 Identities=24% Similarity=0.312 Sum_probs=199.5
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcC-CCCccceeeeEEecCeeEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 97 (315)
++|++.+.||+|++|.||+|.+. +++.+++|++... .......+.+|+.+++.+. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999865 6899999987653 2333456788999999998 99999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|+++.+++|.+.+.+. ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~----~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSK----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999988544 3699999999999999999999999 999999999999999999999999999864433
Q ss_pred CCC--------------------ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHH
Q 046121 178 DDP--------------------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLR 237 (315)
Q Consensus 178 ~~~--------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 237 (315)
... ......++..|+|||...+..++.++|+||||++++++++|..||...... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~ 232 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--LTFQ 232 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--HHHH
Confidence 221 112234678899999988888899999999999999999999999644311 1111
Q ss_pred HhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH----HHHHHH
Q 046121 238 QWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSM----GEVVRL 293 (315)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~----~~il~~ 293 (315)
... . .....+...+..+.+++.+||+.+|++|||+ ++++.+
T Consensus 233 ----~~~-~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 233 ----KIL-K----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred ----HHH-h----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 100 0 0111122224557889999999999999999 777754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=253.52 Aligned_cols=252 Identities=21% Similarity=0.233 Sum_probs=193.4
Q ss_pred cHHHHHHHhcCCccccee--cCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeeeEE
Q 046121 14 SFSEIQQATGDFSKENLL--GEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGFCC 89 (315)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l--g~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 89 (315)
.+.......+.|++.+.+ |.|+||.||++... ++..+++|+......... |+.....+ +|||++++++.+.
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe
Confidence 344455566788888877 99999999999765 688899998765422211 22222222 6999999999999
Q ss_pred ecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC-ceeECC
Q 046121 90 KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF-VPMLGD 168 (315)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~-~i~l~d 168 (315)
..+..++||||+.+++|.+++.... .+++..+..++.|++.++.+||+. +++|+||+|+||+++.++ .++++|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 9999999999999999999885443 789999999999999999999999 999999999999999998 999999
Q ss_pred CCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhc
Q 046121 169 FGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248 (315)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (315)
||.+...... ....++..|+|||++.+..++.++|+||+|+++|+|++|..||........ ....+....
T Consensus 154 fg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~----- 223 (267)
T PHA03390 154 YGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ----- 223 (267)
T ss_pred CccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh-----
Confidence 9988643322 223578899999999988899999999999999999999999974332211 111111110
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHH
Q 046121 249 LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS-MGEVVRL 293 (315)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps-~~~il~~ 293 (315)
. . ........+..+.+++.+||+.+|.+||+ +++++++
T Consensus 224 -~----~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 224 -Q----K--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -c----c--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0 0 00111234556889999999999999996 6998854
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=258.21 Aligned_cols=260 Identities=16% Similarity=0.189 Sum_probs=182.0
Q ss_pred HHhcCCcccceecCCCceEEEEEEeCC----CcEEEEEEecccCcccHH-----------HHHHHHHHHhhcCCCCccce
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELKD----GQMIAAKVRKEASTQGFA-----------EFQSEVYVLNFARHKNIVML 84 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~k~~~~~~~~~~~-----------~~~~e~~~l~~l~~~~i~~~ 84 (315)
...++|++.++||+|+||+||+|.+.+ +..+++|+.......... ....+...+..++|++++.+
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 455799999999999999999998653 456667754332221111 11223345566789999999
Q ss_pred eeeEEecC----eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC
Q 046121 85 LGFCCKEN----LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH 160 (315)
Q Consensus 85 ~~~~~~~~----~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~ 160 (315)
++...... ..+++++++ ..++.+.+... ...++..+..++.|++.++.+||+. +++||||||+||+++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~----~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH----GISHGDIKPENIMVDG 161 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcC
Confidence 98765433 235666764 33454444322 2357788899999999999999999 9999999999999999
Q ss_pred CCceeECCCCcccccCCCCC-------ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccc
Q 046121 161 DFVPMLGDFGLARWKTTDDP-------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ 233 (315)
Q Consensus 161 ~~~i~l~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~ 233 (315)
++.++|+|||++........ ......|++.|+|||++.+..++.++|||||||++|+|++|..||...+....
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 99999999999875432211 11224689999999999999999999999999999999999999975533221
Q ss_pred hhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 234 QSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
..... ........ ..+.... +..+..+.+++..||+.+|++||++.++++.|+
T Consensus 242 ~~~~~-~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAA-KCDFIKRL-----HEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHh-HHHHHHHh-----hhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11100 00011110 0011100 112355789999999999999999999998764
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=261.91 Aligned_cols=266 Identities=17% Similarity=0.167 Sum_probs=193.5
Q ss_pred CcccceecCCCceEEEEEEeCCCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 25 FSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
|.+.+.+|.|+++.++.+.. +++.+|+|++... .......+.+|+.+++.++|+||+++++++...+..+++|||+.
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 34445555555544444433 6889999987654 34556778999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC--
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP-- 180 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~-- 180 (315)
+++|.+++.......+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++||+.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~----~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK----GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 99999998766566789999999999999999999999 999999999999999999999999998753322111
Q ss_pred -----ccccccccccccCcccccc--CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH---Hh-----
Q 046121 181 -----VQTKILGTLGYLAPEYAEN--GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL---IE----- 245 (315)
Q Consensus 181 -----~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~----- 245 (315)
......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||........ ......... ..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchh
Confidence 1122345678999998865 3478899999999999999999999964322110 000000000 00
Q ss_pred --hhccc--------cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 246 --KLALH--------ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 246 --~~~~~--------~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
..... ..................+.+++.+||+.||++|||+++++++-.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~ 298 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence 00000 0000001111223345678899999999999999999999986653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=260.71 Aligned_cols=267 Identities=23% Similarity=0.271 Sum_probs=195.0
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecC---
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN--- 92 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 92 (315)
....++|++.+.||+|++|.||+|.++ +++.+++|.+.... ......+.+|+.+++.++|||++++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456679999999999999999999876 58889999876432 223345678999999999999999999886654
Q ss_pred -------eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCcee
Q 046121 93 -------LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM 165 (315)
Q Consensus 93 -------~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~ 165 (315)
.+++|+||+.+ ++...+... ...+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK----NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCcEE
Confidence 78999999876 565555433 34689999999999999999999999 999999999999999999999
Q ss_pred ECCCCcccccCCCCCc-cccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH
Q 046121 166 LGDFGLARWKTTDDPV-QTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 166 l~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
|+|||.+......... .....++..|+|||.+.+ ..++.++||||||+++++|++|.+||..... ...+.......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--~~~~~~~~~~~ 234 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--LAQLELISRLC 234 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHh
Confidence 9999998754433221 122245678999998764 3468899999999999999999999964332 11111111100
Q ss_pred Hhh--hccccc--------cCCcc-----cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 244 IEK--LALHEL--------IDPRI-----ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 244 ~~~--~~~~~~--------~~~~~-----~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
... ...... .+... ........+..+.+++.+||+.+|++|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 000000 00000 000011124568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=256.11 Aligned_cols=243 Identities=23% Similarity=0.274 Sum_probs=191.1
Q ss_pred ecCCCceEEEEEEeC-CCcEEEEEEecccCc---ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCcc
Q 046121 31 LGEGGFGHVYKGELK-DGQMIAAKVRKEAST---QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSL 106 (315)
Q Consensus 31 lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (315)
||.|++|.||++.+. +++.+++|++..... .....+.+|+..++.++|||++++++.+......+++++|+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 589999998765433 3455688899999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC------
Q 046121 107 HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP------ 180 (315)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~------ 180 (315)
.+++.+.. .+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN----GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc----CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 88886543 689999999999999999999999 999999999999999999999999999864333211
Q ss_pred --ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 181 --VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 181 --~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
......++..|++||...+..++.++|+||||+++|++++|..||....... . ...... .... ..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~----~~~~~~----~~~~---~~ 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--I----FQNILN----GKIE---WP 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--H----HHHHhc----CCcC---CC
Confidence 1223456788999999988888899999999999999999999996443211 0 011100 0000 00
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
.. ...+..+.+++.+||+.+|++|||+..+.+.|
T Consensus 222 ~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 222 ED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred cc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 00 01245678999999999999999994444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=260.53 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=203.4
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
+...+.|..-++||+|+||.|+-+.-. +|+.+|.|.+.+.. .....-..+|..+|++++.+.|+.+-..|+..+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 345578888999999999999999654 78888888755431 12223457899999999999999999999999999
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
|+|+..|.||+|.-++.+..+..+++..+..++.+|+-++.+||+. +||.||+||+||++|..|+++|+|+|++..
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~----~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR----RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc----ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 9999999999999999888888899999999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccch-hHHHhHHHHHhhhcccccc
Q 046121 175 KTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ-SLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 253 (315)
.....+ .....||.+|||||++.+..|+...|.|+|||++|+|+.|+.||.......-. ...+. .
T Consensus 337 i~~g~~-~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr----~--------- 402 (591)
T KOG0986|consen 337 IPEGKP-IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR----T--------- 402 (591)
T ss_pred cCCCCc-cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH----H---------
Confidence 444333 33458999999999999999999999999999999999999999654432211 11110 0
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMG 288 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~ 288 (315)
......++...++.++++.+.+|.+||.+|..-.
T Consensus 403 -~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 403 -LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -hcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 0112233444555677788889999999997543
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=265.06 Aligned_cols=270 Identities=23% Similarity=0.248 Sum_probs=197.7
Q ss_pred HhcCCcc-cceecCCCceEEEEEEeC-CCcEEEEEEecccCccc--------------HHHHHHHHHHHhhcCCCCccce
Q 046121 21 ATGDFSK-ENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQG--------------FAEFQSEVYVLNFARHKNIVML 84 (315)
Q Consensus 21 ~~~~y~~-~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~--------------~~~~~~e~~~l~~l~~~~i~~~ 84 (315)
+.++|.. .+.||.|++|+||+|.+. +++.+++|+........ ...+.+|+.+++.++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4567875 577999999999999866 68899999876432211 1246789999999999999999
Q ss_pred eeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCce
Q 046121 85 LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVP 164 (315)
Q Consensus 85 ~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i 164 (315)
++++...+..+++|||+. ++|.+.+.. ...+++.....++.|++.++.+||+. +++|+||+|+||+++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~----~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKW----YFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHeEECCCCCE
Confidence 999999999999999986 578777743 34589999999999999999999999 99999999999999999999
Q ss_pred eECCCCcccccCCC--------------CCccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCC
Q 046121 165 MLGDFGLARWKTTD--------------DPVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNG 229 (315)
Q Consensus 165 ~l~dfg~~~~~~~~--------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~ 229 (315)
+++|||.+...... ........+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999998644311 1111223457789999988764 36889999999999999999999997554
Q ss_pred CccchhHHHhHHHHHh--hhccccc--------cCCccc---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 230 EEPQQSLRQWAEPLIE--KLALHEL--------IDPRIE---NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 230 ~~~~~~~~~~~~~~~~--~~~~~~~--------~~~~~~---~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
... .+......... ...+... ...... .......+..+.+++.+||+.+|++|||+.+++.+-+-
T Consensus 239 ~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 239 EID--QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred HHH--HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 321 11111000000 0000000 000000 00111234567899999999999999999999987665
Q ss_pred ccc
Q 046121 297 END 299 (315)
Q Consensus 297 ~~~ 299 (315)
...
T Consensus 317 ~~~ 319 (335)
T PTZ00024 317 KSD 319 (335)
T ss_pred CCC
Confidence 443
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=256.98 Aligned_cols=263 Identities=24% Similarity=0.274 Sum_probs=195.4
Q ss_pred CcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc-ccHHHHHHHHHHHhhcC-CCCccceeeeEEecCeeEEEEEec
Q 046121 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-QGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
|++.+.||+|++|+||+|... +++.+++|.+..... .......+|+..++.+. |||++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 778899999999999999876 578899998765422 22233457899999999 999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
+++|.+.+.......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH----GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 78888888665555789999999999999999999999 999999999999999999999999999864433222
Q ss_pred cccccccccccCccccc-cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchh-HH---------HhHHHHHhhhccc
Q 046121 182 QTKILGTLGYLAPEYAE-NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQS-LR---------QWAEPLIEKLALH 250 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~-~~---------~~~~~~~~~~~~~ 250 (315)
.....++..|+|||.+. +..++.++|+||||+++++|++|.+||.......... .. .+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 22345778899999774 4557889999999999999999999986543211100 00 0000000000000
Q ss_pred cccCCcccC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 251 ELIDPRIEN---SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 251 ~~~~~~~~~---~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
......... ...+.....+.+++.+||+.+|++|||+++++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 0111124568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=259.80 Aligned_cols=256 Identities=25% Similarity=0.310 Sum_probs=197.7
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
..+|...+.||+|++|.||+|.+. ++..+++|..... .......+.+|+.+++.++|+|++++.+++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 345888899999999999999876 5788899876532 223345677899999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
+||+. +++.+.+... ...++...+..++.+++.++.+||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 99986 5676655432 34588999999999999999999999 999999999999999999999999999864332
Q ss_pred CCCccccccccccccCccccc---cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 178 DDPVQTKILGTLGYLAPEYAE---NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
. ....+++.|+|||.+. ...++.++||||||+++|+|++|..||....... .... .. .
T Consensus 168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~----~~-~-------- 228 (308)
T cd06634 168 A----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYH----IA-Q-------- 228 (308)
T ss_pred c----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHH----Hh-h--------
Confidence 1 2345678899999874 3457889999999999999999999985432110 0000 00 0
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
...........+..+.+++.+||..+|++||++.+++...+.......
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~ 276 (308)
T cd06634 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (308)
T ss_pred cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence 000111122344567899999999999999999999998776665443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=264.05 Aligned_cols=265 Identities=25% Similarity=0.296 Sum_probs=194.6
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhc-CCCCccceeeeEEe--cCe
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCK--ENL 93 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~ 93 (315)
.+.++|++.+.||+|++|.||+|.+. +++.+++|.+... .......+.+|+.+++.+ +||||+++++++.. ...
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 35679999999999999999999876 6888999976532 233345577899999999 99999999998854 346
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+++|+||+. ++|...+... .+++.....++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~----~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG----NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 899999986 5887777433 678889999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCCC-----ccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchh------------
Q 046121 174 WKTTDDP-----VQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQS------------ 235 (315)
Q Consensus 174 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~------------ 235 (315)
....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 4433221 2223457888999998754 457889999999999999999999996433211000
Q ss_pred -HHHhHHHHHhhhccccccCC--cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 236 -LRQWAEPLIEKLALHELIDP--RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 236 -~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
......... ...+...... .......+..+..+.+++.+||+.+|++|||+.+++++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFA-ATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhH-HHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000 0000000000 00001111134568899999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=265.12 Aligned_cols=265 Identities=22% Similarity=0.231 Sum_probs=193.6
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEec---------
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE--------- 91 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------- 91 (315)
.++|.+.+.||.|++|.||+|.+. +++.+++|.+........+.+.+|+.+++.++|||++++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 479999999999999999999875 6889999988766666667788999999999999999999776543
Q ss_pred -----CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC-CCcee
Q 046121 92 -----NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH-DFVPM 165 (315)
Q Consensus 92 -----~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~-~~~i~ 165 (315)
...++|+||+. ++|.+.+. ...+++..+..++.|++.|+.+||+. |++|+||+|+||+++. ++.++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~----givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCceEE
Confidence 35789999986 57776663 23588999999999999999999999 9999999999999974 56789
Q ss_pred ECCCCcccccCCCCCc---cccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH
Q 046121 166 LGDFGLARWKTTDDPV---QTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE 241 (315)
Q Consensus 166 l~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 241 (315)
++|||.+......... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||........ ......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~ 233 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILE 233 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence 9999998644322111 112346778999997654 5578899999999999999999999964432111 110000
Q ss_pred H-----------H---HhhhccccccCCc-ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 242 P-----------L---IEKLALHELIDPR-IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 242 ~-----------~---~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
. . ...........+. ......+.....+.+++.+||+.||++|||+.+++.+-+-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence 0 0 0000000000000 0000111234557889999999999999999999875443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=292.22 Aligned_cols=268 Identities=30% Similarity=0.488 Sum_probs=203.7
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
..+...|.....||+|+||.||+|.+. ++..||+|.+...... ...|+..++.++||||+++++++.+....++|
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 344567888889999999999999874 7889999987643221 23468889999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|||+++++|.+++. .+++.....++.+++.|+.|||..+ +.+++|+|+||+||+++.++..++. ++.......
T Consensus 762 ~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~-~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRC-SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCC-CCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999999999884 3788899999999999999999321 1289999999999999988877664 444321111
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
.....+++.|+|||++.+..++.++||||||+++|||++|+.||...... ......+..............++.+
T Consensus 835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccc
Confidence 11235678999999999989999999999999999999999998533221 1223333332222222233334433
Q ss_pred cC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 258 EN--SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 258 ~~--~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
.. .........+.+++.+||+.||++|||+.++++.|+.+....+
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 22 2334455668899999999999999999999999998866544
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=256.65 Aligned_cols=261 Identities=28% Similarity=0.287 Sum_probs=197.5
Q ss_pred CcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
|++.+.||+|.+|.||+|... +++.+++|+..... ......+.+|+.+++.++|+|++++++++......++|+|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 677889999999999999876 58999999877653 333456788999999999999999999999999999999998
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
. ++|.+++.+.. ..+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH----RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 6 58988886543 4589999999999999999999999 9999999999999999999999999998644433322
Q ss_pred cccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH--------Hhhhcc--c
Q 046121 182 QTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL--------IEKLAL--H 250 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~--~ 250 (315)
.....++..|+|||.+.+. .++.++|+||||+++|++++|.+||...... ..+....... ...... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--DQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 2333456789999988766 7889999999999999999999998654321 1111100000 000000 0
Q ss_pred cccCCcc----cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 251 ELIDPRI----ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 251 ~~~~~~~----~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...-+.. .....+.....+.+++.+||..+|++||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000 001111124568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=252.78 Aligned_cols=243 Identities=20% Similarity=0.238 Sum_probs=184.8
Q ss_pred cceecCCCceEEEEEEeC-CCcEEEEEEecccCcc---cHHHHHHHHHH-HhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 28 ENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ---GFAEFQSEVYV-LNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
++.||.|++|.||+|.+. +++.+++|++...... .......|... ....+|+|++++++.+..++.+++++||+.
T Consensus 1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 367999999999999765 5889999987654221 12223344433 445589999999999999999999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcc
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~ 182 (315)
+++|.+++... ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++..... .
T Consensus 81 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~ 150 (260)
T cd05611 81 GGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR----GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----N 150 (260)
T ss_pred CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEeecccceeccc----c
Confidence 99999888543 4588999999999999999999999 999999999999999999999999998863322 2
Q ss_pred ccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCC
Q 046121 183 TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYD 262 (315)
Q Consensus 183 ~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (315)
....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ... .... ... ........
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~----~~~~-~~~------~~~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--AVF----DNIL-SRR------INWPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--HHH----HHHH-hcc------cCCCCccc
Confidence 2345778899999998888899999999999999999999999643321 111 1100 000 00111112
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHH---HHHHH
Q 046121 263 TYELYLMAKTAYLCVQRNPEGRPSMG---EVVRL 293 (315)
Q Consensus 263 ~~~~~~l~~l~~~~l~~~p~~Rps~~---~il~~ 293 (315)
...+..+.+++.+||+.+|++||++. +++.+
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 23345688999999999999999665 55544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=256.98 Aligned_cols=249 Identities=25% Similarity=0.308 Sum_probs=192.8
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
.+.|...+.||+|++|+||+|.+. +++.+++|.+.... ......+.+|+.+++.++|||++++++++.+....++|
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 345788889999999999999865 68889999876432 23345678899999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
+||+. +++.+.+... ...+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 100 ~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~- 172 (313)
T cd06633 100 MEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASKSS- 172 (313)
T ss_pred EecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChhhEEECCCCCEEEeecCCCcccC-
Confidence 99985 4666655432 34588999999999999999999999 99999999999999999999999999885322
Q ss_pred CCCccccccccccccCccccc---cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 178 DDPVQTKILGTLGYLAPEYAE---NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
......++..|+|||.+. +..++.++|+||||+++|+|++|.+||....... .... .. ...
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--~~~~----~~-~~~------ 236 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYH----IA-QND------ 236 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHH----HH-hcC------
Confidence 122346788899999874 4567889999999999999999999985432111 0000 00 000
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.........+..+.+++.+||+.+|++||++.+++.+-+
T Consensus 237 --~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 237 --SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDF 275 (313)
T ss_pred --CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 011111223345788999999999999999999997633
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=260.29 Aligned_cols=264 Identities=22% Similarity=0.268 Sum_probs=194.6
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEe-cCeeE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCK-ENLNI 95 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 95 (315)
.+.++|++.+.||.|+||.||+|.+. +++.+++|.+... .......+.+|+.+++.++|||++++.+++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46789999999999999999999766 7889999976542 22334567889999999999999999998865 56789
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
++++|+ +++|...+. ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+...
T Consensus 87 lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~----~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSA----GVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999997 667877763 34578888889999999999999999 9999999999999999999999999998632
Q ss_pred CCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccch-hHHHh--------HHHHHh
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ-SLRQW--------AEPLIE 245 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~--------~~~~~~ 245 (315)
.. ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||......... ..... ......
T Consensus 159 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 159 DP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred CC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 21 2223456788999998765 56889999999999999999999999644321100 00000 000000
Q ss_pred h--hcc-cccc--CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 246 K--LAL-HELI--DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 246 ~--~~~-~~~~--~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
. ... .... .+.......+..+..+.+++.+||+.+|++|||+.+++..-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 0 000 0000 00000001112345688999999999999999999998773
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=278.42 Aligned_cols=261 Identities=25% Similarity=0.348 Sum_probs=214.2
Q ss_pred cCCcccceecCCCceEEEEEEeC----CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
....+.++||.|.||.|++|+.+ ....||||.++.-. +.....+..|+.++-+++||||+.+.+++.......+|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 46678889999999999999876 35689999888654 34455689999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
.|||++|+|..++..+.+. +...+..-+++.|+.+++||.+. ++|||||-++|||++.+...|+.|||++.....
T Consensus 709 TEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm----~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhc----CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999777654 99999999999999999999999 999999999999999999999999999985443
Q ss_pred CCCcccccc---ccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 178 DDPVQTKIL---GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 178 ~~~~~~~~~---~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
..+...+.. -+.+|.|||.+.-.+++.++||||+|+++||.++ |..||..... +++...+.+...+.
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN------QdVIkaIe~gyRLP--- 854 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------QDVIKAIEQGYRLP--- 854 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch------HHHHHHHHhccCCC---
Confidence 332211111 2568999999999999999999999999999886 8888854332 12222222222222
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHL 304 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~ 304 (315)
.+..++..|.+||..||++|=.+||.|.+|+..|+++-++-.++
T Consensus 855 -------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL 898 (996)
T KOG0196|consen 855 -------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL 898 (996)
T ss_pred -------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence 23446777999999999999999999999999999987765544
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=283.23 Aligned_cols=267 Identities=21% Similarity=0.229 Sum_probs=212.6
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecc---cCcccHHHHHHHHHHHhhcCCCCccceeeeEEecC
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKE---ASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN 92 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (315)
+..-..++|.++++||+|+||.|.+++.+ +++.||+|++.+ ........+..|-.++...+.+-|++++..|.++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 33445689999999999999999999875 699999999886 23444566888999999999999999999999999
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
++|+||+|+.||+|..++.+-. .+++..+..++..++.||..+|+. |+|||||||+||++|..|+|+|.|||.|
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m----gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM----GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc----cceeccCCcceeEecccCcEeeccchhH
Confidence 9999999999999998885443 699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc-cccccccccccCccccc----c-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhh
Q 046121 173 RWKTTDDPV-QTKILGTLGYLAPEYAE----N-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK 246 (315)
Q Consensus 173 ~~~~~~~~~-~~~~~~~~~~~aPE~~~----~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (315)
-.....+.. +...+|||-|.+||++. + +.|+..+|.||+|+++|||+.|.-||-..+ .+..+..-
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads---------lveTY~KI 293 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS---------LVETYGKI 293 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH---------HHHHHHHH
Confidence 877766654 55689999999999885 3 568999999999999999999999983211 11111111
Q ss_pred hccccccCCcccCCCC--HHHHHHHHHHHHhhcCCCCCCCCC---HHHHHHHHhcccccccccc
Q 046121 247 LALHELIDPRIENSYD--TYELYLMAKTAYLCVQRNPEGRPS---MGEVVRLLEGENDRFHHLG 305 (315)
Q Consensus 247 ~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~~l~~~p~~Rps---~~~il~~L~~~~~~~~~~~ 305 (315)
++-.-.-.+| ..++...++||.+.+. +|+.|.. ++++-.+.--..+.|..++
T Consensus 294 ------m~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR 350 (1317)
T KOG0612|consen 294 ------MNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIR 350 (1317)
T ss_pred ------hchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhh
Confidence 1111111111 2245556667765554 6888987 9999888877777776554
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=252.20 Aligned_cols=251 Identities=21% Similarity=0.273 Sum_probs=188.7
Q ss_pred eecCCCceEEEEEEeC-CCcEEEEEEecccCcc---cHHHHHHHH---HHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 30 LLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ---GFAEFQSEV---YVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 30 ~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~~e~---~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
.||+|+||.||+|.+. +++.+++|.+...... .......|. ..++...||+++.+.+.+...+..++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999765 5889999987653221 111223333 34445679999999999999999999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcc
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~ 182 (315)
|++|..++.. ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~ 152 (278)
T cd05606 81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (278)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence 9999887743 34689999999999999999999999 99999999999999999999999999986443222 2
Q ss_pred ccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 183 TKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 183 ~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
....|+..|+|||.+.++ .++.++|+||+|+++|+|++|..||............. .. ...... .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~----~~------~~~~~~----~ 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MT------LTMAVE----L 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH----Hh------hccCCC----C
Confidence 234688999999998744 57899999999999999999999996542211111000 00 001111 1
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhccccccc
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEGENDRFH 302 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~~~~~~~ 302 (315)
+...+..+.+++.+||..+|.+|| ++.+++++-+-....|.
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 122345678889999999999999 99999976554443333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=254.43 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=195.4
Q ss_pred CCcccceecCCCceEEEEEEeC----CCcEEEEEEecccC----cccHHHHHHHHHHHhhc-CCCCccceeeeEEecCee
Q 046121 24 DFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEAS----TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 94 (315)
+|++.+.||+|++|.||++.+. +++.+++|++.... ......+.+|+.+++.+ +||+++++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999643 57789999876432 22345577899999999 599999999999999999
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++|+||+.+++|.+.+.. ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~----~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQL----GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999888753 34588999999999999999999999 999999999999999999999999998864
Q ss_pred cCCCCC-ccccccccccccCccccccCC--CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 175 KTTDDP-VQTKILGTLGYLAPEYAENGI--VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 175 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
...... ......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+.... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~----- 227 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS----- 227 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc-----
Confidence 333221 112245788999999887655 67899999999999999999999964332111 11111111100
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.+. .+......+.+++.+||+.+|++|||+.++.+.|+-.
T Consensus 228 --~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 --KPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 011 1122334578899999999999999987776655543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=255.06 Aligned_cols=255 Identities=23% Similarity=0.329 Sum_probs=190.8
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 97 (315)
..++|++.+.||+|++|.||+|.+. +++.+++|.+.... ......+..|+..+... .||||+++++++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 4468999999999999999999876 48899999876543 22334455666656555 499999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
++|+. +++.+.+... ...+++..+..++.+++.++.+||+ . +++|+||+|+||+++.++.++|+|||++....
T Consensus 93 ~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~----~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKH----GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhC----CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99974 4565554332 3468999999999999999999997 6 89999999999999999999999999986433
Q ss_pred CCCCccccccccccccCccccccCC----CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGI----VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
.... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||....... ..+. ..... .
T Consensus 167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~----~~~~~-~---- 235 (296)
T cd06618 167 DSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLT----KILQE-E---- 235 (296)
T ss_pred CCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHH----HHhcC-C----
Confidence 2221 12234677899999887553 7789999999999999999999985422110 1111 00100 0
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.+.... ....+..+.+++.+||..||++||++++++.+.+
T Consensus 236 -~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 236 -PPSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred -CCCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 001110 1123445889999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=253.62 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=197.9
Q ss_pred CCcccceecCCCceEEEEEEeC----CCcEEEEEEecccC----cccHHHHHHHHHHHhhc-CCCCccceeeeEEecCee
Q 046121 24 DFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEAS----TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 94 (315)
.|++.+.||.|++|.||.+.+. ++..+++|++.... ....+.+.+|+.+++.+ +|++|+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999763 68889999876432 22345677899999999 589999999999999999
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++|+||+.+++|.+++... ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999888543 4588999999999999999999999 999999999999999999999999999864
Q ss_pred cCCCCC-ccccccccccccCccccccC--CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 175 KTTDDP-VQTKILGTLGYLAPEYAENG--IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 175 ~~~~~~-~~~~~~~~~~~~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
...... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~----- 227 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS----- 227 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc-----
Confidence 332211 11234578889999988653 467889999999999999999999964332211 11111111000
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhcccccc
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEGENDRF 301 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~~~~~~ 301 (315)
.+ ..+......+.+++.+||+.+|++|| ++++++.+-.-...+|
T Consensus 228 --~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 228 --EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred --CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 01 11222345678899999999999997 7888887644444444
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=263.89 Aligned_cols=256 Identities=23% Similarity=0.333 Sum_probs=206.1
Q ss_pred HhcCCcccceecCCCceEEEEEEeCC-----CcEEEEEEecc-cCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKD-----GQMIAAKVRKE-ASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
.....+..++||.|.||.||.|...+ .-.||+|..+. ..+...+.+..|..+++.++||||++++|++.+.. .
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-M 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-e
Confidence 34455666789999999999996442 33578888775 44555677999999999999999999999998654 5
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++|||.+..|.|..++..+... ++......++.|++.|+.|||+. ..+||||-.+||++.....+||+|||++.+
T Consensus 466 WivmEL~~~GELr~yLq~nk~s-L~l~tL~ly~~Qi~talaYLeSk----rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDS-LPLRTLTLYCYQICTALAYLESK----RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHhcccc-chHHHHHHHHHHHHHHHHHHHhh----chhhhhhhhhheeecCcceeeecccchhhh
Confidence 9999999999999999776655 88999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccc-cccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCC-CccchhHHHhHHHHHhhhcccc
Q 046121 175 KTTDDPVQT-KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNG-EEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 175 ~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
......... ....+.-|+|||.++-..++.++|||.||+.+||++. |..||.+-. .+.. .
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-----------------~ 603 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-----------------G 603 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-----------------E
Confidence 766554322 2334668999999999999999999999999999986 888886422 1111 1
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
.+...-....++.++..+-.|+.+||.++|.+||++.++...|..+..
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 112222223345556667899999999999999999999988877654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=257.34 Aligned_cols=264 Identities=21% Similarity=0.229 Sum_probs=190.1
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--ccHHHHHHHHHHHhhcCCCCccceeeeEEec-------
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--QGFAEFQSEVYVLNFARHKNIVMLLGFCCKE------- 91 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------- 91 (315)
.++|++.+.||+|++|.||+|.+. +++.+++|.+..... .......+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 579999999999999999999876 688899998754322 2234567899999999999999999987443
Q ss_pred -CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCC
Q 046121 92 -NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 92 -~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
..+++|++|+.+ ++...+... ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN----HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECcCc
Confidence 346999999754 555555332 34699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcc-----------ccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHH
Q 046121 171 LARWKTTDDPVQ-----------TKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQ 238 (315)
Q Consensus 171 ~~~~~~~~~~~~-----------~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 238 (315)
++.......... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~--~~~~ 238 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID--QLHL 238 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence 986433222111 12245778999998765 457889999999999999999999996443321 1111
Q ss_pred hHHHHHh--------hhccccc----cCCcccCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 239 WAEPLIE--------KLALHEL----IDPRIENSY---DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 239 ~~~~~~~--------~~~~~~~----~~~~~~~~~---~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
....... ....... ......... .......+.+++.+||+.||++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0000000 0000000 000000000 01122567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=267.75 Aligned_cols=256 Identities=27% Similarity=0.373 Sum_probs=213.2
Q ss_pred hcCCcccceecCCCceEEEEEEeCC-CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
..+.++-.+||-|.||.||.|.|+. .-.||+|.++. ......++..|..+++.+.|||+++++++|..+..+|++.||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3456666789999999999999985 66788887765 466788999999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
|..|+|.+++.+-....++....+.++.||..++.||..+ +.|||||-++|.++.++..+|+.|||++.......+
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk----nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 9999999999887777789999999999999999999999 999999999999999999999999999986655443
Q ss_pred cc-ccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 181 VQ-TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 181 ~~-~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
.. ...--+..|.|||.+....++.++|||+||++|||+.| |..||.. ..+.++.. ++.....
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG------idlSqVY~----------LLEkgyR 484 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYG----------LLEKGYR 484 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC------ccHHHHHH----------HHhcccc
Confidence 21 11223567999999998889999999999999999998 7777743 22232222 2223333
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
-+.+..++...-+||++||+.+|.+||++.|+-+.++.+.
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 3445556667889999999999999999999999988764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=262.97 Aligned_cols=266 Identities=21% Similarity=0.247 Sum_probs=195.3
Q ss_pred HHHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEec-
Q 046121 16 SEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE- 91 (315)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 91 (315)
..+....++|++.+.||+|+||.||+|.+. +++.|++|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 345557799999999999999999999754 68899999876432 22345677899999999999999999987543
Q ss_pred -----CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeE
Q 046121 92 -----NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPML 166 (315)
Q Consensus 92 -----~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l 166 (315)
...+++++++ +++|.+.+. ...+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEcCCCCEEE
Confidence 3457777775 788877663 23588999999999999999999999 9999999999999999999999
Q ss_pred CCCCcccccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH---
Q 046121 167 GDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP--- 242 (315)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 242 (315)
+|||++..... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....... ........
T Consensus 162 ~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~ 236 (345)
T cd07877 162 LDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGT 236 (345)
T ss_pred ecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCC
Confidence 99999864322 2233467888999998765 457889999999999999999999986433211 11100000
Q ss_pred ----HHhhh----------ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 243 ----LIEKL----------ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 243 ----~~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
..... ........... ......+..+.+++.+||+.||++|||+.+++.+-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 00000 00000000000 000012445789999999999999999999988754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=260.66 Aligned_cols=264 Identities=21% Similarity=0.252 Sum_probs=194.8
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecC-
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN- 92 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 92 (315)
.+-.+.++|++++.||+|++|+||++.+. ++..+++|...... ......+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 34446789999999999999999999765 68899999875432 222345789999999999999999999886543
Q ss_pred -----eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeEC
Q 046121 93 -----LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLG 167 (315)
Q Consensus 93 -----~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~ 167 (315)
..++|++++ +++|.+.+. ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~----gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAA----GIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEe
Confidence 358999997 778877763 24589999999999999999999999 99999999999999999999999
Q ss_pred CCCcccccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH-----
Q 046121 168 DFGLARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE----- 241 (315)
Q Consensus 168 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----- 241 (315)
|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...... ........
T Consensus 161 dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~ 235 (343)
T cd07880 161 DFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVTGTP 235 (343)
T ss_pred ecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCC
Confidence 99998643321 123356788999998865 45788999999999999999999999644321 11110000
Q ss_pred ------HHHhh---hccccc--cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 242 ------PLIEK---LALHEL--IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 242 ------~~~~~---~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
..... ...... ..+.......+.....+.+++.+||..||++|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 000000 00000001112234457899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=260.76 Aligned_cols=263 Identities=21% Similarity=0.283 Sum_probs=196.2
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCe--
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL-- 93 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 93 (315)
..+.++|++.+.||+|++|.||+|.+. +++.+++|++... .......+.+|+.+++.++|||++++.+++...+.
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 346789999999999999999999876 5888999987643 22334567789999999999999999998765554
Q ss_pred ----eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCC
Q 046121 94 ----NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDF 169 (315)
Q Consensus 94 ----~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~df 169 (315)
.++|++|+ +++|.+++.. ..+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+||
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA----GIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEccc
Confidence 89999997 7788887743 4689999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH------
Q 046121 170 GLARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP------ 242 (315)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------ 242 (315)
|++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ..+......
T Consensus 163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~~~~~~~~~ 237 (343)
T cd07851 163 GLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCH
Confidence 998644322 233456788999998765 35788999999999999999999999644321 111110000
Q ss_pred -HHhhhc---cccc---cCCcccCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 243 -LIEKLA---LHEL---IDPRIENSY---DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 243 -~~~~~~---~~~~---~~~~~~~~~---~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
...... .... ........+ ....+..+.+++.+||+.+|++|||+.+++.+-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 000000 0000 000000000 011255688999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=244.48 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=204.6
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 96 (315)
.++|.++++||+|+++.|.+++.+ +.+.+|+|++++. ..+.++..+.|..++... +||.++-++..|..++.+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999865 7889999987754 455677788888888777 58999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
|.||+.||+|.-.+ +....++++.+..+...|+.|+.+||++ ||+.+|+|.+||++|..|+|||+|||+++...
T Consensus 329 vieyv~ggdlmfhm--qrqrklpeeharfys~ei~lal~flh~r----giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEICLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh--hhhhcCcHHHhhhhhHHHHHHHHHHhhc----CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999997666 4455699999999999999999999999 99999999999999999999999999998777
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCC-CccchhHHHhHHHHHhhhccccccCC
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNG-EEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
..+...++.+|||.|.|||.+.|..|+...|.|+||+++++|+.|+.||+.-+ ..+.....++..+.+-+.- +.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq---ir-- 477 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ---IR-- 477 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc---cc--
Confidence 77777888999999999999999999999999999999999999999997433 3334444444433332211 11
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRP 285 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp 285 (315)
.+...+-....++..-|++||++|.
T Consensus 478 -----iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 -----IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -----ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1111222345667778999999995
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=247.17 Aligned_cols=239 Identities=26% Similarity=0.313 Sum_probs=191.5
Q ss_pred ecCCCceEEEEEEeC-CCcEEEEEEecccCc---ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCcc
Q 046121 31 LGEGGFGHVYKGELK-DGQMIAAKVRKEAST---QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSL 106 (315)
Q Consensus 31 lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (315)
||+|++|.||.+.+. +++.+++|++..... .....+.+|+.+++.++|||++++++.+..+...+++|+++.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 588999998765432 2355788899999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcccccc
Q 046121 107 HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186 (315)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~ 186 (315)
.+++... ..+++.....++.|++.++.++|+. +++|+||+|+||+++.++.++++|||.+..............
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~----~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSL----GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 9888544 3589999999999999999999999 999999999999999999999999999875443322233446
Q ss_pred ccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHH
Q 046121 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYEL 266 (315)
Q Consensus 187 ~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (315)
++..|++||...+..++.++|+||||+++|++++|..||..... .... ..... . ....+...+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~----~~~~~----~-------~~~~~~~~~ 217 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIY----EKILK----D-------PLRFPEFLS 217 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHH----HHHhc----C-------CCCCCCCCC
Confidence 77889999999888888999999999999999999999954332 1110 11110 0 011122224
Q ss_pred HHHHHHHHhhcCCCCCCCCCH---HHHHH
Q 046121 267 YLMAKTAYLCVQRNPEGRPSM---GEVVR 292 (315)
Q Consensus 267 ~~l~~l~~~~l~~~p~~Rps~---~~il~ 292 (315)
..+.+++.+||..||++||++ ++++.
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 557889999999999999999 56554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=268.23 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=202.3
Q ss_pred CCcccceecCCCceEEEEEEeC--C--CcEEEEEEecccCcc-cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK--D--GQMIAAKVRKEASTQ-GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~--~--~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
+....++||+|+||.||.|.|+ + ...||+|++...... ....+.+|+.++-+++|+|++++++++.+ ...-+|+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 5567789999999999999886 2 346899988866555 67789999999999999999999999987 5678999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
|+...|+|.+.+.+.....+.....-.++.||+.++.||.++ +.||||+-.+|+++.....|||+|||+..-+...
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk----rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK----RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh----hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 999999999999887777899999999999999999999999 9999999999999999999999999998643332
Q ss_pred CCccc---cccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 179 DPVQT---KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 179 ~~~~~---~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
..... ...-+..|+|||.+....++.++|+|++|+++|||++ |..||-+.... +.+. .++
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--qIL~--------------~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--QILK--------------NID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--HHHH--------------hcc
Confidence 21111 1223457999999999999999999999999999998 77888544321 1111 122
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVV 291 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il 291 (315)
.+-.-.-++.+++.+-+++..||..+|++||||..|.
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 2222223556788899999999999999999999996
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=243.16 Aligned_cols=255 Identities=22% Similarity=0.257 Sum_probs=202.3
Q ss_pred ceecCCCceEEEEEE-eCCCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeeeEEecCeeEEEEEeccCCcc
Q 046121 29 NLLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLNILVYEYICNKSL 106 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (315)
+.||+|+++.|..+. ..++..+|+|++.+.......++.+|++++...+ |+||++++++|+++..+|+|||.+.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 479999999999986 5689999999999887777888999999999886 99999999999999999999999999999
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC---ceeECCCCcccccCCCC----
Q 046121 107 HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF---VPMLGDFGLARWKTTDD---- 179 (315)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~---~i~l~dfg~~~~~~~~~---- 179 (315)
...+. ....+++.++..+...|+.||.+||.+ ||.|||+||+||+..... -+||+||.+..-....+
T Consensus 164 LshI~--~~~~F~E~EAs~vvkdia~aLdFlH~k----gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQ--KRKHFNEREASRVVKDIASALDFLHTK----GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHH--HhhhccHHHHHHHHHHHHHHHHHHhhc----CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 98884 445699999999999999999999999 999999999999996654 58999998875322211
Q ss_pred ---CccccccccccccCccccc-----cCCCcccccchhhhHHHHHHHhCCCccCCCCC--------ccchhHHHhHHHH
Q 046121 180 ---PVQTKILGTLGYLAPEYAE-----NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGE--------EPQQSLRQWAEPL 243 (315)
Q Consensus 180 ---~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~ 243 (315)
+...+.+|...|||||+.. ...|+.+.|.||||+++|-|++|.+||.+.-. +.....++.....
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 2223456777899999763 34478899999999999999999999964322 3333444333322
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
+.++. . .++.....+.+...++++..+|..++.+|.++..++.+-+
T Consensus 318 IQEGk-Y-----eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 318 IQEGK-Y-----EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred HhccC-C-----cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 22211 1 1223334456777899999999999999999999887443
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=258.39 Aligned_cols=264 Identities=20% Similarity=0.252 Sum_probs=192.6
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEec------
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE------ 91 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 91 (315)
..++|.+.+.||+|++|.||+|.+. +++.+++|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3579999999999999999999865 6899999987643 222345678899999999999999999998654
Q ss_pred CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCc
Q 046121 92 NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGL 171 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~ 171 (315)
...++|++|+. .++.... ...+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA----GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 34589999974 3554433 23588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH-------H
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP-------L 243 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~ 243 (315)
+..... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ......... .
T Consensus 164 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHH
Confidence 863321 1123456788999998865 45788999999999999999999999754321 111110000 0
Q ss_pred Hh---hh-------ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--Hhcccc
Q 046121 244 IE---KL-------ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL--LEGEND 299 (315)
Q Consensus 244 ~~---~~-------~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~--L~~~~~ 299 (315)
.. .. .........+.. ..+..+..+.+++.+||+.||++||++.+++.+ ++...+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 00 000000000000 001133457899999999999999999999965 555543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=253.50 Aligned_cols=272 Identities=21% Similarity=0.253 Sum_probs=205.1
Q ss_pred ccHHHHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcC-C-C----Ccccee
Q 046121 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-H-K----NIVMLL 85 (315)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~-~----~i~~~~ 85 (315)
+.++..+....+|+++.++|+|+||.|-.+.+. .+..+|+|+++.. ....+...-|++++.++. + | -+++..
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 555566677899999999999999999998655 5788999987743 223344567899998884 2 2 366777
Q ss_pred eeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC-----
Q 046121 86 GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH----- 160 (315)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~----- 160 (315)
++|+-.++.|+|+|.+ |-++.+++.++...+++...+..++.|+++++++||+. +++|.||||+||++..
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~----kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL----KLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc----ceeecCCChheEEEeccceEE
Confidence 8899999999999986 77999999999999999999999999999999999999 9999999999999942
Q ss_pred ---------------CCceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCcc
Q 046121 161 ---------------DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVV 225 (315)
Q Consensus 161 ---------------~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~ 225 (315)
+..|+++|||.+....... ...+.|..|.|||++.|-.++.++||||+||+|.|+.+|...|
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 3468999999997333222 4556788999999999999999999999999999999999988
Q ss_pred CCCCCccchhHHHhH-H----HHHhhh---------cc--cc---------ccCCc----ccCCCCHHHHHHHHHHHHhh
Q 046121 226 DMNGEEPQQSLRQWA-E----PLIEKL---------AL--HE---------LIDPR----IENSYDTYELYLMAKTAYLC 276 (315)
Q Consensus 226 ~~~~~~~~~~~~~~~-~----~~~~~~---------~~--~~---------~~~~~----~~~~~~~~~~~~l~~l~~~~ 276 (315)
..........+.+.+ . ...... .+ .+ ..++. ....-...+...+.+|+..|
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 765432222222111 0 000000 00 00 00000 00011112344589999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 046121 277 VQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 277 l~~~p~~Rps~~~il~~ 293 (315)
|.+||.+|+|+.|++++
T Consensus 390 L~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 390 LEFDPARRITLREALSH 406 (415)
T ss_pred HccCccccccHHHHhcC
Confidence 99999999999999875
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=253.19 Aligned_cols=264 Identities=22% Similarity=0.237 Sum_probs=189.4
Q ss_pred CCcccceecCCCceEEEEEEeC-C--CcEEEEEEecccC--cccHHHHHHHHHHHhhc-CCCCccceeeeEEe----cCe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-D--GQMIAAKVRKEAS--TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCK----ENL 93 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~--~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~ 93 (315)
+|++.+.||+|+||.||++.+. + +..+++|.+.... ......+.+|+.+++.+ +||||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5889999999999999999865 3 7789999876432 22345678899999998 59999999986532 245
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.+++++++ +++|.+.+. ....+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~~~e~~-~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELM-EADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSA----NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEecc-cCCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 68888887 467877774 345689999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCCC----ccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCcc-------------chh
Q 046121 174 WKTTDDP----VQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEP-------------QQS 235 (315)
Q Consensus 174 ~~~~~~~----~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~-------------~~~ 235 (315)
....... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||....... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 4432211 1123467889999998765 467889999999999999999999986543211 000
Q ss_pred HHHhHHHHHhhh--ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 236 LRQWAEPLIEKL--ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 236 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
............ .........+.. ..+.....+.+++.+||+.||++|||+.+++..-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 000000000000 000000000000 11112456889999999999999999999986643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=251.15 Aligned_cols=242 Identities=25% Similarity=0.319 Sum_probs=198.7
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcC-CCCccceeeeEEecCeeE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 95 (315)
...+|..+.+||+|+||.|-+|..+ +.+.+|+|++++. .....+--+.|.++|.... -|.+++++..|..-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 4568999999999999999999655 6888999987754 2334445577888888776 467788999999999999
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+||||+.||+|.-.+++ -..+.+..+..++..|+.+|-+||++ ||+.||||.+||+++..|+|+|+|||++.-.
T Consensus 427 FVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~k----gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcC----CeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999777743 34588999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
........+.+|||.|+|||.+..++|+.++|.||+|++||||+.|++||+...++. ..+.... +
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--lF~aI~e--------h----- 565 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQAIME--------H----- 565 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHH--------c-----
Confidence 666666778999999999999999999999999999999999999999997554322 1111111 0
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRP 285 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp 285 (315)
.-.++...+.....+....|.++|.+|.
T Consensus 566 --nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 --NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1224445555677777788899999995
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=276.04 Aligned_cols=252 Identities=27% Similarity=0.366 Sum_probs=187.2
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEec-------
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE------- 91 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------- 91 (315)
-..+|+.++.||+|+||.||+++++ +|..||+|.+... +......+.+|+..+.+++||||+.|+..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4568999999999999999999988 8999999987654 445566789999999999999999997432110
Q ss_pred --------------------------------------------------------------------------------
Q 046121 92 -------------------------------------------------------------------------------- 91 (315)
Q Consensus 92 -------------------------------------------------------------------------------- 91 (315)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhc
Q 046121 92 --------------------------------NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139 (315)
Q Consensus 92 --------------------------------~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 139 (315)
..+|+=|+||+..++.+.+.++.... .....|+++++|+.|+.|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHh
Confidence 12467788887777777775443321 467899999999999999999
Q ss_pred ccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC------------------CCCCccccccccccccCccccccCC
Q 046121 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT------------------TDDPVQTKILGTLGYLAPEYAENGI 201 (315)
Q Consensus 140 ~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~------------------~~~~~~~~~~~~~~~~aPE~~~~~~ 201 (315)
+ |++||||||.||+++.++.|||+|||+++... .........+||.-|+|||++.+..
T Consensus 716 ~----giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 716 Q----GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred C----ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9 99999999999999999999999999997511 0011123467899999999987644
Q ss_pred ---CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcC
Q 046121 202 ---VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQ 278 (315)
Q Consensus 202 ---~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~ 278 (315)
|+.|+|+||||++++||+. ||+...+. . ..... +....-|.. .++.-.....-.++|.+|++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER-a--------~iL~~--LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMER-A--------SILTN--LRKGSIPEP-ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHH-H--------HHHHh--cccCCCCCC-cccccccchHHHHHHHHHhc
Confidence 8999999999999999987 45432110 0 11111 111111111 22222333345789999999
Q ss_pred CCCCCCCCHHHHHH
Q 046121 279 RNPEGRPSMGEVVR 292 (315)
Q Consensus 279 ~~p~~Rps~~~il~ 292 (315)
.||++|||+.++|.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=261.13 Aligned_cols=244 Identities=21% Similarity=0.194 Sum_probs=196.2
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
....|++...+|.|+|+.|-.+... +++..++|++.... ....+|+.++... +|||+++..+++.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4678999999999999999888765 68889999887652 2234556444444 6999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE-cCCCceeECCCCcccccCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL-THDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~-~~~~~i~l~dfg~~~~~~~ 177 (315)
|.+.|+-+.+.+..... ...++..|+++++.|+.+||++ |++|||+||+||++ +..++++|+|||.+.....
T Consensus 396 e~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH~~----gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLHEQ----GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHHhc----CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999988887754433 2267778999999999999999 99999999999999 6889999999999974444
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
. ..+.+-|..|.|||++....|+.++|+||||++||+|++|..||...... ...... -.
T Consensus 469 ~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~-----------------i~ 527 (612)
T KOG0603|consen 469 S---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTR-----------------IQ 527 (612)
T ss_pred h---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHh-----------------hc
Confidence 3 22334577899999999999999999999999999999999999754433 111110 01
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.+.+....+...++|+.+||++||.+||++.++..+-+.
T Consensus 528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred CCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 122225567779999999999999999999999887766
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=261.87 Aligned_cols=263 Identities=22% Similarity=0.285 Sum_probs=216.9
Q ss_pred cccHHHHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeeeEE
Q 046121 12 KFSFSEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCC 89 (315)
Q Consensus 12 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 89 (315)
.+.+...+--.+.|++.+.||.|.+|.||++... +++..|+|+..... +..+++..|+++++... |||++.+++++.
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 3444444445678999999999999999999765 68888888876543 33466788999998885 899999999985
Q ss_pred e-----cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCce
Q 046121 90 K-----ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVP 164 (315)
Q Consensus 90 ~-----~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i 164 (315)
. ++.++||||||.||+..|+++......+.+..++.|++.++.++.+||.. .++|+|||-.||+++.++.+
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n----kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN----KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc----ceeeecccCceEEEeccCcE
Confidence 3 57899999999999999999888888899999999999999999999999 99999999999999999999
Q ss_pred eECCCCcccccCCCCCccccccccccccCcccccc-----CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHh
Q 046121 165 MLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN-----GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQW 239 (315)
Q Consensus 165 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 239 (315)
||+|||.+......-....+.+|+|.|+|||++.. ..|+..+|+||||++..||-.|.+|+.+.-+
T Consensus 163 KLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--------- 233 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--------- 233 (953)
T ss_pred EEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch---------
Confidence 99999999888877777788999999999998864 3367789999999999999999999864321
Q ss_pred HHHHHhhhccccccCCc-ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 240 AEPLIEKLALHELIDPR-IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 240 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
...+..+.... ....-+....+.+.++|..||.+|..+||+..+++++-
T Consensus 234 ------mraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp 283 (953)
T KOG0587|consen 234 ------MRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP 283 (953)
T ss_pred ------hhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence 11122222221 12223556677899999999999999999999998753
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=234.87 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=190.9
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
++.+.+..||.|+-|.||+++.. +|...|+|.+... +.+..+++...+.+.... ++|+|++.+++|..+...++-||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 45567788999999999999765 6899999987754 445566777777766555 48999999999998888888888
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
.|. +-.+.+......++++..+-++...++.||.||..+. +|+|||+||+||++|..|+|||||||++-.....
T Consensus 172 lMs--~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH---~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS- 245 (391)
T KOG0983|consen 172 LMS--TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS- 245 (391)
T ss_pred HHH--HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc---ceeecccCccceEEccCCCEEeecccccceeecc-
Confidence 762 2233333445567999999999999999999999884 8999999999999999999999999999754433
Q ss_pred CccccccccccccCcccccc---CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 180 PVQTKILGTLGYLAPEYAEN---GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
.......|-+.|+|||-+.. ..|+..+||||||++++|+.||+.||.....+......- .. .. .|.
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv-ln------~e----PP~ 314 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV-LN------EE----PPL 314 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH-Hh------cC----CCC
Confidence 22233456788999998863 458899999999999999999999998765543211111 00 11 121
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
+.... ..+..+.+++..||++|+.+||.+.+++++
T Consensus 315 L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 21111 134457788888999999999999999865
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=281.66 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=198.5
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEec--ccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRK--EASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
..-+++..-.||.|.||.||.|.+. +|...|+|-+. .......+.+.+|..++..+.|||+++++++-..++..++.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 3457778889999999999999754 68888888433 33345566789999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
||||.+|+|.+.+... ...++.....+..|++.++.+||+. |||||||||.||+++.+|.||++|||.+.....
T Consensus 1313 MEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~----gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEH----GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhc----CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999988433 3356666666778999999999999 999999999999999999999999999975443
Q ss_pred CC----CccccccccccccCccccccC---CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccc
Q 046121 178 DD----PVQTKILGTLGYLAPEYAENG---IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250 (315)
Q Consensus 178 ~~----~~~~~~~~~~~~~aPE~~~~~---~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (315)
.. .......||+-|||||++.+. ....++|||||||++.||.||+.||.....+ .+.+-.+ .+
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~V--------~~- 1456 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYHV--------AA- 1456 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhHH--------hc-
Confidence 32 122346899999999998753 3567899999999999999999999643322 1111110 11
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.-.+.+|...+..-++++.+||..||++|-++.+++++
T Consensus 1457 -----gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 -----GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11123344466778899999999999999888877764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=239.40 Aligned_cols=219 Identities=20% Similarity=0.126 Sum_probs=173.3
Q ss_pred CCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCcccccccc
Q 046121 34 GGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFD 112 (315)
Q Consensus 34 g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~ 112 (315)
|.++.||++.+. +++.+++|.+..... ..+|...+....|||++++++++......+++|||+.|++|.+.+.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999875 688999998865432 23344455556799999999999999999999999999999888854
Q ss_pred CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcccccccccccc
Q 046121 113 NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL 192 (315)
Q Consensus 113 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 192 (315)
. ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+....... ....++..|+
T Consensus 79 ~--~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~ 149 (237)
T cd05576 79 F--LNIPEECVKRWAAEMVVALDALHRE----GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYC 149 (237)
T ss_pred h--cCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCcccc
Confidence 3 3489999999999999999999999 99999999999999999999999999875333221 2234466799
Q ss_pred CccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHH
Q 046121 193 APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKT 272 (315)
Q Consensus 193 aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (315)
|||...+..++.++|+||+|+++|+|++|..|+........ .......+...+..+.++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~l 208 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------------THTTLNIPEWVSEEARSL 208 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------------cccccCCcccCCHHHHHH
Confidence 99999888889999999999999999999988753211100 000011222234557889
Q ss_pred HHhhcCCCCCCCCCH
Q 046121 273 AYLCVQRNPEGRPSM 287 (315)
Q Consensus 273 ~~~~l~~~p~~Rps~ 287 (315)
+.+||+.||++||++
T Consensus 209 i~~~l~~dp~~R~~~ 223 (237)
T cd05576 209 LQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHccCCHHHhcCC
Confidence 999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=255.74 Aligned_cols=249 Identities=24% Similarity=0.269 Sum_probs=201.3
Q ss_pred cceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCC
Q 046121 28 ENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNK 104 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (315)
.+.||.|.||+||-|... +|+.||+|++.+. .......+++|+.+|..+.||+|+.+.-.++..+..+.|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 358999999999999765 7999999998764 3444578999999999999999999999999999999999998655
Q ss_pred ccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC---CceeECCCCcccccCCCCCc
Q 046121 105 SLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD---FVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~---~~i~l~dfg~~~~~~~~~~~ 181 (315)
+.+.+.......+++..-..+..||+.||+|||.+ +|+|+||||+||++... ..+||+|||++..... ...
T Consensus 649 -MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k----nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-ksF 722 (888)
T KOG4236|consen 649 -MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK----NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-KSF 722 (888)
T ss_pred -HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc----ceeeccCCchheeeccCCCCCceeeccccceeecch-hhh
Confidence 44555555666799999999999999999999999 99999999999999654 5799999999984443 333
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
.....|||.|+|||++..+.|...-|+||.|+++|--++|..||..+.+-.++ .+... + ..+...
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQNAa----------F---MyPp~P 787 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQNAA----------F---MYPPNP 787 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hhccc----------c---ccCCCc
Confidence 45578999999999999999999999999999999999999999654332211 11000 1 112223
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
..+.+....+||-.+|+..-.+|.|+...+++.|-.
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq 823 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQ 823 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence 334455577888889999999999999998887754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=257.83 Aligned_cols=203 Identities=31% Similarity=0.422 Sum_probs=172.6
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecC------e
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN------L 93 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~ 93 (315)
..-+...+.||+|+||.||+|+++ +|+.||+|.+.... ....+...+|++++++++|+||++++++-+... .
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 356777889999999999999965 79999999987643 334566889999999999999999999865443 5
Q ss_pred eEEEEEeccCCccccccccCC-CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC----CCceeECC
Q 046121 94 NILVYEYICNKSLHWHLFDNT-ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH----DFVPMLGD 168 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~----~~~i~l~d 168 (315)
..+|||||.||+|...+.+-. ...+++.+++.++..++.|+.|||.. ||+||||||.||++.. ....||+|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn----~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN----GIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc----CceeccCCCCcEEEeecCCCceEEeeec
Confidence 589999999999999886533 35799999999999999999999999 9999999999999943 33679999
Q ss_pred CCcccccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCC
Q 046121 169 FGLARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNG 229 (315)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~ 229 (315)
||.+.-.. .+......+||+.|++||.... +.|+...|.|||||++|++.||..||....
T Consensus 168 fG~Arel~-d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 168 FGAARELD-DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccccccCC-CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 99998444 3445556789999999998884 788999999999999999999999996543
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=257.39 Aligned_cols=251 Identities=25% Similarity=0.321 Sum_probs=192.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEE---EEecc-cCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCe--
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAA---KVRKE-ASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL-- 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~---k~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 93 (315)
...-.....+||+|+|.+||+|.+. +|..||= |+... .++...+++..|+.+|+.|+||||+++++++.+...
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 3333445668999999999999876 4554432 22111 244556789999999999999999999999976554
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC-CCceeECCCCcc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH-DFVPMLGDFGLA 172 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~-~~~i~l~dfg~~ 172 (315)
+.+|+|.+..|+|..++.+.. ..+...+..|++||+.+|.|||++.+ .|+|||||=+||+|++ .|.|||+|+|++
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~P--PIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDP--PIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred eeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCC--CccccccccceEEEcCCcCceeecchhHH
Confidence 889999999999999985544 47788999999999999999999966 9999999999999976 589999999999
Q ss_pred cccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
.........+ .+|||.|||||... ..|....||||||+.+.||.|+..||..-.. +-+.++.+.. .....++...
T Consensus 194 tl~r~s~aks--vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-~AQIYKKV~S-GiKP~sl~kV 268 (632)
T KOG0584|consen 194 TLLRKSHAKS--VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-PAQIYKKVTS-GIKPAALSKV 268 (632)
T ss_pred HHhhccccce--eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-HHHHHHHHHc-CCCHHHhhcc
Confidence 8666544433 58999999999886 6789999999999999999999999963221 1112221111 0001111111
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
-+ ..++++|.+||.. ..+|||+.|+|..
T Consensus 269 ~d------------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 KD------------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred CC------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 11 2377899999999 9999999999863
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=239.01 Aligned_cols=269 Identities=26% Similarity=0.354 Sum_probs=202.4
Q ss_pred HHHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHH--hhcCCCCccceeeeEEec----
Q 046121 18 IQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVL--NFARHKNIVMLLGFCCKE---- 91 (315)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l--~~l~~~~i~~~~~~~~~~---- 91 (315)
...+.++.++.+.||+|.||.||+|.|. |+.||+|++....+ ..+.+|.+++ ..++|+||+.+++.-..+
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 3446789999999999999999999997 77899999976543 4555666655 466999999999875432
Q ss_pred CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCC----CCeEeecCccCcEEEcCCCceeEC
Q 046121 92 NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG----GPIIHRDMRPSNILLTHDFVPMLG 167 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~----~~i~h~di~p~nil~~~~~~i~l~ 167 (315)
.+++||.+|.+.|+|+|++.+ .+++....++++..++.+|+|||....+ ..|.|||||..||++.+++...|.
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 367999999999999999954 5689999999999999999999966443 358999999999999999999999
Q ss_pred CCCcccccCCCC----CccccccccccccCccccccCCC-----c-ccccchhhhHHHHHHHhC----------CCccCC
Q 046121 168 DFGLARWKTTDD----PVQTKILGTLGYLAPEYAENGIV-----S-IRTDVYAFGIILLQLMSG----------RKVVDM 227 (315)
Q Consensus 168 dfg~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~-----~-~~~DvwslG~~l~~l~~g----------~~p~~~ 227 (315)
|+|++-...... ...+..+||.+|||||++..... + ..+||||||.++||+.-. .+||-+
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 999996544432 22346789999999999975432 1 258999999999998742 355532
Q ss_pred CCCccchhHHHhHHHHHhhhccccccCCccc-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 228 NGEEPQQSLRQWAEPLIEKLALHELIDPRIE-NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
--+... +..+ ..+....+.+.|.++ ...+......+.++|+.||..||.-|.|+-.+-+.|.++..
T Consensus 439 ~Vp~DP-s~ee-----MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 439 VVPSDP-SFEE-----MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCC-CHHH-----HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 221111 1110 112222233333332 33444567788999999999999999999999888877753
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=237.04 Aligned_cols=275 Identities=21% Similarity=0.247 Sum_probs=196.3
Q ss_pred cCCcccceecCCCceEEEEEEeC-C----CcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEe-cCee
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-D----GQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCK-ENLN 94 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~----~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 94 (315)
..|+.+..||+|++|.||+|..+ + .+.+|+|.++... ........+|+..++.++|||++.+..++.+ +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 58999999999999999999432 2 3478898877542 2334457899999999999999999999877 8889
Q ss_pred EEEEEeccCCcccccccc---CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC----CceeEC
Q 046121 95 ILVYEYICNKSLHWHLFD---NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD----FVPMLG 167 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~----~~i~l~ 167 (315)
++++||.+. +|...++- .....++...+..++.||+.++.|||++ -|+||||||.||++..+ |++||+
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N----WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN----WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh----heeeccCCcceEEEeccCCccCeeEee
Confidence 999999765 45454432 2235799999999999999999999999 79999999999999887 999999
Q ss_pred CCCcccccCCCCCcc---ccccccccccCccccccCC-CcccccchhhhHHHHHHHhCCCccCCCCC-----ccch--hH
Q 046121 168 DFGLARWKTTDDPVQ---TKILGTLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMSGRKVVDMNGE-----EPQQ--SL 236 (315)
Q Consensus 168 dfg~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~p~~~~~~-----~~~~--~~ 236 (315)
|+|++..+...-... .....|..|.|||.+.|.. |+.+.|||+.||++.||++..+.|..... .+.+ .+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999998766543322 2345578999999887754 89999999999999999999988853221 1111 11
Q ss_pred HHhHH----------HHHhhhccc-----ccc----CCc-ccCCCCHH--HHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 237 RQWAE----------PLIEKLALH-----ELI----DPR-IENSYDTY--ELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 237 ~~~~~----------~~~~~~~~~-----~~~----~~~-~~~~~~~~--~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
..... +...+.... ++. ++. +...+... -+....+|+.+||++||.+|.|+++++++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 11000 000000000 000 000 00000000 011256888899999999999999999876
Q ss_pred hccccccc
Q 046121 295 EGENDRFH 302 (315)
Q Consensus 295 ~~~~~~~~ 302 (315)
=-..+.+.
T Consensus 339 yF~~d~lp 346 (438)
T KOG0666|consen 339 YFTEDPLP 346 (438)
T ss_pred ccccCCCC
Confidence 65555544
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=264.80 Aligned_cols=146 Identities=29% Similarity=0.385 Sum_probs=130.1
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
.++|+++++||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++.+......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999876 68899999886532 22345678899999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
|||+.|++|.+++... ..+++..++.++.||+.+|.|||+. +|+|+||||+||+++.++.++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~----gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH----GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999888543 4588899999999999999999999 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=243.92 Aligned_cols=270 Identities=23% Similarity=0.312 Sum_probs=205.0
Q ss_pred CCCCcccHHHHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-------CcccHHHHHHHHHHHhhcCCC
Q 046121 8 KDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-------STQGFAEFQSEVYVLNFARHK 79 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-------~~~~~~~~~~e~~~l~~l~~~ 79 (315)
-|...-.++..+..+++|.++.+||+|+|+.||+|.+- ..+.||+|+-... .+...+...+|..+-+.++||
T Consensus 448 ~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHp 527 (775)
T KOG1151|consen 448 HNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHP 527 (775)
T ss_pred cccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcc
Confidence 34444556777788999999999999999999999754 6888999985532 223344567899999999999
Q ss_pred CccceeeeEE-ecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE
Q 046121 80 NIVMLLGFCC-KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL 158 (315)
Q Consensus 80 ~i~~~~~~~~-~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~ 158 (315)
.|++.++++. +...+|-|.||++|.+|.-++. ..+.+++.++..|+.||+.||.||....+ .|+|-||||.||++
T Consensus 528 RIVKlYDyfslDtdsFCTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEikp--PIIHYDLKPgNILL 603 (775)
T KOG1151|consen 528 RIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEIKP--PIIHYDLKPGNILL 603 (775)
T ss_pred eeeeeeeeeeeccccceeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhccCC--CeeeeccCCccEEE
Confidence 9999999985 4567899999999999988884 34569999999999999999999999855 89999999999999
Q ss_pred c---CCCceeECCCCcccccCCCCCcc-------ccccccccccCccccccC----CCcccccchhhhHHHHHHHhCCCc
Q 046121 159 T---HDFVPMLGDFGLARWKTTDDPVQ-------TKILGTLGYLAPEYAENG----IVSIRTDVYAFGIILLQLMSGRKV 224 (315)
Q Consensus 159 ~---~~~~i~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~aPE~~~~~----~~~~~~DvwslG~~l~~l~~g~~p 224 (315)
- .-|.|+|+|||++.......... ....||..|++||++--+ ..+.+.||||+|+++|+++.|+.|
T Consensus 604 v~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKP 683 (775)
T KOG1151|consen 604 VNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKP 683 (775)
T ss_pred ecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCC
Confidence 4 35899999999998765544332 235689999999987532 357799999999999999999999
Q ss_pred cCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 046121 225 VDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292 (315)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~ 292 (315)
|+-+... ...+.. ..+....... -..-+-++.....+|++||.+.-++|.+..++..
T Consensus 684 FGhnqsQ-QdILqe--NTIlkAtEVq--------FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 684 FGHNQSQ-QDILQE--NTILKATEVQ--------FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred CCCchhH-HHHHhh--hchhcceecc--------CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 9744221 111110 1111111111 0111223455788999999999999998888753
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=231.33 Aligned_cols=273 Identities=25% Similarity=0.322 Sum_probs=196.9
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEec--ccCcccHHHHHHHHHHHhhcCCCCccceeeeEEe-------
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRK--EASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK------- 90 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------- 90 (315)
..+.|+...+||+|.||.||+|+.+ +++.|++|+.- ...+.--....+|+.+|..+.|+|++.++++|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 3467888899999999999999865 57788887533 3334444567899999999999999999998743
Q ss_pred -cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCC
Q 046121 91 -ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDF 169 (315)
Q Consensus 91 -~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~df 169 (315)
..++|+|+++++. +|.-.+ .+....++..++.+++.++..++.|+|.. .|+|||+||.|++++++|.++|.||
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlL-sn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~----kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLL-SNRKVRFSLSEIKKVMKGLMNGLYYIHRN----KILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHh-cCccccccHHHHHHHHHHHHHHHHHHHHh----hHHhhcccHhhEEEcCCceEEeecc
Confidence 4568999999855 454444 23445699999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcc----ccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHH-HhHH--
Q 046121 170 GLARWKTTDDPVQ----TKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLR-QWAE-- 241 (315)
Q Consensus 170 g~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~-- 241 (315)
|++..+....... .....|..|.+||.+.| ..++.+.|+|..||++.+|+++.+.+..++......+. ....
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 9995443322221 22345889999998776 45899999999999999999999998766543222111 1111
Q ss_pred -----HHHhhhcccccc--CCcccCCCCH--HH------HHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 242 -----PLIEKLALHELI--DPRIENSYDT--YE------LYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 242 -----~~~~~~~~~~~~--~~~~~~~~~~--~~------~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
+...+..+...+ .|-..+.+.. +. .....+|+.++|..||++|+++.+++.+-.-.++
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 001111111111 1101111110 01 2246799999999999999999999887655544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=227.74 Aligned_cols=238 Identities=29% Similarity=0.331 Sum_probs=189.1
Q ss_pred CceEEEEEEeC-CCcEEEEEEecccCccc-HHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCcccccccc
Q 046121 35 GFGHVYKGELK-DGQMIAAKVRKEASTQG-FAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFD 112 (315)
Q Consensus 35 ~~~~v~~~~~~-~~~~~~~k~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~ 112 (315)
++|.||+|.+. +++.+++|+........ .+.+.+|++.++.++|++++++++.+......++++|++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 57899999876 48899999987665544 67889999999999999999999999999999999999999999988854
Q ss_pred CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcccccccccccc
Q 046121 113 NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL 192 (315)
Q Consensus 113 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 192 (315)
... ++...++.++.+++.++.+||+. +++|+||+|.||+++.++.++++|||.+....... ......++..|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN----GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc----CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCC
Confidence 333 88999999999999999999999 99999999999999999999999999987544332 223445778899
Q ss_pred CccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHH
Q 046121 193 APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKT 272 (315)
Q Consensus 193 aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (315)
+||.+.+..++.++|+|+||++++++++|..||...... ..... ....... .. ..........+.++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~----~~~~~~~----~~---~~~~~~~~~~~~~~ 220 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFK----KIGKPKP----PF---PPPEWKISPEAKDL 220 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHH----HHhccCC----CC---ccccccCCHHHHHH
Confidence 999998888889999999999999999999998643111 11110 0000000 00 00000033457889
Q ss_pred HHhhcCCCCCCCCCHHHHHH
Q 046121 273 AYLCVQRNPEGRPSMGEVVR 292 (315)
Q Consensus 273 ~~~~l~~~p~~Rps~~~il~ 292 (315)
+.+||..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=235.88 Aligned_cols=274 Identities=28% Similarity=0.402 Sum_probs=204.4
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhc--CCCCccceeeeEEecC----eeE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFA--RHKNIVMLLGFCCKEN----LNI 95 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~~----~~~ 95 (315)
....+..++||+|.||.||+|... ++.||||++.. +..+.+.+|.++++.. +|+||+++++.-.... .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 456677889999999999999876 48999999864 3456778888888765 6999999999865544 789
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCC-----CCeEeecCccCcEEEcCCCceeECCCC
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG-----GPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-----~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
+|++|.+.|+|.+++. ....++....+++..++.+|+|||+..+. ..|+|||||.+|||+..++...|+|||
T Consensus 285 LVt~fh~kGsL~dyL~---~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK---ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EEeeeccCCcHHHHHH---hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 9999999999999994 45689999999999999999999976432 469999999999999999999999999
Q ss_pred cccccCCCCCcc--ccccccccccCccccccCCCc------ccccchhhhHHHHHHHhCCCccC-CCCCccchhHHHhH-
Q 046121 171 LARWKTTDDPVQ--TKILGTLGYLAPEYAENGIVS------IRTDVYAFGIILLQLMSGRKVVD-MNGEEPQQSLRQWA- 240 (315)
Q Consensus 171 ~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~------~~~DvwslG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~- 240 (315)
++-.+....... -...||.+|||||++.|...- .+.||||+|.++|||++.-.-+. ...++.........
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 997665443322 237899999999999764422 25899999999999998654442 11111111111100
Q ss_pred ----HHHHhhhccccccCCcccCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 241 ----EPLIEKLALHELIDPRIENSYDTY-ELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 241 ----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
.........++..+|.+...-..+ ....+++.+..||..||+-|.|+.=+-+.+..+.--++
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 011122233344445444332222 46678999999999999999999988888777754443
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=253.42 Aligned_cols=258 Identities=23% Similarity=0.303 Sum_probs=208.0
Q ss_pred cCCcccceecCCCceEEEEEEeC-C----CcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-D----GQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~----~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
......++||+|+||+||+|.|- . .-+|++|++... ..+...++.+|+.++.+++|||++++++++.... +-+
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 34556678999999999999764 2 346788886654 4455678999999999999999999999997665 788
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
|++|+++|+|.+++..+.. .+.....+.|..||++++.|||.+ .++||||-.+|||+.....+++.|||++....
T Consensus 775 vtq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~q----rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQ----RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhc----chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 9999999999999977554 478888899999999999999999 99999999999999999999999999998665
Q ss_pred CCCCcccc--ccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 177 TDDPVQTK--ILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 177 ~~~~~~~~--~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
........ ..-++.|+|-|.+....++.++||||+||++||++| |..|++....+....+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll---------------- 913 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL---------------- 913 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH----------------
Confidence 55443322 223567999999999999999999999999999997 99998765443322211
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
.....-..++..+..+..++.+||..|++.||+|+++...+.+..+..+
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 1111233455566678888888999999999999999999988877654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=253.44 Aligned_cols=262 Identities=22% Similarity=0.174 Sum_probs=168.6
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-C----CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeee------EE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-D----GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGF------CC 89 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~----~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------~~ 89 (315)
..++|++.+.||+|+||.||+|.+. + +..+++|........ +....+ .++...+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999865 4 688999976543221 111111 1122222222222221 24
Q ss_pred ecCeeEEEEEeccCCccccccccCCCC------------------ccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecC
Q 046121 90 KENLNILVYEYICNKSLHWHLFDNTES------------------VLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDM 151 (315)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~~~~------------------~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di 151 (315)
.....++|++|+.+++|.+++...... ......+..++.|++.+|.|||+. +++|+||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~----gIiHRDL 281 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST----GIVHRDV 281 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC----CEEeCcC
Confidence 566789999999999998887543211 112344667899999999999999 9999999
Q ss_pred ccCcEEEcC-CCceeECCCCcccccCCC-CCccccccccccccCccccccC----------------------CCccccc
Q 046121 152 RPSNILLTH-DFVPMLGDFGLARWKTTD-DPVQTKILGTLGYLAPEYAENG----------------------IVSIRTD 207 (315)
Q Consensus 152 ~p~nil~~~-~~~i~l~dfg~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~----------------------~~~~~~D 207 (315)
||+||+++. ++.++|+|||++...... ........+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 589999999999643322 2223345788999999965321 1234569
Q ss_pred chhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh----hhccccccCCcccCCCC------HHHHHHHHHHHHhhc
Q 046121 208 VYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE----KLALHELIDPRIENSYD------TYELYLMAKTAYLCV 277 (315)
Q Consensus 208 vwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~------~~~~~~l~~l~~~~l 277 (315)
|||+||++|+|+++..+++... ......... ...+.....+....... ........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNL-------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHH-------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 9999999999999776643211 110000000 00000111111000000 001223568999999
Q ss_pred CCCCCCCCCHHHHHHHHhcc
Q 046121 278 QRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 278 ~~~p~~Rps~~~il~~L~~~ 297 (315)
+.||++|||+.+++++-+-.
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~ 454 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFD 454 (566)
T ss_pred cCCcccCCCHHHHhCCcCcC
Confidence 99999999999999975543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=254.15 Aligned_cols=255 Identities=27% Similarity=0.377 Sum_probs=201.8
Q ss_pred CCcccceecCCCceEEEEEEeC----C----CcEEEEEEecccC-cccHHHHHHHHHHHhhcC-CCCccceeeeEEecCe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK----D----GQMIAAKVRKEAS-TQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENL 93 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~----~----~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 93 (315)
...+.+.||+|.||.|++|... . ...||+|...... ....+.+..|+++++.+. |+|++.+++.+..++.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 4466679999999999999633 1 4568888776543 344567899999999985 9999999999999999
Q ss_pred eEEEEEeccCCccccccccCC------------C--CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc
Q 046121 94 NILVYEYICNKSLHWHLFDNT------------E--SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT 159 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~------------~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~ 159 (315)
+++|+||+..|+|.+++.... . ..++....+.++.||+.+++||++. +++|||+-++||++.
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~----~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV----PCVHRDLAARNVLIT 452 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC----CccchhhhhhhEEec
Confidence 999999999999999986655 0 1388999999999999999999999 999999999999999
Q ss_pred CCCceeECCCCcccccCCCCCcc-cccc--ccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchh
Q 046121 160 HDFVPMLGDFGLARWKTTDDPVQ-TKIL--GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQS 235 (315)
Q Consensus 160 ~~~~i~l~dfg~~~~~~~~~~~~-~~~~--~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~ 235 (315)
.+..++++|||++.......... .... -+..|+|||.+....++.++||||+|+++||+++ |..|+..-..
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~----- 527 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP----- 527 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-----
Confidence 99999999999997544333222 1111 3567999999999899999999999999999998 7888864110
Q ss_pred HHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 236 LRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
...... .+.+.-....+.++...+-++|..||+.+|++||++.++.+.++..
T Consensus 528 ~~~l~~----------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 TEELLE----------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHH----------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111100 1122222334445556677999999999999999999999999984
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=208.33 Aligned_cols=262 Identities=23% Similarity=0.285 Sum_probs=195.1
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
.|...++||+|++|+||+|++. +++.|++|-.... .+.--....+|+-+++.++|.||++++++...++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 5677789999999999999865 6899999976543 333345678999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+ ..+|..++ ...+..++.+.+..++.|++.++.++|+. ++.|+|+||.|.+++.+|.+++.|||++.-+.-.-.
T Consensus 83 c-dqdlkkyf-dslng~~d~~~~rsfmlqllrgl~fchsh----nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 C-DQDLKKYF-DSLNGDLDPEIVRSFMLQLLRGLGFCHSH----NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred h-hHHHHHHH-HhcCCcCCHHHHHHHHHHHHhhhhhhhhh----hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 7 44555444 33455689999999999999999999999 999999999999999999999999999976655544
Q ss_pred ccccccccccccCccccccCC-CcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHh--hh---cccccc
Q 046121 181 VQTKILGTLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIE--KL---ALHELI 253 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~ 253 (315)
..+....+..|.+|.++.|.. |+...|+||-||++.|+.. |.+.|..+.- ...+......... +. .+..+.
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--ddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--HHHHHHHHHHhCCCccccCCccccCC
Confidence 444456788999999887654 7889999999999999997 5555644322 2222222211110 11 111122
Q ss_pred CCcccCCCCH---------HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 254 DPRIENSYDT---------YELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 254 ~~~~~~~~~~---------~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
+-...+.++. .....-++++..+|.-+|..|+++++.+++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2222222221 122234678888889999999999998864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-33 Score=216.36 Aligned_cols=258 Identities=17% Similarity=0.254 Sum_probs=192.8
Q ss_pred HhcCCcccceecCCCceEEEEEEe-CCCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeeeEEe--cCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGEL-KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCK--ENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~l 96 (315)
..++|++.+++|+|.++.||.|.. .+++++++|++++.. .+.+.+|+.+|..+. +|||+.++++..+ ...+.+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 357899999999999999999974 578899999987543 356789999999997 9999999999865 456789
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC-CceeECCCCccccc
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD-FVPMLGDFGLARWK 175 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~-~~i~l~dfg~~~~~ 175 (315)
++||+.+.+..... .+++...+...+.+++.|+.|||+. ||.|||+||.|+++|.. ..++|+|||++..
T Consensus 113 iFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~----GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF- 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF- 182 (338)
T ss_pred HhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc----CcccccCCcceeeechhhceeeeeecchHhh-
Confidence 99999777665443 4577788899999999999999999 99999999999999875 5799999999984
Q ss_pred CCCCCccccccccccccCccccc-cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH-------HHHHhhh
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAE-NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA-------EPLIEKL 247 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~ 247 (315)
...+..-+....+-.|.-||.+- -+.|+.+-|+|||||++..|+..+.||.-......+...-.. .....+.
T Consensus 183 YHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 183 YHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred cCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 44444444445566788999775 466899999999999999999999888644443333222100 0111111
Q ss_pred ccccccCCcc----------------cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 248 ALHELIDPRI----------------ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 248 ~~~~~~~~~~----------------~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.+. ++|.. ..+..........+++..+|..|.++|+|++|+..+
T Consensus 263 ~i~--Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 263 QID--LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ccC--CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 110 11111 111111233557788899999999999999998764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-33 Score=241.70 Aligned_cols=261 Identities=22% Similarity=0.232 Sum_probs=207.2
Q ss_pred hcCCcccceecCCCceEEEEEEeCC-CcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
..+++++..||.|+||.|=++..++ ...+|+|++++. .....+.+..|-+++.....|.|++++-.|.+.+..|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 3567788889999999999997654 335788876654 344456678899999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
||-|-||.+...+. ....+...+...++.-+++|+.|||++ |++.|||||+|.+++.+|-+||+|||+++...
T Consensus 499 mEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k----~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~- 571 (732)
T KOG0614|consen 499 MEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRK----GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG- 571 (732)
T ss_pred HHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhc----CceeccCChhheeeccCCceEEeehhhHHHhc-
Confidence 99999999988884 344588888888999999999999999 99999999999999999999999999998444
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
.+...-+++|||.|.|||.+..+..+.++|.||||+++||+++|.+||.... +...+.. ....++...
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d--pmktYn~-ILkGid~i~--------- 639 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD--PMKTYNL-ILKGIDKIE--------- 639 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc--hHHHHHH-HHhhhhhhh---------
Confidence 4445567899999999999999999999999999999999999999996433 2222111 111122211
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHhccccccccc
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPS-----MGEVVRLLEGENDRFHHL 304 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps-----~~~il~~L~~~~~~~~~~ 304 (315)
+|........+|++++-..+|.+|.. +.+|-++-|-..=.|..+
T Consensus 640 ---~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl 688 (732)
T KOG0614|consen 640 ---FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL 688 (732)
T ss_pred ---cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence 22233344667777788889999975 788888877665555544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=229.05 Aligned_cols=137 Identities=26% Similarity=0.320 Sum_probs=117.4
Q ss_pred HHHHh-cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcC--------CCCccceeee
Q 046121 18 IQQAT-GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR--------HKNIVMLLGF 87 (315)
Q Consensus 18 ~~~~~-~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~ 87 (315)
.+.+. ++|.+.++||.|.|+|||++.+. +.+.||+|+.+. .....+....|+.+|+++. ...|+++++.
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 34455 89999999999999999999765 688899998663 3334455788999998884 2468999998
Q ss_pred EE----ecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc
Q 046121 88 CC----KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT 159 (315)
Q Consensus 88 ~~----~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~ 159 (315)
|. ++.++|+|+|++ |.+|..++....-+.++...+..|++||+.+|.|||..| ||+|.||||+|||+.
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLLC 222 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeeee
Confidence 85 467899999997 889989998888888999999999999999999999998 999999999999995
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=238.87 Aligned_cols=242 Identities=22% Similarity=0.301 Sum_probs=186.6
Q ss_pred cCCcccceecCCCceEEEEEE-eCCCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
.-|..++.||-|+||.|.+++ ..+...+|+|.+.+.. ...+.....|-.+|...+.+-|++++..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 456677789999999999996 4468888999776542 334455677889999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC--
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT-- 176 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~-- 176 (315)
+|+.||++..++. ....+.+..+..++..+.-|+.+.|.. |.|||||||+|||||.+|+|||+|||+|.-+.
T Consensus 709 dYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkm----GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhc----cceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999988884 345588999999999999999999999 99999999999999999999999999995210
Q ss_pred -------CCCC---cc------------------------------ccccccccccCccccccCCCcccccchhhhHHHH
Q 046121 177 -------TDDP---VQ------------------------------TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILL 216 (315)
Q Consensus 177 -------~~~~---~~------------------------------~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~ 216 (315)
..+. .+ -..+||+.|+|||++....++..+|.||.|++||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0000 00 0135899999999999999999999999999999
Q ss_pred HHHhCCCccCCCCCccc-hhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 046121 217 QLMSGRKVVDMNGEEPQ-QSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRP 285 (315)
Q Consensus 217 ~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp 285 (315)
+|+.|++||-.+.+... ....+| ..+++=..+..++.++...+.+| | -+++.|.
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw----------~~~l~~~~~~~ls~e~~~li~kL---c--~sad~RL 917 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINW----------RNFLHIPYQGNLSKEALDLIQKL---C--CSADSRL 917 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeeh----------hhccccccccccCHHHHHHHHHH---h--cChhhhh
Confidence 99999999976554332 222222 22233233445555555555554 3 2466665
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-34 Score=224.53 Aligned_cols=254 Identities=24% Similarity=0.315 Sum_probs=187.7
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc-ccHHHHHHHHHHH-hhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-QGFAEFQSEVYVL-NFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+.+-+..||.|+||+|++-.++ .|+..|+|.+..... .+..++..|.... +.-++|||+++++..-.++..++-||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3444567999999999998766 699999997765443 5556677777755 444699999999998888888999998
Q ss_pred ccCCcccc---ccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 101 ICNKSLHW---HLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 101 ~~~~~L~~---~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
| ..++.. .+.......+++...-.+....+.||.||-... .++|||+||+||+++..|.+||||||.+-....
T Consensus 145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l---kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL---KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh---hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 7 445533 333345566899988888889999999998875 799999999999999999999999999964332
Q ss_pred CCCccccccccccccCccccc--cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 178 DDPVQTKILGTLGYLAPEYAE--NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
+ .......|-..|+|||-+. ++.|+.+||+||||+++||+.||..|+....... .+........ .|
T Consensus 221 S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf----eql~~Vv~gd-------pp 288 (361)
T KOG1006|consen 221 S-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF----EQLCQVVIGD-------PP 288 (361)
T ss_pred H-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH----HHHHHHHcCC-------CC
Confidence 2 2222334556799999775 3458999999999999999999999996544311 1111111111 11
Q ss_pred cccCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 256 RIENS-YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 256 ~~~~~-~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.+..+ -.-+.+..+++++--||.+|-..||.+.+++++
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11111 122356678899999999999999999998754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=235.49 Aligned_cols=268 Identities=21% Similarity=0.188 Sum_probs=177.0
Q ss_pred HhcCCcccceecCCCceEEEEEEe-----------------CCCcEEEEEEecccCcccHHH--------------HHHH
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGEL-----------------KDGQMIAAKVRKEASTQGFAE--------------FQSE 69 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~-----------------~~~~~~~~k~~~~~~~~~~~~--------------~~~e 69 (315)
..++|.+.++||+|+||+||+|.. ..++.|++|.+........+. ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467999999999999999999953 134678999876433222222 2346
Q ss_pred HHHHhhcCCCCc-----cceeeeEEe--------cCeeEEEEEeccCCccccccccCC----------------------
Q 046121 70 VYVLNFARHKNI-----VMLLGFCCK--------ENLNILVYEYICNKSLHWHLFDNT---------------------- 114 (315)
Q Consensus 70 ~~~l~~l~~~~i-----~~~~~~~~~--------~~~~~lv~~~~~~~~L~~~l~~~~---------------------- 114 (315)
+.++..++|.++ +.+++++.. .+..++|+||+.+++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666666766543 566666542 356799999999999988875321
Q ss_pred CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc-cccccccccccC
Q 046121 115 ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV-QTKILGTLGYLA 193 (315)
Q Consensus 115 ~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~-~~~~~~~~~~~a 193 (315)
...+++..+..++.|++.++.++|+. +++|+||||+||+++.++.++|+|||++......... .....+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~----~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI----GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 12245677888999999999999999 9999999999999999999999999998643322211 112344789999
Q ss_pred ccccccCC--------------------C--cccccchhhhHHHHHHHhCCC-ccCCCCCccchhHHHhHHHHHhhhccc
Q 046121 194 PEYAENGI--------------------V--SIRTDVYAFGIILLQLMSGRK-VVDMNGEEPQQSLRQWAEPLIEKLALH 250 (315)
Q Consensus 194 PE~~~~~~--------------------~--~~~~DvwslG~~l~~l~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (315)
||.+.... + ..+.|+||+||++++|++|.. |+....... .......... . .+.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~-~~~~~~~~~~-~--~~r 454 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN-TELRQYDNDL-N--RWR 454 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh-hHHhhccchH-H--HHH
Confidence 99875322 1 124699999999999999875 553211100 0000000000 0 000
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhhcCCCC---CCCCCHHHHHHHHhc
Q 046121 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNP---EGRPSMGEVVRLLEG 296 (315)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p---~~Rps~~~il~~L~~ 296 (315)
........-......+...++++.+||..+| .+|+|+.+++++-+-
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 0000011111112234567888888998766 689999999987654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=233.35 Aligned_cols=273 Identities=18% Similarity=0.189 Sum_probs=203.8
Q ss_pred ccHHHHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCC------CCcccee
Q 046121 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARH------KNIVMLL 85 (315)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~ 85 (315)
|.+...+...++|.+....|+|-|++|..|.+. .+..||||++... +...+.=..|+++|++|+. -+++.++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 345566778899999999999999999999876 4789999998864 3344555789999999963 4788999
Q ss_pred eeEEecCeeEEEEEeccCCccccccccC-CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC-Cc
Q 046121 86 GFCCKENLNILVYEYICNKSLHWHLFDN-TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD-FV 163 (315)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~-~~ 163 (315)
..|...+++|+|+|-+ .-+|.+.+..- .+-.+....+..++.|+..||..|-.- ||+|.||||+|||+.++ ..
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c----~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC----GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc----CeeecccCccceEeccCcce
Confidence 9999999999999976 56788877653 345677888889999999999999888 99999999999999875 56
Q ss_pred eeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH---
Q 046121 164 PMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA--- 240 (315)
Q Consensus 164 i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--- 240 (315)
++|||||.+..... + ....+...--|.|||.+.|-+|+...|+||.||+|||+.||+..|++.+.....-+..-.
T Consensus 576 LKLCDfGSA~~~~e-n-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 576 LKLCDFGSASFASE-N-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eeeccCcccccccc-c-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 89999999862222 2 222334455699999999999999999999999999999999999765543221111000
Q ss_pred --HHHHhhh---------------------------ccccccCC------cc-----cCCCCHHHHHHHHHHHHhhcCCC
Q 046121 241 --EPLIEKL---------------------------ALHELIDP------RI-----ENSYDTYELYLMAKTAYLCVQRN 280 (315)
Q Consensus 241 --~~~~~~~---------------------------~~~~~~~~------~~-----~~~~~~~~~~~l~~l~~~~l~~~ 280 (315)
...+.+. .....+.| .+ ..+........+.+|+..||..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 0000000 00001111 00 11222334556899999999999
Q ss_pred CCCCCCHHHHHHH
Q 046121 281 PEGRPSMGEVVRL 293 (315)
Q Consensus 281 p~~Rps~~~il~~ 293 (315)
|++|.|.+++|.+
T Consensus 734 P~KRit~nqAL~H 746 (752)
T KOG0670|consen 734 PEKRITVNQALKH 746 (752)
T ss_pred hhhcCCHHHHhcC
Confidence 9999999999865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=207.73 Aligned_cols=211 Identities=36% Similarity=0.531 Sum_probs=180.7
Q ss_pred ecCCCceEEEEEEeC-CCcEEEEEEecccCcc-cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCcccc
Q 046121 31 LGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ-GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHW 108 (315)
Q Consensus 31 lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~ 108 (315)
||+|.+|.||++... +++.+++|++...... ....+.+|+..++.+.|++++++++++......+++++++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999876 4889999988765432 34678899999999999999999999999899999999999899998
Q ss_pred ccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC-CCceeECCCCcccccCCCCCccccccc
Q 046121 109 HLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH-DFVPMLGDFGLARWKTTDDPVQTKILG 187 (315)
Q Consensus 109 ~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~-~~~i~l~dfg~~~~~~~~~~~~~~~~~ 187 (315)
++.... ..++....+.++.+++.++.+||+. +++|+||+|.||+++. ++.++++|||.+..............+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~----~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN----GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence 885432 4588999999999999999999999 9999999999999999 899999999998754443312233456
Q ss_pred cccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHH
Q 046121 188 TLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYEL 266 (315)
Q Consensus 188 ~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (315)
...|.+||..... .++.++|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7789999998876 788899999999999998
Q ss_pred HHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 267 YLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 267 ~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
..+.+++..|++.+|++||++.++++.+
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2367888889999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=231.65 Aligned_cols=212 Identities=22% Similarity=0.291 Sum_probs=173.9
Q ss_pred CCCCCCcccHHHHH-HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHH-----HHHHHHHHHhh
Q 046121 6 YMKDPMKFSFSEIQ-QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFA-----EFQSEVYVLNF 75 (315)
Q Consensus 6 ~~~~~~~~~~~~~~-~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~-----~~~~e~~~l~~ 75 (315)
+..+|+..+..+.. ....+|+.++.+|.|+||.||+|.++ +...|++|.+.+.. ..+.. .+-.|+++|..
T Consensus 543 ~a~e~e~~~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~ 622 (772)
T KOG1152|consen 543 KAVEPEGNIGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILAT 622 (772)
T ss_pred cccCccccccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHH
Confidence 45566666655443 35578999999999999999999877 46678888776542 11111 13468999988
Q ss_pred cC---CCCccceeeeEEecCeeEEEEEec-cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecC
Q 046121 76 AR---HKNIVMLLGFCCKENLNILVYEYI-CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDM 151 (315)
Q Consensus 76 l~---~~~i~~~~~~~~~~~~~~lv~~~~-~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di 151 (315)
++ |+||++++++|++++.+|+++|.. +|.+|.+++... ..+++.++..++.|++.++++||++ ||+||||
T Consensus 623 l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~----~ivhrdi 696 (772)
T KOG1152|consen 623 LNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQ----GIVHRDI 696 (772)
T ss_pred hhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccccc----Cceeccc
Confidence 87 999999999999999999999975 567788888544 3489999999999999999999999 9999999
Q ss_pred ccCcEEEcCCCceeECCCCcccccCCCCCccccccccccccCccccccCCC-cccccchhhhHHHHHHHhCCCcc
Q 046121 152 RPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVV 225 (315)
Q Consensus 152 ~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p~ 225 (315)
|-+||.++.+|-++|+|||.+.+.. .+ ....+.||..|.|||++.|..| +..-|||+||+++|.++....||
T Consensus 697 kdenvivd~~g~~klidfgsaa~~k-sg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 697 KDENVIVDSNGFVKLIDFGSAAYTK-SG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred ccccEEEecCCeEEEeeccchhhhc-CC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9999999999999999999997333 22 3456789999999999998876 45679999999999999888776
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=240.79 Aligned_cols=239 Identities=23% Similarity=0.307 Sum_probs=180.2
Q ss_pred ceecCCCceE-EEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeeeEEecCeeEEEEEeccCCcc
Q 046121 29 NLLGEGGFGH-VYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLNILVYEYICNKSL 106 (315)
Q Consensus 29 ~~lg~g~~~~-v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (315)
+++|.|+.|+ ||+|... ++.||+|.+-. +..+..++|+..|+.-+ ||||+++++.-.++...|+..|.| ..+|
T Consensus 515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL 589 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL 589 (903)
T ss_pred HHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence 4688999985 6888775 66888886533 33456789999998884 999999999999999999999986 7799
Q ss_pred ccccccC-CCC-ccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC---C--CceeECCCCcccccCCCC
Q 046121 107 HWHLFDN-TES-VLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH---D--FVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 107 ~~~l~~~-~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~---~--~~i~l~dfg~~~~~~~~~ 179 (315)
.+++... ... .......+....|++.+++|||+. +|+||||||.||+|+. + .+++|+|||+|+......
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl----~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL----KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc----ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9888653 111 111145577888999999999998 9999999999999976 2 478999999998665443
Q ss_pred Cc---cccccccccccCccccccCCCcccccchhhhHHHHHHHhC-CCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 180 PV---QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG-RKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 180 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
.. .....|+-+|.|||++....-..++|||||||++|+.++| ..||+..-......+ .....+..+
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl-------~~~~~L~~L--- 735 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL-------TGNYTLVHL--- 735 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh-------cCccceeee---
Confidence 32 2346788999999999988888899999999999999985 899975432211111 111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~ 292 (315)
.... +. ...+||.+|+.++|..||++.+++.
T Consensus 736 --~~~~--d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 --EPLP--DC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --ccCc--hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1110 01 5789999999999999999999964
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=233.94 Aligned_cols=253 Identities=27% Similarity=0.344 Sum_probs=209.1
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
.++|+.+..+|.|++|.||+++++ +++..++|+++......+.-+++|+-+++..+||||+.+++.+.....+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 468999999999999999999876 6999999999998888899999999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.||+|.+.. ....++++.++...++..+.++.|||++ |-+|||||-.||+++..|.+++.|||.+......-.
T Consensus 94 cgggslQdiy--~~TgplselqiayvcRetl~gl~ylhs~----gk~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLKYLHSQ----GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred cCCCccccee--eecccchhHHHHHHHhhhhccchhhhcC----CcccccccccceeecccCceeecccCchhhhhhhhh
Confidence 9999998877 3556799999999999999999999999 999999999999999999999999999987776666
Q ss_pred ccccccccccccCccccc---cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 181 VQTKILGTLGYLAPEYAE---NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
......|+|.|+|||+.. .+.|...+|+|++|++..++--.++|.... .+.+.+.- .. ...++| .
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl--hpmr~l~L-----mT----kS~~qp-p 235 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL--HPMRALFL-----MT----KSGFQP-P 235 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc--chHHHHHH-----hh----ccCCCC-C
Confidence 667789999999999653 455788999999999999988777664321 11111110 00 011111 1
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~ 292 (315)
-..........+.++++.+|.++|++|||++.+|.
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11122335667889999999999999999998765
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=218.47 Aligned_cols=266 Identities=21% Similarity=0.237 Sum_probs=204.0
Q ss_pred cHHHHHHHhcCCcccceecCCCceEEEEEEeCC------CcEEEEEEecc-cCcccHHHHHHHHHHHhhcCCCCccceee
Q 046121 14 SFSEIQQATGDFSKENLLGEGGFGHVYKGELKD------GQMIAAKVRKE-ASTQGFAEFQSEVYVLNFARHKNIVMLLG 86 (315)
Q Consensus 14 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (315)
..+++.....|++...++.+|+||.||.|.|.+ .+.+.+|..+. .++.....+..|--.+..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 445666677889999999999999999996653 33445554443 34445566778888888899999999999
Q ss_pred eEE-ecCeeEEEEEeccCCccccccc------cCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc
Q 046121 87 FCC-KENLNILVYEYICNKSLHWHLF------DNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT 159 (315)
Q Consensus 87 ~~~-~~~~~~lv~~~~~~~~L~~~l~------~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~ 159 (315)
+.. +...++.++++..-++|..++. .+....++..+...++.|++.|+.|||+. +++|.||-.+|.++|
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~----~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH----GVIHKDIAARNCVID 430 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc----Ccccchhhhhcceeh
Confidence 875 4566788899988899988886 23446688889999999999999999999 999999999999999
Q ss_pred CCCceeECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhH
Q 046121 160 HDFVPMLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSL 236 (315)
Q Consensus 160 ~~~~i~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~ 236 (315)
+..+++|+|=.++...-+.... ......+..|++||.+....++.++|+||||+++|||+| |+.|+..-.+.+...+
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y 510 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY 510 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence 9999999999888755444332 122345778999999999999999999999999999998 8888854322211111
Q ss_pred HHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 237 RQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
.. ..-..-.+-+++..+..+|.-||...|++||++++++.-|.++..
T Consensus 511 -------lk---------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 511 -------LK---------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred -------Hh---------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 11 111111223345567778888999999999999999988877644
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=198.65 Aligned_cols=210 Identities=23% Similarity=0.309 Sum_probs=166.0
Q ss_pred HHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-CcccHHHHHHHHHHHhh-cCCCCccceeeeEEecCee
Q 046121 18 IQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-STQGFAEFQSEVYVLNF-ARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~ 94 (315)
.+...+...-+..||+|++|.|-+-++. +|...|+|-+... +.+..+++..|+.+... ..+|.++.+++....+...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 3444556667788999999999887754 7888999866543 34455667777776644 4699999999998888889
Q ss_pred EEEEEeccCCcccccccc--CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 95 ILVYEYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
++.||.| ..+|..+..+ ..+...++..+-+++..++.|+.|||++. .++|||+||+||+++..|++|+||||.+
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL---~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL---SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh---hhhhccCCcceEEEccCCcEEEcccccc
Confidence 9999987 5566544332 34567999999999999999999999997 7999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccCccccc----cCCCcccccchhhhHHHHHHHhCCCccCCCCCcc
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAE----NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEP 232 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~ 232 (315)
-+...+- ......|-..|+|||.+. .+.|+.++||||||+++.||.+++.||+......
T Consensus 197 G~L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 197 GYLVDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred eeehhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence 6443322 222245667799999765 3468999999999999999999999998665543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-31 Score=210.48 Aligned_cols=269 Identities=22% Similarity=0.269 Sum_probs=188.9
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEec-----Ce
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE-----NL 93 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 93 (315)
..+.+-.+-||.|+||.||.+.+. +|+.+++|.+... +-...+.+.+|++++..++|.|++..+++..-. ..
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 345666788999999999999654 7999999876643 233456788999999999999999998876432 23
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+|.+.|.+ ..+|...+ .+...++...+.-+..||+.+++|||+. +|.||||||.|.+++.+..+||+|||++.
T Consensus 132 iYV~TELm-QSDLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHsA----~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKII--VSPQALTPDHVKVFVYQILRGLKYLHTA----NILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHH-Hhhhhhee--ccCCCCCcchhhhhHHHHHhhhHHHhhc----chhhccCCCccEEeccCceEEeccccccc
Confidence 46666665 44565555 3455688888888999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCcc-ccccccccccCccccccCC-CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHH-hH--------HH
Q 046121 174 WKTTDDPVQ-TKILGTLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQ-WA--------EP 242 (315)
Q Consensus 174 ~~~~~~~~~-~~~~~~~~~~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~--------~~ 242 (315)
......... .....|..|.|||.+.|.. |+.+.||||.||++.|++..+..|...++-....+.. .. ..
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 443322221 2234578899999887644 8999999999999999999888886544322221111 00 00
Q ss_pred HHh---hhcccccc-CCcc---cCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 243 LIE---KLALHELI-DPRI---ENSYD-TYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 243 ~~~---~~~~~~~~-~~~~---~~~~~-~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
..+ ...+.... .|.. ..-.+ .........++.+++.+||++|.+.++.+..+..-
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 000 00011111 1111 11111 12233456777889999999999999988766443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=206.26 Aligned_cols=263 Identities=24% Similarity=0.273 Sum_probs=193.9
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEec------
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE------ 91 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 91 (315)
...+|.-++.+|.|.. .|..+.+. .++.+++|..... .....++..+|+..+..++|+|+++.+.++.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4468889999999999 67677655 6888888865432 345567788999999999999999999998543
Q ss_pred CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCc
Q 046121 92 NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGL 171 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~ 171 (315)
...|+|||++ ..+|...+. -.++-..+..+..|.+.|++|||+. ||+||||||+||++..++.+|+.|||+
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~----~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSA----GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc----ceeecccCcccceecchhheeeccchh
Confidence 3459999998 567766664 3366778899999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCC------------ccchhHH--
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGE------------EPQQSLR-- 237 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~------------~~~~~~~-- 237 (315)
+...... -....+..+-.|.|||++.+-.+...+||||+||++.||++|..-|.+... .+.....
T Consensus 165 ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 165 ARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred hcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 9633332 233456778889999999888899999999999999999999988763211 0001111
Q ss_pred --HhHHHHHh---h---hccccc-cCCcccCC--CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 238 --QWAEPLIE---K---LALHEL-IDPRIENS--YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 238 --~~~~~~~~---~---~~~~~~-~~~~~~~~--~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
.....+.. + ....+. .+..+... .++.....+++++.+||..||++|.|+.++|++-
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 10111111 1 111111 11112111 1223455688999999999999999999999863
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=199.25 Aligned_cols=198 Identities=33% Similarity=0.446 Sum_probs=170.5
Q ss_pred CcccceecCCCceEEEEEEeCC-CcEEEEEEecccCcc-cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 25 FSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQ-GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
|.+.+.||.|++|.||++.... ++.+++|........ ..+.+.+|+..++.++|+|++++++.+......+++++++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 6778899999999999998764 889999998866554 56788899999999999999999999998899999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC-Cc
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD-PV 181 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~-~~ 181 (315)
+++|.+++...... +++.....++.+++.++.+||+. +++|+|++|.||+++.++.++++|||.+....... ..
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~----~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL----GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 99999888554322 78899999999999999999999 99999999999999999999999999987544332 12
Q ss_pred cccccccccccCcccc-ccCCCcccccchhhhHHHHHHHhCCCccCC
Q 046121 182 QTKILGTLGYLAPEYA-ENGIVSIRTDVYAFGIILLQLMSGRKVVDM 227 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~-~~~~~~~~~DvwslG~~l~~l~~g~~p~~~ 227 (315)
.....+...|++||.+ ....++.++|+|+||+++++|++|..||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2334567789999988 666677899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=209.05 Aligned_cols=267 Identities=23% Similarity=0.294 Sum_probs=196.5
Q ss_pred HHHHHHhcCCcccceecCCCceEEEEEEeC----CCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeeeEEe
Q 046121 16 SEIQQATGDFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCK 90 (315)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 90 (315)
..++.+...|..+.+||+|+|++||++.+. ....|++|.+... +....+.+|+++|..+. +.||+++.+.+..
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 346778889999999999999999999543 4788999987644 34467899999999885 8999999999999
Q ss_pred cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC-CCceeECCC
Q 046121 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH-DFVPMLGDF 169 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~-~~~i~l~df 169 (315)
+++..+|+||++.....++. ..++...+.++++.++.|+.++|.+ ||+||||||.|++.+. .++-.|+||
T Consensus 107 nd~v~ivlp~~~H~~f~~l~-----~~l~~~~i~~Yl~~ll~Al~~~h~~----GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLY-----RSLSLAEIRWYLRNLLKALAHLHKN----GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CCeeEEEecccCccCHHHHH-----hcCCHHHHHHHHHHHHHHhhhhhcc----CccccCCCccccccccccCCceEEec
Confidence 99999999999998887776 2366888999999999999999999 9999999999999975 567889999
Q ss_pred CcccccCC--------------CCC-----------------c-------------cccccccccccCccccccCC-Ccc
Q 046121 170 GLARWKTT--------------DDP-----------------V-------------QTKILGTLGYLAPEYAENGI-VSI 204 (315)
Q Consensus 170 g~~~~~~~--------------~~~-----------------~-------------~~~~~~~~~~~aPE~~~~~~-~~~ 204 (315)
|++..... ... . .....||++|.|||++.+.+ -+.
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 99861000 000 0 01235899999999887644 567
Q ss_pred cccchhhhHHHHHHHhCCCccCCCCCccchhHH---HhHHHHHhhhcc----------------------ccccC-Ccc-
Q 046121 205 RTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLR---QWAEPLIEKLAL----------------------HELID-PRI- 257 (315)
Q Consensus 205 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~----------------------~~~~~-~~~- 257 (315)
+.||||.|+++..++++..||.....+...... -.......+.+. ...+. ..+
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 899999999999999999998654432221111 000000000000 00000 000
Q ss_pred --------cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 258 --------ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 258 --------~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
........+..+.+|+.+||..||.+|.|++++|.+
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 011111234478899999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=196.64 Aligned_cols=250 Identities=19% Similarity=0.256 Sum_probs=179.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeee-EEecCeeEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGF-CCKENLNILV 97 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~-~~~~~~~~lv 97 (315)
..+.|.+.+.||+|.||.+-+++++ +...+++|.+... ......+.+|...--.+. |.||+.-+++ |+..+.+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 5678999999999999999999877 5777888877653 445677888877655554 7899987775 5667788899
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC--CCceeECCCCccccc
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH--DFVPMLGDFGLARWK 175 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~--~~~i~l~dfg~~~~~ 175 (315)
+||.+.|+|..-+ ....+.+.....++.|+++|+.++|+. +++|||||.+||++.. .-+|||||||.....
T Consensus 101 qE~aP~gdL~snv---~~~GigE~~~K~v~~ql~SAi~fMHsk----nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNV---EAAGIGEANTKKVFAQLLSAIEFMHSK----NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhc---CcccccHHHHHHHHHHHHHHHHHhhcc----chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999998777 345688999999999999999999999 9999999999999943 348999999998633
Q ss_pred CCCCCccccccccccccCccccccC---C--CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccc
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAENG---I--VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~~~---~--~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (315)
+..-... .-...|.+||..... . ..+.+|+|.||++++.+++|.+||...... +..+-.+.. ..
T Consensus 174 g~tV~~~---~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~--w~----- 242 (378)
T KOG1345|consen 174 GTTVKYL---EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQ--WL----- 242 (378)
T ss_pred Cceehhh---hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHH--Hh-----
Confidence 3221111 124458899965422 2 356789999999999999999999733221 122222111 11
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 046121 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEV 290 (315)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~i 290 (315)
....+..+..+. ..+..+.++.++-|..+|++|--..+.
T Consensus 243 ~rk~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 243 KRKNPALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred cccCccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHH
Confidence 111122222221 133345667777889999999444433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=198.18 Aligned_cols=259 Identities=24% Similarity=0.272 Sum_probs=193.7
Q ss_pred CCcccceecCCCceEEEEEEeCC--CcEEEEEEecccCcccHHHHHHHHHHHhhcC----CCCccceeeeE-EecCeeEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELKD--GQMIAAKVRKEASTQGFAEFQSEVYVLNFAR----HKNIVMLLGFC-CKENLNIL 96 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~l 96 (315)
+|.+.++||+|+||.||.+.+.. ...+|+|+...........+..|..++..++ .+++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999998765 3578888877654333336778888888886 36888999888 47778899
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC-----CceeECCCCc
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD-----FVPMLGDFGL 171 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~-----~~i~l~dfg~ 171 (315)
||+.+ |.+|.++........++..+...++.|++.+|+++|+. |++||||||.|+++... ..+.+.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~----G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK----GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc----CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99985 99999988666677899999999999999999999999 99999999999999765 4699999999
Q ss_pred ccccC--CCC--------CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccc-hhHHHhH
Q 046121 172 ARWKT--TDD--------PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ-QSLRQWA 240 (315)
Q Consensus 172 ~~~~~--~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~ 240 (315)
+.... ... .......||..|+++.++.+...+.+.|+||+++++.+++.|..||........ .....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~-- 251 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK-- 251 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH--
Confidence 97222 111 101234589999999999999999999999999999999999999954332211 11111
Q ss_pred HHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
...... ..+ .....+..+.++...+-..+...+|....+...++....+
T Consensus 252 --~~~~~~----~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 252 --DPRKLL----TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred --Hhhhhc----ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 011100 000 1111122344444445558999999999999887665443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-26 Score=179.61 Aligned_cols=168 Identities=23% Similarity=0.228 Sum_probs=124.3
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccc
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~ 183 (315)
|+|.+++... ...+++..++.++.|++.|+.|||+. + ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~----~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ----A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc----C------CcccEeEcCccceee--ccceEeecccc----
Confidence 5677777533 34699999999999999999999999 6 999999999999999 99886433321
Q ss_pred cccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCH
Q 046121 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDT 263 (315)
Q Consensus 184 ~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (315)
..|++.|+|||++.+..++.++||||||+++|+|++|..||....... ........ ... .. .+. ......
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~----~~~--~~-~~~-~~~~~~ 133 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLN----GMP--AD-DPR-DRSNLE 133 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHH----Hhc--cC-Ccc-ccccHH
Confidence 257899999999999999999999999999999999999985432211 11111111 100 00 000 001112
Q ss_pred HHHH--HHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 264 YELY--LMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 264 ~~~~--~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
.... .+.+++.+||..+|++|||+.++++++....
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 2333 5899999999999999999999999987664
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-27 Score=225.00 Aligned_cols=196 Identities=17% Similarity=0.221 Sum_probs=134.5
Q ss_pred cCC-CCccceeeeE-------EecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeE
Q 046121 76 ARH-KNIVMLLGFC-------CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPII 147 (315)
Q Consensus 76 l~~-~~i~~~~~~~-------~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~ 147 (315)
++| +||+.+++.+ .....+++++|++ +++|.+++... ...+++.++..++.||+.||.|||++ ||+
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----gIv 102 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ----GIV 102 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC----Cee
Confidence 344 4666666665 2234567778875 77999988543 45599999999999999999999999 999
Q ss_pred eecCccCcEEEcCCC-------------------ceeECCCCcccccCCCC----------------Ccccccccccccc
Q 046121 148 HRDMRPSNILLTHDF-------------------VPMLGDFGLARWKTTDD----------------PVQTKILGTLGYL 192 (315)
Q Consensus 148 h~di~p~nil~~~~~-------------------~i~l~dfg~~~~~~~~~----------------~~~~~~~~~~~~~ 192 (315)
||||||+||+++..+ .++++|||++....... .......|++.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 45555666553211000 0001135788899
Q ss_pred CccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHH
Q 046121 193 APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKT 272 (315)
Q Consensus 193 aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (315)
|||++.+..++.++|||||||++|||++|.+|+..... ....... . ...+.... .......+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~----~-----~~~~~~~~-----~~~~~~~~ 244 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH----R-----VLPPQILL-----NWPKEASF 244 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH----h-----hcChhhhh-----cCHHHHHH
Confidence 99999999999999999999999999998887642110 1111000 0 01111101 11224567
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHh
Q 046121 273 AYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 273 ~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
+.+||.++|.+|||+.+++++-+
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HHHhCCCChhhCcChHHHhhchh
Confidence 78899999999999999987654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=181.92 Aligned_cols=264 Identities=18% Similarity=0.217 Sum_probs=196.3
Q ss_pred HhcCCcccceecCCCceEEEEEEe-CCCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGEL-KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 98 (315)
..-.|.++++||+|+||.++.|.+ -+++.||||.-...+ ...++..|++.++.+. .++|..++.+..++.+..+|+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 445799999999999999999975 489999999765443 3578899999999995 799999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC-----CceeECCCCccc
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD-----FVPMLGDFGLAR 173 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~-----~~i~l~dfg~~~ 173 (315)
|.+ |.+|.|++ +-....++..+++.++.|++.-++++|++ .+|.|||||+|+||... ..|.++|||+++
T Consensus 104 dLL-GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~k----~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHEK----DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHhc----ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 986 88887654 56677899999999999999999999999 99999999999999754 468899999997
Q ss_pred ccCCCCCc-------cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhh
Q 046121 174 WKTTDDPV-------QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK 246 (315)
Q Consensus 174 ~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (315)
........ .....||.+||+-..+.|..-+...|+-|||-++++++-|.+||...........- +.+.+.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY---eKIGe~ 254 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY---EKIGET 254 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH---HHhccc
Confidence 54432211 12356899999999999999999999999999999999999999765443221111 111110
Q ss_pred hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
. ....-..++..++..... -++-.-..+-.+-|+.+-+...+....++.
T Consensus 255 -K-r~T~i~~Lc~g~P~efa~----Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 255 -K-RSTPIEVLCEGFPEEFAT----YLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred -c-ccCCHHHHHhcCHHHHHH----HHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 0 001111233333333222 222233457777788777766665555443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-26 Score=180.69 Aligned_cols=249 Identities=19% Similarity=0.281 Sum_probs=190.4
Q ss_pred CCcccceecCCCceEEEEEEeCCCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
+..+..+|.+...|..|+|+|+++.. +.|++... .......+..|.-.|+.+.||||.++++.|....++.++..|+
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgndi-vakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGNDI-VAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcch-hhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 44566789999999999999996664 44554432 2333346788999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeE-eecCccCcEEEcCCCceeE--CCCCcccccCCC
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPII-HRDMRPSNILLTHDFVPML--GDFGLARWKTTD 178 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~-h~di~p~nil~~~~~~i~l--~dfg~~~~~~~~ 178 (315)
+.++|+..++.......+..++.+++..++.++.|||+.- .++ .--++...|++|++...++ .|-.++. +
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle---p~ipr~~lns~hvmidedltarismad~kfsf----q 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE---PMIPRFYLNSKHVMIDEDLTARISMADTKFSF----Q 342 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc---hhhhhhhcccceEEecchhhhheecccceeee----e
Confidence 9999999999999888999999999999999999999983 233 3358889999999876554 3433331 1
Q ss_pred CCccccccccccccCccccccCCCc---ccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVS---IRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~---~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
. ....-.|.|++||.++.++-+ .++|+|||++++||+.|...||....+-..... +...
T Consensus 343 e---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk---------------iale 404 (448)
T KOG0195|consen 343 E---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK---------------IALE 404 (448)
T ss_pred c---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh---------------hhhc
Confidence 1 112336889999999876643 578999999999999999999975543221111 1112
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
.+....++..+..+.+|+.-|++.||.+||.+..++-.|+++.
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2333444555566788888899999999999999999998764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=185.77 Aligned_cols=171 Identities=22% Similarity=0.189 Sum_probs=130.3
Q ss_pred ccHHHHHHHhcCCcccceecCCCceEEEEEEeC--CCcEEEEEEeccc-----CcccHHHHHHHHHHHhhcCCCCcccee
Q 046121 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELK--DGQMIAAKVRKEA-----STQGFAEFQSEVYVLNFARHKNIVMLL 85 (315)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (315)
+..++.....++|.+.+.||+|+||+||+|.+. +++.+++|..... .......+.+|+++++.++|+|+++.+
T Consensus 8 ~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l 87 (365)
T PRK09188 8 LPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL 87 (365)
T ss_pred CcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence 344566778899999999999999999999765 5777899875432 122345688999999999999998533
Q ss_pred eeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecC-ccCcEEEcCCCce
Q 046121 86 GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDM-RPSNILLTHDFVP 164 (315)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di-~p~nil~~~~~~i 164 (315)
.. .+..++||||+.|++|.... . .. ...++.+++.++.+||+. |++|||| ||+||+++.++.+
T Consensus 88 ~~---~~~~~LVmE~~~G~~L~~~~---~---~~---~~~~~~~i~~aL~~lH~~----gIiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 88 LA---TGKDGLVRGWTEGVPLHLAR---P---HG---DPAWFRSAHRALRDLHRA----GITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred EE---cCCcEEEEEccCCCCHHHhC---c---cc---hHHHHHHHHHHHHHHHHC----CCeeCCCCCcceEEEcCCCCE
Confidence 22 24579999999999996221 1 11 135778999999999999 9999999 9999999999999
Q ss_pred eECCCCcccccCCCCCcc--------ccccccccccCcccccc
Q 046121 165 MLGDFGLARWKTTDDPVQ--------TKILGTLGYLAPEYAEN 199 (315)
Q Consensus 165 ~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~ 199 (315)
+|+|||++.......... ....+++.|.|||.+..
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999997554432111 12456777899998753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=170.51 Aligned_cols=202 Identities=21% Similarity=0.266 Sum_probs=168.4
Q ss_pred HhcCCcccceecCCCceEEEEEEe-CCCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGEL-KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 98 (315)
..+.|.++++||.|+||.+|+|.. .+|..||+|+-+... ...++.-|..+++.++ ..+|+.+..+..+..+..+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 467999999999999999999964 579999999876442 2356778899999997 478999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC---CceeECCCCccccc
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD---FVPMLGDFGLARWK 175 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~---~~i~l~dfg~~~~~ 175 (315)
+.+ |.+|.+.++ -....++..+++.++-|++.-++|+|.+ +.+|+||||+|++..-+ ..+.++|||+++.+
T Consensus 91 dLL-GPsLEdLfn-fC~R~ftmkTvLMLaDQml~RiEyvH~r----~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFN-FCSRRFTMKTVLMLADQMLSRIEYVHLR----NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHH-HHhhhhhHHhHHHHHHHHHHHHHHHHhh----ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 986 888877663 3455699999999999999999999999 99999999999999643 57899999999754
Q ss_pred CCCCC-------ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCC
Q 046121 176 TTDDP-------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGE 230 (315)
Q Consensus 176 ~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~ 230 (315)
..... ......||.+|.+-..+.+..-+...|+-|+|++++++--|..||.+-.+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 33221 12235689999998888887788999999999999999999999976543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-23 Score=167.34 Aligned_cols=173 Identities=13% Similarity=0.079 Sum_probs=131.8
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHH---------HHHHHHHHhhcCCCCccceeeeEE
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAE---------FQSEVYVLNFARHKNIVMLLGFCC 89 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~---------~~~e~~~l~~l~~~~i~~~~~~~~ 89 (315)
+.+.++|.+.++||.|+||.||++.. ++..+++|++.......... +.+|+..+.++.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 44789999999999999999999766 56689999987543332222 578999999999999999988865
Q ss_pred ec--------CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC
Q 046121 90 KE--------NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD 161 (315)
Q Consensus 90 ~~--------~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~ 161 (315)
.. ...+++|||++|.+|.+... +++ ....+++.++..+|+. |++|+|++|.||+++.+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~----gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH----GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc----CCccCCCChHHEEEeCC
Confidence 33 35789999999999977631 222 2355899999999999 99999999999999998
Q ss_pred CceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHH
Q 046121 162 FVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLM 219 (315)
Q Consensus 162 ~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~ 219 (315)
| ++++|||....... ..... .......+..++|+|+||+++..+.
T Consensus 172 g-i~liDfg~~~~~~e-~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQ-RKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccc-hhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence 8 99999998752211 11100 0222334567899999999987654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-21 Score=168.00 Aligned_cols=259 Identities=27% Similarity=0.354 Sum_probs=194.1
Q ss_pred CcccceecCCCceEEEEEEeCCCcEEEEEEecccCcc---cHHHHHHHHHHHhhcCCC-CccceeeeEEecCeeEEEEEe
Q 046121 25 FSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQ---GFAEFQSEVYVLNFARHK-NIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~~~ 100 (315)
|.+.+.||.|+|+.||.+.+. ..+++|.+...... ....+.+|+..++.+.|+ +++.+.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 788899999999999999877 77788877655433 356788999999999988 799999999877778999999
Q ss_pred ccCCccccccccCCC-CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC-ceeECCCCcccccCCC
Q 046121 101 ICNKSLHWHLFDNTE-SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF-VPMLGDFGLARWKTTD 178 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~-~i~l~dfg~~~~~~~~ 178 (315)
+.++++.+.+..... ..+.......+..|++.++.++|+. +++|+|+||+|++++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~----~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK----GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999865543322 2689999999999999999999999 999999999999999998 7999999998644433
Q ss_pred CC------ccccccccccccCcccccc---CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcc
Q 046121 179 DP------VQTKILGTLGYLAPEYAEN---GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249 (315)
Q Consensus 179 ~~------~~~~~~~~~~~~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (315)
.. ......++..|.+||.+.+ .......|+|++|++++++++|..||...... ......... ......
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~-~~~~~~ 232 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKI-ILELPT 232 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHH-HHhcCC
Confidence 32 2345678999999999987 57788999999999999999999996544321 000110011 111000
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
. .................+.+++..|+..+|..|.+..+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000111111112223557788888999999999998887664
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.2e-24 Score=196.15 Aligned_cols=261 Identities=20% Similarity=0.248 Sum_probs=184.2
Q ss_pred CCcccceecCCCceEEEEEEeCCCcEEEEEEecccC-cccHH---HHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAS-TQGFA---EFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~---~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.|...+.||.+.|=.|.+|.+..|. |++|++-+.. .-... +...|++ ....++||.+++.-+.......|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5777889999999999999988887 7888866543 32333 3344455 566789999999988887888888888
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc--ccCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR--WKTT 177 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~--~~~~ 177 (315)
|+ ..+|+|.+ ....-+...+..+++.|++.|+..+|.. ||+|||||.+|||++.=+=+.|+||..-+ +...
T Consensus 102 yv-khnLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH~~----gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YV-KHNLYDRL--STRPFLVLIEKKWIAFQLLKALSQCHKL----GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HH-hhhhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHHHc----CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 87 55788888 3444478889999999999999999999 99999999999999998888999996542 1222
Q ss_pred CCCcc-----ccccccccccCcccccc-----------CCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhH
Q 046121 178 DDPVQ-----TKILGTLGYLAPEYAEN-----------GIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWA 240 (315)
Q Consensus 178 ~~~~~-----~~~~~~~~~~aPE~~~~-----------~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 240 (315)
.++.. .+...-.+|.|||-+.. ...+++.||||+||++.|+++ |.++|..+ +..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---------QL~ 245 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---------QLL 245 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---------HHH
Confidence 22221 12233457999996532 114567899999999999997 78888532 100
Q ss_pred HHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccccchhhhc
Q 046121 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLGEKFVQR 311 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~~~~~~~~ 311 (315)
..........+.. ........++.|+..|++.||.+|.++++.|+.-.++ .|++....|+++
T Consensus 246 aYr~~~~~~~e~~-------Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~--~FP~yFy~FL~~ 307 (1431)
T KOG1240|consen 246 AYRSGNADDPEQL-------LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL--VFPEYFYSFLYD 307 (1431)
T ss_pred hHhccCccCHHHH-------HHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhcc--ccHHHHHHHHHH
Confidence 0000000000000 0001112478899999999999999999999886665 466666666554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-23 Score=191.74 Aligned_cols=256 Identities=20% Similarity=0.187 Sum_probs=181.6
Q ss_pred cccceecCCCceEEEEEEeC-CCcEEEEEEec-----ccCccc-HHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 26 SKENLLGEGGFGHVYKGELK-DGQMIAAKVRK-----EASTQG-FAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 26 ~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~-----~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
.....+|.|.+|.|+..... ..+.+..|.+. ...+.. ...+..|+-+-..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45668999999977666433 33333433322 111111 112556777778889999988888776665555569
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+++ +|...+.+. ..+....+-.++.|++.+++|+|+. |+.|+|+|++|+++..+|.++++|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~----GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM----GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc----CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 998888544 3588888888999999999999999 9999999999999999999999999999765544
Q ss_pred CCc----cccccccccccCccccccCCCcc-cccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 179 DPV----QTKILGTLGYLAPEYAENGIVSI-RTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 179 ~~~----~~~~~~~~~~~aPE~~~~~~~~~-~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
... ....+|...|+|||++.+..|.. ..||||.|++++.|.+|+.||-.......+.... ... ...-
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-------~~~-~~~~ 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-------NYS-DQRN 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------ccc-cccc
Confidence 332 33567888999999999888765 6899999999999999999996443332211000 000 0000
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
...-........+...+.+|.+||+.+|.+|.|+++|++.=|-
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~ 588 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWI 588 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence 0001111222345556788888999999999999999876553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-22 Score=164.29 Aligned_cols=233 Identities=21% Similarity=0.268 Sum_probs=146.8
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCC----------CCccceeeeE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARH----------KNIVMLLGFC 88 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~----------~~i~~~~~~~ 88 (315)
..+...+.||.|+++.||.+.+. +++.+++|++.... ....+.+.+|......+.+ -.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 34567789999999999999876 69999999866433 3345566666655544321 1222223322
Q ss_pred E---------ec---C-----eeEEEEEeccCCcccccccc-----CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCe
Q 046121 89 C---------KE---N-----LNILVYEYICNKSLHWHLFD-----NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPI 146 (315)
Q Consensus 89 ~---------~~---~-----~~~lv~~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i 146 (315)
. .. . ..+++|+-+ .++|.+.+.. .....+.......+..|++..+++||+. |+
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~----Gl 166 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY----GL 166 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----TE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc----ce
Confidence 1 11 1 225677765 5667665421 2223344555566668999999999999 99
Q ss_pred EeecCccCcEEEcCCCceeECCCCcccccCCCCCccccccccccccCcccccc--------CCCcccccchhhhHHHHHH
Q 046121 147 IHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN--------GIVSIRTDVYAFGIILLQL 218 (315)
Q Consensus 147 ~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~DvwslG~~l~~l 218 (315)
+|+||+|+|++++.+|.++|+||+.....+..... ...+..|.|||.... -.++.+.|.|+||+++|.|
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999999877533322211 234577899996543 2357788999999999999
Q ss_pred HhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 046121 219 MSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGR 284 (315)
Q Consensus 219 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~R 284 (315)
+++..||+.......... .+..+- +.++.+..||..+|+.||.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~-------------------~f~~C~--~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW-------------------DFSRCR--DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG-------------------GGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc-------------------cchhcC--CcCHHHHHHHHHHccCCcccC
Confidence 999999986543322111 222222 677789999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=155.33 Aligned_cols=137 Identities=17% Similarity=0.146 Sum_probs=107.4
Q ss_pred cceecCCCceEEEEEEeCCCcEEEEEEecccCccc--------------------------HHHHHHHHHHHhhcCCCCc
Q 046121 28 ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQG--------------------------FAEFQSEVYVLNFARHKNI 81 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~--------------------------~~~~~~e~~~l~~l~~~~i 81 (315)
...||+|++|.||+|...+|+.||+|++....... ......|+..+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 56899999999999988789999999986542211 0122459999999988877
Q ss_pred cceeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhh-hcccCCCCeEeecCccCcEEEcC
Q 046121 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFL-HEECRGGPIIHRDMRPSNILLTH 160 (315)
Q Consensus 82 ~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~l-h~~~~~~~i~h~di~p~nil~~~ 160 (315)
.....+. ... .++||||+.|+++..... ....++...+..++.|++.++.++ |+. |++|+||||.||+++
T Consensus 82 ~~p~~~~-~~~-~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~----giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL-LKS-HVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDC----RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE-ecC-CEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEE-
Confidence 5443332 222 389999998877654432 234688999999999999999999 788 999999999999998
Q ss_pred CCceeECCCCccc
Q 046121 161 DFVPMLGDFGLAR 173 (315)
Q Consensus 161 ~~~i~l~dfg~~~ 173 (315)
++.++|+|||++.
T Consensus 153 ~~~v~LiDFG~a~ 165 (190)
T cd05147 153 DGKLYIIDVSQSV 165 (190)
T ss_pred CCcEEEEEccccc
Confidence 4789999999986
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=182.96 Aligned_cols=199 Identities=21% Similarity=0.204 Sum_probs=160.0
Q ss_pred HHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.-+..|-|.+.||+|++|.||.|...+++.||+|+-+....-+.--..+-...|+..--+.|..+.....-.+..++|++
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 34567889999999999999999888899999999877665543322222333331124567777766666667799999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC-------CCceeECCCCcc
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH-------DFVPMLGDFGLA 172 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~-------~~~i~l~dfg~~ 172 (315)
|.+.|+|.++++ ..+.+++..+..+..|++..+.+||.. +||||||||+|+++.. +--++|+|||.+
T Consensus 775 y~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~----~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 775 YSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM----GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc----ceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 999999999995 777799999999999999999999999 9999999999999943 346899999998
Q ss_pred cccCCCC--CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCc
Q 046121 173 RWKTTDD--PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKV 224 (315)
Q Consensus 173 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 224 (315)
-.+.... .......++-.+-.+|...|.+|++.+|.|.|+.+++-|+.|...
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 6544332 233445667789999999999999999999999999999998754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-20 Score=148.80 Aligned_cols=140 Identities=22% Similarity=0.207 Sum_probs=109.9
Q ss_pred ccceecCCCceEEEEEEeCCCcEEEEEEecccCccc--------------------------HHHHHHHHHHHhhcCCCC
Q 046121 27 KENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQG--------------------------FAEFQSEVYVLNFARHKN 80 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~--------------------------~~~~~~e~~~l~~l~~~~ 80 (315)
+.+.||+|++|.||+|.+.+|+.||+|+........ ......|...+..+.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 357899999999999987789999999977542210 112357889999999988
Q ss_pred ccceeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEc
Q 046121 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLT 159 (315)
Q Consensus 81 i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~ 159 (315)
+.....+.... .++||||+.|+++..... ....++......++.+++.++.++|+ . |++|+||||.||+++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~----givHrDlkP~NIll~ 152 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEA----GLVHGDLSEYNILYH 152 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhC----CEecCCCChhhEEEE
Confidence 75544443332 489999998886543321 23457788999999999999999999 8 999999999999999
Q ss_pred CCCceeECCCCccccc
Q 046121 160 HDFVPMLGDFGLARWK 175 (315)
Q Consensus 160 ~~~~i~l~dfg~~~~~ 175 (315)
++.++|+|||++...
T Consensus 153 -~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 -DGKPYIIDVSQAVEL 167 (190)
T ss_pred -CCCEEEEEcccceec
Confidence 889999999998633
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=147.32 Aligned_cols=187 Identities=18% Similarity=0.105 Sum_probs=136.2
Q ss_pred CcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHH-----HHHHHHHHHhhcC-CCCccceeeeEEecCeeEEEE
Q 046121 25 FSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFA-----EFQSEVYVLNFAR-HKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~-----~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 98 (315)
.-+...|++|+||+|+.+.. .+.+++.+.+..... ... .+.+|+++++++. +++++.++++ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~-~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPW-WLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchh-hhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678899999999997765 677777766554332 122 4678999999996 4778888886 3459999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecC-ccCcEEEcCCCceeECCCCcccccCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDM-RPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di-~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
+|+.|.+|...... ....++.+++.++.++|+. |++|+|| +|.||+++.++.++|+|||++.....
T Consensus 78 eyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~----GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 78 SYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC----GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC----cCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 99999988643311 1134677899999999999 9999999 79999999999999999999975444
Q ss_pred CCCc----c---------ccccccccccCccccccC-CCc-ccccchhhhHHHHHHHhCCCccCCCCC
Q 046121 178 DDPV----Q---------TKILGTLGYLAPEYAENG-IVS-IRTDVYAFGIILLQLMSGRKVVDMNGE 230 (315)
Q Consensus 178 ~~~~----~---------~~~~~~~~~~aPE~~~~~-~~~-~~~DvwslG~~l~~l~~g~~p~~~~~~ 230 (315)
.... . ......+.+++|+...-- ..+ ...+.++.|+.+|.++|+..|.-.+++
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 3321 0 011235566667643311 122 456788889999999999988765543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.5e-21 Score=167.71 Aligned_cols=225 Identities=23% Similarity=0.274 Sum_probs=175.2
Q ss_pred eecCCCceEEEEEE----eCCCcEEEEEEecccCccc--HHHHHHHHHHHhhcC-CCCccceeeeEEecCeeEEEEEecc
Q 046121 30 LLGEGGFGHVYKGE----LKDGQMIAAKVRKEASTQG--FAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 30 ~lg~g~~~~v~~~~----~~~~~~~~~k~~~~~~~~~--~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
.+|+|++|.|++++ ...+..+++|+..+..... ......|-.++...+ +|.++.....+..+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999984 2247778888765432111 113345666777776 9999999999999999999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcc
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~ 182 (315)
|+.+...+. ....+.+.........++.++.++|+. +++++|+|++||+++.+|.+++.|||++.......
T Consensus 81 gg~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l----~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--- 151 (612)
T KOG0603|consen 81 GGDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKL----GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--- 151 (612)
T ss_pred cchhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchh----HHHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence 999977763 334467777777888899999999999 99999999999999999999999999996433322
Q ss_pred ccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCC
Q 046121 183 TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYD 262 (315)
Q Consensus 183 ~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (315)
..+|+..|+|||++. ....++|.||+|++.++|++|..||.. ..+.. + .+.+...+
T Consensus 152 -~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~~~-------------I--l~~~~~~p 207 (612)
T KOG0603|consen 152 -IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTMKR-------------I--LKAELEMP 207 (612)
T ss_pred -hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHHHH-------------H--hhhccCCc
Confidence 228899999999998 457889999999999999999999965 11111 1 12233455
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCH
Q 046121 263 TYELYLMAKTAYLCVQRNPEGRPSM 287 (315)
Q Consensus 263 ~~~~~~l~~l~~~~l~~~p~~Rps~ 287 (315)
...+..+.+++..++..+|.+|.-.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 6667778899999999999999755
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.5e-19 Score=155.49 Aligned_cols=217 Identities=24% Similarity=0.328 Sum_probs=162.2
Q ss_pred HhhcCCCCccceeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCe-EeecC
Q 046121 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPI-IHRDM 151 (315)
Q Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i-~h~di 151 (315)
++.+.|.|+.++++.+.++...+.|.+|+..|+|.|.+.. ....++......+.+.++.++.|+|.. .+ .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s----~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS----PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC----cceeeeee
Confidence 4568899999999999999999999999999999999865 445588889999999999999999988 55 89999
Q ss_pred ccCcEEEcCCCceeECCCCcccccCCC--CCccccccccccccCccccccCC-------CcccccchhhhHHHHHHHhCC
Q 046121 152 RPSNILLTHDFVPMLGDFGLARWKTTD--DPVQTKILGTLGYLAPEYAENGI-------VSIRTDVYAFGIILLQLMSGR 222 (315)
Q Consensus 152 ~p~nil~~~~~~i~l~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~DvwslG~~l~~l~~g~ 222 (315)
+..|.+++....+|++|||+....... ........-..-|.|||.+.+.. .+.++|+||+|++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998644320 01111112234699999887532 356799999999999999999
Q ss_pred CccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 223 KVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 223 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
.||+........ ...... ... .....+.|.+.... .....+..++..||..+|.+||+++.+-..++.+...
T Consensus 156 ~~~~~~~~~~~~--~eii~~-~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDP--DEIILR-VKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCCh--HHHHHH-HHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 999865443332 111111 111 12223344333222 2233577788889999999999999998888877553
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-18 Score=139.33 Aligned_cols=137 Identities=20% Similarity=0.224 Sum_probs=104.7
Q ss_pred CcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhc-----CCCCccceeeeEEecC---e-eE
Q 046121 25 FSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-----RHKNIVMLLGFCCKEN---L-NI 95 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~-~~ 95 (315)
+.-.+.||+|+++.||. .-.+... ++|+.........+.+.+|+.+++.+ .||||+++++++.++. . +.
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34467899999999996 3234444 68877665444567789999999999 5799999999998864 3 33
Q ss_pred EEEEe--ccCCccccccccCCCCccCHHHHHHHHHHHHHHH-HhhhcccCCCCeEeecCccCcEEEcC----CCceeECC
Q 046121 96 LVYEY--ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGL-RFLHEECRGGPIIHRDMRPSNILLTH----DFVPMLGD 168 (315)
Q Consensus 96 lv~~~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l-~~lh~~~~~~~i~h~di~p~nil~~~----~~~i~l~d 168 (315)
+|+|| ..+++|.+++.+. .+++. ..++.+++.++ .|||+. +|+|+||||+||+++. ++.++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~----~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN----RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 4468999999542 25554 34567777777 999999 9999999999999974 34899999
Q ss_pred CCcc
Q 046121 169 FGLA 172 (315)
Q Consensus 169 fg~~ 172 (315)
++.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-18 Score=141.40 Aligned_cols=143 Identities=18% Similarity=0.107 Sum_probs=109.4
Q ss_pred hcCCcccceecCCCceEEEEEE--eCCCcEEEEEEecccCcc------------------------cHHHHHHHHHHHhh
Q 046121 22 TGDFSKENLLGEGGFGHVYKGE--LKDGQMIAAKVRKEASTQ------------------------GFAEFQSEVYVLNF 75 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~--~~~~~~~~~k~~~~~~~~------------------------~~~~~~~e~~~l~~ 75 (315)
..-|.+.+.||+|++|.||+|. ..+++.|++|++...... ....+..|+..++.
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3459999999999999999998 457999999987643211 01235679999999
Q ss_pred cCCCCccceeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCC-eEeecCccC
Q 046121 76 ARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGP-IIHRDMRPS 154 (315)
Q Consensus 76 l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~-i~h~di~p~ 154 (315)
+.+.+ +.+...+... ..++||||+.|.++...... ...........++.|++.++.+||+. | ++|+||+|+
T Consensus 107 L~~~~-i~~p~~~~~~-~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----g~iiH~Dikp~ 178 (237)
T smart00090 107 LYEAG-VPVPKPIAWR-RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKE----GELVHGDLSEY 178 (237)
T ss_pred HHhcC-CCCCeeeEec-CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhc----CCEEeCCCChh
Confidence 97533 2222222222 34899999999888665422 23455666788999999999999999 9 999999999
Q ss_pred cEEEcCCCceeECCCCccc
Q 046121 155 NILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 155 nil~~~~~~i~l~dfg~~~ 173 (315)
||+++ ++.++++|||.+.
T Consensus 179 NIli~-~~~i~LiDFg~a~ 196 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSV 196 (237)
T ss_pred hEEEE-CCCEEEEEChhhh
Confidence 99999 8899999999885
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.4e-18 Score=136.74 Aligned_cols=134 Identities=24% Similarity=0.278 Sum_probs=110.0
Q ss_pred cceecCCCceEEEEEEeCCCcEEEEEEecccCcc--------cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 28 ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQ--------GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
++.||+|++|.||+|.+ .+..+++|+....... ......+|+..+..+.++++.....++......+++|+
T Consensus 1 ~~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred CcccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 36799999999999987 5667788875532211 12346789999999999998877777777778899999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
|++|++|.+.+.... . ....++.+++.++.++|+. +++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~----~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA----GIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC----CcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 999999988874321 1 7788999999999999999 999999999999999 7889999999875
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.7e-18 Score=141.53 Aligned_cols=192 Identities=19% Similarity=0.227 Sum_probs=130.4
Q ss_pred CCCCccceeeeEEe---------------------------cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHH
Q 046121 77 RHKNIVMLLGFCCK---------------------------ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIG 129 (315)
Q Consensus 77 ~~~~i~~~~~~~~~---------------------------~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 129 (315)
.||||+.+.+.|.+ ..++|+||.-+ ..+|..++-.+ ..+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence 49999999876632 35678999876 56888877433 3555566778889
Q ss_pred HHHHHHhhhcccCCCCeEeecCccCcEEE--cCC--CceeECCCCcccccCCCC----Cc--cccccccccccCcccccc
Q 046121 130 TAKGLRFLHEECRGGPIIHRDMRPSNILL--THD--FVPMLGDFGLARWKTTDD----PV--QTKILGTLGYLAPEYAEN 199 (315)
Q Consensus 130 l~~~l~~lh~~~~~~~i~h~di~p~nil~--~~~--~~i~l~dfg~~~~~~~~~----~~--~~~~~~~~~~~aPE~~~~ 199 (315)
+++++.|||.+ ||.|+|+|.+||++ |.+ ..+.+.|||.+--....+ .. .-...|+...+|||+...
T Consensus 350 lLEav~hL~~h----gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 350 LLEAVTHLHKH----GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHc----cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999 99999999999999 333 357789999874211110 11 112346677999998763
Q ss_pred CC------CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHH
Q 046121 200 GI------VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTA 273 (315)
Q Consensus 200 ~~------~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 273 (315)
-+ .-.++|.|+.|.+.||+++...||-..++-.. ..++ ..+.. .|. .+..++..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~r~-----Yqe~q-----LPa----lp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DTRT-----YQESQ-----LPA----LPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-chhh-----hhhhh-----CCC----CcccCChHHHHHH
Confidence 22 13479999999999999999888854332111 1111 11101 122 2223444577888
Q ss_pred HhhcCCCCCCCCCHHHHH
Q 046121 274 YLCVQRNPEGRPSMGEVV 291 (315)
Q Consensus 274 ~~~l~~~p~~Rps~~~il 291 (315)
...|+.||.+|++.+=..
T Consensus 491 ~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred HHHhcCCccccCCccHHH
Confidence 889999999999865443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-18 Score=160.89 Aligned_cols=214 Identities=25% Similarity=0.291 Sum_probs=142.8
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
.-.....+|..++.|.-|++|.||+++++ +.+.+++|+ .+.+ .+.+- ++.....|.++
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee-------------
Confidence 34456789999999999999999999887 577788854 2211 11110 22222233322
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
|+-...+... .+++... +.+++|+|+. |++|+|+||+|.+++.-|+++++|||+++..
T Consensus 136 --------gDc~tllk~~--g~lPvdm--------vla~Eylh~y----givhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 --------GDCATLLKNI--GPLPVDM--------VLAVEYLHSY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred --------chhhhhcccC--CCCcchh--------hHHhHhhccC----CeecCCCCCCcceeeecccccccchhhhhhh
Confidence 2222222211 2233322 6789999999 9999999999999999999999999998642
Q ss_pred CCCCC--------------cc-ccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH
Q 046121 176 TTDDP--------------VQ-TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240 (315)
Q Consensus 176 ~~~~~--------------~~-~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 240 (315)
.-... .. ...+|+|.|.|||++..+.|+..+|.|++|+++|+++.|..||..++++.. +.+++
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel--fg~vi 271 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVI 271 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH--Hhhhh
Confidence 21100 00 123799999999999999999999999999999999999999987765432 22211
Q ss_pred HHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 046121 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSM 287 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~ 287 (315)
. ....+.+. +. .....+.+++.++|+.+|..|.-.
T Consensus 272 s---d~i~wpE~-de--------a~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 272 S---DDIEWPEE-DE--------ALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred h---hhcccccc-Cc--------CCCHHHHHHHHHHHHhChHhhccc
Confidence 1 11111111 11 122336788888999999999633
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.3e-17 Score=132.08 Aligned_cols=138 Identities=21% Similarity=0.113 Sum_probs=107.3
Q ss_pred HHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcc----------------------cHHHHHHHHHHHhhcC
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQ----------------------GFAEFQSEVYVLNFAR 77 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----------------------~~~~~~~e~~~l~~l~ 77 (315)
.....|.+.+.||+|++|.||++...+++.+++|++...... .......|+..+..+.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 333459999999999999999998888999999986543210 0112567888888887
Q ss_pred CCC--ccceeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCc
Q 046121 78 HKN--IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSN 155 (315)
Q Consensus 78 ~~~--i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~n 155 (315)
+++ ++..++ ....+++|||+.|++|..... ......++.+++.++.++|+. +++|+||+|.|
T Consensus 92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~----gi~H~Dl~p~N 155 (198)
T cd05144 92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKH----GIIHGDLSEFN 155 (198)
T ss_pred HcCCCCCceee----cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHC----CCCcCCCCccc
Confidence 764 333333 234589999999999866532 034456888999999999999 99999999999
Q ss_pred EEEcCCCceeECCCCccc
Q 046121 156 ILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 156 il~~~~~~i~l~dfg~~~ 173 (315)
|+++.++.++++|||.+.
T Consensus 156 ill~~~~~~~liDfg~~~ 173 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMV 173 (198)
T ss_pred EEEcCCCcEEEEECCccc
Confidence 999999999999999985
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.7e-17 Score=131.93 Aligned_cols=129 Identities=25% Similarity=0.308 Sum_probs=103.3
Q ss_pred eecCCCceEEEEEEeCCCcEEEEEEecccCc--------ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 30 LLGEGGFGHVYKGELKDGQMIAAKVRKEAST--------QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 30 ~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.||+|++|+||+|.+. +..+++|....... .....+.+|+++++.+.++++.....++......+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999854 56788887543221 11245678999999999887666555556666779999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+|++|.+.+..... .++.+++.++.++|+. +++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~----gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKA----GIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC----CeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 99999877632211 6788999999999999 999999999999999 8899999999885
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.5e-17 Score=149.76 Aligned_cols=137 Identities=22% Similarity=0.248 Sum_probs=109.3
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEeccc-C------cccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEA-S------TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~-~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
...|...+.||+|+||+||+|.+.+...++.+..... . ....+.+.+|+++++.++|+++.....+.......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3445668899999999999998765544333322211 1 11234578899999999999998877777777778
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
++||||+.|++|.+.+. ....++.+++.++.+||+. +++|+|+||+||++ .++.++++|||++.
T Consensus 412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~----giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA----GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC----CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 99999999999988773 3466889999999999999 99999999999999 67899999999986
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=8e-18 Score=146.29 Aligned_cols=171 Identities=25% Similarity=0.341 Sum_probs=127.3
Q ss_pred CeeEEEEEeccCCccccccc-cCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCC
Q 046121 92 NLNILVYEYICNKSLHWHLF-DNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
..+|+.|+++.-.+|.+++. +......+......++.|++.++.| + +.+|+|+||.||+...+..++|.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k----~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K----GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c----cchhhhccccccccccchhhhhhhhh
Confidence 45789999999999999996 3445568888999999999999999 6 89999999999999999999999999
Q ss_pred cccccCCCCC------ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHH
Q 046121 171 LARWKTTDDP------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 171 ~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
+......... ......|+..|++||.+.+..|+.++|||+||++++|++. -.-.+. ..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---------------r~ 466 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---------------RI 466 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---------------HH
Confidence 9864433331 1234678999999999999999999999999999999987 222211 00
Q ss_pred Hhhhc-cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 046121 244 IEKLA-LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGE 289 (315)
Q Consensus 244 ~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~ 289 (315)
..... ....+.+.+..+++. -..|+.+++.+.|.+||++.+
T Consensus 467 ~t~~d~r~g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 467 ATLTDIRDGIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred HhhhhhhcCCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence 00001 111222233333333 346777799999999995444
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.8e-15 Score=135.46 Aligned_cols=260 Identities=17% Similarity=0.176 Sum_probs=173.2
Q ss_pred CcccceecCCCceEEEE-E-EeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 25 FSKENLLGEGGFGHVYK-G-ELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~-~-~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
|.+ ....-++.+ +|. | +-.++.++.+.+.+..+........+-++.++.++||||+.+++.++.++.+|+|+|-+
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV- 91 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV- 91 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc-
Confidence 444 333444444 443 3 33468888888877666655666788899999999999999999999999999999965
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcc
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~ 182 (315)
.+|..++.+.+ .......++||+.||.+||..+ +++|++++...|+++..|..+|++|.++......+...
T Consensus 92 -~Pl~~~lk~l~-----~~~v~~Gl~qIl~AL~FL~~d~---~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~ 162 (690)
T KOG1243|consen 92 -RPLETVLKELG-----KEEVCLGLFQILAALSFLNDDC---NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA 162 (690)
T ss_pred -ccHHHHHHHhH-----HHHHHHHHHHHHHHHHHHhccC---CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc
Confidence 56665664333 6667778899999999999775 89999999999999999999999998885333322211
Q ss_pred ccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCC
Q 046121 183 TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYD 262 (315)
Q Consensus 183 ~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (315)
.....-..|..|+.+.... -..|.|.||+++++++.|..+-..........-.................++.
T Consensus 163 ~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~~~~~r~n------ 234 (690)
T KOG1243|consen 163 KSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGATELKRPN------ 234 (690)
T ss_pred ccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhccccccccc------
Confidence 1112223466666543221 45699999999999999943322111111111111111111222222222211
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccccchhhh
Q 046121 263 TYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLGEKFVQ 310 (315)
Q Consensus 263 ~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~~~~~~~ 310 (315)
..+++..|....+--|-.+-+++.+|+++.-+-.++..+|++
T Consensus 235 ------~~~~~~~~~~~~gff~n~fvd~~~fLeel~lks~~eK~~Ff~ 276 (690)
T KOG1243|consen 235 ------KLRFILECRLLGGFFRNDFVDTLLFLEELRLKSVEEKQKFFS 276 (690)
T ss_pred ------hhhHHHHHHhccccccchHHHHHHHHHhcccCcHHHHHHHHH
Confidence 345555577778888888888889998888777777776665
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.5e-17 Score=153.30 Aligned_cols=261 Identities=20% Similarity=0.202 Sum_probs=190.5
Q ss_pred hcCCcccceecCCCceEEEEEEeC--CCcEEEEEEecccC--cccHHHHHHHHHHHhhcC-CCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK--DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 96 (315)
...|.+.+.||+|+++.|-+.... ....++.|.+.... ......+..|..+-+.+. |+|++..++........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 568999999999999999888654 34455555544432 333444556777777777 9999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhh-cccCCCCeEeecCccCcEEEcCCC-ceeECCCCcccc
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH-EECRGGPIIHRDMRPSNILLTHDF-VPMLGDFGLARW 174 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~~~~~i~h~di~p~nil~~~~~-~i~l~dfg~~~~ 174 (315)
..++..|+++.+.+........+...+-..+.|+..++.|+| .. ++.|+|++|+|.+++..+ .+++.|||++..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~----~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN----GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc----ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988884333224666677778999999999999 77 999999999999999999 999999999986
Q ss_pred cCC-CCCc--cccccc-cccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcc
Q 046121 175 KTT-DDPV--QTKILG-TLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249 (315)
Q Consensus 175 ~~~-~~~~--~~~~~~-~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (315)
+.. .+.. ....+| ++.|.|||...+. ......|+||.|+++..+++|..|++......... ..+... .
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~---~--- 247 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSN---K--- 247 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeeccc---c---
Confidence 665 2222 223567 8999999998874 45678999999999999999999997543322110 000000 0
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
................+++.+++..+|..|.+.+++-..-+...
T Consensus 248 -----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 248 -----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -----cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 00001111122223567777799899999999999866555444
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=122.16 Aligned_cols=135 Identities=20% Similarity=0.176 Sum_probs=95.6
Q ss_pred ccceecCCCceEEEEEEeCCCcEEEEEEecccCcccH--HH----------------------HHHHHHHHhhcCCCC--
Q 046121 27 KENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGF--AE----------------------FQSEVYVLNFARHKN-- 80 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~--~~----------------------~~~e~~~l~~l~~~~-- 80 (315)
+.+.||+|++|+||+|.+.+++.|++|++........ .. ...|...+..+.+.+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 3578999999999999888899999998765322111 11 134555555554432
Q ss_pred ccceeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEc
Q 046121 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLT 159 (315)
Q Consensus 81 i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~ 159 (315)
+.+.++. ...++||||+.++++......... . ......++.+++.++.++|. . +++|+||+|+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~----~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREA----GLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhcc----CcCcCCCChhhEEEE
Confidence 3333332 235899999998554321111100 1 15677889999999999999 8 999999999999999
Q ss_pred CCCceeECCCCccc
Q 046121 160 HDFVPMLGDFGLAR 173 (315)
Q Consensus 160 ~~~~i~l~dfg~~~ 173 (315)
++.++++|||.+.
T Consensus 150 -~~~~~liDfg~a~ 162 (187)
T cd05119 150 -DGKVYIIDVPQAV 162 (187)
T ss_pred -CCcEEEEECcccc
Confidence 8999999999985
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.3e-15 Score=114.81 Aligned_cols=134 Identities=22% Similarity=0.178 Sum_probs=110.1
Q ss_pred ccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCC--CCccceeeeEEecCeeEEEEEeccCC
Q 046121 27 KENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARH--KNIVMLLGFCCKENLNILVYEYICNK 104 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (315)
+++.|+.|.++.||++...+ ..+++|....... ...+.+|+..++.+++ .++++++......+..+++++|+.|.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46789999999999998765 6788888765433 4567889999999976 58888888887778889999999888
Q ss_pred ccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 105 SLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
++... +......++.+++.++..+|... ..+++|+|++|.||+++..+.++++||+.+.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~-~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLP-LLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCC-ceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 77543 45566778889999999999851 1269999999999999999999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.8e-14 Score=119.04 Aligned_cols=133 Identities=17% Similarity=0.116 Sum_probs=98.2
Q ss_pred ceec-CCCceEEEEEEeCCCcEEEEEEeccc-------------CcccHHHHHHHHHHHhhcCCCCc--cceeeeEEec-
Q 046121 29 NLLG-EGGFGHVYKGELKDGQMIAAKVRKEA-------------STQGFAEFQSEVYVLNFARHKNI--VMLLGFCCKE- 91 (315)
Q Consensus 29 ~~lg-~g~~~~v~~~~~~~~~~~~~k~~~~~-------------~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~- 91 (315)
..|| .|+.|+||.+... +..+++|.+... .......+.+|+.++..+.++++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4576 7888888888765 556777765321 01223457889999999998875 5566654332
Q ss_pred C---eeEEEEEeccC-CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeEC
Q 046121 92 N---LNILVYEYICN-KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLG 167 (315)
Q Consensus 92 ~---~~~lv~~~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~ 167 (315)
. ..++|++++.| .+|.+.+.. ..+++. .+.+++.++.+||+. |++|+||||.||+++.++.++++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~----GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDA----GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHC----CCCCCCCCchhEEEcCCCCEEEE
Confidence 2 22599999987 688777643 234443 356889999999999 99999999999999999999999
Q ss_pred CCCccc
Q 046121 168 DFGLAR 173 (315)
Q Consensus 168 dfg~~~ 173 (315)
|||.+.
T Consensus 185 Dfg~~~ 190 (239)
T PRK01723 185 DFDRGE 190 (239)
T ss_pred ECCCcc
Confidence 999886
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.5e-13 Score=121.98 Aligned_cols=248 Identities=19% Similarity=0.191 Sum_probs=176.9
Q ss_pred HhcCCcccceecC--CCceEEEEEEe--C-CCcEEEEEEecc--cCcccHHHHHHHHHHHhhcC-CCCccceeeeEEecC
Q 046121 21 ATGDFSKENLLGE--GGFGHVYKGEL--K-DGQMIAAKVRKE--ASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKEN 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~--g~~~~v~~~~~--~-~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 92 (315)
....+.+.+.+|. |.+|.+|.+.. . +...+++|.-+. ..+..-..-.+|+...+.+. |++.+.....+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 4457788889999 99999999976 3 577888876332 22232233345666666664 889999888899999
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHH----HHHhhhcccCCCCeEeecCccCcEEEcCC-CceeEC
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK----GLRFLHEECRGGPIIHRDMRPSNILLTHD-FVPMLG 167 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~----~l~~lh~~~~~~~i~h~di~p~nil~~~~-~~i~l~ 167 (315)
..++-.|.+ +.++..+.+.. ...++....+....+... |+.++|+. +++|.|++|.|++...+ ...+++
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~----~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSN----NIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred cceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCC----cccccccchhheecccccceeecC
Confidence 999988886 67776665432 233788888888888888 99999999 99999999999999999 899999
Q ss_pred CCCcccccCCCCCcccc-----ccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH
Q 046121 168 DFGLARWKTTDDPVQTK-----ILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP 242 (315)
Q Consensus 168 dfg~~~~~~~~~~~~~~-----~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 242 (315)
|||+........-.... ..|...|++||...+ .++..+|++++|.++.+..++................+
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~---- 340 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ---- 340 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc----
Confidence 99998765554422222 267888999998864 57889999999999999888776553221111111111
Q ss_pred HHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 046121 243 LIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVV 291 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il 291 (315)
-.++.++-..-...+...+.+|++.+|..|++.+.+.
T Consensus 341 ------------~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 341 ------------GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ------------ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 1111222222233345577789999999999887764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.8e-13 Score=118.92 Aligned_cols=139 Identities=22% Similarity=0.228 Sum_probs=93.9
Q ss_pred ceecCCCceEEEEEEeCCCcEEEEEEecccCcccHH----------------------------------------HHHH
Q 046121 29 NLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFA----------------------------------------EFQS 68 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~----------------------------------------~~~~ 68 (315)
+.||.|++|.||+|...+|+.||+|+..+....... .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 679999999999999999999999997643211110 1223
Q ss_pred HHHHHhhc----CCCCccceeeeE-EecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHH-HHHhhhcccC
Q 046121 69 EVYVLNFA----RHKNIVMLLGFC-CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK-GLRFLHEECR 142 (315)
Q Consensus 69 e~~~l~~l----~~~~i~~~~~~~-~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~-~l~~lh~~~~ 142 (315)
|...+..+ ++.+-+.+-.++ ......++||||++|.+|.+....... ... ...++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhC--
Confidence 44444333 233333333333 223446899999999999886532211 122 2234444544 46778888
Q ss_pred CCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 143 ~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
|++|+|++|.||+++.++.++++|||++...
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999999999998643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.7e-13 Score=113.04 Aligned_cols=200 Identities=18% Similarity=0.234 Sum_probs=137.9
Q ss_pred hhcCCCCccceeeeEEec-----CeeEEEEEeccCCccccccccCC--CCccCHHHHHHHHHHHHHHHHhhhcccCCCCe
Q 046121 74 NFARHKNIVMLLGFCCKE-----NLNILVYEYICNKSLHWHLFDNT--ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPI 146 (315)
Q Consensus 74 ~~l~~~~i~~~~~~~~~~-----~~~~lv~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i 146 (315)
-.+.|.|+++++.++.+. ....++.+|+..+++..++.+.. ...+....-.+|+.||+.||.|||+-.+ .+
T Consensus 122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P--pi 199 (458)
T KOG1266|consen 122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP--PI 199 (458)
T ss_pred HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC--cc
Confidence 344589999999988654 44689999999999999997643 4568888888999999999999999966 89
Q ss_pred EeecCccCcEEEcCCCceeECCCCcccccCCCCC-----ccccccccccccCccccccCCCcccccchhhhHHHHHHHhC
Q 046121 147 IHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP-----VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221 (315)
Q Consensus 147 ~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 221 (315)
+|+++.-+.+++..+|-|++..-.... ...... ......+.++|.+||.=.....+-++|||++|+...+|-.+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999998875322211 111000 01112456789999976666667789999999999999887
Q ss_pred CCccCCCCC--ccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 222 RKVVDMNGE--EPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 222 ~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
..-...... .......+ ..... ...+. +.++..|++..|+.||++++++.+.-.+
T Consensus 279 Eiq~tnseS~~~~ee~ia~---------~i~~l-en~lq-----------r~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIAN---------VIIGL-ENGLQ-----------RGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred eeccCCCcceeehhhhhhh---------heeec-cCccc-----------cCcCcccccCCCCCCcchhhhhcCceee
Confidence 754322111 11111110 00000 01111 1344459999999999999998776544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.7e-12 Score=101.91 Aligned_cols=131 Identities=21% Similarity=0.153 Sum_probs=94.3
Q ss_pred cceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCcc-ceeeeEEecCeeEEEEEeccCCcc
Q 046121 28 ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV-MLLGFCCKENLNILVYEYICNKSL 106 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~~~~~~~~L 106 (315)
++.|+.|.++.||++... +..+++|+...... ......+|+.+++.+...+++ +++... ....++|||+++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999999865 66789998654432 123457889999988765544 444432 3345899999999888
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccC-CCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 107 HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR-GGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
...- .. ....+.+++.++..||+... ..+++|+|++|.||+++ ++.++++||+.+.
T Consensus 79 ~~~~-------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED-------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc-------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6430 11 12346788999999999811 11259999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.7e-12 Score=117.89 Aligned_cols=144 Identities=17% Similarity=0.141 Sum_probs=93.2
Q ss_pred HHhcCCcccceecCCCceEEEEEEeCC-CcEEEEEEecccCccc----------------------------------HH
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQG----------------------------------FA 64 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~----------------------------------~~ 64 (315)
.....|.. +.||.|++|.||+|...+ |+.||+|+..+..... .+
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34556777 789999999999999876 9999999986432110 11
Q ss_pred H------HHHHHHHHhhc----CCCCccceeeeEEe-cCeeEEEEEeccCCcccccc--ccCCC--CccCHHHHHHHHHH
Q 046121 65 E------FQSEVYVLNFA----RHKNIVMLLGFCCK-ENLNILVYEYICNKSLHWHL--FDNTE--SVLEWHQRYAAAIG 129 (315)
Q Consensus 65 ~------~~~e~~~l~~l----~~~~i~~~~~~~~~-~~~~~lv~~~~~~~~L~~~l--~~~~~--~~~~~~~~~~~~~~ 129 (315)
. +.+|.....++ .+.+.+.+-.++.+ ....++||||+.|+++.+.- ..... ..+....+..++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 1 22333333333 23333444444432 44568999999999997642 11110 12333333333333
Q ss_pred HHHHHHhhhcccCCCCeEeecCccCcEEEcCCC----ceeECCCCccccc
Q 046121 130 TAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF----VPMLGDFGLARWK 175 (315)
Q Consensus 130 l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~----~i~l~dfg~~~~~ 175 (315)
+ ... |++|+|++|.||+++.++ .++++|||+....
T Consensus 276 i-------f~~----GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 V-------FRD----GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred H-------HhC----CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 3 346 999999999999999888 9999999998644
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=7.7e-11 Score=93.32 Aligned_cols=134 Identities=16% Similarity=0.101 Sum_probs=94.9
Q ss_pred cceecCCCceEEEEEEeCC-------CcEEEEEEecccC----------------------cccHHH----HHHHHHHHh
Q 046121 28 ENLLGEGGFGHVYKGELKD-------GQMIAAKVRKEAS----------------------TQGFAE----FQSEVYVLN 74 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~-------~~~~~~k~~~~~~----------------------~~~~~~----~~~e~~~l~ 74 (315)
...||.|--+.||.|...+ +..+|+|+..... ...... ..+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999997542 4789999744210 111122 237999998
Q ss_pred hcCCC--CccceeeeEEecCeeEEEEEeccCCcccc-ccccCCCCccCHHHHHHHHHHHHHHHHhh-hcccCCCCeEeec
Q 046121 75 FARHK--NIVMLLGFCCKENLNILVYEYICNKSLHW-HLFDNTESVLEWHQRYAAAIGTAKGLRFL-HEECRGGPIIHRD 150 (315)
Q Consensus 75 ~l~~~--~i~~~~~~~~~~~~~~lv~~~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~l~~~l~~l-h~~~~~~~i~h~d 150 (315)
++..- +++.++++ ..-++||||+.++.+.. .+ ....++......+..+++.++..+ |.. |++|+|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~----glVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKEC----NLVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhC----CeecCC
Confidence 88643 45555554 34589999997654321 12 112344556667788999999988 788 999999
Q ss_pred CccCcEEEcCCCceeECCCCccc
Q 046121 151 MRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 151 i~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+++.||+++ ++.+.++|||.+.
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav 172 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSV 172 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCce
Confidence 999999997 4679999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.3e-11 Score=91.28 Aligned_cols=130 Identities=22% Similarity=0.266 Sum_probs=99.2
Q ss_pred ceecCCCceEEEEEEeCCCcEEEEEEecccC---cc-----cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 29 NLLGEGGFGHVYKGELKDGQMIAAKVRKEAS---TQ-----GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~---~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
..+++|+-+.++.+.+.+. .+++|...+.. ++ ...+..+|.+++..+..-++....-+..+.....++|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999977543 36777544321 11 122356799999988877777666666667777899999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
++|..|.+.+... ...++..+-..+.-||.. |++|+|+.++|+++...+ +.++|||++.
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~----givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA----GIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc----CeecCCCccceEEEeCCc-EEEEECCccc
Confidence 9999999888544 134566677778899999 999999999999998876 8899999985
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.7e-10 Score=94.61 Aligned_cols=142 Identities=21% Similarity=0.201 Sum_probs=106.3
Q ss_pred ceecCCCceEEEEEEeCCCcEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCC--ccceeeeEEec---CeeEEEEEecc
Q 046121 29 NLLGEGGFGHVYKGELKDGQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKN--IVMLLGFCCKE---NLNILVYEYIC 102 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~---~~~~lv~~~~~ 102 (315)
+.|+.|..+.+|++...+++.+++|+...... .....+.+|+.+++.+.+.+ +++++.+.... +..++||+++.
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999876667889998654322 13456789999999997643 56677766543 25689999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccC----------------------------------------
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR---------------------------------------- 142 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---------------------------------------- 142 (315)
|.++.+.+.. ..++......++.+++.++..||+...
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988775521 346666777777788888888875311
Q ss_pred ------------CCCeEeecCccCcEEEcC--CCceeECCCCccc
Q 046121 143 ------------GGPIIHRDMRPSNILLTH--DFVPMLGDFGLAR 173 (315)
Q Consensus 143 ------------~~~i~h~di~p~nil~~~--~~~i~l~dfg~~~ 173 (315)
...++|+|+.|.||+++. ++.+.++||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 235799999999999998 6678899998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.4e-10 Score=88.75 Aligned_cols=142 Identities=24% Similarity=0.236 Sum_probs=106.3
Q ss_pred ccceecCCCceEEEEEEeCCCcEEEEEEecccC--------cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 27 KENLLGEGGFGHVYKGELKDGQMIAAKVRKEAS--------TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
.+..+-+|+-+.|+.+.+. |+..++|...... .-...+..+|++.+.++.--+|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 6788999999999999887 5555555432211 111234567888888887667766666666666668999
Q ss_pred EeccC-CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC---ceeECCCCccc
Q 046121 99 EYICN-KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF---VPMLGDFGLAR 173 (315)
Q Consensus 99 ~~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~---~i~l~dfg~~~ 173 (315)
||++| .++.+++...........-...++..+-+.+.-||.. +++||||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n----diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN----DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC----CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 4667777666665555555578888999999999999 999999999999996554 34899999986
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.7e-09 Score=92.78 Aligned_cols=269 Identities=14% Similarity=0.126 Sum_probs=159.1
Q ss_pred ccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeee-------EEecCeeEEEE
Q 046121 27 KENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGF-------CCKENLNILVY 98 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~-------~~~~~~~~lv~ 98 (315)
..+.||+|+.+.+|..-.- +. .+.|+........... .+..|..- .||-+..-+.+ -.......++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4567999999998865221 11 2556666544432222 22223322 34433221111 12234478889
Q ss_pred EeccCCc-ccccccc----CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 99 EYICNKS-LHWHLFD----NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 99 ~~~~~~~-L~~~l~~----~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+.+.|.. +.+++.. ++.-...+...++.++.++.+...||.. |.+-||++++|++++.++.+.|+|=..-.
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~----Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH----GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc----CCcccccCccceeeecCceEEEEccccee
Confidence 9887642 2223221 2233478889999999999999999999 89999999999999999999999865443
Q ss_pred ccCCCCCccccccccccccCccccc-----cCCCcccccchhhhHHHHHHHhC-CCccCCC---CCccchhHHHhH-HHH
Q 046121 174 WKTTDDPVQTKILGTLGYLAPEYAE-----NGIVSIRTDVYAFGIILLQLMSG-RKVVDMN---GEEPQQSLRQWA-EPL 243 (315)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwslG~~l~~l~~g-~~p~~~~---~~~~~~~~~~~~-~~~ 243 (315)
.+..+.......|.+.|.+||.-. +-.-+...|.|.||+++++++.| ..||.+- ++.+........ ..+
T Consensus 166 -i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 166 -INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred -eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 223334444557888999999543 33346678999999999999986 8998631 111111100000 000
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcC--CCCCCCCCHHHHHHHHhcccccccccc
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQ--RNPEGRPSMGEVVRLLEGENDRFHHLG 305 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~--~~p~~Rps~~~il~~L~~~~~~~~~~~ 305 (315)
...........+......-......+.-|.-+|+. .+++-|||++.++..|....+.+..+-
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCT 308 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence 00000000111110111111122223333444665 347799999999999999988887663
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.8e-09 Score=92.21 Aligned_cols=167 Identities=20% Similarity=0.197 Sum_probs=124.1
Q ss_pred ceEEEEEEe-CCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEe----cCeeEEEEEeccC-Cccccc
Q 046121 36 FGHVYKGEL-KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK----ENLNILVYEYICN-KSLHWH 109 (315)
Q Consensus 36 ~~~v~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~~~~~~-~~L~~~ 109 (315)
..+.|++.. .+|..+++|.+.............-++.++++.|+|++++.+++.. +..+++|++|+++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357788864 4788899988754433333334556888999999999999998863 4577999999864 566665
Q ss_pred cccC-------------CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 110 LFDN-------------TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 110 l~~~-------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
...+ .+...++..+|.++.|+..||.++|+. |...+-+.|.+|+++++.+|++..+|.-....
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss----GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS----GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc----CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 4332 133578899999999999999999999 99999999999999999999998887764322
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCC
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRK 223 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 223 (315)
... .+| +. -..+-|.=.||.++..|.+|..
T Consensus 445 ~d~------------~~~--le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDP------------TEP--LE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC------------Ccc--hh---HHhhhhHHHHHHHHHHHhhccc
Confidence 221 011 11 1234578889999999999854
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.9e-09 Score=87.77 Aligned_cols=135 Identities=20% Similarity=0.135 Sum_probs=101.1
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEeccc------------------Ccc----cHHHHHHHHHHHhhcCCC-
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEA------------------STQ----GFAEFQSEVYVLNFARHK- 79 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~------------------~~~----~~~~~~~e~~~l~~l~~~- 79 (315)
.-+.+...||.|--|.||.|.+..+.++++|.-..- ..+ .....++|..+|.++...
T Consensus 91 ~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 91 IVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred hHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 345677899999999999999999999999963210 111 122357899999998765
Q ss_pred -CccceeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE
Q 046121 80 -NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL 158 (315)
Q Consensus 80 -~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~ 158 (315)
.++..+++ +.-.+|||+++|..|...- ++....-.++..|+..+..+-.. |++|||+++-||++
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~----GiVHGDlSefNIlV 235 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR----GIVHGDLSEFNILV 235 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc----CccccCCchheEEE
Confidence 67777664 3348999999998885433 23344444566677777777777 99999999999999
Q ss_pred cCCCceeECCCCcc
Q 046121 159 THDFVPMLGDFGLA 172 (315)
Q Consensus 159 ~~~~~i~l~dfg~~ 172 (315)
+.+|.+.++||--+
T Consensus 236 ~~dg~~~vIDwPQ~ 249 (304)
T COG0478 236 TEDGDIVVIDWPQA 249 (304)
T ss_pred ecCCCEEEEeCccc
Confidence 99999999999654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=9.4e-09 Score=81.19 Aligned_cols=123 Identities=22% Similarity=0.199 Sum_probs=78.7
Q ss_pred EEEEEEeCCCcEEEEEEecccC----------------------ccc----HHHHHHHHHHHhhcCCCC--ccceeeeEE
Q 046121 38 HVYKGELKDGQMIAAKVRKEAS----------------------TQG----FAEFQSEVYVLNFARHKN--IVMLLGFCC 89 (315)
Q Consensus 38 ~v~~~~~~~~~~~~~k~~~~~~----------------------~~~----~~~~~~e~~~l~~l~~~~--i~~~~~~~~ 89 (315)
.||.|...++..+|+|+..... ... .....+|.+.|..+..-+ ++.++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998889999999754210 000 123568999999998764 55555442
Q ss_pred ecCeeEEEEEecc--CCccccccccCCCCccCHHHHHHHHHHHHHHHHh-hhcccCCCCeEeecCccCcEEEcCCCceeE
Q 046121 90 KENLNILVYEYIC--NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRF-LHEECRGGPIIHRDMRPSNILLTHDFVPML 166 (315)
Q Consensus 90 ~~~~~~lv~~~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~-lh~~~~~~~i~h~di~p~nil~~~~~~i~l 166 (315)
.-++||||+. |.++..... .. ++......++.+++..+.. +|.. |++|||+++.||+++.+ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~-~~---~~~~~~~~~~~~il~~~~~~~~~~----givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD-VD---LSPEEPKELLEEILEEIIKMLHKA----GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH-CG---GGGSTHHHHHHHHHHHHHHHHHCT----TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHh-cc---ccchhHHHHHHHHHHHHHHHHHhc----CceecCCChhhEEeecc-eEEE
Confidence 2379999998 666644331 11 1133445566677775555 5688 99999999999999988 8999
Q ss_pred CCCCccc
Q 046121 167 GDFGLAR 173 (315)
Q Consensus 167 ~dfg~~~ 173 (315)
+|||.+.
T Consensus 148 IDf~qav 154 (188)
T PF01163_consen 148 IDFGQAV 154 (188)
T ss_dssp --GTTEE
T ss_pred EecCcce
Confidence 9999885
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.7e-10 Score=99.48 Aligned_cols=248 Identities=18% Similarity=0.190 Sum_probs=165.6
Q ss_pred HhcCCcccceecCCCceEEEEEEe--CCCcEEEEEEecccCcccHHHH--HHHHHHHhhc-CCCCccceeeeEEecCeeE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGEL--KDGQMIAAKVRKEASTQGFAEF--QSEVYVLNFA-RHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~--~~~~~~~~k~~~~~~~~~~~~~--~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 95 (315)
..++|-.+..||.|.|+.|+.... .++..+++|-..+.......++ ..|+.....+ .|.+++.+...+......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 346888999999999999998753 3577777775554433333332 3455555545 4788888877777777778
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC-CceeECCCCcccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD-FVPMLGDFGLARW 174 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~-~~i~l~dfg~~~~ 174 (315)
+--||++++++.... .....+.+...+.+..|++.++.++|+. ..+|.|++|.||++..+ +.-++.||+....
T Consensus 343 ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~----~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSK----LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccch----hhhcccccccceeeccchhhhhccccccccc
Confidence 888999999886655 3445578888899999999999999999 99999999999999886 6777889988753
Q ss_pred cCCCCCcccccccccccc--CccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 175 KTTDDPVQTKILGTLGYL--APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~--aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
+..... .....-++. ++.......+..++|+++||..+.+..++.+....... .. .....
T Consensus 417 ~~~~~~---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-~~--------------~i~~~ 478 (524)
T KOG0601|consen 417 LAFSSG---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-SL--------------TIRSG 478 (524)
T ss_pred cceecc---cccccccccccchhhccccccccccccccccccccccccCcccCccccc-ce--------------eeecc
Confidence 222221 112222333 44455555677899999999999998887654321110 00 00000
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
..+...... ..+..+..-+...++..||.+.++..+...+
T Consensus 479 ~~p~~~~~~-----~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 479 DTPNLPGLK-----LQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred cccCCCchH-----HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 011111111 2233444458889999999999887665544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=9e-09 Score=86.14 Aligned_cols=139 Identities=17% Similarity=0.072 Sum_probs=95.2
Q ss_pred eecCCCceEEEEEEeCCCcEEEEEEecccCcc-cH----------HHHHHHHHHHhhcCCCCcc--ceeeeEEe-----c
Q 046121 30 LLGEGGFGHVYKGELKDGQMIAAKVRKEASTQ-GF----------AEFQSEVYVLNFARHKNIV--MLLGFCCK-----E 91 (315)
Q Consensus 30 ~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~-~~----------~~~~~e~~~l~~l~~~~i~--~~~~~~~~-----~ 91 (315)
.+.......|..... +|+.+++|......-. .. ....+|...+..+..-+|. ..+.+... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 334333334556554 4667888855322210 01 1367888888877644443 33444432 2
Q ss_pred CeeEEEEEeccCC-ccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC-------CCc
Q 046121 92 NLNILVYEYICNK-SLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH-------DFV 163 (315)
Q Consensus 92 ~~~~lv~~~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~-------~~~ 163 (315)
...++|+|++.+. +|.+++........+......++.+++..+..||.. |++|+|++++||+++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~----Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA----GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC----cCccCCCChhhEEEeccccCCCCCce
Confidence 3468999999876 788777543334456677778999999999999999 9999999999999975 468
Q ss_pred eeECCCCccc
Q 046121 164 PMLGDFGLAR 173 (315)
Q Consensus 164 i~l~dfg~~~ 173 (315)
+.++||+.+.
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=6.1e-10 Score=104.95 Aligned_cols=248 Identities=18% Similarity=0.200 Sum_probs=159.8
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..+.+.+.+-+..|.++.++.+.-. .+.....++.... ..........+-.+.-.-.+|.++.....+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4567778888899999999888543 3444444443221 11111222222222222233555544444556778899
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
+++|..+++|...++... +.+.+........+..+.++||+. .+.|+|++|.|.+...++...+.||+......
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~----~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS----LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc----hhhcccccccchhhcccCCcccCccccccccc
Confidence 999999999988875544 355555555666788899999999 89999999999999999999999997321100
Q ss_pred -------C--------------C---C-------CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCcc
Q 046121 177 -------T--------------D---D-------PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVV 225 (315)
Q Consensus 177 -------~--------------~---~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~ 225 (315)
. . . .......+++.|.+||...+......+|.|+.|+.+++.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 0 0011235788999999999999999999999999999999999999
Q ss_pred CCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 046121 226 DMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMG 288 (315)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~ 288 (315)
...... +... ...-.... ....+........+++...+..+|.+|..+.
T Consensus 1036 na~tpq--~~f~--------ni~~~~~~----~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQ--QIFE--------NILNRDIP----WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchh--hhhh--------ccccCCCC----CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 643321 1111 10000011 1111222233455666668888999998776
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.7e-09 Score=98.04 Aligned_cols=146 Identities=18% Similarity=0.317 Sum_probs=95.9
Q ss_pred HHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc--cc-------cccccccccCcccccc
Q 046121 129 GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV--QT-------KILGTLGYLAPEYAEN 199 (315)
Q Consensus 129 ~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~--~~-------~~~~~~~~~aPE~~~~ 199 (315)
+++.++.++|... ++||++|.|++|.+++++.+|+.+|+++..-...... .. .......|.|||++.+
T Consensus 107 ~v~dgl~flh~sA---k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSA---KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCc---ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3458899999875 8999999999999999999999999988532221110 00 1123457999999998
Q ss_pred CCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcC
Q 046121 200 GIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQ 278 (315)
Q Consensus 200 ~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~ 278 (315)
...+.++|+||+|+++|.+.. |+..+...+......... ..+..-...++...+..+++=+.+++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------------~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------------NLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-------------cccccccccccccCcHHHHHHHHHHhc
Confidence 888899999999999999994 555554433222211111 001111111122333334444555888
Q ss_pred CCCCCCCCHHHH
Q 046121 279 RNPEGRPSMGEV 290 (315)
Q Consensus 279 ~~p~~Rps~~~i 290 (315)
.++.-||++..+
T Consensus 251 ~~~~~rp~~~~l 262 (700)
T KOG2137|consen 251 GDSAVRPTLDLL 262 (700)
T ss_pred CCcccCcchhhh
Confidence 999999977665
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.5e-07 Score=73.71 Aligned_cols=136 Identities=17% Similarity=0.059 Sum_probs=97.9
Q ss_pred cCCCceEEEEEEeCCCcEEEEEEeccc------CcccHHHHHHHHHHHhhcCCCC--ccceeeeEEe-----cCeeEEEE
Q 046121 32 GEGGFGHVYKGELKDGQMIAAKVRKEA------STQGFAEFQSEVYVLNFARHKN--IVMLLGFCCK-----ENLNILVY 98 (315)
Q Consensus 32 g~g~~~~v~~~~~~~~~~~~~k~~~~~------~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~-----~~~~~lv~ 98 (315)
|+|+-|.|+.....+. .+.+|--... .+.....+.+|...+..+..-+ ++++. ++.. .-..+||+
T Consensus 27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 5588888998876544 4666643211 1334567889999988886433 44444 3321 12347899
Q ss_pred EeccC-CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc--eeECCCCccc
Q 046121 99 EYICN-KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV--PMLGDFGLAR 173 (315)
Q Consensus 99 ~~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~--i~l~dfg~~~ 173 (315)
+-+.| .+|.+++.+..-.+.+......+..+++.++..||+. |+.|+|+.+.||+++.++. +.++||.-+.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~----Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV----NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97643 5677777555455677888889999999999999999 9999999999999987777 9999997664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.1e-07 Score=72.21 Aligned_cols=138 Identities=14% Similarity=0.061 Sum_probs=89.9
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHH---------HHHHHHHHhhc---CCCCccceee
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAE---------FQSEVYVLNFA---RHKNIVMLLG 86 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~---------~~~e~~~l~~l---~~~~i~~~~~ 86 (315)
..+.++|.+.+++.......|.+-... ++.+++|.......-.... ..+.+..+..+ .......++-
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 346789999999988888777766554 6788898766433221111 12233333333 3333333332
Q ss_pred eEE-----ecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC
Q 046121 87 FCC-----KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD 161 (315)
Q Consensus 87 ~~~-----~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~ 161 (315)
+.. .....+++|||++|..|.+... +++ .+...+..++..+|+. |++|||++|.|++++.+
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~----G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH----GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc----CCccCCCCcCcEEEECC
Confidence 222 1234468999999998866431 222 2344567789999999 99999999999999966
Q ss_pred CceeECCCCcc
Q 046121 162 FVPMLGDFGLA 172 (315)
Q Consensus 162 ~~i~l~dfg~~ 172 (315)
+ ++++|++.-
T Consensus 172 ~-i~iID~~~k 181 (229)
T PF06176_consen 172 G-IRIIDTQGK 181 (229)
T ss_pred c-EEEEECccc
Confidence 5 889999654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.5e-07 Score=76.07 Aligned_cols=105 Identities=24% Similarity=0.169 Sum_probs=79.9
Q ss_pred HHHHHHHHHHHhhcCCCC--ccceeeeEEec----CeeEEEEEeccCC-ccccccccCCCCccCHHHHHHHHHHHHHHHH
Q 046121 63 FAEFQSEVYVLNFARHKN--IVMLLGFCCKE----NLNILVYEYICNK-SLHWHLFDNTESVLEWHQRYAAAIGTAKGLR 135 (315)
Q Consensus 63 ~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~----~~~~lv~~~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~ 135 (315)
.....+|...+..+..-+ .+..+.+.... ...++|++++++. +|.+.+..... .+......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 345677888777775433 33555555442 2348999999874 78777754222 566677889999999999
Q ss_pred hhhcccCCCCeEeecCccCcEEEcCCC---ceeECCCCccc
Q 046121 136 FLHEECRGGPIIHRDMRPSNILLTHDF---VPMLGDFGLAR 173 (315)
Q Consensus 136 ~lh~~~~~~~i~h~di~p~nil~~~~~---~i~l~dfg~~~ 173 (315)
.||.. |++|+|+++.||+++.++ .+.++||+-+.
T Consensus 133 ~lH~~----gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 133 KLHDA----GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHHHC----cCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 99999 999999999999999887 89999998775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.3e-06 Score=71.63 Aligned_cols=133 Identities=18% Similarity=0.094 Sum_probs=84.0
Q ss_pred ceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCC--ccceeeeEEecCeeEEEEEeccCCc-
Q 046121 29 NLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKN--IVMLLGFCCKENLNILVYEYICNKS- 105 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~~~~~~~~- 105 (315)
..|++|..+.||+. .+..+++|...... ....+.+|.++++.+..-+ ++.++++....+..++||+++.|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 24456788765422 3455788999999886443 4677888777778899999999974
Q ss_pred cccccccCCCCccCHHHHHHHHHHHHHHHHhhh---------------------------------------cccCCCCe
Q 046121 106 LHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH---------------------------------------EECRGGPI 146 (315)
Q Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh---------------------------------------~~~~~~~i 146 (315)
+...+.. +......++..++..+..+| ..-....+
T Consensus 82 ~~~~~~~------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 82 FSRIISD------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred hhhhhcC------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 2111100 00000011111111111111 11112357
Q ss_pred EeecCccCcEEEcCCCceeECCCCccc
Q 046121 147 IHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 147 ~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+|+|+.|.||+++.++ +.++||+.+.
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcC
Confidence 8999999999999988 8999998875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.5e-07 Score=83.07 Aligned_cols=139 Identities=19% Similarity=0.224 Sum_probs=89.6
Q ss_pred ceecCCCceEEEEEEeCCCcEEEEEEecccCccc------------------------------HH----------HHHH
Q 046121 29 NLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQG------------------------------FA----------EFQS 68 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~------------------------------~~----------~~~~ 68 (315)
+-|+.++-|-||+|+..+|+.||+|+..+.-... .+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5789999999999999999999999855421110 11 1233
Q ss_pred HHHHHhhcC----CCCccceeeeE-EecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCC
Q 046121 69 EVYVLNFAR----HKNIVMLLGFC-CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143 (315)
Q Consensus 69 e~~~l~~l~----~~~i~~~~~~~-~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~ 143 (315)
|...+..+. ...-+.+-.++ +-.+.-.++|||++|..+.+...-.. ...+...+.....++. +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~d--- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRD--- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhc---
Confidence 444443332 22222333333 33455589999999999988742222 3344333333333222 2333334
Q ss_pred CCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 144 ~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
|.+|+|.+|.||+++.+|++.+.|||+...
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceec
Confidence 899999999999999999999999999853
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.3e-06 Score=70.81 Aligned_cols=148 Identities=24% Similarity=0.293 Sum_probs=98.2
Q ss_pred HHHHHHHhcCCcccce---ecCCCceEEEEEEeCCCcEEEEEEecccCccc------------------------HHHHH
Q 046121 15 FSEIQQATGDFSKENL---LGEGGFGHVYKGELKDGQMIAAKVRKEASTQG------------------------FAEFQ 67 (315)
Q Consensus 15 ~~~~~~~~~~y~~~~~---lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~------------------------~~~~~ 67 (315)
.+.+....++..+... |++|--+.||+|...++..+|+|++....... .....
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 4455566666666665 55677779999988889999999866432110 11134
Q ss_pred HHHHHHhhcCCCC--ccceeeeEEecCeeEEEEEeccCCcc-ccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCC
Q 046121 68 SEVYVLNFARHKN--IVMLLGFCCKENLNILVYEYICNKSL-HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGG 144 (315)
Q Consensus 68 ~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~~~~~~~~L-~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~ 144 (315)
+|+..|+++..-+ +++.+.+.. ..+||||+...-. ...+ ...++.......+..+++..+.-|-..+
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a--- 186 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEA--- 186 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhc---
Confidence 6777777775433 444455442 3799999844311 1122 2223334356667778888888887732
Q ss_pred CeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 145 PIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 145 ~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+++|+||+.-||++. ++.+.++|++-+.
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV 214 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAV 214 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECcccc
Confidence 999999999999999 7889999998875
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=6.2e-07 Score=68.65 Aligned_cols=129 Identities=22% Similarity=0.256 Sum_probs=92.4
Q ss_pred cccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCc
Q 046121 26 SKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKS 105 (315)
Q Consensus 26 ~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~ 105 (315)
.+.+.|++|++|.||++.+.++ .+++|+.... .....+..|++++..+.-.++.+=+-.+... ++.|+|+.|-+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~---~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED---FIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeeccCc-eEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh---hhhhhhhcCcc
Confidence 4567899999999999999754 6788876643 3457889999999999877776554444332 45599999988
Q ss_pred cccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCc-cCcEEEcCCCceeECCCCccc
Q 046121 106 LHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMR-PSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~-p~nil~~~~~~i~l~dfg~~~ 173 (315)
|.+..... +. +....+++...-|-.. ||-|+.|+ |...++..++.+.|+||..++
T Consensus 99 L~~~~~~~-----~r----k~l~~vlE~a~~LD~~----GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 99 LGKLEIGG-----DR----KHLLRVLEKAYKLDRL----GIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhcc-----cH----HHHHHHHHHHHHHHHh----ccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 86544111 12 2333456666666666 99999987 666666666699999998886
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.7e-06 Score=71.37 Aligned_cols=78 Identities=21% Similarity=0.198 Sum_probs=56.0
Q ss_pred cceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCC--CccceeeeE---EecCeeEEEEEecc
Q 046121 28 ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHK--NIVMLLGFC---CKENLNILVYEYIC 102 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~---~~~~~~~lv~~~~~ 102 (315)
++.|+.|..+.||.+...+ ..+++|..... .....+.+|..+++.+... .++.++... ......+++|+++.
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999998877 58888876544 4456678888888887643 345566533 23345689999999
Q ss_pred CCcccc
Q 046121 103 NKSLHW 108 (315)
Q Consensus 103 ~~~L~~ 108 (315)
|.++..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 988876
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.9e-06 Score=69.82 Aligned_cols=76 Identities=13% Similarity=0.114 Sum_probs=53.4
Q ss_pred eecCCCc-eEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeeeEEecCeeEEEEEeccCCccc
Q 046121 30 LLGEGGF-GHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLNILVYEYICNKSLH 107 (315)
Q Consensus 30 ~lg~g~~-~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~~~~~~~~L~ 107 (315)
.|..|.+ +.||+....+ ..+++|+..... ...+.+|+.+++.+. +-.+++++++....+..++||++++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3455555 7889987554 678888765432 345678888888875 344557777776666779999999998886
Q ss_pred cc
Q 046121 108 WH 109 (315)
Q Consensus 108 ~~ 109 (315)
..
T Consensus 81 ~~ 82 (244)
T cd05150 81 AL 82 (244)
T ss_pred Hh
Confidence 43
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=9.5e-06 Score=73.71 Aligned_cols=138 Identities=17% Similarity=0.188 Sum_probs=85.0
Q ss_pred ceecCCCceEEEEEEeCCCcEEEEEEecccCc-------------------------------ccHHHHHHHHHHH----
Q 046121 29 NLLGEGGFGHVYKGELKDGQMIAAKVRKEAST-------------------------------QGFAEFQSEVYVL---- 73 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~-------------------------------~~~~~~~~e~~~l---- 73 (315)
+-|+..+.|-|++|+..+|+.||+|+-++.-. +..+.+..|+..+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 57899999999999999999999998543211 1111122222222
Q ss_pred ------hhcCCCCc---cceeeeEE-ecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCC
Q 046121 74 ------NFARHKNI---VMLLGFCC-KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143 (315)
Q Consensus 74 ------~~l~~~~i---~~~~~~~~-~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~ 143 (315)
+.+.|-+. +.+-.++. -...-.++|||++|..+.|.-. .....++...+..-+.+... ..+-..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~-i~~~gi~~~~i~~~l~~~~~--~qIf~~--- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA-IDKRGISPHDILNKLVEAYL--EQIFKT--- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH-HHHcCCCHHHHHHHHHHHHH--HHHHhc---
Confidence 22334441 11223332 2334589999999998876532 12233455444443333322 222233
Q ss_pred CCeEeecCccCcEEEcC----CCceeECCCCccc
Q 046121 144 GPIIHRDMRPSNILLTH----DFVPMLGDFGLAR 173 (315)
Q Consensus 144 ~~i~h~di~p~nil~~~----~~~i~l~dfg~~~ 173 (315)
|.+|+|-.|.||++.. ++.+.+.|||+..
T Consensus 321 -GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~ 353 (538)
T KOG1235|consen 321 -GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYA 353 (538)
T ss_pred -CCccCCCCCCcEEEecCCCCCccEEEEcccccc
Confidence 8999999999999983 6789999999985
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.7e-05 Score=64.34 Aligned_cols=75 Identities=16% Similarity=0.227 Sum_probs=50.4
Q ss_pred cceecCCCceEEEEEEeCC--CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCcc-ceeeeEEecCeeEEEEEeccCC
Q 046121 28 ENLLGEGGFGHVYKGELKD--GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV-MLLGFCCKENLNILVYEYICNK 104 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~~~~~~~ 104 (315)
++.|..|-...+|+....+ ++.+++|+....... .....+|+.+++.+...++. +++... . -.+++||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~--~--~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATF--Q--NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEe--C--CcEEEEeeCCC
Confidence 4678889999999997664 678889876543222 22345788888888654444 333322 2 24799999998
Q ss_pred ccc
Q 046121 105 SLH 107 (315)
Q Consensus 105 ~L~ 107 (315)
++.
T Consensus 78 ~l~ 80 (235)
T cd05157 78 TLE 80 (235)
T ss_pred cCC
Confidence 774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=6.9e-07 Score=80.90 Aligned_cols=187 Identities=18% Similarity=0.099 Sum_probs=133.6
Q ss_pred CCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCC-ccceeeeEEecCeeEEEEEecc
Q 046121 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKN-IVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
-|....-+++++++.+++.+....+....+++... ....-+++.|.+.+||| .+.+++.++.+...+++++++.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 34445567889999999988775555555544432 34566888999999999 6677777777888899999987
Q ss_pred CC-ccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 103 NK-SLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 103 ~~-~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
++ +..... ...+-.+.+.+...+.+.-+..+.++|+. .=+|+| ||+..+ +..+..+|+....+.... .
T Consensus 318 ~~rs~~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~----~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~ 386 (829)
T KOG0576|consen 318 TGRSSALEM-TVSEIALEQYQFAYPLRKETRPLAELHSS----YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-K 386 (829)
T ss_pred CCccccccC-ChhhHhhhhhhhhhhhhhhcccccccccc----cccCcc----cccccc-cccccccccCCcccCccc-c
Confidence 66 222222 12233355556666666667788888887 446776 665554 677899998886444433 3
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVD 226 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~ 226 (315)
..+..+++.|+|||+.....+....|+|++|.-..+|--|.+|..
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 345678999999999998889999999999988788877877753
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.16 E-value=4.6e-05 Score=74.47 Aligned_cols=81 Identities=16% Similarity=0.272 Sum_probs=56.5
Q ss_pred ccceecCCCceEEEEEEeCCC---cEEEEEEecccC-cccHHHHHHHHHHHhhcC-CCCc--cceeeeEEec---CeeEE
Q 046121 27 KENLLGEGGFGHVYKGELKDG---QMIAAKVRKEAS-TQGFAEFQSEVYVLNFAR-HKNI--VMLLGFCCKE---NLNIL 96 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~~~---~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~l 96 (315)
.++.++.|.++.+|+....++ ..+++|...... ......+.+|+.+++.+. |+++ ++++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 357789999999999876543 356666543321 223356789999999985 5654 6777776553 46789
Q ss_pred EEEeccCCccc
Q 046121 97 VYEYICNKSLH 107 (315)
Q Consensus 97 v~~~~~~~~L~ 107 (315)
|||+++|..+.
T Consensus 122 VME~v~G~~~~ 132 (822)
T PLN02876 122 IMEYLEGRIFV 132 (822)
T ss_pred EEEecCCcccC
Confidence 99999987654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.15 E-value=3e-05 Score=65.07 Aligned_cols=138 Identities=14% Similarity=0.063 Sum_probs=77.7
Q ss_pred eecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCcc-ceeeeEEecCeeEEEEEeccCCcccc
Q 046121 30 LLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV-MLLGFCCKENLNILVYEYICNKSLHW 108 (315)
Q Consensus 30 ~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~~~~~~~~L~~ 108 (315)
.+..|..+.+|+... +++.+++|..............+|..+++.+...++. +++... . -++|++|++|.++..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 456788889998874 4667788875543222212357899999988754443 333332 2 378999999987753
Q ss_pred c-----------------cccCC--CCccCHH-HHHHHHHHH---------HHHHHhhhcc----cCCCCeEeecCccCc
Q 046121 109 H-----------------LFDNT--ESVLEWH-QRYAAAIGT---------AKGLRFLHEE----CRGGPIIHRDMRPSN 155 (315)
Q Consensus 109 ~-----------------l~~~~--~~~~~~~-~~~~~~~~l---------~~~l~~lh~~----~~~~~i~h~di~p~n 155 (315)
. ++... ..+++.. .+.....++ ...+..+-.. .....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2 01110 1111111 111111111 0111111111 001257999999999
Q ss_pred EEEcCCCceeECCCCccc
Q 046121 156 ILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 156 il~~~~~~i~l~dfg~~~ 173 (315)
|+++.++ +.++||+.+.
T Consensus 158 il~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC-CEEEeccccC
Confidence 9999877 7899998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.08 E-value=0.00015 Score=63.00 Aligned_cols=158 Identities=13% Similarity=0.068 Sum_probs=83.8
Q ss_pred cccHHHHHHHhcCCcc-----cceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCC--ccce
Q 046121 12 KFSFSEIQQATGDFSK-----ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKN--IVML 84 (315)
Q Consensus 12 ~~~~~~~~~~~~~y~~-----~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~ 84 (315)
.++..++......|-+ .+.|+.|....+|.....++ .+++|++.... ...+..+...++.+...+ ++.+
T Consensus 6 ~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 6 DVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred cCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcc
Confidence 3445555555566755 34566788789999876655 57788765222 233344555555443212 3333
Q ss_pred ee------eEEecCeeEEEEEeccCCccccc----c----------ccCCC-------Ccc---CHHHHHH---------
Q 046121 85 LG------FCCKENLNILVYEYICNKSLHWH----L----------FDNTE-------SVL---EWHQRYA--------- 125 (315)
Q Consensus 85 ~~------~~~~~~~~~lv~~~~~~~~L~~~----l----------~~~~~-------~~~---~~~~~~~--------- 125 (315)
+. +....+..++++++++|..+... . +.... ... .......
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 32 12335667899999998765321 0 00100 000 0001000
Q ss_pred ---HHHH-HHHHHHhhhcc-c--CCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 126 ---AAIG-TAKGLRFLHEE-C--RGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 126 ---~~~~-l~~~l~~lh~~-~--~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.... +...+..+.+. + -..+++|+|+.|.||+++.+...-++||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11112222210 0 12379999999999999977666899999885
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.03 E-value=9e-05 Score=61.28 Aligned_cols=75 Identities=12% Similarity=0.076 Sum_probs=46.0
Q ss_pred ceecCCCce-EEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCC---CccceeeeEEec---CeeEEEEEec
Q 046121 29 NLLGEGGFG-HVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHK---NIVMLLGFCCKE---NLNILVYEYI 101 (315)
Q Consensus 29 ~~lg~g~~~-~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~lv~~~~ 101 (315)
+.|+.|+.. .||... ..+++|+.... .....+.+|.++++.+... .++.++...... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~----~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG----DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC----CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456766655 588762 34677765432 2345788999999888632 334444433222 2348899999
Q ss_pred cCCccccc
Q 046121 102 CNKSLHWH 109 (315)
Q Consensus 102 ~~~~L~~~ 109 (315)
+|.++.+.
T Consensus 77 ~G~~l~~~ 84 (235)
T cd05155 77 EGETATAA 84 (235)
T ss_pred cCCCCCcc
Confidence 99888543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.0001 Score=63.15 Aligned_cols=142 Identities=14% Similarity=0.077 Sum_probs=81.5
Q ss_pred cceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCC--ccceee------eEEecCeeEEEEE
Q 046121 28 ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKN--IVMLLG------FCCKENLNILVYE 99 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~------~~~~~~~~~lv~~ 99 (315)
.+.|..|....+|+....++ .+++|+... .....+..|+.++..+...+ +++++. +....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 55678888889999875544 577887654 22345667777777775332 333332 1233456689999
Q ss_pred eccCCccccc----c----------ccCC-C--C------ccCHHHH----------HHHHHHHHHHHHhhhcc---cCC
Q 046121 100 YICNKSLHWH----L----------FDNT-E--S------VLEWHQR----------YAAAIGTAKGLRFLHEE---CRG 143 (315)
Q Consensus 100 ~~~~~~L~~~----l----------~~~~-~--~------~~~~~~~----------~~~~~~l~~~l~~lh~~---~~~ 143 (315)
+++|.++... . +... . . ...+... ......+..++..+... ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9999876430 0 0000 0 0 0000000 00011122223333321 011
Q ss_pred CCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 144 ~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.+++|+|+.|.|++++.++.+.++||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 368999999999999998777899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=9.3e-06 Score=68.35 Aligned_cols=142 Identities=15% Similarity=0.086 Sum_probs=99.9
Q ss_pred HHHHHHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecc-----------------cCc-cc--HH--HHHHHHHH
Q 046121 15 FSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKE-----------------AST-QG--FA--EFQSEVYV 72 (315)
Q Consensus 15 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~-----------------~~~-~~--~~--~~~~e~~~ 72 (315)
.+.......-+-++..||-|.-+.+|.+.+..|...++|+-.. ... ++ .. ...+|...
T Consensus 84 lktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf 163 (465)
T KOG2268|consen 84 LKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF 163 (465)
T ss_pred HHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence 3444444456788889999999999999999999999985221 011 11 11 24578888
Q ss_pred HhhcCC--CCccceeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeec
Q 046121 73 LNFARH--KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRD 150 (315)
Q Consensus 73 l~~l~~--~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~d 150 (315)
++.+.. -.+++.+++. .-++||+++.|-+|...- ...+..+ +...+..-+..|... |+||+|
T Consensus 164 mkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~-----~v~d~~~---ly~~lm~~Iv~la~~----GlIHgD 227 (465)
T KOG2268|consen 164 MKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVR-----HVEDPPT---LYDDLMGLIVRLANH----GLIHGD 227 (465)
T ss_pred HHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeee-----ecCChHH---HHHHHHHHHHHHHHc----Cceecc
Confidence 988864 3455555543 348899999999886533 1122333 333445556778788 999999
Q ss_pred CccCcEEEcCCCceeECCCCcc
Q 046121 151 MRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 151 i~p~nil~~~~~~i~l~dfg~~ 172 (315)
++-=||+++.++.++++||--.
T Consensus 228 FNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 228 FNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred cchheeEEecCCCEEEeechHh
Confidence 9999999999999999999644
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00015 Score=57.89 Aligned_cols=129 Identities=23% Similarity=0.231 Sum_probs=86.3
Q ss_pred cceecCCCceEEEEEEeCCCcEEEEEEecccC----------------cccHHHHHHHHHHHhhcC------CCCcccee
Q 046121 28 ENLLGEGGFGHVYKGELKDGQMIAAKVRKEAS----------------TQGFAEFQSEVYVLNFAR------HKNIVMLL 85 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~----------------~~~~~~~~~e~~~l~~l~------~~~i~~~~ 85 (315)
...||+|+.-.||.- .++...++|+..... ........+|+.....+. +.+|..++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 357899999988854 334455788766554 223455667777666665 78999999
Q ss_pred eeEEecCeeEEEEEeccC------CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc
Q 046121 86 GFCCKENLNILVYEYICN------KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT 159 (315)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~------~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~ 159 (315)
|+.+++.-+.+|+|.+.+ .+|.+++. ...++. ..... +-.-..+|-+. +|+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~~~~~---L~~f~~~l~~~----~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-ELRQA---LDEFKRYLLDH----HIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-HHHHH---HHHHHHHHHHc----CCeecCCCcccEEEE
Confidence 999999999999998633 23444442 223444 33333 33445566666 899999999999996
Q ss_pred CCC----ceeECCC
Q 046121 160 HDF----VPMLGDF 169 (315)
Q Consensus 160 ~~~----~i~l~df 169 (315)
... .+.++|-
T Consensus 153 ~~~~~~~~lvlIDG 166 (199)
T PF10707_consen 153 RRDSGEFRLVLIDG 166 (199)
T ss_pred ecCCCceEEEEEeC
Confidence 432 4666653
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00058 Score=58.51 Aligned_cols=80 Identities=13% Similarity=0.165 Sum_probs=57.7
Q ss_pred CCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCC---CCccceeeeEEe---cCeeEEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARH---KNIVMLLGFCCK---ENLNILV 97 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~~~lv 97 (315)
.-.-.+.|+.|..+.||.....+++ +++|..+.. .....+..|...++.+.. -.++++++++.. .+..++|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 4445568999999999999766564 666764331 123467889999988853 357788877654 3667999
Q ss_pred EEeccCCcc
Q 046121 98 YEYICNKSL 106 (315)
Q Consensus 98 ~~~~~~~~L 106 (315)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998766
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00013 Score=62.84 Aligned_cols=76 Identities=20% Similarity=0.217 Sum_probs=50.9
Q ss_pred cceecCCCceEEEEEEeCC-------CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCcc-ceeeeEEecCeeEEEEE
Q 046121 28 ENLLGEGGFGHVYKGELKD-------GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV-MLLGFCCKENLNILVYE 99 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~~ 99 (315)
++.+..|-...+|+....+ ++.+++|+..... .......+|..+++.+...++. +++..+. + ..|++
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e 77 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEE 77 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhh
Confidence 3567778888999987554 5788999866543 2334567888888888644443 4444443 2 46889
Q ss_pred eccCCcccc
Q 046121 100 YICNKSLHW 108 (315)
Q Consensus 100 ~~~~~~L~~ 108 (315)
|++|.++..
T Consensus 78 ~i~G~~l~~ 86 (302)
T cd05156 78 FIPSRTLTT 86 (302)
T ss_pred eeCCCcCCH
Confidence 998887753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00013 Score=57.90 Aligned_cols=102 Identities=24% Similarity=0.170 Sum_probs=79.1
Q ss_pred HHHHHHHhhcCC-CCccceeeeEEecCeeEEEEEeccCCcccccccc-CCCCccCHHHHHHHHHHHHHHHHhhhcccCCC
Q 046121 67 QSEVYVLNFARH-KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFD-NTESVLEWHQRYAAAIGTAKGLRFLHEECRGG 144 (315)
Q Consensus 67 ~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~ 144 (315)
..|..+++.+++ +++++++|.|- + .++.|+...+++...... ..-...++....+++.+++..+.+++....+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG---~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG---R-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC---C-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457888888876 69999999983 2 667898876655321100 11234789999999999999999999865544
Q ss_pred CeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 145 PIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 145 ~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+...|++|+|+-++.+++++++|.....
T Consensus 83 -~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 83 -FYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred -EEEeecchHHeEEeCCCcEEEEechhcc
Confidence 8889999999999999999999997664
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.0008 Score=58.05 Aligned_cols=157 Identities=15% Similarity=0.075 Sum_probs=86.1
Q ss_pred cHHHHHHHhcCCcc-----cceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCC--ccceee
Q 046121 14 SFSEIQQATGDFSK-----ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKN--IVMLLG 86 (315)
Q Consensus 14 ~~~~~~~~~~~y~~-----~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~ 86 (315)
+-+.+.....+|.+ .+.++.|....+|.....++ .+++|+..... ..+.+..|.+++..+...+ +++++.
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 33455555556655 45677788889999876555 56777654421 1334556667776664322 333332
Q ss_pred e------EEecCeeEEEEEeccCCccccc--------------cccCCCC-ccC-----HHHHHH---------------
Q 046121 87 F------CCKENLNILVYEYICNKSLHWH--------------LFDNTES-VLE-----WHQRYA--------------- 125 (315)
Q Consensus 87 ~------~~~~~~~~lv~~~~~~~~L~~~--------------l~~~~~~-~~~-----~~~~~~--------------- 125 (315)
. ....+..+++++|++|.++... ++..... ..+ ....+.
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 1 1224567899999998765321 0110000 000 000000
Q ss_pred -HHHHHHHHHHhhhcc---cCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 126 -AAIGTAKGLRFLHEE---CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 126 -~~~~l~~~l~~lh~~---~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
....+...+.++... ....+++|+|+.+.|++++.++...++||+.+.
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 011122233333211 011389999999999999998877899998874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00012 Score=71.09 Aligned_cols=196 Identities=18% Similarity=0.166 Sum_probs=128.4
Q ss_pred HHHHHHHHhhcCCCCccceeeeEEecCee----EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhccc
Q 046121 66 FQSEVYVLNFARHKNIVMLLGFCCKENLN----ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141 (315)
Q Consensus 66 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ 141 (315)
..-|+..+..+.|+|+..++.+-.++... .+..+++...++...+ ..-...+..+...+..++..++.++|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~--q~v~~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL--QSVGSIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH--hhccccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 45577788888999999999886544322 2344566666665555 2334578888888999999999999999
Q ss_pred CCCCeEeecCccC---cEEEcCCCceeEC--CCCcccccCCCCCccccccccccccCccccccCCCc--ccccchhhhHH
Q 046121 142 RGGPIIHRDMRPS---NILLTHDFVPMLG--DFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVS--IRTDVYAFGII 214 (315)
Q Consensus 142 ~~~~i~h~di~p~---nil~~~~~~i~l~--dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~DvwslG~~ 214 (315)
...|.-+... +...+..+.+... ||+.+....... .......+..+.+||........ ...|+|++|..
T Consensus 306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~-~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE-KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred ---ccceeEEecccccccccCccceeecchhhhcccccCCCcc-cchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 6666666555 5555666666666 888775333222 22233445667788877655544 34799999999
Q ss_pred HHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 215 LLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 215 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
...+..|..+-...... .. +++. ... ..+.+....|+..++++|+++.+++...
T Consensus 382 ~~~~~~~~~i~~~~~~~---------~~---------~l~~-----~~~---~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAVP---------VS---------LLDV-----LST---SELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HhhhhhcCcccccccch---------hh---------hhcc-----ccc---hhhhhhhhhhcchhhhhccchhhhhhch
Confidence 99999887654211100 00 0000 000 0245666679999999999999988754
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0011 Score=56.81 Aligned_cols=142 Identities=16% Similarity=0.142 Sum_probs=91.5
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEec--ccCcccHHHHHHHHHHHhhcCC--CCccceeeeEEecC--eeEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRK--EASTQGFAEFQSEVYVLNFARH--KNIVMLLGFCCKEN--LNIL 96 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~--~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~--~~~l 96 (315)
....+++.+..|....+|..... ++.++++ .. ...........+|+.+++.+.. -.+...++.+.++. ..+.
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CCCceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 34455566655555555655544 6677777 33 1233345556788888887753 34455566666555 7799
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHH-HHHHHHHHhhhccc----------------------------------
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAA-IGTAKGLRFLHEEC---------------------------------- 141 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~-~~l~~~l~~lh~~~---------------------------------- 141 (315)
||++++|..+.+.+...... -..+ ..+...|..||+..
T Consensus 103 v~~~veGe~~~~~~~~~~~~-------~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~ 175 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLG-------RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGG 175 (321)
T ss_pred EEEEecceeccCcCCcccch-------HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccC
Confidence 99999997665444221111 1122 35666677777441
Q ss_pred --------------------CCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 142 --------------------RGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 142 --------------------~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+...++|||+.+.|++++.++.+-+.||+.+.
T Consensus 176 ~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~ 227 (321)
T COG3173 176 RIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELAT 227 (321)
T ss_pred CCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccc
Confidence 11458999999999999999989999999986
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0016 Score=57.80 Aligned_cols=76 Identities=16% Similarity=0.246 Sum_probs=52.2
Q ss_pred cceecCCCceEEEEEEeCCC-cEEEEEEeccc------C-cccHHHHHHHHHHHhhcC--C-CCccceeeeEEecCeeEE
Q 046121 28 ENLLGEGGFGHVYKGELKDG-QMIAAKVRKEA------S-TQGFAEFQSEVYVLNFAR--H-KNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~~-~~~~~k~~~~~------~-~~~~~~~~~e~~~l~~l~--~-~~i~~~~~~~~~~~~~~l 96 (315)
.+.||.|....||++...++ +.+++|.-... . +...++...|.+.|+.+. . ..+++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46789999999999988766 47888863311 1 224556777888888763 2 345666665 3355689
Q ss_pred EEEeccCCc
Q 046121 97 VYEYICNKS 105 (315)
Q Consensus 97 v~~~~~~~~ 105 (315)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999987643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0014 Score=57.32 Aligned_cols=142 Identities=17% Similarity=0.172 Sum_probs=82.9
Q ss_pred ccceecCCCceEEEEEEeCC-----CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCcc-ceeeeEEecCeeEEEEEe
Q 046121 27 KENLLGEGGFGHVYKGELKD-----GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV-MLLGFCCKENLNILVYEY 100 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~~~ 100 (315)
-++.|..|-...+|++...+ ++.+++|+........++ ..+|..+++.+..-++. ++++.+.. ..|.+|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~ef 114 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEF 114 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC----ceEEEe
Confidence 34456678888999986432 467889987765444333 37899999888755554 44454432 257899
Q ss_pred ccCCccccc-c----------------ccCC----CCccCHHHHHHHHHHH-----------------HHHHHh----hh
Q 046121 101 ICNKSLHWH-L----------------FDNT----ESVLEWHQRYAAAIGT-----------------AKGLRF----LH 138 (315)
Q Consensus 101 ~~~~~L~~~-l----------------~~~~----~~~~~~~~~~~~~~~l-----------------~~~l~~----lh 138 (315)
+.+.++... + +... ........+..+..++ ...+.. +.
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 888777421 0 1100 0011112222222111 111111 11
Q ss_pred cccCCCCeEeecCccCcEEEcC-CCceeECCCCccc
Q 046121 139 EECRGGPIIHRDMRPSNILLTH-DFVPMLGDFGLAR 173 (315)
Q Consensus 139 ~~~~~~~i~h~di~p~nil~~~-~~~i~l~dfg~~~ 173 (315)
.......++|+|+++.||+++. ++.+.++||..+.
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1122236899999999999986 4689999998874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0017 Score=51.70 Aligned_cols=125 Identities=22% Similarity=0.350 Sum_probs=84.3
Q ss_pred cCCcccceecCCCc-eEEEEEEeCCCcEEEEEEecc---cCc------------------ccHHHHHHHHHHHhhcC---
Q 046121 23 GDFSKENLLGEGGF-GHVYKGELKDGQMIAAKVRKE---AST------------------QGFAEFQSEVYVLNFAR--- 77 (315)
Q Consensus 23 ~~y~~~~~lg~g~~-~~v~~~~~~~~~~~~~k~~~~---~~~------------------~~~~~~~~e~~~l~~l~--- 77 (315)
.+++.++.||.|.- |.||+++.. |+.+|+|++.. ..+ ...+.+..|-+.+.+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 68899999999999 999999886 55899998321 111 11224566766665554
Q ss_pred CCCc--cceeeeEEec------------------CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhh
Q 046121 78 HKNI--VMLLGFCCKE------------------NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFL 137 (315)
Q Consensus 78 ~~~i--~~~~~~~~~~------------------~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~l 137 (315)
+.++ ++.+++..-. ....+|.||..... .+... -+.++.+-+..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHHH
Confidence 5566 7888887322 11256777654432 12222 345567778889
Q ss_pred hcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 138 h~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
|.. ||+-+|+++.|.. +| +|+|||.+
T Consensus 181 ~k~----gI~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL----GIVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HHC----CeeeccCcccccc---CC--EEEecccC
Confidence 999 9999999999975 33 58888754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0042 Score=52.59 Aligned_cols=29 Identities=31% Similarity=0.502 Sum_probs=24.5
Q ss_pred CeEeecCccCcEEEcCCCc-eeECCCCccc
Q 046121 145 PIIHRDMRPSNILLTHDFV-PMLGDFGLAR 173 (315)
Q Consensus 145 ~i~h~di~p~nil~~~~~~-i~l~dfg~~~ 173 (315)
.++|+|++|.||+++.++. .-++||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4799999999999997555 4699999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0035 Score=54.22 Aligned_cols=139 Identities=17% Similarity=0.165 Sum_probs=94.0
Q ss_pred ccceecCCCceEEEEEEeCCCcEEEEEEecccC--------------------c-----ccHH-HHHHHHHHHhhcCCCC
Q 046121 27 KENLLGEGGFGHVYKGELKDGQMIAAKVRKEAS--------------------T-----QGFA-EFQSEVYVLNFARHKN 80 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~--------------------~-----~~~~-~~~~e~~~l~~l~~~~ 80 (315)
+...|..|--+.||.|...+|..+|||+++-+- + ..+. ....|++.|+++...+
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 344688899999999998889999999754210 0 0011 2457888888888777
Q ss_pred ccceeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC
Q 046121 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH 160 (315)
Q Consensus 81 i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~ 160 (315)
|+..--+.. .++ .|||+++....- ....-....++...+..+-.+++..+.-|...| ++||.||+--|+++..
T Consensus 228 IP~PePIlL-k~h-VLVM~FlGrdgw--~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c---~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 228 IPCPEPILL-KNH-VLVMEFLGRDGW--AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC---RLVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCCceee-ecc-eEeeeeccCCCC--cCcccccccCChHHHHHHHHHHHHHHHHHHHHh---ceeccchhhhhheEEC
Confidence 554433332 222 789999743211 111123345666677777778888888888887 8999999999998765
Q ss_pred CCceeECCCCccc
Q 046121 161 DFVPMLGDFGLAR 173 (315)
Q Consensus 161 ~~~i~l~dfg~~~ 173 (315)
|.+.++|-+-+.
T Consensus 301 -G~lyiIDVSQSV 312 (520)
T KOG2270|consen 301 -GKLYIIDVSQSV 312 (520)
T ss_pred -CEEEEEEccccc
Confidence 477788876653
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0033 Score=54.75 Aligned_cols=76 Identities=12% Similarity=0.182 Sum_probs=49.6
Q ss_pred ccceecCCCceEEEEEEeCC----CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCcc-ceeeeEEecCeeEEEEEec
Q 046121 27 KENLLGEGGFGHVYKGELKD----GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV-MLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~~----~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~~~~ 101 (315)
.++.|..|-...+|+....+ +..+++|+....... .-...+|..+++.+..-++. ++++++. . .+|.+|+
T Consensus 18 ~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~---G~i~~fi 92 (330)
T PLN02421 18 SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-N---GMIQSFI 92 (330)
T ss_pred EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-C---cEeehhh
Confidence 34566678888899886442 347888887664433 33347888999888766654 4454442 2 2578888
Q ss_pred cCCccc
Q 046121 102 CNKSLH 107 (315)
Q Consensus 102 ~~~~L~ 107 (315)
.|.++.
T Consensus 93 ~g~~l~ 98 (330)
T PLN02421 93 NARTLT 98 (330)
T ss_pred cCCCCC
Confidence 887763
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.014 Score=49.58 Aligned_cols=75 Identities=17% Similarity=0.241 Sum_probs=46.6
Q ss_pred cccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcC---CCCccceeeeEEecCeeEEEEEecc
Q 046121 26 SKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR---HKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 26 ~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
+-.+.++.|..+.+|... .+++.+++|+-... ....+..|..-|+.+. .-.+++++.+....+..++++||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 444578999999999887 56778888876632 2245677877777773 3457788888877777799999987
Q ss_pred CC
Q 046121 103 NK 104 (315)
Q Consensus 103 ~~ 104 (315)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0042 Score=49.92 Aligned_cols=117 Identities=19% Similarity=0.083 Sum_probs=67.0
Q ss_pred CCceEEEEEEeCCCcEEEEEEecccCcc-cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCcccccccc
Q 046121 34 GGFGHVYKGELKDGQMIAAKVRKEASTQ-GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFD 112 (315)
Q Consensus 34 g~~~~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~ 112 (315)
|+.+|.-.+..+-|-.+..|+.+. ... ....+.++.+++.++ .+|+++..- +.-...++.|.+.....
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~sl-p~~~~~~~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSL-PCCINDALYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccchhhhhhccCC-CcccchhhhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCccc------
Confidence 344444444333344444444333 332 334456777776654 345555422 33345677787633211
Q ss_pred CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 113 NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 113 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
..... +.. =+.++.-+|+.. .+.+|||.+|+|||-|+.|.+||+|-+..
T Consensus 142 -----~~~N~---i~a-gi~~L~~fH~~~--~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 142 -----NFSNF---ITA-GIKDLMDFHSEN--QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -----chhHH---HHH-hHHHHHHhhccC--CCeecCCCChhheeecCCCCEEecChhhh
Confidence 11111 111 135677788653 38999999999999999999999998654
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.016 Score=50.07 Aligned_cols=29 Identities=28% Similarity=0.279 Sum_probs=25.3
Q ss_pred CCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 144 ~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.+++|+|+.+.||+++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 37899999999999988 678899998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.012 Score=51.31 Aligned_cols=73 Identities=15% Similarity=0.124 Sum_probs=45.8
Q ss_pred eecCCCceEEEEEEeCCC-cEEEEEEec-------ccCcccHHHHHHHHHHHhhcC--CCCccceeeeEEecCeeEEEEE
Q 046121 30 LLGEGGFGHVYKGELKDG-QMIAAKVRK-------EASTQGFAEFQSEVYVLNFAR--HKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 30 ~lg~g~~~~v~~~~~~~~-~~~~~k~~~-------~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.||-|....||++.+.++ +.+++|--. ..-+-..++..-|...|+... .|..++-+-.+. ++...+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D-~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD-TEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc-cccceehHh
Confidence 579999999999987654 578888411 112444556667888887664 354444333333 334468888
Q ss_pred eccC
Q 046121 100 YICN 103 (315)
Q Consensus 100 ~~~~ 103 (315)
+++.
T Consensus 81 dL~~ 84 (370)
T TIGR01767 81 DLSH 84 (370)
T ss_pred hCcc
Confidence 8743
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0044 Score=50.25 Aligned_cols=57 Identities=18% Similarity=0.195 Sum_probs=34.3
Q ss_pred CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCcc-ceeeeEEecCeeEEEEEeccCCcccc
Q 046121 47 GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV-MLLGFCCKENLNILVYEYICNKSLHW 108 (315)
Q Consensus 47 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~~~~~~~~L~~ 108 (315)
++.|++++.... ....-...+|..+++.+...++. ++++.+.+ ..|.+|+.|.+|..
T Consensus 2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~ 59 (211)
T PF01633_consen 2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSP 59 (211)
T ss_dssp TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--C
T ss_pred CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccCh
Confidence 467888887765 34445668889999988765554 45554422 35678988777643
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.033 Score=48.32 Aligned_cols=139 Identities=22% Similarity=0.169 Sum_probs=80.1
Q ss_pred ecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCcc---c---eeee--EEecC--eeEEEEEe
Q 046121 31 LGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV---M---LLGF--CCKEN--LNILVYEY 100 (315)
Q Consensus 31 lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~---~---~~~~--~~~~~--~~~lv~~~ 100 (315)
|.+ ....+|.....+++. ++|+.... .....+..|+..+..+...++. + .-|- ..-.. ..+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456688888777776 88877654 3446677778877777422221 2 1111 11123 67889999
Q ss_pred ccCCcccc-ccc--------------c----------CCCCc-----------------cCHHHHHHHHHHHHHHHHhhh
Q 046121 101 ICNKSLHW-HLF--------------D----------NTESV-----------------LEWHQRYAAAIGTAKGLRFLH 138 (315)
Q Consensus 101 ~~~~~L~~-~l~--------------~----------~~~~~-----------------~~~~~~~~~~~~l~~~l~~lh 138 (315)
++|..+.. .-. . +.... .+......+...+......+-
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99988873 110 0 00000 111122222222223333333
Q ss_pred cccCCCC--eEeecCccCcEEEcCCCc-eeECCCCccc
Q 046121 139 EECRGGP--IIHRDMRPSNILLTHDFV-PMLGDFGLAR 173 (315)
Q Consensus 139 ~~~~~~~--i~h~di~p~nil~~~~~~-i~l~dfg~~~ 173 (315)
...+..+ +||+|+.|.||+++.+.. .-++||+.+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3333335 999999999999999884 7899998774
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.027 Score=48.63 Aligned_cols=30 Identities=17% Similarity=0.172 Sum_probs=27.4
Q ss_pred CCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 144 ~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.+++|+|+.+.|++++.++.+.++||..++
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 379999999999999999999999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.05 Score=48.39 Aligned_cols=81 Identities=15% Similarity=0.082 Sum_probs=52.4
Q ss_pred ccceecCCCceEEEEEEeCCCcEEEEEEecc----cCc---ccHHHHHHHHHHHhhcC--C-CCccceeeeEEecCeeEE
Q 046121 27 KENLLGEGGFGHVYKGELKDGQMIAAKVRKE----AST---QGFAEFQSEVYVLNFAR--H-KNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~----~~~---~~~~~~~~e~~~l~~l~--~-~~i~~~~~~~~~~~~~~l 96 (315)
..+.||.|....||+..+. ++.+++|.-.. .+. ....+...|...|+.+. . ..+++++.++. +..++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 4568899999999999875 44577875331 111 23455566677776664 2 36777887776 34578
Q ss_pred EEEeccC--Ccccccc
Q 046121 97 VYEYICN--KSLHWHL 110 (315)
Q Consensus 97 v~~~~~~--~~L~~~l 110 (315)
+||++++ ..+.+.+
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 8999977 3444443
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0093 Score=52.65 Aligned_cols=74 Identities=15% Similarity=0.122 Sum_probs=46.3
Q ss_pred cceecCCCceEEEEEEeC-CCcEEEEEEe----cc--cCcccHHHHHHHHHHHhhcC--CCCccceeeeEEecCeeEEEE
Q 046121 28 ENLLGEGGFGHVYKGELK-DGQMIAAKVR----KE--ASTQGFAEFQSEVYVLNFAR--HKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~-~~~~~~~k~~----~~--~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~ 98 (315)
.+.||-|....||++.+. +++.+++|-- .. .-+-..++..-|.+.|+... .|..++-+-.+. .....+||
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D-~e~~~~vM 112 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD-SVMNCCVM 112 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC-cHHhhHHH
Confidence 458899999999999875 3567888741 11 11444666777888888764 454444333333 23335667
Q ss_pred Eecc
Q 046121 99 EYIC 102 (315)
Q Consensus 99 ~~~~ 102 (315)
|+++
T Consensus 113 EdL~ 116 (409)
T PRK12396 113 EDLS 116 (409)
T ss_pred HhCc
Confidence 7653
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.039 Score=49.03 Aligned_cols=77 Identities=13% Similarity=0.227 Sum_probs=48.1
Q ss_pred cccceecCCCceEEEEEEeCCC--c-----EEEEEEecccCcccHHHHHHHHHHHhhcCCCCcc-ceeeeEEecCeeEEE
Q 046121 26 SKENLLGEGGFGHVYKGELKDG--Q-----MIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV-MLLGFCCKENLNILV 97 (315)
Q Consensus 26 ~~~~~lg~g~~~~v~~~~~~~~--~-----~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv 97 (315)
..++.|..|-...+|++...++ . .|.+++....... .-.-.+|+.+++.+...++. ++++.+. -+++
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l-~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l 127 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSL-VIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI 127 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCce-EeccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence 3455677798999999865432 1 2444443222222 22346789999999766555 4445443 2689
Q ss_pred EEeccCCccc
Q 046121 98 YEYICNKSLH 107 (315)
Q Consensus 98 ~~~~~~~~L~ 107 (315)
.+|++|.++.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999998875
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.013 Score=50.77 Aligned_cols=104 Identities=15% Similarity=0.165 Sum_probs=70.9
Q ss_pred cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCC
Q 046121 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
....|++|++ .|+++.-. +.....++..++.+.+..+.-+.... ..-|+|+...||+++ .|+|.|+||.
T Consensus 298 ~~y~yl~~kd-hgt~is~i------k~~~~~e~lsff~s~~sil~~lekkf---~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 298 TLYLYLHFKD-HGTPISII------KADRSEEELSFFWSCISILDILEKKF---PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred ceEEEEEEec-CCceeeee------ecccHHHHHHHHHHHHHHHhhhhhcC---Ccccccccccceeee-cCceEEEEee
Confidence 3455778887 46666422 23556777888888888888887775 678999999999999 9999999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCcccccchhh
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAF 211 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvwsl 211 (315)
++.....++..+.. ++--|-.+.|. .+..-+||.+
T Consensus 367 lsRl~~~q~~isy~-----rldhp~lF~G~-dd~QFeIYrl 401 (488)
T COG5072 367 LSRLSYSQGIISYN-----RLDHPDLFNGV-DDYQFEIYRL 401 (488)
T ss_pred eeecccCCceeecc-----ccCchhhhcCc-cceeeeHHHH
Confidence 99744443333222 23344455543 3566677664
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.00068 Score=68.11 Aligned_cols=157 Identities=13% Similarity=0.015 Sum_probs=108.5
Q ss_pred HHHHHhhcCCCCccceeeeEEe--cCeeEEEEEeccCCccccccccCCCCc--cCHHHHHHHHHHHHHHHHhhhccc-CC
Q 046121 69 EVYVLNFARHKNIVMLLGFCCK--ENLNILVYEYICNKSLHWHLFDNTESV--LEWHQRYAAAIGTAKGLRFLHEEC-RG 143 (315)
Q Consensus 69 e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~~~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~-~~ 143 (315)
|..-.+...|+++.....-... ....+.++.++.+|.+.+.+.+..... +....+.....+.+.+..-+|+.. -+
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 3334455678877766554432 334478889999999998886654432 333333323333344455544431 11
Q ss_pred CCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCC
Q 046121 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRK 223 (315)
Q Consensus 144 ~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 223 (315)
+-.+|.++++.|.++..+.++++.++|+.+...+.........+++.|++|+..+.-.++.++|+|..|+.+|...-|..
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~ 1438 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNA 1438 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccH
Confidence 23589999999999999999999999999744444444455677888899998877777888999999999999888887
Q ss_pred cc
Q 046121 224 VV 225 (315)
Q Consensus 224 p~ 225 (315)
+|
T Consensus 1439 ~f 1440 (2724)
T KOG1826|consen 1439 YF 1440 (2724)
T ss_pred HH
Confidence 76
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.19 Score=43.75 Aligned_cols=72 Identities=17% Similarity=0.116 Sum_probs=44.2
Q ss_pred CCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCc--ccee---e--eEEecCeeEEEEEeccCCcc
Q 046121 34 GGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNI--VMLL---G--FCCKENLNILVYEYICNKSL 106 (315)
Q Consensus 34 g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~---~--~~~~~~~~~lv~~~~~~~~L 106 (315)
+....||.....++..+++|+.... ......+..|+..+..+....+ +... + +...++..+.+++++.|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 3445689888777888999987532 2234566677777766642221 1111 1 22335667889999888654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.11 Score=52.24 Aligned_cols=95 Identities=13% Similarity=0.132 Sum_probs=52.1
Q ss_pred CcccHHHHHH-HhcCCccc---ceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcC-------CC
Q 046121 11 MKFSFSEIQQ-ATGDFSKE---NLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-------HK 79 (315)
Q Consensus 11 ~~~~~~~~~~-~~~~y~~~---~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-------~~ 79 (315)
.+.+..++.. ..+.|-+. +.|+ |..-.+|+....++..+++|+...... ...+..|...+..+. .|
T Consensus 9 p~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP 85 (1013)
T PRK06148 9 PEFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVP 85 (1013)
T ss_pred CCCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcC
Confidence 3445555543 34555543 3453 445778888877788899999875422 233344445554442 22
Q ss_pred Ccccee-e----eEEe-cC--eeEEEEEeccCCcccc
Q 046121 80 NIVMLL-G----FCCK-EN--LNILVYEYICNKSLHW 108 (315)
Q Consensus 80 ~i~~~~-~----~~~~-~~--~~~lv~~~~~~~~L~~ 108 (315)
.+++-. + .... ++ ..+-+++|++|.++.+
T Consensus 86 ~~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 86 RLIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAE 122 (1013)
T ss_pred eeeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHh
Confidence 322221 1 1111 22 4567899999988765
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.17 Score=45.99 Aligned_cols=76 Identities=16% Similarity=0.171 Sum_probs=50.4
Q ss_pred ccceecCCCceEEEEEEeCC---------CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCcc-ceeeeEEecCeeEE
Q 046121 27 KENLLGEGGFGHVYKGELKD---------GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV-MLLGFCCKENLNIL 96 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~~---------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~l 96 (315)
-++.|..|-...+|++...+ ++.|++++.......-+ ...+|..+++.+..-++. ++++.+. -+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~ 183 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGR 183 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCE
Confidence 55677888888999986432 45788888766544443 446788888888655554 3444332 356
Q ss_pred EEEeccCCccc
Q 046121 97 VYEYICNKSLH 107 (315)
Q Consensus 97 v~~~~~~~~L~ 107 (315)
+.+|++|.+|.
T Consensus 184 I~efi~g~~l~ 194 (442)
T PTZ00296 184 IEEWLYGDPLR 194 (442)
T ss_pred EEEeeCCccCC
Confidence 78999887654
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.83 E-value=0.048 Score=49.46 Aligned_cols=47 Identities=23% Similarity=0.188 Sum_probs=36.0
Q ss_pred HHHHHHHHHHhhcCCCCccceeeeEEe-cCeeEEEEEeccCCccccccc
Q 046121 64 AEFQSEVYVLNFARHKNIVMLLGFCCK-ENLNILVYEYICNKSLHWHLF 111 (315)
Q Consensus 64 ~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~~~~~~~~L~~~l~ 111 (315)
..+.....+++.++|++...++++..- ..+..+|++++ +.+|.+.+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence 445667888999999999999998753 34567888875 778877764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.74 E-value=0.75 Score=37.62 Aligned_cols=75 Identities=13% Similarity=0.196 Sum_probs=50.7
Q ss_pred ceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcC---CCCccceeeeEEecCeeEEEEEeccCCc
Q 046121 29 NLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR---HKNIVMLLGFCCKENLNILVYEYICNKS 105 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~~~~~~~~ 105 (315)
+.+.-|.--..|...+. ...+.+|+-... ...-+..|+.-|+.+. .-.+.+++.+-.+..+.|+|++|++-++
T Consensus 22 ~~v~gG~inea~~v~dg-~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRDG-TDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeecC-CcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 35666666667766654 556677764332 2234556666666664 4557788888888999999999998877
Q ss_pred cc
Q 046121 106 LH 107 (315)
Q Consensus 106 L~ 107 (315)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 75
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 315 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-58 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-57 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-47 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-33 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-132
Identities = 120/305 (39%), Positives = 186/305 (60%), Gaps = 7/305 (2%)
Query: 4 ELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGF 63
E+++ +FS E+Q A+ +FS +N+LG GGFG VYKG L DG ++A K KE TQG
Sbjct: 11 EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70
Query: 64 -AEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTES--VLEW 120
+FQ+EV +++ A H+N++ L GFC +LVY Y+ N S+ L + ES L+W
Sbjct: 71 ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 121 HQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD- 179
+R A+G+A+GL +LH+ C IIHRD++ +NILL +F ++GDFGLA+ D
Sbjct: 131 PKRQRIALGSARGLAYLHDHCD-PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189
Query: 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQS--LR 237
V T + GT+G++APEY G S +TDV+ +G++LL+L++G++ D+ L
Sbjct: 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 238 QWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297
W + L+++ L L+D ++ +Y E+ + + A LC Q +P RP M EVVR+LEG+
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
Query: 298 NDRFH 302
Sbjct: 310 GLAER 314
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-124
Identities = 106/289 (36%), Positives = 166/289 (57%), Gaps = 8/289 (2%)
Query: 12 KFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVY 71
+ ++++AT +F + L+G G FG VYKG L+DG +A K R S+QG EF++E+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 72 VLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLF--DNTESVLEWHQRYAAAIG 129
L+F RH ++V L+GFC + N IL+Y+Y+ N +L HL+ D + W QR IG
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 130 TAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP--VQTKILG 187
A+GL +LH IIHRD++ NILL +FVP + DFG+++ T D + T + G
Sbjct: 148 AARGLHYLHTRA----IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203
Query: 188 TLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL 247
TLGY+ PEY G ++ ++DVY+FG++L +++ R + + +L +WA
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296
L +++DP + + L TA C+ + E RPSMG+V+ LE
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 343 bits (882), Expect = e-119
Identities = 97/307 (31%), Positives = 155/307 (50%), Gaps = 23/307 (7%)
Query: 4 ELYMKDPMKFSFSEIQQATGDFSKE------NLLGEGGFGHVYKGELKDGQMIAAK---- 53
E+ FSF E++ T +F + N +GEGGFG VYKG + + +A K
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 54 VRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFD- 112
+ + + +F E+ V+ +H+N+V LLGF + LVY Y+ N SL L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 113 NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172
+ L WH R A G A G+ FLHE IHRD++ +NILL F + DFGLA
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH----HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 173 RWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGE 230
R + ++I+GT Y+APE G ++ ++D+Y+FG++LL++++G VD +
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH-- 237
Query: 231 EPQQSLRQWAEPLI-EKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGE 289
Q L E + E+ + + ID ++ + D+ + M A C+ RP + +
Sbjct: 238 REPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 290 VVRLLEG 296
V +LL+
Sbjct: 297 VQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 3e-80
Identities = 72/306 (23%), Positives = 126/306 (41%), Gaps = 28/306 (9%)
Query: 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
+ + + G FG V+K +L + +A K+ Q + + + EVY
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 73 LNFARHKNIVMLLGFCCKENLN----ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAI 128
L +H+NI+ +G + L+ + SL L N + W++ A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAE 128
Query: 129 GTAKGLRFLHEECRGG------PIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP-- 180
A+GL +LHE+ G I HRD++ N+LL ++ + DFGLA
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 181 VQTKILGTLGYLAPEYAENGI-----VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQS 235
+GT Y+APE E I +R D+YA G++L +L S D +E
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 236 LRQ--WAEPLIE---KLALHELIDPRIENSYDTYE-LYLMAKTAYLCVQRNPEGRPSMGE 289
+ P +E ++ +H+ P + + + + + ++ +T C + E R S G
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 290 VVRLLE 295
V +
Sbjct: 309 VGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-64
Identities = 75/319 (23%), Positives = 126/319 (39%), Gaps = 39/319 (12%)
Query: 11 MKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEV 70
M+ + SE + L+G G +G VYKG L D + +A KV A+ Q F + +
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NI 58
Query: 71 YVLNFARHKNIVMLLGFCCKENLNI-----LVYEYICNKSLHWHLFDNTESVLEWHQRYA 125
Y + H NI + + + LV EY N SL +L +T +W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCR 115
Query: 126 AAIGTAKGLRFLHEECRGG-----PIIHRDMRPSNILLTHDFVPMLGDFGLARWKT---- 176
A +GL +LH E G I HRD+ N+L+ +D ++ DFGL+ T
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 177 ----TDDPVQTKILGTLGYLAPEYAENGI-------VSIRTDVYAFGIILLQLMSGRKVV 225
+D +GT+ Y+APE E + + D+YA G+I ++ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 226 DMNGEEPQQSL----RQWAEPLIE---KLALHELIDPRIENSY--DTYELYLMAKTAYLC 276
P+ + P E L E P+ ++ ++ + + +T C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 277 VQRNPEGRPSMGEVVRLLE 295
++ E R + +
Sbjct: 296 WDQDAEARLTAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-54
Identities = 70/275 (25%), Positives = 125/275 (45%), Gaps = 21/275 (7%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKV--RKEASTQGFAEFQSEVYVLNFARHKNI 81
D + + +G G FG V++ E G +A K+ ++ + EF EV ++ RH NI
Sbjct: 38 DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDN-TESVLEWHQRYAAAIGTAKGLRFLHEE 140
V+ +G + +V EY+ SL+ L + L+ +R + A AKG+ +LH
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-- 154
Query: 141 CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENG 200
R PI+HR+++ N+L+ + + DFGL+R K + GT ++APE +
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 201 IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260
+ ++DVY+FG+IL +L + ++P +L + + I +
Sbjct: 215 PSNEKSDVYSFGVILWELAT--------LQQPWGNLNPAQ---VVAAVGFKCKRLEIPRN 263
Query: 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ ++ C P RPS ++ LL
Sbjct: 264 LNPQVAAIIEG----CWTNEPWKRPSFATIMDLLR 294
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-52
Identities = 73/294 (24%), Positives = 121/294 (41%), Gaps = 50/294 (17%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQG-------FAEFQSEVYVLNF 75
+ E +G+GGFG V+KG L D ++A K ++G F EFQ EV++++
Sbjct: 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 76 ARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLR 135
H NIV L G + V E++ L+ L D ++W + + A G+
Sbjct: 80 LNHPNIVKLYG-LMHNPPRM-VMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIE 136
Query: 136 FLHEECRGGPIIHRDMRPSNILLT-----HDFVPMLGDFGLARWKTTDDPVQTKILGTLG 190
++ + PI+HRD+R NI L + DFGL++ + +LG
Sbjct: 137 YMQ--NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLGNFQ 191
Query: 191 YLAPE--YAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248
++APE AE + + D Y+F +IL +++ GE P I +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILT--------GEGPFDEYSYGKIKFINMIR 243
Query: 249 LHEL-------IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
L PR+ N ++ C +P+ RP +V+ L
Sbjct: 244 EEGLRPTIPEDCPPRLRN--------VIEL----CWSGDPKKRPHFSYIVKELS 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-51
Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 27/284 (9%)
Query: 14 SFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVL 73
S I + E ++G G FG V K + + + +A K + S + F E+ L
Sbjct: 1 SLHMIDYK--EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQL 55
Query: 74 NFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFD-NTESVLEWHQRYAAAIGTAK 132
+ H NIV L G C LV EY SL+ L + + ++
Sbjct: 56 SRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDF-VPMLGDFGLARWKTTDDPVQTKILGTLGY 191
G+ +LH + +IHRD++P N+LL V + DFG A T T G+ +
Sbjct: 114 GVAYLHS-MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAW 169
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251
+APE E S + DV+++GIIL ++++ +P + A ++ A+H
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVIT--------RRKPFDEIGGPAFRIMW--AVHN 219
Query: 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
P + + LM + C ++P RPSM E+V+++
Sbjct: 220 GTRPPLIKNLPKPIESLMTR----CWSKDPSQRPSMEEIVKIMT 259
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-49
Identities = 73/301 (24%), Positives = 117/301 (38%), Gaps = 40/301 (13%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSE--VYVLNFARHKNI 81
+G+G +G V+ G+ + G+ +A KV T A + E +Y RH+NI
Sbjct: 38 QIQMVKQIGKGRYGEVWMGKWR-GEKVAVKV---FFTTEEASWFRETEIYQTVLMRHENI 93
Query: 82 VMLLGFCCKENLNI----LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFL 137
+ + K + L+ +Y N SL+ +L T L+ A + GL L
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHL 150
Query: 138 HEECRGG----PIIHRDMRPSNILLTHDFVPMLGDFGLAR----WKTTDDPVQTKILGTL 189
H E I HRD++ NIL+ + + D GLA D +GT
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 190 GYLAPE------YAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL 243
Y+ PE + I D+Y+FG+IL ++ R V EE Q + + +
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLP---YHDLV 266
Query: 244 IEKLALHELID--------PRIENSYDTYE-LYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294
+ ++ + P N + + E L M K C NP R + V + L
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
Query: 295 E 295
Sbjct: 327 A 327
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 4e-49
Identities = 58/286 (20%), Positives = 104/286 (36%), Gaps = 44/286 (15%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKV--RKEASTQGFAEFQSEVYVLNFARHKNI 81
+ L E G ++KG + G I KV ++ ST+ +F E L H N+
Sbjct: 11 QLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 82 VMLLGFCCKENLNIL--VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
+ +LG C + ++ SL+ L + T V++ Q A+ A+G+ FLH
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH- 128
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE---Y 196
I + ++++ D + + + ++APE
Sbjct: 129 -TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEALQK 182
Query: 197 AENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL---- 252
D+++F ++L +L++ E P L + K+AL L
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVT--------REVPFADLSNME--IGMKVALEGLRPTI 232
Query: 253 ---IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
I P + LM C+ +P RP +V +LE
Sbjct: 233 PPGISPHVSK--------LMKI----CMNEDPAKRPKFDMIVPILE 266
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-48
Identities = 66/291 (22%), Positives = 113/291 (38%), Gaps = 42/291 (14%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
D +LG+G FG K ++ G+++ K + F EV V+ H N++
Sbjct: 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 83 MLLGFCCKE-NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
+G K+ LN + EYI +L + +S W QR + A A G+ +LH
Sbjct: 71 KFIGVLYKDKRLNF-ITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM- 127
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR--------------WKTTDDPVQTKILG 187
IIHRD+ N L+ + ++ DFGLAR K D + ++G
Sbjct: 128 ---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 188 TLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKV---VDMNGEEPQQSLRQWAEPLI 244
++APE + DV++FGI+L +++ + ++R + +
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244
Query: 245 EKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ + C +PE RPS ++ LE
Sbjct: 245 PPNCPPSFFP-------------ITVR----CCDLDPEKRPSFVKLEHWLE 278
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-47
Identities = 74/292 (25%), Positives = 118/292 (40%), Gaps = 47/292 (16%)
Query: 24 DFSK---ENLLGEGGFGHVYKGELKDGQMIAAKVRK----EASTQGFAEFQSEVYVLNFA 76
DF++ E ++G GGFG VY+ G +A K + E +Q + E +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 77 RHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRF 136
+H NI+ L G C KE LV E+ L+ L + A+ A+G+ +
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNY 120
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPM--------LGDFGLARWKTTDDPVQTKILGT 188
LH+E PIIHRD++ SNIL+ + DFGLAR + G
Sbjct: 121 LHDEAI-VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGA 177
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLR--QWAEPLIEK 246
++APE + S +DV+++G++L +L++ GE P + + A +
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLT--------GEVPFRGIDGLAVAYGVAMN 229
Query: 247 ---LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
L + LM C +P RPS ++ L
Sbjct: 230 KLALPIPSTCPEPFAK--------LMED----CWNPDPHSRPSFTNILDQLT 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-47
Identities = 81/274 (29%), Positives = 137/274 (50%), Gaps = 30/274 (10%)
Query: 31 LGEGGFGHVYKGELKDGQMIAAKV--RKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFC 88
+G G FG VYKG+ G +A K+ + Q F++EV VL RH NI++ +G+
Sbjct: 32 IGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 89 CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIH 148
L I V ++ SL+ HL +E+ E + A TA+G+ +LH + IIH
Sbjct: 90 TAPQLAI-VTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAK----SIIH 143
Query: 149 RDMRPSNILLTHDFVPMLGDFGLARWK--TTDDPVQTKILGTLGYLAPE---YAENGIVS 203
RD++ +NI L D +GDFGLA K + ++ G++ ++APE ++ S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 204 IRTDVYAFGIILLQLMSGRK-VVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYD 262
++DVYAFGI+L +LM+G+ ++N Q + + + +L + N
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEM-----VGRGSLSPDLSKVRSNCPK 256
Query: 263 TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ LMA+ C+++ + RPS ++ +E
Sbjct: 257 --RMKRLMAE----CLKKKRDERPSFPRILAEIE 284
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-46
Identities = 67/299 (22%), Positives = 121/299 (40%), Gaps = 36/299 (12%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
D + +G+G +G V++G + G+ +A K+ + + ++E+Y RH+NI+
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWF-RETELYNTVMLRHENILG 66
Query: 84 LLGFCCKENLNI----LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
+ + L+ Y SL+ +L T L+ + A GL LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHI 123
Query: 140 ECRGG----PIIHRDMRPSNILLTHDFVPMLGDFGLARWK----TTDDPVQTKILGTLGY 191
E G I HRD++ NIL+ + + D GLA D +GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 192 LAPE------YAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE 245
+APE + R D++AFG++L ++ R V + E+ + + + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPP---FYDVVPN 239
Query: 246 KLALHELID--------PRIENSYDTYE-LYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ ++ P I N + + L +AK C +NP R + + + L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-46
Identities = 74/295 (25%), Positives = 126/295 (42%), Gaps = 36/295 (12%)
Query: 28 ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGF 87
+ +G+G FG V++G+ + G+ +A K+ + + ++E+Y RH+NI+ +
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAA 104
Query: 88 CCKENLNI----LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
K+N LV +Y + SL +L T + A+ TA GL LH E G
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 144 G----PIIHRDMRPSNILLTHDFVPMLGDFGLARWK----TTDDPVQTKILGTLGYLAPE 195
I HRD++ NIL+ + + D GLA T D +GT Y+APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 196 YAENGI------VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249
++ I R D+YA G++ ++ R + E+ Q + + + ++
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLP---YYDLVPSDPSV 277
Query: 250 HELID--------PRIENSYDTYE-LYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E+ P I N + + E L +MAK C N R + + + L
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-44
Identities = 60/296 (20%), Positives = 114/296 (38%), Gaps = 52/296 (17%)
Query: 24 DFSK---ENLLGEGGFGHVYKGELKDGQMIAAKV--RKEASTQGFAEFQSEVYVLNFARH 78
F + L+G+G FG VY G G+ +A ++ + + F+ EV RH
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRWH-GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
+N+V+ +G C ++ ++L+ + + + VL+ ++ A KG+ +LH
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ-----TKILGTLGYLA 193
+ I+H+D++ N+ + V ++ DFGL + G L +LA
Sbjct: 148 AK----GILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 194 PE---------YAENGIVSIRTDVYAFGIILLQLMSGRK-VVDMNGEEP----QQSLRQW 239
PE + S +DV+A G I +L + E ++
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP- 261
Query: 240 AEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
L + E+ D ++ C E RP+ +++ +LE
Sbjct: 262 --NLSQIGMGKEISD-------------ILLF----CWAFEQEERPTFTKLMDMLE 298
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-35
Identities = 67/286 (23%), Positives = 105/286 (36%), Gaps = 44/286 (15%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNI 81
D +G G FG V+ G L+ D ++A K +E A+F E +L H NI
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
V L+G C ++ +V E + L L A G+ +L +
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESK- 232
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY--LAPEYAEN 199
IHRD+ N L+T V + DFG++R + + L + APE
Sbjct: 233 ---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 200 GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259
G S +DV++FGI+L + S G P L+ + + +E
Sbjct: 290 GRYSSESDVWSFGILLWETFS-------LGASPYP-----------NLSNQQTRE-FVEK 330
Query: 260 SY----------DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ LM + C P RPS + + L+
Sbjct: 331 GGRLPCPELCPDAVFR--LMEQ----CWAYEPGQRPSFSTIYQELQ 370
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 6e-33
Identities = 70/283 (24%), Positives = 120/283 (42%), Gaps = 40/283 (14%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQM-IAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
D + ++ LG G +G VY+G K + +A K KE + + EF E V+ +H N+V
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLV 279
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
LLG C +E ++ E++ +L +L + + A + + +L ++
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN- 338
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY--LAPEYAENG 200
IHR++ N L+ + + + DFGL+R T D APE
Sbjct: 339 ---FIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 201 IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260
SI++DV+AFG++L ++ + G P + L ++ + +E
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPG-----------IDLSQVYE-LLEKD 435
Query: 261 YDTY-------ELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
Y ++Y LM C Q NP RPS E+ + E
Sbjct: 436 YRMERPEGCPEKVYELM----RACWQWNPSDRPSFAEIHQAFE 474
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-33
Identities = 76/282 (26%), Positives = 115/282 (40%), Gaps = 40/282 (14%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
E LG+G FG V+ G +A K K + F E V+ RH+ +V
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ 243
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L +E + I V EY+ SL L T L Q A A G+ ++
Sbjct: 244 LYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 300
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY--LAPEYAENGI 201
+HRD+R +NIL+ + V + DFGLAR D+ + APE A G
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 202 VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261
+I++DV++FGI+L +L + G P + E++D ++E Y
Sbjct: 358 FTIKSDVWSFGILLTELTT-------KGRVPYP-----------GMVNREVLD-QVERGY 398
Query: 262 DTY-------ELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
L+ LM C ++ PE RP+ + LE
Sbjct: 399 RMPCPPECPESLHDLM----CQCWRKEPEERPTFEYLQAFLE 436
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 76/282 (26%), Positives = 115/282 (40%), Gaps = 40/282 (14%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
E LG+G FG V+ G +A K K + F E V+ RH+ +V
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ 326
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L +E + I V EY+ SL L T L Q A A G+ ++
Sbjct: 327 LYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 383
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY--LAPEYAENGI 201
+HRD+R +NIL+ + V + DFGLAR D+ + APE A G
Sbjct: 384 --YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 202 VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261
+I++DV++FGI+L +L + G P + E++D ++E Y
Sbjct: 441 FTIKSDVWSFGILLTELTT-------KGRVPYP-----------GMVNREVLD-QVERGY 481
Query: 262 DTY-------ELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
L+ LM C ++ PE RP+ + LE
Sbjct: 482 RMPCPPECPESLHDLM----CQCWRKEPEERPTFEYLQAFLE 519
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 64/275 (23%), Positives = 106/275 (38%), Gaps = 34/275 (12%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV--RKEASTQGFAEFQSEVYVL-NFARHK 79
F + + LG G +G V+K +DG++ A K + A +EV +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 80 NIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWH-QRYAAAIGTAKGLRFL 137
V L + L + E C SL H S+ E Y L L
Sbjct: 118 CCVRLEQAWEEGGILYL-QTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDT--LLALAHL 173
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYA 197
H +G ++H D++P+NI L LGDFGL T + + G Y+APE
Sbjct: 174 HS--QG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAPELL 228
Query: 198 ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257
+ DV++ G+ +L++ ++ +G E Q LRQ P P
Sbjct: 229 QGSY-GTAADVFSLGLTILEVACNMEL--PHGGEGWQQLRQGYLP------------PEF 273
Query: 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
+ EL + + ++ +P+ R + ++
Sbjct: 274 TAGL-SSELRSVLV---MMLEPDPKLRATAEALLA 304
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-32
Identities = 63/293 (21%), Positives = 123/293 (41%), Gaps = 55/293 (18%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQM-----IAAKVRKEASTQG-FAEFQSEVYVLNFAR 77
+F K +LG G FG VYKG +A K +EA++ E E YV+
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 78 HKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESV-----LEWHQRYAAAIGTAK 132
+ ++ LLG C + + + + + L ++ ++ +++ L W + AK
Sbjct: 76 NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 128
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL--G 190
G+ +L E+ R ++HRD+ N+L+ + DFGLA+ ++ G +
Sbjct: 129 GMNYL-EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 191 YLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250
++A E + I + ++DV+++G+ + +LM+ G +P +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTF-------GSKPYDGIP-----------AS 226
Query: 251 ELIDPRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E+ +E T ++Y +M K C + + RP E++
Sbjct: 227 EISS-ILEKGERLPQPPICTIDVYMIMRK----CWMIDADSRPKFRELIIEFS 274
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 71/282 (25%), Positives = 117/282 (41%), Gaps = 40/282 (14%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
E LG G FG V+ +A K K S F +E V+ +H +V
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVK 247
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L KE + I + E++ SL L + S + + A+G+ F+ +
Sbjct: 248 LHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 304
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY--LAPEYAENGI 201
IHRD+R +NIL++ V + DFGLAR D+ + APE G
Sbjct: 305 --YIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 202 VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261
+I++DV++FGI+L+++++ G P ++ E+I +E Y
Sbjct: 362 FTIKSDVWSFGILLMEIVTY-------GRIPYP-----------GMSNPEVIR-ALERGY 402
Query: 262 DTY-------ELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
ELY +M + C + PE RP+ + +L+
Sbjct: 403 RMPRPENCPEELYNIMMR----CWKNRPEERPTFEYIQSVLD 440
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 64/294 (21%), Positives = 112/294 (38%), Gaps = 40/294 (13%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-----DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARH 78
+ LG+G FG V G ++A K + + +FQ E+ +L
Sbjct: 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 83
Query: 79 KNIVMLLGFCCKENLN--ILVYEYICNKSLHWHLFDNTESVLEWHQ-RYAAAIGTAKGLR 135
IV G LV EY+ + L L + + Y++ I KG+
Sbjct: 84 DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI--CKGME 141
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYL 192
+L R +HRD+ NIL+ + + DFGLA+ D + +
Sbjct: 142 YL-GSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 193 APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE---PLIEKLAL 249
APE + I S ++DV++FG++L +L + ++ ++ + AL
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT-------YCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 250 HELIDPRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
L++ +E E++ LM C +P+ RPS + L+
Sbjct: 251 SRLLE-LLEEGQRLPAPPACPAEVHELMKL----CWAPSPQDRPSFSALGPQLD 299
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 52/286 (18%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
+ +G+G FG V G+ + G +A K K +T F +E V+ RH N+V
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 250
Query: 84 LLGFCCKENLNI-LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
LLG +E + +V EY+ SL +L SVL ++ + + +L
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 309
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD-----PVQTKILGTLGYLAPEYA 197
+HRD+ N+L++ D V + DFGL + ++ PV+ + APE
Sbjct: 310 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--------WTAPEAL 358
Query: 198 ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257
S ++DV++FGI+L ++ S G P + L +++ R+
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYS-------FGRVPYPR-----------IPLKDVVP-RV 399
Query: 258 ENSYDTY-------ELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E Y +Y +M C + RP+ ++ LE
Sbjct: 400 EKGYKMDAPDGCPPAVYDVMKN----CWHLDAATRPTFLQLREQLE 441
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-31
Identities = 64/304 (21%), Positives = 120/304 (39%), Gaps = 41/304 (13%)
Query: 23 GDFSKENLLGEGGFGHVYKGE-LKDGQMIAAK---VRKEASTQGFAEFQSEVYVLNFARH 78
+F E +G G F VY+ L DG +A K + + A+ E+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 79 KNIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTES--------VLEWHQRYAAAIG 129
N++ F LNI V E L + + V ++ +
Sbjct: 92 PNVIKYYASFIEDNELNI-VLELADAGDLSRMIKHFKKQKRLIPERTVWKY------FVQ 144
Query: 130 TAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL 189
L +H ++HRD++P+N+ +T V LGD GL R+ ++ ++GT
Sbjct: 145 LCSALEHMHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 200
Query: 190 GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249
Y++PE + ++D+++ G +L ++ + + + L +K+
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--------LCKKI-E 251
Query: 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLGEKFV 309
P + Y + EL + +C+ +PE RP + V + + R H +
Sbjct: 252 QCDYPPLPSDHY-SEELRQLVN---MCINPDPEKRPDVTYVYDVAK----RMHACTASSL 303
Query: 310 QRHH 313
+ HH
Sbjct: 304 EHHH 307
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 70/293 (23%), Positives = 119/293 (40%), Gaps = 37/293 (12%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-----DGQMIAAKVRKE-ASTQGFAEFQSEVYVLNFAR 77
+ LGEG FG V G+ +A K K + A+ + E+ +L
Sbjct: 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 81
Query: 78 HKNIVMLLGFCCKENLN--ILVYEYICNKSLHWHLFDNTESVLEWHQ-RYAAAIGTAKGL 134
H+NIV G C ++ N L+ E++ + SL +L N + Q +YA I KG+
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI--CKGM 139
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGY 191
+L + +HRD+ N+L+ + +GDFGL + TD T + +
Sbjct: 140 DYL-GSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250
APE I +DV++FG+ L +L++ P + P ++ +
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDS-----DSSPMALFLKMIGPTHGQMTVT 250
Query: 251 ELIDPRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
L++ ++ E+Y LM K C + P R S ++ E
Sbjct: 251 RLVN-TLKEGKRLPCPPNCPDEVYQLMRK----CWEFQPSNRTSFQNLIEGFE 298
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 66/291 (22%), Positives = 122/291 (41%), Gaps = 33/291 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-----DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARH 78
LG+G FG V G+++A K + ++ + +F+ E+ +L +H
Sbjct: 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 70
Query: 79 KNIVMLLGFCCKENLN--ILVYEYICNKSLHWHLFDNTESVLEWHQ-RYAAAIGTAKGLR 135
NIV G C L+ EY+ SL +L + E + +Y + I KG+
Sbjct: 71 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI--CKGME 128
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYL 192
+L R IHRD+ NIL+ ++ +GDFGL + D + +
Sbjct: 129 YL-GTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 193 APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252
APE S+ +DV++FG++L +L + + E + + + ++ + L
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG---QMIVFHL 241
Query: 253 IDPRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
I+ ++N+ E+Y +M + C N RPS ++ ++
Sbjct: 242 IE-LLKNNGRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVD 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-30
Identities = 65/291 (22%), Positives = 122/291 (41%), Gaps = 33/291 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGEL-----KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARH 78
LG+G FG V G+++A K + ++ + +F+ E+ +L +H
Sbjct: 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 101
Query: 79 KNIVMLLGFCCKENLN--ILVYEYICNKSLHWHLFDNTESVLEWHQ-RYAAAIGTAKGLR 135
NIV G C L+ EY+ SL +L + E + +Y + I KG+
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI--CKGME 159
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYL 192
+L + IHRD+ NIL+ ++ +GDFGL + D + +
Sbjct: 160 YLGTKR----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215
Query: 193 APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252
APE S+ +DV++FG++L +L + + E + + + ++ + L
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG---QMIVFHL 272
Query: 253 IDPRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
I+ ++N+ E+Y +M + C N RPS ++ ++
Sbjct: 273 IE-LLKNNGRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVD 318
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-30
Identities = 73/284 (25%), Positives = 123/284 (43%), Gaps = 42/284 (14%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQM-IAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
D + ++ LG G +G VY+G K + +A K KE + + EF E V+ +H N+V
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLV 72
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
LLG C +E ++ E++ +L +L + + A + + +L ++
Sbjct: 73 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN- 131
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL---GYLAPEYAEN 199
IHRD+ N L+ + + + DFGL+R T D T G + APE
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAY 186
Query: 200 GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259
SI++DV+AFG++L ++ + G P + L ++ + +E
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATY-------GMSPYP-----------GIDLSQVYE-LLEK 227
Query: 260 SYDTY-------ELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
Y ++Y LM C Q NP RPS E+ + E
Sbjct: 228 DYRMERPEGCPEKVYELMRA----CWQWNPSDRPSFAEIHQAFE 267
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-30
Identities = 62/289 (21%), Positives = 116/289 (40%), Gaps = 54/289 (18%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
+ + +G G FG V+ G + +A K +E + +F E V+ H +V
Sbjct: 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQ 67
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L G C ++ LV E++ + L +L + + +G+ +L EE
Sbjct: 68 LYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYL-EEAC- 124
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD---------PVQTKILGTLGYLAP 194
+IHRD+ N L+ + V + DFG+ R+ D PV+ + +P
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--------WASP 174
Query: 195 EYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254
E S ++DV++FG+++ ++ S G+ P + + E+++
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSE-------GKIPYE-----------NRSNSEVVE 216
Query: 255 PRIENSYDTY-------ELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
I + Y +Y +M C + PE RP+ ++R L
Sbjct: 217 -DISTGFRLYKPRLASTHVYQIMNH----CWRERPEDRPAFSRLLRQLA 260
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 63/293 (21%), Positives = 123/293 (41%), Gaps = 55/293 (18%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQM-----IAAKVRKEASTQG-FAEFQSEVYVLNFAR 77
+F K +LG G FG VYKG +A K +EA++ E E YV+
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 78 HKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESV-----LEWHQRYAAAIGTAK 132
+ ++ LLG C + + + + + L ++ ++ +++ L W + AK
Sbjct: 76 NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 128
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL--G 190
G+ +L E+ R ++HRD+ N+L+ + DFGLA+ ++ G +
Sbjct: 129 GMNYL-EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 191 YLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250
++A E + I + ++DV+++G+ + +LM+ G +P +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTF-------GSKPYDGIP-----------AS 226
Query: 251 ELIDPRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E+ +E T ++Y +M K C + + RP E++
Sbjct: 227 EISS-ILEKGERLPQPPICTIDVYMIMVK----CWMIDADSRPKFRELIIEFS 274
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-30
Identities = 78/310 (25%), Positives = 116/310 (37%), Gaps = 65/310 (20%)
Query: 25 FSKENL-----LGEGGFGHVYKGELKD------GQMIAAKVRKE-ASTQGFAEFQSEVYV 72
F + L LG G FG V + +A K+ K A SE+ V
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 73 L-NFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGT- 130
L H NIV LLG C +++ EY C L L +S + A
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 131 ---------------AKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175
AKG+ FL + IHRD+ NILLTH + + DFGLAR
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFL--ASKN--CIHRDLAARNILLTHGRITKICDFGLAR-D 194
Query: 176 TTDDPVQTKILGTLGYL-----APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGE 230
+D L APE N + + +DV+++GI L +L S G
Sbjct: 195 IKNDSNYVV--KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL-------GS 245
Query: 231 EPQQSLRQWAEPLIEKLALHELID----PRIENSYDTYELY-LMAKTAYLCVQRNPEGRP 285
P + ++ + + E++ E+Y +M C +P RP
Sbjct: 246 SPYPGMPVDSK------FYKMIKEGFRMLSPEHAPA--EMYDIMKT----CWDADPLKRP 293
Query: 286 SMGEVVRLLE 295
+ ++V+L+E
Sbjct: 294 TFKQIVQLIE 303
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-30
Identities = 70/286 (24%), Positives = 119/286 (41%), Gaps = 52/286 (18%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
+ +G+G FG V G+ + G +A K K +T F +E V+ RH N+V
Sbjct: 22 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 78
Query: 84 LLGFCCKENLNI-LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
LLG +E + +V EY+ SL +L SVL ++ + + +L
Sbjct: 79 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 137
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD-----PVQTKILGTLGYLAPEYA 197
+HRD+ N+L++ D V + DFGL + ++ PV+ + APE
Sbjct: 138 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--------WTAPEAL 186
Query: 198 ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257
S ++DV++FGI+L ++ S G P ++ L +++ R+
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSF-------GRVPYP-----------RIPLKDVVP-RV 227
Query: 258 ENSYDTY-------ELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E Y +Y +M C + RPS ++ LE
Sbjct: 228 EKGYKMDAPDGCPPAVYEVMKN----CWHLDAAMRPSFLQLREQLE 269
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 71/289 (24%), Positives = 112/289 (38%), Gaps = 53/289 (18%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKNI 81
DF + L+G GGFG V+K + DG+ K V+ + + EV L H NI
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNI 66
Query: 82 VMLLGF-----------------CCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRY 124
V G + L I E+ +L + L+
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFI-QMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 125 AAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK 184
KG+ ++H + +I+RD++PSNI L +GDFGL +D +T+
Sbjct: 126 ELFEQITKGVDYIHSKK----LINRDLKPSNIFLVDTKQVKIGDFGLVT-SLKNDGKRTR 180
Query: 185 ILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI 244
GTL Y++PE + D+YA G+IL +L+
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD------------------TAF 222
Query: 245 EKLALHELI-DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
E + D I + +D E L+ K + + PE RP+ E++R
Sbjct: 223 ETSKFFTDLRDGIISDIFDKKEKTLLQK----LLSKKPEDRPNTSEILR 267
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-29
Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 40/282 (14%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
LG G FG V+ G +A K K+ S F +E ++ +H+ +V
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR 72
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L +E + I + EY+ N SL L + L ++ A A+G+ F+ E
Sbjct: 73 LYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY--LAPEYAENGI 201
IHRD+R +NIL++ + DFGLAR D+ + APE G
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 202 VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261
+I++DV++FGI+L ++++ G P + E+I +E Y
Sbjct: 187 FTIKSDVWSFGILLTEIVTH-------GRIPYP-----------GMTNPEVIQ-NLERGY 227
Query: 262 DTY-------ELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
ELY LM LC + PE RP+ + +LE
Sbjct: 228 RMVRPDNCPEELYQLM----RLCWKERPEDRPTFDYLRSVLE 265
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 79/301 (26%), Positives = 122/301 (40%), Gaps = 67/301 (22%)
Query: 28 ENLLGEGGFGHVYKGELKDG---QMIAAKVRKE-ASTQGFAEFQSEVYVL-NFARHKNIV 82
++++GEG FG V K +K A K KE AS +F E+ VL H NI+
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHL--------------FDNTESVLEWHQRYAAAI 128
LLG C L EY + +L L ++T S L Q A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 129 GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT 188
A+G+ +L + IHRD+ NIL+ ++V + DFGL+R V K T
Sbjct: 150 DVARGMDYL--SQKQ--FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK--KT 199
Query: 189 LGYL-----APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL 243
+G L A E + + +DV+++G++L +++S G P
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL-------GGTPYCG-------- 244
Query: 244 IEKLALHELID--------PRIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLL 294
+ EL + + N D E+Y LM + C + P RPS +++ L
Sbjct: 245 ---MTCAELYEKLPQGYRLEKPLNCDD--EVYDLMRQ----CWREKPYERPSFAQILVSL 295
Query: 295 E 295
Sbjct: 296 N 296
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 68/301 (22%), Positives = 115/301 (38%), Gaps = 57/301 (18%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
+ LGEGGF +V E L DG A K Q E Q E + H NI+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 83 MLLGFCCKENLN----ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAA------IGTAK 132
L+ +C +E L+ + +L ++ E + + +G +
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTL----WNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL------ 186
GL +H + HRD++P+NILL + P+L D G + L
Sbjct: 146 GLEAIHAK----GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 187 ---GTLGYLAPEYAE---NGIVSIRTDVYAFGIILLQLMSGR---KVVDMNGEEPQQSLR 237
T+ Y APE + ++ RTDV++ G +L +M G +V G+ +++
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261
Query: 238 -QWAEPLIEKL--ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294
Q + P + AL +L++ + +P RP + ++ L
Sbjct: 262 NQLSIPQSPRHSSALWQLLN--------------------SMMTVDPHQRPHIPLLLSQL 301
Query: 295 E 295
E
Sbjct: 302 E 302
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 65/278 (23%), Positives = 115/278 (41%), Gaps = 38/278 (13%)
Query: 22 TGDFSKEN-LLGEGGFGHVYKG-ELKDGQMIAAKV--RKEASTQGFAEFQSEVYVLNFAR 77
G F K + +G G F VYKG + + +A ++ + F+ E +L +
Sbjct: 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 83
Query: 78 HKNIVMLLGFCC-----KENLNILVYEYICNKSLHWHLFDN---TESVLEWHQRYAAAIG 129
H NIV K+ + + V E + + +L +L VL + + I
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVL-VTELMTSGTLKTYLKRFKVMKIKVL---RSWCRQI- 138
Query: 130 TAKGLRFLHEECRGGPIIHRDMRPSNILLTH-DFVPMLGDFGLARWKTTDDPVQTKILGT 188
KGL+FLH R PIIHRD++ NI +T +GD GLA ++GT
Sbjct: 139 -LKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA--TLKRASFAKAVIGT 193
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248
++APE E DVYAFG+ +L++ + + + + + ++ +
Sbjct: 194 PEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE--YPYSECQNAAQIYRRVTSGVKPAS 250
Query: 249 LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS 286
++ P ++ + C+++N + R S
Sbjct: 251 FDKVAIPEVKE-------IIE-----GCIRQNKDERYS 276
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 63/289 (21%), Positives = 112/289 (38%), Gaps = 54/289 (18%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
D + LG G FG V G+ + +A K+ KE S EF E V+ H+ +V
Sbjct: 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQ 83
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L G C K+ ++ EY+ N L +L + + Q + + +L E +
Sbjct: 84 LYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYL-ESKQ- 140
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD---------PVQTKILGTLGYLAP 194
+HRD+ N L+ V + DFGL+R+ D+ PV+ + P
Sbjct: 141 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR--------WSPP 190
Query: 195 EYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254
E S ++D++AFG+++ ++ S G+ P + + E +
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSL-------GKMPYE-----------RFTNSETAE 232
Query: 255 PRIENSYDTY-------ELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
I Y ++Y +M C + RP+ ++ +
Sbjct: 233 -HIAQGLRLYRPHLASEKVYTIMYS----CWHEKADERPTFKILLSNIL 276
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-29
Identities = 71/313 (22%), Positives = 119/313 (38%), Gaps = 65/313 (20%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQM--------IAAKVRKEASTQGFAEFQSEVYVLNF 75
D LG+G F ++KG ++ + KV +A F +++
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 76 ARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLR 135
HK++V+ G C + NILV E++ SL +L N ++ + + A A +
Sbjct: 69 LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMH 127
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPM--------LGDFGLARWKTTDDPVQTKILG 187
FL EE +IH ++ NILL + L D G++ D +Q +I
Sbjct: 128 FL-EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW 183
Query: 188 TLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK 246
PE EN ++ TD ++FG L ++ SG G++P +
Sbjct: 184 V----PPECIENPKNLNLATDKWSFGTTLWEICSG-------GDKPLSA----------- 221
Query: 247 LALHELIDPRIENSY-----DTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE----- 295
L + E+ + EL L+ C+ P+ RPS ++R L
Sbjct: 222 LDSQRKLQ-FYEDRHQLPAPKAAELANLINN----CMDYEPDHRPSFRAIIRDLNSLFTP 276
Query: 296 -----GENDRFHH 303
G + HH
Sbjct: 277 DLVPRGSHHHHHH 289
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 73/298 (24%), Positives = 117/298 (39%), Gaps = 59/298 (19%)
Query: 31 LGEGGFGHVYKGELKD------GQMIAAK-VRKEASTQGFAEFQSEVYVL-NFARHKNIV 82
LG G FG V + + + +A K +++ A+ SE+ +L + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 83 MLLGFCCKENLNI-LVYEYICNKSLHWHL--------------FDNTESVLEWHQRYAAA 127
LLG C K + ++ E+ +L +L D + L +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 128 IGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILG 187
AKG+ FL R IHRD+ NILL+ V + DFGLAR D +
Sbjct: 155 FQVAKGMEFL--ASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVR--K 207
Query: 188 TLGYL-----APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP 242
L APE + + +I++DV++FG++L ++ S G P ++ E
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-------GASPYPGVKIDEE- 259
Query: 243 LIEKLALHELID----PRIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
L + + + T E+Y M C P RP+ E+V L
Sbjct: 260 -----FCRRLKEGTRMRAPDYT--TPEMYQTMLD----CWHGEPSQRPTFSELVEHLG 306
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 55/293 (18%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQM-----IAAKVRKE-ASTQGFAEFQSEVYVLNFAR 77
+ K +LG G FG V+KG + KV ++ + Q F + +
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 78 HKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESV-----LEWHQRYAAAIGTAK 132
H +IV LLG C +L + V +Y+ SL H+ + ++ L W + AK
Sbjct: 74 HAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAK 126
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL--G 190
G+ +L EE ++HR++ N+LL + DFG+A DD
Sbjct: 127 GMYYL-EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 191 YLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250
++A E G + ++DV+++G+ + +LM+ G EP LR L
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTF-------GAEPYAGLR-----------LA 224
Query: 251 ELIDPRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E+ D +E T ++Y +M K C + RP+ E+
Sbjct: 225 EVPD-LLEKGERLAQPQICTIDVYMVMVK----CWMIDENIRPTFKELANEFT 272
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-29
Identities = 72/282 (25%), Positives = 112/282 (39%), Gaps = 40/282 (14%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
+ + LG G FG V G+ K +A K+ KE S EF E + H +V
Sbjct: 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVK 67
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
G C KE +V EYI N L +L + + LE Q +G+ FL E
Sbjct: 68 FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL--ESHQ 124
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY--LAPEYAENGI 201
IHRD+ N L+ D + DFG+ R+ DD + + APE
Sbjct: 125 --FIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFHYFK 181
Query: 202 VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261
S ++DV+AFGI++ ++ S G+ P E++ ++ +
Sbjct: 182 YSSKSDVWAFGILMWEVFSL-------GKMPYD-----------LYTNSEVVL-KVSQGH 222
Query: 262 DTY-------ELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
Y +Y +M C PE RP+ +++ +E
Sbjct: 223 RLYRPHLASDTIYQIMYS----CWHELPEKRPTFQQLLSSIE 260
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-29
Identities = 66/292 (22%), Positives = 114/292 (39%), Gaps = 37/292 (12%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-----GQMIAAKVRKE-ASTQGFAEFQSEVYVLNFAR 77
K LGEG FG V G+M+A K K A Q + ++ E+ +L
Sbjct: 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY 91
Query: 78 HKNIVMLLGFCCKENLN--ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLR 135
H++I+ G C LV EY+ SL +L ++ + Q A +G+
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMA 148
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYL 192
+L IHRD+ N+LL +D + +GDFGLA+ + +
Sbjct: 149 YL-HAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204
Query: 193 APEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251
APE + +DV++FG+ L +L++ + P + ++ +
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDS-----SQSPPTKFLELIGIAQGQMTVLR 259
Query: 252 LIDPRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
L + +E E+Y LM C + RP+ ++ +L+
Sbjct: 260 LTE-LLERGERLPRPDKCPAEVYHLMKN----CWETEASFRPTFENLIPILK 306
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 77/332 (23%), Positives = 133/332 (40%), Gaps = 75/332 (22%)
Query: 9 DPMKFSFSEIQQATGD---FSKENL-----LGEGGFGHVYKGELKD--------GQMIAA 52
DPM SE + F ++ L LGEG FG V E +A
Sbjct: 13 DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAV 72
Query: 53 K-VRKEASTQGFAEFQSEVYVL-NFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHL 110
K ++ +A+ + ++ SE+ ++ +HKNI+ LLG C ++ ++ EY +L +L
Sbjct: 73 KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 111 FDNTESVLEWHQRYAAAIGT--------------AKGLRFLHEECRGGPIIHRDMRPSNI 156
+E+ A+G+ +L + IHRD+ N+
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQK--CIHRDLAARNV 188
Query: 157 LLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL-----APEYAENGIVSIRTDVYAF 211
L+T + V + DFGLAR D K T G L APE + + + ++DV++F
Sbjct: 189 LVTENNVMKIADFGLARDINNID-YYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
Query: 212 GIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYD-------TY 264
G+++ ++ + G P + + EL ++ + T
Sbjct: 246 GVLMWEIFTL-------GGSPYPG-----------IPVEELFK-LLKEGHRMDKPANCTN 286
Query: 265 ELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
ELY +M C P RP+ ++V L+
Sbjct: 287 ELYMMMRD----CWHAVPSQRPTFKQLVEDLD 314
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 8e-29
Identities = 71/306 (23%), Positives = 117/306 (38%), Gaps = 61/306 (19%)
Query: 25 FSKENL-----LGEGGFGHVYKGELKD------GQMIAAKVRKE-ASTQGFAEFQSEVYV 72
F + NL LG G FG V + +A K+ K A SE+ +
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 73 L-NFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHL------------FDNTESVLE 119
+ + +H+NIV LLG C +++ EY C L L F S
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 120 WHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179
+ A+G+ FL + IHRD+ N+LLT+ V +GDFGLAR +D
Sbjct: 163 TRDLLHFSSQVAQGMAFL--ASKN--CIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMND 217
Query: 180 PVQTKILGTLGYL-----APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ 234
L APE + + ++++DV+++GI+L ++ S G P
Sbjct: 218 SNYIV--KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL-------GLNPYP 268
Query: 235 SLRQWAEPLIEKLALHELID----PRIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGE 289
+ ++ + D + + +Y +M C P RP+ +
Sbjct: 269 GILVNSK------FYKLVKDGYQMAQPAFAPK--NIYSIMQA----CWALEPTHRPTFQQ 316
Query: 290 VVRLLE 295
+ L+
Sbjct: 317 ICSFLQ 322
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-29
Identities = 79/315 (25%), Positives = 116/315 (36%), Gaps = 70/315 (22%)
Query: 25 FSKENL-----LGEGGFGHVYKGELKDG------QMIAAKVRKE-ASTQGFAEFQSEVYV 72
F +ENL LG G FG V +A K+ KE A + SE+ +
Sbjct: 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 73 L-NFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGT- 130
+ H+NIV LLG C L++EY C L +L E E Y
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 131 --------------------AKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170
AKG+ FL E + +HRD+ N+L+TH V + DFG
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFL--EFKS--CVHRDLAARNVLVTHGKVVKICDFG 217
Query: 171 LARWKTTDDPVQTKILGTLGYL-----APEYAENGIVSIRTDVYAFGIILLQLMSGRKVV 225
LAR D L APE GI +I++DV+++GI+L ++ S
Sbjct: 218 LAR-DIMSDSNYVV--RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL---- 270
Query: 226 DMNGEEPQQSLRQWAEPLIEKLALHELID----PRIENSYDTYELY-LMAKTAYLCVQRN 280
G P + A + + + + + E+Y +M C +
Sbjct: 271 ---GVNPYPGIPVDAN------FYKLIQNGFKMDQPFYATE--EIYIIM----QSCWAFD 315
Query: 281 PEGRPSMGEVVRLLE 295
RPS + L
Sbjct: 316 SRKRPSFPNLTSFLG 330
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 77/332 (23%), Positives = 132/332 (39%), Gaps = 75/332 (22%)
Query: 9 DPMKFSFSEIQQATGD---FSKENL-----LGEGGFGHVYKGELKD--------GQMIAA 52
PM SE + F ++ L LGEG FG V E +A
Sbjct: 59 TPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAV 118
Query: 53 KVRKE-ASTQGFAEFQSEVYVL-NFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHL 110
K+ K+ A+ + ++ SE+ ++ +HKNI+ LLG C ++ ++ EY +L +L
Sbjct: 119 KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 178
Query: 111 FDNTESVLEWHQRYAAAIGT--------------AKGLRFLHEECRGGPIIHRDMRPSNI 156
+E+ A+G+ +L + IHRD+ N+
Sbjct: 179 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQK--CIHRDLAARNV 234
Query: 157 LLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL-----APEYAENGIVSIRTDVYAF 211
L+T + V + DFGLAR D K T G L APE + + + ++DV++F
Sbjct: 235 LVTENNVMKIADFGLARDINNID-YYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291
Query: 212 GIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYD-------TY 264
G+++ ++ + G P + + EL ++ + T
Sbjct: 292 GVLMWEIFTL-------GGSPYPG-----------IPVEELFK-LLKEGHRMDKPANCTN 332
Query: 265 ELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
ELY +M C P RP+ ++V L+
Sbjct: 333 ELYMMMRD----CWHAVPSQRPTFKQLVEDLD 360
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 68/307 (22%), Positives = 114/307 (37%), Gaps = 55/307 (17%)
Query: 16 SEIQQATGDFSKE---------NLLGEGGFGHVYKGELKDG----QMIAAKVRKE-ASTQ 61
E+ QA ++G G FG VY G L D A K
Sbjct: 9 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 68
Query: 62 GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL-VYEYICNKSLHWHLFDNTESVLEW 120
++F +E ++ H N++ LLG C + + L V Y+ + L + + T +
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTV 127
Query: 121 HQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180
+ AKG+++L + +HRD+ N +L F + DFGLAR +
Sbjct: 128 KDLIGFGLQVAKGMKYLASKK----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183
Query: 181 --VQTKILGTL--GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSL 236
V K L ++A E + + ++DV++FG++L +LM+ G P
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR-------GAPPYPD- 235
Query: 237 RQWAEPLIEKLALHELIDPRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMG 288
+ ++ + LY +M K C E RPS
Sbjct: 236 ----------VNTFDITV-YLLQGRRLLQPEYCPDPLYEVMLK----CWHPKAEMRPSFS 280
Query: 289 EVVRLLE 295
E+V +
Sbjct: 281 ELVSRIS 287
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 67/297 (22%), Positives = 106/297 (35%), Gaps = 51/297 (17%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKNI 81
DF LG GGFG V++ + K D A K +R + EV L H I
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 82 VMLLGFCCKEN-------------LNILVYEYICNKSL-HWHLFDNTESVLEWHQRYAAA 127
V ++N L I + ++L W T E
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYI-QMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 128 IGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR------------WK 175
+ A+ + FLH +G ++HRD++PSNI T D V +GDFGL
Sbjct: 125 LQIAEAVEFLHS--KG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 176 TTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQS 235
T +GT Y++PE S + D+++ G+IL +L+ E ++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFS----TQMERVRT 236
Query: 236 LRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
L + L P + E ++ + +P RP ++
Sbjct: 237 LTD----------VRNLKFPPLFTQKYPCEYVMVQD----MLSPSPMERPEAINIIE 279
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 63/276 (22%), Positives = 110/276 (39%), Gaps = 32/276 (11%)
Query: 30 LLGEGGFGHVYKGE-LKDGQMIAAKVRKE--ASTQGFAE-FQSE---VYVLNFARHKNIV 82
LG GG VY E +A K + + F+ E L+ H+NIV
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS---HQNIV 74
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
++ +++ LV EYI +L ++ + L G++ H+
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHD--M 130
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT-KILGTLGYLAPEYAENGI 201
I+HRD++P NIL+ + + DFG+A+ + QT +LGT+ Y +PE A+
Sbjct: 131 R--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 202 VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ-SLRQWAEPLIEKLALHELIDPRIENS 260
TD+Y+ GI+L +++ G NGE +++ + + + I S
Sbjct: 189 TDECTDIYSIGIVLYEMLVGE--PPFNGETAVSIAIKHIQDSVPNVTT---DVRKDIPQS 243
Query: 261 YDTYELYLMAKTAYLCVQRNPEGRP-SMGEVVRLLE 295
L K + R ++ E+ L
Sbjct: 244 LSNVILRATEK--------DKANRYKTIQEMKDDLS 271
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 65/287 (22%), Positives = 107/287 (37%), Gaps = 48/287 (16%)
Query: 28 ENLLGEGGFGHVYKGELKDG----QMIAAKVRKE-ASTQGFAEFQSEVYVLNFARHKNIV 82
++G G FG VY G L D A K ++F +E ++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 83 MLLGFCCKENLNIL-VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
LLG C + + L V Y+ + L + + T + + AKG++FL
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFL-ASK 211
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL-----APEY 196
+ +HRD+ N +L F + DFGLAR + T L A E
Sbjct: 212 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTGAKLPVKWMALES 267
Query: 197 AENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256
+ + ++DV++FG++L +LM+ G P + ++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTR-------GAPPYPD-----------VNTFDITV-Y 308
Query: 257 IENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ LY +M K C E RPS E+V +
Sbjct: 309 LLQGRRLLQPEYCPDPLYEVMLK----CWHPKAEMRPSFSELVSRIS 351
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-28
Identities = 60/287 (20%), Positives = 109/287 (37%), Gaps = 48/287 (16%)
Query: 28 ENLLGEGGFGHVYKGELKDG----QMIAAKVRKE-ASTQGFAEFQSEVYVLNFARHKNIV 82
+ ++G+G FG VY GE D A K Q F E ++ H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 83 MLLGFCCK-ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
L+G E L ++ Y+C+ L + + + + A+G+ +L E
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYL-AEQ 143
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL-----APEY 196
+ +HRD+ N +L F + DFGLAR + + L A E
Sbjct: 144 K---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ-QHRHARLPVKWTALES 199
Query: 197 AENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256
+ + ++DV++FG++L +L++ G P + + +L
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTR-------GAPPYRH-----------IDPFDLTH-F 240
Query: 257 IENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ LY +M + C + +P RP+ +V +E
Sbjct: 241 LAQGRRLPQPEYCPDSLYQVMQQ----CWEADPAVRPTFRVLVGEVE 283
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-28
Identities = 65/285 (22%), Positives = 111/285 (38%), Gaps = 48/285 (16%)
Query: 28 ENLLGEGGFGHVYKGELKDGQ---MIAAKV-RKEASTQGFAEFQSEVYVLNFARHKNIVM 83
+ LG G FG V +G + + +A KV ++ E E +++ + IV
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L+G C E L + V E LH L E + + + G+++L EE
Sbjct: 75 LIGVCQAEALML-VMEMAGGGPLHKFLVGKREEIPVSNVAELLH-QVSMGMKYL-EEKN- 130
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAPEYAENG 200
+HRD+ N+LL + + DFGL++ DD T L + APE
Sbjct: 131 --FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 201 IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260
S R+DV+++G+ + + +S G++P + ++ E++ IE
Sbjct: 189 KFSSRSDVWSYGVTMWEALSY-------GQKPYKKMK-----------GPEVMA-FIEQG 229
Query: 261 Y----------DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ Y LM+ C E RP V + +
Sbjct: 230 KRMECPPECPPELYA--LMSD----CWIYKWEDRPDFLTVEQRMR 268
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-28
Identities = 69/290 (23%), Positives = 115/290 (39%), Gaps = 46/290 (15%)
Query: 24 DFSKENLLGEGGFGHVYKGELK--DGQMI--AAKVRKEAST---QGFAEFQSEVYVLNFA 76
D LG+G FG V +GE G+ + A K K + +F EV ++
Sbjct: 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 77 RHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESV-----LEWHQRYAAAIGTA 131
H+N++ L G + + V E SL L + + A+ A
Sbjct: 79 DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVA 131
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT--- 188
+G+ +L E R IHRD+ N+LL + +GDFGL R +D
Sbjct: 132 EGMGYL-ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKV-VDMNGEEPQQSLRQWAEPLIEK 246
+ APE + S +D + FG+ L ++ + G++ + +NG + + + E L
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--- 244
Query: 247 LALHELIDPRIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
PR E+ ++Y +M + C PE RP+ + L
Sbjct: 245 --------PRPEDC--PQDIYNVMVQ----CWAHKPEDRPTFVALRDFLL 280
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 78/325 (24%), Positives = 127/325 (39%), Gaps = 73/325 (22%)
Query: 9 DPMKFSFSEIQQATGDFSKENL-----LGEGGFGHVYKGELKDG------QMIAAKVRKE 57
+P FS + + + ++ LGEG FG V+ E + ++A K KE
Sbjct: 26 NPQYFSDACVHH----IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE 81
Query: 58 ASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHL------- 110
AS +FQ E +L +H++IV G C + ++V+EY+ + L+ L
Sbjct: 82 ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 141
Query: 111 ------FDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVP 164
D L Q A A A G+ +L +HRD+ N L+ V
Sbjct: 142 KLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH----FVHRDLATRNCLVGQGLVV 197
Query: 165 MLGDFGLARWKTTDDPVQTKILGTLGYL-----APEYAENGIVSIRTDVYAFGIILLQLM 219
+GDFG++R + D G L PE + +DV++FG++L ++
Sbjct: 198 KIGDFGMSRDIYSTD-YYRV--GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
Query: 220 SGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID--------PRIENSYDTYELY-LMA 270
+ G++P L+ E ID R E+Y +M
Sbjct: 255 T-------YGKQPWYQ-----------LSNTEAIDCITQGRELERPRACPP--EVYAIMR 294
Query: 271 KTAYLCVQRNPEGRPSMGEVVRLLE 295
C QR P+ R S+ +V L+
Sbjct: 295 G----CWQREPQQRHSIKDVHARLQ 315
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-28
Identities = 80/338 (23%), Positives = 131/338 (38%), Gaps = 75/338 (22%)
Query: 3 TELYMKDPMKFSFSEIQQATGD---FSKENL-----LGEGGFGHVYKGELKD-------- 46
TE M SE + ++ L LGEG FG V E
Sbjct: 41 TENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNR 100
Query: 47 GQMIAAKVRKE-ASTQGFAEFQSEVYVL-NFARHKNIVMLLGFCCKENLNILVYEYICNK 104
+A K+ K A+ + ++ SE+ ++ +HKNI+ LLG C ++ ++ EY
Sbjct: 101 VTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 160
Query: 105 SLHWHLFDNTESVLEWHQRYAAAIGT--------------AKGLRFLHEECRGGPIIHRD 150
+L +L LE+ + A+G+ +L + IHRD
Sbjct: 161 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKK--CIHRD 216
Query: 151 MRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL-----APEYAENGIVSIR 205
+ N+L+T D V + DFGLAR K T G L APE + I + +
Sbjct: 217 LAARNVLVTEDNVMKIADFGLAR-DIHHIDYYKK--TTNGRLPVKWMAPEALFDRIYTHQ 273
Query: 206 TDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYD--- 262
+DV++FG++L ++ + G P + + EL ++ +
Sbjct: 274 SDVWSFGVLLWEIFTL-------GGSPYPG-----------VPVEELFK-LLKEGHRMDK 314
Query: 263 ----TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
T ELY +M C P RP+ ++V L+
Sbjct: 315 PSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDLD 348
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 63/289 (21%), Positives = 116/289 (40%), Gaps = 49/289 (16%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKV--RKEASTQGFAEFQSEVYVLNFARHKN- 80
+S +G GG V++ + Q+ A K +EA Q +++E+ LN + +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 81 -IVMLLGFCCKENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKGL 134
I+ L + + +V E N L+ L D E W + +
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN-------MLEAV 121
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW--KTTDDPVQTKILGTLGYL 192
+H+ I+H D++P+N L+ + L DFG+A T V+ +GT+ Y+
Sbjct: 122 HTIHQHG----IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 193 APE-----------YAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE 241
PE +S ++DV++ G IL + G+ P + +
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--------P------FQQ 222
Query: 242 PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEV 290
+ + LH +IDP E + + C++R+P+ R S+ E+
Sbjct: 223 IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 68/299 (22%), Positives = 119/299 (39%), Gaps = 65/299 (21%)
Query: 31 LGEGGFGHVYKGELKDG------QMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVML 84
LGEG FG V+ E + ++A K K+ + +FQ E +L +H++IV
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 85 LGFCCKENLNILVYEYICNKSLHWHLFDN--------------TESVLEWHQRYAAAIGT 130
G C + I+V+EY+ + L+ L + + L Q A
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 131 AKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLG 190
A G+ +L + +HRD+ N L+ + + +GDFG++R G
Sbjct: 143 ASGMVYLASQH----FVHRDLATRNCLVGANLLVKIGDFGMSR-DVYSTDYYRV--GGHT 195
Query: 191 YL-----APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE 245
L PE + +DV++FG+IL ++ + G++P
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT-------YGKQPWFQ---------- 238
Query: 246 KLALHELID--------PRIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
L+ E+I+ R E+Y +M C QR P+ R ++ E+ ++L
Sbjct: 239 -LSNTEVIECITQGRVLERPRVCPK--EVYDVM----LGCWQREPQQRLNIKEIYKILH 290
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-27
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 11/212 (5%)
Query: 16 SEIQQATGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV--RKEASTQGFAE-FQSEVY 71
+ I + DF NLLG+G F VY+ + G +A K+ +K G + Q+EV
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 72 VLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWH-QRYAAAIGT 130
+ +H +I+ L + N LV E N ++ +L + + E + + I
Sbjct: 64 IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI-- 121
Query: 131 AKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLG 190
G+ +LH G I+HRD+ SN+LLT + + DFGLA + GT
Sbjct: 122 ITGMLYLHS--HG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 191 YLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
Y++PE A + +DV++ G + L+ GR
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 62/285 (21%), Positives = 108/285 (37%), Gaps = 46/285 (16%)
Query: 27 KENLLGEGGFGHVYKGELKDG---QMIAAKVRKEAST--QGFAEFQSEVYVLNFARHKNI 81
++ LG G FG V KG + + +A K+ K + E +E V+ + I
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
V ++G C E+ + V E L+ +L N + + + G+++L EE
Sbjct: 81 VRMIGICEAESWML-VMEMAELGPLNKYLQQNRHVKDKNIIELVHQV--SMGMKYL-EES 136
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAPEYAE 198
+HRD+ N+LL + DFGL++ D+ + + APE
Sbjct: 137 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 199 NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258
S ++DV++FG+++ + S G++P + E+ +E
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSY-------GQKP-----------YRGMKGSEVTA-MLE 234
Query: 259 NSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E+Y LM C + E RP V L
Sbjct: 235 KGERMGCPAGCPREMYDLMNL----CWTYDVENRPGFAAVELRLR 275
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 54/276 (19%), Positives = 93/276 (33%), Gaps = 46/276 (16%)
Query: 30 LLGEGGFGHVYKGE--LKDGQMIAAKVRKEASTQGFAE-FQSEVYVLNFARHKNIVMLLG 86
+ GG G +Y +G+ + K + +E L H +IV +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 87 F-----CCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
F + + +V EY+ +SL L + A + L +LH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLHS-- 200
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI 201
G +++ D++P NI+LT + + L D G + + GT G+ APE G
Sbjct: 201 IG--LVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYL----YGTPGFQAPEIVRTG- 252
Query: 202 VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261
++ TD+Y G L L + G L + L + L+
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRN--GRYV-DGLPEDDPVLKTYDSYGRLL-------- 301
Query: 262 DTYELYLMAKTAYLCVQRNPEGRP-SMGEVVRLLEG 296
+ +P R + E+ L G
Sbjct: 302 ----RRAIDP--------DPRQRFTTAEEMSAQLTG 325
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-27
Identities = 66/294 (22%), Positives = 109/294 (37%), Gaps = 59/294 (20%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKV-----RKEASTQGFAEFQSEVYVLNFARH 78
+GEG FG V++G + A V + S +F E + H
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
+IV L+G + + I + E L L + L+ A + L +L
Sbjct: 76 PHIVKLIGVITENPVWI-IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYL- 132
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD---------PVQTKILGTL 189
E R +HRD+ N+L++ + LGDFGL+R+ P++
Sbjct: 133 ESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------- 182
Query: 190 GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249
++APE + +DV+ FG+ + +++ G +P Q +
Sbjct: 183 -WMAPESINFRRFTSASDVWMFGVCMWEILMH-------GVKPFQG-----------VKN 223
Query: 250 HELIDPRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+++I RIEN LY LM K C +P RP E+ L
Sbjct: 224 NDVIG-RIENGERLPMPPNCPPTLYSLMTK----CWAYDPSRRPRFTELKAQLS 272
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 76/314 (24%), Positives = 127/314 (40%), Gaps = 59/314 (18%)
Query: 9 DPMKFSFSEIQQATGDFSKE---------NLLGEGGFGHVYKGELK----DGQMIAAKVR 55
DP +F + Q +F+KE ++G G FG V G LK +A K
Sbjct: 24 DP--HTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 56 KEAST-QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNT 114
K T + +F E ++ H NI+ L G K ++V EY+ N SL L +
Sbjct: 82 KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH- 140
Query: 115 ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174
++ Q G A G+++L + +HRD+ NIL+ + V + DFGL R
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYL-SDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV 196
Query: 175 KTTDDPVQTKILGT---LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEE 231
D G + + +PE + +DV+++GI+L ++MS GE
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGER 249
Query: 232 PQQSLRQWAEPLIEKLALHELIDPRIENSY----------DTYELYLMAKTAYLCVQRNP 281
P ++ ++I ++ Y Y+L L C Q++
Sbjct: 250 PYWE-----------MSNQDVIK-AVDEGYRLPPPMDCPAALYQLMLD------CWQKDR 291
Query: 282 EGRPSMGEVVRLLE 295
RP ++V +L+
Sbjct: 292 NNRPKFEQIVSILD 305
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 67/294 (22%), Positives = 109/294 (37%), Gaps = 59/294 (20%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKV-----RKEASTQGFAEFQSEVYVLNFARH 78
+GEG FG V++G + A V + S +F E + H
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
+IV L+G + + I + E L L S L+ A + L +L
Sbjct: 451 PHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYL- 507
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD---------PVQTKILGTL 189
E R +HRD+ N+L++ + LGDFGL+R+ P++
Sbjct: 508 ESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------- 557
Query: 190 GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249
++APE + +DV+ FG+ + +++ G +P Q +
Sbjct: 558 -WMAPESINFRRFTSASDVWMFGVCMWEILMH-------GVKPFQG-----------VKN 598
Query: 250 HELIDPRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+++I RIEN LY LM K C +P RP E+ L
Sbjct: 599 NDVIG-RIENGERLPMPPNCPPTLYSLMTK----CWAYDPSRRPRFTELKAQLS 647
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-27
Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 43/282 (15%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIAAK-VRKEASTQGFAEF-QSEVYVLNFARHKN 80
+ + +GEG FG + +DG+ K + + E + EV VL +H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 81 IVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQ--RYAAAIGTAKGLRFL 137
IV F +L I V +Y L + + + Q + I L+ +
Sbjct: 85 IVQYRESFEENGSLYI-VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI--CLALKHV 141
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYA 197
H+ R I+HRD++ NI LT D LGDFG+AR + + +GT YL+PE
Sbjct: 142 HD--RK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC 197
Query: 198 ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID--- 254
EN + ++D++A G +L +L + + E ++ L+
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK-------------------HAFEAGSMKNLVLKII 238
Query: 255 ----PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
P + Y +Y+L + +RNP RPS+ ++
Sbjct: 239 SGSFPPVSLHY-SYDLRSLVS---QLFKRNPRDRPSVNSILE 276
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 63/280 (22%), Positives = 105/280 (37%), Gaps = 38/280 (13%)
Query: 28 ENLLGEGGFGHVYKGE-LKDGQMIAAKVRKE--ASTQGFAE-FQSEVYVLNFAR------ 77
L+G GG G VY+ E +++A K+ E +S F Q E AR
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQRE------ARTAGRLQ 92
Query: 78 HKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFL 137
++V + F + + I L L + L + A L
Sbjct: 93 EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAA 150
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT-KILGTLGYLAPEY 196
H G HRD++P NIL++ D L DFG+A T + Q +GTL Y+APE
Sbjct: 151 HA--AG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206
Query: 197 AENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256
+ R D+YA +L + ++G G++ + + + I
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGS--PPYQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264
Query: 257 IENSYDTYELYLMAKTAYLCVQRNPEGR-PSMGEVVRLLE 295
+ ++A+ + +NPE R + G++
Sbjct: 265 FDA--------VIAR----GMAKNPEDRYVTCGDLSAAAH 292
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 67/285 (23%), Positives = 112/285 (39%), Gaps = 48/285 (16%)
Query: 28 ENLLGEGGFGHVYKGELK--DGQM-IAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVM 83
+ LG G FG V +G + Q+ +A KV K+ + E E +++ + IV
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L+G C E L + V E LH L E + + G+++L EE
Sbjct: 401 LIGVCQAEALML-VMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL-EEKN- 456
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAPEYAENG 200
+HR++ N+LL + + DFGL++ DD T L + APE
Sbjct: 457 --FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 201 IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260
S R+DV+++G+ + + +S G++P + K+ E++ IE
Sbjct: 515 KFSSRSDVWSYGVTMWEALSY-------GQKPYK-----------KMKGPEVMA-FIEQG 555
Query: 261 Y----------DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ Y LM+ C E RP V + +
Sbjct: 556 KRMECPPECPPELYA--LMSD----CWIYKWEDRPDFLTVEQRMR 594
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-27
Identities = 63/299 (21%), Positives = 117/299 (39%), Gaps = 49/299 (16%)
Query: 14 SFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKV--RKEASTQGFAEFQSEVY 71
+ I +S +G GG V++ + Q+ A K +EA Q +++E+
Sbjct: 47 ANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 106
Query: 72 VLNFARHKN--IVMLLGFCCKENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRY 124
LN + + I+ L + + +V E N L+ L D E W
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN-- 163
Query: 125 AAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW--KTTDDPVQ 182
+ + +H+ I+H D++P+N L+ + L DFG+A T V+
Sbjct: 164 -----MLEAVHTIHQHG----IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVK 213
Query: 183 TKILGTLGYLAPE-----------YAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEE 231
+G + Y+ PE +S ++DV++ G IL + G+
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT-------- 265
Query: 232 PQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEV 290
P + + + + LH +IDP E + + C++R+P+ R S+ E+
Sbjct: 266 P------FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 68/293 (23%), Positives = 120/293 (40%), Gaps = 58/293 (19%)
Query: 31 LGEGGFGHVYKGELKDG------QMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
LG+G FG VY+G K +A K V + AS + EF +E V+ ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHL--------FDNTESVLEWHQRYAAAIGTAKGLR 135
LLG + +++ E + L +L + + + A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL--- 192
+L+ +HRD+ N ++ DF +GDFG+ R D K G G L
Sbjct: 153 YLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRK--GGKGLLPVR 205
Query: 193 --APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250
+PE ++G+ + +DV++FG++L ++ + E+P Q L+
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQG-----------LSNE 247
Query: 251 ELIDPRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+++ + L+ LM C Q NP+ RPS E++ ++
Sbjct: 248 QVLR-FVMEGGLLDKPDNCPDMLFELMRM----CWQYNPKMRPSFLEIISSIK 295
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 64/305 (20%), Positives = 119/305 (39%), Gaps = 57/305 (18%)
Query: 12 KFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKV--RKEASTQGFAEFQSE 69
F + +S +G GG V++ + Q+ A K +EA Q +++E
Sbjct: 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE 76
Query: 70 VYVLNFARHKN--IVMLLGFCCKENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQ 122
+ LN + + I+ L + + +V E N L+ L D E W
Sbjct: 77 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN 135
Query: 123 RYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW--KTTDDP 180
+ + +H+ I+H D++P+N L+ + L DFG+A T
Sbjct: 136 -------MLEAVHTIHQHG----IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSV 183
Query: 181 VQTKILGTLGYLAPE-----------YAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNG 229
V+ +GT+ Y+ PE +S ++DV++ G IL + G+
Sbjct: 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------ 237
Query: 230 EEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYE----LYLMAKTAYLCVQRNPEGRP 285
P + + + + LH +IDP E + ++ C++R+P+ R
Sbjct: 238 --P------FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC----CLKRDPKQRI 285
Query: 286 SMGEV 290
S+ E+
Sbjct: 286 SIPEL 290
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 65/312 (20%), Positives = 99/312 (31%), Gaps = 78/312 (25%)
Query: 25 FSKENLLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVL-NFARHKNIV 82
+L EGGF VY+ + + G+ A K + EV + + H NIV
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 83 MLLGFCCKENLN-------ILVYEYICNKSLHWHLFDNTES--------VLEWHQRYAAA 127
L+ +C L ES VL+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQL-VEFLKKMESRGPLSCDTVLKI------F 142
Query: 128 IGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL- 186
T + ++ +H + PIIHRD++ N+LL++ L DFG A +
Sbjct: 143 YQTCRAVQHMH--RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 187 -----------GTLGYLAPE---YAENGIVSIRTDVYAFGIILLQLMSGR---------K 223
T Y PE N + + D++A G IL L + +
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260
Query: 224 VVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEG 283
+V+ P + H LI +Q NPE
Sbjct: 261 IVNGKYSIPP--------HDTQYTVFHSLIR--------------------AMLQVNPEE 292
Query: 284 RPSMGEVVRLLE 295
R S+ EVV L+
Sbjct: 293 RLSIAEVVHQLQ 304
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-27
Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 21/220 (9%)
Query: 14 SFSEIQQATGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
E + +LG+G +G VY G +L + IA K E ++ E+ +
Sbjct: 13 DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 73 LNFARHKNIVMLLGFCCKEN-LNILVYEYICNKSLH------WHLFDNTESVLEWHQRYA 125
+HKNIV LG + + I + E + SL W + E + Y
Sbjct: 73 HKHLKHKNIVQYLGSFSENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTI---GFYT 128
Query: 126 AAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL-THDFVPMLGDFGLARWKTTDDPVQTK 184
I +GL++LH+ I+HRD++ N+L+ T+ V + DFG ++ +P
Sbjct: 129 KQI--LEGLKYLHDNQ----IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182
Query: 185 ILGTLGYLAPEYAENGIV--SIRTDVYAFGIILLQLMSGR 222
GTL Y+APE + G D+++ G ++++ +G+
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 45/289 (15%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQM-----IAAKVRKE-ASTQGFAEFQSEVYVLNFAR 77
+++ ++G G FG VYKG LK +A K K + + +F E ++
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 78 HKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFL 137
H NI+ L G K +++ EY+ N +L L + + Q G A G+++L
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYL 163
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT---LGYLAP 194
+HRD+ NIL+ + V + DFGL+R D G + + AP
Sbjct: 164 -ANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 195 EYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254
E + +DV++FGI++ ++M+ GE P L+ HE++
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMT-------YGERPYWE-----------LSNHEVMK 261
Query: 255 PRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
I + + +Y LM + C Q+ RP ++V +L+
Sbjct: 262 -AINDGFRLPTPMDCPSAIYQLMMQ----CWQQERARRPKFADIVSILD 305
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 69/308 (22%), Positives = 123/308 (39%), Gaps = 53/308 (17%)
Query: 13 FSFSEIQQATGDFSKE---------NLLGEGGFGHVYKGELKDG----QMIAAKVRKE-A 58
++ E +A F++E ++G G G V G L+ +A K K
Sbjct: 30 HTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY 89
Query: 59 STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVL 118
+ + +F SE ++ H NI+ L G + L ++V EY+ N SL L +
Sbjct: 90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-F 148
Query: 119 EWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178
Q G G+R+L + +HRD+ N+L+ + V + DFGL+R D
Sbjct: 149 TIMQLVGMLRGVGAGMRYL-SDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 179 DPVQTKILGT---LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQS 235
G + + APE S +DV++FG+++ ++++ GE P
Sbjct: 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA-------YGERPYW- 256
Query: 236 LRQWAEPLIEKLALHELIDPRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSM 287
+ ++I +E Y + L+ LM C ++ RP
Sbjct: 257 ----------NMTNRDVIS-SVEEGYRLPAPMGCPHALHQLMLD----CWHKDRAQRPRF 301
Query: 288 GEVVRLLE 295
++V +L+
Sbjct: 302 SQIVSVLD 309
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 67/287 (23%), Positives = 115/287 (40%), Gaps = 45/287 (15%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKV-----RKEASTQGFAEFQSEVYVLNFARH 78
D +LGEG FG VY+G + + V +K+ + +F SE ++ H
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
+IV L+G +E I + E L +L N S L+ ++ K + +L
Sbjct: 73 PHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYL- 129
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL---GYLAPE 195
E +HRD+ NIL+ LGDFGL+R+ +D K T +++PE
Sbjct: 130 ESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED--YYKASVTRLPIKWMSPE 184
Query: 196 YAENGIVSIRTDVYAFGIILLQLMS-GRKV-VDMNGEEPQQSLRQWAEPLIEKLALHELI 253
+ +DV+ F + + +++S G++ + ++ + L
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----------------VIGVLE 228
Query: 254 D----PRIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
P+ + LY LM + C +P RP E+V L
Sbjct: 229 KGDRLPKPDLCPP--VLYTLMTR----CWDYDPSDRPRFTELVCSLS 269
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 53/266 (19%), Positives = 91/266 (34%), Gaps = 30/266 (11%)
Query: 8 KDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKD------GQMIAAKVRKEASTQ 61
K P +E Q + +LLGEG F VY+ D Q KV+K A+
Sbjct: 50 KLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW 109
Query: 62 GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHL---FDNTESVL 118
F + L + + +N ++LV E +L + + E V+
Sbjct: 110 EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169
Query: 119 EWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVP-----------MLG 167
+ A+ + +H+ IIH D++P N +L + F+ L
Sbjct: 170 PQGLVISFAMRMLYMIEQVHD----CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225
Query: 168 DFGLARWKTTDDPVQ--TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR--K 223
D G + T T G+ E N + + D + + ++ G K
Sbjct: 226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285
Query: 224 VVDMNGEEPQQSL--RQWAEPLIEKL 247
V + GE + L R + +
Sbjct: 286 VKNEGGECKPEGLFRRLPHLDMWNEF 311
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 73/282 (25%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 30 LLGEGGFGHVYKGE-LKDGQMIAAKVRKE--ASTQGFAE-FQSE---VYVLNFARHKNIV 82
+LG GG V+ L+D + +A KV + A F F+ E LN H IV
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN---HPAIV 75
Query: 83 MLL--GFCCKENLNI--LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
+ G + +V EY+ +L + +TE + + + L F H
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK---ILGTLGYLAPE 195
+ G IIHRD++P+NI+++ + DFG+AR T+ ++GT YL+PE
Sbjct: 134 Q--NG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 196 YAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ-SLRQWAEPLIEKLALHELID 254
A V R+DVY+ G +L ++++G G+ P + + E I A HE +
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGE--PPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247
Query: 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRP-SMGEVVRLLE 295
++ ++ K + +NPE R + E+ L
Sbjct: 248 ADLDA--------VVLK----ALAKNPENRYQTAAEMRADLV 277
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 71/337 (21%), Positives = 124/337 (36%), Gaps = 82/337 (24%)
Query: 10 PMKFSFSEIQQATGD---FSKENL-----LGEGGFGHVYKGELKDG------QMIAAKVR 55
P+ S + F ++NL LGEG FG V K +A K+
Sbjct: 2 PLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML 61
Query: 56 KE-ASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSL------HW 108
KE AS + SE VL H +++ L G C ++ +L+ EY SL
Sbjct: 62 KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 109 HLFDNTESVLEWHQRYAAAIGT----------------AKGLRFLHEECRGGPIIHRDMR 152
+ + ++G+++L ++HRD+
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMK--LVHRDLA 177
Query: 153 PSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL-----APEYAENGIVSIRTD 207
NIL+ + DFGL+R +D K + G + A E + I + ++D
Sbjct: 178 ARNILVAEGRKMKISDFGLSRDVYEED-SYVK--RSQGRIPVKWMAIESLFDHIYTTQSD 234
Query: 208 VYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID--------PRIEN 259
V++FG++L ++++ G P + L + R +N
Sbjct: 235 VWSFGVLLWEIVTL-------GGNPYPG-----------IPPERLFNLLKTGHRMERPDN 276
Query: 260 SYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ E+Y LM C ++ P+ RP ++ + LE
Sbjct: 277 CSE--EMYRLM----LQCWKQEPDKRPVFADISKDLE 307
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 23 GDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV--RKEASTQGFAE-FQSEVYVLNFARH 78
DF LG+G FG+VY E + ++A KV + + G + EV + + RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKG 133
NI+ L G+ L+ EY +++ L FD + Y + A
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT-----ATYITEL--ANA 121
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLA 193
L + H + +IHRD++P N+LL + DFG + +T + GTL YL
Sbjct: 122 LSYCHS--KR--VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLP 175
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMSGR 222
PE E + + D+++ G++ + + G+
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 29/243 (11%), Positives = 56/243 (23%), Gaps = 43/243 (17%)
Query: 16 SEIQQATGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV---RKEASTQGFAEFQSEVY 71
S + Q L G V+ +++ + A KV E S +
Sbjct: 55 SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATF 114
Query: 72 VLNFARHKNIVMLLGFC-------------------------CKENLNILVYEYICNKSL 106
++ N L+ + L
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174
Query: 107 H-----WHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD 161
+ + L +G ++H P N+ + D
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS--KG--LVHGHFTPDNLFIMPD 230
Query: 162 FVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY--AENGIVSIRTDVYAFGIILLQLM 219
MLGD T P + Y E+ A + + + G+ + ++
Sbjct: 231 GRLMLGDVSALWKVGTRGPA---SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 220 SGR 222
Sbjct: 288 CLF 290
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 67/302 (22%), Positives = 118/302 (39%), Gaps = 70/302 (23%)
Query: 28 ENLLGEGGFGHVYKGELKDG----QMIAAKVRKE--ASTQGFAEFQSEVYVLNFARHKNI 81
+LGEG FG V +G LK +A K K +S + EF SE + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 82 VMLLGFCCKEN-----LNILVYEYICNKSLHWHL----FDNTESVLEWHQRYAAAIGTAK 132
+ LLG C + + +++ ++ LH +L + + + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD----------PVQ 182
G+ +L +HRD+ N +L D + DFGL++ + D PV+
Sbjct: 159 GMEYLSNRN----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 183 TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP 242
++A E + + + ++DV+AFG+ + ++ + G P
Sbjct: 215 --------WIAIESLADRVYTSKSDVWAFGVTMWEIATR-------GMTPYPG------- 252
Query: 243 LIEKLALHELID--------PRIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRL 293
+ HE+ D + E+ D ELY +M C + +P RP+ +
Sbjct: 253 ----VQNHEMYDYLLHGHRLKQPEDCLD--ELYEIMYS----CWRTDPLDRPTFSVLRLQ 302
Query: 294 LE 295
LE
Sbjct: 303 LE 304
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 71/294 (24%), Positives = 111/294 (37%), Gaps = 60/294 (20%)
Query: 31 LGEGGFGHVYKGELKDG------QMIAAKVRKE-ASTQGFAEFQSEVYVLNFARHKNIVM 83
LG G FG VY+G++ +A K E S Q +F E +++ H+NIV
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDN-----TESVLEWHQRYAAAIGTAKGLRFLH 138
+G + ++ E + L L + S L A A G ++L
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 139 EECRGGPIIHRDMRPSNILLT---HDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL--- 192
E IHRD+ N LLT V +GDFG+AR + G L
Sbjct: 158 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--YYRK-GGCAMLPVK 210
Query: 193 --APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250
PE GI + +TD ++FG++L ++ S G P S +
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPS-----------KSNQ 252
Query: 251 ELID--------PRIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E+++ +N +Y +M C Q PE RP+ ++ +E
Sbjct: 253 EVLEFVTSGGRMDPPKNCPG--PVYRIM----TQCWQHQPEDRPNFAIILERIE 300
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 67/302 (22%), Positives = 109/302 (36%), Gaps = 64/302 (21%)
Query: 28 ENLLGEGGFGHVYKGELKDG------QMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKN 80
LGE FG VYKG L Q +A K ++ +A EF+ E + +H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDN--------------TESVLEWHQRYAA 126
+V LLG K+ +++ Y + LH L +S LE
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 127 AIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL 186
A G+ +L ++H+D+ N+L+ + D GL R D L
Sbjct: 134 VAQIAAGMEYL-SSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD---YYKL 186
Query: 187 GTLGYL-----APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE 241
L APE G SI +D++++G++L ++ S G +P
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS-------YGLQPYCG------ 233
Query: 242 PLIEKLALHELIDPRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRL 293
+ ++++ I N +Y LM + C P RP ++
Sbjct: 234 -----YSNQDVVE-MIRNRQVLPCPDDCPAWVYALMIE----CWNEFPSRRPRFKDIHSR 283
Query: 294 LE 295
L
Sbjct: 284 LR 285
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 71/294 (24%), Positives = 113/294 (38%), Gaps = 60/294 (20%)
Query: 31 LGEGGFGHVYKGELKDG------QMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
LG G FG VY+G++ +A K + + S Q +F E +++ H+NIV
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDN-----TESVLEWHQRYAAAIGTAKGLRFLH 138
+G + ++ E + L L + S L A A G ++L
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 139 EECRGGPIIHRDMRPSNILLT---HDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL--- 192
E IHRD+ N LLT V +GDFG+AR K G L
Sbjct: 199 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-DIYRAGYYRK--GGCAMLPVK 251
Query: 193 --APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250
PE GI + +TD ++FG++L ++ S G P S +
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPS-----------KSNQ 293
Query: 251 ELID--------PRIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E+++ +N +Y +M + C Q PE RP+ ++ +E
Sbjct: 294 EVLEFVTSGGRMDPPKNCPG--PVYRIMTQ----CWQHQPEDRPNFAIILERIE 341
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 23 GDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV--RKEASTQGFAE-FQSEVYVLNFARH 78
DF LG+G FG+VY E ++ ++A KV + + +G + E+ + + RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKG 133
NI+ + + L+ E+ L+ L FD S + + A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS-----ATFMEEL--ADA 126
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLA 193
L + HE R +IHRD++P N+L+ + + DFG + + + GTL YL
Sbjct: 127 LHYCHE--RK--VIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYLP 180
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMSGR 222
PE E + D++ G++ + + G
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 64/285 (22%), Positives = 105/285 (36%), Gaps = 38/285 (13%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIAAKV--RKEASTQGFAEFQSEVYVLNFARHKN 80
D+ +G G +G K DG+++ K + SEV +L +H N
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 81 IVMLLG-FCCKEN--LNIL--------VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIG 129
IV + N L I+ + I + D E VL
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD-EEFVLRV------MTQ 119
Query: 130 TAKGLRFLHEECRGG-PIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT 188
L+ H GG ++HRD++P+N+ L LGDFGLAR D +GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248
Y++PE + ++D+++ G +L +L + S ++ L K+
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKE----LAGKIR 229
Query: 249 LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293
+ RI Y EL + + RPS+ E++
Sbjct: 230 EGKF--RRIPYRYS-DELNEIIT---RMLNLKDYHRPSVEEILEN 268
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 62/299 (20%), Positives = 110/299 (36%), Gaps = 69/299 (23%)
Query: 31 LGEGGFGHVYKGELKDG----QMIAAKVRKE--ASTQGFAEFQSEVYVLNFARHKNIVML 84
LG+G FG V + +LK +A K+ K ++ EF E + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 85 LGFCCKENLNI------LVYEYICNKSLHWHL----FDNTESVLEWHQRYAAAIGTAKGL 134
+G + ++ ++ + LH L L + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD----------PVQTK 184
+L IHRD+ N +L D + DFGL+R + D PV+
Sbjct: 151 EYLSSRN----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK-- 204
Query: 185 ILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI 244
+LA E + + ++ +DV+AFG+ + ++M+ G+ P
Sbjct: 205 ------WLALESLADNLYTVHSDVWAFGVTMWEIMTR-------GQTPYAG--------- 242
Query: 245 EKLALHELIDPRIENSYD-------TYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ E+ + + E+Y LM + C +P+ RPS + LE
Sbjct: 243 --IENAEIYN-YLIGGNRLKQPPECMEEVYDLMYQ----CWSADPKQRPSFTCLRMELE 294
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 20/209 (9%)
Query: 23 GDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV--RKEASTQGFAE-FQSEVYVLNFARH 78
+ + LG+GGF ++ + ++ A K+ + E E+ + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKG 133
+++V GF + +V E +SL E+ + Y I G
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RYYLRQI--VLG 153
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLA 193
++LH +IHRD++ N+ L D +GDFGLA D + + GT Y+A
Sbjct: 154 CQYLHRNR----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMSGR 222
PE S DV++ G I+ L+ G+
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-25
Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 20/209 (9%)
Query: 23 GDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV--RKEASTQGFAE-FQSEVYVLNFARH 78
+ + LG+GGF ++ + ++ A K+ + E E+ + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKG 133
+++V GF + +V E +SL E+ + Y I G
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RYYLRQI--VLG 127
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLA 193
++LH +IHRD++ N+ L D +GDFGLA D + + GT Y+A
Sbjct: 128 CQYLHR--NR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMSGR 222
PE S DV++ G I+ L+ G+
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 53/233 (22%), Positives = 89/233 (38%), Gaps = 25/233 (10%)
Query: 2 KTELYMKDPMKFSFSEIQQATGDFSK----ENLLGEGGFGHVYKGELKD-GQMIAAKVRK 56
++ ++ LG G FG V++ + G AAK
Sbjct: 132 YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 191
Query: 57 EASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTES 116
+ E+ ++ RH +V L +N +++YE++ LF+
Sbjct: 192 TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE----LFEK--- 244
Query: 117 VLEWHQRY--AAAIGTAK----GLRFLHEECRGGPIIHRDMRPSNILLTHDFVP--MLGD 168
V + H + A+ + GL +HE +H D++P NI+ T L D
Sbjct: 245 VADEHNKMSEDEAVEYMRQVCKGLCHMHE--NN--YVHLDLKPENIMFTTKRSNELKLID 300
Query: 169 FGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
FGL V+ GT + APE AE V TD+++ G++ L+SG
Sbjct: 301 FGLTAHLDPKQSVKV-TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 61/293 (20%), Positives = 101/293 (34%), Gaps = 48/293 (16%)
Query: 9 DPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAEF 66
+ +K E ++ + + +G G FG V++ + + G A K VR E
Sbjct: 44 EKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------ 97
Query: 67 QSEVYVLNFARHKNIVMLLGFCCKEN-LNILVYEYICNKSL-----HWHLFDNTESVLEW 120
E+ IV L G + +NI E + SL E
Sbjct: 98 VEELVACAGLSSPRIVPLYGAVREGPWVNI-FMELLEGGSLGQLIKQMGCLP--EDRA-- 152
Query: 121 HQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM-LGDFGLARWKTTDD 179
Y +GL +LH I+H D++ N+LL+ D L DFG A D
Sbjct: 153 -LYYLGQA--LEGLEYLHTRR----ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205
Query: 180 PVQTK-----ILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ 234
++ I GT ++APE + D+++ ++L + +NG P
Sbjct: 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM--------LNGCHPWT 257
Query: 235 SLRQWAEPLIEKLALHELIDPRIENSY-DTYELYLMAKTAYLCVQRNPEGRPS 286
+ L K+A I S + +++ P R S
Sbjct: 258 QYFRGP--LCLKIASEPPPIREIPPSCAPLTAQAIQ-----EGLRKEPVHRAS 303
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 27/229 (11%)
Query: 8 KDPMKFSFSEIQQATGDFS------KENLLGEGGFGHVYKGELKD-GQMIAAKVRKEAST 60
P F + G + K +LG G FG V+K E G +AAK+ K
Sbjct: 68 APPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM 127
Query: 61 QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEW 120
+ E ++E+ V+N H N++ L +N +LV EY+ L FD +++
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDR---IIDE 180
Query: 121 HQRY--AAAIGTAK----GLRFLHEECRGGPIIHRDMRPSNILLTHDFVP--MLGDFGLA 172
I K G+R +H+ I+H D++P NIL + + DFGLA
Sbjct: 181 SYNLTELDTILFMKQICEGIRHMHQ--MY--ILHLDLKPENILCVNRDAKQIKIIDFGLA 236
Query: 173 RWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
R + ++ GT +LAPE VS TD+++ G+I L+SG
Sbjct: 237 RRYKPREKLKV-NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 61/304 (20%), Positives = 103/304 (33%), Gaps = 66/304 (21%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV--RKEASTQGFAEFQSEVYVLNFARHKN 80
DF + +LG+G FG V K D + A K E SEV +L H+
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASLNHQY 63
Query: 81 IVMLLGFCCKENLNI-------------LVYEYICNKSLHWHL-----FDNTESVLEW-H 121
+V + + + EY N +L+ + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 122 QRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR-------- 173
Q + L ++H +G IIHRD++P NI + +GDFGLA+
Sbjct: 124 Q-------ILEALSYIHS--QG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 174 ------WKTTDDPVQTKILGTLGYLAPE-YAENGIVSIRTDVYAFGIILLQLMSGRKVVD 226
T +GT Y+A E G + + D+Y+ GII +++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFS-TG 231
Query: 227 MNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS 286
M + LR + P +++ E ++ + +P RP
Sbjct: 232 MERVNILKKLRSVSIE----------FPPDFDDNKMKVEKKIIRL----LIDHDPNKRPG 277
Query: 287 MGEV 290
+
Sbjct: 278 ARTL 281
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-24
Identities = 52/223 (23%), Positives = 89/223 (39%), Gaps = 25/223 (11%)
Query: 12 KFSFSEIQQATGDFSK----ENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEF 66
K+ ++ G LG G FG V++ K G++ AK
Sbjct: 36 KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV 95
Query: 67 QSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRY-- 124
++E+ ++N H ++ L + +L+ E++ LFD + +
Sbjct: 96 KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL----SGGELFDR---IAAEDYKMSE 148
Query: 125 AAAIGTAK----GLRFLHEECRGGPIIHRDMRPSNILLTHDFVP--MLGDFGLARWKTTD 178
A I + GL+ +HE I+H D++P NI+ + DFGLA K
Sbjct: 149 AEVINYMRQACEGLKHMHE--HS--IVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNP 203
Query: 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
D + T + APE + V TD++A G++ L+SG
Sbjct: 204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 99.8 bits (248), Expect = 2e-23
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 19 QQATGDFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEASTQGFAEFQSEVYVLNFA 76
Q G + + LG GGFG+V + +D G+ +A K R+E S + + E+ ++
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 77 RHKNIVMLL------GFCCKENLNILVYEYICNKSLHWHL--FDNTESVLEWH-QRYAAA 127
H N+V +L +L EY L +L F+N + E + +
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 128 IGTAKGLRFLHEECRGGPIIHRDMRPSNILL---THDFVPMLGDFGLARWKTTDDPVQTK 184
I + LR+LHE IIHRD++P NI+L + + D G A+ + + T+
Sbjct: 130 I--SSALRYLHENR----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCTE 182
Query: 185 ILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
+GTL YLAPE E ++ D ++FG + + ++G
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-23
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 24/222 (10%)
Query: 19 QQATGDFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEASTQGFAEFQSEVYVLNFA 76
+ + ++LG+G +V++G K G + A KV + + E VL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 77 RHKNIVMLLGF--CCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGT--AK 132
HKNIV L +L+ E+ SL+ L + + + +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVG 123
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLT----HDFVPMLGDFGLARWKTTDDPVQTKILGT 188
G+ L E G I+HR+++P NI+ V L DFG AR D+ + + GT
Sbjct: 124 GMNHLRE--NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-LYGT 178
Query: 189 LGYLAPEYAENGIVSIRT--------DVYAFGIILLQLMSGR 222
YL P+ E ++ D+++ G+ +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-23
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAK-VRKEASTQGFAEFQS--EVYVLNFARHKN 80
+ K +GEG +G VYK + G+++A K +R +A +G + E+ +L H N
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIP-STAIREISLLKELHHPN 80
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEE 140
IV L+ E LV+E+ K L + D ++ L+ Q +G+ H+
Sbjct: 81 IVSLIDVIHSERCLTLVFEF-MEKDLK-KVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 141 CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE----- 195
I+HRD++P N+L+ D L DFGLAR T + TL Y AP+
Sbjct: 139 R----ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 196 --YAENGIVSIRTDVYAFGIILLQLMSGR 222
Y S D+++ G I ++++G+
Sbjct: 195 KKY------STSVDIWSIGCIFAEMITGK 217
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-23
Identities = 61/303 (20%), Positives = 115/303 (37%), Gaps = 69/303 (22%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV--RKEASTQGFAEFQSEVYVL-NFARHK 79
+F + +G G FG V+K + DG + A K + A + EVY +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 80 NIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDN-------TESVLEWHQRYAAAIGTA 131
++V + +++ I EY SL + +N E+ L + +
Sbjct: 72 HVVRYFSAWAEDDHMLI-QNEYCNGGSLADAISENYRIMSYFKEAEL---KDLLLQV--G 125
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM-------------------LGDFGLA 172
+GLR++H ++H D++PSNI ++ +P +GD G
Sbjct: 126 RGLRYIHS--MS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 173 RWKTTDDPVQTKILGTLGYLAPE-YAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEE 231
T Q + G +LA E EN + D++A + ++ +G + + NG++
Sbjct: 182 ---TRISSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVC-AAGAEPLPRNGDQ 236
Query: 232 PQQSLRQWAEPLIEKL--ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGE 289
+ + + + L EL+ + + +PE RPS
Sbjct: 237 WHEIRQGRLPRIPQVLSQEFTELLK--------------------VMIHPDPERRPSAMA 276
Query: 290 VVR 292
+V+
Sbjct: 277 LVK 279
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 8e-23
Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 14 SFSEIQQATGDFSKENL-----LGEGGFGHVYKGELK-DGQMIAAKV-RKEASTQGFAEF 66
+F +Q G+ ++ LG G G V+K K G ++A K+ E +
Sbjct: 19 AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI 78
Query: 67 QSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAA 126
E+ VL+ IV G + + E++ SL + + E +
Sbjct: 79 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPE---QILG 134
Query: 127 AI--GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK 184
+ KGL +L E+ + I+HRD++PSNIL+ L DFG++ + D +
Sbjct: 135 KVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSF 190
Query: 185 ILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
+ GT Y++PE + S+++D+++ G+ L+++ GR
Sbjct: 191 V-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 9e-23
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 24/222 (10%)
Query: 19 QQATGDFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEASTQGFAEFQSEVYVLNFA 76
+ + ++LG+G +V++G K G + A KV + + E VL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 77 RHKNIVMLLGF--CCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGT--AK 132
HKNIV L +L+ E+ SL+ L + + + +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVG 123
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLT----HDFVPMLGDFGLARWKTTDDPVQTKILGT 188
G+ L E G I+HR+++P NI+ V L DFG AR D+ + + GT
Sbjct: 124 GMNHLRE--NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-LYGT 178
Query: 189 LGYLAPEYAENGIVSIRT--------DVYAFGIILLQLMSGR 222
YL P+ E ++ D+++ G+ +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-23
Identities = 78/346 (22%), Positives = 124/346 (35%), Gaps = 86/346 (24%)
Query: 3 TELYMKDPMKFSFSEIQQATGD---FSKENL-----LGEGGFGHVYKGELKDG------Q 48
+ +PM + + + N+ +GEG FG V++
Sbjct: 19 LDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFT 78
Query: 49 MIAAKVRKE-ASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLH 107
M+A K+ KE AS A+FQ E ++ + NIV LLG C L++EY+ L+
Sbjct: 79 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 108 WHL----------------------FDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGP 145
L L ++ A A G+ +L E
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---- 194
Query: 146 IIHRDM--RPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL-----APEYAE 198
+HRD+ R N L+ + V + DFGL+R + D + PE
Sbjct: 195 FVHRDLATR--NCLVGENMVVKIADFGLSRNIYSAD-YYKA--DGNDAIPIRWMPPESIF 249
Query: 199 NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID---- 254
+ +DV+A+G++L ++ S G +P +A E+I
Sbjct: 250 YNRYTTESDVWAYGVVLWEIFS-------YGLQPYYG-----------MAHEEVIYYVRD 291
Query: 255 ----PRIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
EN ELY LM C + P RPS + R+L+
Sbjct: 292 GNILACPENCPL--ELYNLMRL----CWSKLPADRPSFCSIHRILQ 331
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 1e-22
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAEFQS--EVYVLNFARHK 79
+ K +GEG +G V+K + +++A K VR + +G + E+ +L +HK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP-SSALREICLLKELKHK 61
Query: 80 NIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
NIV L + L LV+E+ C++ L FD+ L+ + KGL F H
Sbjct: 62 NIVRLHDVLHSDKKLT-LVFEF-CDQDLK-KYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE--- 195
++HRD++P N+L+ + L +FGLAR + + TL Y P+
Sbjct: 119 SRN----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 196 ----YAENGIVSIRTDVYAFGIILLQLMSGRK 223
Y S D+++ G I +L + +
Sbjct: 175 GAKLY------STSIDMWSAGCIFAELANAGR 200
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 2e-22
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAK-VRKEASTQGFAEFQS--EVYVLNFARHKN 80
+ +GEG +G VYK + G+ A K +R E +G + E+ +L +H N
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIP-STTIREISILKELKHSN 61
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEE 140
IV L + +LV+E+ ++ L L D E LE + + G+ + H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEH-LDQDLK-KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 141 CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE----- 195
++HRD++P N+L+ + + DFGLAR T + TL Y AP+
Sbjct: 120 R----VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 196 --YAENGIVSIRTDVYAFGIILLQLMSGR 222
Y S D+++ G I ++++G
Sbjct: 176 KKY------STTIDIWSVGCIFAEMVNGT 198
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 64/235 (27%), Positives = 102/235 (43%), Gaps = 25/235 (10%)
Query: 2 KTELYMKDPMKFSFSE-IQQATGDFSK----ENLLGEGGFGHVYKGELK-DGQMIAAKV- 54
+ LY + ++ + I G S+ LG G +G V K A K+
Sbjct: 11 RENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII 70
Query: 55 -RKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI-LVYEYICNKSLHWHLFD 112
+ ST ++ EV VL H NI+ L F ++ N LV E L FD
Sbjct: 71 RKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-EDKRNYYLVMECYKGGEL----FD 125
Query: 113 NTESVLEWHQRYAAAIGT--AKGLRFLHEECRGGPIIHRDMRPSNILLT---HDFVPMLG 167
+++++ AA I G+ +LH+ I+HRD++P N+LL D + +
Sbjct: 126 EIIHRMKFNEVDAAVIIKQVLSGVTYLHK--HN--IVHRDLKPENLLLESKEKDALIKIV 181
Query: 168 DFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
DFGL+ + + LGT Y+APE + DV++ G+IL L++G
Sbjct: 182 DFGLSA-VFENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-22
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 40/215 (18%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKNI 81
+++ LG G FG V++ E + AK V+ + + Q + E+ +LN ARH+NI
Sbjct: 8 MIAED--LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ--VLVKKEISILNIARHRNI 63
Query: 82 VMLLGFCCKENLNILVYEY---------ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
+ L ++++E+ I + E +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFEL-----NE---------REIVSYVH 109
Query: 133 ----GLRFLHEECRGGPIIHRDMRPSNILLTH--DFVPMLGDFGLARWKTTDDPVQTKIL 186
L+FLH I H D+RP NI+ + +FG AR D + +
Sbjct: 110 QVCEALQFLHS--HN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LF 164
Query: 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
Y APE ++ +VS TD+++ G ++ L+SG
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 5e-22
Identities = 58/279 (20%), Positives = 98/279 (35%), Gaps = 34/279 (12%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVL-NFARHKNIV 82
F +++LG G G + + D + +A K + F+ EV +L H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR---ILPECFSFADREVQLLRESDEHPNVI 81
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
+ E C +L + + + T GL LH
Sbjct: 82 RYFCTEKDRQFQYIAIEL-CAATLQ-EYVEQKDFAHLGLEPITLLQQTTSGLAHLHS--L 137
Query: 143 GGPIIHRDMRPSNILLTH-----DFVPMLGDFGLARWKTTDDPVQTK---ILGTLGYLAP 194
I+HRD++P NIL++ M+ DFGL + ++ + GT G++AP
Sbjct: 138 N--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 195 EY---AENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251
E + D+++ G + ++S G P Q L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE-------GSHPFGKSLQ--RQANILLGACS 246
Query: 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEV 290
L E D L+ K + +P+ RPS V
Sbjct: 247 LDCLHPEKHEDVIARELIEK----MIAMDPQKRPSAKHV 281
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 6e-22
Identities = 31/253 (12%), Positives = 69/253 (27%), Gaps = 54/253 (21%)
Query: 16 SEIQQATGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV-------------------- 54
SE+ + + +LG+ + + + G+ V
Sbjct: 66 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 125
Query: 55 --------RKEASTQGFAEFQSEVYVLNFARHKNIVMLLG-FCCKENLNILVYEYICNKS 105
+ + + F ++ + K ++ + L+ +
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185
Query: 106 LHWHL-----FDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH 160
L +T L H R + + L LH G ++H +RP +I+L
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YG--LVHTYLRPVDIVLDQ 241
Query: 161 DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY-----------AENGIVSIRTDVY 209
L F + G+ PE +++ D +
Sbjct: 242 RGGVFLTGFEHLVRDGAR----VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAW 297
Query: 210 AFGIILLQLMSGR 222
A G+++ +
Sbjct: 298 ALGLVIYWIWCAD 310
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 6e-22
Identities = 65/219 (29%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 18 IQQATGDFSK----ENLLGEGGFGHVYKGELK-DGQMIAAKV---RKEASTQGFAEFQSE 69
+Q +T FS + +LG+G FG V + K GQ A KV R+ E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 70 VYVLNFARHKNIVMLLGFCCKENLNI-LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAI 128
V +L H NI+ L F ++ LV E L FD S + + AA I
Sbjct: 77 VQLLKQLDHPNIMKLYEFF-EDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARI 131
Query: 129 GT--AKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDDPVQT 183
G+ ++H+ I+HRD++P N+LL D + DFGL+
Sbjct: 132 IRQVLSGITYMHK--NK--IVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMK 186
Query: 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
+GT Y+APE +G + DV++ G+IL L+SG
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 94.0 bits (233), Expect = 7e-22
Identities = 36/290 (12%), Positives = 74/290 (25%), Gaps = 71/290 (24%)
Query: 16 SEIQQATGDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKV---RKEASTQGFAEFQSEVY 71
SE+ + + +LG+ + + G+ V + + + + EV
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 72 VLNFAR----------------------HKNIVMLLGFCCKENLNILVYEYICNKSLHWH 109
L R ++ E ++ + + +
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 110 LFDNTESV---------LEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH 160
L E + L H R + + L LH G ++H +RP +I+L
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YG--LVHTYLRPVDIVLDQ 246
Query: 161 DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY----------AENGIVSIRTDVYA 210
L F + G+ PE +++ D +
Sbjct: 247 RGGVFLTGFEHLV--RDGASAVS--PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302
Query: 211 FGIILLQLMSGR-------------KVVDMNGEEPQQSLRQWAEPLIEKL 247
G+ + + + P Q L+E
Sbjct: 303 LGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIP-----QPVRALLEGF 347
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 7e-22
Identities = 57/213 (26%), Positives = 83/213 (38%), Gaps = 28/213 (13%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV------RKEASTQGFAEFQSEVYVLNFA 76
D +E LG G F V K K G AAK R E + EV +L
Sbjct: 15 DIGEE--LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 77 RHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK---- 132
H N++ L +L+ E + L FD + A K
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGEL----FDFL--AQKESLSEEEATSFIKQILD 126
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVP----MLGDFGLARWKTTDDPVQTKILGT 188
G+ +LH + I H D++P NI+L +P L DFGLA + I GT
Sbjct: 127 GVNYLHT--KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IFGT 181
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
++APE + + D+++ G+I L+SG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-21
Identities = 54/327 (16%), Positives = 105/327 (32%), Gaps = 53/327 (16%)
Query: 6 YMKDPMKFSFSEIQQATGDFSKENLLGEG--GFGHVYKG-ELKDGQMIAAKVRK--EAST 60
+M++ S G + ++G+G V G+ + + S
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 61 QGFAEFQSEVYVLNFARHKNIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLE 119
+ Q E++V H NIV F L + V ++ S + + +
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV-VTSFMAYGSAKDLICTHFMDGMN 126
Query: 120 WHQRYAAAI--GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA----- 172
+ A I G K L ++H +HR ++ S+IL++ D L
Sbjct: 127 --ELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180
Query: 173 --RWKTTDDPVQTKILGTLGYLAPEYAENGIV--SIRTDVYAFGIILLQLMSGR------ 222
+ + + L +L+PE + + ++D+Y+ GI +L +G
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240
Query: 223 ---KVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAY----- 274
+++ L + E+L + D+ +
Sbjct: 241 PATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSH 300
Query: 275 ---------------LCVQRNPEGRPS 286
C+QRNP+ RPS
Sbjct: 301 PYHRTFSPHFHHFVEQCLQRNPDARPS 327
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 53/225 (23%), Positives = 84/225 (37%), Gaps = 18/225 (8%)
Query: 8 KDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKV-RKEASTQGFAE 65
+ Q D +G G G V+K + G +IA K R+ + +
Sbjct: 10 TGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKR 69
Query: 66 FQSEVYVL-NFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRY 124
++ V+ IV G + E + E R
Sbjct: 70 ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL-MGTCAEKLKKRMQGPIPE---RI 125
Query: 125 AAAI--GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182
+ K L +L E+ +IHRD++PSNILL L DFG++ + DD +
Sbjct: 126 LGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISG-RLVDDKAK 181
Query: 183 TKILGTLGYLAPE-----YAENGIVSIRTDVYAFGIILLQLMSGR 222
+ G Y+APE IR DV++ GI L++L +G+
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 58/213 (27%), Positives = 83/213 (38%), Gaps = 28/213 (13%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV------RKEASTQGFAEFQSEVYVLNFA 76
D +E LG G F V K K G AAK R E + EV +L
Sbjct: 15 DIGEE--LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 77 RHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK---- 132
H NI+ L +L+ E + L FD + A K
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGEL----FDFL--AQKESLSEEEATSFIKQILD 126
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVP----MLGDFGLARWKTTDDPVQTKILGT 188
G+ +LH + I H D++P NI+L +P L DFGLA + I GT
Sbjct: 127 GVNYLHT--KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IFGT 181
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
++APE + + D+++ G+I L+SG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-21
Identities = 49/209 (23%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEASTQGFAEFQSEVYVLNFARHKNI 81
F ++ LG G FG V+ E + G K K+ S + ++E+ VL H NI
Sbjct: 25 IFKRK--LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNI 82
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRY----AAAIGT--AKGLR 135
+ + + +V E L + S + A + L
Sbjct: 83 IKIFEVFEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 136 FLHEECRGGPIIHRDMRPSNILLT---HDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL 192
+ H + ++H+D++P NIL + DFGLA D T GT Y+
Sbjct: 139 YFHS--QH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHSTNAAGTALYM 193
Query: 193 APEYAENGIVSIRTDVYAFGIILLQLMSG 221
APE V+ + D+++ G+++ L++G
Sbjct: 194 APEVF-KRDVTFKCDIWSAGVVMYFLLTG 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 4e-21
Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 42/220 (19%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV---RKEASTQGFA---EFQSEVYVLNFA 76
+ +E LG G F V K + G+ AAK R+ +S++ E + EV +L
Sbjct: 8 EMGEE--LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 77 RHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDN-------TESVLEWHQRYAAAIG 129
RH NI+ L + +L+ E + L FD TE A
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTE---------DEATQ 112
Query: 130 TAK----GLRFLHEECRGGPIIHRDMRPSNILLTHDFVP----MLGDFGLARWKTTDDPV 181
K G+ +LH + I H D++P NI+L VP L DFG+A +
Sbjct: 113 FLKQILDGVHYLHS--KR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168
Query: 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
+ I GT ++APE + + D+++ G+I L+SG
Sbjct: 169 KN-IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-21
Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 31 LGEGGFGHVYKGELKD-GQMIAAKV---RKEASTQGFAE--FQSEVYVLNFARHKNIVML 84
+G+G F V + ++ GQ A K+ K S+ G + + E + + +H +IV L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 85 LGFCCKENLNILVYEY---------ICNKSLHWHLFDNTESVLEWHQRYAAAIG--TAKG 133
L + + +V+E+ I ++ ++ +E A+ +
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY--SE-------AVASHYMRQILEA 142
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDDPVQTKILGTLG 190
LR+ H+ IIHRD++P +LL LG FG+A V +GT
Sbjct: 143 LRYCHD--NN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 198
Query: 191 YLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
++APE + DV+ G+IL L+SG
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-21
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKV-RKEASTQGFAEFQSEVYVLNFA-RHKN 80
D +G G +G V K K GQ++A K R + + ++ V+ +
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHW---HLFDNTESVLEWHQRYAAAI--GTAKGLR 135
IV G +E + E + S +++ + V+ + I T K L
Sbjct: 83 IVQFYGALFREGDCWICMEL-MSTSFDKFYKYVYSVLDDVIP--EEILGKITLATVKALN 139
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE 195
L E + IIHRD++PSNILL L DFG++ + D +T+ G Y+APE
Sbjct: 140 HLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISG-QLVDSIAKTRDAGCRPYMAPE 195
Query: 196 ----YAENGIVSIRTDVYAFGIILLQLMSGR 222
A +R+DV++ GI L +L +GR
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 7e-21
Identities = 55/187 (29%), Positives = 77/187 (41%), Gaps = 22/187 (11%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAEFQS----EVYVL---N 74
+ +G G +G VYK + G +A K VR G EV +L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 75 FARHKNIVMLLGFCCKENLNI-----LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIG 129
H N+V L+ C + LV+E+ ++ L +L L
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 130 TAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ-TKILGT 188
+GL FLH C I+HRD++P NIL+T L DFGLAR + T ++ T
Sbjct: 129 FLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPVVVT 182
Query: 189 LGYLAPE 195
L Y APE
Sbjct: 183 LWYRAPE 189
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 7e-21
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAEFQS----EVYVLNFAR 77
+ K + LGEG F VYK + Q++A K ++ ++ E+ +L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 78 HKNIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRF 136
H NI+ LL F K N++ LV+++ L + + VL A + T +GL +
Sbjct: 71 HPNIIGLLDAFGHKSNIS-LVFDF-METDL-EVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE- 195
LH+ I+HRD++P+N+LL + V L DFGLA+ + + T + T Y APE
Sbjct: 128 LHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183
Query: 196 ------YAENGIVSIRTDVYAFGIILLQLMSGR 222
Y V + D++A G IL +L+
Sbjct: 184 LFGARMYG----VGV--DMWAVGCILAELLLRV 210
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-20
Identities = 49/215 (22%), Positives = 81/215 (37%), Gaps = 30/215 (13%)
Query: 22 TGDFSK----ENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQSEVYVLNFA 76
GD ++ EN +G G +G V K AAK + + F+ E+ ++
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63
Query: 77 RHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGT--AKGL 134
H NI+ L LV E LF+ + + AA I +
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAV 119
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDDPVQTKILGTLGY 191
+ H+ + HRD++P N L D L DFGLA + + +GT Y
Sbjct: 120 AYCHK--LN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMMRTKVGTPYY 174
Query: 192 LAPE-----YAENGIVSIRTDVYAFGIILLQLMSG 221
++P+ Y D ++ G+++ L+ G
Sbjct: 175 VSPQVLEGLYGP------ECDEWSAGVMMYVLLCG 203
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 56/226 (24%), Positives = 84/226 (37%), Gaps = 44/226 (19%)
Query: 22 TGDFSK----ENLLGEGGFGHVYKGELKD-GQMIAAKV------RKEASTQGFAEFQSEV 70
+ LG G F V K K G AAK + + + EV
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 71 YVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDN-------TESVLEWHQR 123
+L +H N++ L + IL+ E + L FD TE
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTE-------- 113
Query: 124 YAAAIGTAK----GLRFLHEECRGGPIIHRDMRPSNILLTHDFVP----MLGDFGLARWK 175
A K G+ +LH I H D++P NI+L VP + DFGLA
Sbjct: 114 -EEATEFLKQILNGVYYLHS--LQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 176 TTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
+ + I GT ++APE + + D+++ G+I L+SG
Sbjct: 169 DFGNEFKN-IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 64/227 (28%), Positives = 108/227 (47%), Gaps = 20/227 (8%)
Query: 6 YMKDPMKFSFSEIQQAT-GDFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEA--ST 60
Y +++ + E Q T F + +LG+GGFG V +++ G+M A K K+
Sbjct: 166 YFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 225
Query: 61 QGFAEFQSEVYVLNFARHKNIVMLLGFCC---KENLNILVYEYICNKSLHWHLFDNTESV 117
+G A +E +L + +V L K+ L LV + L +H++ ++
Sbjct: 226 KGEAMALNEKQILEKVNSRFVVSL--AYAYETKDAL-CLVLTLMNGGDLKFHIYHMGQAG 282
Query: 118 L-EWHQR-YAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175
E YAA I GL LH E I++RD++P NILL + D GLA
Sbjct: 283 FPEARAVFYAAEI--CCGLEDLHRER----IVYRDLKPENILLDDHGHIRISDLGLAVHV 336
Query: 176 TTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
++ ++ GT+GY+APE +N + D +A G +L ++++G+
Sbjct: 337 PEGQTIKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-20
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 32/217 (14%)
Query: 22 TGDFSKE----NLLGEGGFGHVYKGELKD-GQMIAAKV--RKEASTQGFAEFQSEVYVLN 74
G F++ +LG+G FG V K + + Q A KV + A + + EV +L
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 75 FARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGT--AK 132
H NI+ L + +V E L FD + + AA I
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFS 132
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDDPVQTKILGTL 189
G+ ++H+ I+HRD++P NILL D + DFGL+ + +GT
Sbjct: 133 GITYMHK--HN--IVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKMKDRIGTA 187
Query: 190 GYLAPE-----YAENGIVSIRTDVYAFGIILLQLMSG 221
Y+APE Y E + DV++ G+IL L+SG
Sbjct: 188 YYIAPEVLRGTYDE------KCDVWSAGVILYILLSG 218
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 76/326 (23%), Positives = 131/326 (40%), Gaps = 68/326 (20%)
Query: 9 DPMKFSFSEIQQATGD----FSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRK-EASTQG 62
P++ +Q D F+K +G+G FG V+KG + + +++A K+ E +
Sbjct: 4 SPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE 63
Query: 63 FAEFQSEVYVLNFARHKNIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWH 121
+ Q E+ VL+ + G + L I + EY+ S L L+
Sbjct: 64 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI-IMEYLGGGSAL-DLL--EPGPLD-- 117
Query: 122 QRYAAAI--GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179
+ A I KGL +LH E IHRD++ +N+LL+ L DFG+A T
Sbjct: 118 ETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173
Query: 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR---------KVVDMNGE 230
+ +GT ++APE + + D+++ GI ++L G KV+ + +
Sbjct: 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK 233
Query: 231 EPQQSLR-QWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGE 289
+L +++PL E + C+ + P RP+ E
Sbjct: 234 NNPPTLEGNYSKPLKEFVE--------------------------ACLNKEPSFRPTAKE 267
Query: 290 VVRLLEGENDRFHHLGEKFVQRHHTK 315
LL+ H KF+ R+ K
Sbjct: 268 ---LLK------H----KFILRNAKK 280
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 24/222 (10%)
Query: 14 SFSEIQQATGDFSK----ENLLGEGGFGHVYKGELK-DGQMIAAKV--RKEASTQGFAEF 66
S E G F++ +LG+G FG V K + + Q A KV + A + +
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 67 QSEVYVLNFARHKNIVMLLGFCCKENLNI-LVYEYICNKSLHWHLFDNTESVLEWHQRYA 125
EV +L H NI+ L +++ + +V E L FD + + A
Sbjct: 69 LREVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDA 123
Query: 126 AAIGT--AKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDDP 180
A I G+ ++H+ I+HRD++P NILL D + DFGL+ +
Sbjct: 124 ARIIKQVFSGITYMHK--HN--IVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNT 178
Query: 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
+GT Y+APE G + DV++ G+IL L+SG
Sbjct: 179 KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 32/233 (13%)
Query: 8 KDPMKFSFSEIQQATG--DFSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGF 63
+ P S S AT + + LGEG +G VYK + + +A K +R E +G
Sbjct: 17 QGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV 76
Query: 64 AEFQS--EVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWH 121
+ EV +L +H+NI+ L + L++EY L ++ + +
Sbjct: 77 P-GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYM--DKNPDVSMR 132
Query: 122 QRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM-----LGDFGLARWKT 176
+ G+ F H +HRD++P N+LL+ +GDFGLAR
Sbjct: 133 VIKSFLYQLINGVNFCHSRR----CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188
Query: 177 TDDPVQTKILGTLGYLAPE-------YAENGIVSIRTDVYAFGIILLQLMSGR 222
T + TL Y PE Y S D+++ I +++
Sbjct: 189 IPIRQFTHEIITLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-20
Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 14/208 (6%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAK-VRKEASTQGFAEFQSEVYV-LNFARHKN 80
D LG G +G V K GQ++A K +R ++Q ++ + +
Sbjct: 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF 67
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAI--GTAKGLRFLH 138
V G +E + E + SL + + I K L LH
Sbjct: 68 TVTFYGALFREGDVWICMEL-MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE--- 195
+ +IHRD++PSN+L+ + DFG++ DD + G Y+APE
Sbjct: 127 SKLS---VIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDIDAGCKPYMAPERIN 182
Query: 196 -YAENGIVSIRTDVYAFGIILLQLMSGR 222
S+++D+++ GI +++L R
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-20
Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 11/176 (6%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAK-VRKEASTQGFAEFQS--EVYVLNFARHK 79
+ L+GEG +G V K KD G+++A K + + + + E+ +L RH+
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV-KKIAMREIKLLKQLRHE 84
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
N+V LL C K+ LV+E+ + ++ + + L++ G+ F H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEF-VDHTIL-DDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE 195
IIHRD++P NIL++ V L DFG AR V + T Y APE
Sbjct: 143 HN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-20
Identities = 55/228 (24%), Positives = 92/228 (40%), Gaps = 33/228 (14%)
Query: 18 IQQATGDFSK----ENLLGEGGFGHVYKGELK-DGQMIAAKV-------------RKEAS 59
+++ G + LG G +G V + K A KV +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 60 TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLE 119
+ E +E+ +L H NI+ L + LV E+ L F+ + +
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHK 142
Query: 120 WHQRYAAAIGT--AKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARW 174
+ + AA I G+ +LH+ I+HRD++P NILL + + DFGL+
Sbjct: 143 FDECDAANIMKQILSGICYLHK--HN--IVHRDIKPENILLENKNSLLNIKIVDFGLSS- 197
Query: 175 KTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
+ D LGT Y+APE + + DV++ G+I+ L+ G
Sbjct: 198 FFSKDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-20
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQS--EVYVLNFARHKN 80
+ K + LGEG + VYKG+ K ++A K + +G + EV +L +H N
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP-CTAIREVSLLKDLKHAN 61
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEE 140
IV L E LV+EY +K L +L D+ +++ H +GL + H +
Sbjct: 62 IVTLHDIIHTEKSLTLVFEY-LDKDLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 141 CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE----- 195
++HRD++P N+L+ L DFGLAR K+ + TL Y P+
Sbjct: 120 K----VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 196 --YAENGIVSIRTDVYAFGIILLQLMSGR 222
Y S + D++ G I ++ +GR
Sbjct: 176 TDY------STQIDMWGVGCIFYEMATGR 198
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 60/229 (26%), Positives = 96/229 (41%), Gaps = 21/229 (9%)
Query: 6 YMKDPMKFSFSEIQQAT-GDFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEA--ST 60
Y +++ + E Q F +LG GGFG V+ ++K G++ A K K+
Sbjct: 167 YFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR 226
Query: 61 QGFAEFQSEVYVLNFARHKNIVMLLGFCC---KENLNILVYEYICNKSLHWHLFDNTESV 117
+G+ E +L + IV L K +L LV + + +H+++ E
Sbjct: 227 KGYQGAMVEKKILAKVHSRFIVSL--AYAFETKTDL-CLVMTIMNGGDIRYHIYNVDEDN 283
Query: 118 ---LEWHQR-YAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173
E Y A I GL LH+ II+RD++P N+LL D + D GLA
Sbjct: 284 PGFQEPRAIFYTAQI--VSGLEHLHQRN----IIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 174 WKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
GT G++APE D +A G+ L ++++ R
Sbjct: 338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-19
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQS--EVYVLNFARHKN 80
F + LG G + VYKG G +A K K S +G + E+ ++ +H+N
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP-STAIREISLMKELKHEN 64
Query: 81 IVMLLGFCCKENLNILVYEYICN---KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFL 137
IV L EN LV+E++ N K + NT LE + +GL F
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE-- 195
HE I+HRD++P N+L+ LGDFGLAR + + TL Y AP+
Sbjct: 125 HENK----ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVL 180
Query: 196 -----YAENGIVSIRTDVYAFGIILLQLMSGR 222
Y S D+++ G IL ++++G+
Sbjct: 181 MGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 29/222 (13%)
Query: 18 IQQATGDFSK-----ENLLGEGGFGHVYKGELKD-GQMIAAKV--RKEASTQGFAEFQSE 69
Q+ +F+ LG G F V + K GQ AAK ++ AE E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78
Query: 70 VYVLNFARH-KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRY--AA 126
+ VL A+ ++ L + IL+ EY + F + E +
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FS--LCLPELAEMVSEND 132
Query: 127 AIGTAK----GLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDD 179
I K G+ +LH+ I+H D++P NILL+ + DFG++R
Sbjct: 133 VIRLIKQILEGVYYLHQ--NN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188
Query: 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
++ I+GT YLAPE ++ TD++ GII L++
Sbjct: 189 ELRE-IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAK-VRKEASTQGFAEFQS-EVYVLNFARHKN 80
+ K +GEG +G V+K +D GQ++A K + + E+ +L +H N
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEE 140
+V LL ++ LV+EY C+ ++ H D + + H + T + + F H+
Sbjct: 64 LVNLLEVFRRKRRLHLVFEY-CDHTVL-HELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 141 CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE----- 195
IHRD++P NIL+T V L DFG AR T + T Y +PE
Sbjct: 122 N----CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177
Query: 196 --YAENGIVSIRTDVYAFGIILLQLMSGR 222
Y + DV+A G + +L+SG
Sbjct: 178 TQYGP----PV--DVWAIGCVFAELLSGV 200
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 60/211 (28%), Positives = 83/211 (39%), Gaps = 24/211 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMI-AAKV-RKEA--STQGFAEFQSEVYVLNFARHK 79
DF +LGEG F V A K+ K E V++ H
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 80 NIVMLLG-FCCKENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKG 133
V L F E L Y N L ++ FD T + + Y A I +A
Sbjct: 91 FFVKLYFTFQDDEKL-YFGLSYAKNGELLKYIRKIGSFDETCT-----RFYTAEIVSA-- 142
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA-RWKTTDDPVQTKIL-GTLGY 191
L +LH +G IIHRD++P NILL D + DFG A + GT Y
Sbjct: 143 LEYLHG--KG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
++PE +D++A G I+ QL++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-19
Identities = 43/228 (18%), Positives = 86/228 (37%), Gaps = 37/228 (16%)
Query: 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKV-----------------RKEASTQGFAE 65
D+ L +G F + E KD + A K K + + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 66 FQSEVYVLNFARHKNIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR- 123
F++E+ ++ +++ + G + + ++YEY+ N S+ +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEV-YIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 124 -------YAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176
++ ++H E I HRD++PSNIL+ + L DFG + +
Sbjct: 149 PIQVIKCIIKSV--LNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEY-M 202
Query: 177 TDDPVQTKILGTLGYLAPE--YAENGIVSIRTDVYAFGIILLQLMSGR 222
D ++ GT ++ PE E+ + D+++ GI L +
Sbjct: 203 VDKKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 16 SEIQQATGDFSKE----NLLGEGGFGHVYKGELKD-GQMIAAKV--RKEASTQGFAEFQS 68
+ A+ FS LG+G F V + K G AAK+ K+ S + F + +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 69 EVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAI 128
E + +H NIV L +E+ + LV++ LF++ + + + A+
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDL-VTGG---ELFEDIVAREFYSEADASHC 133
Query: 129 GT--AKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDDPVQT 183
+ + + H G I+HR+++P N+LL L DFGLA + D
Sbjct: 134 IQQILESIAYCHS--NG--IVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWH 188
Query: 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
GT GYL+PE + S D++A G+IL L+ G
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-19
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 22 TGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKN 80
+ LG+G FG VYK + G + AAKV + S + ++ E+ +L H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAI--GTAKGLRFLH 138
IV LLG + ++ E+ ++ + + L + + + L FLH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVD-AIMLELDRGLT--EPQIQVVCRQMLEALNFLH 134
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGL-ARWKTTDDPVQTKILGTLGYLAPEYA 197
+ IIHRD++ N+L+T + L DFG+ A+ T + I GT ++APE
Sbjct: 135 SK----RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVV 189
Query: 198 ENGIVS-----IRTDVYAFGIILLQLMSG 221
+ + D+++ GI L+++
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-19
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 22 TGDFSKE----NLLGEGGFGHVYKGELKD-GQMIAAKV--RKEASTQGFAEFQSEVYVLN 74
+ FS LG+G F V + K G AAK+ K+ S + F + + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 75 FARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGT--AK 132
+H NIV L +E+ + LV++ LF++ + + + A+ +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDL-VTGG---ELFEDIVAREFYSEADASHCIQQILE 116
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDDPVQTKILGTL 189
+ + H G I+HR+++P N+LL L DFGLA + D GT
Sbjct: 117 SIAYCHS--NG--IVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFAGTP 171
Query: 190 GYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
GYL+PE + S D++A G+IL L+ G
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 5e-19
Identities = 64/342 (18%), Positives = 106/342 (30%), Gaps = 96/342 (28%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAA-------------KVRKEA----------- 58
DF +G GGFG V++ + K D A KV +E
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 59 ----------------------------------STQGFAEFQSEVYVLNFARHKNIVM- 83
S ++ ++ KN V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 84 LLGFCCKENLNILVYEYICNKSLH-WHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
L K L I + ++L W + E I A+ + FLH +
Sbjct: 127 LQPSSPKVYLYI-QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLAR------------WKTTDDPVQTKILGTLG 190
++HRD++PSNI T D V +GDFGL T +GT
Sbjct: 185 ---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 191 YLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250
Y++PE S + D+++ G+IL +L+ E + + +
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS----TQMERVRIITD----------VR 287
Query: 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
L P + E ++ + +P RP +++
Sbjct: 288 NLKFPLLFTQKYPQEHMMVQD----MLSPSPTERPEATDIIE 325
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 5e-19
Identities = 47/232 (20%), Positives = 81/232 (34%), Gaps = 48/232 (20%)
Query: 25 FSKENLLGEGGFGHVYKGELKDGQMIAAKV-RKEASTQGFAEFQSEVYVLN-FARHKNIV 82
E +LG G G V G+ +A K + E+ +L H N++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDI----ALMEIKLLTESDDHPNVI 72
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFD-------NTESVLEWHQRYAAAI--GTAKG 133
+ + E CN + L D + E++ + ++ A G
Sbjct: 73 RYYCSETTDRFLYIALEL-CNLN----LQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTH-------------DFVPMLGDFGLARWKTTDDP 180
+ LH IIHRD++P NIL++ + ++ DFGL + +
Sbjct: 128 VAHLHS--LK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 181 VQTKIL----GTLGYLAPEYAENGIVSIRT-------DVYAFGIILLQLMSG 221
L GT G+ APE E D+++ G + ++S
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-19
Identities = 54/225 (24%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 22 TGDFSKE----NLLGEGGFGHVYKGELKD-GQMIAAKV--RKEASTQGFAEFQSEVYVLN 74
F++E LG+G F V + GQ AA + K+ S + + + E +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 75 FARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDN-------TESVLEWHQRYAAA 127
+H NIV L +E + L+++ LF++ +E A+
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDL-VTGG---ELFEDIVAREYYSE-------ADASH 114
Query: 128 IGT--AKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDDPVQ 182
+ + H+ G ++HR+++P N+LL L DFGLA +
Sbjct: 115 CIQQILEAVLHCHQ--MG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 183 TKILGTLGYLAPEYAENGIVSIRT------DVYAFGIILLQLMSG 221
GT GYL+PE V + D++A G+IL L+ G
Sbjct: 171 FGFAGTPGYLSPE------VLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-19
Identities = 63/237 (26%), Positives = 108/237 (45%), Gaps = 24/237 (10%)
Query: 1 MKTELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEAS 59
M ++ + + S ++ G F L+G G +G VYKG +K GQ+ A KV +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VT 60
Query: 60 TQGFAEFQSEVYVL-NFARHKNIVMLLGFCCKENLNI------LVYEYICNKSLHWHLFD 112
E + E+ +L ++ H+NI G K+N LV E+ S+ + +
Sbjct: 61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120
Query: 113 NTESVLEWHQRYAAAI--GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170
+ L+ + + A I +GL LH+ +IHRD++ N+LLT + L DFG
Sbjct: 121 TKGNTLK--EEWIAYICREILRGLSHLHQHK----VIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 171 L-ARWKTTDDPVQTKILGTLGYLAPEYAENGIVS-----IRTDVYAFGIILLQLMSG 221
+ A+ T T I GT ++APE ++D+++ GI +++ G
Sbjct: 175 VSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-19
Identities = 59/213 (27%), Positives = 85/213 (39%), Gaps = 38/213 (17%)
Query: 26 SKENLLGEGGFGHVYKGELKD-GQMIAAKV---RKEASTQGFAEFQSEVYVL-NFARHKN 80
K+ LGEG F K K Q A K+ R EA+TQ E+ L H N
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ------KEITALKLCEGHPN 67
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDN-------TESVLEWHQRYAAAI--GTA 131
IV L + LV E + L F+ +E A+ I
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSE-------TEASYIMRKLV 116
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDDPVQTKILGT 188
+ +H+ G ++HRD++P N+L T + + DFG AR K D+ T
Sbjct: 117 SAVSHMHD--VG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT 172
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
L Y APE D+++ G+IL ++SG
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-19
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 38/219 (17%)
Query: 22 TGDFSK----ENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQSEVYVLNFA 76
T + K +LG G F V+ + + G++ A K K++ + ++E+ VL
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI 63
Query: 77 RHKNIVMLLGFCCKENLNILVYEY---------ICNKSLHWHLFDNTESVLEWHQRYAAA 127
+H+NIV L LV + I + TE + A+
Sbjct: 64 KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG---VY---TE-------KDASL 110
Query: 128 IGT--AKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDDPVQ 182
+ +++LHE G I+HRD++P N+L + M+ DFGL+ K + +
Sbjct: 111 VIQQVLSAVKYLHE--NG--IVHRDLKPENLLYLTPEENSKIMITDFGLS--KMEQNGIM 164
Query: 183 TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
+ GT GY+APE S D ++ G+I L+ G
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-19
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 22 TGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKN 80
+++ +G+G G VY ++ GQ +A + +E+ V+ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 81 IVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAI--GTAKGLRFL 137
IV L + + L + V EY+ SL + TE+ ++ + AA+ + L FL
Sbjct: 79 IVNYLDSYLVGDELWV-VMEYLAGGSLTDVV---TETCMD--EGQIAAVCRECLQALEFL 132
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYA 197
H +IHRD++ NILL D L DFG T + ++ ++GT ++APE
Sbjct: 133 HSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 198 ENGIVSIRTDVYAFGIILLQLMSG 221
+ D+++ GI+ ++++ G
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 9e-19
Identities = 55/204 (26%), Positives = 84/204 (41%), Gaps = 14/204 (6%)
Query: 22 TGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKN 80
F LGEG +G VYK + GQ++A K E E+ ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAI--GTAKGLRFLH 138
+V G K +V EY S+ + L + A I T KGL +LH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVS-DIIRLRNKTLT--EDEIATILQSTLKGLEYLH 142
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGL-ARWKTTDDPVQTKILGTLGYLAPEYA 197
IHRD++ NILL + L DFG+ + T T I GT ++APE
Sbjct: 143 FM----RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVI 197
Query: 198 ENGIVSIRTDVYAFGIILLQLMSG 221
+ + D+++ GI +++ G
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEG 221
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 63/293 (21%), Positives = 111/293 (37%), Gaps = 57/293 (19%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRK-EASTQGFAEFQSEVYVLNFARHKNI 81
D+ + ++G G V + +A K E E E+ ++ H NI
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 82 VMLLG-FCCKENLNILVYEYICNKSL------HWHLFDNTESVLEWHQRYAAAI--GTAK 132
V F K+ L + V + + S+ ++ VL+ + A I +
Sbjct: 76 VSYYTSFVVKDELWL-VMKLLSGGSVLDIIKHIVAKGEHKSGVLD--ESTIATILREVLE 132
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW--KTTDDPVQTK---ILG 187
GL +LH+ IHRD++ NILL D + DFG++ + D +G
Sbjct: 133 GLEYLHKN----GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 188 TLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGR---------KVVDMNGEEPQQSLR 237
T ++APE E + D+++FGI ++L +G KV+ + + SL
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248
Query: 238 QWAEPLIEKL----ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS 286
+ + ++I LC+Q++PE RP+
Sbjct: 249 TGVQDKEMLKKYGKSFRKMIS--------------------LCLQKDPEKRPT 281
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 22 TGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKN 80
+GEG G V E G+ +A K+ Q +EV ++ +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 81 IVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAI--GTAKGLRFL 137
+V + + E L + + E++ +L + ++ L + A + + L +L
Sbjct: 104 VVEMYKSYLVGEELWV-LMEFLQGGALTDIV---SQVRLN--EEQIATVCEAVLQALAYL 157
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYA 197
H + +IHRD++ +ILLT D L DFG + D P + ++GT ++APE
Sbjct: 158 HAQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 198 ENGIVSIRTDVYAFGIILLQLMSG 221
+ + D+++ GI++++++ G
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDG 237
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 21/224 (9%)
Query: 7 MKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV---RKEASTQG 62
+KDP FS +G G FG VY ++++ +++A K + S +
Sbjct: 38 LKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 97
Query: 63 FAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQ 122
+ + EV L RH N + G +E+ LV EY C S L + + L+ +
Sbjct: 98 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSAS-DLLEVHKKPLQ--E 153
Query: 123 RYAAAI--GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180
AA+ G +GL +LH +IHRD++ NILL+ + LGDFG A + P
Sbjct: 154 VEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSA---SIMAP 206
Query: 181 VQTKILGTLGYLAPE---YAENGIVSIRTDVYAFGIILLQLMSG 221
+ + GT ++APE + G + DV++ GI ++L
Sbjct: 207 ANSFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 58/213 (27%), Positives = 83/213 (38%), Gaps = 21/213 (9%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEA--STQGFAEFQSEVYVLNFARHK 79
DF ++G G F V ++K GQ+ A K+ K + F+ E VL +
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121
Query: 80 NIVMLL-GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-YAAAIGTAKGLRFL 137
I L F + L LV EY L L E + R Y A I A + +
Sbjct: 122 WITQLHFAFQDENYL-YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA--IDSV 178
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL-GTLGYLAPEY 196
H +HRD++P NILL L DFG D V++ + GT YL+PE
Sbjct: 179 HRLG----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 197 AENGIVSIRTDVY-------AFGIILLQLMSGR 222
+ T Y A G+ ++ G+
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-18
Identities = 52/226 (23%), Positives = 86/226 (38%), Gaps = 32/226 (14%)
Query: 19 QQATGDFSKE----NLLGEGGFGHVYKGELKD-GQMIAAKV---RKEASTQGF------A 64
+T F + +LG G V + K + A K+ S
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 65 EFQSEVYVL-NFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR 123
EV +L + H NI+ L LV++ + L FD + ++
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEK 124
Query: 124 YAAAIGT--AKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181
I + + LH+ I+HRD++P NILL D L DFG + + +
Sbjct: 125 ETRKIMRALLEVICALHK--LN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 180
Query: 182 QTKILGTLGYLAPEYAENGIVSIRT------DVYAFGIILLQLMSG 221
+ + GT YLAPE E + D+++ G+I+ L++G
Sbjct: 181 RE-VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 4e-18
Identities = 48/267 (17%), Positives = 86/267 (32%), Gaps = 56/267 (20%)
Query: 8 KDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-----RKEASTQ 61
++ + F + + + + +G+G +G V + A K+ ++ + +
Sbjct: 11 RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPK 70
Query: 62 GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWH 121
++EV ++ H NI L E LV E L L +
Sbjct: 71 DVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKC 130
Query: 122 QRYAAAIGTAK--------------------------------------GLRFLHEECRG 143
L +LH +G
Sbjct: 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN--QG 188
Query: 144 GPIIHRDMRPSNILLTHD--FVPMLGDFGLARW----KTTDDPVQTKILGTLGYLAPEYA 197
I HRD++P N L + + F L DFGL++ + T GT ++APE
Sbjct: 189 --ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246
Query: 198 ENGIVSI--RTDVYAFGIILLQLMSGR 222
S + D ++ G++L L+ G
Sbjct: 247 NTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-18
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 34/219 (15%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKD-GQMIAAK-VRKEASTQGFAEFQS--EVYVL---NF 75
+ +GEG +G V+K +LK+ G+ +A K VR + +G + EV VL
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP-LSTIREVAVLRHLET 70
Query: 76 ARHKNIVMLL----GFCCKENLNI-LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGT 130
H N+V L + LV+E+ ++ L +L E +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 131 AKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ-TKILGTL 189
+GL FLH ++HRD++P NIL+T L DFGLAR + T ++ TL
Sbjct: 130 LRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTL 183
Query: 190 GYLAPE------YAENGIVSIRTDVYAFGIILLQLMSGR 222
Y APE YA + D+++ G I ++ +
Sbjct: 184 WYRAPEVLLQSSYAT----PV--DLWSVGCIFAEMFRRK 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 8e-18
Identities = 56/247 (22%), Positives = 93/247 (37%), Gaps = 47/247 (19%)
Query: 9 DPMKFSF-----SEIQQATGDFSKENL-LGEGGFGHVYKGELKD---GQMIAAKVRKEAS 59
D M + F SE ++ F E +G G +GHVYK + KD + A K +
Sbjct: 1 DKMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG 60
Query: 60 TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI--LVYEYICNKSLHWHLFDNTESV 117
A E+ +L +H N++ L L+++Y L WH+ +
Sbjct: 61 ISMSA--CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDL-WHIIKFHRAS 116
Query: 118 LEWHQRYAAAIGTAK--------GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM---- 165
+ G K G+ +LH ++HRD++P+NIL+ +
Sbjct: 117 KANKKPVQLPRGMVKSLLYQILDGIHYLHANW----VLHRDLKPANILVMGEGPERGRVK 172
Query: 166 LGDFGLARWKTTDDPVQTKILG---TLGYLAPE-------YAENGIVSIRTDVYAFGIIL 215
+ D G AR + + T Y APE Y + D++A G I
Sbjct: 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY------TKAIDIWAIGCIF 226
Query: 216 LQLMSGR 222
+L++
Sbjct: 227 AELLTSE 233
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-18
Identities = 49/232 (21%), Positives = 86/232 (37%), Gaps = 31/232 (13%)
Query: 11 MKFSFSEIQQATGDFSKE----NLLGEGGFGHVYKGELKD-GQMIAAKV--------RKE 57
+ + E LG G G V + + +A ++
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178
Query: 58 ASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESV 117
++E+ +L H I+ + F E+ +V E + L FD
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGEL----FDKVVGN 233
Query: 118 LEWHQRYAAAIGT--AKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLA 172
+ +++LHE G IIHRD++P N+LL+ D + + DFG +
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLHE--NG--IIHRDLKPENVLLSSQEEDCLIKITDFGHS 289
Query: 173 RWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRT---DVYAFGIILLQLMSG 221
+ ++T + GT YLAPE + + D ++ G+IL +SG
Sbjct: 290 KILGETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 55/188 (29%), Positives = 81/188 (43%), Gaps = 23/188 (12%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAEFQS--EVYVLNFARHK 79
+ K +G+G FG V+K K GQ +A K V E +GF + E+ +L +H+
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHE 76
Query: 80 NIVMLLGFCCKENLNI--------LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTA 131
N+V L+ C + LV+++ C L L N +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLA-GLLSNVLVKFTLSEIKRVMQMLL 134
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILG---- 187
GL ++H I+HRDM+ +N+L+T D V L DFGLAR + Q
Sbjct: 135 NGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 188 TLGYLAPE 195
TL Y PE
Sbjct: 191 TLWYRPPE 198
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 58/231 (25%), Positives = 90/231 (38%), Gaps = 46/231 (19%)
Query: 22 TGDFS-----KENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYVL-N 74
+G F +E++LGEG V L Q A K+ ++ + EV +L
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 75 FARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDN-------TESVLEWHQRYAAA 127
H+N++ L+ F +E+ LV+E + S+ + E A+
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNE-------LEASV 115
Query: 128 I--GTAKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLAR-------WK 175
+ A L FLH +G I HRD++P NIL H + DF L
Sbjct: 116 VVQDVASALDFLHN--KG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 176 TTDDPVQTKILGTLGYLAPEYAENGIVSIRT-----DVYAFGIILLQLMSG 221
P G+ Y+APE E D+++ G+IL L+SG
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 31 LGEGGFGHVYKGELKD-GQMIAAKV---RKEASTQGFAE-----FQSEVYVL-NFARHKN 80
+G G V + + G A K+ E + E + E ++L A H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 81 IVMLLGFCCKENLNI-LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGT--AKGLRFL 137
I+ L+ + + + LV++ + L FD + ++ +I + + FL
Sbjct: 162 IITLIDSY-ESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFL 216
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYA 197
H I+HRD++P NILL + L DFG + + ++ + GT GYLAPE
Sbjct: 217 HA--NN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-LCGTPGYLAPEIL 271
Query: 198 ENGIVSIRT------DVYAFGIILLQLMSG 221
+ + D++A G+IL L++G
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 56/241 (23%), Positives = 89/241 (36%), Gaps = 51/241 (21%)
Query: 8 KDPMKFSFSEIQQATGDFSK-----ENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEAST 60
++ F + + + +LG G G V + + GQ A K+
Sbjct: 9 SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-- 66
Query: 61 QGFAEFQSEVYVLN-FARHKNIVMLLGFCCKENLNILVYEYICNKSLHWH---------- 109
+ + EV + +IV +L VYE + +
Sbjct: 67 ----KARQEVDHHWQASGGPHIVCILD----------VYENMHHGKRCLLIIMECMEGGE 112
Query: 110 LFDNTESVLEWHQRY----AAAIGT--AKGLRFLHEECRGGPIIHRDMRPSNILLTH--- 160
LF Q + AA I ++FLH I HRD++P N+L T
Sbjct: 113 LFS--RIQERGDQAFTEREAAEIMRDIGTAIQFLHS--HN--IAHRDVKPENLLYTSKEK 166
Query: 161 DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS 220
D V L DFG A+ +TT + +QT T Y+APE D+++ G+I+ L+
Sbjct: 167 DAVLKLTDFGFAK-ETTQNALQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 224
Query: 221 G 221
G
Sbjct: 225 G 225
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 47/242 (19%), Positives = 91/242 (37%), Gaps = 56/242 (23%)
Query: 8 KDPMKFSFSEIQQATGDFSKE----NLLGEGGFGHVYKGELKD-GQMIAAKV---RKEAS 59
+ ++ + + F+ +G G + + K A K+ K
Sbjct: 3 TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP 62
Query: 60 TQGFAEFQSEVYVLN-FARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDN----- 113
T+ E+ +L + +H NI+ L +V E + L D
Sbjct: 63 TE-------EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQK 111
Query: 114 --TESVLEWHQRYAAAI--GTAKGLRFLHEECRGGPIIHRDMRPSNILLT----HDFVPM 165
+E R A+A+ K + +LH +G ++HRD++PSNIL +
Sbjct: 112 FFSE-------REASAVLFTITKTVEYLHA--QG--VVHRDLKPSNILYVDESGNPESIR 160
Query: 166 LGDFGLARWKTTDDPVQTKILGTLGYLAPE------YAENGIVSIRTDVYAFGIILLQLM 219
+ DFG A+ ++ + T ++APE Y D+++ G++L ++
Sbjct: 161 ICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDA------ACDIWSLGVLLYTML 214
Query: 220 SG 221
+G
Sbjct: 215 TG 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEA--STQGFAEFQSEVYVL---NFA 76
DFS ++G GGFG VY D G+M A K K+ QG +E +L +
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 77 RHKNIVMLLG-FCCKENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGT 130
IV + F + L + + + LH+HL F + YAA I
Sbjct: 250 DCPFIVCMSYAFHTPDKL-SFILDLMNGGDLHYHLSQHGVFSEADMRF-----YAAEI-- 301
Query: 131 AKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLG 190
GL +H +++RD++P+NILL + D GLA +GT G
Sbjct: 302 ILGLEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHG 355
Query: 191 YLAPEYAENGIVSIRT-DVYAFGIILLQLMSGR 222
Y+APE + G+ + D ++ G +L +L+ G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAE---FQSEVYVLNFARHK 79
DF ++G G FG V +LK+ ++ A K+ + AE F+ E VL K
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 80 NIVMLLG-FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-YAAAIGTAKGLRFL 137
I L F NL LV +Y L L + + E R Y A + A + +
Sbjct: 135 WITTLHYAFQDDNNL-YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA--IDSV 191
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL-GTLGYLAPEY 196
H+ +HRD++P NIL+ + L DFG D VQ+ + GT Y++PE
Sbjct: 192 HQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 197 AENGIVSIRT-----DVYAFGIILLQLMSGR 222
+ D ++ G+ + +++ G
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 47/216 (21%), Positives = 84/216 (38%), Gaps = 45/216 (20%)
Query: 28 ENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEASTQGFAEFQSEVYVL-NFARHKNIVML 84
+LG G G V + K + A K+ + + + EV + ++ +IV +
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRI 120
Query: 85 LGFCCKENLNILVYEYICNKSLHWH----------LFDNTESVLEWHQRY----AAAIGT 130
+ VYE + LF + Q + A+ I
Sbjct: 121 VD----------VYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMK 168
Query: 131 --AKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDDPVQTKI 185
+ +++LH I HRD++P N+L T + + L DFG A+ T+ + + T
Sbjct: 169 SIGEAIQYLHS--IN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-P 223
Query: 186 LGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221
T Y+APE D+++ G+I+ L+ G
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 26/212 (12%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEA--STQGFAEFQSEVYVLNFARHK 79
F +G+G FG V + D +M A K K+ E+ ++ H
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 80 NIVMLLG-FCCKENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKG 133
+V L F +E++ +V + + L +HL F L + + A
Sbjct: 76 FLVNLWYSFQDEEDM-FMVVDLLLGGDLRYHLQQNVHFKEETVKL-----FICELVMA-- 127
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLA 193
L +L + IIHRDM+P NILL + DF +A + + T GT Y+A
Sbjct: 128 LDYLQN--QR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA-GTKPYMA 182
Query: 194 PE-YAENGIV--SIRTDVYAFGIILLQLMSGR 222
PE ++ S D ++ G+ +L+ GR
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEASTQG--FAEFQSEVYVLNFARHK 79
+F LLG+G FG V + K G+ A K+ +KE A +E VL +RH
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 80 NIVMLLGFCC---KENLNILVYEYICNKSLHWHLFDNTESVL-EWHQR-YAAAIGTAKGL 134
+ L + L V EY L +HL + E V E R Y A I +A L
Sbjct: 209 FLTAL--KYSFQTHDRL-CFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSA--L 261
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAP 194
+LH E + +++RD++ N++L D + DFGL + D GT YLAP
Sbjct: 262 DYLHSE-KN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318
Query: 195 EYAENGIVSIRTDVYAFGIILLQLMSGR 222
E E+ D + G+++ ++M GR
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-16
Identities = 47/182 (25%), Positives = 70/182 (38%), Gaps = 22/182 (12%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMI-AAKV-RKEA--STQGFAEFQSEVYVLNFARHK 79
D+ ++G G FG V K + + A K+ K A F E ++ FA
Sbjct: 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 80 NIVMLLG-FCCKENLNILVYEYICNKSLHWHL----FDNTESVLEWHQRYAAAIGTAKGL 134
+V L F L +V EY+ L + +W + Y A + A L
Sbjct: 130 WVVQLFYAFQDDRYL-YMVMEYMPGGDLVNLMSNYDVPE-----KWARFYTAEVVLA--L 181
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL-GTLGYLA 193
+H IHRD++P N+LL L DFG + V+ GT Y++
Sbjct: 182 DAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 194 PE 195
PE
Sbjct: 238 PE 239
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-16
Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMI-AAKV-RKEA--STQGFAEFQSEVYVLNFARHK 79
F + LG G FG V + K+ A K+ K+ + +E +L
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 80 NIVMLLGFCCKENLNI-LVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKG 133
+V L F K+N N+ +V EY+ + HL F + YAA I
Sbjct: 102 FLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-----YAAQIVLT-- 153
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLA 193
+LH +I+RD++P N+L+ + DFG A K T + GT LA
Sbjct: 154 FEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRTWT-LCGTPEALA 206
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMSGR 222
PE + + D +A G+++ ++ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-16
Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 27/208 (12%)
Query: 31 LGEGGFGHVYKGELKD-GQMIAAKV---RKEASTQGFAE-----FQSEVYVLNFARHKNI 81
LG G G V + + +A K+ RK A ++E+ +L H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGT--AKGLRFLHE 139
+ + F E+ +V E + L FD + +++LHE
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 140 ECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE- 195
G IIHRD++P N+LL+ D + + DFG ++ + + + GT YLAPE
Sbjct: 133 --NG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLCGTPTYLAPEV 187
Query: 196 --YAENGIVSIRTDVYAFGIILLQLMSG 221
+ D ++ G+IL +SG
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-16
Identities = 56/206 (27%), Positives = 83/206 (40%), Gaps = 33/206 (16%)
Query: 30 LLGEGGFGHVYKGELKD-GQMIAAKV-RKEASTQGFAEFQSEVYVLNFARHKNIVMLLGF 87
LG G VY+ + K + A KV +K + ++E+ VL H NI+ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK---IVRTEIGVLLRLSHPNIIKLKEI 116
Query: 88 CCKENLNILVYEYICNKSLHWHLFDN-------TESVLEWHQRYAAAIGT--AKGLRFLH 138
LV E + L FD +E R AA + + +LH
Sbjct: 117 FETPTEISLVLELVTGGEL----FDRIVEKGYYSE-------RDAADAVKQILEAVAYLH 165
Query: 139 EECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE 195
E G I+HRD++P N+L D + DFGL++ + + GT GY APE
Sbjct: 166 E--NG--IVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMKTVCGTPGYCAPE 220
Query: 196 YAENGIVSIRTDVYAFGIILLQLMSG 221
D+++ GII L+ G
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-15
Identities = 32/270 (11%), Positives = 73/270 (27%), Gaps = 50/270 (18%)
Query: 30 LLGEGGFGHVYKGE-LKDGQMIAAKV--RKEASTQGFAE-FQSEVYVLNFARHKNIVMLL 85
G ++ + +A + + S L+ + +L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 86 GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGP 145
++V E+I SL + ++ A A H G
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQ----EVADTSPSPVGAIRAMQSLAAAADAAHR--AG-- 149
Query: 146 IIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIR 205
+ PS + ++ D +L + + +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP--------------------ATMPD-------ANPQ 182
Query: 206 TDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYE 265
D+ G L L+ R + + L E+ + I+P + ++
Sbjct: 183 DDIRGIGASLYALLVNRWPLP--EAGVRSGL-----APAERDTAGQPIEPADIDRDIPFQ 235
Query: 266 LYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ + A VQ + R + ++ L++
Sbjct: 236 I---SAVAARSVQGDGGIRSA-STLLNLMQ 261
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-15
Identities = 63/217 (29%), Positives = 90/217 (41%), Gaps = 38/217 (17%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKE--------ASTQGFAEFQSEVYVL 73
DF LLG+G FG V K G+ A K+ RKE A T +E VL
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV------TESRVL 59
Query: 74 NFARHKNIVMLLGFCC---KENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYA 125
RH + L + L V EY L +HL F + Y
Sbjct: 60 QNTRHPFLTAL--KYAFQTHDRL-CFVMEYANGGELFFHLSRERVFTEERARF-----YG 111
Query: 126 AAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKI 185
A I +A L +LH R +++RD++ N++L D + DFGL + +D
Sbjct: 112 AEIVSA--LEYLHS--RD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165
Query: 186 LGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
GT YLAPE E+ D + G+++ ++M GR
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 9e-15
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 30/215 (13%)
Query: 24 DFSKENLLGEGGFGHVY---KGELKD-GQMIAAKV-RKEASTQGFAEF---QSEVYVLNF 75
F +LG+GG+G V+ K + G++ A KV +K + + ++E +L
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 76 ARHKNIVMLLGFCC---KENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAA 127
+H IV L L L+ EY+ L L F + Y A
Sbjct: 78 VKHPFIVDL--IYAFQTGGKL-YLILEYLSGGELFMQLEREGIFMEDTACF-----YLAE 129
Query: 128 IGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILG 187
I A L LH+ +G II+RD++P NI+L H L DFGL + D V G
Sbjct: 130 ISMA--LGHLHQ--KG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCG 183
Query: 188 TLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
T+ Y+APE + D ++ G ++ +++G
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 49/243 (20%), Positives = 90/243 (37%), Gaps = 40/243 (16%)
Query: 7 MKDPMKFSFSEIQQATGDFSK----ENLLGEGGFGHVYKGELKDGQMIAAK--VRKEAST 60
M+ + + ++ + + G +G V G +G +A K +
Sbjct: 2 MQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDG 61
Query: 61 QGFAEFQS---------EVYVLNFARHKNIVMLL---GFCCKENLN--ILVYEYICNKSL 106
+ E+ +LN H NI+ L + ++ LV E + L
Sbjct: 62 RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDL 120
Query: 107 HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPML 166
+ D + H +Y GL LHE ++HRD+ P NILL + +
Sbjct: 121 AQVIHDQRIVISPQHIQY-FMYHILLGLHVLHE----AGVVHRDLHPGNILLADNNDITI 175
Query: 167 GDFGLARWKTTDDPVQTKILGTLGYLAPE-------YAENGIVSIRTDVYAFGIILLQLM 219
DF LAR + T D +T + Y APE + + D+++ G ++ ++
Sbjct: 176 CDFNLAR-EDTADANKTHYVTHRWYRAPELVMQFKGFTKL------VDMWSAGCVMAEMF 228
Query: 220 SGR 222
+ +
Sbjct: 229 NRK 231
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMI-AAKV-RKEA--STQGFAEFQSEVYVLNFARHK 79
DF LG G FG V+ + A KV +KE + E +L+ H
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 80 NIVMLLGFCCKENLNI-LVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIGTAKG 133
I+ + ++ I ++ +YI L L F N + YAA + A
Sbjct: 67 FIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-----YAAEVCLA-- 118
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLA 193
L +LH + II+RD++P NILL + + DFG A K D T + GT Y+A
Sbjct: 119 LEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFA--KYVPDVTYT-LCGTPDYIA 171
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMSGR 222
PE + D ++FGI++ ++++G
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEASTQG--FAEFQSEVYVLNFA-RH 78
DF+ +LG+G FG V E K ++ A K+ +K+ Q E VL +
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 79 KNIVMLLGFCC---KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLR 135
+ L C + L V EY+ L +H+ YAA I A GL
Sbjct: 402 PFLTQL--HSCFQTMDRL-YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI--AIGLF 456
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE 195
FL + II+RD++ N++L + + DFG+ + D GT Y+APE
Sbjct: 457 FLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512
Query: 196 YAENGIVSIRTDVYAFGIILLQLMSGR 222
D +AFG++L ++++G+
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 48/229 (20%), Positives = 90/229 (39%), Gaps = 33/229 (14%)
Query: 14 SFSEIQQATGDFSKENLLGEGGFGHVYKGELKD-GQMIAAK-VRKEASTQGFA--EFQSE 69
+ ++ F E + G+G FG V G+ K G +A K V ++ F E Q
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQ-I 69
Query: 70 VYVLNFARHKNIVMLLGF-------CCKENLNILVYEYI---CNKSLHWHLFDNTESVLE 119
+ L H NIV L + ++ +V EY+ ++ +
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI 129
Query: 120 WHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL---THDFVPMLGDFGLARWKT 176
+ + + + + LH + HRD++P N+L+ L DFG A+ +
Sbjct: 130 LIKVFLFQL--IRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLK--LCDFGSAKKLS 183
Query: 177 TDDPVQTKILGTLGYLAPEY---AENGIVSIRTDVYAFGIILLQLMSGR 222
+P + + Y APE ++ ++ D+++ G I ++M G
Sbjct: 184 PSEP-NVAYICSRYYRAPELIFGNQHYTTAV--DIWSVGCIFAEMMLGE 229
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 49/229 (21%), Positives = 88/229 (38%), Gaps = 28/229 (12%)
Query: 10 PMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKV-RKE-------AST 60
++ + + + +S + LG G FG V+ + + + K +KE
Sbjct: 11 ELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIED 70
Query: 61 QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEW 120
+ E+ +L+ H NI+ +L + LV E + LF ++
Sbjct: 71 PKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGL---DLFA----FIDR 123
Query: 121 HQRYAAAIGTAK------GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174
H R + + + +L + IIHRD++ NI++ DF L DFG A +
Sbjct: 124 HPRLDEPLASYIFRQLVSAVGYLRLKD----IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179
Query: 175 KTTDDPVQTKILGTLGYLAPE-YAENGIVSIRTDVYAFGIILLQLMSGR 222
T GT+ Y APE N ++++ G+ L L+
Sbjct: 180 LERGKLFYT-FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 6e-14
Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 24 DFSKENLLGEGGFGHVY---KGELKD-GQMIAAKV-RKEASTQ-GFAEFQSEVYVLNFAR 77
F +LG+G FG V+ K D Q+ A KV +K + E +L
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 78 HKNIVMLLGFCC---KENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAAAIG 129
H IV L + L L+ +++ L L F + Y A +
Sbjct: 85 HPFIVKL--HYAFQTEGKL-YLILDFLRGGDLFTRLSKEVMFTEEDVKF-----YLAELA 136
Query: 130 TAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL 189
A L LH G II+RD++P NILL + L DFGL++ + GT+
Sbjct: 137 LA--LDHLHS--LG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 190 GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
Y+APE + D ++FG+++ ++++G
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 6e-14
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 41/219 (18%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKE--------ASTQGFAEFQSEVYVL 73
DF +LG+G FG V+ E K Q A K +K+ T E VL
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM------VEKRVL 71
Query: 74 NFA-RHKNIVMLLGFCC---KENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRY 124
+ A H + + FC KENL V EY+ L +H+ FD + + Y
Sbjct: 72 SLAWEHPFLTHM--FCTFQTKENL-FFVMEYLNGGDLMYHIQSCHKFDLSRATF-----Y 123
Query: 125 AAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD-FVPMLGDFGLARWKTTDDPVQT 183
AA I L+FLH +G I++RD++ NILL D + + DFG+ + D
Sbjct: 124 AAEIILG--LQFLHS--KG--IVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTN 176
Query: 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
GT Y+APE + D ++FG++L +++ G+
Sbjct: 177 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 7e-14
Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKE--------ASTQGFAEFQSEVYVL 73
DF+ +LG+G FG V E K ++ A K+ +K+ T E VL
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM------VEKRVL 74
Query: 74 NFA-RHKNIVMLLGFCC---KENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-YAAAI 128
+ + L C + L V EY+ L +H+ E H YAA I
Sbjct: 75 ALPGKPPFLTQL--HSCFQTMDRL-YFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEI 130
Query: 129 GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD-FVPMLGDFGLARWKTTDDPVQTKILG 187
L FL +G II+RD++ N++L + + + DFG+ + D G
Sbjct: 131 AIG--LFFLQS--KG--IIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGVTTKTFCG 183
Query: 188 TLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
T Y+APE D +AFG++L ++++G+
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-14
Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 47/222 (21%)
Query: 25 FSKENLLGEGGFGHVYKGELKD-GQMIAAK-VRKEASTQGFAEFQS-EVYVLNFARHKNI 81
++ ++G G FG VY+ +L D G+++A K V ++ F++ E+ ++ H NI
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNI 109
Query: 82 VMLLGFCCKEN-------LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIG----- 129
V L F LN LV +Y+ ++++ V + R +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLN-LVLDYV-PETVY--------RVARHYSRAKQTLPVIYVK 159
Query: 130 -----TAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM-LGDFGLARWKTTDDPVQT 183
+ L ++H I HRD++P N+LL D + L DFG A+ +P +
Sbjct: 160 LYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 184 KILGTLGYLAPEY---AENGIVSIRTDVYAFGIILLQLMSGR 222
I + Y APE A + SI DV++ G +L +L+ G+
Sbjct: 216 YIC-SRYYRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 254
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 55/237 (23%), Positives = 92/237 (38%), Gaps = 24/237 (10%)
Query: 63 FAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQ 122
F + + V + + + + + + + + + D + L
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194
Query: 123 RYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182
+ AKG+ FL R IHRD+ NILL+ V + DFGLAR D
Sbjct: 195 LICYSFQVAKGMEFL--ASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250
Query: 183 TKILGTL--GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240
K L ++APE + + +I++DV++FG++L ++ S G P ++
Sbjct: 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGVKIDE 303
Query: 241 EPLIEKLAL-HELIDPRIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E +L + P Y T E+Y M C P RP+ E+V L
Sbjct: 304 E-FCRRLKEGTRMRAPD----YTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLG 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 25/108 (23%), Positives = 46/108 (42%), Gaps = 14/108 (12%)
Query: 25 FSKENL-----LGEGGFGHVYKGELKD------GQMIAAK-VRKEASTQGFAEFQSEVYV 72
F ++ L LG G FG V + + + +A K +++ A+ SE+ +
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78
Query: 73 L-NFARHKNIVMLLGFCCKE-NLNILVYEYICNKSLHWHLFDNTESVL 118
L + H N+V LLG C K +++ E+ +L +L +
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 126
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEASTQG--FAEFQSEVYVLNFA-RH 78
DF ++G G + V LK ++ A KV +KE Q+E +V A H
Sbjct: 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 79 KNIVMLLGFCC---KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLR 135
+V L C + L V EY+ L +H+ + E + Y+A I A L
Sbjct: 70 PFLVGL--HSCFQTESRL-FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LN 124
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE 195
+LHE RG II+RD++ N+LL + L D+G+ + + GT Y+APE
Sbjct: 125 YLHE--RG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180
Query: 196 YAENGIVSIRTDVYAFGIILLQLMSGR 222
D +A G+++ ++M+GR
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEASTQG--FAEFQSEVYVLNFA-RH 78
DF ++G G + V LK ++ A +V +KE Q+E +V A H
Sbjct: 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 79 KNIVMLLGFCC---KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLR 135
+V L C + L V EY+ L +H+ + E + Y+A I A L
Sbjct: 113 PFLVGL--HSCFQTESRL-FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LN 167
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE 195
+LHE RG II+RD++ N+LL + L D+G+ + + GT Y+APE
Sbjct: 168 YLHE--RG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223
Query: 196 YAENGIVSIRTDVYAFGIILLQLMSGR 222
D +A G+++ ++M+GR
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 27/221 (12%)
Query: 14 SFSEIQQATGDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKV--RKEASTQGFAEFQSEV 70
S ++ Q G++ +G+G F V + G+ +A K+ + + + + EV
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREV 65
Query: 71 YVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR------- 123
++ H NIV L E L+ EY + FD L H R
Sbjct: 66 RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV----FD----YLVAHGRMKEKEAR 117
Query: 124 -YAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ 182
I +A +++ H++ I+HRD++ N+LL D + DFG + T +
Sbjct: 118 SKFRQIVSA--VQYCHQKR----IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171
Query: 183 TKILGTLGYLAPE-YAENGIVSIRTDVYAFGIILLQLMSGR 222
G Y APE + DV++ G+IL L+SG
Sbjct: 172 AFC-GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 42/223 (18%)
Query: 24 DFSKENLLGEGGFGHVY---KGELKD-GQMIAAKV-RKEASTQGFAEF---QSEVYVLNF 75
+F +LG G +G V+ K D G++ A KV +K Q ++E VL
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 76 ARHKN-IVMLLGFCC---KENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQRYAA 126
R +V L + L L+ +YI L HL F E + Y
Sbjct: 115 IRQSPFLVTL--HYAFQTETKL-HLILDYINGGELFTHLSQRERFTEHEVQI-----YVG 166
Query: 127 AIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK-I 185
I A L LH+ G II+RD++ NILL + +L DFGL++ D+ +
Sbjct: 167 EIVLA--LEHLHK--LG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 220
Query: 186 LGTLGYLAPE------YAENGIVSIRTDVYAFGIILLQLMSGR 222
GT+ Y+AP+ + V D ++ G+++ +L++G
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGA 259
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 62/213 (29%), Positives = 88/213 (41%), Gaps = 29/213 (13%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKEASTQG--FAEFQSEVYVL-NFARH 78
DF ++G+G FG V K A KV +K+A + SE VL +H
Sbjct: 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 79 KNIVMLLGFCC---KENLNILVYEYICNKSLHWHL-----FDNTESVLEWHQR-YAAAIG 129
+V L + L V +YI L +HL F E R YAA I
Sbjct: 99 PFLVGL--HFSFQTADKL-YFVLDYINGGELFYHLQRERCFL------EPRARFYAAEIA 149
Query: 130 TAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL 189
+A L +LH I++RD++P NILL +L DFGL + + + GT
Sbjct: 150 SA--LGYLHS--LN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTP 203
Query: 190 GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
YLAPE D + G +L +++ G
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV-RKE--------ASTQGFAEFQSEVYVL 73
+F +LG+G FG V +K+ G + A KV +K+ T +E +L
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM------TEKRIL 77
Query: 74 NFA-RHKNIVMLLGFCC---KENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-YAAAI 128
+ A H + L FCC + L V E++ L +H+ + E R YAA I
Sbjct: 78 SLARNHPFLTQL--FCCFQTPDRL-FFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEI 133
Query: 129 GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGT 188
+A L FLH+ +G II+RD++ N+LL H+ L DFG+ + + GT
Sbjct: 134 ISA--LMFLHD--KG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGT 187
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
Y+APE + + D +A G++L +++ G
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-13
Identities = 48/234 (20%), Positives = 88/234 (37%), Gaps = 57/234 (24%)
Query: 30 LLGEGGFGHVYKGE-LKDGQMIAAKV------RKEASTQGFAEFQS-------------- 68
+G+G +G V D A KV ++A +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 69 ------EVYVLNFARHKNIVML---LGFCCKENLNILVYEYICNKSLHWHLFDNTESVLE 119
E+ +L H N+V L L +++L +V+E + + + +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPV----ME-----VP 129
Query: 120 WHQRYAAAIGTAK--------GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGL 171
+ + A+ G+ +LH + IIHRD++PSN+L+ D + DFG+
Sbjct: 130 TLKPLSED--QARFYFQDLIKGIEYLHY--QK--IIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 172 ARWKTTDDPVQTKILGTLGYLAPE---YAENGIVSIRTDVYAFGIILLQLMSGR 222
+ D + + +GT ++APE DV+A G+ L + G+
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 8e-13
Identities = 51/220 (23%), Positives = 96/220 (43%), Gaps = 44/220 (20%)
Query: 25 FSKENLLGEGGFGHVYKGELKDGQMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
++ ++G G FG V++ +L + +A K V ++ + E+ ++ +H N+V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-----RELQIMRIVKHPNVVD 96
Query: 84 LLGF-------CCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTA----- 131
L F + LN LV EY+ ++++ + + +
Sbjct: 97 LKAFFYSNGDKKDEVFLN-LVLEYV-PETVY--------RASRHYAKLKQTMPMLLIKLY 146
Query: 132 -----KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM-LGDFGLARWKTTDDPVQTKI 185
+ L ++H G I HRD++P N+LL + L DFG A+ +P + I
Sbjct: 147 MYQLLRSLAYIH--SIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202
Query: 186 LGTLGYLAPEY---AENGIVSIRTDVYAFGIILLQLMSGR 222
+ Y APE A N +I D+++ G ++ +LM G+
Sbjct: 203 C-SRYYRAPELIFGATNYTTNI--DIWSTGCVMAELMQGQ 239
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 24/208 (11%)
Query: 30 LLGEGGFGHVYKGE-LKDGQMIAAKV--RKEASTQGFAEFQ--SEVYVLNFARHKNIVML 84
LLGEG +G V + + A K+ +K+ E E+ +L RHKN++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 85 LGFCCKENLN--ILVYEYICNKSLHWHLFDNTES--VLEWH-QRYAAAIGTAKGLRFLHE 139
+ E +V EY + D+ Y + GL +LH
Sbjct: 72 VDVLYNEEKQKMYMVMEYC--VCGMQEMLDSVPEKRFPVCQAHGYFCQL--IDGLEYLHS 127
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW---KTTDDPVQTKILGTLGYLAPEY 196
+G I+H+D++P N+LLT + G+A DD +T G+ + PE
Sbjct: 128 --QG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPPEI 182
Query: 197 AEN--GIVSIRTDVYAFGIILLQLMSGR 222
A + D+++ G+ L + +G
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 47/224 (20%), Positives = 77/224 (34%), Gaps = 44/224 (19%)
Query: 23 GDFSKENLLGEGGFGHVYKGE-LKDGQMIAAK------VRKEASTQGFAEFQSEVYVLNF 75
+ LLG GGFG VY G + D +A K + EV +L
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 76 ARHK--NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR--------YA 125
++ LL + + + +L+ E LFD + +
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQ---DLFD----FITERGALQEELARSFF 155
Query: 126 AAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM-LGDFGLARWKTTDDPVQTK 184
+ + +R H G ++HRD++ NIL+ + + L DFG D
Sbjct: 156 WQV--LEAVRHCHN--CG--VLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTD- 207
Query: 185 ILGTLGYLAPEYAENGIVSIR------TDVYAFGIILLQLMSGR 222
GT Y PE + V++ GI+L ++ G
Sbjct: 208 FDGTRVYSPPE-----WIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 5e-12
Identities = 49/211 (23%), Positives = 78/211 (36%), Gaps = 39/211 (18%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQS---------EVYVLNFARHKN 80
+G G G V + + +A K FQ+ E+ ++ HKN
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKN 122
Query: 81 IVMLL----GFCCKENLN--ILVYEYI---CNKSLHWHLFDNTESVLEWHQRYAAAIGTA 131
I+ LL E LV E + + + L Y
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-------RMSYLL-YQML 174
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY 191
G++ LH IIHRD++PSNI++ D + DFGLAR + T + T Y
Sbjct: 175 CGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYY 229
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
APE D+++ G I+ +++ +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-12
Identities = 51/221 (23%), Positives = 84/221 (38%), Gaps = 36/221 (16%)
Query: 23 GDFSKENLLGEGGFGHVYKGE-LKDGQMIAAK------VRKEASTQGFAEFQSEVYVLNF 75
++ LLG+GGFG V+ G L D +A K V + EV +L
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 76 AR----HKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQR-------- 123
H ++ LL + + +LV E LFD +
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ---DLFD----YITEKGPLGEGPSRC 143
Query: 124 YAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL-THDFVPMLGDFGLARWKTTDDPVQ 182
+ + ++ H RG ++HRD++ NIL+ L DFG D+P
Sbjct: 144 FFGQV--VAAIQHCHS--RG--VVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEPYT 196
Query: 183 TKILGTLGYLAPEY-AENGIVSIRTDVYAFGIILLQLMSGR 222
GT Y PE+ + + ++ V++ GI+L ++ G
Sbjct: 197 D-FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 36/158 (22%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 25 FSKENLLGEGGFGHVYKG-ELKDGQMIAAK-VRKEASTQGFAE--FQSEVYVLNFARHKN 80
+ +L+G G +GHV + + + +++A K + + + + E+ +LN H +
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDH 113
Query: 81 IVMLLGFCCKENLNI-----LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLR 135
+V +L +++ +V E + LF + E H + G++
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIA-DSDFK-KLFRTPVYLTELHIKT-LLYNLLVGVK 170
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173
++H I+HRD++P+N L+ D + DFGLAR
Sbjct: 171 YVHS----AGILHRDLKPANCLVNQDCSVKVCDFGLAR 204
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 5/91 (5%)
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY 191
G++ LH IIHRD++PSNI++ D + DFGLAR + T + T Y
Sbjct: 138 CGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYY 192
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
APE D+++ G I+ +++ G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 24/211 (11%)
Query: 23 GDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKV--RKEASTQGFAE-FQSEVYVLNFARH 78
G + + LG G FG V GE G +A K+ R++ + + E+ L RH
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
+I+ L +V EY+ L FD + H R + + R
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGEL----FD----YICKHGR----VEEMEARRLFQ 118
Query: 139 ------EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL 192
+ C ++HRD++P N+LL + DFGL+ + + ++T G+ Y
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPNYA 177
Query: 193 APE-YAENGIVSIRTDVYAFGIILLQLMSGR 222
APE + D+++ G+IL L+ G
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 25/218 (11%)
Query: 16 SEIQQATGDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKV--RKEASTQGFAE-FQSEVY 71
+ ++ G + LGEG FG V K Q +A K R+ + E+
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 72 VLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTA 131
L RH +I+ L ++V EY + LFD + +R +
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGE-----LFD----YIVEKKR----MTED 108
Query: 132 KGLRFLH------EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKI 185
+G RF E C I+HRD++P N+LL + + DFGL+ T + ++T
Sbjct: 109 EGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC 168
Query: 186 LGTLGYLAPE-YAENGIVSIRTDVYAFGIILLQLMSGR 222
G+ Y APE DV++ GI+L ++ GR
Sbjct: 169 -GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 48/215 (22%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQS---------EVYVLNFARHKN 80
+G G +G V + + G+ +A K FQS E+ +L +H+N
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELLLLKHMQHEN 84
Query: 81 IVMLLG----FCCKENLN--ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGL 134
++ LL N LV ++ L + E +Y KGL
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM---GLKFSEEKIQYLV-YQMLKGL 139
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAP 194
+++H ++HRD++P N+ + D + DFGLAR D T + T Y AP
Sbjct: 140 KYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAP 192
Query: 195 E-------YAENGIVSIRTDVYAFGIILLQLMSGR 222
E Y + D+++ G I+ ++++G+
Sbjct: 193 EVILSWMHYNQT------VDIWSVGCIMAEMLTGK 221
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 40/220 (18%), Positives = 90/220 (40%), Gaps = 47/220 (21%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYVL-NFARHKNI 81
D+ LG G + V++ + + + + K+ K + + + E+ +L N NI
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 93
Query: 82 VMLLG-FCCKENLN-ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
+ L + LV+E++ N +++ ++ R+ +++E
Sbjct: 94 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRF-----------YMYE 138
Query: 140 ECRG------GPIIHRDMRPSNILLTHDFVPM-LGDFGLARWKTTDDPVQ--TKILGTLG 190
+ I+HRD++P N+++ H+ + L D+GLA P Q + +
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE---FYHPGQEYNVRVASRY 195
Query: 191 YLAPE-------YAENGIVSIRTDVYAFGIILLQLMSGRK 223
+ PE Y S+ D+++ G +L ++ ++
Sbjct: 196 FKGPELLVDYQMYD----YSL--DMWSLGCMLASMIFRKE 229
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 24/211 (11%)
Query: 23 GDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKV---RKEASTQGFAEFQSEVYVLNFARH 78
G + + LG G FG V G+ G +A K+ +K S + + E+ L RH
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
+I+ L + +V EY+ LFD + + R + + R
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGG----ELFD----YICKNGR----LDEKESRRLFQ 123
Query: 139 ------EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL 192
+ C ++HRD++P N+LL + DFGL+ + + ++T G+ Y
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPNYA 182
Query: 193 APE-YAENGIVSIRTDVYAFGIILLQLMSGR 222
APE + D+++ G+IL L+ G
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 3e-10
Identities = 51/213 (23%), Positives = 81/213 (38%), Gaps = 41/213 (19%)
Query: 30 LLGEGGFGHVYKGE-LKDGQMIAAKV-RKEASTQGFAEFQSEVYVLNFARHKNIVMLLGF 87
LGEG +G V + +A K+ + + + E+ + H+N+V G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 88 CCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK-------------GL 134
+ N+ L EY L FD G+
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FD-----------RIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL----GTLG 190
+LH G I HRD++P N+LL + DFGLA + ++L GTL
Sbjct: 119 VYLHG--IG--ITHRDIKPENLLLDERDNLKISDFGLA--TVFRYNNRERLLNKMCGTLP 172
Query: 191 YLAPE-YAENGIVSIRTDVYAFGIILLQLMSGR 222
Y+APE + DV++ GI+L +++G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 47/215 (21%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQS---------EVYVLNFARHKN 80
+G G +G V + + G +A K FQS E+ +L RH+N
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELRLLKHMRHEN 85
Query: 81 IVMLLG-FCCKENLNI-----LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGL 134
++ LL F E L+ LV ++ L + E + E ++ KGL
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM--KHEKLGEDRIQFLV-YQMLKGL 141
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAP 194
R++H IIHRD++P N+ + D + DFGLAR D T + T Y AP
Sbjct: 142 RYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYRAP 194
Query: 195 E-------YAENGIVSIRTDVYAFGIILLQLMSGR 222
E Y + D+++ G I+ ++++G+
Sbjct: 195 EVILNWMRYTQT------VDIWSVGCIMAEMITGK 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 35/164 (21%), Positives = 58/164 (35%), Gaps = 44/164 (26%)
Query: 31 LGEGGFGHVYKGELKD-GQMIAAKV-RKEASTQGFAEFQSEVYVL-NFARHKNIVMLLGF 87
LG G G V + K + A K+ + + EV + ++ +IV ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREVELHWRASQCPHIVRIVD- 78
Query: 88 CCKENLNILVYEYICNKSLHWH----------LFDNTESVLEWHQRY----AAAIGT--A 131
VYE + LF Q + A+ I
Sbjct: 79 ---------VYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMKSIG 127
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLA 172
+ +++LH I HRD++P N+L T + + L DFG A
Sbjct: 128 EAIQYLHS--IN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-10
Identities = 49/233 (21%), Positives = 79/233 (33%), Gaps = 29/233 (12%)
Query: 1 MKTELYMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKV--RKE 57
M P+ I + + +G G FG +++A K R
Sbjct: 1 MDRAPVTTGPLD---MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA 57
Query: 58 ASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHL-----FD 112
A + Q E+ RH NIV ++ EY L+ + F
Sbjct: 58 AIDE---NVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFS 114
Query: 113 NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPML--GDFG 170
E+ + Q G+ + H I HRD++ N LL P L DFG
Sbjct: 115 EDEARFFFQQ-------LLSGVSYCHS--MQ--ICHRDLKLENTLLDGSPAPRLKICDFG 163
Query: 171 LARWKTTDDPVQTKILGTLGYLAPE-YAENGIVSIRTDVYAFGIILLQLMSGR 222
++ ++ + GT Y+APE DV++ G+ L ++ G
Sbjct: 164 YSKSSVLHSQPKSTV-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 47/215 (21%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQS---------EVYVLNFARHKN 80
+G G +G V + K G +A K FQS E+ +L +H+N
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELRLLKHMKHEN 89
Query: 81 IVMLLG----FCCKENLN--ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGL 134
++ LL E N LV + L+ + + + + H ++ +GL
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQKLTDDHVQFLI-YQILRGL 145
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAP 194
+++H IIHRD++PSN+ + D + DFGLAR T + T Y AP
Sbjct: 146 KYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAP 198
Query: 195 E-------YAENGIVSIRTDVYAFGIILLQLMSGR 222
E Y + D+++ G I+ +L++GR
Sbjct: 199 EIMLNWMHYNQT------VDIWSVGCIMAELLTGR 227
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 51/213 (23%), Positives = 81/213 (38%), Gaps = 41/213 (19%)
Query: 30 LLGEGGFGHVYKGE-LKDGQMIAAKV-RKEASTQGFAEFQSEVYVLNFARHKNIVMLLGF 87
LGEG +G V + +A K+ + + + E+ + H+N+V G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 88 CCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK-------------GL 134
+ N+ L EY L FD G+
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FD-----------RIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL----GTLG 190
+LH G I HRD++P N+LL + DFGLA + ++L GTL
Sbjct: 119 VYLHG--IG--ITHRDIKPENLLLDERDNLKISDFGLA--TVFRYNNRERLLNKMCGTLP 172
Query: 191 YLAPE-YAENGIVSIRTDVYAFGIILLQLMSGR 222
Y+APE + DV++ GI+L +++G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 42/184 (22%), Positives = 68/184 (36%), Gaps = 29/184 (15%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQS---------EVYVLNFARHKN 80
+G G +G+VY + + +A K F+ E+ +LN +
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREITILNRLKSDY 86
Query: 81 IVMLLGFCCKENLNI-----LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLR 135
I+ L ++L +V E + L LF + E H + G
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIA-DSDLK-KLFKTPIFLTEEHIKTIL-YNLLLGEN 143
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE 195
F+HE IIHRD++P+N LL D + DFGLAR ++
Sbjct: 144 FIHE----SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 196 YAEN 199
+ +N
Sbjct: 200 HNKN 203
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 20/101 (19%)
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ---TKILGT 188
+GL+++H ++HRD++PSN+LL + DFGLAR D T+ + T
Sbjct: 139 RGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 189 LGYLAPE-------YAENGIVSIRTDVYAFGIILLQLMSGR 222
Y APE Y ++ D+++ G IL +++S R
Sbjct: 195 RWYRAPEIMLNSKGYTKS------IDIWSVGCILAEMLSNR 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 6e-09
Identities = 29/108 (26%), Positives = 46/108 (42%), Gaps = 27/108 (25%)
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGY 191
+ ++ LH G +IHRD++PSN+L+ + + DFGLAR ++ G
Sbjct: 123 RAVKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 192 L----------APE-------YAENGIVSIRTDVYAFGIILLQLMSGR 222
+ APE Y+ DV++ G IL +L R
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRA------MDVWSCGCILAELFLRR 220
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 43/216 (19%), Positives = 83/216 (38%), Gaps = 32/216 (14%)
Query: 30 LLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAE-FQSEVYVLNFAR---------- 77
LG G F V+ + + + +A K+ + + + E + E+ +L
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 78 -HKNIVMLLG-FCCKENLNI---LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
+I+ LL F K + +V+E + ++L + + +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM------LGDFGLARWKTTDDPVQTKIL 186
GL ++H C IIH D++P N+L+ P + D G A W D T +
Sbjct: 143 GLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYTNSI 196
Query: 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
T Y +PE D+++ ++ +L++G
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 53/227 (23%), Positives = 88/227 (38%), Gaps = 58/227 (25%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQS---------EVYVLNFARHKN 80
LG GG G V+ + + +A K K E+ ++ H N
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIK--KIV-------LTDPQSVKHALREIKIIRRLDHDN 69
Query: 81 IVMLL------------GFCCKENLN--ILVYEYICNKSLHWHLFDNTESVLEWHQRYAA 126
IV + LN +V EY+ L L +LE H R
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL--EQGPLLEEHARLFM 126
Query: 127 AIGTAKGLRFLHEECRGGPIIHRDMRPSNILL-THDFVPMLGDFGLARWKTTDDPVQ--- 182
+GL+++H ++HRD++P+N+ + T D V +GDFGLAR +
Sbjct: 127 -YQLLRGLKYIH----SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 183 TKILGTLGYLAPE-------YAENGIVSIRTDVYAFGIILLQLMSGR 222
++ L T Y +P Y + D++A G I ++++G+
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKA------IDMWAAGCIFAEMLTGK 222
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 2e-08
Identities = 29/210 (13%), Positives = 50/210 (23%), Gaps = 49/210 (23%)
Query: 8 KDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST------- 60
K P+ FS T + +GEG FG V++ + + E
Sbjct: 8 KGPVPFSHC---LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 61 QGFAEFQSEVYVL---------------NFARHKNIVMLLGFCCKENLNILVYEYICNKS 105
+ F E E+ + F ++ + G L + S
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 106 LHWH---------------------LFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGG 144
+ L + + L R
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR-- 182
Query: 145 PIIHRDMRPSNILLTHDFVPMLGDFGLARW 174
HRD+ N+LL + L +
Sbjct: 183 -FEHRDLHWGNVLLKKTSLKKLHYTLNGKS 211
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 47/243 (19%), Positives = 87/243 (35%), Gaps = 57/243 (23%)
Query: 25 FSKENLLGEGGFGHVYKGELKD-GQMIAAK-VRKEASTQGFAEFQSEVYVLNFARHKNIV 82
+S LG G FG V + + G+ A K V ++ + E+ ++ H NI+
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-----NRELDIMKVLDHVNII 63
Query: 83 MLLGF--CCKENLNILVYEYICNKSLHWHLFDNTES----------------VLEW---- 120
L+ + + + L ++E+
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 121 -HQ--RYAAAIGTA--------------KGLRFLHEECRGGPIIHRDMRPSNILL-THDF 162
H+ + G + + + F+H I HRD++P N+L+ + D
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH----SLGICHRDIKPQNLLVNSKDN 179
Query: 163 VPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY---AENGIVSIRTDVYAFGIILLQLM 219
L DFG A+ +P + + Y APE A SI D+++ G + +L+
Sbjct: 180 TLKLCDFGSAKKLIPSEP-SVAYICSRFYRAPELMLGATEYTPSI--DLWSIGCVFGELI 236
Query: 220 SGR 222
G+
Sbjct: 237 LGK 239
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 36/156 (23%), Positives = 61/156 (39%), Gaps = 27/156 (17%)
Query: 31 LGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCC 89
+G G FG + G+ L + +A K+ S + Y + I + F
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD-GIPQVYYFGP 75
Query: 90 KENLNILVYEYICNKSLHWHLFDN------TESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
N +V E SL LFD ++VL AI + ++H +
Sbjct: 76 CGKYNAMVLEL-LGPSL-EDLFDLCDRTFSLKTVLM------IAIQLISRMEYVHSKN-- 125
Query: 144 GPIIHRDMRPSNILL------THDFVPMLGDFGLAR 173
+I+RD++P N L+ T + ++ DF LA+
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHII-DFALAK 158
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 28/182 (15%)
Query: 31 LGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQS---------EVYVLN-FARHK 79
LG+G +G V+K + + G+++A K +A FQ+ E+ +L + H+
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIMILTELSGHE 69
Query: 80 NIVMLLGFCCKENLN--ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFL 137
NIV LL +N LV++Y+ LH + + H++Y K +++L
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVI--RANILEPVHKQYVV-YQLIKVIKYL 125
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYA 197
H G ++HRDM+PSNILL + + DFGL+R V I ++ +
Sbjct: 126 H----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 198 EN 199
++
Sbjct: 182 DD 183
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 51/216 (23%), Positives = 85/216 (39%), Gaps = 46/216 (21%)
Query: 30 LLGEGGFGHVYKGE-LKDGQMIAAKV---RKEASTQGFAEFQSEVYVLNFARHK------ 79
++G+G FG V K K Q +A K+ K Q E+ +L R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTM 159
Query: 80 NIVMLL------GFCCK--ENLNILVYEYICN---KSLHWHLFDNTESVLEWHQRYAAAI 128
N++ +L C E L++ +YE I + L +++A +I
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLV----------RKFAHSI 209
Query: 129 GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM--LGDFGLARWKTTDDPVQTKIL 186
L LH+ IIH D++P NILL + DFG + + +
Sbjct: 210 LQC--LDALHKNR----IIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYI 260
Query: 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
+ Y APE + D+++ G IL +L++G
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 8e-07
Identities = 35/155 (22%), Positives = 61/155 (39%), Gaps = 25/155 (16%)
Query: 31 LGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCC 89
+GEG FG +++G L + Q +A K S + Y L I + F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT-GIPNVYYFGQ 76
Query: 90 KENLNILVYEYICNKSLHWHLFDN------TESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
+ N+LV + SL L D ++V AA ++ +HE +
Sbjct: 77 EGLHNVLVIDL-LGPSL-EDLLDLCGRKFSVKTVAM------AAKQMLARVQSIHE--KS 126
Query: 144 GPIIHRDMRPSNILLTHDFVP-----MLGDFGLAR 173
+++RD++P N L+ + DFG+ +
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 35/153 (22%), Positives = 63/153 (41%), Gaps = 23/153 (15%)
Query: 31 LGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCC 89
+G G FG +Y G + G+ +A K+ + +S++Y I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIY-KMMQGGVGIPTIRWCGA 75
Query: 90 KENLNILVYEYICNKSLHWHLFDN------TESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
+ + N++V E SL LF+ ++VL A + ++H +
Sbjct: 76 EGDYNVMVMEL-LGPSL-EDLFNFCSRKFSLKTVLL------LADQMISRIEYIHSKN-- 125
Query: 144 GPIIHRDMRPSNILL---THDFVPMLGDFGLAR 173
IHRD++P N L+ + + DFGLA+
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 46/214 (21%), Positives = 85/214 (39%), Gaps = 38/214 (17%)
Query: 29 NLLGEGGFGHVYKGE-LKDGQMIAAKV---RKEASTQGFAEFQSEVYVLNFARH------ 78
+L+G+G FG V K + + +A K+ +K Q Q EV +L
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115
Query: 79 KNIVMLLGF-------C-CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGT 130
IV L C E L+ +Y+ + ++ ++ + +++A +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLL--RNTNFRGV-SLNLT----RKFAQQM-- 166
Query: 131 AKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM--LGDFGLARWKTTDDPVQTKILGT 188
L FL IIH D++P NILL + + DFG + + + +
Sbjct: 167 CTALLFLATPELS--IIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYIQS 221
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
Y +PE + D+++ G IL+++ +G
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 36/155 (23%), Positives = 69/155 (44%), Gaps = 25/155 (16%)
Query: 31 LGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCC 89
+G G FG +Y G ++ + +A K+ + ++S++Y + I + F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRI-LQGGTGIPNVRWFGV 73
Query: 90 KENLNILVYEYICNKSLHWHLFDN------TESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
+ + N+LV + + SL LF+ ++VL A + F+H +
Sbjct: 74 EGDYNVLVMDLL-GPSL-EDLFNFCSRKLSLKTVLM------LADQMINRVEFVHSKS-- 123
Query: 144 GPIIHRDMRPSNILL----THDFVPMLGDFGLARW 174
+HRD++P N L+ + V ++ DFGLA+
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYII-DFGLAKK 155
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 7e-05
Identities = 31/193 (16%), Positives = 61/193 (31%), Gaps = 45/193 (23%)
Query: 46 DGQMIAAK-VRKEASTQGFAEFQSEVYVLNF----------ARHKNIV----MLLGFCCK 90
D ++ K + + E + + A H++IV + F
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD 462
Query: 91 ENLNILVYEYICNKSLH--WHLF--DNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPI 146
+ + + +Y + H HL ++ E + + + RFL I
Sbjct: 463 DLIPPYLDQYFYS---HIGHHLKNIEHPERMTLFRMVFL-------DFRFL-----EQKI 507
Query: 147 IHRDMRPSNILLTHDFVPMLGDFGLARWKTTD-DPVQTKILGTLGYLAPEYAENGIVSIR 205
H + + + L + D DP +++ + P+ EN I S
Sbjct: 508 RHDS---TAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKY 564
Query: 206 TDVYAFGIILLQL 218
TD LL++
Sbjct: 565 TD-------LLRI 570
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 29/173 (16%), Positives = 63/173 (36%), Gaps = 41/173 (23%)
Query: 30 LLGEGGFGHVYKGELKDGQMI------AAKVRKEASTQGFAEFQ-----SEVYVLNFARH 78
+G+GGFG +Y ++ + + KV + F E + ++ +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 79 KNIVMLLGFC----------CKENLNILVYEYICNKSLHWHLFDN------TESVLEWHQ 122
+ LG ++ ++ + L +++ ++VL+
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR-FGSDL-QKIYEANAKRFSRKTVLQ--- 156
Query: 123 RYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL--THDFVPMLGDFGLAR 173
++ L ++HE +H D++ SN+LL + L D+GLA
Sbjct: 157 ---LSLRILDILEYIHEHE----YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 38/235 (16%), Positives = 70/235 (29%), Gaps = 56/235 (23%)
Query: 28 ENLLGEGGFGHVYKGE---------LKDGQMIAAKVRKEASTQGFAEFQSEVYV------ 72
++ G +Y+ Q + K+ + + F E
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAK-DGRLFNEQNFFQRAAKPLQV 105
Query: 73 -----LNFARHKNIVMLLGFCCKENL-NILVYEYICNKSLHWHLFDNTESVLEWHQRYAA 126
L I +GF ++ LV L + +S L+ ++
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS---------LGRSLQSALDVSPKHVL 156
Query: 127 AIGTA--------KGLRFLHEECRGGPIIHRDMRPSNILL---THDFVPMLGDFGLA-RW 174
+ + L FLHE +H ++ NI + V L +G A R+
Sbjct: 157 SERSVLQVACRLLDALEFLHENE----YVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRY 211
Query: 175 KTTDDPVQTK------ILGTLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMSGR 222
+ V G L + G S R+D+ + G +L+ + G
Sbjct: 212 CPSGKHVAYVEGSRSPHEGDLEF-ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 32/170 (18%), Positives = 55/170 (32%), Gaps = 38/170 (22%)
Query: 30 LLGEGGFGHVYKGE-LKDGQMIAAKVRK-EASTQGFAEFQSEVY-------VLNFARHKN 80
+G GGFG +Y + A V K E G + + Y + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 81 IVMLLGF----------CCKENLNILVYEYICNKSLHWHLFD-----NTESVLEWHQRYA 125
+ LG + +V E L + +VL+
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMER-LGIDL-QKISGQNGTFKKSTVLQ------ 155
Query: 126 AAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL--THDFVPMLGDFGLAR 173
I L ++HE +H D++ +N+LL + L D+GL+
Sbjct: 156 LGIRMLDVLEYIHENE----YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 26/140 (18%), Positives = 43/140 (30%), Gaps = 55/140 (39%)
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLT-------------------------------- 159
+GL +LH +CR IIH D++P NILL+
Sbjct: 157 QGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 160 -----------------HDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIV 202
+ D G A W T+ + T Y + E
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQTRQYRSLEVLIGSGY 270
Query: 203 SIRTDVYAFGIILLQLMSGR 222
+ D+++ + +L +G
Sbjct: 271 NTPADIWSTACMAFELATGD 290
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 52/237 (21%), Positives = 83/237 (35%), Gaps = 72/237 (30%)
Query: 30 LLGEGGFGHVYKG--ELKDGQMIAAKVRKEASTQGFAEFQS--EVYVLNFARHK------ 79
LGEG FG V + + +A K+ + + + E + E+ VL + K
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIR--NVGKYRE-AARLEINVLKKIKEKDKENKF 82
Query: 80 NIVMLLGF-------C-CKENLNILVYEYICN---KSLHWHLFDNTESVLEWHQRYAAAI 128
V++ + C E L +E++ + + A +
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHV----------RHMAYQL 132
Query: 129 GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLG-------------------DF 169
A LRFLHE + + H D++P NIL + L DF
Sbjct: 133 CHA--LRFLHE-NQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 170 GLARWKTTDDPVQTKILGTLGYLAPEYAENGIV-----SIRTDVYAFGIILLQLMSG 221
G A T D T I+ T Y PE ++ + DV++ G IL + G
Sbjct: 187 GSA---TFDHEHHTTIVATRHYRPPE-----VILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 33/151 (21%), Positives = 54/151 (35%), Gaps = 38/151 (25%)
Query: 30 LLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQS--EVYVLNFARH-----KNI 81
+G+G FG V + + + + A KV + + + + + E +L ++ NI
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR--NIKKYTR-SAKIEADILKKIQNDDINNNNI 98
Query: 82 VMLLG-FCCK-------ENLNILVYEYICN---KSLHWHLFDNTESVLEWHQRYAAAIGT 130
V G F E L +YE I H + Y I
Sbjct: 99 VKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDI----------KLYCIEILK 148
Query: 131 AKGLRFLHEECRGGPIIHRDMRPSNILLTHD 161
A L +L + + H D++P NILL
Sbjct: 149 A--LNYLRK-MS---LTHTDLKPENILLDDP 173
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 315 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.97 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.83 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.57 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.53 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.49 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.48 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.48 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.15 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.09 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.96 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.77 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.77 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.56 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.55 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.43 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.41 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.35 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.35 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.34 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.21 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.2 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.65 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.59 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.03 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.27 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.37 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-57 Score=388.89 Aligned_cols=255 Identities=20% Similarity=0.283 Sum_probs=215.5
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
..|+++++||+|+||+||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++.+++.+|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46999999999999999999876 69999999988766666777899999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
+||+|.+++.+ ..+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||++.........
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999998854 3599999999999999999999999 9999999999999999999999999999866555555
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+.. ..+.. .... ..+.+ ..
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~----i~~~------~~~~~--~~ 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKM----IRDN------LPPRL--KN 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH----HHHS------SCCCC--SC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHH----HHcC------CCCCC--Cc
Confidence 56678999999999999999999999999999999999999999654321 11111 1111 11111 11
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
....+..+.+|+.+||..||++|||+.|++++-+-..
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 2234556889999999999999999999998765443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=392.94 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=205.2
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
++|++++.||+|+||+||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 58999999999999999999876 6999999998754 33445678999999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.||+|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++.......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999877777789999999999999999999999 99999999999999999999999999997443322
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+.. ......... .. +.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~-~~-----~~--- 244 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLKIISG-SF-----PP--- 244 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHT-CC-----CC---
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHcC-CC-----CC---
Confidence 2334567999999999999999999999999999999999999999654321 111111111 11 11
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 245 -~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 -VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122334568899999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-56 Score=390.09 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=215.0
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
+.|+++++||+|+||+||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++.+++.+|+||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999876 69999999998776666778999999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.||+|.+++.. ..+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++.........
T Consensus 231 ~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~----~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 231 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred CCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 99999998853 3599999999999999999999999 9999999999999999999999999999866655555
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+.. ..+. ..... ..+.+ ..
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~----~i~~~------~~~~~--~~ 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMK----MIRDN------LPPRL--KN 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH----HHHHS------CCCCC--SC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHH----HHHcC------CCCCC--cc
Confidence 56678999999999999999999999999999999999999999643321 1111 11111 11111 11
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
....+..+.+|+.+||..||++|||+.|++++-+-..
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 1223456889999999999999999999998755443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=377.90 Aligned_cols=246 Identities=21% Similarity=0.246 Sum_probs=206.6
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++++.||+|+||+||+|.+. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999875 6999999998753 3445677899999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.||+|.+++.+. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999643 4599999999999999999999999 9999999999999999999999999999865433
Q ss_pred C--CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 179 D--PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 179 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
. ....+.+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.. .. ....... ...
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~----~~~i~~~-------~~~ 252 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG--LI----FAKIIKL-------EYD 252 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH----HHHHHHT-------CCC
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HH----HHHHHcC-------CCC
Confidence 2 2334578999999999999999999999999999999999999999654321 11 1111111 011
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVV 291 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il 291 (315)
++...+..+.+|+.+||.+||++|||++|++
T Consensus 253 ----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 ----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ----CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1222344678999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-56 Score=378.02 Aligned_cols=258 Identities=23% Similarity=0.363 Sum_probs=211.6
Q ss_pred hcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
.++|++.+.||+|+||+||+|.+. ++..||+|++...+....+.+.+|+.++++++||||+++++++.+++.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 357999999999999999999764 47789999998777777788999999999999999999999999999999
Q ss_pred EEEEeccCCccccccccC-----------CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCce
Q 046121 96 LVYEYICNKSLHWHLFDN-----------TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVP 164 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i 164 (315)
+||||+++|+|.+++... ....+++.++..++.|++.|+.|||++ +++||||||+||+++.++.+
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccCHhhEEECCCCcE
Confidence 999999999999999653 235699999999999999999999999 99999999999999999999
Q ss_pred eECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHH
Q 046121 165 MLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAE 241 (315)
Q Consensus 165 ~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 241 (315)
||+|||++......... .....||+.|+|||++.++.++.++|||||||++|||+| |..||...+.. ....
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~ 241 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIE 241 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHH
Confidence 99999999744332221 223468999999999999999999999999999999998 89999654321 1111
Q ss_pred HHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 242 PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
... .... +. .+...+..+.+|+.+||+.||++|||+.++.+.|+.+..
T Consensus 242 ~i~-~~~~-----~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 242 CIT-QGRV-----LQ----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHH-HTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH-cCCC-----CC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111 1111 11 122344568899999999999999999999999987643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=378.48 Aligned_cols=264 Identities=20% Similarity=0.179 Sum_probs=213.0
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
+.|++.++||+|+||+||+|.+. +++.||+|++..... ..+|+.+++.++||||+++++++.+++.+|+||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 46888899999999999999876 699999999875422 247999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC-ceeECCCCcccccCCCCC
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF-VPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~-~i~l~dfg~~~~~~~~~~ 180 (315)
+||+|.+++.+. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.+| .+||+|||++........
T Consensus 133 ~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTR----RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999643 4699999999999999999999999 999999999999999987 699999999975543221
Q ss_pred -----ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 181 -----VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 181 -----~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||........ .... ... +
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~i----~~~--------~ 272 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLKI----ASE--------P 272 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HHHH----HHS--------C
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHHH----HcC--------C
Confidence 12235799999999999999999999999999999999999999976544322 1111 111 0
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccccchhhhc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLGEKFVQR 311 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~~~~~~~~ 311 (315)
......++..+..+.+++.+||..||++|||+.|++++|.........+....+++
T Consensus 273 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 273 PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 00111233345568889999999999999999999999988776665555554443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-55 Score=377.45 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=207.1
Q ss_pred cCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
.+|.+.++||+|+||+||+|.+. ++..||+|++...+....+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999764 478899999987777777889999999999999999999999999999999
Q ss_pred EEEeccCCccccccccCC-------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc
Q 046121 97 VYEYICNKSLHWHLFDNT-------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV 163 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~ 163 (315)
||||+++|+|.+++.... ..++++.+++.++.|++.|+.|||+. +|+||||||+|||++.++.
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL----HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHhhEEECCCCc
Confidence 999999999999886532 24699999999999999999999999 9999999999999999999
Q ss_pred eeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhH
Q 046121 164 PMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWA 240 (315)
Q Consensus 164 i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 240 (315)
+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||+| |..||...+.. ...
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~ 270 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------EAI 270 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------HHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------HHH
Confidence 99999999975433322 2234578999999999999999999999999999999998 89999654321 111
Q ss_pred HHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
...... . .+. .+...+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 271 ~~i~~g-~-----~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCITQG-R-----ELE----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHT-C-----CCC----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHcC-C-----CCC----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111111 0 111 1223345678899999999999999999999999887543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-55 Score=367.42 Aligned_cols=248 Identities=22% Similarity=0.296 Sum_probs=192.3
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++++.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999875 69999999987542 334567899999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+ +|+|.+.+.+. ..+++..+..++.|++.|+.|||++ +|+||||||+||+++.++.++|+|||++.....
T Consensus 93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRH----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD- 164 (275)
T ss_dssp ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCChHHeEECCCCCEEEeecCCCeecCC-
Confidence 998 78898888654 4599999999999999999999999 999999999999999999999999999974433
Q ss_pred CCccccccccccccCccccccCCC-cccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.. ......... . ..
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~~~~i~~~-~------~~- 230 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VLFKNISNG-V------YT- 230 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHT-C------CC-
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcC-C------CC-
Confidence 223345689999999999998876 57899999999999999999999653321 111111111 0 11
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
++...+..+.+|+.+||+.||++|||+.|++++-+
T Consensus 231 ---~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 231 ---LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred ---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 12223456789999999999999999999998644
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-55 Score=372.41 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=208.0
Q ss_pred cCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
+++++.++||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 56788899999999999999763 46789999987543 334567899999999999999999999999999999
Q ss_pred EEEEeccCCccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC
Q 046121 96 LVYEYICNKSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD 161 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~ 161 (315)
+||||+++|+|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+|||++.+
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH----HVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCccccceEECCC
Confidence 9999999999999985432 24589999999999999999999999 99999999999999999
Q ss_pred CceeECCCCcccccCCCC--CccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHH
Q 046121 162 FVPMLGDFGLARWKTTDD--PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQ 238 (315)
Q Consensus 162 ~~i~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 238 (315)
+.+||+|||++....... .......||+.|+|||++.++.++.++|||||||++|||+| |..||...+.. .
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~------~ 255 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------D 255 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH------H
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH------H
Confidence 999999999997443322 12234578999999999999999999999999999999998 89999654321 1
Q ss_pred hHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 239 WAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
...... .... + ..+..++..+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 256 ~~~~i~-~~~~-----~----~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 256 VVEMIR-NRQV-----L----PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHHH-TTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHH-cCCC-----C----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 111111 1111 1 112234456888999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=368.24 Aligned_cols=263 Identities=28% Similarity=0.444 Sum_probs=205.0
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
+++++.++||+|+||+||+|.+++ .+|+|+++.. .....+.+.+|+.+++.++||||+++++++.+ +.+++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 578889999999999999998754 5899987643 34445678999999999999999999998764 568999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC-
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD- 179 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~- 179 (315)
++||+|.+++.... ..+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 113 ~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~----~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK----NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC----CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999886443 4599999999999999999999999 99999999999999999999999999997543322
Q ss_pred -CccccccccccccCcccccc---CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 180 -PVQTKILGTLGYLAPEYAEN---GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 180 -~~~~~~~~~~~~~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
.......||+.|+|||++.+ ..++.++|||||||++|||++|..||...+... ... ...... ...+
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~~~----~~~~~~----~~~p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QII----FMVGRG----YASP 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHH----HHHHTT----CCCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--HHH----HHHhcC----CCCC
Confidence 22334679999999999864 358899999999999999999999996543211 111 111111 1111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHL 304 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~ 304 (315)
.. ...+..++..+.+|+.+||+.||++|||+.++++.|+.++..++.+
T Consensus 258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk~ 305 (307)
T 3omv_A 258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKI 305 (307)
T ss_dssp CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC-
T ss_pred Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCCC
Confidence 11 1223334556889999999999999999999999999887666543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=374.27 Aligned_cols=258 Identities=22% Similarity=0.282 Sum_probs=202.8
Q ss_pred cCCcccceecCCCceEEEEEEeC----CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
++|++++.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 58999999999999999999753 47899999986542 2233467889999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.||+|.+++.+. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||++....
T Consensus 104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999643 4699999999999999999999999 99999999999999999999999999997554
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
.........+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.. ... ...... ..
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~----~~i~~~-------~~- 243 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--ETM----TMILKA-------KL- 243 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHHC-------CC-
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--HHH----HHHHcC-------CC-
Confidence 4444445678999999999999999999999999999999999999999654321 111 111111 01
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHhcccccccc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPS-----MGEVVRLLEGENDRFHH 303 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps-----~~~il~~L~~~~~~~~~ 303 (315)
.++...+..+.+|+.+||+.||++||| +++++++-+--.-.|..
T Consensus 244 ---~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~ 292 (304)
T 3ubd_A 244 ---GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK 292 (304)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence 112234456789999999999999998 47888765543334433
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=363.45 Aligned_cols=250 Identities=24% Similarity=0.327 Sum_probs=198.7
Q ss_pred cCC-cccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEe----cCee
Q 046121 23 GDF-SKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCK----ENLN 94 (315)
Q Consensus 23 ~~y-~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 94 (315)
++| ++.++||+|+||+||+|.+. ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 455 67778999999999999876 6889999987644 33345668999999999999999999999865 3568
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCC--eEeecCccCcEEEcC-CCceeECCCCc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGP--IIHRDMRPSNILLTH-DFVPMLGDFGL 171 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~--i~h~di~p~nil~~~-~~~i~l~dfg~ 171 (315)
|+||||+.||+|.+++.+ ...+++..+..++.|++.||.|||++ + |+||||||+|||++. ++.+||+|||+
T Consensus 105 ~lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~----~~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCCEEecccChhheeEECCCCCEEEEeCcC
Confidence 999999999999999964 34699999999999999999999999 7 999999999999985 79999999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
+..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .+. .. ....
T Consensus 179 a~~~~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~---~~-i~~~---- 245 (290)
T 3fpq_A 179 ATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIY---RR-VTSG---- 245 (290)
T ss_dssp GGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHH---HH-HTTT----
T ss_pred CEeCCC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHH---HH-HHcC----
Confidence 974322 23345689999999999875 58999999999999999999999996432211 111 11 1110
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
...+.. +...+..+.+|+.+||..||++|||+.+++++-+
T Consensus 246 ~~~~~~----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 246 VKPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp CCCGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCCCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 011111 1122335788999999999999999999987644
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=364.74 Aligned_cols=259 Identities=27% Similarity=0.371 Sum_probs=207.6
Q ss_pred HhcCCcccceecCCCceEEEEEEeCC------CcEEEEEEecccC-cccHHHHHHHHHHHhhcCC-CCccceeeeEEec-
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKD------GQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARH-KNIVMLLGFCCKE- 91 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~- 91 (315)
-.++|++.+.||+|+||+||+|.+.+ ++.||+|.+.... ......+.+|+.+++.+.| |||+++++++.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 45789999999999999999997542 4679999887543 3345668999999999976 8999999998664
Q ss_pred CeeEEEEEeccCCccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEE
Q 046121 92 NLNILVYEYICNKSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNIL 157 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil 157 (315)
+.+++||||+++|+|.+++.... ...+++..+..++.|++.|+.|||++ +++||||||+||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~----~iiHRDLK~~NIL 217 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNIL 217 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC----CeecCccCcccee
Confidence 56899999999999999986532 34589999999999999999999999 9999999999999
Q ss_pred EcCCCceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccch
Q 046121 158 LTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQ 234 (315)
Q Consensus 158 ~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~ 234 (315)
++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||+| |..||...... .
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--~ 295 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E 295 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--H
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--H
Confidence 99999999999999975443322 2234578999999999999999999999999999999998 89999754322 1
Q ss_pred hHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 235 SLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
.... ..... ..+.. +...+..+.+++.+||+.||++|||+.+|+++|+.+.
T Consensus 296 ~~~~----~i~~g-----~~~~~----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 296 EFCR----RLKEG-----TRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp HHHH----HHHHT-----CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH----HHHcC-----CCCCC----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1111 11111 11111 2223445788999999999999999999999998763
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=354.74 Aligned_cols=273 Identities=24% Similarity=0.327 Sum_probs=203.2
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecC----eeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN----LNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv 97 (315)
.++|.+.++||+|+||+||+|.++ |+.||+|++...... ......|+..+..++||||+++++++.+++ .+++|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 467899999999999999999884 889999998654322 122345666677889999999999997654 57999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhccc----CCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC----RGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~----~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
|||+++|+|.+++.. ..+++..+..++.|++.|+.|||+.+ ++.+|+||||||+|||++.++.+||+|||++.
T Consensus 80 ~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999954 35899999999999999999999763 22389999999999999999999999999997
Q ss_pred ccCCCCCc----cccccccccccCccccccC------CCcccccchhhhHHHHHHHhCCCccCCCCCccc--hhH--HHh
Q 046121 174 WKTTDDPV----QTKILGTLGYLAPEYAENG------IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ--QSL--RQW 239 (315)
Q Consensus 174 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~------~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~--~~~--~~~ 239 (315)
........ .....||+.|+|||++.+. .++.++|||||||++|||++|.+|+........ ... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 54433221 2235799999999998764 367799999999999999999888754332111 000 000
Q ss_pred HHHHHhhhccccccCCcccCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 240 AEPLIEKLALHELIDPRIENS-YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
..............+|.++.. .+......+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 000111111222333333322 233566778999999999999999999999999988754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-52 Score=352.20 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=188.8
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecC--------
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN-------- 92 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 92 (315)
++|++++.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999876 68999999887543 333456889999999999999999999987654
Q ss_pred ----eeEEEEEeccCCccccccccCCC-CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeEC
Q 046121 93 ----LNILVYEYICNKSLHWHLFDNTE-SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLG 167 (315)
Q Consensus 93 ----~~~lv~~~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~ 167 (315)
.+|+||||+.|++|.+++..... ...+...++.++.|++.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~----~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC----cCccccCcHHHeEECCCCcEEEc
Confidence 36999999999999999865443 3355677889999999999999999 99999999999999999999999
Q ss_pred CCCcccccCCCCCc------------cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchh
Q 046121 168 DFGLARWKTTDDPV------------QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQS 235 (315)
Q Consensus 168 dfg~~~~~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~ 235 (315)
|||++......... ....+||+.|+|||++.+..++.++|||||||++|+|++ ||.... ..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~ 233 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ER 233 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HH
Confidence 99999754432211 123579999999999999999999999999999999996 663211 00
Q ss_pred HHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 236 LRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
... ... ... . ..+ .........+.+|+.+||+.||++|||+.+++++-+
T Consensus 234 ~~~-~~~-~~~-----~---~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~ 282 (299)
T 4g31_A 234 VRT-LTD-VRN-----L---KFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV 282 (299)
T ss_dssp HHH-HHH-HHT-----T---CCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHH-HHH-Hhc-----C---CCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 000 000 000 0 000 011122334678999999999999999999998543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=351.03 Aligned_cols=269 Identities=23% Similarity=0.242 Sum_probs=202.7
Q ss_pred HHHHHHHhcCCcccceecCCCceEEEEEEeC----CCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeeeEE
Q 046121 15 FSEIQQATGDFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGFCC 89 (315)
Q Consensus 15 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 89 (315)
...++.+.++|++.++||+|+||+||+|.++ +++.||+|.+.... ....+.+|+++++.+ +||||+++++++.
T Consensus 13 ~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp HHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred HHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 3455667899999999999999999999753 47889999876543 345678999999988 6999999999999
Q ss_pred ecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC-CceeECC
Q 046121 90 KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD-FVPMLGD 168 (315)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~-~~i~l~d 168 (315)
+.+++|+||||++|++|.+.+. .+++.++..++.|++.||.|||++ ||+||||||+|||++.+ +.++|+|
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~----gIiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF----GIVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECC
T ss_pred ECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCcCCHHHeEEeCCCCeEEECc
Confidence 9999999999999999999882 489999999999999999999999 99999999999999877 8999999
Q ss_pred CCcccccCCCCC----------------------------ccccccccccccCccccccC-CCcccccchhhhHHHHHHH
Q 046121 169 FGLARWKTTDDP----------------------------VQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLM 219 (315)
Q Consensus 169 fg~~~~~~~~~~----------------------------~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~ 219 (315)
||++........ .....+||+.|+|||++.+. .++.++||||+||++|+|+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 999964332111 11235799999999998775 4889999999999999999
Q ss_pred hCCCccCCCCCccchhHHHhHHHH------------------------------HhhhccccccCCccc---------CC
Q 046121 220 SGRKVVDMNGEEPQQSLRQWAEPL------------------------------IEKLALHELIDPRIE---------NS 260 (315)
Q Consensus 220 ~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~---------~~ 260 (315)
+|..||.....+..+ +....... ...........+... ..
T Consensus 242 ~G~~Pf~~~~~~~~~-l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 320 (361)
T 4f9c_A 242 SGRYPFYKASDDLTA-LAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLE 320 (361)
T ss_dssp HTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------------
T ss_pred HCCCCCCCCCCHHHH-HHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccc
Confidence 999999644332211 11110000 000000000000000 00
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.....+..+.+|+.+||..||++|||++|++++-+
T Consensus 321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~ 355 (361)
T 4f9c_A 321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPF 355 (361)
T ss_dssp -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 11123456789999999999999999999997644
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=355.53 Aligned_cols=264 Identities=20% Similarity=0.247 Sum_probs=201.2
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEe------cCe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCK------ENL 93 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~ 93 (315)
++|++++.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999876 79999999987543 3334567899999999999999999998754 367
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+|+||||+. |+|.+.+.+ ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++.++++|||++.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSA----QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----cCcCCCcCccccccCCCCCEEEeecceee
Confidence 899999995 678888843 45799999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCC----CCccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhc
Q 046121 174 WKTTD----DPVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248 (315)
Q Consensus 174 ~~~~~----~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (315)
..... .......+||+.|+|||++.+. .++.++||||+||++|+|++|.+||...+... .+..... ......
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~--~l~~I~~-~~g~p~ 283 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH--QLQLIMM-VLGTPS 283 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHH-HHCCCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH--HHHHHHH-hcCCCC
Confidence 54322 1223456899999999998775 46899999999999999999999997543221 1111110 000000
Q ss_pred c--------------ccccCCcccC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 249 L--------------HELIDPRIEN---SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 249 ~--------------~~~~~~~~~~---~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
. ...+.+.... ...+..+..+.+|+.+||..||++|||+.|++++-+-
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 348 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhh
Confidence 0 0000000000 0111234467899999999999999999999987543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=366.91 Aligned_cols=257 Identities=21% Similarity=0.270 Sum_probs=212.2
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
.++|++++.||+|+||+||+|.++ +++.||+|++........+.+.+|+.+++.++||||+++++++.+...+|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999876 6999999998877666677889999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC--CceeECCCCcccccCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD--FVPMLGDFGLARWKTTD 178 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~--~~i~l~dfg~~~~~~~~ 178 (315)
+.||+|.+++.+. ...+++..+..++.||+.||.|||++ +|+||||||+||+++.+ +.+||+|||++......
T Consensus 236 ~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999888543 34599999999999999999999999 99999999999999854 89999999999855433
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.. ..+. ... .. . ..+.
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~----~i~-~~--~----~~~~ 376 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLR----NVK-SC--D----WNMD 376 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHH----HHH-TT--C----CCCC
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHH----HHH-hC--C----CCCC
Confidence 3334568999999999999999999999999999999999999999654321 1111 111 00 0 0111
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.......+..+.+||.+||..||++|||+.+++++-+-.
T Consensus 377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~ 415 (573)
T 3uto_A 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415 (573)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcC
Confidence 111223345678999999999999999999999975543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=333.66 Aligned_cols=276 Identities=38% Similarity=0.696 Sum_probs=236.9
Q ss_pred HHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
...++|++.+.||+|+||+||+|.+.+++.|++|+.........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 35589999999999999999999988899999999887766677889999999999999999999999999999999999
Q ss_pred eccCCccccccccCC--CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 100 YICNKSLHWHLFDNT--ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|+.+++|.+++.... ...+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC----CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999886543 23589999999999999999999999 999999999999999999999999999874332
Q ss_pred CC--CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 178 DD--PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 178 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
.. .......|++.|+|||.+.+..++.++||||||+++|+|++|..||.............+..............++
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence 22 1223345789999999998888999999999999999999999999866655544445444444445555666677
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
.......+..+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 77777788889999999999999999999999999999997754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=362.27 Aligned_cols=260 Identities=21% Similarity=0.257 Sum_probs=206.2
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHH---HHHHHHhhcCCCCccceeeeEEecCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQ---SEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~---~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
.++|+++++||+|+||+||+|++. +++.||+|++.+.. ........ .++.+++.++||||+++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999876 69999999986432 12222333 446677788999999999999999999
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
|+||||+.||+|.+++.+. ..+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.++|+|||++..
T Consensus 268 ylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~----gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999643 4599999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCccccccccccccCccccc-cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 175 KTTDDPVQTKILGTLGYLAPEYAE-NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
..... ..+.+||+.|+|||++. +..|+.++|+|||||++|+|++|.+||...+......+.. .....
T Consensus 342 ~~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~~~------- 409 (689)
T 3v5w_A 342 FSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLTM------- 409 (689)
T ss_dssp CSSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHHHC-------
T ss_pred cCCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhcCC-------
Confidence 54332 34568999999999986 4578999999999999999999999996543322211111 11110
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHhcccccccc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS-----MGEVVRLLEGENDRFHH 303 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps-----~~~il~~L~~~~~~~~~ 303 (315)
. ..++...+..+.+|+.+||+.||++|++ +++|+++-+--.-.|..
T Consensus 410 ~----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 410 A----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp C----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred C----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 1 1122234456789999999999999998 78888776654444443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=324.73 Aligned_cols=256 Identities=21% Similarity=0.274 Sum_probs=213.4
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
..++|++.+.||+|+||+||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 4578999999999999999999864 689999999877666667788999999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.|++|.+++... .+++..+..++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999988543 589999999999999999999999 99999999999999999999999999987655544
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ... ..... .. ...
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~----~~~~~-~~-------~~~ 236 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALY----LIATN-GT-------PEL 236 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH----HHHHH-CS-------CCC
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHhC-CC-------CCC
Confidence 44455678999999999999999999999999999999999999996443211 111 01110 00 011
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
..+...+..+.+++.+||+.||++|||+.+++++-+-.
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~ 274 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence 11223445688999999999999999999999865543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=330.64 Aligned_cols=290 Identities=40% Similarity=0.755 Sum_probs=235.8
Q ss_pred CCCCCcccHHHHHHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCCcccee
Q 046121 7 MKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVMLL 85 (315)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (315)
+.+...++..++....++|++.+.||+|+||+||+|.+.+++.||+|++..... .....+.+|+.+++.++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 344556788899999999999999999999999999988899999998775432 2233688999999999999999999
Q ss_pred eeEEecCeeEEEEEeccCCccccccccCC--CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc
Q 046121 86 GFCCKENLNILVYEYICNKSLHWHLFDNT--ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV 163 (315)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~ 163 (315)
+++......++||||+.+++|.+++.... ...+++..+..++.|++.++.+||+.+ +.+++|+||||+||+++.++.
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC-DPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS-SSCEECCCCSGGGEEECTTCC
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeCCCchhhEEECCCCC
Confidence 99999999999999999999999887654 345999999999999999999999872 337999999999999999999
Q ss_pred eeECCCCcccccCCCCC-ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCC--CccchhHHHhH
Q 046121 164 PMLGDFGLARWKTTDDP-VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNG--EEPQQSLRQWA 240 (315)
Q Consensus 164 i~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~ 240 (315)
++|+|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.... .........+.
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 99999999975543322 2333458999999999988889999999999999999999999996211 11122223333
Q ss_pred HHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.............+.......+...+..+.+++.+||+.||++|||+.+++++|++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 333333344455566666777888889999999999999999999999999999754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=321.09 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=213.3
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
.++|++.+.||+|+||+||+|.+. +++.+++|++..........+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 468999999999999999999876 6899999988776677778899999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++... ...+++..++.++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM----NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999998654 34589999999999999999999999 999999999999999999999999999975433222
Q ss_pred cc--------------ccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhh
Q 046121 181 VQ--------------TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK 246 (315)
Q Consensus 181 ~~--------------~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (315)
.. ....|++.|+|||++.+..++.++||||||+++|+|++|..|+.............. ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~ 242 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFLDR 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHHHHH
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hccccc
Confidence 11 145689999999999999999999999999999999999999865433221110000 000110
Q ss_pred hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
. . +...+..+.+++.+||+.||++|||+.++++.|+.+...+.
T Consensus 243 ~-----~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 243 Y-----C--------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp T-----C--------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred c-----C--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0 0 11112237789999999999999999999999998876543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=324.21 Aligned_cols=262 Identities=26% Similarity=0.365 Sum_probs=203.3
Q ss_pred HHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
...++|++.+.||+|+||+||+|.+ +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3467899999999999999999987 47789999876543 33445688999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCC-CccCHHHHHHHHHHHHHHHHhhhcccCCCC--eEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 98 YEYICNKSLHWHLFDNTE-SVLEWHQRYAAAIGTAKGLRFLHEECRGGP--IIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~--i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
|||+.+++|.+++..... ..+++..++.++.|++.++.+||+. + ++|+||||+||+++.++.++|+|||++..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR----NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS----SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC----CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999998865432 3489999999999999999999999 8 99999999999999999999999999974
Q ss_pred cCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 175 KTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
............|++.|+|||++.+..++.++||||||+++|+|++|..||....... ........ ...
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~~-----~~~ 257 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFK-----CKR 257 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHHS-----CCC
T ss_pred ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhc-----CCC
Confidence 4433333345678999999999999999999999999999999999999996543211 00111000 011
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
.. .+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 258 ~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 258 LE----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 11 22233445788999999999999999999999998876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=326.54 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=208.8
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
....++|++++.||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 345679999999999999999999874 7999999998654 3344567889999999999999999999999999999
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+||||+.+++|.+++... ..+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK----RIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 999999999999988543 4589999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCccccccccccccCccccccCCCc-ccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAENGIVS-IRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
... .......|++.|+|||++.+..+. .++||||||+++|+|++|..||...+.. ......... .
T Consensus 165 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~-------~ 230 (328)
T 3fe3_A 165 TVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRERVLRG-------K 230 (328)
T ss_dssp SSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-------C
T ss_pred CCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC-------C
Confidence 433 233456799999999999887765 7899999999999999999999654321 111111111 0
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.. .+...+..+.+++.+||..||++|||+++++++-+-
T Consensus 231 ~~----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 231 YR----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp CC----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred CC----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 01 112234457789999999999999999999987554
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=324.74 Aligned_cols=258 Identities=24% Similarity=0.300 Sum_probs=211.7
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
.++|++++.||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++...+.+++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999876 6999999998754 234456788999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|||+.|++|..++.+ ...+++..+..++.|++.||.|||+. |++||||||+||+++.+|.++|+|||++.....
T Consensus 84 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999888854 34589999999999999999999999 999999999999999999999999999975444
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
........+|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.. ......... ...
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~-------~~~- 223 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILME-------EIR- 223 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-------CCC-
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHHcC-------CCC-
Confidence 444445668999999999999989999999999999999999999999643321 111111111 011
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhccccccc
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEGENDRFH 302 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~~~~~~~ 302 (315)
++...+..+.+++.+||+.||++|| ++++++++-+-....|.
T Consensus 224 ---~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 1223345678899999999999999 89999887654443343
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=318.47 Aligned_cols=279 Identities=20% Similarity=0.247 Sum_probs=225.3
Q ss_pred CcccHHHHHHHhcC----------CcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCC
Q 046121 11 MKFSFSEIQQATGD----------FSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHK 79 (315)
Q Consensus 11 ~~~~~~~~~~~~~~----------y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~ 79 (315)
.....+++...... |...+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34556666655443 778889999999999999876 7999999998877667777889999999999999
Q ss_pred CccceeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc
Q 046121 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT 159 (315)
Q Consensus 80 ~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~ 159 (315)
||+++++++...+..++||||+.+++|.+++. ...+++..+..++.|++.|+.+||+. +++|+||||+||+++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQ----GVIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEC
Confidence 99999999999999999999999999999884 34589999999999999999999999 999999999999999
Q ss_pred CCCceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHh
Q 046121 160 HDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQW 239 (315)
Q Consensus 160 ~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 239 (315)
.++.++|+|||++..............|++.|+|||++.+..++.++||||||+++|+|++|..||...... ...
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~--- 250 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAM--- 250 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH---
T ss_pred CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH---
Confidence 999999999999875554444444567899999999999988999999999999999999999999644321 111
Q ss_pred HHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccccchhhh
Q 046121 240 AEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLGEKFVQ 310 (315)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~~~~~~~ 310 (315)
.... . ...+.. ......+..+.+++.+||+.||++|||+.+++++.+-.....++....++|
T Consensus 251 -~~~~-~-----~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~~~~~ 312 (321)
T 2c30_A 251 -KRLR-D-----SPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQ 312 (321)
T ss_dssp -HHHH-H-----SSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGGGGHHHHH
T ss_pred -HHHh-c-----CCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCcccchHHHH
Confidence 1111 1 011111 111223455788999999999999999999999888776666666555554
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=314.83 Aligned_cols=260 Identities=27% Similarity=0.359 Sum_probs=210.7
Q ss_pred HhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
..++|++.+.||+|+||+||+|.+.++..+|+|++..... ..+.+.+|+.+++.++||||+++++++......++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3578999999999999999999998888999999875433 346789999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++... ...+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH----QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999988543 34589999999999999999999999 999999999999999999999999999975443332
Q ss_pred c-cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 181 V-QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 181 ~-~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
. .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ ....... ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~---~~------- 223 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV------VLKVSQG---HR------- 223 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHHHHTT---CC-------
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH------HHHHHcC---CC-------
Confidence 2 122345678999999998889999999999999999998 9999964432110 0111100 00
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
...+...+..+.+++.+||+.||++|||+.++++.|+.+.++-+
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k 267 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence 11111223457889999999999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=325.13 Aligned_cols=257 Identities=23% Similarity=0.266 Sum_probs=208.5
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc------cHHHHHHHHHHHhhcCCCCccceeeeEEecCe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ------GFAEFQSEVYVLNFARHKNIVMLLGFCCKENL 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (315)
+.++|++.+.||+|+||+||+|.+. +++.+|+|++...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 5678999999999999999999876 6899999988754322 34678999999999999999999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC----ceeECCC
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF----VPMLGDF 169 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~----~i~l~df 169 (315)
.++||||+.|++|.+++.. ...+++..+..++.|++.|+.|||+. |++|+||||+||+++.++ .++|+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999854 45699999999999999999999999 999999999999998877 7999999
Q ss_pred CcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcc
Q 046121 170 GLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249 (315)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (315)
|++...... .......|++.|+|||++.+..++.++||||||+++|+|++|.+||...+... .. .... ...
T Consensus 164 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--~~----~~i~-~~~- 234 (361)
T 2yab_A 164 GLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TL----ANIT-AVS- 234 (361)
T ss_dssp SSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HH----HHHH-TTC-
T ss_pred CCceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--HH----HHHH-hcC-
Confidence 999754432 22344578999999999999899999999999999999999999996543211 11 1111 000
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
..+.+. .....+..+.+++.+||..||++|||+.+++++-+-.
T Consensus 235 -~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 235 -YDFDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp -CCCCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred -CCCCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 000110 1112345688999999999999999999999876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=324.65 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=209.5
Q ss_pred hcCCcccceecCCCceEEEEEEeC--------CCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccceeeeEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK--------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKE 91 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 91 (315)
.++|++.+.||+|+||+||+|.+. ++..||+|++.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999752 35679999887543 33456788999999999 899999999999999
Q ss_pred CeeEEEEEeccCCccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEE
Q 046121 92 NLNILVYEYICNKSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNIL 157 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil 157 (315)
+.+++||||+.+++|.+++.... ...++...++.++.|++.|+.|||+. +++|+||||+||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIl 235 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNVL 235 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchhhEE
Confidence 99999999999999999886543 24588999999999999999999999 9999999999999
Q ss_pred EcCCCceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccch
Q 046121 158 LTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQ 234 (315)
Q Consensus 158 ~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~ 234 (315)
++.++.++|+|||++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-- 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999975443322 1223456788999999999899999999999999999999 999997543221
Q ss_pred hHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 235 SLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
... ..... .....+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 314 -~~~----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 314 -LFK----LLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp -HHH----HHHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHH----HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111 01111 01112223345688899999999999999999999999987653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=324.30 Aligned_cols=267 Identities=23% Similarity=0.315 Sum_probs=208.1
Q ss_pred HhcCCcccceecCCCceEEEEEEe-----CCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEe--cCe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGEL-----KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK--ENL 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 93 (315)
..++|++++.||+|+||+||+|.+ .+++.||+|++........+.+.+|+.+++.++||||+++++++.. ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 457999999999999999999973 2688999999887766667788999999999999999999999854 456
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+++||||+.+++|.+++.... ..+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 899999999999999986553 3589999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCC---ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCc--------cc-hhHHHhHH
Q 046121 174 WKTTDDP---VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEE--------PQ-QSLRQWAE 241 (315)
Q Consensus 174 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~--------~~-~~~~~~~~ 241 (315)
....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..|+...... .. ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 5433221 122344677899999999989999999999999999999999887532110 00 00000000
Q ss_pred HHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 242 PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
.... .......+...+..+.+++.+||+.||++|||+.++++.|+.+.+++
T Consensus 243 ~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 243 ELLK---------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHH---------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHh---------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0000 01111122234456888999999999999999999999999987665
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=321.33 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=208.5
Q ss_pred hcCCcccceecCCCceEEEEEEeC----CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
.++|++.+.||+|+||+||+|.+. .+..||+|++... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 468999999999999999999875 3456999988754 33445678899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.+++|.+++... ...+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 128 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDL----GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999988543 34599999999999999999999999 99999999999999999999999999997554
Q ss_pred CCCCc---cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 177 TDDPV---QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 177 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
..... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||....... ........
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~~~~------ 270 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISSVEEG------ 270 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHHHTT------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHHcC------
Confidence 33221 112345678999999998889999999999999999998 999996443211 11111111
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHL 304 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~ 304 (315)
.....+...+..+.+++.+||..||++|||+.++++.|+.+.....+.
T Consensus 271 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 271 ----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred ----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 011122233456888999999999999999999999999987766554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=312.90 Aligned_cols=270 Identities=21% Similarity=0.249 Sum_probs=213.8
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecC--eeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN--LNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~l 96 (315)
..++|++.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 4578999999999999999999876 58999999987543 344567789999999999999999999987755 7799
Q ss_pred EEEeccCCccccccccCCC-CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE----cCCCceeECCCCc
Q 046121 97 VYEYICNKSLHWHLFDNTE-SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL----THDFVPMLGDFGL 171 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~----~~~~~i~l~dfg~ 171 (315)
||||+.+++|.+++..... ..+++..++.++.|++.|+.+||+. +++|+||||+||++ +.++.++|+|||+
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 9999999999998865433 3499999999999999999999999 99999999999999 7888899999999
Q ss_pred ccccCCCCCccccccccccccCccccc--------cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAE--------NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
+....... ......|++.|+|||++. +..++.++||||||+++|+|++|..||......... .......
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~ 239 (319)
T 4euu_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI 239 (319)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHH
T ss_pred ceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHH
Confidence 97544333 223456899999999876 567889999999999999999999999643322111 1111111
Q ss_pred Hhhhc---cccc---------c--CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 244 IEKLA---LHEL---------I--DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 244 ~~~~~---~~~~---------~--~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
..... .... + .-......+......+.+++.+||+.||++|||+.+++++....
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11110 0000 0 11122345677888999999999999999999999999998854
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=327.64 Aligned_cols=259 Identities=23% Similarity=0.335 Sum_probs=205.3
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 95 (315)
..++|++++.||+|+||+||+|.+. +++.||+|++... .........+|..+++.+ +||||+++++++.+.+.+|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4579999999999999999999876 6899999998753 234456678899999988 6999999999999999999
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+||||+.|++|..++.+. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 101 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999888543 4599999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
..........+|++.|+|||++.+..++.++|+||||+++|+|++|..||...+... . .......
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~----~~~i~~~--------- 239 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--L----FEAILND--------- 239 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----HHHHHHC---------
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--H----HHHHHcC---------
Confidence 444444456689999999999998889999999999999999999999996543211 1 1111111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHHHHhccccccc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSM------GEVVRLLEGENDRFH 302 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~------~~il~~L~~~~~~~~ 302 (315)
...++...+..+.+++.+||+.||++||++ .+++++-+--.-.|.
T Consensus 240 --~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 240 --EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred --CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 011122234557889999999999999998 788876554433443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=313.27 Aligned_cols=256 Identities=21% Similarity=0.344 Sum_probs=209.0
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.++|++.+.||+|+||+||+|.+.+++.+++|++..... ..+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 468999999999999999999998888999999876433 3467899999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC-
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP- 180 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~- 180 (315)
.+++|.+++.... ..+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 88 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC----CeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 9999999885433 4589999999999999999999999 999999999999999999999999999974432211
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ......... .. .
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~~~------~~----~ 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTG------FR----L 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT------CC----C
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhcC------cc----C
Confidence 1122345678999999998889999999999999999999 99999654321 111111110 11 1
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
..+...+..+.+++.+||+.||++|||+.+++++|+.+.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 1122234557889999999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=316.81 Aligned_cols=267 Identities=23% Similarity=0.264 Sum_probs=204.0
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
+.+.++|++++.||+|+||+||+|.+.+++.+|+|++.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34568999999999999999999999889999999876542 2234568899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.+ +|.+.+... ...+++..+..++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||++....
T Consensus 97 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH----RILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9999975 676666543 34589999999999999999999999 99999999999999999999999999997655
Q ss_pred CCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhc---c---
Q 046121 177 TDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA---L--- 249 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~--- 249 (315)
..........+++.|+|||++.+ ..++.++||||||+++|+|++|..||........ ...... ...... +
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~-~~~~~~~~~~~~~ 247 (311)
T 3niz_A 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFS-ILGTPNPREWPQV 247 (311)
T ss_dssp SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHH-HHCCCCTTTSGGG
T ss_pred CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHH-HHCCCChHHhhhh
Confidence 44444445578999999998876 5689999999999999999999999975443321 111111 000000 0
Q ss_pred ----------ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 250 ----------HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 250 ----------~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
.............+..+..+.+++.+||+.||++|||+.+++++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 302 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 000000000001112334578999999999999999999999853
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=326.72 Aligned_cols=265 Identities=22% Similarity=0.291 Sum_probs=208.5
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 96 (315)
.++|+++++||+|+||+||+|+++ +++.+|+|++.... ......+.+|..+++.+ +||||+++++++.+.+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999876 68899999987542 23344578899998876 89999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.|++|..++.+. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 131 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999998888543 4599999999999999999999999 99999999999999999999999999997544
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccc--hhHHHhHHHHHhhhccccccC
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ--QSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 254 (315)
.........+|++.|+|||++.+..++.++|+||||+++|+|++|.+||...+.... .............. .
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------~ 278 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------Q 278 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC------C
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc------c
Confidence 444445567899999999999999999999999999999999999999964332111 11111111111110 0
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHHHHhccccccc
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSM------GEVVRLLEGENDRFH 302 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~------~~il~~L~~~~~~~~ 302 (315)
. .++...+..+.+++.+||+.||++||++ .+++++-+-..-.|.
T Consensus 279 ~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 279 I----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred c----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence 1 1222234557889999999999999985 678776554433443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=323.94 Aligned_cols=263 Identities=21% Similarity=0.279 Sum_probs=207.7
Q ss_pred ccHHHHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEE
Q 046121 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCC 89 (315)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (315)
+.+.....+.++|++.+.||+|+||+||+|.+. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 98 (362)
T 2bdw_A 19 FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98 (362)
T ss_dssp -----CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred EeecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 334444456789999999999999999999876 68999999987543 334567889999999999999999999999
Q ss_pred ecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC---CceeE
Q 046121 90 KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD---FVPML 166 (315)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~---~~i~l 166 (315)
+.+..++||||+.|++|.+.+.. ...+++..++.++.|++.|+.|||+. +++|+||||+||+++.+ +.++|
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 99 EESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred eCCEEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEE
Confidence 99999999999999999888853 34689999999999999999999999 99999999999999865 45999
Q ss_pred CCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhh
Q 046121 167 GDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK 246 (315)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (315)
+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|.+||...... ....... .
T Consensus 173 ~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~i~-~ 244 (362)
T 2bdw_A 173 ADFGLAIEVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIK-A 244 (362)
T ss_dssp CCCTTCBCCTTCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-H
T ss_pred eecCcceEecCCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-h
Confidence 9999997544322 223457899999999999988999999999999999999999999643321 1111111 1
Q ss_pred hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.. .... .......+..+.+++.+||..||++|||+.+++++-+
T Consensus 245 ~~-~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 245 GA-YDYP-----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp TC-CCCC-----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred CC-CCCC-----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 00 0011 1111223455789999999999999999999988754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=317.54 Aligned_cols=274 Identities=24% Similarity=0.332 Sum_probs=209.4
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecC----eeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN----LNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv 97 (315)
.++|++.+.||+|+||+||+|.+. ++.||+|++..... .......|+.+++.++||||+++++++.... .+++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999876 78899999865432 2344566899999999999999999998754 36999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcc------cCCCCeEeecCccCcEEEcCCCceeECCCCc
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEE------CRGGPIIHRDMRPSNILLTHDFVPMLGDFGL 171 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~------~~~~~i~h~di~p~nil~~~~~~i~l~dfg~ 171 (315)
|||+.+++|.+++.. ..+++..++.++.|++.|+.|||+. .++.+++|+||||+||+++.++.++|+|||+
T Consensus 101 ~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 999999999999854 3489999999999999999999976 2333899999999999999999999999999
Q ss_pred ccccCCCCCc--cccccccccccCcccccc-----CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH----
Q 046121 172 ARWKTTDDPV--QTKILGTLGYLAPEYAEN-----GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA---- 240 (315)
Q Consensus 172 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---- 240 (315)
+......... .....|++.|+|||++.+ ..++.++||||||+++|+|++|..||...............
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 9754433221 223578999999999876 34567889999999999999999999765443222211100
Q ss_pred -HHHHhhhccccccCCcccCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 241 -EPLIEKLALHELIDPRIENS-YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 241 -~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
..............+.+... .....+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00011111111222222221 2234566789999999999999999999999999988643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=330.83 Aligned_cols=260 Identities=20% Similarity=0.235 Sum_probs=208.5
Q ss_pred HHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 18 IQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
.....++|++.+.||+|+||+||+|.+. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 3456789999999999999999999865 68999999876543 33345688999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc---CCCceeECCCCc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT---HDFVPMLGDFGL 171 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~---~~~~i~l~dfg~ 171 (315)
++||||+.|++|.+.+... ..+++..+..++.|++.|+.|||+. |++|+||||+||+++ .++.++|+|||+
T Consensus 86 ~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~----givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQM----GVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 9999999999999888654 4599999999999999999999999 999999999999998 468899999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
+..............|++.|+|||++.+..++.++||||||+++|+|++|.+||....... .. .... ... ..
T Consensus 160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--~~----~~i~-~~~-~~ 231 (444)
T 3soa_A 160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--LY----QQIK-AGA-YD 231 (444)
T ss_dssp CBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH----HHHH-HTC-CC
T ss_pred eEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--HH----HHHH-hCC-CC
Confidence 9755544444445679999999999999899999999999999999999999996433211 11 1111 110 01
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
...+ .....+..+.+++.+||+.||++|||+.+++++-+-
T Consensus 232 ~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~ 271 (444)
T 3soa_A 232 FPSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271 (444)
T ss_dssp CCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred CCcc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 1111 112234558899999999999999999999987553
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=312.21 Aligned_cols=251 Identities=23% Similarity=0.279 Sum_probs=197.8
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--------------------------ccHHHHHHHHHHHh
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--------------------------QGFAEFQSEVYVLN 74 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--------------------------~~~~~~~~e~~~l~ 74 (315)
.++|++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 479999999999999999999875 688999998765421 12356789999999
Q ss_pred hcCCCCccceeeeEEe--cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCc
Q 046121 75 FARHKNIVMLLGFCCK--ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMR 152 (315)
Q Consensus 75 ~l~~~~i~~~~~~~~~--~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~ 152 (315)
.++||||+++++++.. ....++||||+.+++|.+.+ ....+++..++.++.|++.|+.+||+. +++|+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQ----KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCC
Confidence 9999999999999986 66889999999999998865 345699999999999999999999999 99999999
Q ss_pred cCcEEEcCCCceeECCCCcccccCCCCCccccccccccccCccccccCC---CcccccchhhhHHHHHHHhCCCccCCCC
Q 046121 153 PSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI---VSIRTDVYAFGIILLQLMSGRKVVDMNG 229 (315)
Q Consensus 153 p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~DvwslG~~l~~l~~g~~p~~~~~ 229 (315)
|+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++||||||+++|+|++|..||....
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999976554443344567899999999987655 3678999999999999999999996432
Q ss_pred CccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 230 EEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
.. ......... .. .. + .....+..+.+++.+||+.||++|||+.+++++-
T Consensus 245 ~~------~~~~~~~~~-~~-~~--~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 245 IM------CLHSKIKSQ-AL-EF--P-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp HH------HHHHHHHHC-CC-CC--C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred HH------HHHHHHhcc-cC-CC--C-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 11 111111110 00 00 0 1112334578899999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=317.73 Aligned_cols=257 Identities=23% Similarity=0.285 Sum_probs=207.9
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc------cHHHHHHHHHHHhhcCCCCccceeeeEEecCe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ------GFAEFQSEVYVLNFARHKNIVMLLGFCCKENL 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (315)
+.++|++.+.||+|+||+||+|.+. +++.+|+|++...... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 5578999999999999999999876 6899999987754321 35678999999999999999999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC----ceeECCC
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF----VPMLGDF 169 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~----~i~l~df 169 (315)
.++||||+.+++|.+++.. ...+++..++.++.|++.|+.|||+. +++|+||||+||+++.++ .++|+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHC----CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999998853 45699999999999999999999999 999999999999998887 8999999
Q ss_pred CcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcc
Q 046121 170 GLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249 (315)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (315)
|++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ... .....
T Consensus 163 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~----~~~~~--- 232 (326)
T 2y0a_A 163 GLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLA----NVSAV--- 232 (326)
T ss_dssp TTCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHH----HHHHT---
T ss_pred CCCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHH----HHHhc---
Confidence 9997544322 2334578999999999998889999999999999999999999996443211 111 11000
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
............+..+.+++.+||..||++|||+.+++++-+-.
T Consensus 233 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 276 (326)
T 2y0a_A 233 ----NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276 (326)
T ss_dssp ----CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred ----CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence 00000001112244578999999999999999999999876544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=322.00 Aligned_cols=257 Identities=22% Similarity=0.280 Sum_probs=206.6
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-----cccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-----TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
+.++|++.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4578999999999999999999875 68999999876421 22456789999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccC--CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc---eeECCC
Q 046121 95 ILVYEYICNKSLHWHLFDN--TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV---PMLGDF 169 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~---i~l~df 169 (315)
++||||+.|++|.+.+... ....+++..++.++.|++.|+.|||+. +++|+||||+||+++.++. ++|+||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN----NIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChHHeEEecCCCCCcEEEecC
Confidence 9999999999998777543 234589999999999999999999999 9999999999999987654 999999
Q ss_pred CcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcc
Q 046121 170 GLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249 (315)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (315)
|++..............|++.|+|||++.+..++.++||||||+++|+|++|..||..... ......... ..
T Consensus 178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~i~~~-~~ 249 (351)
T 3c0i_A 178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RLFEGIIKG-KY 249 (351)
T ss_dssp TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HHHHHHHHT-CC
T ss_pred cceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HHHHHHHcC-CC
Confidence 9997655544444456789999999999998899999999999999999999999965321 111111110 00
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
...+... ...+..+.+++.+||..||++|||+.+++++-+
T Consensus 250 --~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 250 --KMNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp --CCCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred --CCCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 0000000 112456789999999999999999999987544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=312.90 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=208.1
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
+.++|++++.||+|+||+||+|.+. +++.+++|++.... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 4578999999999999999999875 68899999875432 3334668899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.|++|.+++... ..+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 89 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM----RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999988543 3589999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCC-ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 177 TDDP-VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 177 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||........ ....... ..+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~------~~~ 230 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQD------SVP 230 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSS------CCC
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhc------cCC
Confidence 3221 22335689999999999998899999999999999999999999965432110 0000000 001
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhccccccc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRP-SMGEVVRLLEGENDRFH 302 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-s~~~il~~L~~~~~~~~ 302 (315)
..........+..+.+++.+||..||++|| ++.++.+.|......-.
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 111112223345688899999999999998 99999999998765443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=318.13 Aligned_cols=257 Identities=21% Similarity=0.229 Sum_probs=207.5
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
+.++|++.+.||+|+||+||+|.+. +++.+++|++... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3579999999999999999999876 6889999987654 3344568899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC--CCceeECCCCcccccCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH--DFVPMLGDFGLARWKTT 177 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~--~~~i~l~dfg~~~~~~~ 177 (315)
|+.|++|.+.+... ...+++..++.++.|++.++.|||+. |++|+||||+||+++. ++.++|+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99999999988543 34589999999999999999999999 9999999999999987 78999999999975443
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
. .......|++.|+|||++.+..++.++||||||+++|+|++|..||...... .. ........ . .+.+.
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~----~~~i~~~~-~--~~~~~- 225 (321)
T 1tki_A 157 G-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QI----IENIMNAE-Y--TFDEE- 225 (321)
T ss_dssp T-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HH----HHHHHHTC-C--CCCHH-
T ss_pred C-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HH----HHHHHcCC-C--CCChh-
Confidence 2 2333457899999999999888899999999999999999999999654321 11 11111110 0 00000
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.....+..+.+++.+||..||++|||+.+++++-+-.
T Consensus 226 ---~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 262 (321)
T 1tki_A 226 ---AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp ---HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ---hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence 0112244588999999999999999999999976643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=324.26 Aligned_cols=269 Identities=24% Similarity=0.322 Sum_probs=213.4
Q ss_pred HhcCCcccceecCCCceEEEEEEeC--------CCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccceeeeEEe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK--------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCK 90 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 90 (315)
..++|++.+.||+|+||+||+|.+. .+..||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3478999999999999999999753 23579999886543 33456788999999999 89999999999999
Q ss_pred cCeeEEEEEeccCCccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcE
Q 046121 91 ENLNILVYEYICNKSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNI 156 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~ni 156 (315)
.+..++||||+.+++|.+++.... ...+++..++.++.|++.||.+||+. +++|+||||+||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NI 222 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNV 222 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCcceE
Confidence 999999999999999999987644 24599999999999999999999999 999999999999
Q ss_pred EEcCCCceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccc
Q 046121 157 LLTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQ 233 (315)
Q Consensus 157 l~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~ 233 (315)
+++.++.++|+|||++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-- 300 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 300 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999975443321 2223456788999999999999999999999999999999 99999644321
Q ss_pred hhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccccchhh
Q 046121 234 QSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLGEKFV 309 (315)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~~~~~~ 309 (315)
..... ..... .. ..+...+..+.+++.+||+.||++|||+.++++.|+.+............
T Consensus 301 ----~~~~~-~~~~~-----~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 301 ----ELFKL-LKEGH-----RM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp ----HHHHH-HHTTC-----CC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred ----HHHHH-HHcCC-----CC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 11111 11110 11 11122344578899999999999999999999999999776655544443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=323.28 Aligned_cols=256 Identities=24% Similarity=0.355 Sum_probs=206.3
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhc-CCCCccceeeeEEec
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKE 91 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 91 (315)
......++|++.+.||+|+||+||+|.++ +++.||+|++.... .........|..+++.+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 34556789999999999999999999876 68999999987542 34456678899998876 899999999999999
Q ss_pred CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCc
Q 046121 92 NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGL 171 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~ 171 (315)
+.+|+||||+.|++|.+++... ..+++..+..++.|++.|+.|||+. |++||||||+||+++.+|.++|+|||+
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCChhhEEECCCCCEEEeEChh
Confidence 9999999999999999988543 4589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
+.............+|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.. ... ......
T Consensus 165 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~----~~i~~~----- 233 (345)
T 1xjd_A 165 CKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELF----HSIRMD----- 233 (345)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHHC-----
T ss_pred hhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHH----HHHHhC-----
Confidence 975443333445568999999999999989999999999999999999999999644321 111 111110
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHHHHh
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMG-EVVRLLE 295 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~-~il~~L~ 295 (315)
.+. ++...+..+.+++.+||..||++||++. +++++-+
T Consensus 234 --~~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~ 272 (345)
T 1xjd_A 234 --NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272 (345)
T ss_dssp --CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred --CCC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence 111 1222345678999999999999999998 7765443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=320.56 Aligned_cols=261 Identities=21% Similarity=0.271 Sum_probs=209.5
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++++.||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3478999999999999999999876 6889999987653 23445678899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.|++|..++.. ...+++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++....
T Consensus 93 v~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQ----RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 9999999999988854 34599999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCccccccccccccCcccccc---CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAEN---GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
. ........|++.|+|||++.+ ..++.++|+|||||++|+|++|..||............. .....
T Consensus 167 ~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~~~------- 235 (384)
T 4fr4_A 167 R-ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---TFETT------- 235 (384)
T ss_dssp T-TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH---HHHHC-------
T ss_pred C-CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhhc-------
Confidence 3 233345679999999999863 458899999999999999999999997554433222111 11100
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHHHhccccccc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS-MGEVVRLLEGENDRFH 302 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps-~~~il~~L~~~~~~~~ 302 (315)
...++...+..+.+++.+||+.||++||+ +++++++-+--.-.|.
T Consensus 236 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 236 ----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred ----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 01122233456889999999999999998 7888765444333343
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=317.71 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=206.9
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 96 (315)
.++|++++.||+|+||.||+|+++ +++.+|+|++.... ......+.+|..+++.+ +||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 468999999999999999999876 68899999987542 33355678899999887 89999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.|++|.+++.+. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 88 v~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999888543 4589999999999999999999999 99999999999999999999999999997544
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccch--hHHHhHHHHHhhhccccccC
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ--SLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 254 (315)
.........+|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..... ............. .
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~------~ 235 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------Q 235 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC------C
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC------C
Confidence 4444445568999999999999989999999999999999999999999643221110 1111111111110 0
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHHHHhcc
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSM------GEVVRLLEGE 297 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~------~~il~~L~~~ 297 (315)
.. ++...+..+.+++.+||+.||++||++ .+++.+-+-.
T Consensus 236 ~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~ 280 (345)
T 3a8x_A 236 IR----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280 (345)
T ss_dssp CC----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred CC----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence 11 122334567889999999999999995 6777665443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=321.69 Aligned_cols=257 Identities=19% Similarity=0.241 Sum_probs=209.3
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
..++|++++.||+|+||+||+|.+. +++.+|+|++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 4578999999999999999999876 688999999877655556678999999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC--CCceeECCCCcccccCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH--DFVPMLGDFGLARWKTT 177 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~--~~~i~l~dfg~~~~~~~ 177 (315)
|+.|++|.+.+... ...+++..++.++.|++.|+.+||+. +++|+||||+||+++. ++.++|+|||++.....
T Consensus 129 ~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 129 FLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999888543 34589999999999999999999999 9999999999999974 57899999999975543
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... .... ... ... . ..
T Consensus 204 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~----~i~-~~~--~----~~ 269 (387)
T 1kob_A 204 DE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQ----NVK-RCD--W----EF 269 (387)
T ss_dssp TS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHH----HHH-HCC--C----CC
T ss_pred Cc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--HHHH----HHH-hCC--C----CC
Confidence 32 223457899999999999988999999999999999999999999654321 1111 111 100 0 11
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
........+..+.+++.+||..||++|||+.+++++-+-
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 308 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence 111122334568899999999999999999999987543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=314.07 Aligned_cols=257 Identities=22% Similarity=0.281 Sum_probs=204.8
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
..++|++++.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3579999999999999999999876 789999998764432 23456889999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+++.. ...+++..+..++.|++.++.+||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 85 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 85 EYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp ECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999998853 34599999999999999999999999 9999999999999999999999999999744322
Q ss_pred C--CccccccccccccCccccccCCC-cccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 179 D--PVQTKILGTLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 179 ~--~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
. .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+ ...
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~----~~~--------- 224 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW----KEK--------- 224 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHH----HTT---------
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH----hcc---------
Confidence 2 12234578999999999987665 7789999999999999999999975443221 11110 000
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
..........+..+.+++.+||..||++|||+.+++++-+-.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 266 (323)
T 3tki_A 225 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266 (323)
T ss_dssp CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence 000011122344577899999999999999999999876643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=319.03 Aligned_cols=251 Identities=21% Similarity=0.262 Sum_probs=204.9
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++......++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3579999999999999999999874 78999999876432 2234568899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+ +++|.+.+... ..+++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++....
T Consensus 87 v~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRH----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH----TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99998 78888877543 4589999999999999999999999 99999999999999999999999999997443
Q ss_pred CCCCccccccccccccCccccccCCC-cccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
. ........|++.|+|||++.+..+ +.++||||||+++|+|++|..||......... ..+..
T Consensus 160 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~ 222 (336)
T 3h4j_B 160 D-GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNS 222 (336)
T ss_dssp T-SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCS
T ss_pred C-CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHc
Confidence 3 233345678999999999988776 68999999999999999999999754322110 00000
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.....+...+..+.+++.+||..||++|||+.+++++-+-
T Consensus 223 -~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 223 -CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp -SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred -CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 0111223344567899999999999999999999887653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=311.77 Aligned_cols=258 Identities=22% Similarity=0.327 Sum_probs=206.8
Q ss_pred HhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
..++|++++.||+|+||+||++.+.++..|++|++..... ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 3468999999999999999999999888999999876433 346788999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++... ...+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999999988543 34599999999999999999999999 999999999999999999999999999974433211
Q ss_pred -ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 181 -VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 181 -~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ........ ...
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~------~~~--- 240 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQG------LRL--- 240 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTT------CCC---
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------HHHHHhcc------cCC---
Confidence 1122345678999999998889999999999999999998 999996543211 11111110 111
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
..+...+..+.+++.+||+.||++|||+.++++.|+.+.++
T Consensus 241 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 -YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 11122234578899999999999999999999999987543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=313.90 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=210.7
Q ss_pred hcCCcccceecCCCceEEEEEEeC------CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
.++|++.+.||+|+||.||+|.+. ++..|++|++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 578999999999999999999752 4578999988754 334456788999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccCCC----------------------CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCc
Q 046121 95 ILVYEYICNKSLHWHLFDNTE----------------------SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMR 152 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~----------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~ 152 (315)
++||||+.+++|.+++..... ..+++..++.++.|++.|+.+||+. +++|+|||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dik 177 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM----KLVHRDLA 177 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT----TEECCCCS
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC----CCcccccc
Confidence 999999999999999876432 4589999999999999999999999 99999999
Q ss_pred cCcEEEcCCCceeECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCC
Q 046121 153 PSNILLTHDFVPMLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNG 229 (315)
Q Consensus 153 p~nil~~~~~~i~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~ 229 (315)
|+||+++.++.++|+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999754433221 123456788999999998889999999999999999999 999997544
Q ss_pred CccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 230 EEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
.... .. ...... ....+...+..+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus 258 ~~~~---~~----~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PERL---FN----LLKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGGH---HH----HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHH---HH----HhhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 3221 11 111110 1111223345688899999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=310.01 Aligned_cols=264 Identities=21% Similarity=0.220 Sum_probs=202.0
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
++|++++.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 58999999999999999999876 68999999886543 3334667899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+ ++.+.+... ...+++..+..++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~----~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9976 444444332 34599999999999999999999999 99999999999999999999999999997655444
Q ss_pred CccccccccccccCccccccCC-CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcc------ccc
Q 046121 180 PVQTKILGTLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL------HEL 252 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 252 (315)
.......+++.|+|||++.+.. ++.++||||||+++|+|++|..|+....... ........ ....... ...
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-~~~~~i~~-~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFR-LLGTPTEEQWPSMTKL 233 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHH-HHCCCCTTTCTTGGGS
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHH-HhCCCChhhhhhhccc
Confidence 4445567899999999987765 7999999999999999999887764332211 11111111 1000000 000
Q ss_pred ---------cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 253 ---------IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 253 ---------~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
..........+..+..+.+++.+||+.||++|||+++++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 284 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence 000001112223456678999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=313.13 Aligned_cols=263 Identities=17% Similarity=0.162 Sum_probs=210.3
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
..++|++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+|+.+++.+ +||||+++++++......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 3578999999999999999999864 789999998765432 34688999999999 8999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc-----eeECCCCccc
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV-----PMLGDFGLAR 173 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~-----i~l~dfg~~~ 173 (315)
||+ +++|.+++... ...+++..++.++.|++.|+.|||+. +++|+||||+||+++.++. ++|+|||++.
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK----NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 999 99999988654 45699999999999999999999999 9999999999999999887 9999999997
Q ss_pred ccCCCCCc-------cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhh
Q 046121 174 WKTTDDPV-------QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK 246 (315)
Q Consensus 174 ~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (315)
........ .....|++.|+|||++.+..++.++||||||+++|+|++|..||.....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 54433221 23457899999999999999999999999999999999999999765433322211111111100
Q ss_pred hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
... ...... .+ .+.+++..||+.||.+||++.++.+.|+.+..+.
T Consensus 239 ~~~-----~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 239 TPI-----EVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp SCH-----HHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCH-----HHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 000 000111 12 5889999999999999999999999998776544
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=326.42 Aligned_cols=258 Identities=25% Similarity=0.352 Sum_probs=207.5
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 468899999999999999999886 78999999877542 2334567899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|.+++... ...+++..++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 193 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK----CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999988543 33589999999999999999999999 99999999999999999999999999986433221
Q ss_pred Ccc--ccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 180 PVQ--TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 180 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... .. ....... .
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~----~~~~~~~-----~-- 333 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TR----EFVEKGG-----R-- 333 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HH----HHHHTTC-----C--
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCC-----C--
Confidence 111 11234678999999998889999999999999999998 999996543211 11 1111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
...+...+..+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus 334 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 334 --LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 111222345678899999999999999999999999988654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=304.85 Aligned_cols=280 Identities=34% Similarity=0.572 Sum_probs=221.2
Q ss_pred CcccHHHHHHHhcCCccc------ceecCCCceEEEEEEeCCCcEEEEEEeccc----CcccHHHHHHHHHHHhhcCCCC
Q 046121 11 MKFSFSEIQQATGDFSKE------NLLGEGGFGHVYKGELKDGQMIAAKVRKEA----STQGFAEFQSEVYVLNFARHKN 80 (315)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~------~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~~~~ 80 (315)
..+...++....+.|... +.||+|+||+||+|.+ +++.+++|++... .....+.+.+|+.+++.++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 456677778877777666 8999999999999987 4778999987643 2334567889999999999999
Q ss_pred ccceeeeEEecCeeEEEEEeccCCccccccccCC-CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc
Q 046121 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNT-ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT 159 (315)
Q Consensus 81 i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~ 159 (315)
|+++++++...+..++||+|+.+++|.+++.... ...+++..++.++.|++.++.+||+. +++|+||+|+||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANILLD 167 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHEEEc
Confidence 9999999999999999999999999998886432 34689999999999999999999999 999999999999999
Q ss_pred CCCceeECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHH
Q 046121 160 HDFVPMLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLR 237 (315)
Q Consensus 160 ~~~~i~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 237 (315)
.++.++|+|||++......... .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||........ ..
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~ 244 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LL 244 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TT
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HH
Confidence 9999999999998744332221 223568999999998875 478899999999999999999999975543321 11
Q ss_pred HhHHHHHhh-hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 238 QWAEPLIEK-LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 238 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
.+....... ......+++.. ...+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 111111111 11122222222 33566678889999999999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=306.70 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=194.6
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCc----ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST----QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
.++|++.+.||+|+||+||+|.+. ++.+++|++..... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999876 78899998765432 3356788999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCC---eEeecCccCcEEEcC--------CCceeE
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGP---IIHRDMRPSNILLTH--------DFVPML 166 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~---i~h~di~p~nil~~~--------~~~i~l 166 (315)
|||+.+++|.+++. ...+++..++.++.|++.++.+||+. + ++|+||||+||+++. ++.++|
T Consensus 85 ~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~----~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 85 MEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDE----AIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHS----SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CCCceeecCCchHHEEEecccccccccCcceEE
Confidence 99999999988883 44699999999999999999999999 8 899999999999986 778999
Q ss_pred CCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhh
Q 046121 167 GDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK 246 (315)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (315)
+|||++....... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||........ ......
T Consensus 158 ~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~- 228 (271)
T 3dtc_A 158 TDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AYGVAM- 228 (271)
T ss_dssp CCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHT-
T ss_pred ccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHhhhc-
Confidence 9999996443322 2234689999999999988899999999999999999999999964332110 000000
Q ss_pred hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.......+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 229 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 --------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111112223345688999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=305.93 Aligned_cols=265 Identities=17% Similarity=0.178 Sum_probs=212.0
Q ss_pred HhcCCcccceecCCCceEEEEEEe-CCCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGEL-KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
..++|++.+.||+|+||+||+|.+ .+++.||+|++.... ....+.+|+..++.+ +|++++.+++++......++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 567899999999999999999986 478999999876443 234678899999999 7999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc-----eeECCCCccc
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV-----PMLGDFGLAR 173 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~-----i~l~dfg~~~ 173 (315)
||+ +++|.+++.... ..+++..++.++.|++.|+.+||+. +++|+||||+||+++.++. ++|+|||++.
T Consensus 86 e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 999999986543 3599999999999999999999999 9999999999999987776 9999999997
Q ss_pred ccCCCCC-------ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhh
Q 046121 174 WKTTDDP-------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK 246 (315)
Q Consensus 174 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (315)
....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 5443322 123456899999999999988999999999999999999999999765433222211111111111
Q ss_pred hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
... +.... ..+..+.+++.+||+.||++|||+.++++.|+.+..+..
T Consensus 240 ~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 240 TPL-----RELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp SCH-----HHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccH-----HHHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 110 01111 123457889999999999999999999999999877654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=313.58 Aligned_cols=255 Identities=22% Similarity=0.286 Sum_probs=208.8
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
.++|++++.||+|+||+||+|.+. +++.+|+|++.... ......+.+|..+++.++||||+++++++.+...+++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 468999999999999999999876 69999999987542 23456678999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|||+.|++|.+++... ..+++..+..++.|++.|+.+||+. +++|+||||+||+++.+|.++|+|||++.....
T Consensus 85 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999988653 4589999999999999999999999 999999999999999999999999999974332
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.. .. ....... ..
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~----~~~i~~~-------~~-- 220 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KT----YEKILNA-------EL-- 220 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HH----HHHHHHC-------CC--
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HH----HHHHHhC-------CC--
Confidence 223457899999999999999999999999999999999999999643321 11 1111111 01
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhccccccc
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEGENDRFH 302 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~~~~~~~ 302 (315)
.++...+..+.+++.+||..||++|| ++++++++-+-....|.
T Consensus 221 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 221 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 11223345678899999999999999 89999877654443333
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=318.75 Aligned_cols=264 Identities=24% Similarity=0.358 Sum_probs=210.6
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEec
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE 91 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (315)
....++|++.+.||+|+||.||+|.+. +++.|++|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 335689999999999999999999864 34789999987543 33456788999999999999999999999999
Q ss_pred CeeEEEEEeccCCccccccccCC----------------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEee
Q 046121 92 NLNILVYEYICNKSLHWHLFDNT----------------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHR 149 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~----------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~ 149 (315)
+..++||||+.+++|.+++.... ...+++..++.++.|++.++.+||+. +++|+
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----~ivH~ 198 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHR 198 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCS
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecC
Confidence 99999999999999999886643 25689999999999999999999999 99999
Q ss_pred cCccCcEEEcCCCceeECCCCcccccCCCC--CccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccC
Q 046121 150 DMRPSNILLTHDFVPMLGDFGLARWKTTDD--PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVD 226 (315)
Q Consensus 150 di~p~nil~~~~~~i~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~ 226 (315)
||||+||+++.++.++|+|||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999999999999999999986443221 11223457889999999998889999999999999999999 999996
Q ss_pred CCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 227 MNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
..... ..... ...... . ..+...+..+.+++.+||+.||++|||+.++++.|+.+..++.
T Consensus 279 ~~~~~------~~~~~-~~~~~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHE------EVIYY-VRDGNI-----L----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSCHH------HHHHH-HHTTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCChH------HHHHH-HhCCCc-----C----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 43321 11111 111111 1 1122334568889999999999999999999999999987764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=319.16 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=207.0
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCee
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 94 (315)
...++|++++.||+|+||+||+|.+. +++.||+|++... .......+.+|..++..+ +||+|+++++++.+.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 35589999999999999999999876 4889999998754 234456678899999887 799999999999999999
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
|+||||+.|++|.+++.+. ..+++..++.++.|++.||.|||+. |++||||||+||+++.+|.++|+|||++..
T Consensus 97 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999988543 3589999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 175 KTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
...........+|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.. .. ....... .
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~----~~~i~~~-------~ 237 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--EL----FQSIMEH-------N 237 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH----HHHHHHC-------C
T ss_pred cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--HH----HHHHHhC-------C
Confidence 444444445668999999999999999999999999999999999999999644321 11 1111111 0
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHhc
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPS-----MGEVVRLLEG 296 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps-----~~~il~~L~~ 296 (315)
. .++...+..+.+++.+||..||++||+ +++++++-+-
T Consensus 238 ~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f 280 (353)
T 2i0e_A 238 V----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280 (353)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred C----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence 1 112234456888999999999999995 5888776543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=304.90 Aligned_cols=254 Identities=27% Similarity=0.468 Sum_probs=202.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCccc-------HHHHHHHHHHHhhcCCCCccceeeeEEecC
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQG-------FAEFQSEVYVLNFARHKNIVMLLGFCCKEN 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (315)
..++|++.+.||+|+||+||+|.+. +++.||+|++....... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3479999999999999999999875 78999999876433221 256889999999999999999999986554
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCC--eEeecCccCcEEEcCCCc-----ee
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGP--IIHRDMRPSNILLTHDFV-----PM 165 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~--i~h~di~p~nil~~~~~~-----i~ 165 (315)
++||||+.+++|.+.+... ...+++..++.++.|++.++.+||+. + ++|+||||+||+++.++. ++
T Consensus 97 --~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~----~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQ----NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred --eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhC----CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 7999999999998877544 34699999999999999999999999 8 999999999999988776 99
Q ss_pred ECCCCcccccCCCCCccccccccccccCccccc--cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH
Q 046121 166 LGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE--NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
|+|||++.... .......|++.|+|||++. +..++.++||||||+++|+|++|..||............. .
T Consensus 170 l~Dfg~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~ 242 (287)
T 4f0f_A 170 VADFGLSQQSV---HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM----I 242 (287)
T ss_dssp ECCCTTCBCCS---SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH----H
T ss_pred eCCCCcccccc---ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH----H
Confidence 99999986322 2233457899999999984 4557889999999999999999999997554332111111 1
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
. . ....+ ..+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 243 ~-~----~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 R-E----EGLRP----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp H-H----SCCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred h-c----cCCCC----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1 1 11111 12223345688999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=306.25 Aligned_cols=260 Identities=23% Similarity=0.307 Sum_probs=201.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhh--cCCCCccceeeeEEe----cCee
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNF--ARHKNIVMLLGFCCK----ENLN 94 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~----~~~~ 94 (315)
..++|++.+.||+|+||+||+|.+ +++.||+|++... .......|.+++.. ++||||+++++++.. ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 567999999999999999999988 5888999998653 23445566666665 789999999998654 3457
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhh--------cccCCCCeEeecCccCcEEEcCCCceeE
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH--------EECRGGPIIHRDMRPSNILLTHDFVPML 166 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh--------~~~~~~~i~h~di~p~nil~~~~~~i~l 166 (315)
++||||+.+++|.+++. ...+++..++.++.|++.|+.||| +. +++|+||||+||+++.++.++|
T Consensus 82 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP----AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC----EEECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC----CeecCCCChHhEEEcCCCCEEE
Confidence 99999999999999983 346999999999999999999999 78 9999999999999999999999
Q ss_pred CCCCcccccCCCCCc----cccccccccccCccccccC------CCcccccchhhhHHHHHHHhC----------CCccC
Q 046121 167 GDFGLARWKTTDDPV----QTKILGTLGYLAPEYAENG------IVSIRTDVYAFGIILLQLMSG----------RKVVD 226 (315)
Q Consensus 167 ~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~------~~~~~~DvwslG~~l~~l~~g----------~~p~~ 226 (315)
+|||++......... .....|++.|+|||++.+. .++.++||||||+++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999998644333222 1234789999999998876 455789999999999999999 77775
Q ss_pred CCCCccchhHHHhHHHHHhhhccccccCCccc-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 227 MNGEEPQQSLRQWAEPLIEKLALHELIDPRIE-NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
........ .... .... ......+... ...+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 235 ~~~~~~~~-~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPS-FEDM-RKVV----CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCC-HHHH-HHHH----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcc-hhhh-hHHH----hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 43222111 1111 1111 1111111111 223445677899999999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=326.10 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=207.3
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecC-eeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN-LNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~~~ 100 (315)
.++|++.+.||+|+||+||+|.+. ++.||+|++.... ..+.+.+|+.+++.++||||+++++++.... ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 468999999999999999999886 6789999987543 4567899999999999999999999987665 78999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.......++...++.++.|++.++.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999776666689999999999999999999999 9999999999999999999999999999743222
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ .. . .... .. .
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~----~-i~~~-----~~----~ 405 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VP----R-VEKG-----YK----M 405 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--HH----H-HHTT-----CC----C
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----H-HHcC-----CC----C
Confidence 122356788999999999899999999999999999998 9999975443221 11 1 1111 01 1
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
..+...+..+.++|.+||+.||++|||+.++++.|+.+...
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 12223445688899999999999999999999999987543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=314.41 Aligned_cols=269 Identities=26% Similarity=0.289 Sum_probs=192.1
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
..++|++++.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3568999999999999999999876 68999999886543 333467889999999999999999999999999999999
Q ss_pred EeccCCccccccccC----CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 99 EYICNKSLHWHLFDN----TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
||+. ++|.+++... ....+++..+..++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN----KILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 9997 5887777532 224589999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh---ccc
Q 046121 175 KTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL---ALH 250 (315)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 250 (315)
............+++.|+|||++.+ ..++.++||||||+++|+|++|..||....... ....... ..... .+.
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~-~~~~~~~~~~~ 234 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--QLKLIFD-IMGTPNESLWP 234 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH-HHCSCCTTTCG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-HhCCCChhHhh
Confidence 5444333345578999999999876 458899999999999999999999997543221 1111111 00000 000
Q ss_pred -----cccCCcc------------cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 251 -----ELIDPRI------------ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 251 -----~~~~~~~------------~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
....+.. ........+..+.+++.+||+.||++|||+.+++++-+-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 298 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence 0000000 0001112345688999999999999999999999875543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=310.51 Aligned_cols=264 Identities=22% Similarity=0.244 Sum_probs=199.9
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
++|++++.||+|+||+||+|.+.+++.+|+|++.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5899999999999999999998889999999876543 23346678999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+ +|.+.+... ...+++..+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 865 787777543 34589999999999999999999999 999999999999999999999999999975543333
Q ss_pred ccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhc---c-----cc
Q 046121 181 VQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA---L-----HE 251 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~-----~~ 251 (315)
......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...... ........ ...... . ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFR-ILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHH-HHCCCCTTTSTTGGGST
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH-HHCCCChhhchhhhccc
Confidence 3344578999999999875 45889999999999999999999999654321 11111111 000000 0 00
Q ss_pred ccCCcc-------cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 252 LIDPRI-------ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 252 ~~~~~~-------~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
..++.. ........+..+.+++.+||+.||++|||+.+++++-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 000000 01111224556789999999999999999999987643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=309.74 Aligned_cols=260 Identities=26% Similarity=0.351 Sum_probs=215.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
..++|++.+.||+|+||+||+|.+. ++..+++|++... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4578999999999999999999876 5888999988753 3446778899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|.+++.......+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH----TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC----CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999877777899999999999999999999999 99999999999999999999999999997544333
Q ss_pred Cc-cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 180 PV-QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 180 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
.. .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ .. .... ..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~----~~~~---------~~ 229 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YE----LLEK---------DY 229 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HH----HHHT---------TC
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHhc---------cC
Confidence 22 223445778999999998889999999999999999999 9999965443211 11 0111 01
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
....+...+..+.+++.+||..||++|||+.++++.|+.+....
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11112233456889999999999999999999999999876643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=307.27 Aligned_cols=254 Identities=20% Similarity=0.281 Sum_probs=206.1
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEec--CeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE--NLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 97 (315)
.++|++.+.||+|+||+||+|.++ ++.+++|++.... ....+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 468999999999999999999986 7889999887543 33455688999999999999999999999876 788999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCC--eEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGP--IIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~--i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
|||+.+++|.+++.......+++..++.++.|++.|+.+||+. + ++|+||||+||+++.++.+++.|||+....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL----EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS----SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC----CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999877666799999999999999999999999 8 999999999999999999999988876422
Q ss_pred CCCCCccccccccccccCccccccCCCcc---cccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAENGIVSI---RTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
. .....+++.|+|||.+.+..++. ++||||||+++|+|++|..||....... ....... ..
T Consensus 164 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~-----~~ 227 (271)
T 3kmu_A 164 Q-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVAL-----EG 227 (271)
T ss_dssp S-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHH-----SC
T ss_pred c-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHh-----cC
Confidence 1 12346789999999998765544 7999999999999999999996443211 0011111 11
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
..+. .+...+..+.+++.+||+.||++|||+.++++.|+.+.++
T Consensus 228 ~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~~ 271 (271)
T 3kmu_A 228 LRPT----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271 (271)
T ss_dssp CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC-
T ss_pred CCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 1111 2223345588899999999999999999999999988653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=313.17 Aligned_cols=276 Identities=22% Similarity=0.253 Sum_probs=217.1
Q ss_pred CCCcccHHHHHHHhcCCccc-ceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcC-CCCccc
Q 046121 9 DPMKFSFSEIQQATGDFSKE-NLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFAR-HKNIVM 83 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~y~~~-~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~ 83 (315)
++..+.++..+.+.++|.+. +.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.+. ||||++
T Consensus 14 ~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~ 93 (327)
T 3lm5_A 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93 (327)
T ss_dssp --CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred cchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEE
Confidence 34455666778889999998 89999999999999876 68999999877542 334567889999999995 699999
Q ss_pred eeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC---
Q 046121 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH--- 160 (315)
Q Consensus 84 ~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~--- 160 (315)
+++++......++||||+.+++|.+++.......+++..++.++.|++.++.+||+. |++|+||||+||+++.
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~----givH~Dikp~NIl~~~~~~ 169 (327)
T 3lm5_A 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN----NIVHLDLKPQNILLSSIYP 169 (327)
T ss_dssp EEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESCBTT
T ss_pred EEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCChHHEEEecCCC
Confidence 999999999999999999999999998776667899999999999999999999999 9999999999999988
Q ss_pred CCceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH
Q 046121 161 DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240 (315)
Q Consensus 161 ~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 240 (315)
++.++|+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ...
T Consensus 170 ~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~--- 243 (327)
T 3lm5_A 170 LGDIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYL--- 243 (327)
T ss_dssp BCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---
T ss_pred CCcEEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHH---
Confidence 7899999999997544322 2234578999999999999999999999999999999999999996533211 100
Q ss_pred HHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
... .. ............+..+.+++.+||+.||++|||+++++++-+-....|.
T Consensus 244 -~i~-~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 244 -NIS-QV------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp -HHH-HT------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred -HHH-hc------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 000 00 0111111222334567889999999999999999999988775544444
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=310.19 Aligned_cols=266 Identities=20% Similarity=0.314 Sum_probs=201.8
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++.+.||+|+||.||+|.+. +++.+++|++... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 4568999999999999999999864 7899999988753 23345668899999999999999999999999999999
Q ss_pred EEEeccCCcccccccc--CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 97 VYEYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
||||+.+++|.+++.. .....+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 9999999999988854 2345689999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 175 KTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
............+++.|+|||.+.+..++.++||||||+++|+|++|..||.......... ... .......
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~-~~~~~~~---- 256 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL----CKK-IEQCDYP---- 256 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH----HHH-HHTTCSC----
T ss_pred ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH----HHH-hhcccCC----
Confidence 4443333344568899999999998889999999999999999999999996543221111 111 1111111
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccccc
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~ 303 (315)
+ ......+..+.+++.+||+.||++|||+.++++.|+.+...+.+
T Consensus 257 ~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 257 P----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp C----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred C----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 1 11122344578899999999999999999999999998776654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=323.84 Aligned_cols=251 Identities=20% Similarity=0.318 Sum_probs=206.4
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3578999999999999999999876 79999999986542 2345678899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.|++|.+++.+ ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 94 v~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 94 VMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999999854 45699999999999999999999999 99999999999999999999999999997544
Q ss_pred CCCCccccccccccccCccccccCCC-cccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
.. ......+|++.|+|||++.+..+ +.++||||||+++|+|++|..||....... . ....... . .
T Consensus 168 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--~----~~~i~~~-~---~--- 233 (476)
T 2y94_A 168 DG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--L----FKKICDG-I---F--- 233 (476)
T ss_dssp TT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH--H----HHHHHTT-C---C---
T ss_pred cc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH--H----HHHHhcC-C---c---
Confidence 32 23345678999999999988765 689999999999999999999997543211 1 1111111 0 0
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
..+...+..+.+++.+||+.||++|||+.+++++-+
T Consensus 234 ----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 234 ----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred ----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 111223345788999999999999999999998543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=314.96 Aligned_cols=258 Identities=23% Similarity=0.315 Sum_probs=199.8
Q ss_pred HhcCCcccceecCCCceEEEEEEe----CCCcEEEEEEecccC----cccHHHHHHHHHHHhhcCCCCccceeeeEEecC
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGEL----KDGQMIAAKVRKEAS----TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~----~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (315)
..++|++.+.||+|+||+||++.. .+++.+|+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 457899999999999999999986 478999999987542 233455778999999999999999999999999
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
..++||||+.|++|.+++... ..+++..+..++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK----GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC----CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999888543 4588999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
..............|++.|+|||++.+..++.++||||||+++|+|++|..||...... .. .......
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~----~~~i~~~------ 236 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--KT----IDKILKC------ 236 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH----HHHHHHT------
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--HH----HHHHHhC------
Confidence 64443333344567899999999999888999999999999999999999999654321 11 1111111
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhcccccc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEGENDRF 301 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~~~~~~ 301 (315)
.. ..+...+..+.+++.+||..||++|| ++.+++++-+-....|
T Consensus 237 -~~----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 237 -KL----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp -CC----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred -CC----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 00 11223345678899999999999999 7889988766544333
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=329.02 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=211.4
Q ss_pred HhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
..++|++.+.||+|+||+||+|.++++..||+|++.... ...+.+.+|+.+++.++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 456899999999999999999999888899999987643 45678899999999999999999999986 6678999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.......++...++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999999999755555688999999999999999999999 999999999999999999999999999974432211
Q ss_pred c-cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 181 V-QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 181 ~-~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
. .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...... .......... ..
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~~~~------~~--- 404 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVIRALERGY------RM--- 404 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHHTC------CC---
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCC------CC---
Confidence 1 122345678999999998889999999999999999999 99999644321 1111111110 00
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
..+...+..+.+++.+||..||++|||++++++.|+.+.....
T Consensus 405 -~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 405 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 1122234568889999999999999999999999999876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=316.86 Aligned_cols=265 Identities=22% Similarity=0.342 Sum_probs=196.0
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeCC-C---cEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELKD-G---QMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCK 90 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~---~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (315)
.+....++|++.+.||+|+||+||+|.+.. + ..||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 333456789999999999999999998663 3 27899987754 34446778999999999999999999999987
Q ss_pred cCee------EEEEEeccCCccccccccCC----CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC
Q 046121 91 ENLN------ILVYEYICNKSLHWHLFDNT----ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH 160 (315)
Q Consensus 91 ~~~~------~lv~~~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~ 160 (315)
.... ++|++|+.+++|.+++.... ...+++..++.++.|++.|+.+||+. +++|+||||+||+++.
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR----NFIHRDLAARNCMLAE 172 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC----CcccCCCCcceEEEcC
Confidence 6655 99999999999998885422 22589999999999999999999999 9999999999999999
Q ss_pred CCceeECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHH
Q 046121 161 DFVPMLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLR 237 (315)
Q Consensus 161 ~~~i~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~ 237 (315)
++.++|+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ ..
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~ 250 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--YN 250 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--HH
Confidence 999999999999744332211 123345778999999999899999999999999999999 8999975443211 11
Q ss_pred HhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 238 QWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
..... . ....+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 251 ----~~~~~-~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 251 ----YLIGG-N---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp ----HHHTT-C---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ----HHhcC-C---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 01110 0 01112223456889999999999999999999999999876543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=319.68 Aligned_cols=259 Identities=24% Similarity=0.339 Sum_probs=198.3
Q ss_pred hcCCcccceecCCCceEEEEEEeC----CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
.++|++.+.||+|+||+||+|.+. ++..||+|++... .......+.+|+.+++.++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 358999999999999999999764 5778999988754 33345678899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.+++|.+++... ...+++..++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 124 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999988643 34589999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCcc---ccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 177 TDDPVQ---TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 177 ~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
...... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||...... .........
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~~~~~i~~~------ 266 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------DVIKAVDEG------ 266 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------HHHHHHHTT------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcC------
Confidence 322111 12234678999999998899999999999999999997 99999644321 111111111
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 267 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 267 ----YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ----EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ----CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 001111223456888999999999999999999999999886543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=320.94 Aligned_cols=271 Identities=26% Similarity=0.366 Sum_probs=213.1
Q ss_pred CCcccHHHHHHHhcCCcccceecCCCceEEEEEEe------CCCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCc
Q 046121 10 PMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGEL------KDGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNI 81 (315)
Q Consensus 10 ~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i 81 (315)
..+...+..+...++|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+.+++.+ +||||
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence 34455566666788999999999999999999973 246889999987543 33345688999999999 78999
Q ss_pred cceeeeEEecC-eeEEEEEeccCCccccccccCCC---------------------------------------------
Q 046121 82 VMLLGFCCKEN-LNILVYEYICNKSLHWHLFDNTE--------------------------------------------- 115 (315)
Q Consensus 82 ~~~~~~~~~~~-~~~lv~~~~~~~~L~~~l~~~~~--------------------------------------------- 115 (315)
+++++++.+.+ ..++||||+.+++|.+++.....
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 99999987754 48999999999999998865432
Q ss_pred -------------------CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 116 -------------------SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 116 -------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
..+++..++.++.|++.++.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 1289999999999999999999999 99999999999999999999999999997443
Q ss_pred CCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 177 TDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 177 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
.... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||....... .... ......
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~~----- 313 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGT----- 313 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH----HHHHTC-----
T ss_pred ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH----HHHcCC-----
Confidence 3222 2233567888999999998899999999999999999998 999996544321 1111 111110
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
.... +...+..+.+++.+||..||++|||+.+++++|+.+..
T Consensus 314 ~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 314 RMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1111 12233457889999999999999999999999987753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=315.75 Aligned_cols=254 Identities=19% Similarity=0.190 Sum_probs=208.9
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
.++|++++.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999876 68999999986532 23456788999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|||+.|++|.+++.+. ..+++..+..++.|++.||.+||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 120 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999988643 3589999999999999999999999 999999999999999999999999999974432
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
. .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...... .. ....... . .
T Consensus 194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~----~~~i~~~-~------~-- 255 (350)
T 1rdq_E 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QI----YEKIVSG-K------V-- 255 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH----HHHHHHC-C------C--
T ss_pred C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH--HH----HHHHHcC-C------C--
Confidence 2 23457899999999999989999999999999999999999999644321 11 1111111 0 1
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHhcccccc
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPS-----MGEVVRLLEGENDRF 301 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps-----~~~il~~L~~~~~~~ 301 (315)
.++...+..+.+++.+||+.||++||+ +++++++-+-....|
T Consensus 256 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 112233456889999999999999998 899988766544444
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=316.38 Aligned_cols=257 Identities=18% Similarity=0.184 Sum_probs=195.7
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
..++|++++.||+|+||+||++.+. +++.||+|++..... ....+.+|+.+++.++||||+++++++......++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3579999999999999999999876 789999998875432 33568899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc--eeECCCCcccccCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV--PMLGDFGLARWKTT 177 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~--i~l~dfg~~~~~~~ 177 (315)
|+.+++|.+++... ..+++..+..++.|++.|+.|||+. |++|+||||+||+++.++. ++|+|||++.....
T Consensus 97 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~----~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSM----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999888543 3599999999999999999999999 9999999999999987765 99999999863222
Q ss_pred CCCccccccccccccCccccccCCCccc-ccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIR-TDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
. .......|++.|+|||++.+..+..+ +||||||+++|+|++|..||........ ........... .
T Consensus 171 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~---------~ 238 (361)
T 3uc3_A 171 H-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSV---------K 238 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTT---------C
T ss_pred c-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcC---------C
Confidence 2 22234578999999999988777555 8999999999999999999975433221 11111111111 0
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.........+..+.+++.+||..||++|||+.+++++-+-
T Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 0000011123457899999999999999999999987554
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=305.37 Aligned_cols=256 Identities=21% Similarity=0.336 Sum_probs=208.7
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.++|++.+.||+|+||+||+|.+.+++.+++|++..... ..+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 468999999999999999999998888999999876543 3467899999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC-
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP- 180 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~- 180 (315)
.+++|.+++.... ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 9999999886543 4589999999999999999999999 999999999999999999999999999874432211
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
......+++.|+|||++.+..++.++|+||||+++|+|++ |..||...... ......... ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~i~~~------~~~---- 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTG------FRL---- 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT------CCC----
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHHHHhcC------CcC----
Confidence 1122345678999999998889999999999999999999 89998654321 111111110 011
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
..+...+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1112234557889999999999999999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=317.07 Aligned_cols=271 Identities=18% Similarity=0.197 Sum_probs=208.0
Q ss_pred HHHhcCCcccceecCC--CceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCe
Q 046121 19 QQATGDFSKENLLGEG--GFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL 93 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g--~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (315)
....++|++++.||+| +||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 3456899999999999 99999999876 69999999987543 3345667889999999999999999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.++||||+.+++|.+++.......+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||.+.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 99999999999999999877667799999999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCC-------CccccccccccccCcccccc--CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH
Q 046121 174 WKTTDD-------PVQTKILGTLGYLAPEYAEN--GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI 244 (315)
Q Consensus 174 ~~~~~~-------~~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (315)
...... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||........ .........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 254 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTV 254 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-----
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCC
Confidence 322111 11123467889999999987 5789999999999999999999999975433221 111000000
Q ss_pred hh----------------------hcccccc---------CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 245 EK----------------------LALHELI---------DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 245 ~~----------------------~~~~~~~---------~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.. ....... ........+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 0000000 0000011223345568899999999999999999999976
Q ss_pred Hh
Q 046121 294 LE 295 (315)
Q Consensus 294 L~ 295 (315)
-+
T Consensus 335 p~ 336 (389)
T 3gni_B 335 SF 336 (389)
T ss_dssp GG
T ss_pred HH
Confidence 33
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=328.41 Aligned_cols=258 Identities=26% Similarity=0.357 Sum_probs=212.8
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
..+|++.+.||+|+||+||+|.+. ++..||+|++.... ...+.+.+|+.+++.++||||+++++++......++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 467889999999999999999877 48899999987543 3467789999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.......+++..++.++.|++.++.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999999876667799999999999999999999999 999999999999999999999999999975433221
Q ss_pred c-cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 181 V-QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 181 ~-~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
. .....+++.|+|||++.+..++.++||||||+++|+|++ |..||....... ... .... ...
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~---------~~~ 437 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEK---------DYR 437 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHT---------TCC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHc---------CCC
Confidence 1 122345678999999998889999999999999999999 899997544221 111 1111 011
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
...+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 112223345678899999999999999999999999988654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=314.90 Aligned_cols=263 Identities=27% Similarity=0.393 Sum_probs=206.7
Q ss_pred HhcCCcccceecCCCceEEEEEEe------CCCcEEEEEEeccc-CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecC
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGEL------KDGQMIAAKVRKEA-STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKEN 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 92 (315)
..++|++.+.||+|+||+||+|.+ .++..||+|++... .......+.+|+.+++.+ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 357899999999999999999975 24668999988754 233456788999999999 8999999999999999
Q ss_pred eeEEEEEeccCCccccccccCCC---------------------CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecC
Q 046121 93 LNILVYEYICNKSLHWHLFDNTE---------------------SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDM 151 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di 151 (315)
..++||||+.+++|.+++..... ..+++..++.++.|++.|+.+||+. |++|+||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Di 198 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDL 198 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEETTC
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCC
Confidence 99999999999999998865432 3478999999999999999999999 9999999
Q ss_pred ccCcEEEcCCCceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCC
Q 046121 152 RPSNILLTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMN 228 (315)
Q Consensus 152 ~p~nil~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~ 228 (315)
||+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999974433222 1223456778999999988889999999999999999998 99999654
Q ss_pred CCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 229 GEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
.... .... ..... .. ...+...+..+.+++.+||..||++|||+.++++.|+.+.....
T Consensus 279 ~~~~--~~~~----~~~~~-----~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 279 PVDA--NFYK----LIQNG-----FK----MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCSH--HHHH----HHHTT-----CC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CcHH--HHHH----HHhcC-----CC----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 4321 1111 11110 11 11122234568889999999999999999999999998876554
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=319.98 Aligned_cols=261 Identities=25% Similarity=0.325 Sum_probs=207.9
Q ss_pred hcCCcccceecCCCceEEEEEEeC------CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
.++|++++.||+|+||+||+|.+. ++..||+|++... .......+.+|+.+++.++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 468999999999999999999843 4678999988643 334445688999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccCC-----CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC---ceeE
Q 046121 95 ILVYEYICNKSLHWHLFDNT-----ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF---VPML 166 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~---~i~l 166 (315)
++||||+.+++|.+++.... ...+++..++.++.|++.|+.|||+. +++||||||+||+++.++ .++|
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999886533 24589999999999999999999999 999999999999999555 5999
Q ss_pred CCCCcccccCCC--CCccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHH
Q 046121 167 GDFGLARWKTTD--DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 167 ~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
+|||++...... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||....... .....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~------~~~~i 299 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEFV 299 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH
Confidence 999998643211 122234567889999999998899999999999999999998 999996543211 11111
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
... . ....+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 300 ~~~-~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 300 TSG-G---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HTT-C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HcC-C---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 111 0 011122234457889999999999999999999999998866544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=329.22 Aligned_cols=259 Identities=23% Similarity=0.294 Sum_probs=200.9
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
.++|++++.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++...+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999875 6899999998753 333445677899999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+ . |++|+||||+||+++.++.++|+|||++....
T Consensus 227 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~----giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT----CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC----CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999998888543 468999999999999999999998 8 99999999999999999999999999997544
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
..........|++.|+|||++.+..++.++||||||+++|+|++|..||....... ........ ...
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~-------~~~ 367 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILME-------EIR 367 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHC-------CCC
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHHhC-------CCC
Confidence 44444455689999999999999999999999999999999999999996443211 11111110 011
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhcccccccc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~~~~~~~~ 303 (315)
++...+..+.+++.+||+.||++|| |+++++++-+-....|..
T Consensus 368 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~ 415 (446)
T 4ejn_A 368 ----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 415 (446)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred ----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHH
Confidence 1222345578899999999999999 999999876655444443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=310.68 Aligned_cols=269 Identities=25% Similarity=0.252 Sum_probs=201.6
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc-----ccHHHHHHHHHHHhhc---CCCCccceeeeEEe
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-----QGFAEFQSEVYVLNFA---RHKNIVMLLGFCCK 90 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~ 90 (315)
...++|++++.||+|+||+||+|.+. +++.||+|++..... .......+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 45789999999999999999999874 689999998764321 1223556777777666 49999999999987
Q ss_pred cC-----eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCcee
Q 046121 91 EN-----LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPM 165 (315)
Q Consensus 91 ~~-----~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~ 165 (315)
.. ..++|+|++. ++|.+++.......+++..++.++.|++.|+.|||+. +++|+||||+||+++.++.++
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEE
Confidence 65 5799999986 5999988777766799999999999999999999999 999999999999999999999
Q ss_pred ECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh
Q 046121 166 LGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE 245 (315)
Q Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (315)
|+|||++...... .......|++.|+|||++.+..++.++||||||+++|+|++|.+||...... ......... ..
T Consensus 161 l~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~-~~ 236 (308)
T 3g33_A 161 LADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFDL-IG 236 (308)
T ss_dssp ECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH--HHHHHHHHH-HC
T ss_pred EeeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHH-hC
Confidence 9999999744332 2234457899999999999888999999999999999999999999654322 111111110 00
Q ss_pred hhcccccc------CCccc-------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 246 KLALHELI------DPRIE-------NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 246 ~~~~~~~~------~~~~~-------~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
........ ...+. ....+..+..+.+++.+||+.||++|||+.+++++-+-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~ 301 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcccc
Confidence 00000000 00000 001122345678999999999999999999999875543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=309.95 Aligned_cols=269 Identities=24% Similarity=0.257 Sum_probs=199.8
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
.++|++++.||+|+||+||+|.+. +++.+|+|++..... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999876 589999998765432 22455788999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+++.. ...+++..+..++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKH----NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999999887743 34589999999999999999999999 9999999999999999999999999999755544
Q ss_pred CCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH--------HHHHhhhcc
Q 046121 179 DPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA--------EPLIEKLAL 249 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~ 249 (315)
........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||............... .........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 443445578999999998876 56789999999999999999999999654432111110000 000000000
Q ss_pred -ccccCCcccCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 250 -HELIDPRIENSY-----DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 250 -~~~~~~~~~~~~-----~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.....+...... .+..+..+.+++.+||+.||++|||+++++++-+-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 288 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGG
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHH
Confidence 000000000000 01234557899999999999999999999987543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=313.60 Aligned_cols=275 Identities=24% Similarity=0.304 Sum_probs=210.0
Q ss_pred HhcCC-cccceecCCCceEEEEEEeC-----CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEe--c
Q 046121 21 ATGDF-SKENLLGEGGFGHVYKGELK-----DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCK--E 91 (315)
Q Consensus 21 ~~~~y-~~~~~lg~g~~~~v~~~~~~-----~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 91 (315)
+.++| ++++.||+|+||+||++.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 34566 99999999999999888543 58899999987543 3445668899999999999999999999987 4
Q ss_pred CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCc
Q 046121 92 NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGL 171 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~ 171 (315)
..+++||||+.+++|.+++... .+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||+
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ----HYIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred ceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEEcCCCCEEECCccc
Confidence 6789999999999999998543 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc---cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhc
Q 046121 172 ARWKTTDDPV---QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248 (315)
Q Consensus 172 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (315)
+......... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||......... .............
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQMTVLR 259 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccchhHHH
Confidence 9755443321 22345678899999999888999999999999999999999998642211000 0000000000000
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccccc
Q 046121 249 LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~ 303 (315)
.............+...+..+.+++.+||+.||++|||+.++++.|+.+.+++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 0011111111122233445688999999999999999999999999998877654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=310.29 Aligned_cols=257 Identities=23% Similarity=0.266 Sum_probs=207.7
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc------cHHHHHHHHHHHhhcCCCCccceeeeEEecCe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ------GFAEFQSEVYVLNFARHKNIVMLLGFCCKENL 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (315)
+.++|++.+.||+|+||+||+|.+. +++.+|+|++...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 5678999999999999999999876 6899999987754322 35678999999999999999999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC----ceeECCC
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF----VPMLGDF 169 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~----~i~l~df 169 (315)
.++||||+.+++|.+++.. ...+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++ .++|+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~----~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999998854 34689999999999999999999999 999999999999999888 7999999
Q ss_pred CcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcc
Q 046121 170 GLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249 (315)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (315)
|++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... .. .... ..
T Consensus 164 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~----~~i~-~~-- 233 (321)
T 2a2a_A 164 GLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TL----ANIT-SV-- 233 (321)
T ss_dssp TTCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HH----HHHH-TT--
T ss_pred ccceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--HH----HHHH-hc--
Confidence 9997544322 2234568999999999998889999999999999999999999996443211 11 1110 00
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.....+. .....+..+.+++.+||..||++|||+.+++++-+-.
T Consensus 234 ~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~ 277 (321)
T 2a2a_A 234 SYDFDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (321)
T ss_dssp CCCCCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTS
T ss_pred ccccChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 0001111 1112345588999999999999999999999876543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=313.02 Aligned_cols=257 Identities=18% Similarity=0.230 Sum_probs=205.5
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 97 (315)
.+.++|++.+.||+|+||+||+|.++ +++.+|+|++...... ..+|+.++..+ +||||+++++++.+....|+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 46788999999999999999999876 6899999998765332 34677888777 799999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC----CceeECCCCccc
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD----FVPMLGDFGLAR 173 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~----~~i~l~dfg~~~ 173 (315)
|||+.|++|.+.+.+. ..+++..+..++.|++.|+.|||+. |++|+||||+||++... +.++|+|||++.
T Consensus 95 ~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~----givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 95 TELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQ----GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp ECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999988543 4589999999999999999999999 99999999999998443 359999999997
Q ss_pred ccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 174 WKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
.............|++.|+|||++.+..++.++||||||+++|+|++|..||............. ... ...
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~i~-~~~----- 239 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---RIG-SGK----- 239 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH---HHH-HCC-----
T ss_pred cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH---HHc-cCC-----
Confidence 65554444455678999999999988888999999999999999999999997543322211111 111 110
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
...........+..+.+++.+||..||++|||+.+++++-+-
T Consensus 240 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 240 -FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp -CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred -cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 011112223345568899999999999999999999987664
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=316.71 Aligned_cols=208 Identities=25% Similarity=0.311 Sum_probs=180.9
Q ss_pred ccHHHHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcC-----CCCccceee
Q 046121 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-----HKNIVMLLG 86 (315)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~ 86 (315)
++.++...+.++|+++++||+|+||+||+|.+. +++.||+|++... .........|+.+++.+. ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 344455556789999999999999999999875 6889999998642 334456778999999886 999999999
Q ss_pred eEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC------
Q 046121 87 FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH------ 160 (315)
Q Consensus 87 ~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~------ 160 (315)
++...+..++|||++ +++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM----SLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCcccEEEcccccccc
Confidence 999999999999998 99999999877777799999999999999999999999 9999999999999975
Q ss_pred -------------------CCceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhC
Q 046121 161 -------------------DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG 221 (315)
Q Consensus 161 -------------------~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 221 (315)
++.++|+|||++..... ......|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 78999999999974332 22345789999999999999999999999999999999999
Q ss_pred CCccCCCC
Q 046121 222 RKVVDMNG 229 (315)
Q Consensus 222 ~~p~~~~~ 229 (315)
..||....
T Consensus 256 ~~pf~~~~ 263 (360)
T 3llt_A 256 SLLFRTHE 263 (360)
T ss_dssp SCSCCCSS
T ss_pred CCCCCCCc
Confidence 99996543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=309.87 Aligned_cols=261 Identities=27% Similarity=0.399 Sum_probs=210.7
Q ss_pred HhcCCcccceecCCCceEEEEEEe------CCCcEEEEEEecccCc-ccHHHHHHHHHHHhhc-CCCCccceeeeEEecC
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGEL------KDGQMIAAKVRKEAST-QGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKEN 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 92 (315)
..++|++.+.||+|+||+||+|.+ .+++.|++|++..... ...+.+.+|+.+++.+ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 457999999999999999999974 2577899998875432 3456788999999999 8999999999999999
Q ss_pred eeEEEEEeccCCccccccccCCC----------------CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcE
Q 046121 93 LNILVYEYICNKSLHWHLFDNTE----------------SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNI 156 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~ni 156 (315)
..++||||+.+++|.+++..... ..+++..++.++.|++.++.+||+. +++|+||||+||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Ni 176 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNI 176 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceE
Confidence 99999999999999999876543 2589999999999999999999999 999999999999
Q ss_pred EEcCCCceeECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccc
Q 046121 157 LLTHDFVPMLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQ 233 (315)
Q Consensus 157 l~~~~~~i~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~ 233 (315)
+++.++.++|+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-
Confidence 9999999999999999754433221 223456778999999988889999999999999999998 999996544321
Q ss_pred hhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 234 QSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
.... ..... ... ..+...+..+.+++.+||..||++|||+.++++.|+.+..+
T Consensus 256 -~~~~----~~~~~-----~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 256 -KFYK----MIKEG-----FRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp -HHHH----HHHHT-----CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHH----HhccC-----CCC----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1111 11110 111 11122345678899999999999999999999999887553
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=305.23 Aligned_cols=258 Identities=25% Similarity=0.337 Sum_probs=208.7
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.++|++++.||+|+||+||+|.+.++..+++|++.... ...+.+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 46899999999999999999998888899999887543 34577899999999999999999999986 45679999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.+++|.+++.......+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999998654444699999999999999999999999 9999999999999999999999999999754433221
Q ss_pred -cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 182 -QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 182 -~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ...... .. ...
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~-~~-----~~~---- 229 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLE-RG-----YRM---- 229 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHH-TT-----CCC----
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HHHHHh-cc-----cCC----
Confidence 123345778999999988889999999999999999999 899986543211 111111 10 011
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
..+...+..+.+++.+||..||++|||+.++++.|+.+....
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 112223456888999999999999999999999999876544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=305.89 Aligned_cols=256 Identities=19% Similarity=0.199 Sum_probs=206.3
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
..+.++|++.+.||+|+||+||+|.+. ++..+++|++........+.+.+|+.+++.++||||+++++++......++|
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 346789999999999999999999876 5778999988876666678899999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE---cCCCceeECCCCcccc
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL---THDFVPMLGDFGLARW 174 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~---~~~~~i~l~dfg~~~~ 174 (315)
|||+.+++|.+.+... ..+++..++.++.|++.++.+||+. +++|+||+|+||++ +.++.++|+|||++..
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 85 MELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL----NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 9999999998887543 4589999999999999999999999 99999999999999 7889999999999975
Q ss_pred cCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 175 KTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
.... .......+++.|+|||.+.+. ++.++||||||+++|+|++|..||....... .. ...... ....
T Consensus 159 ~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~----~~~~~~----~~~~ 226 (277)
T 3f3z_A 159 FKPG-KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--VM----LKIREG----TFTF 226 (277)
T ss_dssp CCTT-SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHHHC----CCCC
T ss_pred ccCc-cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH--HH----HHHHhC----CCCC
Confidence 4433 233445789999999998765 8899999999999999999999996543211 11 111100 0000
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
+ .......+..+.+++.+||+.||++|||+.+++++-+
T Consensus 227 ~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 227 P---EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp C---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred C---chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 0 0000012445788999999999999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=312.81 Aligned_cols=260 Identities=22% Similarity=0.225 Sum_probs=185.4
Q ss_pred hcCCccc---ceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKE---NLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~---~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 96 (315)
.++|.+. +.||+|+||+||+|.+. +++.||+|++... ......+|+.+++.+. ||||+++++++.+....++
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 3456664 78999999999999876 6899999998653 3456788999999997 9999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC---ceeECCCCccc
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF---VPMLGDFGLAR 173 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~---~i~l~dfg~~~ 173 (315)
||||+.+++|.+++... ..+++..+..++.|++.++.+||+. +++|+||||+||+++.++ .++|+|||++.
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV----GVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 99999999999988654 4699999999999999999999999 999999999999998766 89999999997
Q ss_pred ccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccc-hhHHHhHHHHHhhhccccc
Q 046121 174 WKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ-QSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 252 (315)
.............+++.|+|||++.+..++.++||||||+++|+|++|..||........ ......... .....
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~---- 232 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGD---- 232 (325)
T ss_dssp ECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTC----
T ss_pred ecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCC----
Confidence 555444444556789999999999999999999999999999999999999975443211 111111111 11100
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
...........+..+.+++.+||..||++|||+.+++++-+-.
T Consensus 233 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~ 275 (325)
T 3kn6_A 233 --FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275 (325)
T ss_dssp --CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred --CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence 0011111122355688999999999999999999998765543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=316.07 Aligned_cols=273 Identities=16% Similarity=0.186 Sum_probs=202.9
Q ss_pred HhcCCcccceecCCCceEEEEEEeC----CCcEEEEEEecccCccc-----------HHHHHHHHHHHhhcCCCCcccee
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEASTQG-----------FAEFQSEVYVLNFARHKNIVMLL 85 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~i~~~~ 85 (315)
..++|++.+.||+|+||+||+|.+. ++..+++|+........ ...+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 4578999999999999999999875 57789999877543211 12355788889999999999999
Q ss_pred eeEEe----cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC
Q 046121 86 GFCCK----ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD 161 (315)
Q Consensus 86 ~~~~~----~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~ 161 (315)
+++.. ....++||||+ +++|.+++.... .+++..++.++.|++.|+.|||+. +++|+||||+||+++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN----EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEESS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCcCHHHEEEccC
Confidence 99987 77889999999 999999886543 799999999999999999999999 99999999999999988
Q ss_pred C--ceeECCCCcccccCCCC-------CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCcc
Q 046121 162 F--VPMLGDFGLARWKTTDD-------PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEP 232 (315)
Q Consensus 162 ~--~i~l~dfg~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~ 232 (315)
+ .++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 99999999996543211 11134578999999999999889999999999999999999999996433222
Q ss_pred chhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccccc
Q 046121 233 QQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLGE 306 (315)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~~~ 306 (315)
... .......... ....+..... ....+..+.+++.+||..||++|||+.++++.|+.....+...+.
T Consensus 268 ~~~-~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d~ 335 (345)
T 2v62_A 268 VAV-QTAKTNLLDE--LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLDF 335 (345)
T ss_dssp HHH-HHHHHHHHHT--TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCCC
T ss_pred HHH-HHHHHhhccc--ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCCc
Confidence 111 1111111110 0000000000 012334588899999999999999999999999998766655543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=328.28 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=214.4
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999876 7999999998653 23345567899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.|++|.+++.......+++..+..++.|++.|+.|||+. +++|+||||+||+++.+|.++|+|||++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~----gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999988776666799999999999999999999999 99999999999999999999999999997544
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
... ......|++.|+|||++.+..++.++|+|||||++|+|++|..||......... ...... ....
T Consensus 338 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~-i~~~--------- 404 (576)
T 2acx_A 338 EGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERL-VKEV--------- 404 (576)
T ss_dssp TTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHH-HHHC---------
T ss_pred cCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHH-hhcc---------
Confidence 332 223457999999999999988999999999999999999999999765432211 111111 1110
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhccccccc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEGENDRFH 302 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~~~~~~~ 302 (315)
...++...+..+.+++.+||+.||++|| ++.+++++-+-..-.|.
T Consensus 405 -~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 405 -PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred -cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 1112223445688999999999999999 78999887655444443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=316.37 Aligned_cols=269 Identities=22% Similarity=0.277 Sum_probs=210.0
Q ss_pred hcCCcccceecCCCceEEEEEEe-----CCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEE--ecCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGEL-----KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCC--KENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~ 94 (315)
.++|++++.||+|+||+||+|.+ .+++.|++|++........+.+.+|+.+++.++||||+++++++. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999983 368899999988776666777899999999999999999999886 45678
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++||||+.+++|.+++.... ..+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR----RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChhhEEECCCCCEEEccccccee
Confidence 99999999999999886432 3589999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCC---ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCcc---------chhHHHhHHH
Q 046121 175 KTTDDP---VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEP---------QQSLRQWAEP 242 (315)
Q Consensus 175 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~~~~ 242 (315)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||....... ..........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 443322 1223457788999999998889999999999999999999999985322110 0000110000
Q ss_pred HHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccccccc
Q 046121 243 LIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLG 305 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~~ 305 (315)
.........+...+..+.+++.+||+.||++|||+.++++.|+.+........
T Consensus 257 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 257 ----------LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp ----------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred ----------hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 01111112233345568899999999999999999999999999987666543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=304.68 Aligned_cols=259 Identities=22% Similarity=0.275 Sum_probs=197.3
Q ss_pred HHhcCCcccceecCCCceEEEEEEeCC----CcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELKD----GQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
...++|++.+.||+|+||+||+|.+.. +..+++|+.... .....+.+.+|+.+++.++||||+++++++. ++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 356799999999999999999997642 456899987653 3334566889999999999999999999984 5668
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++||||+.+++|.+++... ...+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHEEECCCCCEEECccccccc
Confidence 9999999999999988654 34589999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCC-ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 175 KTTDDP-VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 175 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ .. . .....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~----~-i~~~~---- 234 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IG----R-IENGE---- 234 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH----H-HHTTC----
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HH----H-HHcCC----
Confidence 433221 1223456778999999998889999999999999999996 8999975433211 11 1 11100
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
.. ..+...+..+.+++.+||..||++|||+.++++.|+.+...
T Consensus 235 -~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 235 -RL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp -CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01 12223345678899999999999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=321.55 Aligned_cols=263 Identities=19% Similarity=0.220 Sum_probs=209.5
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++++.||+|+||+||+|.+. +++.+|+|++... .......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 4578999999999999999999876 6889999998652 12233457899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.|++|.+++.. ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 147 V~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 9999999999998854 3589999999999999999999999 99999999999999999999999999997544
Q ss_pred CCCC-ccccccccccccCccccccCC----CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 177 TDDP-VQTKILGTLGYLAPEYAENGI----VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 177 ~~~~-~~~~~~~~~~~~aPE~~~~~~----~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
.... .....+|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.. .... ..........
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~----~i~~~~~~~~ 293 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYS----KIMNHKNSLT 293 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH----HHHTHHHHCC
T ss_pred cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--hHHH----HHHhcccccc
Confidence 4332 223567999999999987655 788999999999999999999999644321 1111 1111100000
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHHhcccccccc
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEG--RPSMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~--Rps~~~il~~L~~~~~~~~~ 303 (315)
. +. ....+..+.+|+.+||+.+|++ ||++++++++-+-....|..
T Consensus 294 ~--p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~ 340 (410)
T 3v8s_A 294 F--PD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW 340 (410)
T ss_dssp C--CT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred C--CC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence 0 00 0123345788999999999988 99999999988766555543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=316.54 Aligned_cols=273 Identities=21% Similarity=0.243 Sum_probs=214.3
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecC--eeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN--LNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~l 96 (315)
..++|++.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 4578999999999999999999876 58999999987543 334566789999999999999999999998755 7799
Q ss_pred EEEeccCCccccccccCCC-CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE----cCCCceeECCCCc
Q 046121 97 VYEYICNKSLHWHLFDNTE-SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL----THDFVPMLGDFGL 171 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~----~~~~~i~l~dfg~ 171 (315)
||||+.+++|.+++..... ..+++..++.++.|++.|+.|||+. +++|+||||+||++ +.++.++|+|||+
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC----CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 9999999999998865432 3399999999999999999999999 99999999999999 7888899999999
Q ss_pred ccccCCCCCccccccccccccCcccccc--------CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAEN--------GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
+....... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||......... .......
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~ 239 (396)
T 4eut_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI 239 (396)
T ss_dssp CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHH
T ss_pred ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHH
Confidence 97443322 2234568999999998864 45778999999999999999999999643322111 1111111
Q ss_pred Hhhhcc------ccc------c--CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 244 IEKLAL------HEL------I--DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 244 ~~~~~~------~~~------~--~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
...... ... + .-......+......+.+++.+||..||++|||+.++++.++.+.++
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111100 000 0 11122345577888899999999999999999999999999887664
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=325.59 Aligned_cols=260 Identities=25% Similarity=0.340 Sum_probs=207.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
..++|++.+.||+|+||+||+|.+.++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 456799999999999999999999888889999987543 345678999999999999999999999876 678999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.......+++..++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999654445689999999999999999999999 999999999999999999999999999974432221
Q ss_pred -ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 181 -VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 181 -~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ....... .. ..
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~-~~-----~~---- 399 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVE-RG-----YR---- 399 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHH-TT-----CC----
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH-cC-----CC----
Confidence 1122345778999999998889999999999999999999 89999644321 1111111 10 00
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
...+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 11122344568889999999999999999999999998866443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=314.93 Aligned_cols=256 Identities=20% Similarity=0.217 Sum_probs=195.0
Q ss_pred HhcCCccc-ceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHH-hhcCCCCccceeeeEEe----cCe
Q 046121 21 ATGDFSKE-NLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVL-NFARHKNIVMLLGFCCK----ENL 93 (315)
Q Consensus 21 ~~~~y~~~-~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----~~~ 93 (315)
+.++|.+. +.||+|+||+||+|.+. +++.||+|++... ....+|+.++ +..+||||+++++++.. ...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 34567776 68999999999999876 6899999998642 4567788876 45589999999999876 667
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC---CCceeECCCC
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFG 170 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~---~~~i~l~dfg 170 (315)
+|+||||+.|++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.++|+|||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCcceEEEecCCCCccEEEEecc
Confidence 89999999999999999776666799999999999999999999999 9999999999999998 7899999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccc-hhHHHhHHHHHhhhcc
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ-QSLRQWAEPLIEKLAL 249 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 249 (315)
++...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||........ ...... .....
T Consensus 210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~- 283 (400)
T 1nxk_A 210 FAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQ- 283 (400)
T ss_dssp TCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTC-
T ss_pred cccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCc-
Confidence 99744332 223345789999999999999999999999999999999999999975443221 111110 00000
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.....+ .....+..+.+|+.+||+.||++|||+.+++++.+-
T Consensus 284 ~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 284 YEFPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp CCCCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred ccCCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 001111 112234568899999999999999999999987654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=311.40 Aligned_cols=261 Identities=20% Similarity=0.207 Sum_probs=202.9
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-----CcccHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-----STQGFAEFQSEVYVLNFARHKNIVMLLGFCCK 90 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (315)
.+..+.++|++.+.||+|+||+||+|.+. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45678889999999999999999999875 6889999987643 34556778999999999999999999999999
Q ss_pred cCeeEEEEEeccCCccccccccC--------------------------------------CCCccCHHHHHHHHHHHHH
Q 046121 91 ENLNILVYEYICNKSLHWHLFDN--------------------------------------TESVLEWHQRYAAAIGTAK 132 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~--------------------------------------~~~~~~~~~~~~~~~~l~~ 132 (315)
.+..++||||+.|++|.+++... ....+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999998887420 1223567888999999999
Q ss_pred HHHhhhcccCCCCeEeecCccCcEEEcCCC--ceeECCCCcccccCCCCC----ccccccccccccCcccccc--CCCcc
Q 046121 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDF--VPMLGDFGLARWKTTDDP----VQTKILGTLGYLAPEYAEN--GIVSI 204 (315)
Q Consensus 133 ~l~~lh~~~~~~~i~h~di~p~nil~~~~~--~i~l~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~--~~~~~ 204 (315)
++.+||+. +++|+||||+||+++.++ .++|+|||++........ ......|++.|+|||.+.+ ..++.
T Consensus 180 ~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 180 ALHYLHNQ----GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHT----TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHC----CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 99999999 999999999999998776 899999999975432211 1234568999999999865 66889
Q ss_pred cccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 046121 205 RTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGR 284 (315)
Q Consensus 205 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~R 284 (315)
++||||||+++|+|++|..||....... .. ........ ..........+..+.+++.+||..||++|
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~--~~----~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDAD--TI----SQVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHH--HH----HHHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 9999999999999999999996443211 11 11111100 00111111234568899999999999999
Q ss_pred CCHHHHHHHH
Q 046121 285 PSMGEVVRLL 294 (315)
Q Consensus 285 ps~~~il~~L 294 (315)
||+.+++++-
T Consensus 323 ps~~~~l~hp 332 (345)
T 3hko_A 323 FDAMRALQHP 332 (345)
T ss_dssp CCHHHHHHSH
T ss_pred CCHHHHhcCh
Confidence 9999999853
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=304.65 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=204.6
Q ss_pred hcCCcccceecCCCceEEEEEEe-----CCCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEec--Ce
Q 046121 22 TGDFSKENLLGEGGFGHVYKGEL-----KDGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE--NL 93 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 93 (315)
.++|++++.||+|+||+||+|.+ .+++.||+|++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 46799999999999999999983 36899999998744 334457789999999999999999999999876 66
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.++||||+.+++|.+++.... ..+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC----CcccCCCchheEEEcCCCCEEECcccccc
Confidence 899999999999999885443 3489999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCC---ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCC--------Ccc-chhHHHhHH
Q 046121 174 WKTTDDP---VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNG--------EEP-QQSLRQWAE 241 (315)
Q Consensus 174 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~--------~~~-~~~~~~~~~ 241 (315)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|..|+.... ... .........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 5544332 1223457788999999998889999999999999999999998864221 000 011111111
Q ss_pred HHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 242 PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
. ... ......+...+..+.+++.+||..||++|||+.++++.|+.+
T Consensus 255 ~-~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 255 T-LKE---------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp H-HHT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-Hhc---------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1 110 111112233445688999999999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=317.74 Aligned_cols=245 Identities=23% Similarity=0.281 Sum_probs=193.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc---ccHHHHHHHHHH-HhhcCCCCccceeeeEEecCeeE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST---QGFAEFQSEVYV-LNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
..++|++++.||+|+||+||+|+++ +++.+|+|++..... .....+.+|..+ ++.++||||+++++++.+.+.+|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3468999999999999999999876 588999999875432 223445666666 57789999999999999999999
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+||||+.|++|.+++.+ ...+++..+..++.|++.||.|||+. |++||||||+||+++.+|.++|+|||++...
T Consensus 116 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999988854 34588999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
..........+|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.. .. ....... ..
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~----~~~i~~~-------~~ 256 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EM----YDNILNK-------PL 256 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--HH----HHHHHHS-------CC
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HH----HHHHHhc-------cc
Confidence 44444445678999999999999999999999999999999999999999643321 11 1111111 00
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMG 288 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~ 288 (315)
. ++...+..+.+++.+||+.||++||++.
T Consensus 257 ~----~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 257 Q----LKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp C----CCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred C----CCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 1 1122344578899999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=315.19 Aligned_cols=282 Identities=24% Similarity=0.308 Sum_probs=209.2
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc--cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ--GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
..++|++++.||+|+||+||+|.+. +++.|++|++...... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4578999999999999999999876 5899999987654332 244577899999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|||+.+++|.++... ...+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 103 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHC----CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999988876543 34589999999999999999999999 999999999999999999999999999975544
Q ss_pred CCCccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH----------H-HHh
Q 046121 178 DDPVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE----------P-LIE 245 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------~-~~~ 245 (315)
.........+++.|+|||.+.+. .++.++||||||+++|+|++|.+||....... ....... . ...
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHH
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhhHhhh
Confidence 44444456789999999998775 67899999999999999999999996543221 1111100 0 000
Q ss_pred hhccccccCCcccCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccccchhhh
Q 046121 246 KLALHELIDPRIENSY-----DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLGEKFVQ 310 (315)
Q Consensus 246 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~~~~~~~ 310 (315)
.........+...... .+..+..+.+++.+||+.||++|||+.+++++-+-..+.+.+.-.+.+|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~ 324 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQ 324 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHHHHHHHHH
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhhhhhHHHh
Confidence 0011111111111111 1123566889999999999999999999998776655555444333343
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=315.44 Aligned_cols=267 Identities=22% Similarity=0.305 Sum_probs=209.8
Q ss_pred HhcCCcccceecCCCceEEEEEEe-----CCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEec--Ce
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGEL-----KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE--NL 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 93 (315)
..++|++++.||+|+||.||+|.. .+++.|++|++..........+.+|+.+++.++||||+++++++... ..
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 346799999999999999999973 36889999998876666677899999999999999999999988654 37
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.++||||+.+++|.+++.... ..+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 899999999999999986543 3589999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCc---cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCC---------ccchhHHHhHH
Q 046121 174 WKTTDDPV---QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGE---------EPQQSLRQWAE 241 (315)
Q Consensus 174 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~---------~~~~~~~~~~~ 241 (315)
........ .....++..|+|||.+.+..++.++||||||+++|+|++|..|+..... ...........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 55433221 1223466789999999988899999999999999999999988753210 00000000000
Q ss_pred HHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 242 PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
..... ......+...+..+.+++.+||+.||++|||+.++++.|+.+.+++
T Consensus 274 ~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 274 ELLKN---------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHT---------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhhc---------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11110 0011112233456888999999999999999999999999987654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=310.43 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=200.4
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCc----EEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQ----MIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~----~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
.++|++.+.||+|+||+||+|.+. +++ ++++|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 468999999999999999999865 344 3577766533 3345667899999999999999999999998765 68
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
++++++.+++|.+++.... ..+++..++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 8999999999999886543 4589999999999999999999999 9999999999999999999999999999755
Q ss_pred CCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 176 TTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 176 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ .. ......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~----~~~~~~---- 236 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SS----ILEKGE---- 236 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----HHHTTC----
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---HH----HHHcCC----
Confidence 433222 223345778999999999999999999999999999999 9999975443221 11 111110
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
....+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 237 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 237 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1111222344578899999999999999999999999887653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=301.22 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=206.9
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEe--------
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK-------- 90 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------- 90 (315)
...++|++++.||+|+||.||+|.+. +++.+++|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 46688999999999999999999876 78999999887543 356789999999999999999998854
Q ss_pred --------cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC
Q 046121 91 --------ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF 162 (315)
Q Consensus 91 --------~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~ 162 (315)
....++||||+.+++|.+++.......+++..++.++.|++.++.+||+. +++|+||+|+||+++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK----KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHEEEcCCC
Confidence 45579999999999999999766666799999999999999999999999 999999999999999999
Q ss_pred ceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH
Q 046121 163 VPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP 242 (315)
Q Consensus 163 ~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 242 (315)
.++|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..|+... ......
T Consensus 160 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~~ 230 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFTD 230 (284)
T ss_dssp EEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHHH
T ss_pred CEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHHH
Confidence 99999999987544332 223456899999999999888999999999999999999998887311 111111
Q ss_pred HHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 243 LIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
.. ....... .+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 231 -~~--------~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 231 -LR--------DGIISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp -HH--------TTCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred -hh--------ccccccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11 1111122 23447789999999999999999999999998876544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=302.39 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=186.1
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++.+.||+|+||+||+|.+. +++.+++|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 4578999999999999999999874 78999999986432 2334678899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
|+||+.+++|.+++... ...+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH----GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999888643 34689999999999999999999999 99999999999999999999999999997554
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
..........+++.|+|||.+.+..++.++|+||||+++|+|++|..||........ .. . .....
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~--------~-----~~~~~ 228 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--LN--------K-----VVLAD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--HH--------H-----Hhhcc
Confidence 333333345688999999999988899999999999999999999999975432211 00 0 00000
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
...+...+..+.+++.+||+.||++|||+.+++++-+
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence 0112223456789999999999999999999998644
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=304.55 Aligned_cols=254 Identities=24% Similarity=0.303 Sum_probs=208.7
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
..++|++++.||+|+||+||+|.+. +++.|++|++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3467999999999999999999865 68899999887543 344677899999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+++. ...+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 100 e~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 100 EYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp ECCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EeCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999884 34689999999999999999999999 9999999999999999999999999999755444
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
........+++.|+|||.+.+..++.++||||||+++|+|++|..||....... .... ... ...+...
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~-----~~~~~~~ 240 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK------VLFL-IPK-----NNPPTLE 240 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH-HHH-----SCCCCCC
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH------HHHH-hhc-----CCCCCCc
Confidence 333445678999999999998889999999999999999999999996433211 0011 111 0111122
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
. ..+..+.+++.+||..||++|||+.+++++.+-.
T Consensus 241 ~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 241 G----NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp S----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred c----ccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence 2 2334578899999999999999999999865543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=311.23 Aligned_cols=256 Identities=21% Similarity=0.237 Sum_probs=192.1
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
+.++|++.+.||+|+||+||+|.+. +++.||+|++.... ..+.+.+|+.+++.++||||+++++++......++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567999999999999999999876 58899999987543 34567889999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC---CCceeECCCCcccccC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKT 176 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~---~~~i~l~dfg~~~~~~ 176 (315)
|+.+++|.+.+.. ...+++..++.++.|++.++.+||+. +++|+||||+||+++. ++.++|+|||++....
T Consensus 129 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHEN----GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999998854 34589999999999999999999999 9999999999999975 8899999999987443
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
.. .......|++.|+|||++.+..++.++||||||+++|+|++|..||........ .. ...... . ...
T Consensus 203 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~----~~i~~~-~-~~~---- 270 (349)
T 2w4o_A 203 HQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-MF----RRILNC-E-YYF---- 270 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-HH----HHHHTT-C-CCC----
T ss_pred cc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-HH----HHHHhC-C-Ccc----
Confidence 32 222345789999999999998899999999999999999999999964432210 10 111110 0 000
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
........+..+.+++.+||..||++|||+.+++++-+-.
T Consensus 271 -~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 310 (349)
T 2w4o_A 271 -ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310 (349)
T ss_dssp -CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred -CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 1111122345688999999999999999999999875543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=302.46 Aligned_cols=259 Identities=22% Similarity=0.298 Sum_probs=207.7
Q ss_pred hcCCcccc-eecCCCceEEEEEEeC---CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKEN-LLGEGGFGHVYKGELK---DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~-~lg~g~~~~v~~~~~~---~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
.++|.+.+ .||+|+||+||+|.+. ++..|++|++.... ....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45677777 9999999999999753 57789999987643 34456788999999999999999999999 5567899
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.+++|.+++... ...+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 99999999999988543 34589999999999999999999999 99999999999999999999999999997554
Q ss_pred CCCCc---cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 177 TDDPV---QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 177 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
..... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~i~~~~---- 230 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA----FIEQGK---- 230 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHH----HHHTTC----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHH----HHhcCC----
Confidence 33221 122345788999999988889999999999999999998 999996543321 111 111110
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
.+ ..+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 231 -~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 231 -RM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp -CC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -cC----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 11 1222344568889999999999999999999999999866554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=313.05 Aligned_cols=254 Identities=25% Similarity=0.305 Sum_probs=199.7
Q ss_pred cCCcc--cceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSK--ENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~--~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
+.|.+ .+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34554 568999999999999875 689999999887666666788999999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE--cCCCceeECCCCcccccCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL--THDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~--~~~~~i~l~dfg~~~~~~~ 177 (315)
|+.+++|.+.+... ...+++..++.++.|++.++.|||+. +++|+||||+||++ +.++.++|+|||++.....
T Consensus 167 ~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 167 YVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQM----YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp CCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred CCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 99999998887543 34589999999999999999999999 99999999999999 5678999999999975443
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... .... ..... .. . +
T Consensus 242 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~----~i~~~-~~-~-~---- 307 (373)
T 2x4f_A 242 RE-KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLN----NILAC-RW-D-L---- 307 (373)
T ss_dssp TC-BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH----HHHHT-CC-C-S----
T ss_pred cc-ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH----HHHhc-cC-C-C----
Confidence 32 223456899999999999888999999999999999999999999654321 1111 11111 00 0 0
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
........+..+.+++.+||+.||++|||+.+++++-+
T Consensus 308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 11111223456889999999999999999999998544
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=311.16 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=209.2
Q ss_pred HhcCCcccceecCCCceEEEEEEeC--------CCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccceeeeEEe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK--------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCK 90 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 90 (315)
..++|++.+.||+|+||+||+|.+. ++..||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3579999999999999999999763 46789999887543 34456788999999999 89999999999999
Q ss_pred cCeeEEEEEeccCCccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcE
Q 046121 91 ENLNILVYEYICNKSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNI 156 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~ni 156 (315)
.+..++||||+.+++|.+++.... ...+++..++.++.|++.|+.+||+. +++|+||||+||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NI 188 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNV 188 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCccceE
Confidence 999999999999999999886543 23489999999999999999999999 999999999999
Q ss_pred EEcCCCceeECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccc
Q 046121 157 LLTHDFVPMLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQ 233 (315)
Q Consensus 157 l~~~~~~i~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~ 233 (315)
+++.++.++|+|||++......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-- 266 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 266 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--
Confidence 9999999999999999754433221 122356788999999988889999999999999999999 99999654321
Q ss_pred hhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 234 QSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
...... .... ... .+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 267 ----~~~~~~-~~~~-----~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 267 ----ELFKLL-KEGH-----RMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp ----HHHHHH-HHTC-----CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ----HHHHHH-hcCC-----CCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 111111 1110 111 122234457889999999999999999999999999866544
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=308.34 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=197.7
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecC------
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN------ 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 92 (315)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4578999999999999999999886 79999999987543 334567899999999999999999999986543
Q ss_pred ---------------------------------------------------eeEEEEEeccCCccccccccCCC-CccCH
Q 046121 93 ---------------------------------------------------LNILVYEYICNKSLHWHLFDNTE-SVLEW 120 (315)
Q Consensus 93 ---------------------------------------------------~~~lv~~~~~~~~L~~~l~~~~~-~~~~~ 120 (315)
..++||||+.+++|.+++.+... ...+.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 37999999999999999876543 34566
Q ss_pred HHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC------------cccccccc
Q 046121 121 HQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP------------VQTKILGT 188 (315)
Q Consensus 121 ~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~------------~~~~~~~~ 188 (315)
..++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++........ ......|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred HHHHHHHHHHHHHHHHHHhC----CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 67899999999999999999 999999999999999999999999999975544321 12235689
Q ss_pred ccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHH
Q 046121 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYL 268 (315)
Q Consensus 189 ~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (315)
+.|+|||.+.+..++.++||||||+++|+|++|..|+.. ....... ... .. ...........
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~~~-~~~-----~~----~~~~~~~~~~~ 301 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRIITD-VRN-----LK----FPLLFTQKYPQ 301 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHHHH-HHT-----TC----CCHHHHHHCHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHHHH-hhc-----cC----CCcccccCChh
Confidence 999999999998999999999999999999998766421 0000000 000 00 01111223345
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 269 MAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 269 l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
+.+++.+||+.||++|||+.+++++-
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhch
Confidence 68899999999999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=303.24 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=202.6
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++.+.||+|+||+||+|.+. ++..+++|++.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3578999999999999999999876 57789999876432 2334568899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.+++|.+.+... ..+++..++.++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT----TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999998888543 4589999999999999999999999 99999999999999999999999999885332
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
. .......+++.|+|||.+.+..++.++||||||+++|+|++|..||....... . .......
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~----~~~~~~~---------- 222 (279)
T 3fdn_A 161 S--SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--T----YKRISRV---------- 222 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--H----HHHHHHT----------
T ss_pred c--ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--H----HHHHHhC----------
Confidence 2 22234578999999999999889999999999999999999999996433211 1 1111100
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
....+...+..+.+++.+||+.||++|||+.+++++-+-.
T Consensus 223 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~ 262 (279)
T 3fdn_A 223 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262 (279)
T ss_dssp -CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred -CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence 0111222345578899999999999999999999876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=310.53 Aligned_cols=257 Identities=24% Similarity=0.330 Sum_probs=200.5
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcE----EEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQM----IAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~----~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
.++|++.+.||+|+||+||+|.+. +++. +++|.+.... ......+.+|+.+++.++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 468999999999999999999865 3443 6777664332 333456778999999999999999999886 56689
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+|++|+.+++|.+++... ...+++..++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 91 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH----GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT----TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC----CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999988644 34689999999999999999999999 9999999999999999999999999999755
Q ss_pred CCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 176 TTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 176 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
..... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.......... ....... .
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~~--~ 236 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-------LLEKGER--L 236 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-------HHHTTCB--C
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH-------HHHcCCC--C
Confidence 43322 2233456778999999998899999999999999999999 999997544322111 1111100 0
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
. .+...+..+.+++.+||..||++|||+.++++.|+.+...
T Consensus 237 ~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 237 A-------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp C-------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred C-------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 0111122367889999999999999999999999887543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=303.05 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=202.3
Q ss_pred hcCCcccceecCCCceEEEEEEeCC-C-------cEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKD-G-------QMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL 93 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~-~-------~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (315)
.++|++.+.||+|+||+||+|.+.. + ..+++|++........+.+.+|+.+++.++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 5789999999999999999997653 3 4699999887766777889999999999999999999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc--------ee
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV--------PM 165 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~--------i~ 165 (315)
.++||||+.+++|.+++.... ..+++..++.++.|++.++.+||+. +++|+||||+||+++.++. ++
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN----TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC----CeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999986543 3489999999999999999999999 9999999999999998887 99
Q ss_pred ECCCCcccccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCC-CccCCCCCccchhHHHhHHHH
Q 046121 166 LGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGR-KVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~ 243 (315)
|+|||++..... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|. +|+...... ......
T Consensus 162 l~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~------~~~~~~ 231 (289)
T 4fvq_A 162 LSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ------RKLQFY 231 (289)
T ss_dssp ECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHH
T ss_pred eccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH------HHHHHh
Confidence 999999853221 223457888999999887 66899999999999999999955 444332211 000111
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
... ....+.. +..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 232 ~~~----~~~~~~~--------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 EDR----HQLPAPK--------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HTT----CCCCCCS--------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hcc----CCCCCCC--------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 0111111 2237789999999999999999999999998865
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=316.46 Aligned_cols=271 Identities=18% Similarity=0.235 Sum_probs=202.4
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--------cccHHHHHHHHHHHhhcCCCCccceeeeEE
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--------TQGFAEFQSEVYVLNFARHKNIVMLLGFCC 89 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (315)
....++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 346789999999999999999999865 68999999976532 122234789999999999999999999975
Q ss_pred ecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC---ceeE
Q 046121 90 KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF---VPML 166 (315)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~---~i~l 166 (315)
.+..++||||+.+++|.+.+.. ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++ .++|
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -cCceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCCCcceEEE
Confidence 4557999999999999988853 45699999999999999999999999 999999999999997554 5999
Q ss_pred CCCCcccccCCCCCccccccccccccCcccccc---CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH
Q 046121 167 GDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN---GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
+|||++..... ........|++.|+|||++.+ ..++.++||||||+++|+|++|.+||........ ....
T Consensus 284 ~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~---- 356 (419)
T 3i6u_A 284 TDFGHSKILGE-TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ---- 356 (419)
T ss_dssp CCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHH----
T ss_pred eecccceecCC-CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHH----
Confidence 99999974433 222334678999999998853 5678899999999999999999999975433221 1110
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccccchhh
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLGEKFV 309 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~~~~~~ 309 (315)
...... . ..+.. ....+..+.+++.+||+.||++|||+.+++++-+-....+.....+++
T Consensus 357 i~~~~~-~-~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~ll 416 (419)
T 3i6u_A 357 ITSGKY-N-FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL 416 (419)
T ss_dssp HHTTCC-C-CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHHHHHHHH
T ss_pred HhcCCC-C-CCchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHHHHHHHh
Confidence 000000 0 00000 011244578999999999999999999999988876666555544444
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=305.78 Aligned_cols=259 Identities=27% Similarity=0.380 Sum_probs=202.5
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.++|++.+.||+|+||+||+|.+. ++.+++|++... ...+.+.+|+.+++.++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 368999999999999999999876 678999987643 34567889999999999999999999886 3479999999
Q ss_pred cCCccccccccCCC-CccCHHHHHHHHHHHHHHHHhhhc---ccCCCCeEeecCccCcEEEcCCCc-eeECCCCcccccC
Q 046121 102 CNKSLHWHLFDNTE-SVLEWHQRYAAAIGTAKGLRFLHE---ECRGGPIIHRDMRPSNILLTHDFV-PMLGDFGLARWKT 176 (315)
Q Consensus 102 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~~~i~h~di~p~nil~~~~~~-i~l~dfg~~~~~~ 176 (315)
.+++|.+++..... ..++...++.++.|++.++.+||+ . +++|+||||+||+++.++. ++|+|||++....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~----~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK----ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSS----CCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCC----CeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 99999999865443 247889999999999999999999 6 8999999999999998886 7999999986433
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
.. .....|++.|+|||++.+..++.++||||||+++|+|++|..||........... ... .. ...+.
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~-~~-----~~~~~ 224 (307)
T 2eva_A 158 TH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM----WAV-HN-----GTRPP 224 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH----HHH-HT-----TCCCC
T ss_pred cc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH----HHH-hc-----CCCCC
Confidence 21 2234689999999999998999999999999999999999999975433221111 000 01 11111
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccccc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLGE 306 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~~~ 306 (315)
.. ...+..+.+++.+||+.||++|||+.++++.|+.+...+.....
T Consensus 225 ~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 225 LI----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp CB----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred cc----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 11 22334578899999999999999999999999998877765443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=306.94 Aligned_cols=267 Identities=22% Similarity=0.326 Sum_probs=201.5
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeC----CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCK 90 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (315)
.+....++|++.+.||+|+||+||+|.+. ++..+++|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33445678999999999999999999654 3558999987654 23345668899999999999999999999876
Q ss_pred cC-----eeEEEEEeccCCcccccccc----CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC
Q 046121 91 EN-----LNILVYEYICNKSLHWHLFD----NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD 161 (315)
Q Consensus 91 ~~-----~~~lv~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~ 161 (315)
.. ..++|++|+.+++|.+++.. .....+++..++.++.|++.|+.+||+. +++|+||||+||+++.+
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR----NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCSGGGEEECTT
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCC
Confidence 54 35999999999999988743 2345699999999999999999999999 99999999999999999
Q ss_pred CceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHH
Q 046121 162 FVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQ 238 (315)
Q Consensus 162 ~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 238 (315)
+.++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ ..
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~ 260 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YD 260 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HH
Confidence 9999999999864433221 1223456788999999999889999999999999999999 8889865443211 11
Q ss_pred hHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccccc
Q 046121 239 WAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~ 303 (315)
..... ..+ ..+...+..+.+++.+||..||++|||+.++++.|+.+..++++
T Consensus 261 ---~~~~~------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 261 ---YLLHG------HRL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp ---HHHTT------CCC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred ---HHHcC------CCC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 00100 011 11222344688899999999999999999999999998776654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=301.75 Aligned_cols=256 Identities=21% Similarity=0.272 Sum_probs=205.3
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
+.++|++.+.||+|+||+||+|.+. +++.+++|++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4689999999999999999999876 68899999876543 33456688999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc---eeECCCCcccc
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV---PMLGDFGLARW 174 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~---i~l~dfg~~~~ 174 (315)
|||+.+++|.+.+... ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++. ++|+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999998877543 4589999999999999999999999 9999999999999987655 99999999974
Q ss_pred cCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 175 KTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
..... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... . ..... ... .....
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~----~~~~~-~~~-~~~~~ 228 (284)
T 3kk8_A 158 VNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--L----YAQIK-AGA-YDYPS 228 (284)
T ss_dssp CCSSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----HHHHH-HTC-CCCCT
T ss_pred cccCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--H----HHHHH-hcc-ccCCc
Confidence 44322 2234578999999999999999999999999999999999999996433211 1 11111 100 01111
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
+ .....+..+.+++.+||+.||++|||+.+++++-+-
T Consensus 229 ~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 229 P-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp T-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred h-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 1 111233457889999999999999999999986543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=296.16 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=205.8
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
..++|++.+.||+|++|+||+|.+. +++.+++|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 5679999999999999999999876 68999999886543 334567889999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+++.. ...+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 85 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999998853 34689999999999999999999999 9999999999999999999999999998644322
Q ss_pred C--CccccccccccccCccccccCCC-cccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 179 D--PVQTKILGTLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 179 ~--~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
. .......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||........ ....+ .... ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----~~~~---~~--- 227 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW----KEKK---TY--- 227 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH----HTTC---TT---
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh----hhcc---cc---
Confidence 2 11234568899999999987665 7789999999999999999999975443221 11111 1000 00
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.......+..+.+++.+||+.||++|||+.+++++-+
T Consensus 228 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 228 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred ---cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 0011223445788999999999999999999987544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=305.43 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=199.7
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEe-cCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK-ENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~~~ 100 (315)
.++|++.+.||+|++|+||++.++ ++.+++|++... ...+.+.+|+.+++.++||||+++++++.+ .+..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 578999999999999999999875 788999988654 345678899999999999999999998654 4578999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.......+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC----CccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999998665445589999999999999999999999 9999999999999999999999999998633322
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ... .... ....
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~----~~~~---------~~~~ 233 (278)
T 1byg_A 171 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEK---------GYKM 233 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHH----HHTT---------TCCC
T ss_pred -ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhc---------CCCC
Confidence 223356788999999998889999999999999999998 999996543221 110 0111 0111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
..+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 12223345688899999999999999999999999988654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=323.27 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=209.6
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 378999999999999999999876 69999999986532 23456788999999999999999999999999999999
Q ss_pred EEeccCCccccccccCC--CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 98 YEYICNKSLHWHLFDNT--ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
|||+.|++|.+++.... ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.+|.++|+|||++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~----gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR----NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc----CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999998886543 45699999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
...........|++.|+|||++.+..++.++|+|||||++|+|++|..||......... ..........
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i~~~--------- 408 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRVLEQ--------- 408 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHHHHC---------
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHHhhc---------
Confidence 54443344468999999999999999999999999999999999999999765432211 1111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHHHhc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSM-----GEVVRLLEG 296 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~-----~~il~~L~~ 296 (315)
...++...+..+.+++.+||+.||++||++ .+++.+-+-
T Consensus 409 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff 452 (543)
T 3c4z_A 409 --AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452 (543)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGG
T ss_pred --ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccc
Confidence 011122334567889999999999999965 677765443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=308.52 Aligned_cols=265 Identities=23% Similarity=0.234 Sum_probs=201.9
Q ss_pred HhcCCccc-ceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEE
Q 046121 21 ATGDFSKE-NLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 21 ~~~~y~~~-~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 97 (315)
..++|++. +.||+|+||+||+|.+. +++.||+|++..........+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 45689985 78999999999999865 6899999998876666677889999999885 799999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc---eeECCCCcccc
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV---PMLGDFGLARW 174 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~---i~l~dfg~~~~ 174 (315)
|||+.+++|.+++... ..+++..+..++.|++.|+.+||+. +++|+||||+||+++.++. ++|+|||++..
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK----GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999988653 4589999999999999999999999 9999999999999988776 99999999864
Q ss_pred cCCCC-------CccccccccccccCcccccc-----CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhH------
Q 046121 175 KTTDD-------PVQTKILGTLGYLAPEYAEN-----GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSL------ 236 (315)
Q Consensus 175 ~~~~~-------~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~------ 236 (315)
..... .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 33211 11123458999999999865 4578899999999999999999999975543221100
Q ss_pred --HHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 237 --RQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 237 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
............ .. .........+..+.+++.+||..||++|||+.+++++-+-.
T Consensus 244 ~~~~~~~~~i~~~~-~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 244 ACQNMLFESIQEGK-YE-----FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp HHHHHHHHHHHHCC-CC-----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred hHHHHHHHHHhccC-cc-----cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 000001111100 00 00000011345688999999999999999999999976543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=312.35 Aligned_cols=275 Identities=20% Similarity=0.199 Sum_probs=197.9
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--ccHHHHHHHHHHHhhcCCCCccceeeeEEecCe
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL 93 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (315)
......++|++++.||+|+||+||+|.+. +++.||+|++..... .....+.+|+.+++.++||||+++++++.....
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 44456689999999999999999999865 789999999865432 224456789999999999999999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc-----CCCceeECC
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT-----HDFVPMLGD 168 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~-----~~~~i~l~d 168 (315)
.++||||+. ++|.+++.... .+++..++.++.|++.++.+||+. +++|+||||+||+++ ..+.++|+|
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR----RCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC----CEECCCCCHHHEEEecCCCCccceEEECc
Confidence 999999986 48888885543 489999999999999999999999 999999999999994 455699999
Q ss_pred CCcccccCCCCCccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh
Q 046121 169 FGLARWKTTDDPVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL 247 (315)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (315)
||++..............+++.|+|||++.+. .++.++||||||+++|+|++|..||...... ......... ....
T Consensus 181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~-~~~~ 257 (329)
T 3gbz_A 181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQLFKIFEV-LGLP 257 (329)
T ss_dssp TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHH-HCCC
T ss_pred CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHHHHHHHH-hCCC
Confidence 99997655443344455779999999998764 4799999999999999999999999654321 111111110 0000
Q ss_pred c---ccc-----ccCCcc--------cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 248 A---LHE-----LIDPRI--------ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 248 ~---~~~-----~~~~~~--------~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
. ... ...... ....+...+..+.+++.+||+.||++|||+.+++++-+--...|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 0 000 000000 00011113456789999999999999999999998766544443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=298.91 Aligned_cols=265 Identities=17% Similarity=0.247 Sum_probs=203.4
Q ss_pred HHhcCCcccceecCCCceEEEEEEe-CCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeE-EecCeeEEE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGEL-KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFC-CKENLNILV 97 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv 97 (315)
...++|++.+.||+|+||+||+|.+ .+++.||+|+...... ...+.+|+.+++.++|++++..+..+ ......++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3568999999999999999999987 4788999998654332 24578899999999988877666655 677788999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE---cCCCceeECCCCcccc
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL---THDFVPMLGDFGLARW 174 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~---~~~~~i~l~dfg~~~~ 174 (315)
|||+ +++|.+++.... ..+++..++.++.|++.|+.+||+. +++|+||||+||++ +.++.++|+|||++..
T Consensus 84 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 9999 999999886433 3599999999999999999999999 99999999999999 7899999999999975
Q ss_pred cCCCCC-------ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccch-hHHHhHHHHHhh
Q 046121 175 KTTDDP-------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ-SLRQWAEPLIEK 246 (315)
Q Consensus 175 ~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~ 246 (315)
...... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||......... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 443322 123457899999999999989999999999999999999999999765433322 222211111110
Q ss_pred hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
.. +..... .+..+.+++.+||+.||++|||+.++++.|+.+..+..
T Consensus 238 -~~-----~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 238 -PI-----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -CH-----HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -hh-----hhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 00 001111 13458889999999999999999999999998876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=301.88 Aligned_cols=264 Identities=28% Similarity=0.467 Sum_probs=197.8
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
..+...++|++.+.||+|+||+||+|.+.. .+++|++.... ....+.+.+|+.+++.++||||++++++. .....
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 334457899999999999999999998654 48999876543 33456788999999999999999999965 55668
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++||+|+.+++|.+.+... ...+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 95 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK----SIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred EEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCCCEEEccceeccc
Confidence 9999999999998888543 35589999999999999999999999 999999999999999999999999999864
Q ss_pred cCCCC--CccccccccccccCccccc---cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcc
Q 046121 175 KTTDD--PVQTKILGTLGYLAPEYAE---NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249 (315)
Q Consensus 175 ~~~~~--~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (315)
..... .......|++.|+|||.+. +..++.++||||||+++|+|++|..||....... ... ........
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~----~~~~~~~~ 243 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QII----EMVGRGSL 243 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHH----HHHHHTSC
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHH----HHhccccc
Confidence 33211 1223356899999999886 5667889999999999999999999996543221 111 11111111
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
. +. ........+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 244 ~----~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 S----PD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp C----CC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred C----cc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1 11 111222334568899999999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=304.54 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=204.3
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
.+.++|++.+.||+|+||+||+|.+. +++.+++|++..........+.+|+.+++.++||||+++++++......++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 46789999999999999999999876 68999999988665555567889999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE---cCCCceeECCCCccccc
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL---THDFVPMLGDFGLARWK 175 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~---~~~~~i~l~dfg~~~~~ 175 (315)
||+.+++|.+.+... ..+++..++.++.|++.++.+||+. +++|+||+|+||++ +.++.++|+|||++...
T Consensus 86 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 86 QLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN----GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999998888543 3589999999999999999999999 99999999999999 78899999999998633
Q ss_pred CCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
.. .......|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ......... . .
T Consensus 160 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~-~-~----- 224 (304)
T 2jam_A 160 QN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KLFEKIKEG-Y-Y----- 224 (304)
T ss_dssp CC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHC-C-C-----
T ss_pred CC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcC-C-C-----
Confidence 22 2223346899999999999988999999999999999999999999654321 111111111 0 0
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
..........+..+.+++.+||..||++|||+.+++++-+
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 225 EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 0111112233456889999999999999999999998544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=306.64 Aligned_cols=264 Identities=23% Similarity=0.273 Sum_probs=206.0
Q ss_pred HhcCCcccceecCCCceEEEEEEe-CCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEe----cCeeE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGEL-KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK----ENLNI 95 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~ 95 (315)
..++|++.+.||+|+||+||++.+ .+++.||+|++........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 357899999999999999999987 4789999998876666667788999999999999999999999863 34779
Q ss_pred EEEEeccCCccccccccC--CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 96 LVYEYICNKSLHWHLFDN--TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+|+||+.+++|.+++... ....+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK----GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 999999999999888652 346699999999999999999999999 99999999999999999999999999886
Q ss_pred ccCCCCCc---------cccccccccccCccccccCC---CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH
Q 046121 174 WKTTDDPV---------QTKILGTLGYLAPEYAENGI---VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE 241 (315)
Q Consensus 174 ~~~~~~~~---------~~~~~~~~~~~aPE~~~~~~---~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 241 (315)
........ .....|++.|+|||.+.+.. ++.++||||||+++|+|++|..||.......... ..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~--- 258 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV-AL--- 258 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH-HH---
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh-hH---
Confidence 43221110 01234688999999987654 6789999999999999999999985311111000 00
Q ss_pred HHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 242 PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
.... ..........+..+.+++.+||+.||++|||+.++++.|+.+....+
T Consensus 259 -~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 259 -AVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp -HHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred -Hhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 0000 00001112234568899999999999999999999999998876544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=306.92 Aligned_cols=259 Identities=22% Similarity=0.251 Sum_probs=206.4
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEe--cCeeE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCK--ENLNI 95 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 95 (315)
..++|++++.||+|+||+||+|.+. +++.+++|++.... ....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4579999999999999999999876 68999999886542 3345668899999999999999999998754 67889
Q ss_pred EEEEeccCCccccccccC--CCCccCHHHHHHHHHHHHHHHHhhhcccCCCC-----eEeecCccCcEEEcCCCceeECC
Q 046121 96 LVYEYICNKSLHWHLFDN--TESVLEWHQRYAAAIGTAKGLRFLHEECRGGP-----IIHRDMRPSNILLTHDFVPMLGD 168 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~-----i~h~di~p~nil~~~~~~i~l~d 168 (315)
+||||+.+++|.+++... ....+++..++.++.|++.++.+||+. + ++|+||+|+||+++.++.++|+|
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR----SDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH----C------CCCCCSGGGEEECSSSCEEECC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc----cCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 999999999999988643 234589999999999999999999999 8 99999999999999999999999
Q ss_pred CCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhc
Q 046121 169 FGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248 (315)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (315)
||++..............+++.|+|||.+.+..++.++||||||+++|+|++|..||...... ..... .....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-i~~~~ 232 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGK-IREGK 232 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHTC
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------HHHHH-Hhhcc
Confidence 999975544333333456889999999999888999999999999999999999999654321 11111 11111
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 249 LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
. +. .+...+..+.+++.+||+.||++|||+.++++.++...+
T Consensus 233 ~-----~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 233 F-----RR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp C-----CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred c-----cc----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 1 11 122234568889999999999999999999998876644
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=310.53 Aligned_cols=247 Identities=21% Similarity=0.240 Sum_probs=202.9
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--------ccHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--------QGFAEFQSEVYVLNFARHKNIVMLLGFCCK 90 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (315)
...++|++.+.||+|+||+||+|.+. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 35679999999999999999999865 688999998775431 123456789999999999999999999999
Q ss_pred cCeeEEEEEeccCC-ccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCC
Q 046121 91 ENLNILVYEYICNK-SLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDF 169 (315)
Q Consensus 91 ~~~~~lv~~~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~df 169 (315)
.+..++|||++.++ +|.+++... ..+++..++.++.|++.++.|||+. +++|+||||+||+++.++.++|+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLK----DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999998666 888888543 3599999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCccccccccccccCccccccCCC-cccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhc
Q 046121 170 GLARWKTTDDPVQTKILGTLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248 (315)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (315)
|++....... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.......
T Consensus 175 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------- 237 (335)
T 3dls_A 175 GSAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------- 237 (335)
T ss_dssp TTCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----------------
T ss_pred ccceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----------------
Confidence 9997544332 2334578999999999988776 788999999999999999999995421100
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 249 LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.... ..+...+..+.+++.+||+.||++|||+.+++++-+-
T Consensus 238 -~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 238 -EAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp -TTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred -hhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 0000 0111134457889999999999999999999998653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=302.26 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=203.9
Q ss_pred HhcCCcccceecCCCceEEEEEEeCC----CcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeE-EecCee
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKD----GQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFC-CKENLN 94 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~ 94 (315)
...+|++.+.||+|+||+||+|.+.. ...+++|.+... .....+.+.+|+.+++.++||||+++++++ ..++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 45679999999999999999997542 335788877653 334456788999999999999999999985 456688
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++||||+.+++|.+++... ...+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 103 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEECCCCCEEECccccccc
Confidence 9999999999999988643 34589999999999999999999999 999999999999999999999999999964
Q ss_pred cCCCCC----ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcc
Q 046121 175 KTTDDP----VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249 (315)
Q Consensus 175 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (315)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.......... . ....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~--~----~~~~--- 248 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV--Y----LLQG--- 248 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH--H----HHTT---
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH--H----HhcC---
Confidence 432211 1123456788999999998899999999999999999999 556665443322111 0 0000
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccccc
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~ 303 (315)
... ..+...+..+.+++.+||..||++|||+.++++.|+.+...+..
T Consensus 249 ---~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 249 ---RRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp ---CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred ---CCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 001 11112234588899999999999999999999999998776543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=310.80 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=198.5
Q ss_pred HhcCCcccceecCCCceEEEEEEeCCCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCC--CCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARH--KNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~l 96 (315)
..++|++++.||+|+||+||++.+.+++.||+|++... .....+.+.+|+.+++.++| |||+++++++......++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 45789999999999999999999888999999987654 33345678899999999986 999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||| +.+++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++ ++.++|+|||++....
T Consensus 87 v~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~----~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 4688999988653 4589999999999999999999999 999999999999997 6789999999997543
Q ss_pred CCCC--ccccccccccccCcccccc-----------CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH
Q 046121 177 TDDP--VQTKILGTLGYLAPEYAEN-----------GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 177 ~~~~--~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
.... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||....... .. ....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~-~~~~ 233 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SK-LHAI 233 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HH-HHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH----HH-HHHH
Confidence 3222 1234578999999998864 667889999999999999999999996432211 11 0111
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.++......+...+..+.+++.+||+.||++|||+.+++++.+-
T Consensus 234 ---------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 234 ---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp ---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ---------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 11111122222233457899999999999999999999987654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=304.18 Aligned_cols=266 Identities=21% Similarity=0.250 Sum_probs=199.9
Q ss_pred HHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc---ccHHHHHHHHHHHhhcCCCCccceeeeEEecCe
Q 046121 18 IQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST---QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL 93 (315)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (315)
.....++|++.+.||+|+||+||+|.+. +++.|++|++..... ...+.+.+|+.+++.++||||+++++++..++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 4446689999999999999999999876 688999999875432 234668899999999999999999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.++|+||+.+++|.+++... ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~ 182 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA----GATHRDVKPENILVSADDFAYLVDFGIAS 182 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----cCCcCCCChHHEEEcCCCCEEEecCccCc
Confidence 99999999999999988643 4589999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCC-CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 174 WKTTDD-PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 174 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...... . ........ .
T Consensus 183 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~-~~~~~~~~----~ 251 (309)
T 2h34_A 183 ATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------V-MGAHINQA----I 251 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------H-HHHHHHSC----C
T ss_pred cccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------H-HHHHhccC----C
Confidence 443322 1223456889999999999888999999999999999999999999643211 1 01111110 0
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhcccccccc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRP-SMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-s~~~il~~L~~~~~~~~~ 303 (315)
.. ....+...+..+.+++.+||+.||++|| |++++++.|+........
T Consensus 252 ~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 252 PR---PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp CC---GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred CC---ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 00 1111222334578899999999999999 999999999988765543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=308.54 Aligned_cols=260 Identities=26% Similarity=0.347 Sum_probs=204.3
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEE--EEEEeccc-CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMI--AAKVRKEA-STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~--~~k~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 96 (315)
.++|++.+.||+|+||.||+|.+. ++..+ ++|.+... .......+.+|+.+++.+ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 368999999999999999999765 45544 88876643 333456688999999999 89999999999999999999
Q ss_pred EEEeccCCccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC
Q 046121 97 VYEYICNKSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF 162 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~ 162 (315)
||||+.+++|.+++.... ...+++..++.++.|++.++.+||+. +++|+||||+||+++.++
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENY 179 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGG
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCccceEEEcCCC
Confidence 999999999999886543 34699999999999999999999999 999999999999999999
Q ss_pred ceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHH
Q 046121 163 VPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAE 241 (315)
Q Consensus 163 ~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 241 (315)
.++|+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~ 252 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE 252 (327)
T ss_dssp CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHH
T ss_pred eEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HHH
Confidence 9999999998632211 11223456788999999988889999999999999999998 999996543211 001
Q ss_pred HHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 242 PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
. ... .... ..+...+..+.+++.+||..||++|||+.++++.|+.+..+..
T Consensus 253 ~-~~~-----~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 253 K-LPQ-----GYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp H-GGG-----TCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred H-hhc-----CCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 000 1111 1122234568899999999999999999999999998766544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=303.09 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=207.5
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++.+.||+|+||+||++.+. +++.+++|++.... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 4578999999999999999999876 58889999876542 3345668899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.+++|.+++... ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 93 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999998887543 4589999999999999999999999 99999999999999999999999999997554
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
..........+++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ........ ...
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~-------~~~ 233 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKN-------EYS 233 (294)
T ss_dssp STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTT-------CCC
T ss_pred cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhhc-------cCC
Confidence 44444445678999999999998889999999999999999999999996543211 00111100 001
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.+...+..+.+++.+||+.||++|||+.+++++.+-
T Consensus 234 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 234 ----IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred ----CccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 112233457889999999999999999999986543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=319.04 Aligned_cols=267 Identities=19% Similarity=0.198 Sum_probs=210.3
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|+++++||+|+||+||+|.+. +++.||+|++.... ......+.+|..+++.++||||+++++++.+.+.+|+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 4579999999999999999999876 58899999986532 2223347889999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.|++|.+++.+. ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 152 V~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 99999999999998653 34599999999999999999999999 99999999999999999999999999997544
Q ss_pred CCCCc-cccccccccccCccccc-----cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccc
Q 046121 177 TDDPV-QTKILGTLGYLAPEYAE-----NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250 (315)
Q Consensus 177 ~~~~~-~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (315)
..... ....+|++.|+|||++. +..++.++|||||||++|+|++|.+||...+.. ..... .......
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~--~~~~~----i~~~~~~- 299 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGK----IMNHKER- 299 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH----HHTHHHH-
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh--HHHHh----hhhcccc-
Confidence 43322 23457999999999886 456889999999999999999999999654321 11111 1110000
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHHhccccccccc
Q 046121 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEG--RPSMGEVVRLLEGENDRFHHL 304 (315)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~--Rps~~~il~~L~~~~~~~~~~ 304 (315)
..-+... ...+..+.+|+.+||..+|++ ||++++++++-+--.-.|..+
T Consensus 300 -~~~p~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 300 -FQFPTQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp -CCCCSSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred -ccCCccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 0011111 113445788999999888888 999999999877655555544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=296.92 Aligned_cols=264 Identities=17% Similarity=0.247 Sum_probs=207.1
Q ss_pred HhcCCcccceecCCCceEEEEEEe-CCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeE-EecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGEL-KDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFC-CKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~ 98 (315)
..++|++.+.||+|+||+||+|.+ .+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357999999999999999999987 4799999998765433 34688999999999988877666655 6677889999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE---cCCCceeECCCCccccc
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL---THDFVPMLGDFGLARWK 175 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~---~~~~~i~l~dfg~~~~~ 175 (315)
||+ +++|.+++.... ..+++..++.++.|++.|+.+||+. +++|+||||+||++ +.++.++|+|||++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 999999886433 4599999999999999999999999 99999999999999 58899999999999754
Q ss_pred CCCCC-------ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccc-hhHHHhHHHHHhhh
Q 046121 176 TTDDP-------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ-QSLRQWAEPLIEKL 247 (315)
Q Consensus 176 ~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~ 247 (315)
..... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||........ .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 237 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST- 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-
Confidence 43322 12345789999999999998999999999999999999999999976443322 2222211111110
Q ss_pred ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
.. +..... .+..+.+++.+||+.||++|||+.++++.|+.+..+..
T Consensus 238 ~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 238 PI-----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp CH-----HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ch-----HHHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 00 001111 23457889999999999999999999999998765543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=306.68 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=199.8
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcE----EEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQM----IAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~----~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
.++|++++.||+|+||+||+|.+. +++. +++|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 478999999999999999999865 4443 466665433 3445677899999999999999999999998765 78
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
++++++.+++|.+++.... ..+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC----CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 8999999999999886543 3589999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 176 TTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 176 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ .. ......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~----~~~~~~---- 236 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SS----ILEKGE---- 236 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----HHHTTC----
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HH----HHHcCC----
Confidence 332221 223345778999999999999999999999999999999 9999975543321 11 111110
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
....+...+..+.+++.+||..||++|||+.++++.|+.+...
T Consensus 237 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 -----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111222344578899999999999999999999999988754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=310.00 Aligned_cols=270 Identities=16% Similarity=0.186 Sum_probs=202.2
Q ss_pred HhcCCcccceecCCCceEEEEEEeCC------CcEEEEEEecccCcccH-----------HHHHHHHHHHhhcCCCCccc
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKD------GQMIAAKVRKEASTQGF-----------AEFQSEVYVLNFARHKNIVM 83 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~k~~~~~~~~~~-----------~~~~~e~~~l~~l~~~~i~~ 83 (315)
..++|++.+.||+|+||+||+|.+.. ++.||+|++........ .....|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34589999999999999999998754 47899998765432111 11334556677788999999
Q ss_pred eeeeEEec----CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc
Q 046121 84 LLGFCCKE----NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT 159 (315)
Q Consensus 84 ~~~~~~~~----~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~ 159 (315)
+++++... ...++||||+ |++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~----~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH----EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEEecCCHHHEEEe
Confidence 99998764 5589999999 99999988654 34599999999999999999999999 999999999999999
Q ss_pred --CCCceeECCCCcccccCCCCC-------ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCC
Q 046121 160 --HDFVPMLGDFGLARWKTTDDP-------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGE 230 (315)
Q Consensus 160 --~~~~i~l~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~ 230 (315)
.++.++|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 889999999999964432211 11234589999999999999999999999999999999999999975333
Q ss_pred ccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 231 EPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
....... ..... .......+++.+. ....+..+.+++..||..||++||++.++++.|+.+..+..
T Consensus 267 ~~~~~~~--~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 267 DPKYVRD--SKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp CHHHHHH--HHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CHHHHHH--HHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 2211111 01000 0111111111111 01123457889999999999999999999999988766543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=313.01 Aligned_cols=265 Identities=25% Similarity=0.298 Sum_probs=194.7
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCccc-HHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQG-FAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
++|++++.||+|+||+||+|.+. +++.||+|++....... ...+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 58999999999999999999876 78999999886543221 12345799999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+. ++|.+++... ...+++..+..++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 86 5787777554 34589999999999999999999999 999999999999999999999999999975444443
Q ss_pred ccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh---ccccccC--
Q 046121 181 VQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL---ALHELID-- 254 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-- 254 (315)
......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....... .... ........ .+.....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~-i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHF-IFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCTTTSTTGGGCH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCChHhchhhhcch
Confidence 3444578999999998876 567899999999999999999999997543221 1111 11110000 0000000
Q ss_pred -------Cccc----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 255 -------PRIE----NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 255 -------~~~~----~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
+... ....+..+..+.+++.+||+.||++|||+++++++-+-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 285 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence 0000 00111234557899999999999999999999986543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=301.35 Aligned_cols=254 Identities=21% Similarity=0.238 Sum_probs=198.4
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
+.++|++.+.||+|+||+||+|.+. ++..+++|++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 5678999999999999999999875 68899999876543 344677899999999999999999999999999999999
Q ss_pred EeccCCccccccccC--CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE---cCCCceeECCCCccc
Q 046121 99 EYICNKSLHWHLFDN--TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL---THDFVPMLGDFGLAR 173 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~---~~~~~i~l~dfg~~~ 173 (315)
||+.+++|.+.+... ....+++..++.++.|++.++.+||+. +++|+||+|+||++ +.++.++|+|||++.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ----HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999998887543 235699999999999999999999999 99999999999999 456889999999996
Q ss_pred ccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 174 WKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
..... .......+++.|+|||.+. ..++.++||||||+++|+|++|..||....... ......... ..
T Consensus 176 ~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~----~~ 243 (285)
T 3is5_A 176 LFKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQKATYKE----PN 243 (285)
T ss_dssp C-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC----CC
T ss_pred ecCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHhhhccCC----cc
Confidence 43332 2233456899999999886 467899999999999999999999996543211 111111000 00
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
....... .+..+.+++.+||+.||++|||+.+++++-
T Consensus 244 ~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 280 (285)
T 3is5_A 244 YAVECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280 (285)
T ss_dssp CCC--CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred cccccCc----CCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0000011 234577899999999999999999998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=306.43 Aligned_cols=266 Identities=18% Similarity=0.264 Sum_probs=209.0
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCccc-----------------HHHHHHHHHHHhhcCCCCccce
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQG-----------------FAEFQSEVYVLNFARHKNIVML 84 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~-----------------~~~~~~e~~~l~~l~~~~i~~~ 84 (315)
.++|++.+.||+|+||+||+|.+ +++.||+|++....... ...+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47999999999999999999998 89999999876542221 1778999999999999999999
Q ss_pred eeeEEecCeeEEEEEeccCCccccc------cccCCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEE
Q 046121 85 LGFCCKENLNILVYEYICNKSLHWH------LFDNTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNIL 157 (315)
Q Consensus 85 ~~~~~~~~~~~lv~~~~~~~~L~~~------l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil 157 (315)
++++.+.+..++||||+.+++|.++ +.......+++..++.++.|++.|+.+||+ . |++|+||+|+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK----NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS----CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC----CEeecCCChHhEE
Confidence 9999999999999999999999998 655546789999999999999999999999 8 9999999999999
Q ss_pred EcCCCceeECCCCcccccCCCCCccccccccccccCccccccC-CCcc-cccchhhhHHHHHHHhCCCccCCCCCccchh
Q 046121 158 LTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENG-IVSI-RTDVYAFGIILLQLMSGRKVVDMNGEEPQQS 235 (315)
Q Consensus 158 ~~~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~ 235 (315)
++.++.++|+|||.+...... ......+++.|+|||.+.+. .++. ++||||||+++|+|++|..||....... .
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--E 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--H
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--H
Confidence 999999999999999754332 33445789999999999877 5665 9999999999999999999997544311 1
Q ss_pred HHHhHHHHHhhhccccccC----------CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 236 LRQWAEPLIEKLALHELID----------PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
.. .. ...... .... +..........+..+.+++.+||+.||++|||+.+++++-+-....+
T Consensus 261 ~~---~~-i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 261 LF---NN-IRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp HH---HH-HTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred HH---HH-HhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 11 01 111000 0000 00000011234556889999999999999999999999765444333
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=321.60 Aligned_cols=256 Identities=22% Similarity=0.239 Sum_probs=204.4
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
.+.++|++++.||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++......++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 46789999999999999999999876 7899999997643 23445678999999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc---CCCceeECCCCccc
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT---HDFVPMLGDFGLAR 173 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~---~~~~i~l~dfg~~~ 173 (315)
||||+.+++|.+.+... ..+++..++.++.|++.|+.|||+. +++|+||||+||+++ .++.++|+|||++.
T Consensus 99 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999998888543 4589999999999999999999999 999999999999995 45679999999997
Q ss_pred ccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 174 WKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
..... .......|++.|+|||++.+ .++.++||||||+++|+|++|.+||....... .. .... .... ..
T Consensus 173 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~----~~i~-~~~~-~~- 241 (486)
T 3mwu_A 173 CFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--IL----KRVE-TGKY-AF- 241 (486)
T ss_dssp TBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHH-HTCC-CS-
T ss_pred ECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH----HHHH-hCCC-CC-
Confidence 44332 22344578999999999876 48899999999999999999999996543211 11 1111 1100 00
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
........+..+.+++.+||+.||++|||+.+++++-+-
T Consensus 242 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 242 ----DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp ----CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred ----CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence 001112234568899999999999999999999987543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=307.58 Aligned_cols=274 Identities=25% Similarity=0.270 Sum_probs=200.2
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc-----cHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ-----GFAEFQSEVYVLNFARHKNIVMLLGFCCK 90 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (315)
.+....++|++.+.||+|+||+||+|.+. +++.||+|++...... ....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 34556789999999999999999999876 6899999987643221 12457899999999999999999999999
Q ss_pred cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCC
Q 046121 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
.+..++||||+.+ +|.+.+... ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred CCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCCHHHEEEcCCCCEEEEecc
Confidence 9999999999976 777766443 34588899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhh--h
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK--L 247 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~ 247 (315)
++..............+++.|+|||++.+. .++.++||||||+++|+|++|.+||...... ..+.......... .
T Consensus 158 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 158 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEE 235 (346)
T ss_dssp GGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTT
T ss_pred cceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHcCCCChh
Confidence 997554444444456789999999998654 4788999999999999999999998654321 1111111110000 0
Q ss_pred cccc------ccCCcccCC-----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 248 ALHE------LIDPRIENS-----YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 248 ~~~~------~~~~~~~~~-----~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
.+.. ......... .....+..+.+++.+||..||++|||+.+++++-+-..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 0000 000000000 01223466889999999999999999999999876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=318.27 Aligned_cols=263 Identities=20% Similarity=0.198 Sum_probs=196.5
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEec------C
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE------N 92 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 92 (315)
.++|++++.||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999866 6899999998754 344456788999999999999999999999654 3
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
..|+||||+.++ +.+.+. ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999765 544442 2388999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH----------
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP---------- 242 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 242 (315)
...... .......|++.|+|||++.+..++.++|||||||++|+|++|.+||...... ..+......
T Consensus 212 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~--~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 212 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp -----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHHT
T ss_pred eecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHHHH
Confidence 744332 2234467899999999999999999999999999999999999999654321 111111100
Q ss_pred --------HHhhhc------cccccCCcccC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 243 --------LIEKLA------LHELIDPRIEN---SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 243 --------~~~~~~------~~~~~~~~~~~---~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
...... ....+...... ......+..+.+|+.+||..||++|||+++++++-+-
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence 000000 00000000000 0111225668999999999999999999999987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=308.13 Aligned_cols=284 Identities=21% Similarity=0.243 Sum_probs=210.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEe-------
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCK------- 90 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------- 90 (315)
..++|++++.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 3579999999999999999999875 78999999876443 2234567899999999999999999999877
Q ss_pred -cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCC
Q 046121 91 -ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDF 169 (315)
Q Consensus 91 -~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~df 169 (315)
.+..++||||+.+ +|.+.+... ...+++..++.++.|++.|+.+||+. |++|+||||+||+++.++.++|+||
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4568999999875 665555433 34599999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCC----CccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH
Q 046121 170 GLARWKTTDD----PVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI 244 (315)
Q Consensus 170 g~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (315)
|++....... .......|++.|+|||++.+ ..++.++||||||+++|+|++|.+||........ ... .....
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~-i~~~~ 245 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ--LAL-ISQLC 245 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHh
Confidence 9997543221 12234567999999998876 4579999999999999999999999975432211 111 11111
Q ss_pred hhhc---ccc--------ccC--CcccCCCCHH-----HHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccccc
Q 046121 245 EKLA---LHE--------LID--PRIENSYDTY-----ELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLGE 306 (315)
Q Consensus 245 ~~~~---~~~--------~~~--~~~~~~~~~~-----~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~~~ 306 (315)
.... ... ... .......... .+..+.+|+.+||+.||++|||+.+++++-+-..+..+..-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~ 325 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLK 325 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCSH
T ss_pred CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccccc
Confidence 0000 000 000 0000000000 133478999999999999999999999998877666666655
Q ss_pred hhhhccc
Q 046121 307 KFVQRHH 313 (315)
Q Consensus 307 ~~~~~~~ 313 (315)
..++.+.
T Consensus 326 ~~~~~~~ 332 (351)
T 3mi9_A 326 GMLSTHL 332 (351)
T ss_dssp HHHHSSC
T ss_pred cccCcch
Confidence 5555543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=298.39 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=199.5
Q ss_pred CcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccC
Q 046121 25 FSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
|.....||+|+||+||+|.+. +++.|++|++........+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 444449999999999999875 6889999998876666677889999999999999999999999999999999999999
Q ss_pred CccccccccCC-CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC-CCceeECCCCcccccCCCCCc
Q 046121 104 KSLHWHLFDNT-ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH-DFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 104 ~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~-~~~i~l~dfg~~~~~~~~~~~ 181 (315)
++|.+++.... ...+++..++.++.|++.|+.+||+. +++|+||+|+||+++. ++.++|+|||++.........
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC----CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 99999886543 34567889999999999999999999 9999999999999988 899999999999755444433
Q ss_pred cccccccccccCccccccCC--CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 182 QTKILGTLGYLAPEYAENGI--VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.....|++.|+|||++.+.. ++.++||||||+++|+|++|..||.......... ... ... ...+.+
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~-~~~----~~~~~~-- 247 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM-----FKV-GMF----KVHPEI-- 247 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH-----HHH-HHH----CCCCCC--
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH-----Hhh-ccc----cccccc--
Confidence 44567899999999987643 7889999999999999999999996433211100 000 000 111122
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
+...+..+.+++.+||+.||++|||+.+++++-+-
T Consensus 248 --~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 282 (295)
T 2clq_A 248 --PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282 (295)
T ss_dssp --CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred --cccCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 22334557889999999999999999999875443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=308.22 Aligned_cols=262 Identities=24% Similarity=0.351 Sum_probs=208.9
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEec
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE 91 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (315)
....++|++.+.||+|+||+||+|.+. +++.|++|++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345679999999999999999999754 37789999887543 23345688999999999999999999999999
Q ss_pred CeeEEEEEeccCCccccccccCC--------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc
Q 046121 92 NLNILVYEYICNKSLHWHLFDNT--------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV 163 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~ 163 (315)
+..++||||+.+++|.+++.... ...+++..++.++.|++.|+.+||+. +++|+||||+||+++.++.
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTCC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CCccCCCccceEEEcCCCe
Confidence 99999999999999999885422 24578999999999999999999999 9999999999999999999
Q ss_pred eeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhH
Q 046121 164 PMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWA 240 (315)
Q Consensus 164 i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 240 (315)
++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~ 250 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVL 250 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HHH
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------HHH
Confidence 99999999864432221 1123456788999999998889999999999999999999 88988643321 111
Q ss_pred HHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
.. ...... ...+...+..+.+++.+||+.||++|||+.++++.|+.....
T Consensus 251 ~~-~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 251 RF-VMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HH-HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HH-HHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 11 111111 111223345588899999999999999999999999987653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=316.73 Aligned_cols=269 Identities=22% Similarity=0.216 Sum_probs=210.0
Q ss_pred HHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCe
Q 046121 18 IQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL 93 (315)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (315)
.....++|++++.||+|+||+||+|..+ +++.||+|++.+.. ......+.+|..++..++||||+++++++.+.+.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 3345689999999999999999999876 69999999986532 2334457899999999999999999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+|+||||+.|++|.+++.+.. ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL----GYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccCHHHeeecCCCCEEEeechhhe
Confidence 999999999999999986432 3589999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCc-cccccccccccCccccc-------cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh
Q 046121 174 WKTTDDPV-QTKILGTLGYLAPEYAE-------NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE 245 (315)
Q Consensus 174 ~~~~~~~~-~~~~~~~~~~~aPE~~~-------~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (315)
........ ....+|++.|+|||++. +..++.++|+|||||++|+|++|..||...+... .... ...
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~----i~~ 284 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE--TYGK----IVH 284 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH----HHT
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--HHHH----HHh
Confidence 55443322 23457999999999886 3568899999999999999999999996543211 1111 111
Q ss_pred hhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCC---CCHHHHHHHHhccccccccc
Q 046121 246 KLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGR---PSMGEVVRLLEGENDRFHHL 304 (315)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~R---ps~~~il~~L~~~~~~~~~~ 304 (315)
... ....+.. ....+..+.+++.+||. +|++| |++++++++-+--.-.|..+
T Consensus 285 ~~~--~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 285 YKE--HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp HHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred ccc--CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 000 0001111 12234568899999999 99998 59999998766544455443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=302.07 Aligned_cols=272 Identities=24% Similarity=0.322 Sum_probs=212.3
Q ss_pred cccHHHHHHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhh--cCCCCccceeeeEE
Q 046121 12 KFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNF--ARHKNIVMLLGFCC 89 (315)
Q Consensus 12 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~ 89 (315)
.........+.++|++.+.||+|+||+||+|.+. ++.||+|++... ....+.+|.++++. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 3445556677889999999999999999999884 889999998643 33566788888877 78999999999998
Q ss_pred ecC----eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhh--------cccCCCCeEeecCccCcEE
Q 046121 90 KEN----LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH--------EECRGGPIIHRDMRPSNIL 157 (315)
Q Consensus 90 ~~~----~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh--------~~~~~~~i~h~di~p~nil 157 (315)
... ..++||||+.+++|.+++.+ ..+++..++.++.|++.++.+|| +. +++|+||||+||+
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP----AIAHRDLKSKNIL 179 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC----EEECSCCSGGGEE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC----CeeeCCCCHHHEE
Confidence 776 78999999999999999854 35899999999999999999999 77 9999999999999
Q ss_pred EcCCCceeECCCCcccccCCCCCc----cccccccccccCccccccCC------CcccccchhhhHHHHHHHhC------
Q 046121 158 LTHDFVPMLGDFGLARWKTTDDPV----QTKILGTLGYLAPEYAENGI------VSIRTDVYAFGIILLQLMSG------ 221 (315)
Q Consensus 158 ~~~~~~i~l~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~------~~~~~DvwslG~~l~~l~~g------ 221 (315)
++.++.++|+|||++......... .....|++.|+|||.+.+.. ++.++||||||+++|+|++|
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999999754433321 23456899999999987652 34689999999999999999
Q ss_pred ----CCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 222 ----RKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS-YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 222 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
..||........ ........ . ......+.+... ........+.+++.+||+.||++|||+.++++.|+.
T Consensus 260 ~~~~~~p~~~~~~~~~-~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDP-SVEEMRKV-V----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCCCCTTTTTSCSSC-CHHHHHHH-H----TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccccCccccCcCcc-cHHHHHHH-H----HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 667754332211 11111111 1 111122222221 234567789999999999999999999999999998
Q ss_pred cccc
Q 046121 297 ENDR 300 (315)
Q Consensus 297 ~~~~ 300 (315)
+..+
T Consensus 334 i~~~ 337 (342)
T 1b6c_B 334 LSQQ 337 (342)
T ss_dssp HHHT
T ss_pred HHHH
Confidence 8654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=304.19 Aligned_cols=249 Identities=22% Similarity=0.259 Sum_probs=191.6
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--ccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--QGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++.++||+|+||+||+|.+. +++.||+|++..... ........|+..+..+ +||||+++++++.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 4578999999999999999999876 799999998764322 2223344455555444 89999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+ +++|.+.+.... ..+++..++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 135 v~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ----GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99998 778877775443 4599999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
... ......|++.|+|||++.+ .++.++||||||+++|+|++|..|+.... ... .... ....+.
T Consensus 209 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~-----~~~~----~~~~~~ 272 (311)
T 3p1a_A 209 TAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GWQ-----QLRQ----GYLPPE 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HHH-----HHTT----TCCCHH
T ss_pred cCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHH-----HHhc----cCCCcc
Confidence 322 2334568999999999876 68999999999999999999966553210 000 0000 011111
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.+...+..+.+++.+||+.||++|||+.+++++-+
T Consensus 273 ----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 273 ----FTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp ----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 11123456888999999999999999999997654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=309.35 Aligned_cols=254 Identities=25% Similarity=0.324 Sum_probs=201.6
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++++.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 56999999999999999999864 78999999886543 233456889999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+. +++.+.+... ...+++..++.++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9996 5676666432 34689999999999999999999999 999999999999999999999999999964432
Q ss_pred CCccccccccccccCccccc---cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 179 DPVQTKILGTLGYLAPEYAE---NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
.....|++.|+|||++. +..++.++||||||+++|+|++|..||...... ... ...... . .+
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~~----~~~~~~-~-----~~ 271 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SAL----YHIAQN-E-----SP 271 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH----HHHHHS-C-----CC
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHH----HHHHhc-C-----CC
Confidence 23457899999999874 566889999999999999999999998643321 111 111111 0 11
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
. ..+...+..+.+++.+||+.||++|||+.+++++.+-.....
T Consensus 272 ~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 272 A---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred C---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 1 111223455788999999999999999999998776554433
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=312.55 Aligned_cols=265 Identities=16% Similarity=0.179 Sum_probs=207.0
Q ss_pred hcCCcccceecCCCceEEEEEEeCC---------CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccc---------
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKD---------GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM--------- 83 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~--------- 83 (315)
.++|++.+.||+|+||+||+|.+.. ++.||+|++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4799999999999999999998763 789999988654 46788999999999999887
Q ss_pred ------eeeeEEe-cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcE
Q 046121 84 ------LLGFCCK-ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNI 156 (315)
Q Consensus 84 ------~~~~~~~-~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~ni 156 (315)
+++++.. ....++||||+ +++|.+++.......+++..++.++.|++.|+.|||+. +++|+||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN----EYVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHE
Confidence 5666665 77889999999 99999999776567799999999999999999999999 999999999999
Q ss_pred EEcCCC--ceeECCCCcccccCCCCC-------ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCC
Q 046121 157 LLTHDF--VPMLGDFGLARWKTTDDP-------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDM 227 (315)
Q Consensus 157 l~~~~~--~i~l~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~ 227 (315)
+++.++ .++|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 999999999964432211 11234789999999999998899999999999999999999999975
Q ss_pred CCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 228 NGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
....... .......... .......... .....+..+.+++.+||..||++|||+.++++.|+.+..+..
T Consensus 271 ~~~~~~~-~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 271 CLPNTED-IMKQKQKFVD--KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GTTCHHH-HHHHHHHHHH--SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCcCHHH-HHHHHHhccC--Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 5422211 1111111111 1111111100 011123458889999999999999999999999999876654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=305.71 Aligned_cols=261 Identities=23% Similarity=0.341 Sum_probs=202.5
Q ss_pred hcCCcccceecCCCceEEEEEEeCC-----CcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKD-----GQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
.++|++.+.||+|+||+||+|.+.. +..|++|++.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3578889999999999999997542 3458999877543 333456889999999999999999999999999999
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+||||+.+++|.+++... ...+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 123 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999988654 34589999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCc---cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 176 TTDDPV---QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 176 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .........
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~~~~~~----- 266 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDG----- 266 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT-----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHHCC-----
Confidence 332211 112345678999999998889999999999999999998 99999643321 111111111
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccccc
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~ 303 (315)
... ..+...+..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 267 -~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 267 -FRL----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp -CCC----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred -CcC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 001 11122345578899999999999999999999999988765544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=300.14 Aligned_cols=275 Identities=23% Similarity=0.298 Sum_probs=205.8
Q ss_pred ccHHHHHHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhh--cCCCCccceeeeEEe
Q 046121 13 FSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNF--ARHKNIVMLLGFCCK 90 (315)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~ 90 (315)
........+.++|++.+.||+|+||+||+|.+. ++.||+|++.... ......|.+++.. ++||||+++++++..
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 344455567789999999999999999999886 8899999876432 2344455555554 489999999999987
Q ss_pred c----CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhccc----CCCCeEeecCccCcEEEcCCC
Q 046121 91 E----NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC----RGGPIIHRDMRPSNILLTHDF 162 (315)
Q Consensus 91 ~----~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~----~~~~i~h~di~p~nil~~~~~ 162 (315)
. ...++||||+.+++|.+++... .+++..++.++.|++.++.+||+.. +..+++|+||||+||+++.++
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 7 7889999999999999998543 5899999999999999999999762 122799999999999999999
Q ss_pred ceeECCCCcccccCCCCCc----cccccccccccCccccccCCCccc------ccchhhhHHHHHHHhC----------C
Q 046121 163 VPMLGDFGLARWKTTDDPV----QTKILGTLGYLAPEYAENGIVSIR------TDVYAFGIILLQLMSG----------R 222 (315)
Q Consensus 163 ~i~l~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~------~DvwslG~~l~~l~~g----------~ 222 (315)
.++|+|||++......... .....|++.|+|||++.+...... +||||||+++|+|++| .
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 9999999999644333221 124578999999999987666554 9999999999999999 5
Q ss_pred CccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 223 KVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS-YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 223 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
.||........ ..... ... .......+..... .....+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 260 ~p~~~~~~~~~-~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 260 LPYHDLVPSDP-SYEDM-REI----VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CTTTTTSCSSC-CHHHH-HHH----HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccHhhhcCCCC-chhhh-HHH----HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 55543222111 11111 111 1111122222221 2235677899999999999999999999999999987653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=308.26 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=206.7
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++.+.||+|+||.||++.+. +++.+++|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4578999999999999999999876 5888999987654 23345668899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.+++|.+++... ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 119 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC----CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999998887543 4589999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
..........|++.|+|||++.+..++.++||||||+++|+|++|..||....... . ....... ...
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~----~~~~~~~-------~~~ 259 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--T----YLRIKKN-------EYS 259 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H----HHHHHHT-------CCC
T ss_pred cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--H----HHHHhcC-------CCC
Confidence 44444445678999999999998889999999999999999999999996543211 0 1111110 001
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
+ +......+.+++.+||+.||++|||+.+++++-+
T Consensus 260 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 260 I----PKHINPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred C----CccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 1 1122345778999999999999999999997544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=300.14 Aligned_cols=254 Identities=23% Similarity=0.313 Sum_probs=201.8
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc------ccHHHHHHHHHHHhhcCCCCccceeeeEEecCe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST------QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (315)
+.++|++.+.||+|+||+||+|.+. +++.+++|++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 4568999999999999999999876 689999998765422 235678999999999999999999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC----ceeECCC
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF----VPMLGDF 169 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~----~i~l~df 169 (315)
.++||||+.+++|.+++.. ...+++..++.++.|++.++.+||+. +++|+||+|+||+++.++ .++|+||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK----RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 9999999999999998854 34589999999999999999999999 999999999999998877 8999999
Q ss_pred CcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcc
Q 046121 170 GLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249 (315)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (315)
|++........ .....+++.|+|||++.+..++.++|+||||+++|+|++|..||....... .. ... .. .
T Consensus 157 g~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~~~-~~--~ 226 (283)
T 3bhy_A 157 GIAHKIEAGNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--TL----TNI-SA--V 226 (283)
T ss_dssp TTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH----HHH-HT--T
T ss_pred ccceeccCCCc-ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--HH----HHh-Hh--c
Confidence 99975433222 234468899999999998889999999999999999999999996543211 00 000 00 0
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
.....+. .....+..+.+++.+||..||++|||+.+++++-
T Consensus 227 ~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 227 NYDFDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp CCCCCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred ccCCcch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 0000000 1112244578999999999999999999999854
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=321.50 Aligned_cols=255 Identities=23% Similarity=0.263 Sum_probs=199.8
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
.+.++|++++.||+|+||+||+|.+. ++..+|+|++.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 46678999999999999999999876 68899999877543 3345678899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC---CceeECCCCccc
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD---FVPMLGDFGLAR 173 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~---~~i~l~dfg~~~ 173 (315)
||||+.+++|.+.+... ..+++..++.++.|++.|+.|||+. +++|+||||+||+++.. +.++|+|||++.
T Consensus 114 v~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH----NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 99999999998887543 4589999999999999999999999 99999999999999764 459999999997
Q ss_pred ccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 174 WKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
..... .......|++.|+|||++. +.++.++||||||+++|+|++|.+||....... .. .... ... ....
T Consensus 188 ~~~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~----~~i~-~~~-~~~~ 257 (494)
T 3lij_A 188 VFENQ-KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--IL----RKVE-KGK-YTFD 257 (494)
T ss_dssp ECBTT-BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHH-HTC-CCCC
T ss_pred ECCCC-ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HH----HHHH-hCC-CCCC
Confidence 54433 2234457899999999886 458999999999999999999999996543211 11 1111 100 0011
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.+. ....+..+.+++.+||+.||++|||+.+++++-+
T Consensus 258 ~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 258 SPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp SGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred chh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence 111 1123445789999999999999999999987643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=306.38 Aligned_cols=270 Identities=26% Similarity=0.365 Sum_probs=212.1
Q ss_pred cccHHHHHHHhcCCcccceecCCCceEEEEEEe------CCCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccc
Q 046121 12 KFSFSEIQQATGDFSKENLLGEGGFGHVYKGEL------KDGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVM 83 (315)
Q Consensus 12 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~ 83 (315)
+..........++|++.+.||+|+||+||+|.+ .+++.|++|++.... ......+.+|+.+++.+ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 344455555678999999999999999999974 256889999987543 33345688999999999 6899999
Q ss_pred eeeeEEecC-eeEEEEEeccCCccccccccCCCC--------------ccCHHHHHHHHHHHHHHHHhhhcccCCCCeEe
Q 046121 84 LLGFCCKEN-LNILVYEYICNKSLHWHLFDNTES--------------VLEWHQRYAAAIGTAKGLRFLHEECRGGPIIH 148 (315)
Q Consensus 84 ~~~~~~~~~-~~~lv~~~~~~~~L~~~l~~~~~~--------------~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h 148 (315)
+++++...+ ..++||||+.+++|.+++...... .+++..++.++.|++.|+.+||+. +++|
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H 171 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIH 171 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT----TCCC
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC----Cccc
Confidence 999987654 589999999999999998765432 388999999999999999999999 9999
Q ss_pred ecCccCcEEEcCCCceeECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCcc
Q 046121 149 RDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVV 225 (315)
Q Consensus 149 ~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~ 225 (315)
+||||+||+++.++.++|+|||++......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999754333221 223456788999999998889999999999999999998 99999
Q ss_pred CCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 226 DMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
....... .... . ..... ... .+...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 252 ~~~~~~~--~~~~---~-~~~~~-----~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 252 PGVKIDE--EFCR---R-LKEGT-----RMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp TTCCCSH--HHHH---H-HHHTC-----CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchhH--HHHH---H-hccCc-----cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 6543221 1111 1 11110 011 1122334578899999999999999999999999987543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=298.87 Aligned_cols=258 Identities=23% Similarity=0.304 Sum_probs=202.6
Q ss_pred HhcCCcccceecCCCceEEEEEEeCC----CcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKD----GQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
..++|++.+.||+|+||+||+|.+.. +..+++|++... .....+.+.+|+.+++.++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 45789999999999999999997542 346899987754 334456788999999999999999999998654 568
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+||||+.+++|.+++.... ..+++..++.++.|++.++.+||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI----NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999886533 3489999999999999999999999 9999999999999999999999999999744
Q ss_pred CCCCC-ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 176 TTDDP-VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 176 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
..... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ .. . ......
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~---~-~~~~~~---- 232 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IG---V-LEKGDR---- 232 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HH---H-HHHTCC----
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HH---H-HhcCCC----
Confidence 33221 1223456778999999998889999999999999999998 9999964433211 11 0 111100
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
.. .+...+..+.+++.+||..||++|||+.++++.|+.+...
T Consensus 233 -~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 233 -LP----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CC----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 01 1112344588899999999999999999999999987543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=302.50 Aligned_cols=263 Identities=24% Similarity=0.294 Sum_probs=206.7
Q ss_pred HHHHHhcCCcccc-eecCCCceEEEEEEeC---CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 046121 17 EIQQATGDFSKEN-LLGEGGFGHVYKGELK---DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCK 90 (315)
Q Consensus 17 ~~~~~~~~y~~~~-~lg~g~~~~v~~~~~~---~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (315)
++....++|++.+ .||+|+||+||+|.+. +++.+++|++.... ....+.+.+|+.+++.++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3334457899998 9999999999999542 47889999887543 22356788999999999999999999999 5
Q ss_pred cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCC
Q 046121 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
.+..++||||+.+++|.+++... ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC----CeEcCCCCcceEEEeCCCcEEEccCC
Confidence 67789999999999999998654 4589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcc---ccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhh
Q 046121 171 LARWKTTDDPVQ---TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEK 246 (315)
Q Consensus 171 ~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (315)
++.......... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... .. .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~ 235 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VT----AMLEK 235 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH----HHHHT
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHHc
Confidence 997544333211 12345688999999988889999999999999999999 999996543211 11 11111
Q ss_pred hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
.. .+ ..+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 236 ~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 236 GE-----RM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp TC-----CC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CC-----CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 10 11 1222344568889999999999999999999999998866543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=299.63 Aligned_cols=258 Identities=24% Similarity=0.279 Sum_probs=202.5
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
+...++|++.+.||+|+||+||+|.+. +++.|++|++.... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 345688999999999999999999876 58999999887543 346788999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|||+.+++|.+++... ...+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 103 MEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM----RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred eecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 9999999999888532 34589999999999999999999999 999999999999999999999999999975544
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
.........+++.|+|||.+.+..++.++||||||+++|+|++|..||...... .. ... ..... .+
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~-~~~-~~~~~-----~~-- 243 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----RA-IFM-IPTNP-----PP-- 243 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HH-HHH-HHHSC-----CC--
T ss_pred hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HH-HHH-HhcCC-----Cc--
Confidence 333334457889999999999888999999999999999999999999643321 10 000 01100 00
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
....+...+..+.+++.+||..||++|||+.+++++-+-.
T Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~ 283 (314)
T 3com_A 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283 (314)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 0111222345688999999999999999999998755433
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=299.04 Aligned_cols=250 Identities=21% Similarity=0.300 Sum_probs=204.7
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++.+.||+|++|+||+|.+. +++.+++|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3478999999999999999999876 57889999876432 2334678899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.+++|.+.+... ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHER----KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999888543 3589999999999999999999999 99999999999999999999999999986443
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
.. ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ........ ..
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~-------~~- 229 (284)
T 2vgo_A 166 SL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THRRIVNV-------DL- 229 (284)
T ss_dssp SS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTT-------CC-
T ss_pred cc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHHHHhcc-------cc-
Confidence 32 2234568999999999999889999999999999999999999996433211 01111110 11
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
..+...+..+.+++.+||..||++|||+.+++++-+
T Consensus 230 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 230 ---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred ---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence 112223456789999999999999999999987543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=299.02 Aligned_cols=259 Identities=20% Similarity=0.296 Sum_probs=202.1
Q ss_pred CCcccceecCCCceEEEEEEeC-C---CcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCee-EEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-D---GQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN-ILV 97 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~---~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~lv 97 (315)
.|.+.++||+|+||+||+|.+. + +..+++|++.... ....+.+.+|+.+++.++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 5666789999999999999753 2 3368999877543 33456788999999999999999999999766555 999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
++|+.+++|.+++... ...+++..++.++.|++.++.+||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ----KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999988653 45588999999999999999999999 999999999999999999999999999964332
Q ss_pred CC----CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCc-cCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 178 DD----PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKV-VDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 178 ~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
.. .......+++.|+|||.+.+..++.++||||||+++|+|++|..| |....... ... ......
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~----~~~~~~---- 245 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTH----FLAQGR---- 245 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHH----HHHTTC----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHH----HhhcCC----
Confidence 11 112234568899999999998999999999999999999995544 44332211 111 011100
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccccc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~ 303 (315)
....+...+..+.+++.+||+.||++|||+.++++.|+.+...+..
T Consensus 246 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 -----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred -----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 0111222345688999999999999999999999999998776643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=304.62 Aligned_cols=258 Identities=22% Similarity=0.305 Sum_probs=201.6
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
..++|++++.||+|+||+||+|.+. +++.+++|++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999876 589999999887777777889999999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|.+++... ...+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSK----RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999998877543 34589999999999999999999999 99999999999999999999999999874322111
Q ss_pred CccccccccccccCcccc-----ccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 180 PVQTKILGTLGYLAPEYA-----ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~-----~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
.......|++.|+|||.+ .+..++.++||||||+++|+|++|..||....... . ....... ..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~----~~~~~~~-~~----- 239 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--V----LLKIAKS-DP----- 239 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--H----HHHHHHS-CC-----
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--H----HHHHhcc-CC-----
Confidence 112234678999999987 46678899999999999999999999996543211 1 1111110 00
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
+ ....+...+..+.+++.+||..||++|||+.+++++-+-.
T Consensus 240 ~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 280 (302)
T 2j7t_A 240 P--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS 280 (302)
T ss_dssp C--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTT
T ss_pred c--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHh
Confidence 0 0111223345688999999999999999999998865443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=322.62 Aligned_cols=256 Identities=24% Similarity=0.264 Sum_probs=207.3
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
.+.++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35678999999999999999999876 78999999986542 345677899999999999999999999999999999
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE---cCCCceeECCCCcc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL---THDFVPMLGDFGLA 172 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~---~~~~~i~l~dfg~~ 172 (315)
+|+||+.+++|.+.+... ..+++..++.++.|++.|+.|||+. +++|+||||+||++ +.++.++|+|||++
T Consensus 103 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999998888543 4589999999999999999999999 99999999999999 56789999999999
Q ss_pred cccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
....... ......|++.|+|||++.+ .++.++||||||+++|+|++|.+||...... .... .. ..... .
T Consensus 177 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~----~i-~~~~~-~- 245 (484)
T 3nyv_A 177 THFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILK----KV-EKGKY-T- 245 (484)
T ss_dssp HHBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HH-HHCCC-C-
T ss_pred EEccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHH----HH-HcCCC-C-
Confidence 7554333 2334578999999999876 5889999999999999999999999654321 1111 11 11100 0
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.........+..+.+++.+||+.||++|||+.+++++-+-
T Consensus 246 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 246 ----FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp ----CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred ----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 0011112234568899999999999999999999986654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=309.18 Aligned_cols=266 Identities=24% Similarity=0.320 Sum_probs=192.1
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcC-CCCccceeeeEEecC--
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKEN-- 92 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~-- 92 (315)
....++|++++.||+|+||+||+|.+. +++.||+|++... .........+|+.+++.+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 346789999999999999999999875 6899999987543 3344566789999999997 999999999997544
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
.+|+||||+. ++|...+.. ..+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG----GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 7899999986 578777754 3689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC---------------------CCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCC
Q 046121 173 RWKTTD---------------------DPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGE 230 (315)
Q Consensus 173 ~~~~~~---------------------~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~ 230 (315)
...... ........|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 644221 111233578999999998876 6689999999999999999999999975432
Q ss_pred ccchhHHHhHHHHHhhhc---ccc------------------ccCCcccCCC------------CHHHHHHHHHHHHhhc
Q 046121 231 EPQQSLRQWAEPLIEKLA---LHE------------------LIDPRIENSY------------DTYELYLMAKTAYLCV 277 (315)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~---~~~------------------~~~~~~~~~~------------~~~~~~~l~~l~~~~l 277 (315)
. ..+...... ..... ... .........+ ....+..+.+|+.+||
T Consensus 237 ~--~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 237 M--NQLERIIGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp H--HHHHHHHHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred H--HHHHHHHHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 1 111111100 00000 000 0000000000 0012345789999999
Q ss_pred CCCCCCCCCHHHHHHHHh
Q 046121 278 QRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 278 ~~~p~~Rps~~~il~~L~ 295 (315)
..||++|||+.+++++-+
T Consensus 314 ~~dP~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPF 331 (388)
T ss_dssp CSSGGGSCCHHHHTTSTT
T ss_pred ccCcccCCCHHHHhCCHH
Confidence 999999999999998844
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=311.05 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=197.1
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEeccc--CcccHHHHHHHHHHHhhcC--CCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEA--STQGFAEFQSEVYVLNFAR--HKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++++.||+|+||+||+|.+.+++.||+|++... .......+.+|+.+++.++ ||||+++++++...+.+++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 459999999999999999999888999999988654 3344567889999999997 599999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
| +.+++|.+++.... .+++..++.++.|++.+|.|||+. +++|+||||+||+++ ++.++|+|||++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 57889999886543 688999999999999999999999 999999999999995 589999999999754332
Q ss_pred CC--ccccccccccccCcccccc-----------CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh
Q 046121 179 DP--VQTKILGTLGYLAPEYAEN-----------GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE 245 (315)
Q Consensus 179 ~~--~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (315)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||....... .. .....
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~-~~~~~- 281 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SK-LHAII- 281 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HH-HHHHH-
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH----HH-HHHHh-
Confidence 21 1234578999999998865 357889999999999999999999996432210 11 11111
Q ss_pred hhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 246 KLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.+......+...+..+.+++.+||+.||++|||+.+++++.+-
T Consensus 282 --------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 282 --------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp --------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred --------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 1111111122223457899999999999999999999976543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=331.64 Aligned_cols=258 Identities=21% Similarity=0.278 Sum_probs=209.7
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 95 (315)
..++|++++.||+|+||+||+|.+. +++.||+|++... ..........|..++..+ +||+|+.+++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4478999999999999999999876 6889999998753 234456678899999887 6999999999999999999
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+||||+.|++|..++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 419 lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999988643 4599999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
...........|++.|+|||++.+..++.++|+||||+++|+|++|.+||...+.. .. .......
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--~~----~~~i~~~--------- 557 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--EL----FQSIMEH--------- 557 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH----HHHHHSS---------
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--HH----HHHHHhC---------
Confidence 44444455678999999999999999999999999999999999999999654321 11 1111110
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHHHhcccccc
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSM-----GEVVRLLEGENDRF 301 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~-----~~il~~L~~~~~~~ 301 (315)
...++...+..+.+|+.+||+.||++||++ ++|+++-.--.-.|
T Consensus 558 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 558 --NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred --CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 011223345568899999999999999997 78876544333333
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=308.85 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=195.2
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCe---
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL--- 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--- 93 (315)
+.++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4579999999999999999999874 78999999987543 2334567899999999999999999999876543
Q ss_pred -eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 94 -NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 94 -~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
.++||||+.|++|.+++... ..+++..++.++.|++.++.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 49999999999999988543 4589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcc
Q 046121 173 RWKTTDDP---VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249 (315)
Q Consensus 173 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (315)
........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||....... . .........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--~----~~~~~~~~~- 236 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--V----AYQHVREDP- 236 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H----HHHHHHCCC-
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--H----HHHHhcCCC-
Confidence 64433221 1223468999999999999899999999999999999999999996543211 0 011111100
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH-HHHhcc
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVV-RLLEGE 297 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il-~~L~~~ 297 (315)
.. ........+..+.+++.+||..||++||++.+++ ..+...
T Consensus 237 ---~~---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 237 ---IP---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ---CC---HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---CC---cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00 0001112344578899999999999999766654 444443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=326.93 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=210.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
..++|++.+.||+|+||+||+|.+.++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 456789999999999999999999888889999987643 345678999999999999999999999876 678999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.+++|.+++.......+++..++.++.|++.+|.|||++ +++|+||||+||+++.++.++|+|||++........
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999999654445689999999999999999999999 999999999999999999999999999964332111
Q ss_pred -ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 181 -VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 181 -~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
......++..|+|||++.+..++.++||||||+++|+|++ |..||...... ......... ..
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~~~i~~~------~~---- 482 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERG------YR---- 482 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHHHHHHTT------CC----
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcC------CC----
Confidence 1112345678999999998889999999999999999999 89999644321 111111111 00
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
...+...+..+.++|.+||+.||++|||+.+|++.|+.+.....
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 11122334568889999999999999999999999998866443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=322.25 Aligned_cols=255 Identities=22% Similarity=0.256 Sum_probs=202.1
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc-------------ccHHHHHHHHHHHhhcCCCCcccee
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST-------------QGFAEFQSEVYVLNFARHKNIVMLL 85 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (315)
.+.++|+++++||+|+||+||+|.+. +++.+|+|++..... .....+.+|+.+++.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 46789999999999999999999876 688999998765421 3356788999999999999999999
Q ss_pred eeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC---
Q 046121 86 GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF--- 162 (315)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~--- 162 (315)
+++.+....++||||+.|++|.+.+... ..+++..++.++.|++.|+.|||+. +++|+||||+||+++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH----NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999998888543 4589999999999999999999999 999999999999998876
Q ss_pred ceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH
Q 046121 163 VPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP 242 (315)
Q Consensus 163 ~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 242 (315)
.++|+|||++...... .......|++.|+|||++.+ .++.++||||||+++|+|++|.+||....... . ...
T Consensus 187 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~----~~~ 258 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--I----IKK 258 (504)
T ss_dssp SEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----HHH
T ss_pred cEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--H----HHH
Confidence 6999999999754433 23344678999999999874 58999999999999999999999997543211 1 111
Q ss_pred HHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 243 LIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.... .. ...... ....+..+.+++.+||+.||++|||+.+++++-+
T Consensus 259 i~~~-~~--~~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 259 VEKG-KY--YFDFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHHC-CC--CCCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHcC-CC--CCCccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 1110 00 000000 0112345889999999999999999999998654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=310.36 Aligned_cols=261 Identities=23% Similarity=0.313 Sum_probs=196.7
Q ss_pred cCCcccceecCCCceEEEEEEeC--C--CcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEE-ecCeeEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK--D--GQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCC-KENLNIL 96 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~--~--~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~l 96 (315)
..|++.+.||+|+||+||+|.+. + ...+++|.+... .......+.+|+.+++.++||||+++++++. .++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35778899999999999999753 2 235788887643 2344567889999999999999999999864 4567899
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.+++|.+++... ...+++..++.++.|++.++.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 169 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999988543 34578899999999999999999999 99999999999999999999999999996443
Q ss_pred CCCCc----cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 177 TDDPV----QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 177 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
..... .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......... .. .....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~--~~-----~~~~~--- 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--VY-----LLQGR--- 313 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH--HH-----HHTTC---
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH--HH-----HHcCC---
Confidence 22211 122356778999999999999999999999999999999 67788654432211 10 11100
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccc
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHL 304 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~ 304 (315)
.. ..+...+..+.+++.+||..||++|||+.++++.|+.+...+...
T Consensus 314 --~~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 314 --RL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp --CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred --CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 00 111223445788999999999999999999999999987766543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=304.24 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=198.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeeeEEe------cC
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCK------EN 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------~~ 92 (315)
..++|++.+.||+|+||+||+|.+. +++.|++|++.... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 5678999999999999999999875 68999999886543 3456788999999998 79999999999977 56
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
..++||||+.+++|.+++.......+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 889999999999999999776667799999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCccccc-----cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAE-----NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL 247 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (315)
..............|++.|+|||.+. +..++.++||||||+++|+|++|..||....... .. .. ....
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~~-~~~~ 249 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--AL----FL-IPRN 249 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH----HH-HHHS
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HH----HH-hhcC
Confidence 75443333334457899999999886 5568889999999999999999999996433211 00 01 1111
Q ss_pred ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 248 ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
.. +. ......+..+.+++.+||..||++|||+.+++++-
T Consensus 250 ~~-----~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 250 PA-----PR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp CC-----CC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred cc-----cc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 11 11 11112234678899999999999999999999853
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=308.66 Aligned_cols=263 Identities=24% Similarity=0.379 Sum_probs=208.7
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeCC------CcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccceeeeEEe
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELKD------GQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCK 90 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 90 (315)
....++|++.+.||+|+||+||+|.+.. ...+++|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3345789999999999999999998652 2479999887543 33456688999999999 89999999999999
Q ss_pred cCeeEEEEEeccCCccccccccCC------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE
Q 046121 91 ENLNILVYEYICNKSLHWHLFDNT------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL 158 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~ 158 (315)
.+..++||||+.+++|.+++.... ...+++..++.++.|++.|+.+||+. +++|+||||+||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK----NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGCEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC----CcccCCcccceEEE
Confidence 999999999999999999886432 34589999999999999999999999 99999999999999
Q ss_pred cCCCceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchh
Q 046121 159 THDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQS 235 (315)
Q Consensus 159 ~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~ 235 (315)
+.++.++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... .
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~ 275 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--K 275 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--H
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--H
Confidence 9999999999999974433222 1223456778999999988889999999999999999998 889986543221 1
Q ss_pred HHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 236 LRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
... ..... ... ..+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 276 ~~~----~~~~~-----~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 FYK----LVKDG-----YQM----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHH----HHHHT-----CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH----HHhcC-----CCC----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 111 11110 011 11112244578899999999999999999999999887554
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=295.93 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=197.1
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
...++|++.+.||+|++|.||+|.+. +++.+++|++.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 34579999999999999999999876 78999999876532 334567889999999999999999999999999999
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+||||+.+++|.+++... ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 88 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH----CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 999999999999988543 3589999999999999999999999 9999999999999999999999999999744
Q ss_pred CCCCCccccccccccccCccccccCCC-cccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
... .......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...... ......... .
T Consensus 162 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~--~----- 227 (276)
T 2h6d_A 162 SDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------TLFKKIRGG--V----- 227 (276)
T ss_dssp CC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC--C-----
T ss_pred CCC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhcC--c-----
Confidence 332 22234568899999999987765 68999999999999999999999643211 111111110 0
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.. .+...+..+.+++.+||+.||++|||+.+++++-+
T Consensus 228 ~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 228 FY----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred cc----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 01 11223345788999999999999999999998643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=305.47 Aligned_cols=262 Identities=24% Similarity=0.326 Sum_probs=205.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeC------CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (315)
..++|++.+.||+|+||+||+|.+. ++..||+|++... .......+.+|+.+++.++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 4579999999999999999999742 5778999998643 33445568899999999999999999999999999
Q ss_pred eEEEEEeccCCccccccccCCC-----CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC---CCcee
Q 046121 94 NILVYEYICNKSLHWHLFDNTE-----SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPM 165 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~---~~~i~ 165 (315)
.++||||+.+++|.+++..... ..+++..++.++.|++.|+.+||+. +++|+||+|+||+++. +..++
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999876542 4589999999999999999999999 9999999999999984 44699
Q ss_pred ECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHH
Q 046121 166 LGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEP 242 (315)
Q Consensus 166 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 242 (315)
|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~ 257 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEF 257 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------HHHHH
Confidence 999999864332221 2223457889999999988889999999999999999998 88998654321 11111
Q ss_pred HHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 243 LIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
.. ... .. ..+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 258 ~~-~~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 258 VT-SGG-----RM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HH-TTC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred Hh-cCC-----CC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 11 100 01 1122234467889999999999999999999999998765443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=299.23 Aligned_cols=260 Identities=18% Similarity=0.226 Sum_probs=201.8
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeeeEEe--cCeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCK--ENLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv 97 (315)
.++|++++.||+|+||+||+|.+. +++.||+|++... ..+.+.+|+.+++.++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 468999999999999999999864 7899999998643 3467889999999997 9999999999987 6778999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC-ceeECCCCcccccC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF-VPMLGDFGLARWKT 176 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~-~i~l~dfg~~~~~~ 176 (315)
|||+.+++|.+.+. .+++..+..++.|++.++.+||+. +++|+||||+||+++.++ .++|+|||++....
T Consensus 112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999988773 388999999999999999999999 999999999999999777 89999999997544
Q ss_pred CCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH--------Hhhh
Q 046121 177 TDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL--------IEKL 247 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 247 (315)
... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......... +....... ....
T Consensus 183 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 183 PGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHT
T ss_pred CCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHHHh
Confidence 332 2344578899999999876 66899999999999999999999999544332211 11110000 0000
Q ss_pred c--------------cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 248 A--------------LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 248 ~--------------~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
. ....+............+..+.+++.+||+.||++|||+.+++++-+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 0 00000111111222234567889999999999999999999998644
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=297.19 Aligned_cols=255 Identities=21% Similarity=0.232 Sum_probs=199.3
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC----cccHHHHHHHHHHHhhcCCCCccceeeeE--EecC
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS----TQGFAEFQSEVYVLNFARHKNIVMLLGFC--CKEN 92 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~ 92 (315)
+..++|++.+.||+|+||.||++.+. +++.+++|++.... ......+.+|+.+++.++||||+++++++ .+..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 35689999999999999999999875 68899999987542 33456789999999999999999999998 4556
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
..++||||+.++ |.+.+.......+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ----GIVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEcCCCcEEeeccccc
Confidence 889999999776 66677666667799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC--CccccccccccccCccccccCC--CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhc
Q 046121 173 RWKTTDD--PVQTKILGTLGYLAPEYAENGI--VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248 (315)
Q Consensus 173 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (315)
....... .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||...... ...... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i-~~~~ 229 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFENI-GKGS 229 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHH-HHCC
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHHH-hcCC
Confidence 7544222 2223456889999999987644 367899999999999999999999653311 111111 1110
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 249 LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
..... ..+..+.+++.+||..||++|||+.+++++-+-
T Consensus 230 ------~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 230 ------YAIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp ------CCCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred ------CCCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 11111 233457789999999999999999999986543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=315.39 Aligned_cols=274 Identities=19% Similarity=0.196 Sum_probs=188.2
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEe-----cCe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCK-----ENL 93 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 93 (315)
.++|++++.||+|+||+||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999876 6899999987653 33345678899999999999999999999843 356
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+|+|||++ +++|.+.+.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~----~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSA----GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhC----CcCCCCCChhhEEECCCCCEeecccccch
Confidence 89999986 6788887743 34699999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCC---------------------------ccccccccccccCcccc-ccCCCcccccchhhhHHHHHHHh-----
Q 046121 174 WKTTDDP---------------------------VQTKILGTLGYLAPEYA-ENGIVSIRTDVYAFGIILLQLMS----- 220 (315)
Q Consensus 174 ~~~~~~~---------------------------~~~~~~~~~~~~aPE~~-~~~~~~~~~DvwslG~~l~~l~~----- 220 (315)
....... ......||+.|+|||++ .+..++.++|||||||++|+|++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 5432211 12235679999999976 56678999999999999999998
Q ss_pred ------CCCccCCCCCccchh---------------HHH--hHHHHHhhh--------------ccccccCCc---ccCC
Q 046121 221 ------GRKVVDMNGEEPQQS---------------LRQ--WAEPLIEKL--------------ALHELIDPR---IENS 260 (315)
Q Consensus 221 ------g~~p~~~~~~~~~~~---------------~~~--~~~~~~~~~--------------~~~~~~~~~---~~~~ 260 (315)
|.++|......+... ..+ ......... .....+... ....
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 566664332110000 000 000000000 000000000 0001
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
..+..+..+.+|+.+||..||++|||+++++++-+-....+.
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 112235567899999999999999999999998665444333
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=308.65 Aligned_cols=276 Identities=21% Similarity=0.228 Sum_probs=201.7
Q ss_pred CcccHHHHHHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCc-----------ccHHHHHHHHHHHhhcCCC
Q 046121 11 MKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST-----------QGFAEFQSEVYVLNFARHK 79 (315)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~-----------~~~~~~~~e~~~l~~l~~~ 79 (315)
+....+.+....++|++.+.||+|+||+||+|.+.++..||+|++..... ...+.+.+|+.+++.++||
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 89 (362)
T 3pg1_A 10 MRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89 (362)
T ss_dssp HHHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred HHHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCc
Confidence 34556678888999999999999999999999988899999998754322 1236788999999999999
Q ss_pred CccceeeeEEe-----cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccC
Q 046121 80 NIVMLLGFCCK-----ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPS 154 (315)
Q Consensus 80 ~i~~~~~~~~~-----~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~ 154 (315)
||+++++++.. ....++||||+. ++|.+.+... ...+++..+..++.|++.++.+||+. +++|+||||+
T Consensus 90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~ 163 (362)
T 3pg1_A 90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA----GVVHRDLHPG 163 (362)
T ss_dssp TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGG
T ss_pred CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----cCEecCCChH
Confidence 99999999854 346799999987 5777766533 34699999999999999999999999 9999999999
Q ss_pred cEEEcCCCceeECCCCcccccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccc
Q 046121 155 NILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ 233 (315)
Q Consensus 155 nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~ 233 (315)
||+++.++.++|+|||++...... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~- 241 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN- 241 (362)
T ss_dssp GEEECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred HEEEcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-
Confidence 999999999999999999633322 22334568899999998876 668999999999999999999999996543211
Q ss_pred hhHHHhHHHHHh--------------hhccccccC---CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 234 QSLRQWAEPLIE--------------KLALHELID---PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 234 ~~~~~~~~~~~~--------------~~~~~~~~~---~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
........... ......... ........+..+..+.+++.+||..||++|||+.+++++-+
T Consensus 242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 242 -QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp -HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred -HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 11111100000 000000000 00001111223455889999999999999999999998654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=304.91 Aligned_cols=261 Identities=23% Similarity=0.272 Sum_probs=195.8
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecC-----
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN----- 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 92 (315)
..++|++++.||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3578999999999999999999875 6999999987543 2333566889999999999999999999997653
Q ss_pred -eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCc
Q 046121 93 -LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGL 171 (315)
Q Consensus 93 -~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~ 171 (315)
..|+||||+ +++|.+++.. ..+++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999998 8899888854 4589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH-------
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL------- 243 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 243 (315)
+..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..+.......
T Consensus 175 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred cccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHH
Confidence 974432 2234578999999998876 67899999999999999999999999654321 1111110000
Q ss_pred Hhh----------hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 244 IEK----------LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 244 ~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
... ..+.......+ ....+..+..+.+|+.+||..||++|||+.+++++-.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 000 00000001111 1112233456889999999999999999999998643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=295.35 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=198.2
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEe----cCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCK----ENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 94 (315)
...|++.+.||+|+||+||+|.+. ++..+++|++... .....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345888999999999999999875 6888999987644 33445678899999999999999999999865 4568
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCC--eEeecCccCcEEEc-CCCceeECCCCc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGP--IIHRDMRPSNILLT-HDFVPMLGDFGL 171 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~--i~h~di~p~nil~~-~~~~i~l~dfg~ 171 (315)
++||||+.+++|.+++... ..+++..++.++.|++.++.+||+. + ++|+||+|+||+++ .++.++|+|||+
T Consensus 105 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC----CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999998543 4589999999999999999999999 8 99999999999997 789999999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
+...... ......|++.|+|||.+.+ .++.++||||||+++|+|++|..||....... ..... ....
T Consensus 179 ~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~-~~~~---- 245 (290)
T 1t4h_A 179 ATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRR-VTSG---- 245 (290)
T ss_dssp GGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHH-HTTT----
T ss_pred ccccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----HHHHH-Hhcc----
Confidence 9643322 2334568999999998875 48899999999999999999999996533211 10011 0000
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
... ...+...+..+.+++.+||+.||++|||+.+++++-+
T Consensus 246 ~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 246 VKP----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp CCC----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCc----cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 001 1111122345789999999999999999999997644
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=302.62 Aligned_cols=281 Identities=24% Similarity=0.317 Sum_probs=201.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHH--HHHHhhcCCCCccceeeeEEe-----cCe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSE--VYVLNFARHKNIVMLLGFCCK-----ENL 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e--~~~l~~l~~~~i~~~~~~~~~-----~~~ 93 (315)
..++|++.+.||+|+||+||+|.. +++.||+|++..... .....| +..++.++||||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 457999999999999999999977 578999999865432 333334 444556899999999986543 335
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCC-----CCeEeecCccCcEEEcCCCceeECC
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG-----GPIIHRDMRPSNILLTHDFVPMLGD 168 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-----~~i~h~di~p~nil~~~~~~i~l~d 168 (315)
+++||||+.+++|.+++... ..++..++.++.|++.||.|||+.... .+++|+||||+||+++.++.++|+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 68999999999999998543 358889999999999999999977221 2799999999999999999999999
Q ss_pred CCcccccCCCC--------CccccccccccccCcccccc-------CCCcccccchhhhHHHHHHHhCCCccCCCCC-cc
Q 046121 169 FGLARWKTTDD--------PVQTKILGTLGYLAPEYAEN-------GIVSIRTDVYAFGIILLQLMSGRKVVDMNGE-EP 232 (315)
Q Consensus 169 fg~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~-~~ 232 (315)
||++....... .......|++.|+|||++.+ ..++.++||||||+++|+|++|..|+..... ..
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 99997543221 11223468999999999876 3456789999999999999999766643222 11
Q ss_pred ch-hHHHhH-----HHHHhhhccccccCCcccCC--CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccc
Q 046121 233 QQ-SLRQWA-----EPLIEKLALHELIDPRIENS--YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHL 304 (315)
Q Consensus 233 ~~-~~~~~~-----~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~ 304 (315)
.. ...... ..............+.+... .....+..+.+++.+||+.||++|||+.++++.|+.+...|..-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 11 100000 00000001111112222221 22346667999999999999999999999999999999988866
Q ss_pred cchh
Q 046121 305 GEKF 308 (315)
Q Consensus 305 ~~~~ 308 (315)
+.+.
T Consensus 324 ~~~~ 327 (336)
T 3g2f_A 324 KSVS 327 (336)
T ss_dssp ----
T ss_pred ccCC
Confidence 6554
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=310.50 Aligned_cols=275 Identities=21% Similarity=0.269 Sum_probs=207.8
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.++|++.+.||+|+||+||+|.+. +++.+|+|++... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 568999999999999999999876 6899999988754 33445678899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.+++|.+++... ..+++..+..++.+++.++.+||+.. +++|+||||+||+++.++.++|+|||++......
T Consensus 112 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999988543 35899999999999999999999841 7999999999999999999999999998533221
Q ss_pred CccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH---------------HHH
Q 046121 180 PVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE---------------PLI 244 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------------~~~ 244 (315)
......|++.|+|||++.+..++.++||||||+++|+|++|..||................ ...
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 1223468999999999999999999999999999999999999997543221110000000 000
Q ss_pred hh--------h----ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccccc
Q 046121 245 EK--------L----ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 245 ~~--------~----~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~ 303 (315)
.. . ..................+..+.+++.+||+.||++|||+.+++++-+-....+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 335 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhh
Confidence 00 0 00000000001111112345688999999999999999999999876655444433
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.69 Aligned_cols=259 Identities=21% Similarity=0.295 Sum_probs=204.6
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--------ccHHHHHHHHHHHhhc-CCCCccceee
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--------QGFAEFQSEVYVLNFA-RHKNIVMLLG 86 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l-~~~~i~~~~~ 86 (315)
....+.++|++.+.||+|++|.||+|.+. +++.||+|++..... .....+.+|+.+++.+ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34556688999999999999999999876 799999999765431 1134577899999999 7999999999
Q ss_pred eEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeE
Q 046121 87 FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPML 166 (315)
Q Consensus 87 ~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l 166 (315)
++......++||||+.|++|.+++... ..+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~----gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN----NIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999988543 4589999999999999999999999 9999999999999999999999
Q ss_pred CCCCcccccCCCCCccccccccccccCcccccc------CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH
Q 046121 167 GDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN------GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240 (315)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 240 (315)
+|||++....... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||...... ....
T Consensus 242 ~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~--- 315 (365)
T 2y7j_A 242 SDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--LMLR--- 315 (365)
T ss_dssp CCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---
T ss_pred EecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--HHHH---
Confidence 9999987544332 2334578999999998863 35788999999999999999999999643211 1111
Q ss_pred HHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
. ...... ....+. .. ..+..+.+++.+||..||++|||+.+++++-+
T Consensus 316 -~-i~~~~~-~~~~~~-~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 316 -M-IMEGQY-QFSSPE-WD----DRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp -H-HHHTCC-CCCHHH-HS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred -H-HHhCCC-CCCCcc-cc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 1 111000 000000 01 12345788999999999999999999998543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=307.60 Aligned_cols=262 Identities=24% Similarity=0.334 Sum_probs=207.2
Q ss_pred cCCcccceecCCCceEEEEEEe----CCCcEEEEEEecccC----cccHHHHHHHHHHHhhc-CCCCccceeeeEEecCe
Q 046121 23 GDFSKENLLGEGGFGHVYKGEL----KDGQMIAAKVRKEAS----TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENL 93 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~----~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 93 (315)
++|++.+.||+|+||+||+|.+ .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6899999999999999999987 368999999876532 23345567899999999 69999999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.++||||+.+++|.+++... ..+++..+..++.|++.+|.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999988543 3589999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCC-CccccccccccccCccccccC--CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccc
Q 046121 174 WKTTDD-PVQTKILGTLGYLAPEYAENG--IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250 (315)
Q Consensus 174 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (315)
...... .......|++.|+|||++.+. .++.++||||||+++|+|++|..||......... ..........
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~---- 281 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS---- 281 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC----
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhcc----
Confidence 443222 122345789999999998853 4678999999999999999999999755433221 1111111110
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhcccccccc
Q 046121 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~~~~~~~~ 303 (315)
.+. .+...+..+.+++.+||..||++|| |+.+++++.+-....|..
T Consensus 282 ---~~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~ 332 (355)
T 1vzo_A 282 ---EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 332 (355)
T ss_dssp ---CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH
T ss_pred ---CCC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhH
Confidence 111 2223345578899999999999999 999999988766555543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=300.79 Aligned_cols=265 Identities=22% Similarity=0.273 Sum_probs=205.3
Q ss_pred HHhcCCcccceecCCCceEEEEEEe-C-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCC------CccceeeeEEec
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGEL-K-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHK------NIVMLLGFCCKE 91 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~-~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~ 91 (315)
.+.++|++.+.||+|+||+||+|.+ . +++.||+|++... ......+.+|+.+++.++|+ +++++++++...
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 3567999999999999999999986 3 6889999998653 33456678899999888755 489999999999
Q ss_pred CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC-----------
Q 046121 92 NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH----------- 160 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~----------- 160 (315)
+..++||||+ +++|.+++.......+++..+..++.|++.|+.+||+. +++|+||||+||+++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN----KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeccccccccCCcc
Confidence 9999999999 89999999877767799999999999999999999999 9999999999999987
Q ss_pred --------CCceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCcc
Q 046121 161 --------DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEP 232 (315)
Q Consensus 161 --------~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~ 232 (315)
++.++|+|||++..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 66899999999974332 2234578999999999998889999999999999999999999997543221
Q ss_pred chhHHHhH-----HHHHhhhccccc---------------------cCC-cccCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 046121 233 QQSLRQWA-----EPLIEKLALHEL---------------------IDP-RIENSYDTYELYLMAKTAYLCVQRNPEGRP 285 (315)
Q Consensus 233 ~~~~~~~~-----~~~~~~~~~~~~---------------------~~~-~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp 285 (315)
........ ............ ..+ ..........+..+.+++.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 11100000 000000000000 000 001112344567789999999999999999
Q ss_pred CHHHHHHH
Q 046121 286 SMGEVVRL 293 (315)
Q Consensus 286 s~~~il~~ 293 (315)
|+.+++++
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=297.06 Aligned_cols=249 Identities=21% Similarity=0.315 Sum_probs=199.1
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 96 (315)
..++|++.+.||+|+||+||+|.+. +++.|++|++... .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 5678999999999999999999876 7999999987753 233345678899999988 89999999999999999999
Q ss_pred EEEeccCCccccccccCC--CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC-------------
Q 046121 97 VYEYICNKSLHWHLFDNT--ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD------------- 161 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~------------- 161 (315)
||||+.+++|.+++.... ...+++..++.++.|++.|+.+||+. +++|+||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM----SLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999886542 25689999999999999999999999 99999999999999844
Q ss_pred ------CceeECCCCcccccCCCCCccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccch
Q 046121 162 ------FVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ 234 (315)
Q Consensus 162 ------~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~ 234 (315)
..++|+|||.+....... ...+++.|+|||.+.+. .++.++||||||+++|+|++|.+++....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred cccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 479999999987544322 23588999999998765 56689999999999999999987763221
Q ss_pred hHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 235 SLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.... ..... .+... ...+..+.+++.+||+.||++|||+.+++++-+-
T Consensus 236 ~~~~-----~~~~~-----~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 283 (289)
T 1x8b_A 236 QWHE-----IRQGR-----LPRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283 (289)
T ss_dssp HHHH-----HHTTC-----CCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred HHHH-----HHcCC-----CCCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence 1000 11111 11122 2234557889999999999999999999886543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=295.93 Aligned_cols=260 Identities=20% Similarity=0.197 Sum_probs=204.7
Q ss_pred HHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---------cccHHHHHHHHHHHhhcC-CCCccceee
Q 046121 18 IQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---------TQGFAEFQSEVYVLNFAR-HKNIVMLLG 86 (315)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~-~~~i~~~~~ 86 (315)
.....++|++.+.||+|++|.||+|.+. +++.|++|++.... ......+.+|+.+++.+. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 4456789999999999999999999876 68999999986543 122345778999999995 999999999
Q ss_pred eEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeE
Q 046121 87 FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPML 166 (315)
Q Consensus 87 ~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l 166 (315)
++......++||||+.+++|.+++... ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEE
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEcCCCcEEE
Confidence 999999999999999999999988543 4589999999999999999999999 9999999999999999999999
Q ss_pred CCCCcccccCCCCCccccccccccccCccccc------cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH
Q 046121 167 GDFGLARWKTTDDPVQTKILGTLGYLAPEYAE------NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240 (315)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 240 (315)
+|||++....... ......+++.|+|||++. ...++.++||||||+++|+|++|..||....... . .
T Consensus 166 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~----~ 238 (298)
T 1phk_A 166 TDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--M----L 238 (298)
T ss_dssp CCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----H
T ss_pred ecccchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--H----H
Confidence 9999997544322 233456889999999874 4557889999999999999999999996433211 0 1
Q ss_pred HHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 241 EPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
...... .. . .........+..+.+++.+||..||++|||+.+++++-+-.
T Consensus 239 ~~~~~~-~~-~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (298)
T 1phk_A 239 RMIMSG-NY-Q-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288 (298)
T ss_dssp HHHHHT-CC-C-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHhcC-Cc-c-----cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence 111111 00 0 01111123345688999999999999999999999865443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=306.65 Aligned_cols=264 Identities=19% Similarity=0.228 Sum_probs=196.0
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEe-------
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK------- 90 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------- 90 (315)
+...++|++++.||+|+||+||+|.+. +++.||+|++..... ...+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 456789999999999999999999865 799999998764422 23479999999999999999999843
Q ss_pred -------------------------------cCeeEEEEEeccCCcccccccc--CCCCccCHHHHHHHHHHHHHHHHhh
Q 046121 91 -------------------------------ENLNILVYEYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFL 137 (315)
Q Consensus 91 -------------------------------~~~~~lv~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~l 137 (315)
...+++||||+. ++|.+.+.. .....+++..+..++.|++.|+.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999997 477666543 3345699999999999999999999
Q ss_pred hcccCCCCeEeecCccCcEEEc-CCCceeECCCCcccccCCCCCccccccccccccCccccccCC-CcccccchhhhHHH
Q 046121 138 HEECRGGPIIHRDMRPSNILLT-HDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI-VSIRTDVYAFGIIL 215 (315)
Q Consensus 138 h~~~~~~~i~h~di~p~nil~~-~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwslG~~l 215 (315)
|+. |++|+||||+||+++ .++.++|+|||++....... ......+++.|+|||.+.+.. ++.++||||+||++
T Consensus 158 H~~----gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL----GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT----TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC----cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 999999999999998 68899999999997544332 233457789999999887654 89999999999999
Q ss_pred HHHHhCCCccCCCCCccchhHHHhHHHH--------Hh-hh-----ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCC
Q 046121 216 LQLMSGRKVVDMNGEEPQQSLRQWAEPL--------IE-KL-----ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNP 281 (315)
Q Consensus 216 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~-~~-----~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p 281 (315)
|+|++|.+||...... ..+....... .. .. .........+...++...+..+.+++.+||..||
T Consensus 233 ~ell~g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 233 GELILGKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999754321 1111111100 00 00 0000001111111233345568899999999999
Q ss_pred CCCCCHHHHHHHH
Q 046121 282 EGRPSMGEVVRLL 294 (315)
Q Consensus 282 ~~Rps~~~il~~L 294 (315)
++|||+.+++++-
T Consensus 311 ~~R~t~~e~l~hp 323 (383)
T 3eb0_A 311 DLRINPYEAMAHP 323 (383)
T ss_dssp GGSCCHHHHHTSG
T ss_pred hhCCCHHHHhcCH
Confidence 9999999998653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=299.87 Aligned_cols=258 Identities=20% Similarity=0.245 Sum_probs=198.6
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--------cccHHHHHHHHHHHhhcCCCCccceeeeEEe
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--------TQGFAEFQSEVYVLNFARHKNIVMLLGFCCK 90 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (315)
.+.++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 45679999999999999999999876 68899999876432 1223457899999999999999999999876
Q ss_pred cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc---eeEC
Q 046121 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV---PMLG 167 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~---i~l~ 167 (315)
.. .++||||+.+++|.+.+.. ...+++..++.++.|++.++.+||+. +++|+||||+||+++.++. ++|+
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred Cc-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 55 7999999999999988853 45689999999999999999999999 9999999999999987664 9999
Q ss_pred CCCcccccCCCCCccccccccccccCccccc---cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH
Q 046121 168 DFGLARWKTTDDPVQTKILGTLGYLAPEYAE---NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI 244 (315)
Q Consensus 168 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (315)
|||++...... .......|++.|+|||++. +..++.++||||||+++|+|++|..||........ .... .
T Consensus 160 Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~----~ 232 (322)
T 2ycf_A 160 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ----I 232 (322)
T ss_dssp CCTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHH----H
T ss_pred cCccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHH----H
Confidence 99999744322 2223356889999999863 46688899999999999999999999975443221 1110 0
Q ss_pred hhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 245 EKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
...... ..+... ...+..+.+++.+||..||++|||+.+++++-+-.
T Consensus 233 ~~~~~~--~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~ 279 (322)
T 2ycf_A 233 TSGKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279 (322)
T ss_dssp HHTCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGC
T ss_pred HhCccc--cCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcC
Confidence 110000 001111 11244578999999999999999999999865543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=308.56 Aligned_cols=200 Identities=22% Similarity=0.265 Sum_probs=173.2
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhc------CCCCccceeeeEEecCe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFA------RHKNIVMLLGFCCKENL 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~ 93 (315)
+..+|++++.||+|+||+||+|.+. +++.||+|++... ......+.+|+.+++.+ .|+||+.+++.+.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4568999999999999999999766 5899999998753 23345567788888776 56799999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc--eeECCCCc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV--PMLGDFGL 171 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~--i~l~dfg~ 171 (315)
.++|||++. ++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++. ++|+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN----RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH----TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999985 6888888777777799999999999999999999999 9999999999999999987 99999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCC
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNG 229 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~ 229 (315)
+..... ......+++.|+|||++.+..++.++|||||||++|+|++|.+||....
T Consensus 249 a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTC---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCC---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 964332 2234578999999999999889999999999999999999999996543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=302.28 Aligned_cols=262 Identities=20% Similarity=0.193 Sum_probs=193.0
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecC------
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN------ 92 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 92 (315)
.++|++++.||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999875 6889999988653 2334556889999999999999999999997654
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
..++||||+.+ +|.+.+. ..+++..+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999865 6766663 3488999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH------------
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA------------ 240 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------ 240 (315)
...... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ......
T Consensus 175 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 175 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHC-CCCCCHHHHT
T ss_pred cccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHH
Confidence 744322 22234578999999999999889999999999999999999999996543211 111000
Q ss_pred ------HHHHhhhcc------ccccCCcccCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 241 ------EPLIEKLAL------HELIDPRIENS---YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 241 ------~~~~~~~~~------~~~~~~~~~~~---~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
......... ........... .....+..+.+|+.+||..||++|||+.+++++-+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 000000000 00000000000 11223667899999999999999999999998764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.97 Aligned_cols=262 Identities=18% Similarity=0.141 Sum_probs=206.7
Q ss_pred hcCCcccceecCCCceEEEEEE------eCCCcEEEEEEecccCcccHHHHHHHHHHHhhcC---CCCccceeeeEEecC
Q 046121 22 TGDFSKENLLGEGGFGHVYKGE------LKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR---HKNIVMLLGFCCKEN 92 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~------~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~ 92 (315)
.++|++.+.||+|+||+||+|. ..+++.||+|++.... ...+..|+.+++.+. |+|++.+++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 4679999999999999999993 3468899999987543 345667777777776 899999999999999
Q ss_pred eeEEEEEeccCCccccccccC---CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC---------
Q 046121 93 LNILVYEYICNKSLHWHLFDN---TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH--------- 160 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~--------- 160 (315)
..++||||+.+++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~----~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC----EIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECGGGTCC----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEecccccCccccc
Confidence 999999999999999998642 355699999999999999999999999 9999999999999998
Q ss_pred --CCceeECCCCcccccC--CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhH
Q 046121 161 --DFVPMLGDFGLARWKT--TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSL 236 (315)
Q Consensus 161 --~~~i~l~dfg~~~~~~--~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~ 236 (315)
++.++|+|||++.... ..........|++.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 8999999999996433 222233456789999999999999999999999999999999999999853322110
Q ss_pred HHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCC-CCHHHHHHHHhccccccccccchhhhc
Q 046121 237 RQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGR-PSMGEVVRLLEGENDRFHHLGEKFVQR 311 (315)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~R-ps~~~il~~L~~~~~~~~~~~~~~~~~ 311 (315)
. +...+.... ....+.+++..||+.+|.+| |++.++.+.|+....+-..-+.+.+++
T Consensus 294 -----------~----~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~~~~~~l~~ 351 (365)
T 3e7e_A 294 -----------K----PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRN 351 (365)
T ss_dssp -----------E----ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTTTTHHHHHH
T ss_pred -----------e----echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhhhchHHHHH
Confidence 0 001111111 23456788888999999999 678888888887766544444444443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=297.07 Aligned_cols=257 Identities=23% Similarity=0.303 Sum_probs=195.4
Q ss_pred hcCCcccceecCCCceEEEEEEeC--CCc--EEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK--DGQ--MIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~--~~~--~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
.++|++.+.||+|+||+||+|.+. +++ .|++|++... .....+.+.+|+.+++.++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 468999999999999999999753 333 6889987643 2344567889999999999999999999998665 7
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++|++|+.+++|.+++... ...+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 9999999999999888643 24589999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCc---cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccc
Q 046121 175 KTTDDPV---QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250 (315)
Q Consensus 175 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (315)
....... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~---- 240 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKE---- 240 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTS----
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHcc----
Confidence 4433221 122356778999999998889999999999999999999 99999654321 111111111
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
... ...+...+..+.+++.+||..||++|||+.++++.|+....
T Consensus 241 -~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 241 -GER----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -CCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -CCC----CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 000 11122334568889999999999999999999999988754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=305.86 Aligned_cols=267 Identities=21% Similarity=0.244 Sum_probs=205.5
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcC--------CCCccceeeeEE--
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR--------HKNIVMLLGFCC-- 89 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~-- 89 (315)
+.++|++.+.||+|+||+||+|.+. +++.||+|++... ......+.+|+.+++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 4579999999999999999999865 6889999998643 334567789999999885 778999999987
Q ss_pred --ecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC-----
Q 046121 90 --KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF----- 162 (315)
Q Consensus 90 --~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~----- 162 (315)
.....++||||+ ++++.+.+.......+++..++.++.|++.||.|||+++ |++|+||||+||+++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC---RIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHeeEeccchhhhh
Confidence 556889999998 666666666665567999999999999999999999863 799999999999998775
Q ss_pred --------------------------------------------ceeECCCCcccccCCCCCccccccccccccCccccc
Q 046121 163 --------------------------------------------VPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE 198 (315)
Q Consensus 163 --------------------------------------------~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 198 (315)
.++|+|||++...... .....|++.|+|||++.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhc
Confidence 7999999999744322 23457899999999999
Q ss_pred cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh-----------cc-ccccCC-----c-----
Q 046121 199 NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL-----------AL-HELIDP-----R----- 256 (315)
Q Consensus 199 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~-~~~~~~-----~----- 256 (315)
+..++.++|||||||++|+|++|..||...................... .. ...+.. .
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 9889999999999999999999999997654433221111111111100 00 000000 0
Q ss_pred ---------ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 257 ---------IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 257 ---------~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.....+...+..+.+|+.+||+.||++|||+.+++++-+
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 001234567778999999999999999999999997643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=321.70 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=199.1
Q ss_pred eecCCCceEEEEEEeC---CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccCCc
Q 046121 30 LLGEGGFGHVYKGELK---DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKS 105 (315)
Q Consensus 30 ~lg~g~~~~v~~~~~~---~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~ 105 (315)
.||+|+||+||+|.+. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.. +..++||||+.+++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999764 46679999987643 3456788999999999999999999999976 56899999999999
Q ss_pred cccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc---c
Q 046121 106 LHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV---Q 182 (315)
Q Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~---~ 182 (315)
|.+++... ...+++..++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++......... .
T Consensus 422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~----~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK----NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99988543 44599999999999999999999999 9999999999999999999999999999754322211 1
Q ss_pred ccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 183 TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 183 ~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
....+++.|+|||++.+..++.++||||||+++|+|++ |..||....... .. .. ..... ....
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~---~~-i~~~~---------~~~~ 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM---AF-IEQGK---------RMEC 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HH---HH-HHTTC---------CCCC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH---HH-HHcCC---------CCCC
Confidence 12345678999999998899999999999999999998 999997544321 11 11 11111 1112
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccccc
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~ 303 (315)
+...+..+.+++.+||..||++|||+.++++.|+.+......
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 223445688899999999999999999999999987665543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=310.79 Aligned_cols=198 Identities=24% Similarity=0.303 Sum_probs=165.5
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEec-----C
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE-----N 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 92 (315)
+.++|++++.||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4579999999999999999999876 6889999998753 333456788999999999999999999998766 5
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
..|+|||++. ++|.+.+.. ...+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~----givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHES----GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 7899999875 689888853 34599999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC----------------------ccccccccccccCcccc-ccCCCcccccchhhhHHHHHHHhCCCcc
Q 046121 173 RWKTTDDP----------------------VQTKILGTLGYLAPEYA-ENGIVSIRTDVYAFGIILLQLMSGRKVV 225 (315)
Q Consensus 173 ~~~~~~~~----------------------~~~~~~~~~~~~aPE~~-~~~~~~~~~DvwslG~~l~~l~~g~~p~ 225 (315)
........ ......|++.|+|||++ .+..++.++|||||||++|+|++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 75433221 12456789999999985 5666899999999999999999855444
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=302.37 Aligned_cols=257 Identities=22% Similarity=0.227 Sum_probs=188.8
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeeeEE--------e
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCC--------K 90 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--------~ 90 (315)
...+|++.+.||+|+||+||+|.+. +++.||+|++..........+.+|+.+++.+. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3458999999999999999999875 68999999887666666777899999999996 999999999984 3
Q ss_pred cCeeEEEEEeccCCcccccccc-CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCC--eEeecCccCcEEEcCCCceeEC
Q 046121 91 ENLNILVYEYICNKSLHWHLFD-NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGP--IIHRDMRPSNILLTHDFVPMLG 167 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~--i~h~di~p~nil~~~~~~i~l~ 167 (315)
....++|++|+. ++|.+++.. .....+++..++.++.|++.++.+||+. + ++|+||||+||+++.++.++|+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ----KPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCEEEccCCcccEEECCCCCEEEe
Confidence 445799999985 688777754 2344699999999999999999999999 8 9999999999999999999999
Q ss_pred CCCcccccCCCCCc------------cccccccccccCcccc---ccCCCcccccchhhhHHHHHHHhCCCccCCCCCcc
Q 046121 168 DFGLARWKTTDDPV------------QTKILGTLGYLAPEYA---ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEP 232 (315)
Q Consensus 168 dfg~~~~~~~~~~~------------~~~~~~~~~~~aPE~~---~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~ 232 (315)
|||++......... .....+++.|+|||++ .+..++.++||||||+++|+|++|..||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 99999754432211 1134578999999988 56678899999999999999999999996432211
Q ss_pred chhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 233 QQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
. ... ........ .....+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 261 ~----------~~~-----~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 261 I----------VNG-----KYSIPPHD----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp --------------------CCCCTTC----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred h----------hcC-----cccCCccc----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 000 00000011 11223778999999999999999999999999886543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=303.10 Aligned_cols=216 Identities=23% Similarity=0.271 Sum_probs=178.8
Q ss_pred CCCCCcccHHHHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CC-----
Q 046121 7 MKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HK----- 79 (315)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~----- 79 (315)
-.+...+.+.......++|++.+.||+|+||+||+|.+. +++.||+|++... ......+..|+.+++.+. |+
T Consensus 38 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~ 116 (382)
T 2vx3_A 38 DDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKY 116 (382)
T ss_dssp BCTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGG
T ss_pred CCCCCcEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccce
Confidence 334444555555566789999999999999999999876 6889999998743 333456778888888875 44
Q ss_pred CccceeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc
Q 046121 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT 159 (315)
Q Consensus 80 ~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~ 159 (315)
+++.+.+++...+..++||||+. ++|.+++.......+++..+..++.|++.|+.+||+. ..+++|+||||+||+++
T Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~ 193 (382)
T 2vx3_A 117 YIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLC 193 (382)
T ss_dssp GBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEES
T ss_pred eEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEe
Confidence 48999999999999999999985 5999988777666799999999999999999999952 11899999999999994
Q ss_pred --CCCceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCC
Q 046121 160 --HDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNG 229 (315)
Q Consensus 160 --~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~ 229 (315)
.++.++|+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|.+||....
T Consensus 194 ~~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 194 NPKRSAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp STTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCCcEEEEeccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 5788999999999754322 234578999999999999899999999999999999999999997543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=299.62 Aligned_cols=268 Identities=22% Similarity=0.283 Sum_probs=188.0
Q ss_pred HHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 18 IQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
.....++|++.+.||+|++|+||+|.+. +++.|++|++.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3445689999999999999999999865 68899999876443 334566789999999999999999999999999999
Q ss_pred EEEEeccCCcccccccc------CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCC
Q 046121 96 LVYEYICNKSLHWHLFD------NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDF 169 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~df 169 (315)
+||||+.+++|.+++.. .....+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|+||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN----GQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCCChhhEEEcCCCCEEEEec
Confidence 99999999999988853 2345689999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCC-----ccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH
Q 046121 170 GLARWKTTDDP-----VQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 170 g~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
|++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||........ ... .
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~----~ 239 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LML----T 239 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHH----H
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHH----H
Confidence 99864433211 1223468899999998865 5678999999999999999999999975443211 100 0
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
... ..................+..+.+++.+||+.||++|||+.+++++-+-
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 291 (303)
T 2vwi_A 240 LQN-DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291 (303)
T ss_dssp HTS-SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC
T ss_pred hcc-CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 000 0000000000011112233457889999999999999999999986543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=294.15 Aligned_cols=264 Identities=21% Similarity=0.303 Sum_probs=200.5
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEe---------
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK--------- 90 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------- 90 (315)
..++|++++.||+|+||+||+|.+. +++.+++|++... ......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 5678999999999999999999875 7899999988643 3445678899999999999999999998755
Q ss_pred ----cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeE
Q 046121 91 ----ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPML 166 (315)
Q Consensus 91 ----~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l 166 (315)
....++||||+.+++|.+++... ...+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQ----GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhC----CeecccCCHHhEEEcCCCCEEE
Confidence 45679999999999999998653 34578899999999999999999999 9999999999999999999999
Q ss_pred CCCCcccccCCCC--------------CccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCc
Q 046121 167 GDFGLARWKTTDD--------------PVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEE 231 (315)
Q Consensus 167 ~dfg~~~~~~~~~--------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~ 231 (315)
+|||++....... .......|++.|+|||.+.+. .++.++||||||+++|+|++ ||....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 9999986443211 112234678999999998764 68899999999999999998 442110
Q ss_pred cchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccccccc
Q 046121 232 PQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLG 305 (315)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~~ 305 (315)
.......... . .........+...+..+.+++.+||+.||++|||+.+++++-+-......+.-
T Consensus 233 ---~~~~~~~~~~---~----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~ 296 (303)
T 1zy4_A 233 ---ERVNILKKLR---S----VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVI 296 (303)
T ss_dssp ---HHHHHHHHHH---S----TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHHHHH
T ss_pred ---hHHHHHHhcc---c----cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChHHHH
Confidence 0011111110 0 11122233344445567899999999999999999999998776554444433
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=306.64 Aligned_cols=264 Identities=18% Similarity=0.211 Sum_probs=205.8
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCC-CCccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARH-KNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~ 98 (315)
+.++|+++++||+|+||.||+|.+. +++.||+|+...... ...+.+|+.+++.++| +++..+..++......++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 3579999999999999999999874 689999998765433 2457889999999987 55556666667788889999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE---cCCCceeECCCCccccc
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL---THDFVPMLGDFGLARWK 175 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~---~~~~~i~l~dfg~~~~~ 175 (315)
||+ +++|.+++... ...+++..++.++.||+.+|.|||+. +++|+||||+||++ +.++.++|+|||++...
T Consensus 83 e~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK----SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 998 99999988643 34599999999999999999999999 99999999999999 68899999999999754
Q ss_pred CCCCCc-------cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhc
Q 046121 176 TTDDPV-------QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248 (315)
Q Consensus 176 ~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (315)
...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 433221 1245789999999999999999999999999999999999999976544322211111111100000
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 249 LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
.. .+... .+..+.+++..||..+|++||++.+|++.|+.+..+.
T Consensus 237 ~~-----~l~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 237 IE-----ALCRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HH-----HHHTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HH-----HHhcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 00 01111 1345788999999999999999999999998886543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=303.93 Aligned_cols=260 Identities=21% Similarity=0.248 Sum_probs=184.4
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEec------
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE------ 91 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 91 (315)
+.++|++++.||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3479999999999999999999865 6899999997653 233456678999999999999999999998654
Q ss_pred CeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCc
Q 046121 92 NLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGL 171 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~ 171 (315)
...++|++++ +++|.+++.. ..+++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999997 8899888743 4699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh---
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL--- 247 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 247 (315)
+..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..+..... .....
T Consensus 179 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~-~~g~p~~~ 252 (367)
T 2fst_X 179 ARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILR-LVGTPGAE 252 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHH-HHCSCCHH
T ss_pred cccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH-HhCCCCHH
Confidence 964332 2234578999999999876 67899999999999999999999999654321 11111110 00000
Q ss_pred ---------------ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 248 ---------------ALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 248 ---------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.+.......+. ......+..+.+|+.+||..||++|||+.+++++-+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHH-HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHH-HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 00000000000 000112445789999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=311.87 Aligned_cols=242 Identities=12% Similarity=0.130 Sum_probs=187.4
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHH---HHhhcCCCCcccee-------ee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVY---VLNFARHKNIVMLL-------GF 87 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~---~l~~l~~~~i~~~~-------~~ 87 (315)
.++|++.+.||+|+||+||+|.+. +++.||+|++... .....+.+.+|+. .++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 367999999999999999999864 6999999998743 3445577889994 55555799999998 66
Q ss_pred EEecC-----------------eeEEEEEeccCCccccccccCC-----CCccCHHHHHHHHHHHHHHHHhhhcccCCCC
Q 046121 88 CCKEN-----------------LNILVYEYICNKSLHWHLFDNT-----ESVLEWHQRYAAAIGTAKGLRFLHEECRGGP 145 (315)
Q Consensus 88 ~~~~~-----------------~~~lv~~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~ 145 (315)
+...+ ..++||||+ +|+|.+++.... ...+++..++.++.|++.||.|||+. +
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ 226 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----G 226 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT----T
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC----C
Confidence 65543 278999998 689999886431 12344588888999999999999999 9
Q ss_pred eEeecCccCcEEEcCCCceeECCCCcccccCCCCCccccccccccccCccccccC-----------CCcccccchhhhHH
Q 046121 146 IIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENG-----------IVSIRTDVYAFGII 214 (315)
Q Consensus 146 i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~DvwslG~~ 214 (315)
++|+||||+||+++.++.++|+|||++.... .......| +.|+|||++.+. .++.++||||||++
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999997422 22334567 999999999877 78999999999999
Q ss_pred HHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 215 LLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 215 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
+|+|++|..||.......... .... . . ...+..+.+++.+||+.||++|||+.+++++
T Consensus 303 l~elltg~~Pf~~~~~~~~~~---------------~~~~-~-~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSE---------------WIFR-S-C----KNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC------CCSG---------------GGGS-S-C----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCcccccccchh---------------hhhh-h-c----cCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999999996443221100 0000 0 0 1223457889999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=306.19 Aligned_cols=264 Identities=19% Similarity=0.234 Sum_probs=194.7
Q ss_pred HhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCe------e
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL------N 94 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------~ 94 (315)
...+|++.+.||+|+||+||+|.+..+..+++|.+..... ...+|+.+++.++||||+++++++..... +
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 4568999999999999999999987666688877654322 22479999999999999999999865443 7
Q ss_pred EEEEEeccCCccccccc-cCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc-CCCceeECCCCcc
Q 046121 95 ILVYEYICNKSLHWHLF-DNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT-HDFVPMLGDFGLA 172 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~-~~~~i~l~dfg~~ 172 (315)
++||||+.++.+..... ......+++..+..++.|++.|+.|||+. |++|+||||+||+++ .++.++|+|||++
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI----GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 89999997654433221 12345699999999999999999999999 999999999999999 7999999999999
Q ss_pred cccCCCCCccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH-------H
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL-------I 244 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~ 244 (315)
....... ......+++.|+|||++.+. .++.++|||||||++|+|++|.+||...... ..+....... .
T Consensus 190 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 190 KILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp EECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHH
T ss_pred ccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 7543332 23345789999999988764 5899999999999999999999999754321 1111111100 0
Q ss_pred h--hhcccc-----ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 245 E--KLALHE-----LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 245 ~--~~~~~~-----~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
. ...... .....+...++...+..+.+|+.+||..||++|||+.+++++-+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 0 000000 00001111122234456889999999999999999999998643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=297.84 Aligned_cols=266 Identities=24% Similarity=0.289 Sum_probs=201.6
Q ss_pred HhcCCcccceecCCCceEEEEEEeC--CCcEEEEEEecccCc--ccHHHHHHHHHHHhhc---CCCCccceeeeEE----
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK--DGQMIAAKVRKEAST--QGFAEFQSEVYVLNFA---RHKNIVMLLGFCC---- 89 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~---- 89 (315)
..++|++.+.||+|+||+||+|.+. +++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4579999999999999999999873 688899998764322 2223456777777666 8999999999987
Q ss_pred -ecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECC
Q 046121 90 -KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGD 168 (315)
Q Consensus 90 -~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~d 168 (315)
.....++|+||+. ++|.+++.......+++..++.++.|++.++.+||+. |++|+||+|+||+++.++.++|+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHHHeEEcCCCCEEEec
Confidence 5667899999987 5998988777666799999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh--h
Q 046121 169 FGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE--K 246 (315)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 246 (315)
||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...... ............ .
T Consensus 164 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 164 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGE 240 (326)
T ss_dssp CCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCG
T ss_pred CcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCCc
Confidence 9998643322 2223456889999999999888999999999999999999999999654321 111111110000 0
Q ss_pred hcccc-------cc---CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 247 LALHE-------LI---DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 247 ~~~~~-------~~---~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
..+.. .. ............+..+.+++.+||..||++|||+.+++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 298 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 00000 00 00000112223455678999999999999999999999653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=320.18 Aligned_cols=249 Identities=24% Similarity=0.305 Sum_probs=196.7
Q ss_pred ceecCCCceEEEEEEeC---CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK---DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~---~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. +..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999543 46789999987543 2335678999999999999999999999864 557899999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC---
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP--- 180 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~--- 180 (315)
++|.+++... ..+++..++.++.|++.++.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~----~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHC----CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999998543 4589999999999999999999999 999999999999999999999999999975443221
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
......+++.|+|||++.+..++.++||||||+++|+|++ |..||....... ... ...... ..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~-~i~~~~---------~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTA-MLEKGE---------RM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHH-HHHTTC---------CC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH-HHHcCC---------CC
Confidence 1122345778999999999899999999999999999998 999996543211 111 111111 11
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
..+...+..+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11223345688899999999999999999999999877544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=298.78 Aligned_cols=266 Identities=21% Similarity=0.191 Sum_probs=201.0
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEec-----C
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE-----N 92 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 92 (315)
...++|++++.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34579999999999999999999876 68889999887533 33346688999999999999999999998654 4
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
..++|++++. ++|.+.+.. ..+++..+..++.|++.++.+||+. |++|+||||+||+++.++.++|+|||++
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 6899999986 588887743 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc---cccccccccccCccccc-cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh-
Q 046121 173 RWKTTDDPV---QTKILGTLGYLAPEYAE-NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL- 247 (315)
Q Consensus 173 ~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 247 (315)
......... .....|++.|+|||++. +..++.++||||||+++|+|++|.+||........ ....... ....
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~-~~~~~ 252 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGI-LGSPS 252 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--HHHHHHH-HCSCC
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--HHHHHHH-hCCCC
Confidence 754322211 23357899999999765 45589999999999999999999999965443221 1111100 0000
Q ss_pred --------------ccccccCCcc--cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 248 --------------ALHELIDPRI--ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 248 --------------~~~~~~~~~~--~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.......+.. .....+..+..+.+++.+||+.||++|||+.+++++-+-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 0000000000 000111234457899999999999999999999987653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=292.63 Aligned_cols=257 Identities=22% Similarity=0.265 Sum_probs=187.5
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc--ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST--QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
..++|++.+.||+|+||+||+|.+. +++.||+|++..... .....+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3578999999999999999999875 789999998865422 2223344555668888999999999999999999999
Q ss_pred EEeccCCcccccccc--CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 98 YEYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
|||+.+ +|.+++.. .....+++..++.++.|++.++.+||+.. +++|+||||+||+++.++.++|+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL---SVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS---CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999964 77666643 23456999999999999999999999853 8999999999999999999999999999644
Q ss_pred CCCCCccccccccccccCcccc----ccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 176 TTDDPVQTKILGTLGYLAPEYA----ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
.... ......|++.|+|||.+ .+..++.++||||||+++|+|++|..||........ ... ..... .
T Consensus 161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~----~~~~~-~--- 230 (290)
T 3fme_A 161 VDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLK----QVVEE-P--- 230 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHH----HHHHS-C---
T ss_pred cccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHH----HHhcc-C---
Confidence 3322 22334688999999985 566688999999999999999999999964332211 111 11111 0
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.+ .......+..+.+++.+||+.||++|||+.+++++-+-
T Consensus 231 --~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f 270 (290)
T 3fme_A 231 --SP---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270 (290)
T ss_dssp --CC---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred --CC---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccc
Confidence 01 11111234457889999999999999999999885443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=289.93 Aligned_cols=257 Identities=22% Similarity=0.231 Sum_probs=203.7
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCe
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL 93 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (315)
......++|++++.||+|++|+||+|.+. +++.|++|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 16 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 34556789999999999999999999876 68999999976542 3456778899999999999999999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC---CceeECCCC
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD---FVPMLGDFG 170 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~---~~i~l~dfg 170 (315)
.++|+|++.+++|.+.+... ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.+ +.++|+|||
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChhhEEEecCCCcccEEEeccC
Confidence 99999999999998887543 3589999999999999999999999 99999999999999764 479999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccc
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (315)
++....... ......+++.|+|||.+.+. ++.++|+||||+++|+|++|..||...... ....... ....
T Consensus 170 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~~~- 239 (287)
T 2wei_A 170 LSTCFQQNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVE-TGKY- 239 (287)
T ss_dssp GGGTBCCCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HCCC-
T ss_pred cceeecCCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-cCCC-
Confidence 987443322 22334578899999998764 889999999999999999999999654321 1111111 1100
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
....+ .....+..+.+++.+||..||++|||+.+++++-
T Consensus 240 ~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 240 AFDLP-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp CCCSG-----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred CCCch-----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 00000 0112244578899999999999999999999853
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=296.25 Aligned_cols=258 Identities=20% Similarity=0.221 Sum_probs=178.4
Q ss_pred HhcCCcccc-eecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEe----cCee
Q 046121 21 ATGDFSKEN-LLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK----ENLN 94 (315)
Q Consensus 21 ~~~~y~~~~-~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 94 (315)
+.++|++.+ .||+|+||+||+|.+. +++.||+|++.... ....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 567899965 6999999999999876 69999999986531 222333344677799999999999876 4568
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC---CCceeECCCCc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGL 171 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~---~~~i~l~dfg~ 171 (315)
++||||+.|++|.+++.......+++..++.++.|++.++.+||+. +++|+||||+||+++. ++.++|+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~----~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH----NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999999877767899999999999999999999999 9999999999999976 45599999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
+...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||............. ......
T Consensus 178 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------~~~~~~- 248 (336)
T 3fhr_A 178 AKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK------RRIRLG- 248 (336)
T ss_dssp CEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred ceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH------Hhhhcc-
Confidence 9644322 2234567899999999988889999999999999999999999996543221100000 000000
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
............+..+.+++.+||+.||++|||+.+++++-+-.
T Consensus 249 --~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 292 (336)
T 3fhr_A 249 --QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred --ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 00011111122345678899999999999999999999866543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=299.75 Aligned_cols=277 Identities=20% Similarity=0.199 Sum_probs=193.6
Q ss_pred CcccHHHHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEE
Q 046121 11 MKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCC 89 (315)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (315)
..-.........++|++.+.||+|+||+||+|.+. +++.||+|++.... .......+++..++.++||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 11 AAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp -CBSSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred ccChhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 33444566777889999999999999999999875 68999999876532 23345677888889999999999999987
Q ss_pred ecCe-------eEEEEEeccCCcccccccc--CCCCccCHHHHHHHHHHHHHHHHhhh--cccCCCCeEeecCccCcEEE
Q 046121 90 KENL-------NILVYEYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLH--EECRGGPIIHRDMRPSNILL 158 (315)
Q Consensus 90 ~~~~-------~~lv~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~~~~~i~h~di~p~nil~ 158 (315)
.... .++||||+.++ |...+.. .....+++..+..++.|++.++.+|| +. +++|+||||+||++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~----~ivH~Dlkp~NIll 164 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV----NVCHRDIKPHNVLV 164 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT----CCBCSCCCGGGEEE
T ss_pred ccccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC----CeecCcCCHHHEEE
Confidence 6443 78999999764 3333321 34556899999999999999999999 88 99999999999999
Q ss_pred cC-CCceeECCCCcccccCCCCCccccccccccccCccccccCC-CcccccchhhhHHHHHHHhCCCccCCCCCccchhH
Q 046121 159 TH-DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSL 236 (315)
Q Consensus 159 ~~-~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~ 236 (315)
+. ++.++|+|||++....... ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||...... ...
T Consensus 165 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~ 241 (360)
T 3e3p_A 165 NEADGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQL 241 (360)
T ss_dssp ETTTTEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH
T ss_pred eCCCCcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHH
Confidence 97 8999999999997444322 233456899999999886544 799999999999999999999999754322 111
Q ss_pred HHhHHH-------HHhhh----ccccccC------CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 237 RQWAEP-------LIEKL----ALHELID------PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 237 ~~~~~~-------~~~~~----~~~~~~~------~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
...... ..... ....... ...........+..+.+++.+||+.||++|||+.+++++-+-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 318 (360)
T 3e3p_A 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318 (360)
T ss_dssp HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence 111110 00000 0000000 000111122245678999999999999999999999987554
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=304.57 Aligned_cols=274 Identities=19% Similarity=0.213 Sum_probs=187.9
Q ss_pred HhcCCcc-cceecCCCceEEEEEEeC---CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEe--cCee
Q 046121 21 ATGDFSK-ENLLGEGGFGHVYKGELK---DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK--ENLN 94 (315)
Q Consensus 21 ~~~~y~~-~~~lg~g~~~~v~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 94 (315)
..+.|++ .++||+|+||+||+|.+. +++.||+|++.... ....+.+|+.+++.++||||+++++++.. ....
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 4566777 458999999999999865 57889999887543 23567899999999999999999999954 6788
Q ss_pred EEEEEeccCCcccccccc-------CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE----cCCCc
Q 046121 95 ILVYEYICNKSLHWHLFD-------NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL----THDFV 163 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~----~~~~~ 163 (315)
++||||+. ++|.+.+.. .....+++..++.++.|++.||.|||+. +++|+||||+||++ +.++.
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeCCCcCHHHeEEecCCCCCCc
Confidence 99999985 467666542 1223599999999999999999999999 99999999999999 77889
Q ss_pred eeECCCCcccccCCCC---CccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCcc-------
Q 046121 164 PMLGDFGLARWKTTDD---PVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEP------- 232 (315)
Q Consensus 164 i~l~dfg~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~------- 232 (315)
++|+|||++....... .......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.......
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 9999999997544321 12234578999999999877 458999999999999999999999996543321
Q ss_pred chhHHHhHHHHHhhhc---cccc------------cCCcccCCCC---------HHHHHHHHHHHHhhcCCCCCCCCCHH
Q 046121 233 QQSLRQWAEPLIEKLA---LHEL------------IDPRIENSYD---------TYELYLMAKTAYLCVQRNPEGRPSMG 288 (315)
Q Consensus 233 ~~~~~~~~~~~~~~~~---~~~~------------~~~~~~~~~~---------~~~~~~l~~l~~~~l~~~p~~Rps~~ 288 (315)
...+..... ...... +... +......... ...+..+.+|+.+||..||++|||+.
T Consensus 251 ~~~l~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 251 HDQLDRIFN-VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp HHHHHHHHH-HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred HHHHHHHHH-hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 011111100 000000 0000 0000000000 00134577999999999999999999
Q ss_pred HHHHHHhccccccc
Q 046121 289 EVVRLLEGENDRFH 302 (315)
Q Consensus 289 ~il~~L~~~~~~~~ 302 (315)
+++++-+-....+.
T Consensus 330 e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 330 QAMQDPYFLEDPLP 343 (405)
T ss_dssp HHHTSGGGTSSSCC
T ss_pred HHhcChhhccCCCC
Confidence 99998876654443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=303.21 Aligned_cols=255 Identities=11% Similarity=0.009 Sum_probs=180.1
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc---ccHHHHHHHHHHHhhc--CCCCcccee-------eeEEe
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST---QGFAEFQSEVYVLNFA--RHKNIVMLL-------GFCCK 90 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l--~~~~i~~~~-------~~~~~ 90 (315)
+|++.+.||+|+||+||+|.+. +++.||+|++..... .....+.+|+.+++.+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 4999999999999999999876 789999999886542 3344567775444444 699987754 44443
Q ss_pred c-----------------CeeEEEEEeccCCccccccccCCCCccCHHHH------HHHHHHHHHHHHhhhcccCCCCeE
Q 046121 91 E-----------------NLNILVYEYICNKSLHWHLFDNTESVLEWHQR------YAAAIGTAKGLRFLHEECRGGPII 147 (315)
Q Consensus 91 ~-----------------~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~------~~~~~~l~~~l~~lh~~~~~~~i~ 147 (315)
. ...++||||+. ++|.+++..... .++.... ..++.|++.|+.|||+. +++
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~----~iv 216 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK----GLV 216 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT----TEE
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC----CCc
Confidence 3 33799999998 899998865422 2344455 67779999999999999 999
Q ss_pred eecCccCcEEEcCCCceeECCCCcccccCCCCCccccccccccccCcccccc--CCCcccccchhhhHHHHHHHhCCCcc
Q 046121 148 HRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN--GIVSIRTDVYAFGIILLQLMSGRKVV 225 (315)
Q Consensus 148 h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~ 225 (315)
|+||||+||+++.++.++|+|||++..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999974432 1213456699999999987 67899999999999999999999999
Q ss_pred CCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 226 DMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
............ ....................+..+.+++.+||+.||++|||+.+++++-+
T Consensus 294 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 294 GLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp TBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred CCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 765432111000 00000000111111111234556889999999999999999999986543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=291.98 Aligned_cols=256 Identities=22% Similarity=0.321 Sum_probs=198.0
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEeccc--CcccHHHHHHHHHHHhhcC--CCCccceeeeEEecCee
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEA--STQGFAEFQSEVYVLNFAR--HKNIVMLLGFCCKENLN 94 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~ 94 (315)
....++|++++.||+|+||+||++.+.+++.+|+|++... .......+.+|+.+++.++ ||||+++++++...+..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3456789999999999999999999888999999988644 2334567889999999997 59999999999999999
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++||| +.+++|.+++... ..+++..++.++.|++.|+.+||+. +++|+||+|+||+++. +.++|+|||++..
T Consensus 104 ~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEEEC-CeEEEeecccccc
Confidence 99999 5788999988654 4589999999999999999999999 9999999999999965 8999999999974
Q ss_pred cCCCCC--ccccccccccccCcccccc-----------CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH
Q 046121 175 KTTDDP--VQTKILGTLGYLAPEYAEN-----------GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE 241 (315)
Q Consensus 175 ~~~~~~--~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 241 (315)
...... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||....... .. ..
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~-~~ 250 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SK-LH 250 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HH-HH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH----HH-HH
Confidence 433221 1223468999999998865 467889999999999999999999996433211 11 01
Q ss_pred HHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 242 PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
... .+......+...+..+.+++.+||+.||++|||+.+++++.+-
T Consensus 251 ~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 251 AII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp HHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHH---------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 111 1111111122224467889999999999999999999986553
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=298.19 Aligned_cols=261 Identities=19% Similarity=0.216 Sum_probs=197.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCee---
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN--- 94 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~--- 94 (315)
+.++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3579999999999999999999876 68999999887542 33356688999999999999999999999877655
Q ss_pred ---EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCc
Q 046121 95 ---ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGL 171 (315)
Q Consensus 95 ---~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~ 171 (315)
++||||+. ++|.+.+ ...+++..+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999986 5776665 33499999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH------
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI------ 244 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------ 244 (315)
+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...... ...........
T Consensus 191 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 191 ARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGTEF 265 (371)
T ss_dssp C-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred cccccc---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCcHHH
Confidence 964332 2234567999999998876 67899999999999999999999999654321 11111100000
Q ss_pred -hh-------hccccccCCcccC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 245 -EK-------LALHELIDPRIEN---SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 245 -~~-------~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.. ...... ...... ...+..+..+.+++.+||+.||++|||+.+++++-+-
T Consensus 266 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 327 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSL-PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327 (371)
T ss_dssp HTTCSCHHHHHHHHHS-CCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHhhhhhhhhhhhcc-CCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence 00 000000 000000 0111234568899999999999999999999987653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=295.50 Aligned_cols=266 Identities=21% Similarity=0.260 Sum_probs=203.7
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeC-CC-cEEEEEEecccCcccHHHHHHHHHHHhhcCCCC------ccceeeeEEe
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELK-DG-QMIAAKVRKEASTQGFAEFQSEVYVLNFARHKN------IVMLLGFCCK 90 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~-~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~~~ 90 (315)
..+.++|++.+.||+|+||+||+|.+. ++ ..||+|++... ......+.+|+.+++.++|++ ++.+.+++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 335689999999999999999999875 34 68999998643 334566788999999887655 8899999999
Q ss_pred cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE------------
Q 046121 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL------------ 158 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~------------ 158 (315)
.+..++||||+ ++++.+.+.......+++..++.++.|++.||.+||+. +++|+||||+||++
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN----QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeccccccccccc
Confidence 99999999998 66777777666666799999999999999999999999 99999999999999
Q ss_pred -------cCCCceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCc
Q 046121 159 -------THDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEE 231 (315)
Q Consensus 159 -------~~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~ 231 (315)
+.++.++|+|||++...... .....|++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 67889999999999743322 23457899999999999989999999999999999999999999754322
Q ss_pred cchhHHHhHHHHHhh--------hccccc---------------------cCC-cccCCCCHHHHHHHHHHHHhhcCCCC
Q 046121 232 PQQSLRQWAEPLIEK--------LALHEL---------------------IDP-RIENSYDTYELYLMAKTAYLCVQRNP 281 (315)
Q Consensus 232 ~~~~~~~~~~~~~~~--------~~~~~~---------------------~~~-~~~~~~~~~~~~~l~~l~~~~l~~~p 281 (315)
.. .... ...... ...... ..+ .............+.+++.+||..||
T Consensus 246 ~~--~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 246 EH--LVMM-EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp HH--HHHH-HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HH--HHHH-HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 11 1110 000000 000000 000 00011223445678899999999999
Q ss_pred CCCCCHHHHHHHHhc
Q 046121 282 EGRPSMGEVVRLLEG 296 (315)
Q Consensus 282 ~~Rps~~~il~~L~~ 296 (315)
++|||+.+++++-+-
T Consensus 323 ~~Rpt~~e~l~hp~f 337 (355)
T 2eu9_A 323 AQRITLAEALLHPFF 337 (355)
T ss_dssp TTSCCHHHHTTSGGG
T ss_pred hhCcCHHHHhcChhh
Confidence 999999999976443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=297.08 Aligned_cols=268 Identities=18% Similarity=0.255 Sum_probs=203.2
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcC-----------CCCccceeeeE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-----------HKNIVMLLGFC 88 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~ 88 (315)
..++|++.+.||+|+||+||+|.+. +++.||+|++... ......+.+|+.+++.+. ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 3579999999999999999999875 6899999998743 333456788999888876 78999999998
Q ss_pred EecC----eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc-----
Q 046121 89 CKEN----LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT----- 159 (315)
Q Consensus 89 ~~~~----~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~----- 159 (315)
...+ ..++||+++ +++|.+++.......+++..++.++.|++.|+.+||++. +++|+||||+||+++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChHHeEEeccCCC
Confidence 7654 789999998 999999998777777999999999999999999999953 899999999999994
Q ss_pred -CCCceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHH
Q 046121 160 -HDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQ 238 (315)
Q Consensus 160 -~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 238 (315)
..+.++|+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 3448999999999744322 233468999999999999889999999999999999999999997554322111111
Q ss_pred hHHHHHhhh-cc-----------------ccccCC-------------cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 046121 239 WAEPLIEKL-AL-----------------HELIDP-------------RIENSYDTYELYLMAKTAYLCVQRNPEGRPSM 287 (315)
Q Consensus 239 ~~~~~~~~~-~~-----------------~~~~~~-------------~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~ 287 (315)
......... .. ...... .....++...+..+.+|+.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 111111000 00 000000 00113456778889999999999999999999
Q ss_pred HHHHHHHhc
Q 046121 288 GEVVRLLEG 296 (315)
Q Consensus 288 ~~il~~L~~ 296 (315)
.+++++-+-
T Consensus 329 ~ell~hp~f 337 (373)
T 1q8y_A 329 GGLVNHPWL 337 (373)
T ss_dssp HHHHTCGGG
T ss_pred HHHhhChhh
Confidence 999986553
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=292.95 Aligned_cols=267 Identities=20% Similarity=0.236 Sum_probs=195.8
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEE----------
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCC---------- 89 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---------- 89 (315)
+.++|++++.||+|+||+||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 4579999999999999999999876 58999999988776666778899999999999999999998873
Q ss_pred ----ecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc-CCCce
Q 046121 90 ----KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT-HDFVP 164 (315)
Q Consensus 90 ----~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~-~~~~i 164 (315)
.....++||||+. ++|.+++. ...+++..++.++.|++.|+.+||+. +++|+||||+||+++ .++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCeE
Confidence 4467899999997 58988874 34689999999999999999999999 999999999999997 56799
Q ss_pred eECCCCcccccCCCC---CccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH
Q 046121 165 MLGDFGLARWKTTDD---PVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240 (315)
Q Consensus 165 ~l~dfg~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 240 (315)
+|+|||++....... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...... .......
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~ 238 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLIL 238 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHH
Confidence 999999997443221 11223456888999998765 67889999999999999999999999754321 1111110
Q ss_pred HHH-------Hhh--hccc-----cccCCc-ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 241 EPL-------IEK--LALH-----ELIDPR-IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 241 ~~~-------~~~--~~~~-----~~~~~~-~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
... ... .... ....+. ......+..+..+.+++.+||+.||++|||+.+++++-+-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence 000 000 0000 000000 00001122345688999999999999999999999865543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=294.17 Aligned_cols=260 Identities=19% Similarity=0.220 Sum_probs=196.9
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCe-----
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL----- 93 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----- 93 (315)
.++|.+.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 478999999999999999999875 68999999886532 3334567899999999999999999999977654
Q ss_pred -eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 94 -NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 94 -~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
.++||||+. ++|.+.+. ..+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999986 57777662 3489999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH-------H
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL-------I 244 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~ 244 (315)
..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...... ..+....... .
T Consensus 174 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 174 RHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp TC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH--HHHHHHHHHHCBCCHHHH
T ss_pred cCCCC---CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 64322 2234567899999998876 66889999999999999999999999754321 1111110000 0
Q ss_pred hh----------hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 245 EK----------LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 245 ~~----------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
.. ........+.+ ....+..+..+.+++.+||..||++|||+.+++++-+-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 309 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 00 00000001111 11222345668899999999999999999999987553
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=302.00 Aligned_cols=261 Identities=21% Similarity=0.255 Sum_probs=193.2
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEec------CeeE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE------NLNI 95 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~ 95 (315)
.+|++.+.||+|+||+||+|.+. +++.||+|++.... ....+|+.+++.++||||+++++++... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 36999999999999999999876 68999999876432 2234799999999999999999988542 2367
Q ss_pred EEEEeccCCcccccccc--CCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC-CceeECCCCcc
Q 046121 96 LVYEYICNKSLHWHLFD--NTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD-FVPMLGDFGLA 172 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~-~~i~l~dfg~~ 172 (315)
+||||+.+ ++.+.+.. .....+++..+..++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 99999865 55444432 2345699999999999999999999999 99999999999999965 67899999999
Q ss_pred cccCCCCCccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH--------H
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP--------L 243 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~ 243 (315)
....... ......+++.|+|||++.+. .++.++|||||||++|+|++|.+||...... ..+...... .
T Consensus 205 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 205 KQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp EECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHH
T ss_pred hhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 7544332 22345789999999998764 6899999999999999999999999754321 111111110 0
Q ss_pred Hh-hhccccccCCccc-----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 244 IE-KLALHELIDPRIE-----NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 244 ~~-~~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.. .........+... ..++...+..+.+|+.+||..||++|||+.+++.+-+
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 00 0000111011110 1122233456889999999999999999999997654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=294.82 Aligned_cols=261 Identities=22% Similarity=0.311 Sum_probs=197.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
..++|++.+.||+|+||+||+|.+.+ .+++|++.... ....+.+.+|+.+++.++||||+++++++......++|+
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45789999999999999999998764 38888876432 333455778999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+++|.+++... ...+++..++.++.|++.|+.+||+. +++|+||+|+||+++ ++.++|+|||++......
T Consensus 109 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK----GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp BCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHT----TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 999999999988543 34589999999999999999999999 999999999999998 679999999997643211
Q ss_pred -----CCccccccccccccCcccccc---------CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH
Q 046121 179 -----DPVQTKILGTLGYLAPEYAEN---------GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI 244 (315)
Q Consensus 179 -----~~~~~~~~~~~~~~aPE~~~~---------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (315)
........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||....... .....
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~- 255 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------IIWQM- 255 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------HHHHH-
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHh-
Confidence 112223458899999998864 346889999999999999999999996543211 11111
Q ss_pred hhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccccc
Q 046121 245 EKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHL 304 (315)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~~ 304 (315)
.......... . ..+..+.+++.+||..||++|||+.++++.|+.+..+....
T Consensus 256 ~~~~~~~~~~----~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 256 GTGMKPNLSQ----I----GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp HTTCCCCCCC----S----SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred ccCCCCCCCc----C----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 1111111111 1 12233788999999999999999999999999998776543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=316.63 Aligned_cols=257 Identities=21% Similarity=0.263 Sum_probs=201.7
Q ss_pred HhcCCcccceecCCCceEEEEEEeC----CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
..++|++.+.||+|+||+||+|.+. .+..+++|...... ....+.+.+|+.+++.++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 4567999999999999999999764 25578888876533 333467889999999999999999999985 45689
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+||||+.+++|.+++... ...+++..++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 467 lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999988654 33589999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCC-ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 176 TTDDP-VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 176 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
..... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ........ .
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------~~~~i~~~-~----- 609 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENG-E----- 609 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHHT-C-----
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHcC-C-----
Confidence 33221 1223456778999999998899999999999999999997 899996543211 11111111 0
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
... .+...+..+.+++.+||..||++|||+.++++.|+.+.+
T Consensus 610 ~~~----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 610 RLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 011 122334567889999999999999999999999998754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=293.83 Aligned_cols=264 Identities=22% Similarity=0.236 Sum_probs=198.6
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEec-----Ce
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE-----NL 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 93 (315)
+.++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4679999999999999999999876 68899999886433 33345678999999999999999999987654 67
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.++|+||+. ++|.+.+.. ..+++..+..++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS----NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999986 588877754 4589999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCc----------cccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH
Q 046121 174 WKTTDDPV----------QTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP 242 (315)
Q Consensus 174 ~~~~~~~~----------~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 242 (315)
........ .....|++.|+|||++.+ ..++.++||||||+++|+|++|.+||....... ...... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~-~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH--QLLLIF-G 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-H
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHH-H
Confidence 54322111 122467899999998754 678999999999999999999999997543211 111000 0
Q ss_pred HHhhhc-------------------cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 243 LIEKLA-------------------LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 243 ~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
...... ........ .....+..+..+.+++.+||..||++|||+.+++++-+-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAP-LEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCC-HHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcc-hhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 000000 00000000 000111234567899999999999999999999986554
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=289.39 Aligned_cols=259 Identities=24% Similarity=0.296 Sum_probs=180.0
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHH-HHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVY-VLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
.++|++++.||+|+||+||+|.+. +++.||+|++.... ......+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 478999999999999999999876 68999999887543 223334555555 778889999999999999999999999
Q ss_pred EeccCCccccccc---cCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 99 EYICNKSLHWHLF---DNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 99 ~~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
||+.+ +|.+++. ......+++..+..++.|++.++.+||+.. +++|+||+|+||+++.++.++|+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL---KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH---SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC---CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99875 6666553 233567999999999999999999999853 8999999999999999999999999999644
Q ss_pred CCCCCccccccccccccCcccc----ccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccc
Q 046121 176 TTDDPVQTKILGTLGYLAPEYA----ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (315)
.... ......|++.|+|||++ .+..++.++||||||+++|+|++|..||......... . .....
T Consensus 177 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------~--~~~~~ 244 (327)
T 3aln_A 177 VDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------L--TQVVK 244 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCCC
T ss_pred cccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---------H--HHHhc
Confidence 3322 22234688999999998 4566889999999999999999999999653321100 0 00111
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
...+.+........+..+.+++.+||+.||++|||+.+++++-+-
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 111112222222344568889999999999999999999875443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=294.51 Aligned_cols=250 Identities=21% Similarity=0.281 Sum_probs=199.8
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc------cHHHHHHHHHHHhhcC--CCCccceeee
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ------GFAEFQSEVYVLNFAR--HKNIVMLLGF 87 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~------~~~~~~~e~~~l~~l~--~~~i~~~~~~ 87 (315)
..+...++|++.+.||+|+||+||+|.+. +++.||+|++...... ....+.+|+.+++.+. ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 44456789999999999999999999865 6889999987754322 1234668999999996 5999999999
Q ss_pred EEecCeeEEEEEeccC-CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc-CCCcee
Q 046121 88 CCKENLNILVYEYICN-KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT-HDFVPM 165 (315)
Q Consensus 88 ~~~~~~~~lv~~~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~-~~~~i~ 165 (315)
+...+..++|++++.+ ++|.+++.. ...+++..++.++.|++.++.+||+. +++|+||||+||+++ .++.++
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcEeCCCCHHHEEEeCCCCCEE
Confidence 9999999999999876 899888854 34589999999999999999999999 999999999999999 789999
Q ss_pred ECCCCcccccCCCCCccccccccccccCccccccCCC-cccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH
Q 046121 166 LGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI 244 (315)
Q Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (315)
|+|||++...... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.... ...
T Consensus 191 L~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~ 256 (320)
T 3a99_A 191 LIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EII 256 (320)
T ss_dssp ECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHH
T ss_pred EeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhh
Confidence 9999998754432 2234568999999999877665 678999999999999999999995321 000
Q ss_pred hhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 245 EKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.. .. . .+...+..+.+++.+||..||++|||+.+++++-+-.
T Consensus 257 ~~---~~----~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~ 298 (320)
T 3a99_A 257 RG---QV----F----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298 (320)
T ss_dssp HC---CC----C----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred cc---cc----c----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhc
Confidence 00 00 0 1112234578899999999999999999999865543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=291.30 Aligned_cols=250 Identities=21% Similarity=0.286 Sum_probs=191.0
Q ss_pred HHHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc------cHHHHHHHHHHHhhc----CCCCccce
Q 046121 16 SEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ------GFAEFQSEVYVLNFA----RHKNIVML 84 (315)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~------~~~~~~~e~~~l~~l----~~~~i~~~ 84 (315)
+..+...++|++.+.||+|+||+||+|.+. +++.|++|++...... ....+.+|+.+++.+ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 345667889999999999999999999865 6889999998654321 223456789999888 89999999
Q ss_pred eeeEEecCeeEEEEEe-ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc-CCC
Q 046121 85 LGFCCKENLNILVYEY-ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT-HDF 162 (315)
Q Consensus 85 ~~~~~~~~~~~lv~~~-~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~-~~~ 162 (315)
++++...+..++|+++ +.+++|.+++... ..+++..++.++.|++.++.+||+. +++|+||+|+||+++ .++
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSR----GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH----TEECCCCSGGGEEEETTTT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChhhEEEeCCCC
Confidence 9999999999999999 7899999988653 3589999999999999999999999 999999999999999 889
Q ss_pred ceeECCCCcccccCCCCCccccccccccccCccccccCCC-cccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH
Q 046121 163 VPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE 241 (315)
Q Consensus 163 ~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 241 (315)
.++|+|||++....... .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||....
T Consensus 178 ~~kl~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------ 243 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------ 243 (312)
T ss_dssp EEEECCCSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------
T ss_pred eEEEEEcchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------
Confidence 99999999987544322 234568899999998876665 458999999999999999999995321
Q ss_pred HHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 242 PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
..... .. ..+...+..+.+++.+||+.||++|||+.+++++-+-
T Consensus 244 ~~~~~-------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~ 287 (312)
T 2iwi_A 244 EILEA-------EL----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287 (312)
T ss_dssp HHHHT-------CC----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred HHhhh-------cc----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 00100 00 1122234457889999999999999999999986553
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=297.99 Aligned_cols=254 Identities=20% Similarity=0.228 Sum_probs=189.5
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
.+.|.+.+.||+|+||+||.+...+++.||+|.+... ..+.+.+|+.+++.+ +||||+++++++.+....++||||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 4566777899999999998876678999999987643 235678899999876 899999999999999999999999
Q ss_pred ccCCccccccccCCCCc-----cCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC-------------C
Q 046121 101 ICNKSLHWHLFDNTESV-----LEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD-------------F 162 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~-------------~ 162 (315)
+. ++|.+++....... .++..++.++.|++.|+.|||+. +++|+||||+||+++.+ +
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL----KIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCcccccccccCCCce
Confidence 85 69999886543221 12334577999999999999999 99999999999999754 4
Q ss_pred ceeECCCCcccccCCCCCc----cccccccccccCcccccc-------CCCcccccchhhhHHHHHHHh-CCCccCCCCC
Q 046121 163 VPMLGDFGLARWKTTDDPV----QTKILGTLGYLAPEYAEN-------GIVSIRTDVYAFGIILLQLMS-GRKVVDMNGE 230 (315)
Q Consensus 163 ~i~l~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~-------~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~ 230 (315)
.++|+|||++......... .....|++.|+|||++.+ ..++.++|||||||++|+|++ |..||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999755433221 223578999999999865 568899999999999999998 8999964432
Q ss_pred ccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 231 EPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.. .. .... . ...+..........+..+.+++.+||+.||++|||+.+++++-+
T Consensus 246 ~~----~~----i~~~-~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 246 RE----SN----IIRG-I---FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp HH----HH----HHHT-C---CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hH----HH----HhcC-C---CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence 11 00 1110 0 01111222234566778999999999999999999999987543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=285.65 Aligned_cols=254 Identities=21% Similarity=0.285 Sum_probs=179.3
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc--cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ--GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
.++|++++.||+|+||+||+|.+. +++.|++|++...... ....+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999876 6899999998754322 2223445556788889999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
||+ ++.+.... ......+++..++.++.|++.++.+||+ . +++|+||+|+||+++.++.++|+|||++.....
T Consensus 104 e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLKEKH----GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHHHH----CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHhhC----CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 998 54444333 3334568999999999999999999998 6 899999999999999999999999999864433
Q ss_pred CCCccccccccccccCccccc-----cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 178 DDPVQTKILGTLGYLAPEYAE-----NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
.. ......+++.|+|||++. +..++.++||||||+++|+|++|..||....... .. ....... .
T Consensus 178 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~----~~~~~~~-~---- 246 (318)
T 2dyl_A 178 DK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-EV----LTKVLQE-E---- 246 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HH----HHHHHHS-C----
T ss_pred Cc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-HH----HHHHhcc-C----
Confidence 22 223346889999999984 4567889999999999999999999996533211 11 1111111 0
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.+.... ....+..+.+++.+||..||++|||+.+++++-+
T Consensus 247 -~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 247 -PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp -CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred -CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 011110 0112345778999999999999999999987543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=308.78 Aligned_cols=267 Identities=23% Similarity=0.264 Sum_probs=197.6
Q ss_pred HHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEe-----
Q 046121 18 IQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCK----- 90 (315)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 90 (315)
.....++|++.+.||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++..
T Consensus 9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 3445689999999999999999999875 6899999987653 34445668899999999999999999998755
Q ss_pred -cCeeEEEEEeccCCccccccccCC-CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCc---ee
Q 046121 91 -ENLNILVYEYICNKSLHWHLFDNT-ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFV---PM 165 (315)
Q Consensus 91 -~~~~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~---i~ 165 (315)
.+..++||||+.|++|.+++.... ...+++..++.++.|++.|+.|||+. |++|+||+|+||+++.++. ++
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~----gIVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN----RIIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT----TBCCCCCCSTTEEEECCSSSCEEE
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEeecCCCceeEE
Confidence 677899999999999999886543 33689999999999999999999999 9999999999999997765 89
Q ss_pred ECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh
Q 046121 166 LGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE 245 (315)
Q Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (315)
|+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ............
T Consensus 165 L~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-~~~~~i~~~~~~ 242 (676)
T 3qa8_A 165 IIDLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-QWHGKVREKSNE 242 (676)
T ss_dssp ECSCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-HSSTTCC-----
T ss_pred Eccccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-hhhhhhhcccch
Confidence 99999997544332 2334578999999999999999999999999999999999999996432110 000000000000
Q ss_pred hhcccccc--------CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 046121 246 KLALHELI--------DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEV 290 (315)
Q Consensus 246 ~~~~~~~~--------~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~i 290 (315)
........ ............+..+.+++.+||..||++|||+.++
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00000000 0011233455677889999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=293.77 Aligned_cols=249 Identities=20% Similarity=0.253 Sum_probs=186.6
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEEEEec
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.+|.+.+.||+|+||+|+.....+++.||+|++..... ....+|+.+++.+ +||||+++++++.+....++|||++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 46889999999999997766666789999998865433 2356899999999 7999999999999999999999998
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC-----CCceeECCCCcccccC
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH-----DFVPMLGDFGLARWKT 176 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~-----~~~i~l~dfg~~~~~~ 176 (315)
. ++|.+++..... ......++.++.|++.|+.|||+. +++|+||||+||+++. ...++|+|||++....
T Consensus 101 ~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 101 A-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL----NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp S-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT----TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred C-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC----cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 5 588888865443 344556678999999999999999 9999999999999953 2357799999997544
Q ss_pred CCC---CccccccccccccCccccc---cCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcc
Q 046121 177 TDD---PVQTKILGTLGYLAPEYAE---NGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249 (315)
Q Consensus 177 ~~~---~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (315)
... .......|++.|+|||++. +..++.++|||||||++|+|++ |..||........ .. ...
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~-~~~--- 243 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NI-LLG--- 243 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HH-HTT---
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HH-Hhc---
Confidence 322 1223457899999999987 4556789999999999999999 8999864332110 00 000
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
.. ..............+.+++.+||+.||++|||+.+++++-
T Consensus 244 -~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 244 -AC--SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp -CC--CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred -cC--CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 00 0001112234556688999999999999999999998653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=273.39 Aligned_cols=232 Identities=14% Similarity=0.051 Sum_probs=184.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc---ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST---QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
+.++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+..++.++||||+++++++...+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 4578999999999999999999876 589999999875532 334678899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.|++|.+++... .....+..++.|++.++.|||+. |++|+||||+||+++.++.++|++++
T Consensus 109 v~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~----givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA----GVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC----CCccCCCCcccEEEcCCCCEEEEecc------
Confidence 99999999999998432 35667888999999999999999 99999999999999999999997443
Q ss_pred CCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
|++ .++.++||||||+++|+|++|..||...+...... .........
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~~ 221 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAGQ 221 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTSC
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhccC
Confidence 222 26889999999999999999999997554321100 000000000
Q ss_pred --ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 257 --IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 257 --~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
.........+..+.+++.+||..||++| |+.++++.|+.....
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0001112234558899999999999999 999999999987543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=275.05 Aligned_cols=232 Identities=19% Similarity=0.229 Sum_probs=183.0
Q ss_pred HhcCCccc-ceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHH-hhcCCCCccceeeeEEe----cCe
Q 046121 21 ATGDFSKE-NLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVL-NFARHKNIVMLLGFCCK----ENL 93 (315)
Q Consensus 21 ~~~~y~~~-~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----~~~ 93 (315)
+.++|.+. +.||+|+||+||+|.+. +++.||+|++... ....+|+.++ +..+||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 45678887 78999999999999875 6899999998642 4567788887 66689999999999987 778
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC---CCceeECCCC
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFG 170 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~---~~~i~l~dfg 170 (315)
.++||||+.+++|.+++.......+++..++.++.|++.|+.+||+. +++|+||||+||+++. ++.++|+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 89999999999999999887777899999999999999999999999 9999999999999998 7899999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccc
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (315)
++.... +..++.++||||||+++|+|++|..||........ .. ...
T Consensus 166 ~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~-~~~ 211 (299)
T 3m2w_A 166 FAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SP-GMK 211 (299)
T ss_dssp TCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------C-CSC
T ss_pred cccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hH-HHH
Confidence 885221 23467889999999999999999999964332110 00 000
Q ss_pred cccCCcccCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 251 ELIDPRIENSYD----TYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 251 ~~~~~~~~~~~~----~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
...... ....+ ...+..+.+++.+||+.||++|||+.+++++.+-
T Consensus 212 ~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 212 TRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp CSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 000000 00111 1235568899999999999999999999986543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=302.68 Aligned_cols=240 Identities=22% Similarity=0.289 Sum_probs=192.4
Q ss_pred HhcCCcccceecCCCceEEEEEEeC--CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCe----
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK--DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL---- 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 93 (315)
+.++|++.+.||+|+||+||+|.+. +++.|++|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4589999999999999999999875 58999999876443 3344567899999999999999999999987765
Q ss_pred -eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 94 -NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 94 -~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
.|+||||+.|++|.+.+.. .+++..++.++.|++.+|.|||+. |++|+||||+||+++.+ .++|+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~----giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI----GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC----CCeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999887632 699999999999999999999999 99999999999999985 8999999999
Q ss_pred cccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccc
Q 046121 173 RWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252 (315)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (315)
...... ....|++.|+|||++.+.. +.++||||||+++|+|++|.+|+.........
T Consensus 229 ~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------ 285 (681)
T 2pzi_A 229 SRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------ 285 (681)
T ss_dssp EETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------------
T ss_pred hhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc------------------
Confidence 754432 3456899999999987654 88999999999999999999888532111000
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHHHhcc
Q 046121 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPS-MGEVVRLLEGE 297 (315)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps-~~~il~~L~~~ 297 (315)
...........+.+++.+||..||++||+ ++++.+.|...
T Consensus 286 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 -----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00011112345789999999999999995 56666666554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=276.86 Aligned_cols=244 Identities=12% Similarity=0.087 Sum_probs=185.1
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccC--------cccHHHHHHHHHHHhhcC---------CCCccce
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAS--------TQGFAEFQSEVYVLNFAR---------HKNIVML 84 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~---------~~~i~~~ 84 (315)
.++|++++.||+|+||+||+|.+ +++.||+|++.... ....+.+.+|+.+++.++ ||||+.+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46899999999999999999988 67999999987542 233467889999988886 6666665
Q ss_pred eee-----------------EEe-------------cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHH
Q 046121 85 LGF-----------------CCK-------------ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGL 134 (315)
Q Consensus 85 ~~~-----------------~~~-------------~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l 134 (315)
.++ +.. ...+++||||+.+|++.+.+.+ ..+++..+..++.|++.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 554 332 6789999999999987777632 5589999999999999999
Q ss_pred Hhhh-cccCCCCeEeecCccCcEEEcCCC--------------------ceeECCCCcccccCCCCCccccccccccccC
Q 046121 135 RFLH-EECRGGPIIHRDMRPSNILLTHDF--------------------VPMLGDFGLARWKTTDDPVQTKILGTLGYLA 193 (315)
Q Consensus 135 ~~lh-~~~~~~~i~h~di~p~nil~~~~~--------------------~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~a 193 (315)
.||| +. +++||||||+||+++.++ .++|+|||++..... ....|++.|+|
T Consensus 175 ~~lH~~~----~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL----RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH----CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTC
T ss_pred HHHHHhC----CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccC
Confidence 9999 89 999999999999999887 999999999974432 23478999999
Q ss_pred ccccccCCCcccccchhhhHH-HHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHH
Q 046121 194 PEYAENGIVSIRTDVYAFGII-LLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKT 272 (315)
Q Consensus 194 PE~~~~~~~~~~~DvwslG~~-l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (315)
||++.+.. +.++||||++++ .+++++|..||... ............. ...............+..+.+|
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~----~~~~~~~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQ----MTFKTKCNTPAMKQIKRKIQEF 315 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHT----CCCSSCCCSHHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhh----hccCcccchhhhhhcCHHHHHH
Confidence 99998776 889999998777 67788888887310 0001111111111 1111112222344577889999
Q ss_pred HHhhcCCCCCCCCCHHHHH-HH
Q 046121 273 AYLCVQRNPEGRPSMGEVV-RL 293 (315)
Q Consensus 273 ~~~~l~~~p~~Rps~~~il-~~ 293 (315)
+.+||+.| |+.+++ ++
T Consensus 316 i~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHGGGSS-----SHHHHHHHC
T ss_pred HHHHhccC-----CHHHHHhcC
Confidence 99999976 899998 54
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=279.83 Aligned_cols=240 Identities=14% Similarity=0.142 Sum_probs=178.3
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCC-CCccc---------eeee--
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARH-KNIVM---------LLGF-- 87 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~-~~i~~---------~~~~-- 87 (315)
.|...+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.+++.+.| ++... ..+.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 4778889999999999999865 69999999987332 2335678899999999976 22111 1111
Q ss_pred ----------EEe-----cCeeEEEEEeccCCccccccc-----cCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeE
Q 046121 88 ----------CCK-----ENLNILVYEYICNKSLHWHLF-----DNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPII 147 (315)
Q Consensus 88 ----------~~~-----~~~~~lv~~~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~ 147 (315)
+.. ....+++|+. .+++|.+++. ......+++..++.++.|++.||.|||+. +++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ii 233 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----GLV 233 (413)
T ss_dssp CCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----TEE
T ss_pred cCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC----Ccc
Confidence 111 1234666765 4788888774 34456688899999999999999999999 999
Q ss_pred eecCccCcEEEcCCCceeECCCCcccccCCCCCccccccccccccCcccc----------ccCCCcccccchhhhHHHHH
Q 046121 148 HRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYA----------ENGIVSIRTDVYAFGIILLQ 217 (315)
Q Consensus 148 h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~DvwslG~~l~~ 217 (315)
||||||+||+++.++.++|+|||++...... .....| +.|+|||++ .+..++.++|||||||++|+
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999998643322 334567 999999998 55567889999999999999
Q ss_pred HHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 218 LMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 218 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
|++|..||.......... ..+.. ... .+..+.+++.+||..||++|||+.++++.
T Consensus 310 lltg~~Pf~~~~~~~~~~---------------~~~~~--~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSE---------------WIFRS--CKN----IPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHSSCCCCTTGGGSCSG---------------GGGSS--CCC----CCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHCCCCCCCcchhhhHH---------------HHHhh--ccc----CCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999996543221100 01110 011 23458899999999999999998777543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-31 Score=242.74 Aligned_cols=169 Identities=16% Similarity=0.072 Sum_probs=125.8
Q ss_pred CCcEEEEEEecccC----------cccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEEEEEeccCCccccccccCC
Q 046121 46 DGQMIAAKVRKEAS----------TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNT 114 (315)
Q Consensus 46 ~~~~~~~k~~~~~~----------~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~ 114 (315)
.|+.+++|++.... +...+++.+|+++|+++ .|+||++++++++++..+||||||++|++|.+.+.+.
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~- 336 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG- 336 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT-
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC-
Confidence 47788999876432 22234588999999999 6999999999999999999999999999999999654
Q ss_pred CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCccccccccccccCc
Q 046121 115 ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAP 194 (315)
Q Consensus 115 ~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aP 194 (315)
.+++.. .++.||+.||.|+|++ ||+||||||+|||++.+|.+||+|||++.............+||+.|+||
T Consensus 337 -~~l~~~---~I~~QIl~AL~ylH~~----GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAP 408 (569)
T 4azs_A 337 -EEIDRE---KILGSLLRSLAALEKQ----GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVN 408 (569)
T ss_dssp -CCCCHH---HHHHHHHHHHHHHHHT----TCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHH
T ss_pred -CCCCHH---HHHHHHHHHHHHHHHC----CceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccH
Confidence 345554 4788999999999999 99999999999999999999999999997655544445567899999999
Q ss_pred cccccCCCcccccchhhhHHHHHHHhCCCc
Q 046121 195 EYAENGIVSIRTDVYAFGIILLQLMSGRKV 224 (315)
Q Consensus 195 E~~~~~~~~~~~DvwslG~~l~~l~~g~~p 224 (315)
|++.+. +..++|+|++|++++++.++..+
T Consensus 409 E~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 409 ELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHC------------------CCCCTTHHH
T ss_pred HHhCCC-CCCcccccccccchhhhccccch
Confidence 999764 56789999999988777655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=213.00 Aligned_cols=184 Identities=18% Similarity=0.155 Sum_probs=139.1
Q ss_pred CcccceecCCCceEEEEEEeCCCcEEEEEEecccCc--------ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 25 FSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST--------QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
+...+.||+|+||+||+|... +..+++|....... ...+.+.+|+.+++.++||||+.+..++...+..++
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ----------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 345678999999999999544 56677776433211 113447899999999999999976666667788899
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||++|++|.+++.. +..++.|++.++.|||++ +++|+||||+||+++. .++|+|||++....
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~----gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN----DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT----TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC----cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999998854 557899999999999999 9999999999999999 99999999997554
Q ss_pred CCCCc-------cccccccccccCcccccc--CCCcccccchhhhHHHHHHHhCCCcc
Q 046121 177 TDDPV-------QTKILGTLGYLAPEYAEN--GIVSIRTDVYAFGIILLQLMSGRKVV 225 (315)
Q Consensus 177 ~~~~~-------~~~~~~~~~~~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~ 225 (315)
..... .....||+.|+|||++.+ ..|+..+|+|+...-..+-..++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 124578999999999986 55778899999888877777665554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.4e-24 Score=179.72 Aligned_cols=151 Identities=16% Similarity=0.045 Sum_probs=119.5
Q ss_pred HHHHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCc------------------ccHHHHHHHHHHHhhcCC
Q 046121 17 EIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST------------------QGFAEFQSEVYVLNFARH 78 (315)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~------------------~~~~~~~~e~~~l~~l~~ 78 (315)
........|.+.+.||+|+||.||+|.+.+++.+|+|++..... .....+.+|+.+++.++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34445566777899999999999999887799999999864321 12456789999999999
Q ss_pred CCccceeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEE
Q 046121 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILL 158 (315)
Q Consensus 79 ~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~ 158 (315)
| +++.+++.. +..++||||++|++|.+ +.. .....++.|++.++.+||+. |++|+||||+||++
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~----giiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC----CCEeCCCCHHHEEE
Confidence 5 677776654 45699999999999987 411 12346899999999999999 99999999999999
Q ss_pred cCCCceeECCCCcccccCCCCCccccccccccccCccccc
Q 046121 159 THDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE 198 (315)
Q Consensus 159 ~~~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 198 (315)
+ ++.++|+|||++.. +..+.|||.+.
T Consensus 227 ~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence 9 99999999999851 23357788764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.2e-20 Score=153.00 Aligned_cols=135 Identities=19% Similarity=0.198 Sum_probs=103.0
Q ss_pred CcccceecCCCceEEEEEEe-CCCcE--EEEEEecccCcc------------------------cHHHHHHHHHHHhhcC
Q 046121 25 FSKENLLGEGGFGHVYKGEL-KDGQM--IAAKVRKEASTQ------------------------GFAEFQSEVYVLNFAR 77 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~-~~~~~--~~~k~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 77 (315)
|.+.+.||+|+||.||+|.+ .+|+. ||+|++...... ....+.+|+..++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999987 57888 999986543111 0125788999999998
Q ss_pred CCCcc--ceeeeEEecCeeEEEEEeccC-C----ccccccccCCCCccCHHHHHHHHHHHHHHHHhhh-cccCCCCeEee
Q 046121 78 HKNIV--MLLGFCCKENLNILVYEYICN-K----SLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH-EECRGGPIIHR 149 (315)
Q Consensus 78 ~~~i~--~~~~~~~~~~~~~lv~~~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~~~~~i~h~ 149 (315)
|+++. .+++. ...++||||+.+ | +|.+.... .++..+..++.|++.++.+|| +. |++|+
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~----givHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA----ELVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS----CEECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC----CEEeC
Confidence 87653 33322 356899999932 3 44443311 234567789999999999999 88 99999
Q ss_pred cCccCcEEEcCCCceeECCCCcccc
Q 046121 150 DMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 150 di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
||||.||+++. .++|+|||++..
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEE
T ss_pred CCCHHHEEEcC--cEEEEECccccc
Confidence 99999999998 899999999963
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=6.8e-17 Score=140.19 Aligned_cols=140 Identities=11% Similarity=0.080 Sum_probs=101.5
Q ss_pred HHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcc--------------cHH--------HHHHHHHHHhhcC
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQ--------------GFA--------EFQSEVYVLNFAR 77 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~--------------~~~--------~~~~e~~~l~~l~ 77 (315)
....=|.+...||+|++|.||+|.+.+|+.||+|++...... ... ...+|...+.++.
T Consensus 92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 92 ARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 334459999999999999999999989999999986532110 000 1235677777775
Q ss_pred CCCccceeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEE
Q 046121 78 HKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNIL 157 (315)
Q Consensus 78 ~~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil 157 (315)
+.++.... .+.... .++||||+.|.+|..... . .....++.|++.++.+||+. |++||||||.|||
T Consensus 172 ~~gv~vp~-p~~~~~-~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~----gIVHrDLKp~NIL 237 (397)
T 4gyi_A 172 EEGFPVPE-PIAQSR-HTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKH----GLIHGDFNEFNIL 237 (397)
T ss_dssp HTTCSCCC-EEEEET-TEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEE
T ss_pred hcCCCCCe-eeeccC-ceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEE
Confidence 55443222 222222 379999999998866541 1 12346788999999999999 9999999999999
Q ss_pred EcCCC----------ceeECCCCccc
Q 046121 158 LTHDF----------VPMLGDFGLAR 173 (315)
Q Consensus 158 ~~~~~----------~i~l~dfg~~~ 173 (315)
++.++ .+.++||+-+.
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred EeCCCCcccccccccceEEEEeCCcc
Confidence 98876 38899998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=2.9e-13 Score=112.85 Aligned_cols=147 Identities=13% Similarity=0.026 Sum_probs=113.0
Q ss_pred HHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeeeEEecCeeEEE
Q 046121 19 QQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 97 (315)
....+.|++...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. +..+++++++....+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 455678999999999999999999755 6788999876432223346889999999885 56788899999888899999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhccc------------------------------------
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC------------------------------------ 141 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~------------------------------------ 141 (315)
|++++|.++.+.+. +......++.+++.++..||+..
T Consensus 89 ~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999999876531 11223357788899999999810
Q ss_pred -------------------CCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 142 -------------------RGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 142 -------------------~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
....++|+|++|.||+++.++.+.++||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 00258999999999999876666799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=1.2e-11 Score=102.77 Aligned_cols=140 Identities=14% Similarity=0.070 Sum_probs=101.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCC--ccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKN--IVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~ 98 (315)
....|.+....+.|..+.||++...++..+++|+.... ....+.+|+.+++.+.+.+ +++++.+....+..++||
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 34456665555567779999998777788999986543 2345778999998886544 456888887777889999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhccc-------------------------------------
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC------------------------------------- 141 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~------------------------------------- 141 (315)
++++|.++. ... ... ..++.+++..+..||+..
T Consensus 95 e~i~G~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 95 GEVPGQDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp ECCSSEETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EecCCcccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 999999884 211 111 245667777778887641
Q ss_pred -----------------CCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 142 -----------------RGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 142 -----------------~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
....++|+|++|.||+++.++.+.++||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 01139999999999999887666799998874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.9e-10 Score=100.23 Aligned_cols=144 Identities=13% Similarity=0.119 Sum_probs=104.7
Q ss_pred CcccceecCCCceEEEEEEeCCCcEEEEEEec--ccC-cccHHHHHHHHHHHhhcCC--CCccceeeeEEec---CeeEE
Q 046121 25 FSKENLLGEGGFGHVYKGELKDGQMIAAKVRK--EAS-TQGFAEFQSEVYVLNFARH--KNIVMLLGFCCKE---NLNIL 96 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~--~~~-~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~---~~~~l 96 (315)
...++.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+.. ..+++++.++.+. +..++
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred CceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 4456789999999999998764 567777654 221 1223467889999998874 4577888887665 44799
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccC----------------------------------
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR---------------------------------- 142 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---------------------------------- 142 (315)
||+++.|.++.+.. -..++......++.+++..+..||+...
T Consensus 119 vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99999998885422 1236777888889999999999997310
Q ss_pred --------------------CCCeEeecCccCcEEEcCCCc--eeECCCCccc
Q 046121 143 --------------------GGPIIHRDMRPSNILLTHDFV--PMLGDFGLAR 173 (315)
Q Consensus 143 --------------------~~~i~h~di~p~nil~~~~~~--i~l~dfg~~~ 173 (315)
...++|+|+++.||+++.++. +.++||+.+.
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 136999999999999987753 6899999886
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.97 E-value=8.7e-10 Score=93.71 Aligned_cols=187 Identities=19% Similarity=0.147 Sum_probs=117.8
Q ss_pred cceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCC--ccceeeeEEecC---eeEEEEEec
Q 046121 28 ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKN--IVMLLGFCCKEN---LNILVYEYI 101 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~lv~~~~ 101 (315)
++.++.|..+.||++. ..+++|+... ......+.+|...++.+. +.. ++.++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4578999999999874 4577887542 234567889999998874 333 334443332222 348899999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhccc----------------------------------------
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC---------------------------------------- 141 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---------------------------------------- 141 (315)
+|.++.+... ..++..+...++.+++..+..||+..
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9998865332 23566677777888888888887521
Q ss_pred --------------CCCCeEeecCccCcEEEcC--CCceeECCCCcccccCCCCCccccccccccccCccccc------c
Q 046121 142 --------------RGGPIIHRDMRPSNILLTH--DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE------N 199 (315)
Q Consensus 142 --------------~~~~i~h~di~p~nil~~~--~~~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~ 199 (315)
....++|+|++|.||+++. .+.+.++||+.+............ .....-..|+... +
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~-~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISL-MEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTT-CCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHH-HhhccccCHHHHHHHHHHcC
Confidence 0125799999999999998 556789999988643221100000 0000001222111 0
Q ss_pred CC--------CcccccchhhhHHHHHHHhCCCcc
Q 046121 200 GI--------VSIRTDVYAFGIILLQLMSGRKVV 225 (315)
Q Consensus 200 ~~--------~~~~~DvwslG~~l~~l~~g~~p~ 225 (315)
.. ...-.+.|+++.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 011258899999999999998877
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=5.7e-07 Score=76.34 Aligned_cols=136 Identities=21% Similarity=0.124 Sum_probs=90.6
Q ss_pred cceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCC---CccceeeeEE-ecCeeEEEEEeccC
Q 046121 28 ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHK---NIVMLLGFCC-KENLNILVYEYICN 103 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~lv~~~~~~ 103 (315)
++.++.|....||+. +..+++|+.. .......+.+|..+++.+.+. .+..++.+.. ..+..++||++++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888999999988 4557777642 233456788999999998753 3455565553 34557899999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhccc------------------------------------------
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC------------------------------------------ 141 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~------------------------------------------ 141 (315)
.++...... .++......++.++...+..||+..
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 988653211 1234444444455555555554321
Q ss_pred --------------CCCCeEeecCccCcEEEcC---CCc-eeECCCCccc
Q 046121 142 --------------RGGPIIHRDMRPSNILLTH---DFV-PMLGDFGLAR 173 (315)
Q Consensus 142 --------------~~~~i~h~di~p~nil~~~---~~~-i~l~dfg~~~ 173 (315)
....++|+|++|.||+++. ++. +.++||+.+.
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1125699999999999987 455 4799998875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=2.1e-06 Score=71.28 Aligned_cols=141 Identities=17% Similarity=0.060 Sum_probs=97.0
Q ss_pred cCCcccceecCCCce-EEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFG-HVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~-~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
..|+. +.+..|..+ .||+.... ++..+++|+.... ....+.+|...++.+. +-.+.+++.++.+.+..++||+
T Consensus 25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 34443 344556554 68988765 4667888875432 3456788999998875 3346788888888899999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhccc--------------------------------------
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC-------------------------------------- 141 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-------------------------------------- 141 (315)
+++|.++.+..... ......+..++...+..||+..
T Consensus 101 ~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp CCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred eeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 99998876654221 1122345556666666676431
Q ss_pred ----------------CCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 142 ----------------RGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 142 ----------------~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
....++|+|+.+.||+++.++.+-++||+.+.
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 00137899999999999988777899998774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=7.2e-07 Score=77.34 Aligned_cols=81 Identities=10% Similarity=0.004 Sum_probs=55.4
Q ss_pred ccee-cCCCceEEEEEEeC-------CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCC---CCccceeeeEEec--
Q 046121 28 ENLL-GEGGFGHVYKGELK-------DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARH---KNIVMLLGFCCKE-- 91 (315)
Q Consensus 28 ~~~l-g~g~~~~v~~~~~~-------~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~-- 91 (315)
.+.| +.|..+.+|+.... ++..+++|+..... ......+.+|+.+++.+.. -.+++++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88999999988654 25678888754322 1012456788888887753 2466777776554
Q ss_pred -CeeEEEEEeccCCcccc
Q 046121 92 -NLNILVYEYICNKSLHW 108 (315)
Q Consensus 92 -~~~~lv~~~~~~~~L~~ 108 (315)
+..++||++++|.++.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999988764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=5.9e-05 Score=64.65 Aligned_cols=74 Identities=12% Similarity=0.269 Sum_probs=41.9
Q ss_pred ceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCC--CCccceee------eEEecCeeEEEEEe
Q 046121 29 NLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARH--KNIVMLLG------FCCKENLNILVYEY 100 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~------~~~~~~~~~lv~~~ 100 (315)
+.|+.|..+.||++...++. +++|+.... ...+..|+.+++.+.. -.++.++. +....+..++++++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGA-VCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTEE-EEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCCC-EEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 34666778899999776554 788877642 2333445555554431 12333332 22346778999999
Q ss_pred ccCCccc
Q 046121 101 ICNKSLH 107 (315)
Q Consensus 101 ~~~~~L~ 107 (315)
++|.++.
T Consensus 113 i~G~~~~ 119 (346)
T 2q83_A 113 IEGRPFE 119 (346)
T ss_dssp CCCBCCC
T ss_pred ecCccCC
Confidence 9987653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=2.6e-05 Score=68.55 Aligned_cols=76 Identities=11% Similarity=0.076 Sum_probs=49.1
Q ss_pred ccceecCCCceEEEEEEeC-CCcEEEEEEecccC-------cccHHHHHHHHHHHhhcCC--CC-ccceeeeEEecCeeE
Q 046121 27 KENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-------TQGFAEFQSEVYVLNFARH--KN-IVMLLGFCCKENLNI 95 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-------~~~~~~~~~e~~~l~~l~~--~~-i~~~~~~~~~~~~~~ 95 (315)
..+.||.|..+.||++... +++.+++|...... .........|.++++.+.. |. ++.++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 4568999999999999754 46788898754321 1223456778888887742 33 3344433 345568
Q ss_pred EEEEeccCC
Q 046121 96 LVYEYICNK 104 (315)
Q Consensus 96 lv~~~~~~~ 104 (315)
+|||++.|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.02 E-value=3.9e-05 Score=64.29 Aligned_cols=82 Identities=17% Similarity=0.234 Sum_probs=59.0
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCC---CccceeeeEEecCeeEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHK---NIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~~~lv~ 98 (315)
.....-++.+|.|..+.||+....+|+.+++|+...........+..|+..|+.+... .++.++.+ + ..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~-~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---D-DRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---E-TTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---c-CceEEE
Confidence 3456677889999999999999999999999986654444445578899999988532 23344433 2 237899
Q ss_pred EeccCCccc
Q 046121 99 EYICNKSLH 107 (315)
Q Consensus 99 ~~~~~~~L~ 107 (315)
+++.+....
T Consensus 90 e~l~~~~~~ 98 (288)
T 3f7w_A 90 EWVDERPPT 98 (288)
T ss_dssp ECCCCCCCC
T ss_pred EeecccCCC
Confidence 998776553
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.96 E-value=0.00016 Score=61.20 Aligned_cols=77 Identities=14% Similarity=0.182 Sum_probs=59.5
Q ss_pred ccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcC---CCCccceeeeEEecCeeEEEEEeccC
Q 046121 27 KENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR---HKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
-.+.|+.|....+|+.... +..+++|+.... ....+..|...++.+. ...+++++.+....+..++||++++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3457999999999999764 567788876532 3456788988888874 35677888888777889999999999
Q ss_pred Cccc
Q 046121 104 KSLH 107 (315)
Q Consensus 104 ~~L~ 107 (315)
.++.
T Consensus 116 ~~~~ 119 (312)
T 3jr1_A 116 SKNK 119 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.77 E-value=8e-05 Score=62.77 Aligned_cols=75 Identities=11% Similarity=0.171 Sum_probs=47.3
Q ss_pred CcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCcc-ceeeeEEecCeeEEEEEec-c
Q 046121 25 FSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV-MLLGFCCKENLNILVYEYI-C 102 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~~~~-~ 102 (315)
+.-++.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++. +++.. +.+.-+++++|+ .
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence 333788999999999999 45788876643222 12345688888777543433 44443 333457899999 7
Q ss_pred CCccc
Q 046121 103 NKSLH 107 (315)
Q Consensus 103 ~~~L~ 107 (315)
|.++.
T Consensus 92 g~~l~ 96 (301)
T 3dxq_A 92 AQTMS 96 (301)
T ss_dssp CEECC
T ss_pred CccCC
Confidence 76664
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00078 Score=57.11 Aligned_cols=159 Identities=11% Similarity=0.085 Sum_probs=86.0
Q ss_pred cccHHHHHHHhcCCcc-----cceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCC--ccce
Q 046121 12 KFSFSEIQQATGDFSK-----ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKN--IVML 84 (315)
Q Consensus 12 ~~~~~~~~~~~~~y~~-----~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~ 84 (315)
.++...+.....+|-+ .+.|+.|....+|+....++ .+++|+.... .....+..|+.+++.+...+ ++.+
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 4556677777777765 23567788899999987655 5778876642 11234556777766664222 2333
Q ss_pred ee------eEEecCeeEEEEEeccCCccccc--------------cccCC-C--Cc----cC---HHHHHH---------
Q 046121 85 LG------FCCKENLNILVYEYICNKSLHWH--------------LFDNT-E--SV----LE---WHQRYA--------- 125 (315)
Q Consensus 85 ~~------~~~~~~~~~lv~~~~~~~~L~~~--------------l~~~~-~--~~----~~---~~~~~~--------- 125 (315)
+. +....+..++++++++|.++... ++... . .+ .. +...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 31 12234667899999998765321 11100 0 00 01 000000
Q ss_pred ---HHHHHHHHHHhhhccc---CCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 126 ---AAIGTAKGLRFLHEEC---RGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 126 ---~~~~l~~~l~~lh~~~---~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+...+...+..+.... ...+++|+|+++.||+++.++.+.++||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0001222333333211 12378999999999999987666899998774
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00031 Score=62.29 Aligned_cols=75 Identities=13% Similarity=0.201 Sum_probs=50.3
Q ss_pred ccceecCCCceEEEEEEeCC--------CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCc-cceeeeEEecCeeEEE
Q 046121 27 KENLLGEGGFGHVYKGELKD--------GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNI-VMLLGFCCKENLNILV 97 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~~--------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv 97 (315)
.++.|+.|....+|++...+ +..+++|+.... .....+.+|..+++.+...++ +++++.+. + .+|
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v 150 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL 150 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEE
Confidence 34578889999999997642 578889887432 122455678888888764444 45555443 2 488
Q ss_pred EEeccCCccc
Q 046121 98 YEYICNKSLH 107 (315)
Q Consensus 98 ~~~~~~~~L~ 107 (315)
++|++|.++.
T Consensus 151 ~e~l~G~~l~ 160 (429)
T 1nw1_A 151 EEYIPSRPLS 160 (429)
T ss_dssp ECCCCEEECC
T ss_pred EEEeCCcccC
Confidence 9999876663
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00053 Score=60.65 Aligned_cols=76 Identities=14% Similarity=0.145 Sum_probs=44.1
Q ss_pred CeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcccccc--ccccccCccccccC---CCcccccchhhhHHHHHHH
Q 046121 145 PIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKIL--GTLGYLAPEYAENG---IVSIRTDVYAFGIILLQLM 219 (315)
Q Consensus 145 ~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~~~--~~~~~~aPE~~~~~---~~~~~~DvwslG~~l~~l~ 219 (315)
.++|||++|.||+++.++ +.++||+.+......... .... ....|++|+..... .......+..+...+|..+
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 799999999999999877 999999988632211110 0001 01235555543211 1112234456667777766
Q ss_pred hCC
Q 046121 220 SGR 222 (315)
Q Consensus 220 ~g~ 222 (315)
.+.
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00093 Score=59.64 Aligned_cols=76 Identities=13% Similarity=0.051 Sum_probs=49.8
Q ss_pred ccceecCCCceEEEEEEeCC-CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCc-cceeeeEEecCeeEEEEEeccCC
Q 046121 27 KENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNI-VMLLGFCCKENLNILVYEYICNK 104 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~~~~~~~ 104 (315)
.++.|+.|....+|++...+ +..+++|+........ -...+|..+++.+...++ +++++.+. + ..|++|++|.
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 34678889999999998764 5778888865432222 223688999988876555 45555552 2 4599999887
Q ss_pred ccc
Q 046121 105 SLH 107 (315)
Q Consensus 105 ~L~ 107 (315)
++.
T Consensus 187 ~l~ 189 (458)
T 2qg7_A 187 ALS 189 (458)
T ss_dssp ECC
T ss_pred cCC
Confidence 664
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0017 Score=51.16 Aligned_cols=102 Identities=17% Similarity=0.051 Sum_probs=62.7
Q ss_pred ccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCcccc
Q 046121 105 SLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK 184 (315)
Q Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~~~~ 184 (315)
+|.+.+ +..+.+++++++|.++.|.+.++..+-... .-...=+.|..|++..+|.|.+.+- .+.
T Consensus 34 SL~eIL-~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~---~~~~~i~~~~~i~l~~dG~V~f~~~-~s~----------- 97 (229)
T 2yle_A 34 SLEEIL-RLYNQPINEEQAWAVCYQCCGSLRAAARRR---QPRHRVRSAAQIRVWRDGAVTLAPA-ADD----------- 97 (229)
T ss_dssp EHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSGGGEEEETTSCEEECCC---------------
T ss_pred cHHHHH-HHcCCCcCHHHHHHHHHHHHHHHHhhhhcc---cCCceecCCcceEEecCCceecccc-ccc-----------
Confidence 344444 234678999999999999999987762210 1112335688999999999887531 110
Q ss_pred ccccccccCccccccCCCcccccchhhhHHHHHHHhCCCc
Q 046121 185 ILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKV 224 (315)
Q Consensus 185 ~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 224 (315)
.....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888753 2345677899999999998875444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00087 Score=58.10 Aligned_cols=74 Identities=15% Similarity=0.134 Sum_probs=45.1
Q ss_pred cceecCCCceEEEEEEeCC---------CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCc-cceeeeEEecCeeEEE
Q 046121 28 ENLLGEGGFGHVYKGELKD---------GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNI-VMLLGFCCKENLNILV 97 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~---------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv 97 (315)
.+.|+.|....+|+....+ +..+++|+....... ......|..+++.+...++ +++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4577888889999997653 267888886543222 2234678888887754443 3555433 2 3789
Q ss_pred EEeccCCcc
Q 046121 98 YEYICNKSL 106 (315)
Q Consensus 98 ~~~~~~~~L 106 (315)
++|++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999988765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0034 Score=53.23 Aligned_cols=77 Identities=10% Similarity=0.091 Sum_probs=49.1
Q ss_pred ceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCC--ccceeee-----EEecCeeEEEEEec
Q 046121 29 NLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKN--IVMLLGF-----CCKENLNILVYEYI 101 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~-----~~~~~~~~lv~~~~ 101 (315)
+.++ |....||+....+|+.+++|+..... .....+..|..+++.+...+ ++.++.. ....+..+++++++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999877667778898875321 12345667887777664222 3333332 22355668899999
Q ss_pred cCCccc
Q 046121 102 CNKSLH 107 (315)
Q Consensus 102 ~~~~L~ 107 (315)
.|.++.
T Consensus 110 ~G~~~~ 115 (328)
T 1zyl_A 110 GGRQFE 115 (328)
T ss_dssp CCEECC
T ss_pred CCCCCC
Confidence 886653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.002 Score=55.95 Aligned_cols=141 Identities=15% Similarity=0.121 Sum_probs=80.8
Q ss_pred cceecCCCceEEEEEEeC--------CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCc-cceeeeEEecCeeEEEE
Q 046121 28 ENLLGEGGFGHVYKGELK--------DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNI-VMLLGFCCKENLNILVY 98 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~--------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~ 98 (315)
++.|..|-...+|++... +++.+++|+.... ........+|..+++.+...++ +++++.+.+ .+|+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 456778888999998764 2478888886432 2345566789999988864333 455555432 3899
Q ss_pred EeccCCcccccc-c----------------cCC---CCccC--HHHHHHHHHHHHH-------------------HHHh-
Q 046121 99 EYICNKSLHWHL-F----------------DNT---ESVLE--WHQRYAAAIGTAK-------------------GLRF- 136 (315)
Q Consensus 99 ~~~~~~~L~~~l-~----------------~~~---~~~~~--~~~~~~~~~~l~~-------------------~l~~- 136 (315)
+|++|.++...- . ... ..... ..++..+..++-. .+..
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 999987774311 0 000 11111 2333334333211 1111
Q ss_pred ---hhcccCCCCeEeecCccCcEEEcCC----CceeECCCCccc
Q 046121 137 ---LHEECRGGPIIHRDMRPSNILLTHD----FVPMLGDFGLAR 173 (315)
Q Consensus 137 ---lh~~~~~~~i~h~di~p~nil~~~~----~~i~l~dfg~~~ 173 (315)
|........++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2222122368999999999999876 789999998874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0075 Score=51.56 Aligned_cols=29 Identities=17% Similarity=0.283 Sum_probs=26.4
Q ss_pred CeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 145 PIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 145 ~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.++|+|+.+.||+++.++.+.++||+.+.
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 68999999999999988889999998775
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0026 Score=54.21 Aligned_cols=29 Identities=28% Similarity=0.347 Sum_probs=26.0
Q ss_pred CeEeecCccCcEEEcCC----CceeECCCCccc
Q 046121 145 PIIHRDMRPSNILLTHD----FVPMLGDFGLAR 173 (315)
Q Consensus 145 ~i~h~di~p~nil~~~~----~~i~l~dfg~~~ 173 (315)
.++|+|+.+.||+++.+ +.+.++||+.+.
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 79999999999999874 678999999886
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.022 Score=50.16 Aligned_cols=76 Identities=13% Similarity=0.137 Sum_probs=50.0
Q ss_pred ccceecCCCceEEEEEEeCC--------CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCc-cceeeeEEecCeeEEE
Q 046121 27 KENLLGEGGFGHVYKGELKD--------GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNI-VMLLGFCCKENLNILV 97 (315)
Q Consensus 27 ~~~~lg~g~~~~v~~~~~~~--------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv 97 (315)
-++.+..|....+|+....+ +..+++++...... ..-...+|..+++.+...++ +++++.+ . -+.|
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I 148 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRI 148 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence 34578888899999997652 57888888654322 22234678888888753333 3444422 2 2789
Q ss_pred EEeccCCccc
Q 046121 98 YEYICNKSLH 107 (315)
Q Consensus 98 ~~~~~~~~L~ 107 (315)
++|++|.++.
T Consensus 149 ~efI~G~~l~ 158 (424)
T 3mes_A 149 EEFIDGEPLT 158 (424)
T ss_dssp EECCCSEECC
T ss_pred EEEeCCccCC
Confidence 9999997763
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.03 E-value=0.038 Score=48.35 Aligned_cols=29 Identities=34% Similarity=0.424 Sum_probs=24.5
Q ss_pred CeEeecCccCcEEE------cCCCceeECCCCccc
Q 046121 145 PIIHRDMRPSNILL------THDFVPMLGDFGLAR 173 (315)
Q Consensus 145 ~i~h~di~p~nil~------~~~~~i~l~dfg~~~ 173 (315)
.++|+|+.+.||++ +.+..+.++||.++.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 35799999999999 456789999998875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.27 E-value=0.57 Score=36.76 Aligned_cols=84 Identities=8% Similarity=0.037 Sum_probs=59.9
Q ss_pred CCCCccceeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcE
Q 046121 77 RHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNI 156 (315)
Q Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~ni 156 (315)
.+|++++. .+-..++.+.+.++.- .....+- .-...+....++++..|+....++++. +|--++|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~---~ik~~~~~eKlr~l~ni~~l~~~~~~r------~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFD---NIKSFTKNEKLRYLLNIKNLEEVNRTR------YTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGG---GGGGSCHHHHHHHHHHGGGGGGGGGSS------EECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcC--cccCCHH---HHHhcCHHHHHHHHHHHHHHHHHhcCc------eEEEEecceE
Confidence 57888876 5666666666555543 2222222 234588889999999998877666544 7778999999
Q ss_pred EEcCCCceeECCCCcc
Q 046121 157 LLTHDFVPMLGDFGLA 172 (315)
Q Consensus 157 l~~~~~~i~l~dfg~~ 172 (315)
+++.++.+++.-.|+.
T Consensus 111 ~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp EECTTSCEEESCCEET
T ss_pred EEcCCCCEEEEEccCc
Confidence 9999999999877654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.37 E-value=0.83 Score=35.97 Aligned_cols=83 Identities=13% Similarity=0.093 Sum_probs=59.3
Q ss_pred CCCCccceeeeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHH-hhhcccCCCCeEeecCccCc
Q 046121 77 RHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLR-FLHEECRGGPIIHRDMRPSN 155 (315)
Q Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~-~lh~~~~~~~i~h~di~p~n 155 (315)
.+|++ -..+-.+++.+.+.++.-.+..=...+ ..++....++++..++.... ++++. +|--++|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~~r------~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSARR------LIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCSSS------EECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhhCc------eeEEEeCce
Confidence 47777 555556677777666653222222222 45888899999999988777 56544 777899999
Q ss_pred EEEcCCCceeECCCCcc
Q 046121 156 ILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 156 il~~~~~~i~l~dfg~~ 172 (315)
++++.++.+++.-.|+-
T Consensus 115 L~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVK 131 (219)
T ss_dssp EEECTTCCEEESCCEET
T ss_pred EEEeCCCcEEEEEcCCc
Confidence 99999999999877764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 315 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-39 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-62
Identities = 74/278 (26%), Positives = 125/278 (44%), Gaps = 22/278 (7%)
Query: 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
G + +G G FG VYKG+ + + Q F++EV VL RH NI+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
+ +G+ L +V ++ SL+ HL E+ E + A TA+G+ +LH +
Sbjct: 68 LFMGYSTAPQL-AIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK-- 123
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ--TKILGTLGYLAPEYA--- 197
IIHRD++ +NI L D +GDFGLA K+ ++ G++ ++APE
Sbjct: 124 --SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 198 ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257
+ S ++DVYAFGI+L +LM+G+ Q I + + P +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ----------IIFMVGRGYLSPDL 231
Query: 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
M + C+++ + RP +++ +E
Sbjct: 232 SKVRSNC-PKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-59
Identities = 69/275 (25%), Positives = 118/275 (42%), Gaps = 26/275 (9%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
LG G FG V+ G +A K K+ S F +E ++ +H+ +V
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 72
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L +E + ++ EY+ N SL L + L ++ A A+G+ F+ E
Sbjct: 73 LYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARW-KTTDDPVQTKILGTLGYLAPEYAENGIV 202
IHRD+R +NIL++ + DFGLAR + + + + + APE G
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 203 SIRTDVYAFGIILLQLMSGRKVV--DMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260
+I++DV++FGI+L ++++ ++ M E Q+L + + EL
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ------ 241
Query: 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
LM C + PE RP+ + +LE
Sbjct: 242 -------LMRL----CWKERPEDRPTFDYLRSVLE 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (465), Expect = 1e-56
Identities = 73/306 (23%), Positives = 131/306 (42%), Gaps = 41/306 (13%)
Query: 9 DPMKFSFSEIQQATGDFSKE---------NLLGEGGFGHVYKGELK----DGQMIAAKV- 54
DP F+F + +A +F+KE ++G G FG V G LK +A K
Sbjct: 5 DP--FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 62
Query: 55 RKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNT 114
+ + + +F SE ++ H N++ L G K +++ E++ N SL L N
Sbjct: 63 KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND 122
Query: 115 ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174
Q G A G+++L + +HRD+ NIL+ + V + DFGL+R+
Sbjct: 123 GQF-TVIQLVGMLRGIAAGMKYLADMN----YVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 175 KTTDDPVQT-----KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNG 229
D T + + APE + + +DV+++GI++ ++MS G
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY-------G 230
Query: 230 EEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGE 289
E P + + +I + + P ++ ++L C Q++ RP G+
Sbjct: 231 ERPYWDMTN--QDVINAIEQDYRLPPPMDCPSALHQL------MLDCWQKDRNHRPKFGQ 282
Query: 290 VVRLLE 295
+V L+
Sbjct: 283 IVNTLD 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-56
Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 28/291 (9%)
Query: 28 ENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGF 87
+ +G+G FG V++G+ + G+ +A K+ + + ++E+Y RH+NI+ +
Sbjct: 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAA 65
Query: 88 CCKENLNI----LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
K+N LV +Y + SL +L T + A+ TA GL LH E G
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 144 G----PIIHRDMRPSNILLTHDFVPMLGDFGLARW----KTTDDPVQTKILGTLGYLAPE 195
I HRD++ NIL+ + + D GLA T D +GT Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 196 YAENGI------VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ----SLRQWAEPLIE 245
++ I R D+YA G++ ++ + ++ + + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 246 KLALHELIDPRIENSYDTYE-LYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
K+ + + P I N + + E L +MAK C N R + + + L
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-55
Identities = 67/304 (22%), Positives = 119/304 (39%), Gaps = 36/304 (11%)
Query: 18 IQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKV-RKEASTQGFAEFQSEVYVLNF 75
++ DF K + LG G G V+K K G ++A K+ E + E+ VL+
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 76 ARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLR 135
IV G + + E++ SL L + +I KGL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLT 118
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE 195
+L E+ + I+HRD++PSNIL+ L DFG++ D + +GT Y++PE
Sbjct: 119 YLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSFVGTRSYMSPE 173
Query: 196 YAENGIVSIRTDVYAFGIILLQLMSGRK-VVDMNGEEPQQSLRQWAEPLIEKLALHELID 254
+ S+++D+++ G+ L+++ GR + + +E + E +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 255 PRIENSYDTYELYLMAKTAYL--------------------------CVQRNPEGRPSMG 288
R +SY MA L C+ +NP R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 289 EVVR 292
+++
Sbjct: 294 QLMV 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 7e-55
Identities = 57/273 (20%), Positives = 113/273 (41%), Gaps = 22/273 (8%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
+ + +G G FG V+ G + +A K +E +F E V+ H +V
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L G C ++ LV+E++ + L +L + + +G+ +L E C
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEAC-- 121
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK-ILGTLGYLAPEYAENGIV 202
+IHRD+ N L+ + V + DFG+ R+ D + + + +PE
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 203 SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYD 262
S ++DV++FG+++ ++ S K+ + + + L PR+ +++
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDISTGF-------RLYKPRLASTH- 230
Query: 263 TYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ + C + PE RP+ ++R L
Sbjct: 231 ------VYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-54
Identities = 74/275 (26%), Positives = 113/275 (41%), Gaps = 26/275 (9%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
E LG+G FG V+ G +A K K T F E V+ RH+ +V
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L +E + I V EY+ SL L T L Q A A G+ ++
Sbjct: 77 LYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 133
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD-PVQTKILGTLGYLAPEYAENGIV 202
+HRD+R +NIL+ + V + DFGLAR ++ + + + APE A G
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 203 SIRTDVYAFGIILLQLMSGRKVV--DMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260
+I++DV++FGI+L +L + +V M E + + L D
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------ 245
Query: 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
LM + C ++ PE RP+ + LE
Sbjct: 246 -------LMCQ----CWRKEPEERPTFEYLQAFLE 269
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-54
Identities = 59/275 (21%), Positives = 107/275 (38%), Gaps = 26/275 (9%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
D + LG G FG V G+ + +A K+ KE S EF E V+ H+ +V
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 84 LLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRG 143
L G C K+ ++ EY+ N L +L + + Q + + +L +
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ-- 120
Query: 144 GPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP-VQTKILGTLGYLAPEYAENGIV 202
+HRD+ N L+ V + DFGL+R+ D+ + + PE
Sbjct: 121 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 203 SIRTDVYAFGIILLQLMSGRKVV--DMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260
S ++D++AFG+++ ++ S K+ E + + Q LA ++
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT------ 232
Query: 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+M C + RP+ ++ +
Sbjct: 233 -------IMYS----CWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 175 bits (444), Expect = 1e-53
Identities = 68/289 (23%), Positives = 122/289 (42%), Gaps = 22/289 (7%)
Query: 9 DPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQ 67
DP ++ + + D + ++ LG G +G VY+G K +A K KE + + EF
Sbjct: 3 DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFL 61
Query: 68 SEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAA 127
E V+ +H N+V LLG C +E ++ E++ +L +L + + A
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121
Query: 128 IGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP-VQTKIL 186
+ + +L ++ IHRD+ N L+ + + + DFGL+R T D
Sbjct: 122 TQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK 246
+ + APE SI++DV+AFG++L ++ + + Q
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------- 224
Query: 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
++EL++ + + C Q NP RPS E+ + E
Sbjct: 225 --VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-53
Identities = 65/273 (23%), Positives = 115/273 (42%), Gaps = 26/273 (9%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVM 83
+ +G+G FG V G+ + G +A K K +T F +E V+ RH N+V
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64
Query: 84 LLGFCCKENLNI-LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
LLG +E + +V EY+ SL +L SVL ++ + + +L
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 122
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIV 202
+HRD+ N+L++ D V + DFGL + ++ Q + + APE
Sbjct: 123 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKF 177
Query: 203 SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYD 262
S ++DV++FGI+L ++ S +V + + + + K+ + P +
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKG--YKMDAPDGCPPAVYE--- 231
Query: 263 TYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+M C + RPS ++ LE
Sbjct: 232 -----VMKN----CWHLDAAMRPSFLQLREQLE 255
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 4e-53
Identities = 59/290 (20%), Positives = 112/290 (38%), Gaps = 31/290 (10%)
Query: 16 SEIQQATGDFSKENLLGEGGFGHVYKGELKDGQ-----MIAAKV-RKEASTQGFAEFQSE 69
+EI +++ ++G G FG VYKG LK +A K + + + +F E
Sbjct: 2 TEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59
Query: 70 VYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIG 129
++ H NI+ L G K +++ EY+ N + + Q G
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRG 118
Query: 130 TAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP---VQTKIL 186
A G+++L +HRD+ NIL+ + V + DFGL+R D +
Sbjct: 119 IAAGMKYLANMN----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK 246
+ + APE + +DV++FGI++ ++M+ + +
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------- 221
Query: 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296
+ + I+ + + C Q+ RP ++V +L+
Sbjct: 222 --VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 5e-52
Identities = 66/275 (24%), Positives = 116/275 (42%), Gaps = 25/275 (9%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
+ LG+G FG VYK + K+ + AAKV S + ++ E+ +L H NIV
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
LL EN ++ E+ ++ + + E L Q T L +LH+
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN-- 129
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYA----- 197
IIHRD++ NIL T D L DFG++ T + +GT ++APE
Sbjct: 130 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 198 ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257
++ + DV++ GI L+++ P + L + A+ LA
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHH--ELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245
Query: 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
++ + K C+++N + R + ++++
Sbjct: 246 KD--------FLKK----CLEKNVDARWTTSQLLQ 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-51
Identities = 61/277 (22%), Positives = 104/277 (37%), Gaps = 24/277 (8%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKV-RKEASTQGFAE-FQSEVYVLNFARHKN 80
D+ +G G +G K K DG+++ K + T+ + SEV +L +H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 81 IVMLLGFCCKENLNIL--VYEYICNKSLHWHLFDNTES--VLEWHQRYAAAIGTAKGLRF 136
IV L V EY L + T+ L+ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 137 LHEECRGG-PIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE 195
H GG ++HRD++P+N+ L LGDFGLAR D +GT Y++PE
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184
Query: 196 YAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255
+ ++D+++ G +L +L + ++ + E
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKELAGKIREGKF----------R 232
Query: 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
RI Y ++ + + RPS+ E++
Sbjct: 233 RIPYRYSDELNEIITR----MLNLKDYHRPSVEEILE 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-51
Identities = 75/318 (23%), Positives = 119/318 (37%), Gaps = 49/318 (15%)
Query: 9 DPMKFSFS---EIQQATGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKV-RKEA 58
DP + + E + S LG G FG V + +A K+ + A
Sbjct: 8 DPTQLPYDHKWEFPRN--RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65
Query: 59 STQGFAEFQSEVYVL-NFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHL------- 110
SE+ VL H NIV LLG C +++ EY C L L
Sbjct: 66 HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 125
Query: 111 ---------FDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD 161
++ E L+ + + AKG+ FL + IHRD+ NILLTH
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN----CIHRDLAARNILLTHG 181
Query: 162 FVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLM 219
+ + DFGLAR D V+ + ++APE N + + +DV+++GI L +L
Sbjct: 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 220 SGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQR 279
S + +++I + M C
Sbjct: 242 SLGSSPYPGMPVDSK--------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDA 287
Query: 280 NPEGRPSMGEVVRLLEGE 297
+P RP+ ++V+L+E +
Sbjct: 288 DPLKRPTFKQIVQLIEKQ 305
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-51
Identities = 72/299 (24%), Positives = 123/299 (41%), Gaps = 36/299 (12%)
Query: 28 ENLLGEGGFGHVYKGELKD----GQMIAAKVRKEASTQGF-AEFQSEVYVLNFARHKNIV 82
++G G FG VY G L D A K + G ++F +E ++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 83 MLLGFCCK-ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
LLG C + E ++V Y+ + L + + T + + AKG++FL +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFLASK- 149
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP----VQTKILGTLGYLAPEYA 197
+HRD+ N +L F + DFGLAR + +T + ++A E
Sbjct: 150 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 198 ENGIVSIRTDVYAFGIILLQLMSGRKV--VDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255
+ + ++DV++FG++L +LM+ D+N + L Q L + L +
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE- 265
Query: 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLGEKFVQRHHT 314
+M K C E RPS E+V + F +GE +V + T
Sbjct: 266 ------------VMLK----CWHPKAEMRPSFSELVSRISAIFSTF--IGEHYVHVNAT 306
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 8e-51
Identities = 60/280 (21%), Positives = 112/280 (40%), Gaps = 22/280 (7%)
Query: 14 SFSEIQQATGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYV 72
S + +++ +G+G G VY ++ GQ +A + +E+ V
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 73 LNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
+ ++ NIV L + +V EY+ SL + + Q A +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQ 127
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL 192
L FLH +IHRD++ NILL D L DFG T + ++ ++GT ++
Sbjct: 128 ALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183
Query: 193 APEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHEL 252
APE + D+++ GI+ ++++ G E P ++L A +L E
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEK 241
Query: 253 IDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
+ + + + C+ + E R S E+++
Sbjct: 242 LSAIFRD--------FLNR----CLDMDVEKRGSAKELLQ 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-50
Identities = 69/307 (22%), Positives = 117/307 (38%), Gaps = 36/307 (11%)
Query: 17 EIQQATGDFSKENL-LGEGGFGHVYKGELK---DGQMIAAKVRKEASTQGFAE-FQSEVY 71
++ + ++ LG G FG V +G + +A KV K+ + + E E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 72 VLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTA 131
+++ + IV L+G C E L +LV E LH L E + +
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVS 119
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP---VQTKILGT 188
G+++L E+ +HRD+ N+LL + + DFGL++ DD ++
Sbjct: 120 MGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 189 LGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKV--VDMNGEEPQQSLRQWAEPLIEK 246
L + APE S R+DV+++G+ + + +S + M G E + Q
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 235
Query: 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLGE 306
EL LM+ C E RP V + + ++ L
Sbjct: 236 ECPPELYA-------------LMSD----CWIYKWEDRPDFLTVEQRMR---ACYYSLAS 275
Query: 307 KFVQRHH 313
K HH
Sbjct: 276 KVEGHHH 282
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-50
Identities = 65/279 (23%), Positives = 109/279 (39%), Gaps = 34/279 (12%)
Query: 27 KENLLGEGGFGHVYKGELKD---GQMIAAKV-RKEASTQGF-AEFQSEVYVLNFARHKNI 81
++ LG G FG V KG + + +A K+ + EA+ E +E V+ + I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
V ++G C E+ +LV E L+ +L N ++ + G+++L E
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESN 127
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP---VQTKILGTLGYLAPEYAE 198
+HRD+ N+LL + DFGL++ D+ QT + + APE
Sbjct: 128 ----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 199 NGIVSIRTDVYAFGIILLQLMSGRKV--VDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256
S ++DV++FG+++ + S + M G E L + E+ D
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD-- 241
Query: 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
LM C + E RP V L
Sbjct: 242 -----------LMNL----CWTYDVENRPGFAAVELRLR 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 8e-50
Identities = 61/273 (22%), Positives = 114/273 (41%), Gaps = 29/273 (10%)
Query: 28 ENLLGEGGFGHVYKGELKD-GQMIAAKV--RKEASTQGFAEFQSEVYVLNFARHKNIVML 84
+ +G G F VYKG + +A ++ + F+ E +L +H NIV
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 85 LGFCC----KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEE 140
+ +LV E + + +L +L V++ + KGL+FLH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH-- 129
Query: 141 CRGGPIIHRDMRPSNILLTH-DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN 199
R PIIHRD++ NI +T +GD GLA K ++GT ++APE E
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPEMYEE 187
Query: 200 GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259
DVYAFG+ +L++ + + + + ++ + ++ P ++
Sbjct: 188 K-YDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244
Query: 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
++ C+++N + R S+ +++
Sbjct: 245 --------IIEG----CIRQNKDERYSIKDLLN 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 1e-49
Identities = 68/313 (21%), Positives = 118/313 (37%), Gaps = 50/313 (15%)
Query: 14 SFSEIQQATGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKV-RKEASTQGFAEF 66
++ + +GEG FG V++ M+A K+ ++EAS A+F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 67 QSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTES---------- 116
Q E ++ + NIV LLG C L++EY+ L+ L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 117 ------------VLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVP 164
L ++ A A G+ +L E +HRD+ N L+ + V
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK----FVHRDLATRNCLVGENMVV 179
Query: 165 MLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
+ DFGL+R + D + ++ PE + +DV+A+G++L ++ S
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 223 KVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPE 282
G ++ + + LA E + N LM C + P
Sbjct: 240 LQPY-YGMAHEEVIYYVRDG--NILACPENCPLELYN--------LMRL----CWSKLPA 284
Query: 283 GRPSMGEVVRLLE 295
RPS + R+L+
Sbjct: 285 DRPSFCSIHRILQ 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 1e-49
Identities = 65/292 (22%), Positives = 114/292 (39%), Gaps = 34/292 (11%)
Query: 9 DPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKV---RKEASTQGFA 64
DP FS +G G FG VY +++ +++A K + S + +
Sbjct: 1 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60
Query: 65 EFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRY 124
+ EV L RH N + G +E+ LV EY + L+ +
Sbjct: 61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIA 118
Query: 125 AAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK 184
A G +GL +LH +IHRD++ NILL+ + LGDFG A
Sbjct: 119 AVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NS 170
Query: 185 ILGTLGYLAPEYAE---NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE 241
+GT ++APE G + DV++ GI ++L + + +L A+
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQ 228
Query: 242 PLIEKLALHELIDPRIENSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVR 292
P +++ + + + C+Q+ P+ RP+ +++
Sbjct: 229 N----------ESPALQSGHWSEYFRNFVDS----CLQKIPQDRPTSEVLLK 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-49
Identities = 77/323 (23%), Positives = 124/323 (38%), Gaps = 54/323 (16%)
Query: 9 DPMKFSFS---EIQQATGDFSKENLLGEGGFGHVYKGELKD------GQMIAAKVRKEAS 59
D ++ + E + + +LG G FG V +A K+ KE +
Sbjct: 22 DFREYEYDLKWEFPRE--NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA 79
Query: 60 TQGFAE-FQSEVYVL-NFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTE-- 115
E SE+ ++ H+NIV LLG C L++EY C L +L E
Sbjct: 80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 139
Query: 116 -------------------SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNI 156
+VL + A AKG+ FL + +HRD+ N+
Sbjct: 140 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARNV 195
Query: 157 LLTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGII 214
L+TH V + DFGLAR +D V+ + ++APE GI +I++DV+++GI+
Sbjct: 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 255
Query: 215 LLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAY 274
L ++ S G P + A ++LI + Y +
Sbjct: 256 LWEIFSL-------GVNPYPGIPVDAN-------FYKLIQNGFKMDQPFYATEEIYIIMQ 301
Query: 275 LCVQRNPEGRPSMGEVVRLLEGE 297
C + RPS + L +
Sbjct: 302 SCWAFDSRKRPSFPNLTSFLGCQ 324
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-49
Identities = 60/275 (21%), Positives = 108/275 (39%), Gaps = 25/275 (9%)
Query: 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKV-RKEASTQGFAEFQSEVYVLNFARHKN 80
D+ LGEG +G V + + +A K+ + + + E+ + H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEE 140
+V G + N+ L EY L + + QR+ + G+ +LH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 122
Query: 141 CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAE 198
I HRD++P N+LL + DFGLA ++ + K+ GTL Y+APE +
Sbjct: 123 G----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 199 NG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257
+ DV++ GI+L +++G D + Q+ + ID
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK--IDSAP 236
Query: 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
L+ K + NP R ++ ++ +
Sbjct: 237 LA--------LLHK----ILVENPSARITIPDIKK 259
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-49
Identities = 73/293 (24%), Positives = 122/293 (41%), Gaps = 43/293 (14%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKV---RKEASTQGFAEFQSEVYVL-NFARH 78
D ++++GEG FG V K +K DG + A + ++ AS +F E+ VL H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDN--------------TESVLEWHQRY 124
NI+ LLG C L EY + +L L + T S L Q
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 125 AAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK 184
A A+G+ +L ++ IHRD+ NIL+ ++V + DFGL+R + +T
Sbjct: 131 HFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KTM 185
Query: 185 ILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKV--VDMNGEEPQQSLRQWAEP 242
+ ++A E + + +DV+++G++L +++S M E + L Q
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245
Query: 243 LIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E+ D LM + C + P RPS +++ L
Sbjct: 246 EKPLNCDDEVYD-------------LMRQ----CWREKPYERPSFAQILVSLN 281
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 3e-49
Identities = 62/273 (22%), Positives = 108/273 (39%), Gaps = 29/273 (10%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKV---RKEASTQGFAEFQSEVYVLNFARHK 79
DF LG+G FG+VY K ++A KV + + + EV + + RH
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
NI+ L G+ L+ EY +++ L S + + A L + H
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS 124
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN 199
+ +IHRD++P N+LL + DFG + +T + GTL YL PE E
Sbjct: 125 K----RVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG 178
Query: 200 GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259
+ + D+++ G++ + + G+ + N + E D
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD----- 233
Query: 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
L+++ ++ NP RP + EV+
Sbjct: 234 --------LISR----LLKHNPSQRPMLREVLE 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-48
Identities = 55/282 (19%), Positives = 114/282 (40%), Gaps = 33/282 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKV-----RKEASTQGFAEFQSEVYVLNFAR 77
+F K +LG G FG VYKG +G+ + V R+ S + E E YV+
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 78 HKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFL 137
+ ++ LLG C + L+ + + L ++ ++ +++ + AKG+ +L
Sbjct: 70 NPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYL 127
Query: 138 HEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD--PVQTKILGTLGYLAPE 195
+ ++HRD+ N+L+ + DFGLA+ ++ + ++A E
Sbjct: 128 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 196 YAENGIVSIRTDVYAFGIILLQLMSGRKVV--DMNGEEPQQSLRQWAEPLIEKLALHELI 253
+ I + ++DV+++G+ + +LM+ + E L + + ++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 243
Query: 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+M K C + + RP E++
Sbjct: 244 M-------------IMVK----CWMIDADSRPKFRELIIEFS 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-46
Identities = 66/283 (23%), Positives = 107/283 (37%), Gaps = 32/283 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGELK----DGQMIAAKV---RKEASTQGFAEFQSEVYVLNFA 76
D LG+G FG V +GE +A K + + +F EV ++
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 77 RHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRF 136
H+N++ L G + + V E SL L + A+ A+G+ +
Sbjct: 69 DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGY 126
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP---VQTKILGTLGYLA 193
L + IHRD+ N+LL + +GDFGL R +D +Q + A
Sbjct: 127 LESKR----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 194 PEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253
PE + S +D + FG+ L ++ + G+EP L ++ K+
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTY-------GQEPWIGLNGSQ--ILHKIDKEGER 233
Query: 254 DPRIEN-SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
PR E+ D Y + C PE RP+ + L
Sbjct: 234 LPRPEDCPQDIYNV------MVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-46
Identities = 68/295 (23%), Positives = 124/295 (42%), Gaps = 36/295 (12%)
Query: 24 DFSKENLLGEGGFGHVYKGELK------DGQMIAAKV-RKEASTQGFAEFQSEVYVLNFA 76
+ LG+G FG VY+G K +A K + AS + EF +E V+
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 77 RHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESV--------LEWHQRYAAAI 128
++V LLG + +++ E + L +L ++ + A
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 129 GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQ--TKIL 186
A G+ +L+ +HRD+ N ++ DF +GDFG+ R D + K L
Sbjct: 141 EIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 187 GTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK 246
+ +++PE ++G+ + +DV++FG++L ++ + + G +Q LR E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEG---- 251
Query: 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301
L+D +EL +C Q NP+ RPS E++ ++ E +
Sbjct: 252 ----GLLDKPDNCPDMLFEL------MRMCWQYNPKMRPSFLEIISSIKEEMEPG 296
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 154 bits (390), Expect = 5e-45
Identities = 62/288 (21%), Positives = 106/288 (36%), Gaps = 25/288 (8%)
Query: 6 YMKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFA 64
Y P++ + + LG G FG V++ E G AAK
Sbjct: 12 YYPQPVEIKHDHV---LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 68
Query: 65 EFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRY 124
+ E+ ++ RH +V L +N +++YE++ L + D + + +
Sbjct: 69 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAV 127
Query: 125 AAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF--VPMLGDFGLARWKTTDDPVQ 182
KGL +HE +H D++P NI+ T L DFGL V+
Sbjct: 128 EYMRQVCKGLCHMHENN----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183
Query: 183 TKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP 242
GT + APE AE V TD+++ G++ L+SG GE ++LR
Sbjct: 184 VTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG--GENDDETLRNVKSC 240
Query: 243 LIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEV 290
+D + + K + +P R ++ +
Sbjct: 241 DWN-------MDDSAFSGISEDGKDFIRK----LLLADPNTRMTIHQA 277
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-43
Identities = 60/278 (21%), Positives = 107/278 (38%), Gaps = 27/278 (9%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD----GQMIAAKVRKEASTQGFAE-FQSEVYVLNFARH 78
+GEG FG V++G +A K K ++ E F E + H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
+IV L+G + + I + E L L S L+ A + L +L
Sbjct: 68 PHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE 125
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW-KTTDDPVQTKILGTLGYLAPEYA 197
+ +HRD+ N+L++ + LGDFGL+R+ + + +K + ++APE
Sbjct: 126 SKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 198 ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257
+ +DV+ FG+ + +++ G + + + E+L + P +
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGV-KPFQGVKNNDVIGRIENG--ERLPMPPNCPPTL 238
Query: 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
+ LM K C +P RP E+ L
Sbjct: 239 YS--------LMTK----CWAYDPSRRPRFTELKAQLS 264
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 5e-42
Identities = 61/284 (21%), Positives = 98/284 (34%), Gaps = 29/284 (10%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV---RKEASTQGFAEFQSEVYVLNFARHK 79
DF +LGEG F V EL + A K+ R E V++ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
V L + Y N L ++ + Y A I L +LH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLHG 126
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYA 197
+ IIHRD++P NILL D + DFG A+ + + +GT Y++PE
Sbjct: 127 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 198 ENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257
+D++A G I+ QL++G ++ + + E P+
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIK---LEYDFPEKFFPKA 237
Query: 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301
+ L+ K + + R E+ + F
Sbjct: 238 RD--------LVEK----LLVLDATKRLGCEEMEGYGPLKAHPF 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 9e-42
Identities = 69/300 (23%), Positives = 122/300 (40%), Gaps = 49/300 (16%)
Query: 24 DFSKENLLGEGGFGHVYKGELK--------DGQMIAAKV-RKEASTQGFAEFQSEVYVL- 73
LGEG FG V E +A K+ + +A+ + ++ SE+ ++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 74 NFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFD--------------NTESVLE 119
+HKNI+ LLG C ++ ++ EY +L +L N E L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 120 WHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179
+ A A+G+ +L + IHRD+ N+L+T D V + DFGLAR D
Sbjct: 134 SKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 180 PVQT--KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVV--DMNGEEPQQS 235
+ + ++APE + I + ++DV++FG++L ++ + + EE +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 236 LRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
L++ +EL +M C P RP+ ++V L+
Sbjct: 250 LKEGHRMDKPSNCTNELYM-------------MMRD----CWHAVPSQRPTFKQLVEDLD 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 145 bits (367), Expect = 1e-41
Identities = 55/273 (20%), Positives = 104/273 (38%), Gaps = 22/273 (8%)
Query: 23 GDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNI 81
+ LG G FG V++ E G++ AK ++E+ ++N H +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
+ L + +L+ E++ L + + + +GL+ +HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEH- 146
Query: 142 RGGPIIHRDMRPSNILLTHDFVP--MLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN 199
I+H D++P NI+ + DFGLA D+ V+ T + APE +
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDR 202
Query: 200 GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259
V TD++A G++ L+SG GE+ ++L+ E D +
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWE-------FDEDAFS 253
Query: 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
S + +Q+ P R ++ + +
Sbjct: 254 SVSPEAKDFIKN----LLQKEPRKRLTVHDALE 282
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-41
Identities = 71/297 (23%), Positives = 117/297 (39%), Gaps = 43/297 (14%)
Query: 24 DFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEASTQG-FAEFQSEVYVL-NF 75
LG G FG V + + + +A K+ KE +T SE+ +L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 76 ARHKNIVMLLGFCCKENLNI-LVYEYICNKSLHWHLF--------------DNTESVLEW 120
H N+V LLG C K + ++ E+ +L +L D + L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 121 HQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180
+ AKG+ FL IHRD+ NILL+ V + DFGLAR D
Sbjct: 134 EHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 181 --VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQ 238
+ L ++APE + + +I++DV++FG++L ++ S + ++ R+
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 239 WAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
E ++ + P M +T C P RP+ E+V L
Sbjct: 250 LKEG--TRMRAPDYTTPE------------MYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 9e-41
Identities = 68/274 (24%), Positives = 103/274 (37%), Gaps = 28/274 (10%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKV---RKEASTQGFAEFQSEVYVLNFA-RH 78
DF +LG+G FG V+ E K Q A K E VL+ A H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
+ + + V EY+ L +H+ + L YAA I GL+FLH
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI--ILGLQFLH 120
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE 198
+ I++RD++ NILL D + DFG+ + D GT Y+APE
Sbjct: 121 SKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 176
Query: 199 NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258
+ D ++FG++L +++ G+ EE + P + E D
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD---- 232
Query: 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
L+ K R PE R + +R
Sbjct: 233 ---------LLVK----LFVREPEKRLGVRGDIR 253
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 142 bits (358), Expect = 3e-40
Identities = 60/274 (21%), Positives = 108/274 (39%), Gaps = 30/274 (10%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKV------RKEASTQGFAEFQSEVYVLNFA 76
DFS ++G GGFG VY D G+M A K + + + + +++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 77 RHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRF 136
IV + + + + + LH+HL + + YAA I GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI--ILGLEH 122
Query: 137 LHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEY 196
+H +++RD++P+NILL + D GLA + P + GT GY+APE
Sbjct: 123 MHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPEV 176
Query: 197 AENGI-VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255
+ G+ D ++ G +L +L+ G + + + + + L + L + P
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--TLTMAVELPDSFSP 234
Query: 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGE 289
+ + L+ +QR+ R
Sbjct: 235 ELRS--------LLEG----LLQRDVNRRLGCLG 256
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-39
Identities = 57/272 (20%), Positives = 102/272 (37%), Gaps = 23/272 (8%)
Query: 24 DFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
+ LG G FG V++ E + AK K T + E+ +LN ARH+NI+
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNIL 64
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
L ++++E+I + + + L + + + L+FLH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSH-- 121
Query: 143 GGPIIHRDMRPSNILLTHD--FVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENG 200
I H D+RP NI+ + +FG AR D + Y APE ++
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEYYAPEVHQHD 178
Query: 201 IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260
+VS TD+++ G ++ L+SG E QQ + D
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFL--AETNQQIIENIMNAEYT-------FDEEAFKE 229
Query: 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
+ + + + + + R + E ++
Sbjct: 230 ISIEAMDFVDR----LLVKERKSRMTASEALQ 257
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 137 bits (345), Expect = 3e-39
Identities = 64/286 (22%), Positives = 112/286 (39%), Gaps = 31/286 (10%)
Query: 22 TGDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKV---RKEASTQGFAEFQSEVYVLNFAR 77
+ + +LG GG V+ L+ + +A KV + F+ E
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 78 HKNIVMLLGFCCKEN----LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKG 133
H IV + E L +V EY+ +L + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTK---ILGTLG 190
L F H+ IIHRD++P+NI+++ + DFG+AR T+ ++GT
Sbjct: 124 LNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 191 YLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250
YL+PE A V R+DVY+ G +L ++++G + + E I A H
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIPPSARH 238
Query: 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRP-SMGEVVRLLE 295
E + ++ ++ K + +NPE R + E+ L
Sbjct: 239 EGLSADLDA--------VVLK----ALAKNPENRYQTAAEMRADLV 272
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (341), Expect = 3e-38
Identities = 57/274 (20%), Positives = 106/274 (38%), Gaps = 25/274 (9%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIAAKV-RKEASTQGFAEFQSEVYVLNFARHKNI 81
+ ++LG G F V E + +++A K K+A ++E+ VL+ +H NI
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 69
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
V L L+ + + L + + R + +++LH+
Sbjct: 70 VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV--LDAVKYLHDLG 127
Query: 142 RGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE 198
I+HRD++P N+L D M+ DFGL++ + + T GT GY+APE
Sbjct: 128 ----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC-GTPGYVAPEVLA 182
Query: 199 NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258
S D ++ G+I L+ G E + Q + E D
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDAKLFEQILKAEYE-------FDSPYW 233
Query: 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
+ + ++++PE R + + ++
Sbjct: 234 DDISDSAKDFIRH----LMEKDPEKRFTCEQALQ 263
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 135 bits (341), Expect = 4e-38
Identities = 54/267 (20%), Positives = 100/267 (37%), Gaps = 30/267 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKV---RKEASTQGFAEFQSEVYVLNFARHK 79
DF LG G FG V+ + +G+ A KV + E +L+ H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
I+ + G ++ +YI L L + + YAA + L
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALEY 119
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN 199
II+RD++P NILL + + DFG A++ V + GT Y+APE
Sbjct: 120 LHSKD-IIYRDLKPENILLDKNGHIKITDFGFAKY---VPDVTYTLCGTPDYIAPEVVST 175
Query: 200 GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259
+ D ++FGI++ ++++G ++ + +L + +++
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKTYEKILN---AELRFPPFFNEDVKD 230
Query: 260 SYDTYELYLMAKTAYLCVQRNPEGRPS 286
L+++ + R+ R
Sbjct: 231 --------LLSR----LITRDLSQRLG 245
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 8e-38
Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 29/287 (10%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKV-RKEASTQGFAE-FQSEVYVLNFARHKN 80
+F K +GEG +G VYK K G+++A K R + T+G E+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEE 140
IV LL EN LV+E+ ++ L + + + + + +GL F H
Sbjct: 63 IVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 141 CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE-YAEN 199
++HRD++P N+L+ + L DFGLAR T + TL Y APE
Sbjct: 122 R----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 200 GIVSIRTDVYAFGIILLQLMSGR-------------KVVDMNGEEPQQSLRQWAEPLIEK 246
S D+++ G I ++++ R ++ G + K
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 247 LALHELIDPRIENSYDTYE---LYLMAKTAYLCVQRNPEGRPSMGEV 290
+ + + L+++ + +P R S
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQ----MLHYDPNKRISAKAA 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-37
Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 24/282 (8%)
Query: 29 NLLGEGGFGHVYKGELK-DGQMIAAKV-----RKEASTQGFAEFQSEVYVLNFARHKNIV 82
+ LGEG F VYK K Q++A K R EA E+ +L H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 83 MLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECR 142
LL ++ LV++++ ++ + Y +GL +LH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT--LQGLEYLHQHW- 120
Query: 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN-GI 201
I+HRD++P+N+LL + V L DFGLA+ + + T + T Y APE +
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 202 VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSL------RQWAEPLIEKLALHELIDP 255
+ D++A G IL +L+ + + + Q + E + +L + +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 256 RIENSYDTYELYLMAKTAYL-----CVQRNPEGRPSMGEVVR 292
+ + ++ A L NP R + + ++
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 1e-37
Identities = 45/297 (15%), Positives = 91/297 (30%), Gaps = 30/297 (10%)
Query: 23 GDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNI 81
+ +G G FG +Y G + G+ +A K+ + + E + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
+ + +C E ++ + SL F+ A + ++H +
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDL-FNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 142 RGGPIIHRDMRPSNILLT---HDFVPMLGDFGLARW-------KTTDDPVQTKILGTLGY 191
IHRD++P N L+ + + DFGLA+ + + GT Y
Sbjct: 124 ----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 192 LAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251
+ S R D+ + G +L+ G ++ + +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHHLGEKF 308
L + C + +P + +L + FH G +
Sbjct: 240 LCKGYPSEFAT-----YLNF----CRSLRFDDKPDYSYLRQLFR---NLFHRQGFSY 284
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (334), Expect = 2e-37
Identities = 58/288 (20%), Positives = 113/288 (39%), Gaps = 29/288 (10%)
Query: 24 DFSKENLLGEGGFGHVYKGELKDGQMIAAK-VRKEASTQGFAE-FQSEVYVLNFARHKNI 81
+ +GEG +G VYK + G+ A K +R E +G E+ +L +H NI
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
V L + +LV+E++ D E LE + + G+ + H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKL--LDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 142 RGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE-YAENG 200
++HRD++P N+L+ + + DFGLAR T + TL Y AP+ +
Sbjct: 121 ----VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 201 IVSIRTDVYAFGIILLQLMSGR----------------KVVDMNGEEPQQSLRQWAEPLI 244
S D+++ G I ++++G +++ + ++ + +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 245 EKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
L D + L++K ++ +P R + + +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSK----MLKLDPNQRITAKQALE 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 7e-37
Identities = 65/288 (22%), Positives = 113/288 (39%), Gaps = 40/288 (13%)
Query: 25 FSKENL---------LGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGF------AEFQS 68
F +EN+ LG G F V K K G AAK K+ T+ + +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 69 EVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAI 128
EV +L +H N++ L + IL+ E + L L + E + I
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 129 GTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVP----MLGDFGLARWKTTDDPVQTK 184
G+ +LH I H D++P NI+L VP + DFGLA K
Sbjct: 123 --LNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 175
Query: 185 ILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI 244
I GT ++APE + + D+++ G+I L+SG G+ Q++L +
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANVSAVNY 233
Query: 245 EKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
E + ++ + + + ++P+ R ++ + ++
Sbjct: 234 E-------FEDEYFSNTSALAKDFIRR----LLVKDPKKRMTIQDSLQ 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 130 bits (328), Expect = 1e-36
Identities = 46/286 (16%), Positives = 91/286 (31%), Gaps = 29/286 (10%)
Query: 23 GDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNI 81
+ +GEG FG +++G L + Q +A K S + + E
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 82 VMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
+ + + +E L+ ++ + S L D AA ++ +HE+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPS-LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 142 RGGPIIHRDMRPSNILLTHDFVPM-----LGDFGLARW-------KTTDDPVQTKILGTL 189
+++RD++P N L+ + DFG+ ++ + + + GT
Sbjct: 122 ----LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 190 GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249
Y++ S R D+ A G + + + G + + + L
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295
EL E Y M + P + L
Sbjct: 238 RELCAGFPEEFYK-----YMHY----ARNLAFDATPDYDYLQGLFS 274
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-36
Identities = 64/270 (23%), Positives = 108/270 (40%), Gaps = 27/270 (10%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKV---RKEASTQGFAEFQSEVYVLNFARHK 79
DF LLG+G FG V K G+ A K+ + A +E VL RH
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
+ L + V EY L +HL E + Y A I L +LH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI--VSALEYLHS 123
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN 199
+++RD++ N++L D + DFGL + +D GT YLAPE E+
Sbjct: 124 R----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 200 GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259
D + G+++ ++M GR + ++ ++ L+E++ + P ++
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELI---LMEEIRFPRTLSPEAKS 234
Query: 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGE 289
L+A ++++P+ R G
Sbjct: 235 --------LLAG----LLKKDPKQRLGGGP 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 5e-35
Identities = 56/292 (19%), Positives = 109/292 (37%), Gaps = 25/292 (8%)
Query: 22 TGDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKVRKEASTQGFAE-FQSEVYVLNFARHK 79
++ + +GEG +G V + + +A K Q + + E+ +L RH+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTES-VLEWHQRYAAAIGTAKGLRFLH 138
NI+ + + + Y+ + L+ ++ L +GL+++H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP---VQTKILGTLGYLAPE 195
++HRD++PSN+LL + DFGLAR D T+ + T Y APE
Sbjct: 127 SA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 196 YAENGIVSIR-TDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254
N + D+++ G IL +++S R + Q + + L+ +I+
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 255 PRIENSYDTYELYLMAKTAYL--------------CVQRNPEGRPSMGEVVR 292
+ N + L + NP R + + +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 6e-35
Identities = 67/299 (22%), Positives = 112/299 (37%), Gaps = 37/299 (12%)
Query: 23 GDFSKENLLGEGGFGHVYKGE-LKDGQMIAAK-VRKEASTQGFA-EFQSEVYVLNFARHK 79
+ K +G+G FG V+K K GQ +A K V E +GF E+ +L +H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 80 NIVMLLGFCC--------KENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTA 131
N+V L+ C + LV+++ + + L +R +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 132 KGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW----KTTDDPVQTKILG 187
L L+ R I+HRDM+ +N+L+T D V L DFGLAR K + T +
Sbjct: 127 --LNGLYYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 188 TLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMSGR-------------KVVDMNGEEPQ 233
TL Y PE D++ G I+ ++ + + + G
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 234 QSLRQWAE-PLIEKLALHELIDPRIENSYDTYELYLMAKT-AYLCVQRNPEGRPSMGEV 290
+ L EKL L + ++++ Y A + +P R +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 125 bits (314), Expect = 1e-34
Identities = 55/284 (19%), Positives = 100/284 (35%), Gaps = 37/284 (13%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIAAKV---------RKEASTQGFAEFQSEVYVL 73
++ + +LG G V + + A K+ E + EV +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 74 -NFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAK 132
+ H NI+ L LV++ + L +L + L + +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLE 121
Query: 133 GLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYL 192
+ LH+ I+HRD++P NILL D L DFG + + + ++ GT YL
Sbjct: 122 VICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYL 176
Query: 193 APEYAENGIV------SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK 246
APE E + D+++ G+I+ L++G + LR +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW--HRKQMLMLRMIMSGNYQ- 233
Query: 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEV 290
+ Y L+++ + P+ R + E
Sbjct: 234 ------FGSPEWDDYSDTVKDLVSR----FLVVQPQKRYTAEEA 267
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-34
Identities = 50/275 (18%), Positives = 105/275 (38%), Gaps = 30/275 (10%)
Query: 28 ENLLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVL-NFARHKNIVMLL 85
+LG G G V + + + A K+ ++ + + EV + ++ +IV ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIV 71
Query: 86 GFC----CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC 141
++V E + L + D + + + +++LH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 142 RGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE 198
I HRD++P N+L T + + L DFG A+ T+ + + T T Y+APE
Sbjct: 132 ----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-YTPYYVAPEVLG 186
Query: 199 NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258
D+++ G+I+ L+ G + + ++ + + P E
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPF------YSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 259 NSYDTYELY-LMAKTAYLCVQRNPEGRPSMGEVVR 292
S + E+ L+ ++ P R ++ E +
Sbjct: 241 WSEVSEEVKMLIRN----LLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 4e-34
Identities = 53/281 (18%), Positives = 95/281 (33%), Gaps = 41/281 (14%)
Query: 23 GDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV------RKEASTQGFAEFQSEVYVLNF 75
+ LLG GGFG VY G + D +A K EV +L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 76 AR--HKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKG 133
++ LL + + + +L+ E + L+ + +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEA 122
Query: 134 LRFLHEECRGGPIIHRDMRPSNILLTHD-FVPMLGDFGLARWKTTDDPVQTKILGTLGYL 192
+R H ++HRD++ NIL+ + L DFG D V T GT Y
Sbjct: 123 VRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTVYTDFDGTRVYS 176
Query: 193 APEY-AENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251
PE+ + V++ GI+L ++ G + + E + ++ +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----------EEIIRGQVFFRQ 225
Query: 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVR 292
+ ++ L+ C+ P RP+ E+
Sbjct: 226 RVSSECQH--------LIRW----CLALRPSDRPTFEEIQN 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 6e-34
Identities = 68/295 (23%), Positives = 109/295 (36%), Gaps = 34/295 (11%)
Query: 21 ATGDFSKENLLGEGGFGHVYKGELK--DGQMIAAK-VRKEASTQGFAE-FQSEVYV---L 73
A + +GEG +G V+K G+ +A K VR + +G EV V L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 74 NFARHKNIVMLLGFCCKENLNILVYEYI----CNKSLHWHLFDNTESVLEWHQRYAAAIG 129
H N+V L C + + ++ L +L E +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 130 TAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTL 189
+GL FLH ++HRD++P NIL+T L DFGLAR + + + + TL
Sbjct: 125 LLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-VTL 179
Query: 190 GYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR-------------KVVDMNGEEPQQSL 236
Y APE + D+++ G I ++ + K++D+ G ++
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 237 -RQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEV 290
R A P + + D L+ K C+ NP R S
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK----CLTFNPAKRISAYSA 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 9e-34
Identities = 61/286 (21%), Positives = 115/286 (40%), Gaps = 23/286 (8%)
Query: 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAK-VRKEASTQGFAE-FQSEVYVLNFARHKN 80
+ K +GEG +G V+K + + +++A K VR + +G E+ +L +HKN
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 81 IVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEE 140
IV L + LV+E+ + N + E + + + KGL F H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL--LKGLGFCHSR 120
Query: 141 CRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE-YAEN 199
++HRD++P N+L+ + L +FGLAR + + TL Y P+
Sbjct: 121 N----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 200 GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQ---------SLRQWAEPLIEKLALH 250
+ S D+++ G I +L + + + + Q + + P + KL +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 251 ELIDPRIENSYDTYELYLMAKTAY----LCVQRNPEGRPSMGEVVR 292
+ + + + T ++ NP R S E ++
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-33
Identities = 57/296 (19%), Positives = 107/296 (36%), Gaps = 45/296 (15%)
Query: 24 DFSKENLLGEGGFGHVYKGELKD-GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV 82
++ ++G G FG VY+ +L D G+++A K + E+ ++ H NIV
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76
Query: 83 MLLGFCCKENLN------ILVYEYICNKSLHWHL-FDNTESVLEWHQRYAAAIGTAKGLR 135
L F LV +Y+ + + L + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHD-FVPMLGDFGLARWKTTDDPVQTKILGTLGYLAP 194
++H I HRD++P N+LL D V L DFG A+ +P + I
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 195 EYAENGIVSIRTDVYAFGIILLQLMSGR-------------KVVDMNGEEPQQSLRQWAE 241
+ DV++ G +L +L+ G+ +++ + G ++ +R+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 242 -------PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEV 290
P I+ ++ PR + L ++ ++ P R + E
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRT----PPEAIALCSR----LLEYTPTARLTPLEA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 115 bits (288), Expect = 2e-30
Identities = 45/220 (20%), Positives = 80/220 (36%), Gaps = 15/220 (6%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIAAKV---RKEASTQGFAEFQSEVYVLNFARHK 79
F + LG G FG V + + G A K+ +K + +E +L
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 80 NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
+V L + +V EY+ + HL A +LH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS 159
Query: 140 ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAEN 199
+I+RD++P N+L+ + DFG A+ + GT LAPE +
Sbjct: 160 LD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILS 212
Query: 200 GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQW 239
+ D +A G+++ ++ +G ++P Q +
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP--FFADQPIQIYEKI 250
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 3e-29
Identities = 60/278 (21%), Positives = 110/278 (39%), Gaps = 31/278 (11%)
Query: 24 DFSKENLLGEGGFGHVYKGEL----KDGQMIAAKVRKEAS----TQGFAEFQSEVYVLNF 75
+F +LG G +G V+ G++ A KV K+A+ + ++E VL
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 76 ARHK-NIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGL 134
R +V L E L+ +YI L HL Q Y I +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI-----V 139
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT-KILGTLGYLA 193
L + G II+RD++ NILL + +L DFGL++ D+ + GT+ Y+A
Sbjct: 140 LALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 194 PEYAENGIVSI--RTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHE 251
P+ G D ++ G+++ +L++G + + S + + +++
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKS----- 251
Query: 252 LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGE 289
+P L+ + + ++P+ R G
Sbjct: 252 --EPPYPQEMSALAKDLIQR----LLMKDPKKRLGCGP 283
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 5e-28
Identities = 49/301 (16%), Positives = 106/301 (35%), Gaps = 29/301 (9%)
Query: 13 FSFSEIQQATGDFSK----ENLLGEGGFGHVYKG-ELKDGQMIAAKV-RKEASTQGFAE- 65
F E+ + + +G G +G V + + G +A K + ++ FA+
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 66 FQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDN--TESVLEWHQR 123
E+ +L RH+N++ LL + ++ L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 124 YAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQT 183
KGLR++H IHRD++P N+ + D + DFGLAR D +
Sbjct: 124 QFLVYQMLKGLRYIHAAGI----IHRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMTG 177
Query: 184 KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR-------------KVVDMNGE 230
++ + D+++ G I+ ++++G+ +++ + G
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 231 EPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKT-AYLCVQRNPEGRPSMGE 289
P + +++ + + + + +A + + E R + GE
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 290 V 290
Sbjct: 298 A 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 105 bits (263), Expect = 7e-27
Identities = 48/294 (16%), Positives = 107/294 (36%), Gaps = 40/294 (13%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVL-NFARHKNI 81
D+ LG G + V++ + + + + K+ K + + + E+ +L N NI
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 92
Query: 82 VMLLGFC--CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE 139
+ L LV+E++ N L + K L + H
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS 147
Query: 140 ECRGGPIIHRDMRPSNILLTHDF-VPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE 198
I+HRD++P N+++ H+ L D+GLA + + + + PE
Sbjct: 148 MG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLV 202
Query: 199 N-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLR-------QWAEPLIEKLALH 250
+ + D+++ G +L ++ ++ + Q +R + I+K +
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 251 ---ELIDPRIENSYDTYELYLMAKTAYL-----------CVQRNPEGRPSMGEV 290
D +S +E ++ ++ +L ++ + + R + E
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 7e-26
Identities = 50/289 (17%), Positives = 104/289 (35%), Gaps = 31/289 (10%)
Query: 24 DFSKENLLGEGGFGHVYKGE-LKDGQMIAAKV--RKEASTQGFAEFQSEVYVLNFARHKN 80
+ + +G G +G V K G +A K R S E+ +L +H+N
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 81 IVMLLGFC-----CKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLR 135
++ LL +E ++ + ++ L+ + L +GL+
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLK 135
Query: 136 FLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPE 195
++H IHRD++PSN+ + D + DFGLAR TDD + +
Sbjct: 136 YIHSADI----IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEI 189
Query: 196 YAENGIVSIRTDVYAFGIILLQLMSGR-------------KVVDMNGEEPQQSLRQWAEP 242
+ D+++ G I+ +L++GR ++ + G + L++ +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 243 LIEKLALHELIDPRIENSYDTYELYLMAKT-AYLCVQRNPEGRPSMGEV 290
P++ + +A + + + R + +
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (245), Expect = 3e-24
Identities = 57/299 (19%), Positives = 110/299 (36%), Gaps = 34/299 (11%)
Query: 23 GDFSKENLLGEGGFGHVYKG-ELKDGQMIAAKV-RKEASTQGFAE-FQSEVYVLNFARHK 79
+ +G G G V + + +A K + Q A+ E+ ++ HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 80 NIVMLLGFCCKEN-LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLH 138
NI+ LL + L Y+ + + +L + L+ + G++ LH
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 139 EECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAE 198
IHRD++PSNI++ D + DFGLAR T T + T Y APE
Sbjct: 137 SAGI----IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVIL 191
Query: 199 NGIVSIRTDVYAFGIILLQLMSGR-------------KVVDMNGEEPQQSLRQWAE---- 241
D+++ G I+ +++ + KV++ G + +++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 242 -----PLIEKLALHELIDPRIENSYDTYELYLMAKTAYL---CVQRNPEGRPSMGEVVR 292
P L +L + + + ++ L + +P R S+ + ++
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.4 bits (215), Expect = 4e-20
Identities = 33/220 (15%), Positives = 74/220 (33%), Gaps = 26/220 (11%)
Query: 23 GDFSKENLLGEGGFGHVYKGE-LKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNI 81
+ LG G F V+ + + + +A K+ + + E+ +L +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADN 71
Query: 82 VMLLGFCCKENLNILVYEYICNKS----------------LHWHLFDNTESVLEWHQRYA 125
L +L + + +++ L + ++ +
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 126 AAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT-HDFVPMLGDFGLARWKTTDDPVQT- 183
+ GL ++H C IIH D++P N+L+ D L +A +
Sbjct: 132 KQL--LLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 184 -KILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR 222
+ T Y +PE D+++ ++ +L++G
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.3 bits (192), Expect = 5e-18
Identities = 26/159 (16%), Positives = 46/159 (28%), Gaps = 28/159 (17%)
Query: 29 NLLGEGGFGHVYKGELKDGQMIAAKVRKEAST----------QGFAEFQSEVYVLNFARH 78
L+GEG V+ + K K T G F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 79 KNIVMLLGFCCKENL----NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGL 134
+ + L G + N ++ E I K L+ +E I + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-------RVENPDEVLDMI--LEEV 116
Query: 135 RFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173
+ I+H D+ N+L+ + + DF +
Sbjct: 117 AKFYHRG----IVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 315 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.88 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.37 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.78 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.64 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.4 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.38 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-55 Score=368.79 Aligned_cols=252 Identities=22% Similarity=0.281 Sum_probs=212.4
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
++|++++.||+|+||+||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++.+.+.+|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999875 69999999988766666778999999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.|++|.+++.+ ..+++..+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++.........
T Consensus 100 ~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999987754 3599999999999999999999999 9999999999999999999999999999866555555
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSY 261 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (315)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. .... ...... ......
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~----~~~~~~--------~~~~~~ 238 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALY----LIATNG--------TPELQN 238 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH----HHHHHC--------SCCCSS
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHHH----HHHhCC--------CCCCCC
Confidence 55678999999999999999999999999999999999999999643321 1111 111110 001112
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 262 DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 262 ~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
+...+..+.+++.+||+.||++|||+.|++++-+
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 2334566889999999999999999999987643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=362.20 Aligned_cols=252 Identities=22% Similarity=0.281 Sum_probs=203.4
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.++|++++.||+|+||+||+|.+. +++.||+|++.... .+..+.+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999875 68999999987543 2334568899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.|++|.+++.+ ...+++..+..++.|++.|+.|||++ |++||||||+||+++.++.++|+|||++.......
T Consensus 84 y~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~----~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc----CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999999853 45699999999999999999999999 99999999999999999999999999997544332
Q ss_pred C--ccccccccccccCccccccCCC-cccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 180 P--VQTKILGTLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 180 ~--~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
. ......||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.......... .. .... .
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~----~~~~---------~ 223 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SD----WKEK---------K 223 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HH----HHTT---------C
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HH----HhcC---------C
Confidence 2 2334679999999999988775 678999999999999999999997544322111 11 0000 0
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.........+..+.+|+.+||+.||++|||+++++++
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111112234557789999999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=361.48 Aligned_cols=246 Identities=24% Similarity=0.382 Sum_probs=205.5
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++++.||+|+||+||+|.++ +++.||+|++... .......+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999876 6899999987643 2344567889999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+|+|.+.+.+. ..+++..+..++.|++.|+.|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 158 (263)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred eecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeeeeccccceecCCCCEeecccceeeecCC-
Confidence 999999999988543 4599999999999999999999999 999999999999999999999999999964332
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. ... ...... .
T Consensus 159 -~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~----~~i~~~-------~---- 220 (263)
T d2j4za1 159 -SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETY----KRISRV-------E---- 220 (263)
T ss_dssp -CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH----HHHHTT-------C----
T ss_pred -CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--HHH----HHHHcC-------C----
Confidence 2234467999999999999999999999999999999999999999654321 111 111110 1
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...+...+..+.+++.+||+.||++|||+++++++
T Consensus 221 ~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 11222344568889999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=364.99 Aligned_cols=255 Identities=24% Similarity=0.303 Sum_probs=210.0
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
+.|++++.||+|+||+||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++.+++.+++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 47999999999999999999876 68999999988777777788999999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
.||+|.+++.+. ..++++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.........
T Consensus 92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~----~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 999998887543 34599999999999999999999999 9999999999999999999999999998644332223
Q ss_pred cccccccccccCccccc-----cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 182 QTKILGTLGYLAPEYAE-----NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
.....|++.|+|||++. +..++.++|||||||++|+|++|..||...+... .+... ... .. +
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~~~i----~~~-~~-----~- 233 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VLLKI----AKS-EP-----P- 233 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHHH----HHS-CC-----C-
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HHHHH----HcC-CC-----C-
Confidence 34567999999999874 4557889999999999999999999996544321 11111 110 00 0
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
....+...+..+.+|+.+||+.||++|||+.|++++-+-
T Consensus 234 -~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 234 -TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp -CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred -CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 111223345568899999999999999999999986443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=362.83 Aligned_cols=256 Identities=22% Similarity=0.279 Sum_probs=194.0
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEe--cCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCK--ENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 96 (315)
.++|++++.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+ .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 368999999999999999999875 68999999876543 3345568899999999999999999999854 566899
Q ss_pred EEEeccCCccccccccC--CCCccCHHHHHHHHHHHHHHHHhhhccc-CCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 97 VYEYICNKSLHWHLFDN--TESVLEWHQRYAAAIGTAKGLRFLHEEC-RGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~-~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
||||+.||+|.+++.+. ....+++..++.++.|++.|+.|||++. .+.+++||||||+||+++.++.++|+|||++.
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999988643 3456999999999999999999999971 01139999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 174 WKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
.............||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.. ...... .....
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~~~i-~~~~~---- 231 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKI-REGKF---- 231 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHH-HHTCC----
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHHHHH-HcCCC----
Confidence 6555444445568899999999999999999999999999999999999999643321 111111 11111
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
+.+ +...+..+.+|+.+||+.||++|||+.+++++
T Consensus 232 -~~~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 -RRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111 22234468899999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-54 Score=364.51 Aligned_cols=260 Identities=26% Similarity=0.344 Sum_probs=213.2
Q ss_pred HHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 20 QATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
...++|++.+.||+|+||+||+|.+. +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34568999999999999999999876 5889999988754 344677899999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.+|+|.+++.......+++..+..++.|++.|+.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC----CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999999877778899999999999999999999999 9999999999999999999999999999754433
Q ss_pred CCc-cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 179 DPV-QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 179 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
... .....|++.|+|||++.+..++.++||||||+++|+|++|..|+...... ..... .... ..
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~----~i~~---------~~ 233 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYE----LLEK---------DY 233 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHH----HHHT---------TC
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHH----HHhc---------CC
Confidence 322 22235788999999999999999999999999999999976665332221 11111 1111 11
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
....+...+..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112223344568899999999999999999999999987643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-54 Score=357.14 Aligned_cols=254 Identities=21% Similarity=0.336 Sum_probs=199.4
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
++|++++.||+|+||+||+|.+.+++.||+|++... ....+.+.+|+.+++.++||||+++++++..++..++||||+.
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 579999999999999999999988889999998754 3345678999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc-
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV- 181 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~- 181 (315)
+|+|.+++... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhcc----ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999887543 34588999999999999999999999 9999999999999999999999999999754433322
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHhC-CCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSG-RKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
.....|++.|+|||++.+..++.++||||||+++|||+++ .+|+..... .... ...... ... .
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~---~~i~~~------~~~----~ 222 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVV---EDISTG------FRL----Y 222 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHH---HHHHHT------CCC----C
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHH---HHHHhc------CCC----C
Confidence 2235688999999999999999999999999999999995 555543221 1111 111111 111 1
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
.+...+..+.+++.+||+.||++|||++++++.|+++.
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 12223445789999999999999999999999998874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=356.12 Aligned_cols=261 Identities=28% Similarity=0.452 Sum_probs=202.9
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
.++|++.+.||+|+||+||+|.+++ .||+|++... .....+.+.+|+.++++++||||+++++++. .+.+++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 4689999999999999999998653 5899987643 3455677899999999999999999999875 456899999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+++|+|.+++.... ..+++..+..++.|++.|+.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 84 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~----~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC----CEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999999886443 4599999999999999999999999 99999999999999999999999999997543322
Q ss_pred --CccccccccccccCcccccc---CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 180 --PVQTKILGTLGYLAPEYAEN---GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 180 --~~~~~~~~~~~~~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
.......||+.|+|||++.+ ..++.++|||||||++|||++|..||....... .... ...... ..
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~----~~~~~~----~~ 228 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIF----MVGRGY----LS 228 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHH----HHHHTS----CC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHH----HHhcCC----CC
Confidence 22234578999999999864 347889999999999999999999996543221 1111 111111 11
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
+.. ...+...+..+.+++.+||+.||++|||+.++++.|+.+...+
T Consensus 229 p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 229 PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 111 1122233456889999999999999999999999998775443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-53 Score=349.76 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=209.1
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEecc
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYIC 102 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 102 (315)
++|+++++||+|+||+||+|+++++..||+|+++.... ..+.+.+|+.+++.++||||+++++++.+++.+++||||+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 68999999999999999999998888999999876433 45678999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc-
Q 046121 103 NKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV- 181 (315)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~- 181 (315)
+|+|..++... ...+++..++.++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~----~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT----TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhc----CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99998876443 34588999999999999999999999 9999999999999999999999999999754433222
Q ss_pred cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 182 QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 182 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
.....+++.|+|||.+.+..++.++||||||+++|||++ |..||...+... .. .... .. ... .
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~---~~i~-~~-----~~~----~ 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TA---EHIA-QG-----LRL----Y 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HH---HHHH-TT-----CCC----C
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HH---HHHH-hC-----CCC----C
Confidence 223568899999999999999999999999999999998 799996554221 11 1111 11 111 1
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.+...+..+.+++.+||+.||++|||+++++++|..+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1223345688999999999999999999999998653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-53 Score=361.93 Aligned_cols=254 Identities=21% Similarity=0.312 Sum_probs=192.9
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
+.++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999999876 68999999987543 223355779999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc---CCCceeECCCCccccc
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT---HDFVPMLGDFGLARWK 175 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~---~~~~i~l~dfg~~~~~ 175 (315)
||++|++|.+++.+ ...+++..+..++.|++.|+.|||+. +++||||||+||++. .++.++|+|||++...
T Consensus 87 E~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDL----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhc----eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999854 45699999999999999999999999 999999999999994 5789999999999744
Q ss_pred CCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|.+||....... ........ ..
T Consensus 161 ~~-~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~-------~~ 226 (307)
T d1a06a_ 161 DP-GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKA-------EY 226 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHTT-------CC
T ss_pred cC-CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHhcc-------CC
Confidence 33 223345679999999999999999999999999999999999999996433211 11111111 01
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
..........+..+.+++.+||++||++|||+.|++++-
T Consensus 227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 265 (307)
T d1a06a_ 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265 (307)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 111122233445688999999999999999999999963
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.9e-53 Score=364.89 Aligned_cols=266 Identities=21% Similarity=0.289 Sum_probs=215.3
Q ss_pred CCCCCcccHHHHHHHhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCcccee
Q 046121 7 MKDPMKFSFSEIQQATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLL 85 (315)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (315)
.+.|..+.-. .+.++|++++.||+|+||+||+|.+. +|+.||+|++........+.+.+|+.+++.++||||++++
T Consensus 13 ~p~p~~l~~~---~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~ 89 (350)
T d1koaa2 13 YPQPVEIKHD---HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89 (350)
T ss_dssp CCCCCCCBCS---CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred CCCCCcCCCC---CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3445444432 24579999999999999999999875 6899999998877666677889999999999999999999
Q ss_pred eeEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc--CCCc
Q 046121 86 GFCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT--HDFV 163 (315)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~--~~~~ 163 (315)
+++.+++.+|+||||+.||+|.+++.+. ...+++..+..++.||+.||.|||++ |++||||||+||+++ .++.
T Consensus 90 ~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHrDiKp~NIll~~~~~~~ 164 (350)
T d1koaa2 90 DAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNE 164 (350)
T ss_dssp EEEEETTEEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTSCC
T ss_pred EEEEECCEEEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhc----CCeeeeechhHeeeccCCCCe
Confidence 9999999999999999999999888543 34599999999999999999999999 999999999999995 4688
Q ss_pred eeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHH
Q 046121 164 PMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 164 i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (315)
++|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. ..+.. .
T Consensus 165 vkL~DFG~a~~~~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~----i 237 (350)
T d1koaa2 165 LKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRN----V 237 (350)
T ss_dssp EEECCCTTCEECCTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----H
T ss_pred EEEeecchheecccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHH----H
Confidence 999999999754433 2334567899999999999999999999999999999999999999644321 11111 1
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
... . ...........+..+.+|+.+||..||++|||+.+++++-
T Consensus 238 ~~~-~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp 281 (350)
T d1koaa2 238 KSC-D------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 281 (350)
T ss_dssp HHT-C------CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHST
T ss_pred HhC-C------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 110 0 0111112223345688999999999999999999999973
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.2e-53 Score=364.61 Aligned_cols=254 Identities=20% Similarity=0.258 Sum_probs=210.2
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
+.++|++++.||+|+||+||+|.+. +++.||+|++..........+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3578999999999999999999875 799999999887666666678899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEc--CCCceeECCCCcccccCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLT--HDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~--~~~~i~l~dfg~~~~~~~ 177 (315)
|+.|++|.+.+... ...+++..++.++.||+.||.|||+. |++||||||+|||++ .++.++|+|||++.....
T Consensus 107 ~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 107 FLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred cCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999998876433 34599999999999999999999999 999999999999997 678999999999985544
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
.. ......|++.|+|||++.+..++.++|||||||++|+|++|..||....... .+ ...... ....
T Consensus 182 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~----~~i~~~-------~~~~ 247 (352)
T d1koba_ 182 DE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TL----QNVKRC-------DWEF 247 (352)
T ss_dssp TS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HH----HHHHHC-------CCCC
T ss_pred CC-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HH----HHHHhC-------CCCC
Confidence 33 3345678999999999999999999999999999999999999996443211 11 111110 1111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
........+..+.+|+.+||+.||++|||+.+++++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222223344567899999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=359.97 Aligned_cols=248 Identities=21% Similarity=0.248 Sum_probs=203.3
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++++.||+|+||+||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999875 6899999998643 2345567899999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.||+|.+++... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccc----cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999887543 4699999999999999999999999 9999999999999999999999999999755433
Q ss_pred CC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCc
Q 046121 179 DP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPR 256 (315)
Q Consensus 179 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (315)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. ... ...... ..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~----~~i~~~-------~~- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--LIF----QKIIKL-------EY- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHTT-------CC-
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH--HHH----HHHHcC-------CC-
Confidence 22 233457999999999999999999999999999999999999999654321 111 111110 01
Q ss_pred ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 257 IENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 257 ~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.++...+..+.+|+.+||+.||++|||++|++..
T Consensus 228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1222334567899999999999999999997554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-53 Score=353.80 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=206.3
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.++|++.+.||+|+||+||+|.+++++.||+|++.... ...+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 36899999999999999999999888999999987543 345678999999999999999999998754 5679999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC-
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP- 180 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~- 180 (315)
++|+|.+.+.......+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~----~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999887655555699999999999999999999999 999999999999999999999999999975543322
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCc-cCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKV-VDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
......|++.|+|||++.++.++.++||||||+++|+|+||..| +...... ... ... .. ...+.
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~---~~i-~~-----~~~~~--- 230 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVI---QNL-ER-----GYRMV--- 230 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH---HHH-HT-----TCCCC---
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHH---HHH-Hh-----cCCCC---
Confidence 22335678899999999988899999999999999999996554 4332211 111 111 11 11111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
.+...+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 231 -~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 12233456889999999999999999999999988653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=360.03 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=210.0
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
-++|++++.||+|+||+||+|+++ +++.||+|++.+. .......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 368999999999999999999875 7999999998753 234567788999999999999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|||+.||+|.+++.+ ...+++..+..++.|++.||.|||++ |++||||||+||+++.+|.++|+|||++.....
T Consensus 84 ~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhc----CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999988854 34589999999999999999999999 999999999999999999999999999986555
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
........+||+.|+|||++.+..++.++|+|||||++|+|++|.+||...+... . ....... ...
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~----~~~i~~~-------~~~- 223 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--L----FELILME-------EIR- 223 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----HHHHHHC-------CCC-
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--H----HHHHhcC-------CCC-
Confidence 4555556789999999999999999999999999999999999999997544211 1 1111110 011
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHh
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPS-----MGEVVRLLE 295 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps-----~~~il~~L~ 295 (315)
++...+..+.+|+.+||++||++||+ +.+++++-+
T Consensus 224 ---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred ---CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence 12233445789999999999999994 888988644
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=365.80 Aligned_cols=267 Identities=21% Similarity=0.273 Sum_probs=205.6
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
..++|+++++||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3678999999999999999999875 6899999998754 3344567889999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
||+.|++|.+++.+. ..+++..+..++.|++.|+.|||+ . +|+||||||+||+++.++.++|+|||++.....
T Consensus 84 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH----CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC----CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999988643 459999999999999999999997 5 899999999999999999999999999974432
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH--HHHH-----------
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA--EPLI----------- 244 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~----------- 244 (315)
. ......||+.|+|||++.+..++.++||||+||++|+|++|+.||............... ....
T Consensus 158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 1 223468999999999999999999999999999999999999999754432211100000 0000
Q ss_pred --hhhcc------------ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 245 --EKLAL------------HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 245 --~~~~~------------~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
..... ................+..+.+++.+||..||++|||++|++++-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence 00000 0000000000011112345788999999999999999999998643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-52 Score=356.21 Aligned_cols=260 Identities=24% Similarity=0.352 Sum_probs=199.3
Q ss_pred hcCCcccceecCCCceEEEEEEeCC-C---cEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKD-G---QMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~-~---~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
.++|++.++||+|+||+||+|.+.. + ..+++|.+... .....+.+.+|+.++++++||||+++++++...+.+++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3678889999999999999998752 2 35778876543 34445678999999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.+|+|.+++... ...+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 105 v~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhC----CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999877543 34589999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCc-----cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccc
Q 046121 177 TDDPV-----QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250 (315)
Q Consensus 177 ~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (315)
..... .....+++.|+|||.+.++.++.++|||||||++|||++ |.+||...... .........
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------~~~~~i~~~---- 249 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------DVINAIEQD---- 249 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT----
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------HHHHHHHcC----
Confidence 32211 112356889999999999999999999999999999998 89999654321 111111111
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
. ....+...+..+.+++.+||+.||++|||+.++++.|+.+....+
T Consensus 250 --~----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 250 --Y----RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp --C----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred --C----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChh
Confidence 0 111222345568899999999999999999999999988755433
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=348.72 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=197.1
Q ss_pred hcCC-cccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEe----cCe
Q 046121 22 TGDF-SKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCK----ENL 93 (315)
Q Consensus 22 ~~~y-~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 93 (315)
.++| ++.++||+|+||+||+|.+. +++.||+|++... .....+.+.+|+++++.++||||+++++++.. ...
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 3456 67778999999999999876 6889999987654 33445668899999999999999999999865 356
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCC--eEeecCccCcEEEc-CCCceeECCCC
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGP--IIHRDMRPSNILLT-HDFVPMLGDFG 170 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~--i~h~di~p~nil~~-~~~~i~l~dfg 170 (315)
+++||||+++++|.+++.+. ..+++..+..++.|++.|+.|||++ + ++||||||+||+++ .++.++|+|||
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~----~~~IiHrDiKp~NILl~~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLG 160 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC----CCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence 79999999999999988543 4589999999999999999999999 7 99999999999996 57899999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccc
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (315)
++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .+. ... ..
T Consensus 161 la~~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~---~~i-~~---- 227 (270)
T d1t4ha_ 161 LATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIY---RRV-TS---- 227 (270)
T ss_dssp GGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHH---HHH-TT----
T ss_pred cceeccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHH---HHH-Hc----
Confidence 9974332 22345689999999999876 58999999999999999999999996433211 111 111 11
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
....+. .+...+..+.+++.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 228 GVKPAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TCCCGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCcc----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 001111 112223347899999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=354.08 Aligned_cols=256 Identities=22% Similarity=0.275 Sum_probs=207.8
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC------cccHHHHHHHHHHHhhcCCCCccceeeeEEecCe
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS------TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENL 93 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (315)
+.++|++++.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4578999999999999999999875 79999999876432 2235678999999999999999999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC----ceeECCC
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF----VPMLGDF 169 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~----~i~l~df 169 (315)
+|+||||+.||+|.+++.+. ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++ .++++||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~----~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhc----ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999988543 4699999999999999999999999 999999999999998776 5999999
Q ss_pred CcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcc
Q 046121 170 GLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249 (315)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (315)
|++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...+... ... .....
T Consensus 162 G~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~----~i~~~--- 231 (293)
T d1jksa_ 162 GLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLA----NVSAV--- 231 (293)
T ss_dssp TTCEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHTT---
T ss_pred hhhhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--HHH----HHHhc---
Confidence 9997544332 3344578999999999999999999999999999999999999996543211 111 11100
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
............+..+.+|+.+||+.||++|||+++++++-+-
T Consensus 232 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 232 ----NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp ----CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred ----CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 0011111112234567899999999999999999999986443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=349.67 Aligned_cols=256 Identities=23% Similarity=0.285 Sum_probs=204.9
Q ss_pred cCCcccc-eecCCCceEEEEEEeC---CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEE
Q 046121 23 GDFSKEN-LLGEGGFGHVYKGELK---DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 23 ~~y~~~~-~lg~g~~~~v~~~~~~---~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
++|.+.. +||+|+||+||+|.+. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.. +.+++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4677777 4999999999999754 35579999987543 3445678999999999999999999999865 467999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|||+++|+|.+++... ...+++..+..++.|++.|+.|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 87 mE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999887433 34699999999999999999999999 999999999999999999999999999976544
Q ss_pred CCCc---cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 178 DDPV---QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 178 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
.... .....|++.|+|||++.++.++.++|||||||++|||++ |..||....... ... . .... .
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~---~-i~~~-----~ 229 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA---F-IEQG-----K 229 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHH---H-HHTT-----C
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHH---H-HHcC-----C
Confidence 3322 223467899999999998899999999999999999998 899997543221 111 1 1111 1
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
.+. .++..+..+.+|+.+||+.||++|||+.++++.|+.....
T Consensus 230 ~~~----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 230 RME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111 2233445678999999999999999999999998876543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-52 Score=356.06 Aligned_cols=246 Identities=25% Similarity=0.350 Sum_probs=199.9
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCc---ccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAST---QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
..|+.++.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999875 688999999875432 33456889999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.++++...+.. ...+++..+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++.....
T Consensus 95 E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 99999998665533 35699999999999999999999999 999999999999999999999999999974332
Q ss_pred CCccccccccccccCcccccc---CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCC
Q 046121 179 DPVQTKILGTLGYLAPEYAEN---GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDP 255 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (315)
.....||+.|+|||++.+ +.++.++|||||||++|+|++|..||...+.. .... ..... . .+
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--~~~~----~i~~~-~-----~~ 232 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALY----HIAQN-E-----SP 232 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH----HHHHS-C-----CC
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--HHHH----HHHhC-C-----CC
Confidence 234579999999999864 45788999999999999999999999643321 1111 11111 0 01
Q ss_pred cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 256 RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 256 ~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 233 ---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 233 ---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ---CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11122234568899999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=354.48 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=203.0
Q ss_pred cCCcccceecCCCceEEEEEEeCC------CcEEEEEEeccc-CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCee
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKD------GQMIAAKVRKEA-STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 94 (315)
++|++.++||+|+||+||+|.+.. ...|++|.+... .......+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 689999999999999999997642 236888887543 334445688999999988 899999999999999999
Q ss_pred EEEEEeccCCccccccccCCC---------------------CccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCcc
Q 046121 95 ILVYEYICNKSLHWHLFDNTE---------------------SVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRP 153 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p 153 (315)
++||||+++|+|.+++..... ..+++..++.++.|++.|+.|||++ +|+||||||
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~----~IiHRDlKp 192 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAA 192 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEETTCSG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCch
Confidence 999999999999999865432 3589999999999999999999999 999999999
Q ss_pred CcEEEcCCCceeECCCCcccccCCCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCC
Q 046121 154 SNILLTHDFVPMLGDFGLARWKTTDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGE 230 (315)
Q Consensus 154 ~nil~~~~~~i~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~ 230 (315)
+||+++.++.++|+|||++......... .....||+.|+|||++.++.++.++|||||||++|+|++ |.+||...+.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999754433322 224567899999999999999999999999999999997 8999975443
Q ss_pred ccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 231 EPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.. .+.. .... ......+...+..+.+|+.+||+.||++|||+++|+++|.
T Consensus 273 ~~--~~~~----~~~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DA--NFYK----LIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SH--HHHH----HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH--HHHH----HHhc---------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 1111 1111 1111222334556889999999999999999999999985
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-51 Score=350.86 Aligned_cols=248 Identities=22% Similarity=0.291 Sum_probs=205.3
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++++.||+|+||+||+|+++ +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999875 6999999998643 2344667889999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
||+.|++|...+... ..+++..+..++.|++.|+.|||++ +++||||||+||+++.+|.++|+|||++......
T Consensus 84 E~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccC----cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999998887543 4578889999999999999999999 9999999999999999999999999999754332
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. ... ...... ..
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~----~~i~~~-------~~--- 218 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTY----EKILNA-------EL--- 218 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH----HHHHHC-------CC---
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--HHH----HHHHcC-------CC---
Confidence 23467999999999999999999999999999999999999999654321 111 111111 01
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHhc
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLEG 296 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~~ 296 (315)
..++..+..+.+++.+||..||.+|+ |+++++++-+-
T Consensus 219 -~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f 260 (316)
T d1fota_ 219 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260 (316)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred -CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence 11222344578899999999999996 89999986443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=345.38 Aligned_cols=247 Identities=25% Similarity=0.300 Sum_probs=195.9
Q ss_pred ceecCCCceEEEEEEeC---CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEeccC
Q 046121 29 NLLGEGGFGHVYKGELK---DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYICN 103 (315)
Q Consensus 29 ~~lg~g~~~~v~~~~~~---~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (315)
++||+|+||+||+|.+. .++.||+|++... .....+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999754 3568999988643 23335678999999999999999999999865 457899999999
Q ss_pred CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc--
Q 046121 104 KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV-- 181 (315)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~-- 181 (315)
|+|.+++.+. ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++++|||++.........
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~----~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhC----CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9999988543 4589999999999999999999999 9999999999999999999999999999755433322
Q ss_pred -cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 182 -QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 182 -~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
.....||+.|+|||++.+..++.++||||||+++|||++ |.+||...... +.... .... ..+
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~------~~~~~-i~~~-----~~~---- 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAM-LEKG-----ERM---- 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHH-HHTT-----CCC----
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH------HHHHH-HHcC-----CCC----
Confidence 123468899999999999999999999999999999997 89999754321 11111 1111 111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
..+...+..+.+|+.+||+.||++|||+.++++.|+...
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 122234456889999999999999999999998887653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=345.97 Aligned_cols=259 Identities=25% Similarity=0.336 Sum_probs=205.0
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEYI 101 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 101 (315)
.++|++.+.||+|+||+||+|.+++++.||+|++... ....+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 4689999999999999999999988888999998754 3445779999999999999999999999854 5679999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC-
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP- 180 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~- 180 (315)
++|+|...+.......+++.+++.++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~----~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh----heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999888766566799999999999999999999999 999999999999999999999999999975433222
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENS 260 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (315)
......|++.|+|||++.++.++.++||||||+++|+|++|..|+...... .... ..... ... ..
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~---~~i~~------~~~----~~ 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVL---DQVER------GYR----MP 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH---HHHHT------TCC----CC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHH---HHHHh------cCC----CC
Confidence 223356889999999999999999999999999999999966555332211 1111 11111 011 11
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccc
Q 046121 261 YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRF 301 (315)
Q Consensus 261 ~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~ 301 (315)
.+...+..+.+++.+||+.||++|||+++|++.|+......
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 22334456889999999999999999999999998866543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-51 Score=343.03 Aligned_cols=258 Identities=23% Similarity=0.335 Sum_probs=198.9
Q ss_pred cCCcccceecCCCceEEEEEEeCCC-----cEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDG-----QMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
++|++.++||+|+||+||+|.+++. ..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5799999999999999999976532 468999876543 3334568899999999999999999999999999999
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.++++.+.+.... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc----ccccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999988765443 4599999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCC---ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 177 TDDP---VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 177 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
.... ......||+.|+|||++.++.++.++||||||+++|||++|..|+...... .... .. ... ..
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~---~~-i~~-----~~ 230 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVM---KA-IND-----GF 230 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH---HH-HHT-----TC
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHH---HH-Hhc-----cC
Confidence 3221 122345788999999999999999999999999999999966554322211 1111 11 111 11
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDR 300 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~ 300 (315)
.+ ..+...+..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 231 ~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 RL----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CC----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CC----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11 12223445688999999999999999999999999877553
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=348.08 Aligned_cols=253 Identities=19% Similarity=0.226 Sum_probs=202.2
Q ss_pred HhcCCcccc-eecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHh-hcCCCCccceeeeEEe----cCe
Q 046121 21 ATGDFSKEN-LLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLN-FARHKNIVMLLGFCCK----ENL 93 (315)
Q Consensus 21 ~~~~y~~~~-~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~----~~~ 93 (315)
+.++|+++. .||+|+||+||+|.+. +++.||+|++... ....+|+.++. ..+||||+++++++.+ +..
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 346898875 6999999999999875 7899999998643 45678998865 5589999999999875 467
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC---CCceeECCCC
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFG 170 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~---~~~i~l~dfg 170 (315)
+|+||||+.||+|.+++.+.....+++.++..++.|++.|+.|||+. |++||||||+||+++. .+.++|+|||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~----~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc----CCccccccccccccccccccccccccccc
Confidence 89999999999999999876667899999999999999999999999 9999999999999975 5679999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccc-hhHHHhHHHHHhhhcc
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQ-QSLRQWAEPLIEKLAL 249 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 249 (315)
++....... ......|++.|+|||++.+..++.++|||||||++|+|++|.+||...+.... ..... .
T Consensus 160 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~-------~--- 228 (335)
T d2ozaa1 160 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------R--- 228 (335)
T ss_dssp TCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------C---
T ss_pred eeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH-------H---
Confidence 997554433 33456799999999999999999999999999999999999999975443211 00000 0
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.......+........+..+.+|+.+||+.||++|||+.+++++
T Consensus 229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000111111223446678999999999999999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=341.79 Aligned_cols=251 Identities=25% Similarity=0.325 Sum_probs=199.3
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEe-cCeeEEEEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK-ENLNILVYEY 100 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~~~ 100 (315)
.++|++.+.||+|+||.||+|.++ +..||+|+++.. ...+.+.+|+.++++++||||+++++++.+ .+.+++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 357899999999999999999985 678999998653 345778999999999999999999998854 5668999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+++|+|.+++.......+++..++.++.||+.|+.|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--- 155 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 155 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC----ceeccccchHhheecCCCCEeecccccceecCC---
Confidence 9999999999766666799999999999999999999999 999999999999999999999999999974332
Q ss_pred ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccC
Q 046121 181 VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIEN 259 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (315)
......+++.|+|||++.++.++.++||||||+++|||++ |.+||....... .... ... ...+.
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~----i~~-----~~~~~--- 220 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEK-----GYKMD--- 220 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----HTT-----TCCCC---
T ss_pred CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHc-----CCCCC---
Confidence 2233467889999999998899999999999999999998 678776443221 1111 111 11122
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 260 SYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 260 ~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
.+...+..+.+|+.+||+.||++|||+.++++.|+.++
T Consensus 221 -~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 221 -APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 22233456789999999999999999999999998774
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.8e-51 Score=342.13 Aligned_cols=259 Identities=22% Similarity=0.300 Sum_probs=201.2
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHHHHHHHHhhcCCCCccceeeeEEecC----
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN---- 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 92 (315)
+.++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 3578999999999999999999875 79999999987543 333456889999999999999999999987654
Q ss_pred eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcc
Q 046121 93 LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLA 172 (315)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~ 172 (315)
.+|+||||++|++|.+.+... ..+++.++..++.|++.|+.|||+. |++||||||+||+++.++.++++|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~----~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhC----CccCccccCcccccCccccceeehhhhh
Confidence 379999999999998877543 4599999999999999999999999 9999999999999999999999999988
Q ss_pred cccCCCCC---ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhcc
Q 046121 173 RWKTTDDP---VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLAL 249 (315)
Q Consensus 173 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (315)
........ ......|++.|+|||++.+..++.++|||||||++|+|++|.+||...+.. .. ........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~----~~~~~~~~-- 230 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SV----AYQHVRED-- 230 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH----HHHHHHCC--
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--HH----HHHHHhcC--
Confidence 64333221 223457899999999999999999999999999999999999999644321 11 11111111
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhccc
Q 046121 250 HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRP-SMGEVVRLLEGEN 298 (315)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-s~~~il~~L~~~~ 298 (315)
+..........+..+.+++.+||++||++|| |++++++.|.++.
T Consensus 231 -----~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 231 -----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -----CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0111111222345678899999999999999 8999999887764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-51 Score=351.22 Aligned_cols=247 Identities=19% Similarity=0.205 Sum_probs=205.5
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (315)
++|++++.||+|+||+||+|.++ +++.||+|++... .....+.+.+|+.+++.++||||+++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999875 7999999987643 2344567889999999999999999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCC
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTD 178 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~ 178 (315)
+|+.|++|...+.+. ..+++..+..++.||+.||.|||+. +++||||||+||+++.+|.++|+|||++......
T Consensus 121 e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~----~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999998888544 3599999999999999999999999 9999999999999999999999999999754432
Q ss_pred CCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCccc
Q 046121 179 DPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIE 258 (315)
Q Consensus 179 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (315)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...+.. .... ..... ...
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~----~i~~~-------~~~-- 256 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYE----KIVSG-------KVR-- 256 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HHHHC-------CCC--
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH--HHHH----HHhcC-------CCC--
Confidence 23467999999999999999999999999999999999999999643321 1111 11111 011
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHh
Q 046121 259 NSYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLE 295 (315)
Q Consensus 259 ~~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~ 295 (315)
.+...+..+.+++.+||..||++|+ |+++++++-+
T Consensus 257 --~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred --CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcc
Confidence 1223344578999999999999994 8999998644
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=346.64 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=205.1
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
+.++|++++.||+|+||+||+|.+. +++.||+|++...... ...+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4578999999999999999999876 6889999998765432 3457899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC--CceeECCCCcccccCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD--FVPMLGDFGLARWKTT 177 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~--~~i~l~dfg~~~~~~~ 177 (315)
|+.|++|.+.+... ...+++.++..++.|++.|+.|||+. |++||||||+||+++.+ +.++++|||++.....
T Consensus 82 ~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~----~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc----CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999988543 23589999999999999999999999 99999999999999854 5899999999975433
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
. .......+++.|+|||...+..++.++|||||||++|+|++|..||...+... . ....... . ..+...
T Consensus 157 ~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--~----~~~i~~~-~--~~~~~~- 225 (321)
T d1tkia_ 157 G-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--I----IENIMNA-E--YTFDEE- 225 (321)
T ss_dssp T-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H----HHHHHHT-C--CCCCHH-
T ss_pred C-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH--H----HHHHHhC-C--CCCChh-
Confidence 2 33344578999999999999999999999999999999999999996543211 1 1111110 0 000100
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.....+..+.+|+.+||..||++|||+.|++++
T Consensus 226 ---~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 ---AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---hccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011124457899999999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-51 Score=348.18 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=203.2
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc---CcccHHHHHHHHHHH-hhcCCCCccceeeeEEecCeeEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA---STQGFAEFQSEVYVL-NFARHKNIVMLLGFCCKENLNILV 97 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~---~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~lv 97 (315)
++|++++.||+|+||+||+|.+. +++.||+|++.+. .......+..|..++ +.++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999876 6999999998643 233445566666665 468999999999999999999999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTT 177 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~ 177 (315)
|||+.||+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||+++.+++++|+|||++.....
T Consensus 82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~----~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999988543 4589999999999999999999999 999999999999999999999999999976555
Q ss_pred CCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 178 DDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 178 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. .... ..... .+.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~----~i~~~-------~~~- 221 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFH----SIRMD-------NPF- 221 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HHHHC-------CCC-
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHH----HHHcC-------CCC-
Confidence 555555578999999999999999999999999999999999999999654321 1111 11100 111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMG-EVVR 292 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~-~il~ 292 (315)
++...+..+.+|+.+||..||++|||+. ++++
T Consensus 222 ---~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 ---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2223345588999999999999999996 6764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=339.37 Aligned_cols=256 Identities=21% Similarity=0.281 Sum_probs=196.1
Q ss_pred hcCCcccceecCCCceEEEEEEeCC----CcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKD----GQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
.++|++.+.||+|+||+||+|.+.. +..|++|.+.... ....+.+.+|+.+++.++||||+++++++. ++.+++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4689999999999999999997642 3467888776433 334566889999999999999999999986 467899
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
||||+.+++|.+++... ...+++..++.++.|++.|+.|||+. +++||||||+||+++.++.++++|||++....
T Consensus 85 v~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhccc----CeeccccchhheeecCCCcEEEccchhheecc
Confidence 99999999998876543 34589999999999999999999999 99999999999999999999999999997544
Q ss_pred CCCC-ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 177 TDDP-VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 177 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
.... ......||+.|+|||++.+..++.++||||||+++|+|++ |.+||....... .... . .... .
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~----i-~~~~-----~ 227 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGR----I-ENGE-----R 227 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH----H-HTTC-----C
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHH----H-HcCC-----C
Confidence 3322 2234567899999999999999999999999999999998 889987554321 1111 1 1111 1
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
+ ..++..+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 228 ~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 228 L----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 1223344568899999999999999999999999987754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-50 Score=337.44 Aligned_cols=252 Identities=21% Similarity=0.214 Sum_probs=204.1
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc---------cHHHHHHHHHHHhhcC-CCCccceeeeEEe
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ---------GFAEFQSEVYVLNFAR-HKNIVMLLGFCCK 90 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---------~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 90 (315)
.++|++.+.||+|+||+||+|++. +++.+|+|++...... ..+.+.+|+.+++.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999875 7899999997754321 1235778999999997 9999999999999
Q ss_pred cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCC
Q 046121 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
++.+|+||||++|++|.+++.. ...+++..+..++.||+.|+.|||+. |++||||||+||+++.++.++|+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHc----CCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999964 34699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCcccccc------CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHH
Q 046121 171 LARWKTTDDPVQTKILGTLGYLAPEYAEN------GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLI 244 (315)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (315)
++....... ......|++.|.|||.+.+ ..++.++||||+||++|+|++|..||....... .. ....
T Consensus 156 ~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--~~----~~i~ 228 (277)
T d1phka_ 156 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--ML----RMIM 228 (277)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHH
T ss_pred heeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--HH----HHHH
Confidence 998655433 3344678999999998753 346789999999999999999999997543211 11 1111
Q ss_pred hhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 245 EKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.. . ...........+..+.+|+.+||++||++|||+++++++
T Consensus 229 ~~-~------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 SG-N------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HT-C------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hC-C------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11 0 011111223345568899999999999999999999765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=342.76 Aligned_cols=270 Identities=23% Similarity=0.268 Sum_probs=206.1
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
++|++++.||+|+||+||+|.+. +++.||+|++.... ......+.+|+++++.++||||+++++++.++..+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999875 68999999986443 2335678899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.++ +...+.......+++..+..++.|++.|+.|||++ +++||||||+||+++.++.++++|||.+.......
T Consensus 82 ~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~----~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC----CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 98654 44455555566799999999999999999999999 99999999999999999999999999998666555
Q ss_pred CccccccccccccCccccccCC-CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh--hhcccc-----
Q 046121 180 PVQTKILGTLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE--KLALHE----- 251 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~----- 251 (315)
.......|++.|+|||.+.... ++.++|+||+||++|+|++|..||...+.. ..+......... ......
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHHHHHhcCCCchhhcccccccc
Confidence 5555678999999999876655 578999999999999999999999644321 111111100000 000000
Q ss_pred ccCCccc---CC----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--Hhcccc
Q 046121 252 LIDPRIE---NS----YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL--LEGEND 299 (315)
Q Consensus 252 ~~~~~~~---~~----~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~--L~~~~~ 299 (315)
....... .. .....+..+.+|+.+||+.||++|||+.|++++ ++.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 0000000 00 111234567899999999999999999999986 544443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7e-50 Score=347.54 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=200.3
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC---cccHHHHH---HHHHHHhhcCCCCccceeeeEEecCeeE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS---TQGFAEFQ---SEVYVLNFARHKNIVMLLGFCCKENLNI 95 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~---~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (315)
++|+++++||+|+||+||+|.+. +++.||+|++.... ......+. +++.+++.++||||+++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999876 69999999976432 11222233 4467777888999999999999999999
Q ss_pred EEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccccc
Q 046121 96 LVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWK 175 (315)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~ 175 (315)
+||||+.|++|.+++.+. ..+++..+..++.|++.||.|||+. +++||||||+||+++.+|.++|+|||++...
T Consensus 84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~----~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHC----CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999988543 4588999999999999999999999 9999999999999999999999999999755
Q ss_pred CCCCCccccccccccccCccccc-cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccC
Q 046121 176 TTDDPVQTKILGTLGYLAPEYAE-NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELID 254 (315)
Q Consensus 176 ~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (315)
.... .....||+.|+|||++. +..++.++|||||||++|+|++|..||............. ... ...
T Consensus 158 ~~~~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~-------~~~---~~~ 225 (364)
T d1omwa3 158 SKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-------MTL---TMA 225 (364)
T ss_dssp SSSC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-------HSS---SCC
T ss_pred CCCc--ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hcc---cCC
Confidence 4332 33457999999999986 4568999999999999999999999997654332211110 000 001
Q ss_pred CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHHh
Q 046121 255 PRIENSYDTYELYLMAKTAYLCVQRNPEGRPS-----MGEVVRLLE 295 (315)
Q Consensus 255 ~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps-----~~~il~~L~ 295 (315)
...+...+..+.+||.+||+.||++||| +++++++-+
T Consensus 226 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 226 ----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp ----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 1112223445789999999999999999 789987644
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=341.50 Aligned_cols=261 Identities=24% Similarity=0.260 Sum_probs=198.1
Q ss_pred cccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc-----cHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 26 SKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ-----GFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 26 ~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
+.+++||+|+||+||+|.+. +++.||+|++...... ....+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 35689999999999999875 6999999987644322 23457899999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
|+.++++.... .....+++..+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 81 FMETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CCSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hhcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcc----ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 99888776655 3445689999999999999999999999 99999999999999999999999999997655544
Q ss_pred CccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccc---cc---
Q 046121 180 PVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH---EL--- 252 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--- 252 (315)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...... ..+..... ........ ..
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~l~~i~~-~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFE-TLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-HHCCCCTTTSSSTTSS
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--HHHHHHHH-hcCCCChhhccchhcc
Confidence 44455678999999998864 45789999999999999999999999654321 11111111 11000000 00
Q ss_pred ---cC-CcccCC----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 253 ---ID-PRIENS----YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 253 ---~~-~~~~~~----~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
.. ...... ..+..+..+.+|+.+||+.||++|||++|++++-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 00 000000 01123456889999999999999999999998643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-50 Score=341.46 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=200.5
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCc----EEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQ----MIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~----~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (315)
++|+++++||+|+||+||+|.+. +++ +||+|.+... .....+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 57999999999999999999865 343 5788876543 344567789999999999999999999999865 4678
Q ss_pred EEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccC
Q 046121 97 VYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKT 176 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~ 176 (315)
+++++.+++|.+.+... ...+++..++.++.|++.|+.|||++ +++||||||+||+++.++.++|+|||++....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~----~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc----CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 88999999998877554 45699999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCc--cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhcccccc
Q 046121 177 TDDPV--QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELI 253 (315)
Q Consensus 177 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (315)
..... .....||+.|+|||++.++.++.++||||||+++|||+| |.+||....... .... .... .
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~----i~~~-----~ 230 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKG-----E 230 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHH----HHHT-----C
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcC-----C
Confidence 43322 223457899999999999999999999999999999998 788886544322 1111 1111 0
Q ss_pred CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 254 DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
.+ ..+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 231 ~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 231 RL----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 11 1122344568899999999999999999999999887654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=335.89 Aligned_cols=255 Identities=23% Similarity=0.286 Sum_probs=194.5
Q ss_pred hcCCcccceecCCCceEEEEEEeC--C--CcEEEEEEeccc---CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK--D--GQMIAAKVRKEA---STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~--~--~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
.++|++.+.||+|+||+||+|+.. + ...||+|++... .....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 367999999999999999999753 2 236888987643 33445678999999999999999999999965 467
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
++||||+.++++.+.+... ...+++..+..++.|++.|+.|||++ +++||||||+||+++.++.++|+|||++..
T Consensus 86 ~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhC----CEeeeeecHHHhccccccceeeccchhhhh
Confidence 8999999999998877543 34599999999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCCc---cccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccchhHHHhHHHHHhhhccc
Q 046121 175 KTTDDPV---QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250 (315)
Q Consensus 175 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (315)
....... .....++..|+|||++.+..++.++||||||+++|||++ |..||...+... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~~~---- 230 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKE---- 230 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTS----
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHHHHhC----
Confidence 5443322 123456789999999999999999999999999999998 899996443221 11111111
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
...+ ..+...+..+.+|+.+||+.||++|||+.+|.+.|++.
T Consensus 231 -~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 -GERL----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -CCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCC----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111 12223345688999999999999999999999998764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.2e-50 Score=337.60 Aligned_cols=262 Identities=21% Similarity=0.239 Sum_probs=201.6
Q ss_pred cCCcccceecCCCceEEEEEEeCCCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYEY 100 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 100 (315)
++|+++++||+|+||+||+|.+++++.||+|++.... ....+.+.+|+.+++.++||||+++++.+...+..++++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999999999999986543 33356789999999999999999999999999999999999
Q ss_pred ccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC
Q 046121 101 ICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP 180 (315)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~ 180 (315)
+.++.+.... .....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++++|||.+........
T Consensus 82 ~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhccC----cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 8777666555 3346699999999999999999999999 999999999999999999999999999976555444
Q ss_pred ccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhc---------c-
Q 046121 181 VQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA---------L- 249 (315)
Q Consensus 181 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~- 249 (315)
......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.. ..+.+.... ..... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i~~~-~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRI-LGTPNSKNWPNVTELP 232 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHH-HCCCCTTTSTTGGGST
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHHHHHHHh-hCCCChhhccchhhhh
Confidence 4455678899999998865 45689999999999999999999999644321 111111110 00000 0
Q ss_pred -----ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 250 -----HELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 250 -----~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.....+..........+..+.+|+.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001111111223345568899999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-49 Score=338.47 Aligned_cols=257 Identities=24% Similarity=0.338 Sum_probs=205.7
Q ss_pred hcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccCc-ccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAST-QGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
.++|++.+.||+|+||+||+|++. +++.||+|++..... .....+.+|+.+++.++||||+++++++...+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 468999999999999999999764 357899998875433 3345689999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccCC----------------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCc
Q 046121 95 ILVYEYICNKSLHWHLFDNT----------------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMR 152 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~----------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~ 152 (315)
+++++|+.+++|.+++.... ...+++..++.++.|++.|+.|||+. +++|||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~----~ivHrDlK 167 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLA 167 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCS
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC----CeEeeEEc
Confidence 99999999999999885432 23488999999999999999999999 99999999
Q ss_pred cCcEEEcCCCceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCC-CccCCCC
Q 046121 153 PSNILLTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR-KVVDMNG 229 (315)
Q Consensus 153 p~nil~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~-~p~~~~~ 229 (315)
|+||+++.++.+||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|||++|. +||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999864433221 223456788999999999999999999999999999999986 5665433
Q ss_pred CccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 230 EEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
... .. .. ..... .+... ...+..+.+|+.+||+.||++|||+.+|++.|+++.
T Consensus 248 ~~e--~~----~~-v~~~~-----~~~~p----~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEE--VI----YY-VRDGN-----ILACP----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHH--HH----HH-HHTTC-----CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHH--HH----HH-HHcCC-----CCCCC----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 211 11 11 11111 11122 223345788999999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=335.50 Aligned_cols=257 Identities=26% Similarity=0.353 Sum_probs=202.4
Q ss_pred hcCCcccceecCCCceEEEEEEeCC--------CcEEEEEEecccCc-ccHHHHHHHHHHHhhc-CCCCccceeeeEEec
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKD--------GQMIAAKVRKEAST-QGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKE 91 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 91 (315)
.++|++.+.||+|+||.||+|+..+ +..||+|++..... .....+.+|...+.++ +||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4689999999999999999997532 24789998875443 3346678888888888 799999999999999
Q ss_pred CeeEEEEEeccCCccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEE
Q 046121 92 NLNILVYEYICNKSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNIL 157 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil 157 (315)
+..++||||+++|+|.+++.... ...+++.+++.++.|++.|+.|||+. +++||||||+||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~----~ivHrDiKp~NiL 167 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVL 167 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC----CEEeeeeccccee
Confidence 99999999999999999986443 34689999999999999999999999 9999999999999
Q ss_pred EcCCCceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh-CCCccCCCCCccch
Q 046121 158 LTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS-GRKVVDMNGEEPQQ 234 (315)
Q Consensus 158 ~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~ 234 (315)
++.++.++|+|||++........ ......+++.|+|||.+.++.++.++||||||+++|+|++ |.+||......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--- 244 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 244 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence 99999999999999875433222 2234568899999999999999999999999999999998 68888644321
Q ss_pred hHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 235 SLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
... ...... ..+. .+...+..+.+|+.+||+.||++|||+.++++.|+++.
T Consensus 245 ~~~----~~i~~~-----~~~~----~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 ELF----KLLKEG-----HRMD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHH----HHHHTT-----CCCC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH----HHHHcC-----CCCC----CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 111 111111 1111 22233456889999999999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=337.31 Aligned_cols=260 Identities=26% Similarity=0.333 Sum_probs=203.2
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCc--EEEEEEeccc-CcccHHHHHHHHHHHhhc-CCCCccceeeeEEecCeeEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQ--MIAAKVRKEA-STQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKENLNIL 96 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~--~~~~k~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 96 (315)
.++|++.++||+|+||+||+|.++ ++. .|++|.+... .....+.+.+|+.+++.+ +||||+++++++.+.+.+++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 368999999999999999999865 444 4566765433 334456789999999998 79999999999999999999
Q ss_pred EEEeccCCccccccccC--------------CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC
Q 046121 97 VYEYICNKSLHWHLFDN--------------TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF 162 (315)
Q Consensus 97 v~~~~~~~~L~~~l~~~--------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~ 162 (315)
||||+++|+|.+++... ....+++..+..++.|++.|+.|+|+. +++||||||+||+++.++
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~----~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGG
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC----CccccccccceEEEcCCC
Confidence 99999999999998654 345699999999999999999999999 999999999999999999
Q ss_pred ceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCC-CccCCCCCccchhHHHhHH
Q 046121 163 VPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR-KVVDMNGEEPQQSLRQWAE 241 (315)
Q Consensus 163 ~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~ 241 (315)
.++|+|||++...... .......|+..|+|||.+.++.++.++||||||+++|+|++|. +||...+.. .....
T Consensus 165 ~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~~~--- 238 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEK--- 238 (309)
T ss_dssp CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH---
T ss_pred ceEEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--HHHHH---
Confidence 9999999999633322 2223446889999999999999999999999999999999975 566433211 11110
Q ss_pred HHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 242 PLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
... ...+ ..+...+..+.+|+.+||+.||++|||++++++.|+.+....+
T Consensus 239 --i~~-----~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 239 --LPQ-----GYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp --GGG-----TCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred --HHh-----cCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 001 1111 1222344568899999999999999999999999988765443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-49 Score=333.10 Aligned_cols=273 Identities=24% Similarity=0.333 Sum_probs=203.0
Q ss_pred hcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEecC----eeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN----LNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv 97 (315)
.++|.+.+.||+|+||+||+|+. +|+.||+|++...... ......|+..++.++||||+++++++...+ .+++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 56899999999999999999987 4789999988654221 122344566667789999999999997654 57999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhccc----CCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC----RGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~----~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
|||+++|+|.+++.+. .+++...+.++.+++.++.++|+.+ ++.+++||||||+||+++.++.+||+|||++.
T Consensus 80 ~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 9999999999999653 5889999999999999999999732 12389999999999999999999999999997
Q ss_pred ccCCCCC----ccccccccccccCccccccCC------CcccccchhhhHHHHHHHhCCCccCCCCCccchhHH----Hh
Q 046121 174 WKTTDDP----VQTKILGTLGYLAPEYAENGI------VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLR----QW 239 (315)
Q Consensus 174 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~------~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~----~~ 239 (315)
....... ......||+.|+|||++.+.. ++.++|||||||++|||++|..|+............ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 5544332 223467899999999987643 567899999999999999999887543322110000 00
Q ss_pred HHHHHhhhccccccCCcccCCC-CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 240 AEPLIEKLALHELIDPRIENSY-DTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
..............+|.+.... +......+.+|+.+||+.||++|||+.++++.|+.+.+
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0011111122223333333222 33456678999999999999999999999999987754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-49 Score=333.96 Aligned_cols=258 Identities=26% Similarity=0.365 Sum_probs=194.0
Q ss_pred HhcCCcccceecCCCceEEEEEEeC------CCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CCCCccceeeeEEec-
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RHKNIVMLLGFCCKE- 91 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~- 91 (315)
..++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|...+.++ +|+||+.+++++...
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3478999999999999999999753 34689999876533 33345567777777766 588999999987654
Q ss_pred CeeEEEEEeccCCccccccccCC--------------CCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEE
Q 046121 92 NLNILVYEYICNKSLHWHLFDNT--------------ESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNIL 157 (315)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil 157 (315)
..+++||||+++|+|.+++.... ...+++..+..++.|++.|+.|||++ +++||||||+||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~----~ivHrDlKp~NIL 166 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNIL 166 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC----CCcCCcCCcccee
Confidence 56899999999999999886532 24589999999999999999999999 9999999999999
Q ss_pred EcCCCceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCC-CccCCCCCccch
Q 046121 158 LTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR-KVVDMNGEEPQQ 234 (315)
Q Consensus 158 ~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~-~p~~~~~~~~~~ 234 (315)
++.++.+||+|||++........ ......||+.|+|||++.++.++.++|||||||++|+|++|. +||...... .
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~ 244 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E 244 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--H
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--H
Confidence 99999999999999975433322 223457899999999999999999999999999999999864 677543322 1
Q ss_pred hHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 046121 235 SLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGE 297 (315)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~ 297 (315)
.... ...... .+.. +...+..+.+++.+||+.||++|||+.+++++|+.+
T Consensus 245 ~~~~----~~~~~~-----~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 245 EFCR----RLKEGT-----RMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHH----HHHHTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH----HHhcCC-----CCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111 111111 1111 222344578899999999999999999999999876
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=333.95 Aligned_cols=244 Identities=21% Similarity=0.286 Sum_probs=196.1
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcc------cHHHHHHHHHHHhhcC--CCCccceeeeEEec
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQ------GFAEFQSEVYVLNFAR--HKNIVMLLGFCCKE 91 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~------~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~ 91 (315)
+.++|++.+.||+|+||+||+|.+. +++.||+|++...... ....+.+|+.+++.++ ||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 3579999999999999999999875 6899999987643211 1233568999999987 89999999999999
Q ss_pred CeeEEEEEeccC-CccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCC-CceeECCC
Q 046121 92 NLNILVYEYICN-KSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHD-FVPMLGDF 169 (315)
Q Consensus 92 ~~~~lv~~~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~-~~i~l~df 169 (315)
+..++|||++.+ +++.+.+.. ...+++..+..++.|++.|+.|||++ +++||||||+||+++.+ +.++|+||
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CeEEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCccccCcccceEEecCCCeEEECcc
Confidence 999999999976 566666643 34599999999999999999999999 99999999999999854 79999999
Q ss_pred CcccccCCCCCccccccccccccCccccccCCC-cccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhc
Q 046121 170 GLARWKTTDDPVQTKILGTLGYLAPEYAENGIV-SIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLA 248 (315)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (315)
|++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .....
T Consensus 156 G~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~-- 219 (273)
T d1xwsa_ 156 GSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRG-- 219 (273)
T ss_dssp TTCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHC--
T ss_pred ccceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhc--
Confidence 99974332 22345679999999999887665 677999999999999999999995321 01110
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 249 LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
. .. ++...+..+.+++.+||+.||++|||++|++++-+
T Consensus 220 -~----~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 220 -Q----VF----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp -C----CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred -c----cC----CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 0 01 11123345789999999999999999999998644
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=332.23 Aligned_cols=272 Identities=28% Similarity=0.403 Sum_probs=213.0
Q ss_pred CCCCcccHHH-HHHHhcCCcccceecCCCceEEEEEEe------CCCcEEEEEEecccC-cccHHHHHHHHHHHhhc-CC
Q 046121 8 KDPMKFSFSE-IQQATGDFSKENLLGEGGFGHVYKGEL------KDGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFA-RH 78 (315)
Q Consensus 8 ~~~~~~~~~~-~~~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~ 78 (315)
.||.+++... -+.-.++|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+.+++.+ +|
T Consensus 7 ~~~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~H 86 (311)
T d1t46a_ 7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86 (311)
T ss_dssp CCTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCC
T ss_pred eCcccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCC
Confidence 3555555443 111247999999999999999999975 246789999987543 33445688999999998 69
Q ss_pred CCccceeeeEEecCeeEEEEEeccCCccccccccCC----------------CCccCHHHHHHHHHHHHHHHHhhhcccC
Q 046121 79 KNIVMLLGFCCKENLNILVYEYICNKSLHWHLFDNT----------------ESVLEWHQRYAAAIGTAKGLRFLHEECR 142 (315)
Q Consensus 79 ~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~ 142 (315)
|||+++++++.+....++||||+++++|.+++.... ...+++..+..++.|++.|+.|||++
T Consensus 87 pnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~-- 164 (311)
T d1t46a_ 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-- 164 (311)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred CCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 999999999999999999999999999999886533 23689999999999999999999999
Q ss_pred CCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHh
Q 046121 143 GGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMS 220 (315)
Q Consensus 143 ~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 220 (315)
+++||||||+||+++.++.++++|||.+........ ......|++.|+|||.+.++.++.++||||||+++|+|++
T Consensus 165 --~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt 242 (311)
T d1t46a_ 165 --NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242 (311)
T ss_dssp --TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred --CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHh
Confidence 999999999999999999999999999975443322 2233578999999999999999999999999999999998
Q ss_pred -CCCccCCCCCccchhHHHhHHHHHhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 221 -GRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 221 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
|.+|+....... ..... ... ...+ ..+...+..+.+|+.+||+.||++|||+.++++.|+++.
T Consensus 243 ~g~p~~~~~~~~~--~~~~~----i~~-----~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 243 LGSSPYPGMPVDS--KFYKM----IKE-----GFRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp TTCCSSTTCCSSH--HHHHH----HHH-----TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHH--HHHHH----Hhc-----CCCC----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 556664433221 11111 111 1111 122233456889999999999999999999999998753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-48 Score=327.79 Aligned_cols=256 Identities=23% Similarity=0.342 Sum_probs=200.5
Q ss_pred cceecCCCceEEEEEEeCC----CcEEEEEEecc-cCcccHHHHHHHHHHHhhcCCCCccceeeeEEe-cCeeEEEEEec
Q 046121 28 ENLLGEGGFGHVYKGELKD----GQMIAAKVRKE-ASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK-ENLNILVYEYI 101 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~----~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~~~~ 101 (315)
.++||+|+||+||+|.+.. ...||+|.+.. ......+.+.+|+.++++++||||+++++++.. ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5689999999999997643 23588898764 345556779999999999999999999999865 56889999999
Q ss_pred cCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCCCc
Q 046121 102 CNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDDPV 181 (315)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~~~ 181 (315)
++++|.+++... ....++..++.++.|++.|+.|+|+. +++||||||+||+++.++.++|+|||++.........
T Consensus 112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~----~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhccc----CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999877543 44577888999999999999999999 9999999999999999999999999999754433222
Q ss_pred ----cccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccccccCCcc
Q 046121 182 ----QTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALHELIDPRI 257 (315)
Q Consensus 182 ----~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (315)
.....|++.|+|||.+.+..++.++||||||+++|||++|..||....... .. ..... ... .+.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~----~~~i~-~g~-----~~~- 254 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DI----TVYLL-QGR-----RLL- 254 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------C----HHHHH-TTC-----CCC-
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HH----HHHHH-cCC-----CCC-
Confidence 223467899999999999999999999999999999999877765332111 11 11111 110 111
Q ss_pred cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccccccc
Q 046121 258 ENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFHH 303 (315)
Q Consensus 258 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~~ 303 (315)
.+...+..+.+|+.+||+.||++|||+.|+++.|+.+...+..
T Consensus 255 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 255 ---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ---CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 1222345688999999999999999999999999998776443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=330.49 Aligned_cols=265 Identities=23% Similarity=0.276 Sum_probs=198.1
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-C-CcEEEEEEecccC--cccHHHHHHHHHHHhhc---CCCCccceeeeEEe---
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-D-GQMIAAKVRKEAS--TQGFAEFQSEVYVLNFA---RHKNIVMLLGFCCK--- 90 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~--- 90 (315)
..++|++++.||+|+||+||+|.+. + ++.||+|++.... ........+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3579999999999999999999874 4 6678999876432 22233466777776655 79999999999853
Q ss_pred --cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECC
Q 046121 91 --ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGD 168 (315)
Q Consensus 91 --~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~d 168 (315)
....++++|++.++++... .......+++..+..++.|++.||.|||+. +++||||||+|||++..+.++++|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~----~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHH-HHSCTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhh-hhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEEecCCCccEEEEcCCCCeeecc
Confidence 3567999999988776433 334556699999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhh--
Q 046121 169 FGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK-- 246 (315)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 246 (315)
||++.... .........||+.|+|||++.+..++.++||||+||++|+|++|.+||...+.. ..+..........
T Consensus 160 fg~~~~~~-~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYS-FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCC-GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCG
T ss_pred hhhhhhhc-ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCch
Confidence 99986332 223334568999999999999999999999999999999999999999654321 1111111110000
Q ss_pred hccc----------cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 247 LALH----------ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 247 ~~~~----------~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
.... ....+..........+..+.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0000001111222345567899999999999999999999886
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=326.32 Aligned_cols=258 Identities=24% Similarity=0.343 Sum_probs=206.7
Q ss_pred hcCCcccceecCCCceEEEEEEeC------CCcEEEEEEeccc-CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCee
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK------DGQMIAAKVRKEA-STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLN 94 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (315)
.++|++.+.||+|+||+||+|.+. ++..||+|++... .......+.+|+.++++++||||+++++++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 479999999999999999999764 3578999988754 333345678999999999999999999999999999
Q ss_pred EEEEEeccCCccccccccC--------CCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeE
Q 046121 95 ILVYEYICNKSLHWHLFDN--------TESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPML 166 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l 166 (315)
++||||+.+|+|.+++... ....++...+..++.|++.|+.|||+. +++||||||+||+++.++.++|
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~----~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTCCEEE
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeeceEcCCceeecCCceEEE
Confidence 9999999999999887542 224578899999999999999999999 9999999999999999999999
Q ss_pred CCCCcccccCCCCC--ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCC-CccCCCCCccchhHHHhHHHH
Q 046121 167 GDFGLARWKTTDDP--VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGR-KVVDMNGEEPQQSLRQWAEPL 243 (315)
Q Consensus 167 ~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~ 243 (315)
+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++|. +||...+.. ......
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~~~~~i 248 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFV 248 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HHHHHH
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------HHHHHH
Confidence 99999974433222 123346789999999999999999999999999999999985 677543211 111111
Q ss_pred HhhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccc
Q 046121 244 IEKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEND 299 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~ 299 (315)
. ... .+ ..+...+..+.+++.+||+.||++|||++++++.|+....
T Consensus 249 ~-~~~-----~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 M-EGG-----LL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp H-TTC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H-hCC-----CC----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 111 11 1122334568899999999999999999999999988744
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=324.59 Aligned_cols=266 Identities=21% Similarity=0.256 Sum_probs=196.7
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEe--------
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCK-------- 90 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------- 90 (315)
.++|+++++||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++.++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 479999999999999999999875 7999999987543 33445678899999999999999999998754
Q ss_pred cCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCC
Q 046121 91 ENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFG 170 (315)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg 170 (315)
...+++|||++.++++.... .....+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++++|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~----~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccC----CEEecCcCchheeecCCCcEEeeecc
Confidence 45679999999777765443 3445689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC----ccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh
Q 046121 171 LARWKTTDDP----VQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE 245 (315)
Q Consensus 171 ~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (315)
++........ ......||+.|+|||++.+. .++.++||||+||++|+|++|..||....... .... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~--~~~~-i~~~~~ 239 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--QLAL-ISQLCG 239 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH--HHHH-HHHhcC
Confidence 9965442221 12235689999999998765 57899999999999999999999996433211 1111 111110
Q ss_pred hhc---cccc--------cC--CcccCCCCH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 246 KLA---LHEL--------ID--PRIENSYDT-----YELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 246 ~~~---~~~~--------~~--~~~~~~~~~-----~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
... .... .. ......... .....+.+|+.+||+.||++|||++|++++-+-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff 308 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence 000 0000 00 000000000 013356789999999999999999999988653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=327.63 Aligned_cols=266 Identities=20% Similarity=0.189 Sum_probs=195.1
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC-cccHHHHHHHHHHHhhcCCCCccceeeeEEecC----ee
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS-TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN----LN 94 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~ 94 (315)
+.++|+++++||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 3468999999999999999999865 79999999987543 344567889999999999999999999986543 23
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccc
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARW 174 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~ 174 (315)
+++++++.+++|.+++.. ..+++..+..++.|++.||.|||++ ||+||||||+||+++.++.++|+|||++..
T Consensus 86 ~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~----~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 455566789999998854 3599999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCC---ccccccccccccCccccc-cCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH-----HHH-
Q 046121 175 KTTDDP---VQTKILGTLGYLAPEYAE-NGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE-----PLI- 244 (315)
Q Consensus 175 ~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~- 244 (315)
...... ......|++.|+|||++. +..++.++||||+||++|+|++|..||................ ...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 433221 234467899999999884 4567889999999999999999999996543211111000000 000
Q ss_pred ------hhhcccccc--CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 245 ------EKLALHELI--DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 245 ------~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
......... .+.......+..+..+.+|+.+||+.||++|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 0000000111223457899999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-47 Score=327.37 Aligned_cols=263 Identities=23% Similarity=0.278 Sum_probs=195.3
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecC-----
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKEN----- 92 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 92 (315)
+.++|+++++||+|+||+||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4579999999999999999999875 6999999998753 3344567889999999999999999999997654
Q ss_pred -eeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCc
Q 046121 93 -LNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGL 171 (315)
Q Consensus 93 -~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~ 171 (315)
.+|+||||+ +.+|..... ...+++..+..++.|++.||.|||++ |++||||||+||+++.++.++++|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~----~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhC----CCcccccCcchhhcccccccccccccc
Confidence 469999998 666766653 34599999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH-------H
Q 046121 172 ARWKTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP-------L 243 (315)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~ 243 (315)
+...... .....|++.|+|||++.+ ..++.++||||+||++|+|++|.+||...+... .+...... .
T Consensus 168 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHH
T ss_pred eeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH--HHHHHHhccCCCcHHH
Confidence 9744332 234578999999998876 456889999999999999999999996543211 11110000 0
Q ss_pred H----------hhhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--Hhcc
Q 046121 244 I----------EKLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL--LEGE 297 (315)
Q Consensus 244 ~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~--L~~~ 297 (315)
. ............+ .......+..+.+|+.+||..||++|||+.+++++ ++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0 0000001111111 11122334567899999999999999999999986 4443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=319.23 Aligned_cols=264 Identities=20% Similarity=0.206 Sum_probs=205.4
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEecCeeEEEEE
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCKENLNILVYE 99 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 99 (315)
++|++++.||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++......++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999875 7899999997643 33446778999999999999999999999999999999999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCcccccCCCC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLARWKTTDD 179 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~~~~~~~ 179 (315)
++.++++...+. ....+++..+..++.|++.|+.|||++ +++||||||+||+++.++.++++|||.+.......
T Consensus 82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~----~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcC----CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999998877664 345688999999999999999999999 99999999999999999999999999998665555
Q ss_pred CccccccccccccCccccccCC-CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhh--cc---cc--
Q 046121 180 PVQTKILGTLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKL--AL---HE-- 251 (315)
Q Consensus 180 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~---~~-- 251 (315)
.......+++.|.|||.+.+.. ++.++||||+||++|+|++|..||....... .............. .. ..
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH-HHHHHHHhhcCCCChhhhhhhhhcc
Confidence 4444556788899999887655 6889999999999999999998875333211 11111111100000 00 00
Q ss_pred -------ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 252 -------LIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 252 -------~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
..............+..+.+|+.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000011111223345567899999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-47 Score=327.83 Aligned_cols=259 Identities=21% Similarity=0.258 Sum_probs=194.1
Q ss_pred CCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCccceeeeEEe------cCeeEE
Q 046121 24 DFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIVMLLGFCCK------ENLNIL 96 (315)
Q Consensus 24 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~l 96 (315)
+|+.+++||+|+||+||+|.+. +++.||+|++..... ...+|+.+++.++||||+++++++.. ..++++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 7999999999999999999876 699999999875432 23479999999999999999999854 335789
Q ss_pred EEEeccCCccccccc-cCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC-ceeECCCCcccc
Q 046121 97 VYEYICNKSLHWHLF-DNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF-VPMLGDFGLARW 174 (315)
Q Consensus 97 v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~-~i~l~dfg~~~~ 174 (315)
||||+.++.+..... ......+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~----~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc----CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 999997664433322 13455699999999999999999999999 999999999999999775 899999999975
Q ss_pred cCCCCCccccccccccccCcccccc-CCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHH-------HHhh
Q 046121 175 KTTDDPVQTKILGTLGYLAPEYAEN-GIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEP-------LIEK 246 (315)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~ 246 (315)
..... ......|++.|+|||.+.+ ..++.++||||+||++|+|++|..||....... .+...... ....
T Consensus 173 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHH
T ss_pred ccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhhh
Confidence 44332 3344578999999998765 568999999999999999999999996543211 11111100 0000
Q ss_pred -------hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 046121 247 -------LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRL 293 (315)
Q Consensus 247 -------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~ 293 (315)
...................+..+.+|+.+||..||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000001111111223345568899999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-46 Score=321.39 Aligned_cols=261 Identities=17% Similarity=0.230 Sum_probs=198.9
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeeeEEe--cCeeEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCK--ENLNILV 97 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv 97 (315)
.++|+++++||+|+||+||+|++. +++.||+|++... ..+.+.+|+.+++.++ ||||+++++++.. ...+++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 468999999999999999999875 7999999998653 3467889999999995 9999999999874 4568999
Q ss_pred EEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCC-ceeECCCCcccccC
Q 046121 98 YEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDF-VPMLGDFGLARWKT 176 (315)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~-~i~l~dfg~~~~~~ 176 (315)
|||+.+++|.... ..+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++++|||++....
T Consensus 111 ~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~----gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 111 FEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc----ccccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999987653 3599999999999999999999999 999999999999998755 69999999997544
Q ss_pred CCCCccccccccccccCccccccC-CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHh--H-----HHHHhhhc
Q 046121 177 TDDPVQTKILGTLGYLAPEYAENG-IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQW--A-----EPLIEKLA 248 (315)
Q Consensus 177 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~-----~~~~~~~~ 248 (315)
... ......+|+.|+|||.+.+. .++.++||||+||++|+|++|..||.............. . ........
T Consensus 182 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 182 PGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 332 33456789999999987764 478999999999999999999999975543322111100 0 00000000
Q ss_pred c------cccc--------CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 046121 249 L------HELI--------DPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLE 295 (315)
Q Consensus 249 ~------~~~~--------~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~ 295 (315)
. .... ............+..+.+||.+||..||++|||++|++++-+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0 0000 000111122223556889999999999999999999988543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-45 Score=311.52 Aligned_cols=265 Identities=17% Similarity=0.189 Sum_probs=206.8
Q ss_pred HhcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCC-CCccceeeeEEecCeeEEEE
Q 046121 21 ATGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARH-KNIVMLLGFCCKENLNILVY 98 (315)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~ 98 (315)
+.++|++++.||+|+||+||+|++. +++.||+|+...... ...+.+|++.++.++| ++++.+++++......++||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 3579999999999999999999876 689999998765432 3457789999999975 89999999999999999999
Q ss_pred EeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC-----CCceeECCCCccc
Q 046121 99 EYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH-----DFVPMLGDFGLAR 173 (315)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~-----~~~i~l~dfg~~~ 173 (315)
|++ +++|.+.+... ...++...+..++.|++.++.+||++ |++||||||+||+++. ++.++++|||++.
T Consensus 81 e~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~----giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 81 DLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHC----CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 997 78888877543 34699999999999999999999999 9999999999999974 5789999999997
Q ss_pred ccCCCCC-------ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhh
Q 046121 174 WKTTDDP-------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEK 246 (315)
Q Consensus 174 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (315)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 5433211 122357999999999999999999999999999999999999999755443322211111111111
Q ss_pred hccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccccccc
Q 046121 247 LALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGENDRFH 302 (315)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~~~~~ 302 (315)
.. .+.+.... +..+.+++..|+..+|++||+++.+.+.|+.+..+..
T Consensus 235 ~~-----~~~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 235 TP-----LRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp SC-----HHHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CC-----hHHhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 00 01111222 2347788888999999999999999888887655443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-45 Score=313.43 Aligned_cols=259 Identities=17% Similarity=0.197 Sum_probs=194.9
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCcc-ceeeeEEecCeeEEEEE
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV-MLLGFCCKENLNILVYE 99 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~~ 99 (315)
.++|++++.||+|+||+||+|.+. +++.||+|+...... ...+..|+++++.++|++++ .+..+..+....++||+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 468999999999999999999875 689999998765432 34678899999999877655 55566677888899999
Q ss_pred eccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcC---CCceeECCCCcccccC
Q 046121 100 YICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTH---DFVPMLGDFGLARWKT 176 (315)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~---~~~i~l~dfg~~~~~~ 176 (315)
|+ ++++.+.+.. ....+++..+..++.|++.|+.|||++ |++||||||+||+++. +..++++|||++....
T Consensus 84 ~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred Ec-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 97 5566555433 345699999999999999999999999 9999999999999854 5579999999997554
Q ss_pred CCCC-------ccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHH-HhHHHHHhhhc
Q 046121 177 TDDP-------VQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLR-QWAEPLIEKLA 248 (315)
Q Consensus 177 ~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 248 (315)
.... ......||+.|+|||.+.+..++.++|||||||++|+|++|..||............ ....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~- 235 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-ST- 235 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-HS-
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-CC-
Confidence 3221 123457899999999999999999999999999999999999999754433221111 1111000 00
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 046121 249 LHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEGEN 298 (315)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~~~ 298 (315)
..+..... .+..+.+++..||+.||++||++.++.+.|+.+.
T Consensus 236 ----~~~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 236 ----PIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp ----CHHHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred ----ChhHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 00111111 2344778899999999999999999988877653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=319.83 Aligned_cols=262 Identities=20% Similarity=0.193 Sum_probs=192.6
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEeccc--CcccHHHHHHHHHHHhhcCCCCccceeeeEEe------cCe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA--STQGFAEFQSEVYVLNFARHKNIVMLLGFCCK------ENL 93 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~ 93 (315)
++|+++++||+|+||+||+|.+. +++.||+|++... +......+.+|+.+++.++||||+++++++.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999876 6999999998754 23445568899999999999999999999853 468
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
+|+||||+.++.+.. + ...+++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++++|||++.
T Consensus 97 ~~iv~Ey~~~~l~~~-~----~~~~~~~~i~~~~~qil~gl~~LH~~----giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-I----QMELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHH-H----TSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHh-h----hcCCCHHHHHHHHHHHHHHHHHhhhc----ccccccCCccccccccccceeeechhhhh
Confidence 899999997765543 3 24589999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHH------------
Q 046121 174 WKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAE------------ 241 (315)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 241 (315)
..... .......+|+.|+|||++.+..++.++||||+||++++|++|.+||...+.... ......
T Consensus 168 ~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~--~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHTT
T ss_pred ccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH--HHHHHHhccCCCHHHHHH
Confidence 44332 233445789999999999999999999999999999999999999964432111 110000
Q ss_pred ------HHHhhh-cc-----ccccCCcccCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 046121 242 ------PLIEKL-AL-----HELIDPRIENS---YDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLLEG 296 (315)
Q Consensus 242 ------~~~~~~-~~-----~~~~~~~~~~~---~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L~~ 296 (315)
...... .. ........... .....+..+.+|+.+||..||++|||++|++++-+-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~ 314 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 000000 00 00000111111 122346678999999999999999999999987543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=319.18 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=201.2
Q ss_pred cCCcccceecCCCceEEEEEEeC----CCcEEEEEEecccC----cccHHHHHHHHHHHhhcCC-CCccceeeeEEecCe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK----DGQMIAAKVRKEAS----TQGFAEFQSEVYVLNFARH-KNIVMLLGFCCKENL 93 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~ 93 (315)
++|++++.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999752 47899999876432 2345667899999999976 899999999999999
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.++++||+.+++|.+.+... ..+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.++|+|||++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcC----CEEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999988544 3478899999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCC-CccccccccccccCccccccC--CCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHhhhccc
Q 046121 174 WKTTDD-PVQTKILGTLGYLAPEYAENG--IVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIEKLALH 250 (315)
Q Consensus 174 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (315)
...... .......|++.|+|||.+.+. .++.++|||||||++|+|++|..||...+...... .........
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~i~~~~~~~---- 251 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKS---- 251 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHC----
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcccC----
Confidence 543322 223346789999999988754 36779999999999999999999997654433211 111111100
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHHh
Q 046121 251 ELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRP-----SMGEVVRLLE 295 (315)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp-----s~~~il~~L~ 295 (315)
....+...+..+.+++.+||++||++|| |++|++++-+
T Consensus 252 -------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 252 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred -------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 1112223455688899999999999999 4889987544
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=317.15 Aligned_cols=260 Identities=20% Similarity=0.226 Sum_probs=193.7
Q ss_pred hcCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccC--cccHHHHHHHHHHHhhcCCCCccceeeeEEec-----Ce
Q 046121 22 TGDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEAS--TQGFAEFQSEVYVLNFARHKNIVMLLGFCCKE-----NL 93 (315)
Q Consensus 22 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 93 (315)
.++|++++.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.+++.++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999875 79999999987543 33455688999999999999999999998543 33
Q ss_pred eEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 94 NILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.+++++++.|++|.+++. ...+++..+..++.|++.||.|||++ |++||||||+||+++.++.++++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~~----giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHhC----CCcccccCCccccccccccccccccchhc
Confidence 466677888999999884 34599999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCCCccccccccccccCccccccCC-CcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhHHHHHh-------
Q 046121 174 WKTTDDPVQTKILGTLGYLAPEYAENGI-VSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWAEPLIE------- 245 (315)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 245 (315)
... .......|++.|+|||...+.. ++.++|||||||++|+|++|.+||........ ..........
T Consensus 170 ~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~--~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHHHHT
T ss_pred ccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCChHHhh
Confidence 332 2334467889999999876654 68899999999999999999999965432111 1100000000
Q ss_pred ----------hhccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 046121 246 ----------KLALHELIDPRIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGEVVRLL 294 (315)
Q Consensus 246 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~il~~L 294 (315)
...........+. ......+..+.+||.+||..||++|||++|++++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp 302 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCH
Confidence 0000000000000 00112344578999999999999999999999853
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-40 Score=285.63 Aligned_cols=264 Identities=17% Similarity=0.189 Sum_probs=191.4
Q ss_pred cCCcccceecCCCceEEEEEEeC-CCcEEEEEEecccCcccHHHHHHHHHHHhhcC-----------CCCccceeeeEEe
Q 046121 23 GDFSKENLLGEGGFGHVYKGELK-DGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-----------HKNIVMLLGFCCK 90 (315)
Q Consensus 23 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~~ 90 (315)
++|+++++||+|+||+||+|++. +++.||+|++.... ...+...+|+.+++.+. |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 57999999999999999999875 79999999987543 23456788888888775 5789999988754
Q ss_pred --cCeeEEEEEeccCCcc-ccccccCCCCccCHHHHHHHHHHHHHHHHhhhc-ccCCCCeEeecCccCcEEEcCCC----
Q 046121 91 --ENLNILVYEYICNKSL-HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHE-ECRGGPIIHRDMRPSNILLTHDF---- 162 (315)
Q Consensus 91 --~~~~~lv~~~~~~~~L-~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~~~i~h~di~p~nil~~~~~---- 162 (315)
....++++.+...+.. ...........+++..+..++.|++.|+.+||+ . ||+||||||+||+++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~----~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC----GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT----CEECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc----CcccccCChhHeeeeccCcccc
Confidence 3455666666544433 333344566779999999999999999999998 6 899999999999998765
Q ss_pred --ceeECCCCcccccCCCCCccccccccccccCccccccCCCcccccchhhhHHHHHHHhCCCccCCCCCccchhHHHhH
Q 046121 163 --VPMLGDFGLARWKTTDDPVQTKILGTLGYLAPEYAENGIVSIRTDVYAFGIILLQLMSGRKVVDMNGEEPQQSLRQWA 240 (315)
Q Consensus 163 --~i~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 240 (315)
.++++|||.+..... ......|++.|+|||++.+..++.++|+||+||++++|++|..||...............
T Consensus 168 ~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 389999999874332 224457899999999999989999999999999999999999999644322111111000
Q ss_pred HHHHh-----------h----------hccccccCC----------cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 046121 241 EPLIE-----------K----------LALHELIDP----------RIENSYDTYELYLMAKTAYLCVQRNPEGRPSMGE 289 (315)
Q Consensus 241 ~~~~~-----------~----------~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~~~l~~~p~~Rps~~~ 289 (315)
..... . ......... ..........+..+.+|+.+||..||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 00000 0 000000000 0012234567788999999999999999999999
Q ss_pred HHHHH
Q 046121 290 VVRLL 294 (315)
Q Consensus 290 il~~L 294 (315)
++++-
T Consensus 325 ~L~Hp 329 (362)
T d1q8ya_ 325 LVNHP 329 (362)
T ss_dssp HHTCG
T ss_pred HhcCc
Confidence 99863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.6e-23 Score=164.87 Aligned_cols=167 Identities=16% Similarity=0.076 Sum_probs=117.6
Q ss_pred CcccceecCCCceEEEEEEeCCCcEEEEEEecccCc------------------ccHHHHHHHHHHHhhcCCCCccceee
Q 046121 25 FSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEAST------------------QGFAEFQSEVYVLNFARHKNIVMLLG 86 (315)
Q Consensus 25 y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~------------------~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (315)
+.+.++||+|+||+||+|.+.+|+.||+|++..... ........|...+..+.+++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 457889999999999999988899999998653211 01122456888899999999888776
Q ss_pred eEEecCeeEEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeE
Q 046121 87 FCCKENLNILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPML 166 (315)
Q Consensus 87 ~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l 166 (315)
+. ..+++|+++.+..+.. ++......++.|++.++.+||+. |++|+||||+||+++.++ +++
T Consensus 82 ~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~----giiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEETTE-EEE
T ss_pred ec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC----CEEEccCChhheeeeCCC-EEE
Confidence 53 2379999998876543 33344567889999999999999 999999999999999764 889
Q ss_pred CCCCcccccCCCCCccccccc-cccccCccccccCCCcccccchhhhH
Q 046121 167 GDFGLARWKTTDDPVQTKILG-TLGYLAPEYAENGIVSIRTDVYAFGI 213 (315)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~-~~~~~aPE~~~~~~~~~~~DvwslG~ 213 (315)
+|||.+........ ..... +.. ...+.+ .+.|+.++|+||+.-
T Consensus 144 iDFG~a~~~~~~~~--~~~l~rd~~-~~~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 144 IDFPQSVEVGEEGW--REILERDVR-NIITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp CCCTTCEETTSTTH--HHHHHHHHH-HHHHHH-HHHHCCCCCHHHHHH
T ss_pred EECCCcccCCCCCc--HHHHHHHHH-HHHHHH-cCCCCCcccHHHHHH
Confidence 99999864332221 11000 000 000111 355788999999743
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.88 E-value=9.2e-09 Score=83.33 Aligned_cols=150 Identities=14% Similarity=0.057 Sum_probs=103.3
Q ss_pred HHHHHHhcCCcccceecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcC-CCCccceeeeEEecCee
Q 046121 16 SEIQQATGDFSKENLLGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFAR-HKNIVMLLGFCCKENLN 94 (315)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 94 (315)
.++......|++.+..+-++.+.||+.... ++.+++|............+.+|...++.+. +=.+..++.+...++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 355666678988887666667889988654 5556777766554444556788888888775 33367778888888899
Q ss_pred EEEEEeccCCccccccccCCCCccCHHHHHHHHHHHHHHHHhhhccc---------------------------------
Q 046121 95 ILVYEYICNKSLHWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC--------------------------------- 141 (315)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--------------------------------- 141 (315)
++||++++|.++.+..... .....++.++...+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998886544211 112223445555566666431
Q ss_pred ----------------------CCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 142 ----------------------RGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 142 ----------------------~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
....++|+|+.|.||+++.++.+.++||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01237899999999999987777799998774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.37 E-value=4.3e-06 Score=66.70 Aligned_cols=131 Identities=16% Similarity=0.112 Sum_probs=88.3
Q ss_pred eecCCCc-eEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCC--CccceeeeEEecCeeEEEEEeccCCcc
Q 046121 30 LLGEGGF-GHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHK--NIVMLLGFCCKENLNILVYEYICNKSL 106 (315)
Q Consensus 30 ~lg~g~~-~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (315)
.+..|.. +.||+....++..+++|...... ...+..|...++.+... .+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455554 67899988888888888765433 23467788877766432 356777777888888999999998877
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHHHHHhhhccc---------------------------------------------
Q 046121 107 HWHLFDNTESVLEWHQRYAAAIGTAKGLRFLHEEC--------------------------------------------- 141 (315)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--------------------------------------------- 141 (315)
.+.. ..... .+.++...+..||+..
T Consensus 94 ~~~~-------~~~~~---~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSH-------LAPAE---KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSC-------CCHHH---HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cccc-------ccHHH---HHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 5422 12111 2234444455555320
Q ss_pred ---------CCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 142 ---------RGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 142 ---------~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
....++|+|+.|.||+++.+..+-++||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 01237999999999999987777899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.78 E-value=0.00014 Score=61.71 Aligned_cols=77 Identities=10% Similarity=0.057 Sum_probs=48.9
Q ss_pred cceecCCCceEEEEEEeC-CCcEEEEEEeccc-------CcccHHHHHHHHHHHhhcC--CCC-ccceeeeEEecCeeEE
Q 046121 28 ENLLGEGGFGHVYKGELK-DGQMIAAKVRKEA-------STQGFAEFQSEVYVLNFAR--HKN-IVMLLGFCCKENLNIL 96 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~-~~~~~~~k~~~~~-------~~~~~~~~~~e~~~l~~l~--~~~-i~~~~~~~~~~~~~~l 96 (315)
.+.||.|....||++.+. +++.+++|.-... -+...++...|+..++.+. .|. +++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999865 4677888853221 1223455667888887664 233 4444433 4555688
Q ss_pred EEEeccCCcc
Q 046121 97 VYEYICNKSL 106 (315)
Q Consensus 97 v~~~~~~~~L 106 (315)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999877554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.64 E-value=0.00088 Score=54.66 Aligned_cols=159 Identities=9% Similarity=-0.033 Sum_probs=85.9
Q ss_pred cccHHHHHHHhcCCcccce-----ecCCCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCC-----CCc
Q 046121 12 KFSFSEIQQATGDFSKENL-----LGEGGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARH-----KNI 81 (315)
Q Consensus 12 ~~~~~~~~~~~~~y~~~~~-----lg~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-----~~i 81 (315)
.++.+++..+..+|-+.+. |..|...+.|+....+++ +++|++.... ..+.+..|+..+..+.. |..
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 4677888898899988654 446777889999877665 7888875431 22344555666655542 222
Q ss_pred ccee---eeEEecCeeEEEEEeccCCcccccccc-----------------C---C-CC------------------ccC
Q 046121 82 VMLL---GFCCKENLNILVYEYICNKSLHWHLFD-----------------N---T-ES------------------VLE 119 (315)
Q Consensus 82 ~~~~---~~~~~~~~~~lv~~~~~~~~L~~~l~~-----------------~---~-~~------------------~~~ 119 (315)
+... .+.........++.+..|......-.. . . .. ...
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 2111 122334555666776666544321100 0 0 00 000
Q ss_pred HHHHHHHHHHHHHHHHhhhcccCCCCeEeecCccCcEEEcCCCceeECCCCccc
Q 046121 120 WHQRYAAAIGTAKGLRFLHEECRGGPIIHRDMRPSNILLTHDFVPMLGDFGLAR 173 (315)
Q Consensus 120 ~~~~~~~~~~l~~~l~~lh~~~~~~~i~h~di~p~nil~~~~~~i~l~dfg~~~ 173 (315)
.......+......+.......-..|++|+|+.++||+++.+...-++||+.++
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 001111122222223333322223489999999999999998877899999885
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.40 E-value=0.0011 Score=54.38 Aligned_cols=72 Identities=8% Similarity=0.044 Sum_probs=47.7
Q ss_pred CCceEEEEEEeCCCcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCcc--cee-----eeEEecCeeEEEEEeccCCcc
Q 046121 34 GGFGHVYKGELKDGQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNIV--MLL-----GFCCKENLNILVYEYICNKSL 106 (315)
Q Consensus 34 g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~--~~~-----~~~~~~~~~~lv~~~~~~~~L 106 (315)
+....||.+...+|..+++|+.... ..+.+.+..|...+..+...++. ..+ ..+...+..+.+++++.|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 3346899999888999999987643 23456677888888776532221 111 223456677889999877655
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.38 E-value=0.00053 Score=57.99 Aligned_cols=74 Identities=14% Similarity=0.185 Sum_probs=51.6
Q ss_pred cceecCCCceEEEEEEeCC--------CcEEEEEEecccCcccHHHHHHHHHHHhhcCCCCc-cceeeeEEecCeeEEEE
Q 046121 28 ENLLGEGGFGHVYKGELKD--------GQMIAAKVRKEASTQGFAEFQSEVYVLNFARHKNI-VMLLGFCCKENLNILVY 98 (315)
Q Consensus 28 ~~~lg~g~~~~v~~~~~~~--------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~ 98 (315)
++.|+.|-.-.+|++...+ ...+++++... . .......+|..+++.+...++ +++++++.. +.|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4678899999999997543 35678887663 2 233456789999988864454 466666532 6889
Q ss_pred EeccCCccc
Q 046121 99 EYICNKSLH 107 (315)
Q Consensus 99 ~~~~~~~L~ 107 (315)
+|++|.++.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999887664
|